Citrus Sinensis ID: 013238
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 447 | 2.2.26 [Sep-21-2011] | |||||||
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.991 | 0.720 | 0.869 | 0.0 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.997 | 0.719 | 0.802 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.991 | 0.708 | 0.815 | 0.0 | |
| Q9XIC7 | 628 | Somatic embryogenesis rec | no | no | 0.991 | 0.705 | 0.810 | 0.0 | |
| Q8LPS5 | 601 | Somatic embryogenesis rec | no | no | 0.966 | 0.718 | 0.728 | 1e-179 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.979 | 0.721 | 0.593 | 1e-139 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.988 | 0.721 | 0.574 | 1e-136 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.975 | 0.686 | 0.522 | 1e-133 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.968 | 0.678 | 0.549 | 1e-132 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.803 | 0.568 | 0.609 | 1e-130 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/446 (86%), Positives = 412/446 (92%), Gaps = 3/446 (0%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAG 64
DLSNN LTGDIP NGSFSLFTPISFAN +L P SPPPP+ PTPP + N TGAIAG
Sbjct: 170 DLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAG 229
Query: 65 GVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
GVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNF
Sbjct: 230 GVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNF 289
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
SN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 290 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 349
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCD
Sbjct: 350 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 409
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 410 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 469
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++GN
Sbjct: 470 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 529
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH-T 423
Y +EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN+ T
Sbjct: 530 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPT 589
Query: 424 PHPN-NTWIV-DSTSHIQPDELSGPR 447
HP + WI+ DSTS I+ + SGPR
Sbjct: 590 HHPAVSGWIIGDSTSQIENEYPSGPR 615
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/450 (80%), Positives = 392/450 (87%), Gaps = 4/450 (0%)
Query: 1 MNCRDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATG 60
+ D+SNN+L+GDIP NGSFSLFTPISFANN L + P PP PTPP SG T
Sbjct: 172 LQVLDISNNRLSGDIPVNGSFSLFTPISFANNSLTDLPEPPPTSTSPTPP-PPSGGQMTA 230
Query: 61 AIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 120
AIAGGVAAGAALLFA PAIA A+W +RKP+DHFFDVPAEEDPEVHLGQLKRF+LREL VA
Sbjct: 231 AIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVA 290
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
TDNFSN+N+LGRGGFGKVYKGRL DG+LVAVKRLKEERT+GGELQFQTEVEMISMAVHRN
Sbjct: 291 TDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRN 350
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
LLRLRGFCMTPTERLLVYP+M NGSVASCLRER + P L+W RK IALG+ARGLAYLH
Sbjct: 351 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLH 410
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
DHCD KIIHRDVKAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLS
Sbjct: 411 DHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLS 470
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
TGKSSEKTDVFGYGVMLLELITGQ+AFDLARLANDDD+MLLDWVK +LKEKKLE LVD++
Sbjct: 471 TGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAE 530
Query: 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF 420
+EG Y+E EVEQLIQ+ALLCTQ S MERPKMSEVVRMLEGDGLAERWEEWQKEEM DF
Sbjct: 531 LEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDF 590
Query: 421 NHT--PHPNNTWIVD-STSHIQPDELSGPR 447
N+ PH W++ S S I+ D SGPR
Sbjct: 591 NYQAYPHAGTDWLIPYSNSLIENDYPSGPR 620
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 692 bits (1786), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/455 (81%), Positives = 402/455 (88%), Gaps = 12/455 (2%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANN-QLNNPPPS-----------PPPPLQPTPPGA 52
DLSNN+L+G +P NGSFSLFTPISFANN L P S PPP +QP P
Sbjct: 171 DLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVST 230
Query: 53 SSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRF 112
SG TGAIAGGVAAGAALLFAAPAIA A+WR+RKP D FFDVPAEEDPEVHLGQLKRF
Sbjct: 231 PSGYGITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRF 290
Query: 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM 172
SLRELQVA+D FSN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERT GGELQFQTEVEM
Sbjct: 291 SLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEM 350
Query: 173 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 232
ISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER SQPPL+W RK+IALG+
Sbjct: 351 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGS 410
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 292
ARGL+YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG
Sbjct: 411 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 470
Query: 293 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352
HIAPEYLSTGKSSEKTDVFGYG+MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK
Sbjct: 471 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 530
Query: 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQK 412
LE LVD D++ NY E E+EQ+IQVALLCTQGSPMERPKMSEVVRMLEGDGLAE+W+EWQK
Sbjct: 531 LEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQK 590
Query: 413 EEMFRQDFNHTPHPNNTWIVDSTSHIQPDELSGPR 447
E+ R++ + +P+PN+ WI+DST ++ ELSGPR
Sbjct: 591 VEILREEIDLSPNPNSDWILDSTYNLHAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 688 bits (1775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/455 (81%), Positives = 399/455 (87%), Gaps = 12/455 (2%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANN-QLNNPPPS-----------PPPPLQPTPPGA 52
DLSNN+L+G +P NGSFSLFTPISFANN L P S PPP + P
Sbjct: 174 DLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSPPFSPPPPFIPPPIVPT 233
Query: 53 SSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRF 112
G SATGAIAGGVAAGAALLFAAPA+A A+WR+RKP++ FFDVPAEEDPEVHLGQLKRF
Sbjct: 234 PGGYSATGAIAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRF 293
Query: 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM 172
SLRELQVATD+FSN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERT GGELQFQTEVEM
Sbjct: 294 SLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEM 353
Query: 173 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 232
ISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER SQ PL WS+R+QIALG+
Sbjct: 354 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIALGS 413
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 292
ARGL+YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA+LMDYKDTHVTTAVRGTIG
Sbjct: 414 ARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTIG 473
Query: 293 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352
HIAPEYLSTGKSSEKTDVFGYG+MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK
Sbjct: 474 HIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 533
Query: 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQK 412
LE LVD D++ NY E EVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAE+W+EWQK
Sbjct: 534 LEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAEKWDEWQK 593
Query: 413 EEMFRQDFNHTPHPNNTWIVDSTSHIQPDELSGPR 447
E+ RQ+ + HP + WI+DST ++ ELSGPR
Sbjct: 594 VEVLRQEVELSSHPTSDWILDSTDNLHAMELSGPR 628
|
Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 629 bits (1623), Expect = e-179, Method: Compositional matrix adjust.
Identities = 328/450 (72%), Positives = 365/450 (81%), Gaps = 18/450 (4%)
Query: 1 MNCRDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATG 60
++ D+SNN+L+GDIP NGSFS FT +SFANN+L + S + +
Sbjct: 167 LDVLDISNNRLSGDIPVNGSFSQFTSMSFANNKLR----------PRPASPSPSPSGTSA 216
Query: 61 AIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 120
AI GVAAGAALLFA +RK + HF DVPAEEDPEV+LGQ KRFSLREL VA
Sbjct: 217 AIVVGVAAGAALLFALAWWL-----RRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVA 271
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
T+ FS RN+LG+G FG +YKGRL D +LVAVKRL EERT+GGELQFQTEVEMISMAVHRN
Sbjct: 272 TEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRN 331
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
LLRLRGFCMTPTERLLVYP+M NGSVASCLRER + P L+W RK IALG+ARGLAYLH
Sbjct: 332 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLH 391
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
DHCD KIIH DVKAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLS
Sbjct: 392 DHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLS 451
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
TGKSSEKTDVFGYGVMLLELITGQ+AFDLARLANDDD+MLLDWVK +LKEKKLE LVD++
Sbjct: 452 TGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAE 511
Query: 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF 420
+EG Y+E EVEQLIQ+ALLCTQ S MERPKMSEVVRMLEGDGLAERWEEWQKEEM DF
Sbjct: 512 LEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDF 571
Query: 421 NHT--PHPNNTWIVD-STSHIQPDELSGPR 447
N+ PH W++ S S I+ D SGPR
Sbjct: 572 NYQAYPHAGTDWLIPYSNSLIENDYPSGPR 601
|
Serine/threonine-kinase of unknown function. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 496 bits (1276), Expect = e-139, Method: Compositional matrix adjust.
Identities = 264/445 (59%), Positives = 316/445 (71%), Gaps = 7/445 (1%)
Query: 6 LSNNKLTGDIPTNGSFSLFT--PISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIA 63
L +N L+G+IP SLF +F N L+ P P + + P S + TG IA
Sbjct: 167 LDSNNLSGEIPQ----SLFKIPKYNFTANNLSCGGTFPQPCVTESSPSGDSSSRKTGIIA 222
Query: 64 GGVAAGAALLFAAPAIALAYWR-KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATD 122
G V+ A +L + K D F DV E D + GQL+RF+ RELQ+ATD
Sbjct: 223 GVVSGIAVILLGFFFFFFCKDKHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWRELQLATD 282
Query: 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
FS +N+LG+GGFGKVYKG L+DG+ VAVKRL + GG+ FQ EVEMIS+AVHRNLL
Sbjct: 283 EFSEKNVLGQGGFGKVYKGLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISVAVHRNLL 342
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
RL GFC T TERLLVYPFM N SVA CLRE P L+W RKQIALGAARGL YLH+H
Sbjct: 343 RLIGFCTTQTERLLVYPFMQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARGLEYLHEH 402
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
C+PKIIHRDVKAAN+LLDE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPE +STG
Sbjct: 403 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPECISTG 462
Query: 303 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362
KSSEKTDVFGYG+MLLEL+TGQRA D +RL +DDV+LLD VK L +EK+LE +VD ++
Sbjct: 463 KSSEKTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLEDIVDKKLD 522
Query: 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH 422
+YI+EEVE +IQVALLCTQ +P ERP MSEVVRMLEG+GLAERWEEWQ E+ RQ+
Sbjct: 523 EDYIKEEVEMMIQVALLCTQAAPEERPAMSEVVRMLEGEGLAERWEEWQNLEVTRQEEFQ 582
Query: 423 TPHPNNTWIVDSTSHIQPDELSGPR 447
W DS ++ ELSG R
Sbjct: 583 RLQRRFDWGEDSINNQDAIELSGGR 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1247), Expect = e-136, Method: Compositional matrix adjust.
Identities = 267/465 (57%), Positives = 313/465 (67%), Gaps = 23/465 (4%)
Query: 6 LSNNKLTGDIPTN------------------GSF--SLFT--PISFANNQLNNPPPSPPP 43
LS NKL G IP + G SLF +F +N LN P P
Sbjct: 149 LSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNLNCGGRQPHP 208
Query: 44 PLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWR-KRKPEDHFFDVPAEEDP 102
+ S TG IAG VA +LF R K D F DV E D
Sbjct: 209 CVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDR 268
Query: 103 EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG 162
+ GQLKRF+ RELQ+ATDNFS +N+LG+GGFGKVYKG L D + VAVKRL + + GG
Sbjct: 269 RIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGG 328
Query: 163 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNW 222
+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYPFM N S+A LRE P L+W
Sbjct: 329 DAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDW 388
Query: 223 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282
RK+IALGAARG YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDFGLAKL+D + T+
Sbjct: 389 ETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTN 448
Query: 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 342
VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +RL +DDV+LLD
Sbjct: 449 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 508
Query: 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402
VK L +EK+L +VD +++G YI+EEVE +IQVALLCTQGSP +RP MSEVVRMLEG+G
Sbjct: 509 HVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEG 568
Query: 403 LAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDELSGPR 447
LAERWEEWQ E+ R+ W DS + ELSG R
Sbjct: 569 LAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1219), Expect = e-133, Method: Compositional matrix adjust.
Identities = 252/482 (52%), Positives = 327/482 (67%), Gaps = 46/482 (9%)
Query: 6 LSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP------------------------- 39
++NN LTG IP++ + + T + + N L+ P P
Sbjct: 160 VNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPTGTEKDCN 219
Query: 40 -SPPPPLQPTPPGASSGNSATG------AIAGGVAAGAALLFAAPAIALAYWRKR-KPED 91
+ P P+ T + + +S G A+ GV+ L L +WR+R +
Sbjct: 220 GTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWRRRHNKQV 279
Query: 92 HFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAV 151
FFD+ + E+ LG L+RF+ +ELQ AT NFS++N++G+GGFG VYKG L DGS++AV
Sbjct: 280 LFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAV 339
Query: 152 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 211
KRLK+ GGE+QFQTE+EMIS+AVHRNLLRL GFC T +ERLLVYP+M NGSVAS
Sbjct: 340 KRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVAS--- 396
Query: 212 ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271
R +++P L+W RK+IALGA RGL YLH+ CDPKIIHRDVKAANILLD+ FEAVVGDFG
Sbjct: 397 -RLKAKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFG 455
Query: 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 331
LAKL+D++++HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG RA + +
Sbjct: 456 LAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGK 515
Query: 332 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391
AN +LDWVK L +EKKLEQ+VD D++ NY EVE+++QVALLCTQ P+ RPKM
Sbjct: 516 AANQRGA-ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKM 574
Query: 392 SEVVRMLEGDGLAERWE-EWQKEEMFR-----QDFNHTPHPNNTWIVDSTSHIQPDELSG 445
SEVVRMLEGDGL E+WE Q+ E R +F+ + ++ DS+ +Q ELSG
Sbjct: 575 SEVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSD-LTDDSSVLVQAMELSG 633
Query: 446 PR 447
PR
Sbjct: 634 PR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1217), Expect = e-132, Method: Compositional matrix adjust.
Identities = 256/466 (54%), Positives = 326/466 (69%), Gaps = 33/466 (7%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP----PPLQP---------TPPG 51
DLS N L+G +P + S N L P + P L P P
Sbjct: 183 DLSYNNLSGPVPRFAA----KTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLY 238
Query: 52 ASSGNSATGAIAGGVAAG-AALLFAAPAIALAYWRKRKPEDHFFDVP-AEEDPEVHLGQL 109
A + AIA G + G +L+F A + L +WR+R ++ FFDV EV LG L
Sbjct: 239 AGGSRNHKMAIAVGSSVGTVSLIFIAVGLFL-WWRQRHNQNTFFDVKDGNHHEEVSLGNL 297
Query: 110 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTE 169
+RF RELQ+AT+NFS++N+LG+GG+G VYKG L D ++VAVKRLK+ GGE+QFQTE
Sbjct: 298 RRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTE 357
Query: 170 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 229
VEMIS+AVHRNLLRL GFC+T TE+LLVYP+M NGSVAS R +++P L+WS+RK+IA
Sbjct: 358 VEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVAS----RMKAKPVLDWSIRKRIA 413
Query: 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 289
+GAARGL YLH+ CDPKIIHRDVKAANILLD+ EAVVGDFGLAKL+D++D+HVTTAVRG
Sbjct: 414 IGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRG 473
Query: 290 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349
T+GHIAPEYLSTG+SSEKTDVFG+G++LLEL+TGQRAF+ + AN VM LDWVK + +
Sbjct: 474 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVM-LDWVKKIHQ 532
Query: 350 EKKLEQLVDSDM--EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 407
EKKLE LVD ++ + +Y E E++++++VALLCTQ P RPKMSEVVRMLEGDGLAE+W
Sbjct: 533 EKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKW 592
Query: 408 EEWQKEEMFRQDFNH------TPHPNNTWIVDSTSHIQPDELSGPR 447
E Q+ + + N + + DS+ +Q ELSGPR
Sbjct: 593 EASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLLVQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 467 bits (1201), Expect = e-130, Method: Compositional matrix adjust.
Identities = 231/379 (60%), Positives = 291/379 (76%), Gaps = 20/379 (5%)
Query: 83 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 142
+WR R+ + FFDV + DPEV LG LKR++ +EL+ AT++F+++NILGRGG+G VYKG
Sbjct: 260 WWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGH 319
Query: 143 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202
L DG+LVAVKRLK+ GGE+QFQTEVE IS+A+HRNLLRLRGFC + ER+LVYP+M
Sbjct: 320 LNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMP 379
Query: 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262
NGSVAS L++ + +P L+WS RK+IA+G ARGL YLH+ CDPKIIHRDVKAANILLDE+
Sbjct: 380 NGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDED 439
Query: 263 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELIT
Sbjct: 440 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 499
Query: 323 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQ 382
GQ+A D R A+ VM LDWVK L +E KL+QL+D D+ + E+E+++QVALLCTQ
Sbjct: 500 GQKALDFGRSAHQKGVM-LDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQ 558
Query: 383 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHP--------------NN 428
+P RPKMSEV++MLEGDGLAERWE Q H P P +
Sbjct: 559 FNPSHRPKMSEVMKMLEGDGLAERWEATQNGTG-----EHQPPPLPPGMVSSSPRVRYYS 613
Query: 429 TWIVDSTSHIQPDELSGPR 447
+I +S+ ++ ELSGPR
Sbjct: 614 DYIQESSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 447 | ||||||
| 333952414 | 620 | somatic embryogenesis receptor-like kina | 0.988 | 0.712 | 0.893 | 0.0 | |
| 255558673 | 611 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.991 | 0.725 | 0.923 | 0.0 | |
| 312283129 | 594 | unnamed protein product [Thellungiella h | 1.0 | 0.752 | 0.862 | 0.0 | |
| 327422167 | 620 | somatic embryogenesis receptor-like kina | 0.988 | 0.712 | 0.888 | 0.0 | |
| 397880702 | 632 | leucine-rich repeat receptor-like kinase | 1.0 | 0.707 | 0.857 | 0.0 | |
| 334187131 | 662 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.991 | 0.669 | 0.869 | 0.0 | |
| 18418211 | 615 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.991 | 0.720 | 0.869 | 0.0 | |
| 14573459 | 615 | somatic embryogenesis receptor-like kina | 0.991 | 0.720 | 0.869 | 0.0 | |
| 297798596 | 612 | bri1-associated receptor kinase [Arabido | 1.0 | 0.730 | 0.862 | 0.0 | |
| 356558614 | 616 | PREDICTED: BRASSINOSTEROID INSENSITIVE 1 | 0.991 | 0.719 | 0.880 | 0.0 |
| >gi|333952414|gb|AEG25668.1| somatic embryogenesis receptor-like kinase 3 protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/449 (89%), Positives = 417/449 (92%), Gaps = 7/449 (1%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAG 64
DLSNN L GD+P NGSFSLFTPISFANN+LNNPPP+PPPP P P A SG S+TGAIAG
Sbjct: 173 DLSNNGLVGDVPVNGSFSLFTPISFANNKLNNPPPAPPPP-IPPTPPAQSGISSTGAIAG 231
Query: 65 GVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
GVAAGAALLFAAPAI LA WRKRK DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF
Sbjct: 232 GVAAGAALLFAAPAIVLALWRKRKAPDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 291
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
SN+NILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 292 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 351
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYPFMVNGSVASCLRER +SQP L+W++RK+IALGAARGLAYLHDHCD
Sbjct: 352 RGFCMTPTERLLVYPFMVNGSVASCLRERSESQPALDWAIRKRIALGAARGLAYLHDHCD 411
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 412 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 471
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE+KLE LVDSD+ GN
Sbjct: 472 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKERKLETLVDSDLNGN 531
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTP 424
YI+EEVEQLIQVALLCTQG+PMERPKMSEVVRMLEGDGLAERWEEWQKEEM RQ+FN
Sbjct: 532 YIDEEVEQLIQVALLCTQGTPMERPKMSEVVRMLEGDGLAERWEEWQKEEMVRQEFNQAH 591
Query: 425 H-----PNNTWIV-DSTSHIQPDELSGPR 447
H PN WI+ DSTSHI PDELSGPR
Sbjct: 592 HYSHHQPNANWIIADSTSHIPPDELSGPR 620
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558673|ref|XP_002520361.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223540459|gb|EEF42027.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1939), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/443 (92%), Positives = 427/443 (96%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAG 64
DLSNNKLTGDIP NGSFSLFTPISF+NN LNNPPPSPPPPL P PG S+GNSATGAIAG
Sbjct: 169 DLSNNKLTGDIPVNGSFSLFTPISFSNNSLNNPPPSPPPPLTPPSPGPSNGNSATGAIAG 228
Query: 65 GVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
GVAAGAALLFAAPAIALAYWR+RKP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVATD+F
Sbjct: 229 GVAAGAALLFAAPAIALAYWRRRKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDSF 288
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
SN+NILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 289 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 348
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYPFMVNGSVASCLRER +SQ PLNW +RK+IALG+ARGLAYLHDHCD
Sbjct: 349 RGFCMTPTERLLVYPFMVNGSVASCLRERPESQTPLNWPIRKRIALGSARGLAYLHDHCD 408
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 409 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 468
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK+KKLE LVD+D++GN
Sbjct: 469 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKDKKLETLVDADLQGN 528
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTP 424
YI++EVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ+FNHT
Sbjct: 529 YIDDEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQEFNHTY 588
Query: 425 HPNNTWIVDSTSHIQPDELSGPR 447
HP+ WIVDSTSHI PDELSGPR
Sbjct: 589 HPSTNWIVDSTSHIPPDELSGPR 611
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312283129|dbj|BAJ34430.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/450 (86%), Positives = 414/450 (92%), Gaps = 3/450 (0%)
Query: 1 MNCRDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATG 60
+ DLSNN LTGDIP NGSFSLFTPISFAN +L P +PPPP+ PTPP + N TG
Sbjct: 145 LQVLDLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPAAPPPPISPTPPSPAGSNRITG 204
Query: 61 AIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 120
AIAGGVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA
Sbjct: 205 AIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 264
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
+DNFSNRNILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN
Sbjct: 265 SDNFSNRNILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 324
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
LLRLRGFCMTPTERLLVYP+M NGSVASCLRER +SQ PL+W R++IALG+ARGLAYLH
Sbjct: 325 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQQPLDWPKRQRIALGSARGLAYLH 384
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS
Sbjct: 385 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 444
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D
Sbjct: 445 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD 504
Query: 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF 420
++GNYI+EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF
Sbjct: 505 LQGNYIDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF 564
Query: 421 NHTPH--PNNTWIV-DSTSHIQPDELSGPR 447
N+ + PN +W++ DSTSHI+ + SGPR
Sbjct: 565 NYQNYNQPNTSWLIGDSTSHIENEYPSGPR 594
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|327422167|gb|AEA76434.1| somatic embryogenesis receptor-like kinase 2 protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1927), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/449 (88%), Positives = 415/449 (92%), Gaps = 7/449 (1%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAG 64
DLSNN L GD+P NGSFSLFTPISFANN+LNNPPP+PPPP P P A SG S+TGAIAG
Sbjct: 173 DLSNNGLIGDVPVNGSFSLFTPISFANNKLNNPPPAPPPP-IPPTPPAQSGISSTGAIAG 231
Query: 65 GVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
GVAAGAALLFAAPAI LA WRKRK DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF
Sbjct: 232 GVAAGAALLFAAPAIVLALWRKRKAPDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 291
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
SN+NILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 292 SNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 351
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYPFMVNGSVASCLRER + QP L+W++RK+IALGAARGLAYLHDHCD
Sbjct: 352 RGFCMTPTERLLVYPFMVNGSVASCLRERSEFQPALDWAIRKRIALGAARGLAYLHDHCD 411
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 412 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 471
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
SEKTDV GYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE+KLE LVDSD+ GN
Sbjct: 472 SEKTDVSGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKERKLETLVDSDLNGN 531
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTP 424
YI+EEVEQLIQVALLCTQG+PMERPKMSEVVRMLEGDGLAERWEEWQKEEM RQ+FN
Sbjct: 532 YIDEEVEQLIQVALLCTQGTPMERPKMSEVVRMLEGDGLAERWEEWQKEEMVRQEFNQAH 591
Query: 425 H-----PNNTWIV-DSTSHIQPDELSGPR 447
H PN WI+ DSTSHI PDELSGPR
Sbjct: 592 HYNHHQPNANWIIADSTSHIPPDELSGPR 620
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397880702|gb|AFO67895.1| leucine-rich repeat receptor-like kinase (mitochondrion) [Brassica rapa subsp. campestris] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/450 (85%), Positives = 412/450 (91%), Gaps = 3/450 (0%)
Query: 1 MNCRDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATG 60
+ DLSN +LTGDIP NGSFSLFTPISFAN L P SPPPP+ PTPP + N TG
Sbjct: 183 LQVLDLSNTRLTGDIPVNGSFSLFTPISFANTNLTPLPASPPPPISPTPPSPAGSNRITG 242
Query: 61 AIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 120
AIAGGVAAGAALLFA PAIALA WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA
Sbjct: 243 AIAGGVAAGAALLFAVPAIALALWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVA 302
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
+DNFSNRNILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRN
Sbjct: 303 SDNFSNRNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 362
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
LLRLRGFCMTPTERLLVYP+M NGSVASCLR+R +SQPPL+W R++IALG+ARGLAYLH
Sbjct: 363 LLRLRGFCMTPTERLLVYPYMANGSVASCLRDRPESQPPLDWPKRQRIALGSARGLAYLH 422
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
DHCDPKIIHRDVKAANILLDE+FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS
Sbjct: 423 DHCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 482
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D
Sbjct: 483 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD 542
Query: 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF 420
++GNYI+EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF
Sbjct: 543 LQGNYIDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDF 602
Query: 421 NHTPH--PNNTWIV-DSTSHIQPDELSGPR 447
++ + PN W++ DSTSHI+ D SGPR
Sbjct: 603 SYQNYNQPNTAWLIGDSTSHIENDYPSGPR 632
|
Source: Brassica rapa subsp. campestris Species: Brassica rapa Genus: Brassica Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334187131|ref|NP_001190904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] gi|332660824|gb|AEE86224.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/446 (86%), Positives = 412/446 (92%), Gaps = 3/446 (0%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAG 64
DLSNN LTGDIP NGSFSLFTPISFAN +L P SPPPP+ PTPP + N TGAIAG
Sbjct: 217 DLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAG 276
Query: 65 GVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
GVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNF
Sbjct: 277 GVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNF 336
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
SN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 337 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 396
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCD
Sbjct: 397 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 456
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 457 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 516
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++GN
Sbjct: 517 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 576
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH-T 423
Y +EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN+ T
Sbjct: 577 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPT 636
Query: 424 PHPNNT-WIV-DSTSHIQPDELSGPR 447
HP + WI+ DSTS I+ + SGPR
Sbjct: 637 HHPAVSGWIIGDSTSQIENEYPSGPR 662
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18418211|ref|NP_567920.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] gi|29427920|sp|Q94F62.2|BAK1_ARATH RecName: Full=BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1; Short=AtBAK1; Short=BRI1-associated receptor kinase 1; AltName: Full=Protein ELONGATED; AltName: Full=Somatic embryogenesis receptor kinase 3; Short=AtSERK3; AltName: Full=Somatic embryogenesis receptor-like kinase 3; Flags: Precursor gi|224589645|gb|ACN59355.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332660823|gb|AEE86223.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/446 (86%), Positives = 412/446 (92%), Gaps = 3/446 (0%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAG 64
DLSNN LTGDIP NGSFSLFTPISFAN +L P SPPPP+ PTPP + N TGAIAG
Sbjct: 170 DLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAG 229
Query: 65 GVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
GVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNF
Sbjct: 230 GVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNF 289
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
SN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 290 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 349
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCD
Sbjct: 350 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 409
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 410 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 469
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++GN
Sbjct: 470 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 529
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH-T 423
Y +EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN+ T
Sbjct: 530 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPT 589
Query: 424 PHPN-NTWIV-DSTSHIQPDELSGPR 447
HP + WI+ DSTS I+ + SGPR
Sbjct: 590 HHPAVSGWIIGDSTSQIENEYPSGPR 615
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14573459|gb|AAK68074.1|AF384970_1 somatic embryogenesis receptor-like kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/446 (86%), Positives = 412/446 (92%), Gaps = 3/446 (0%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAG 64
DLSNN LTGDIP NGSFSLFTPISFAN +L P SPPPP+ PTPP + N TGAIAG
Sbjct: 170 DLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAG 229
Query: 65 GVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
GVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNF
Sbjct: 230 GVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNF 289
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
SN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 290 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 349
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R++IALG+ARGLAYLHDHCD
Sbjct: 350 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 409
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 410 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 469
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD D++GN
Sbjct: 470 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 529
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH-T 423
Y +EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN+ T
Sbjct: 530 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPT 589
Query: 424 PHPN-NTWIV-DSTSHIQPDELSGPR 447
HP + WI+ DSTS I+ + SGPR
Sbjct: 590 HHPAVSGWIIGDSTSQIENEYPSGPR 615
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798596|ref|XP_002867182.1| bri1-associated receptor kinase [Arabidopsis lyrata subsp. lyrata] gi|297313018|gb|EFH43441.1| bri1-associated receptor kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/452 (86%), Positives = 414/452 (91%), Gaps = 5/452 (1%)
Query: 1 MNCRDLSNNKLTGDIPTNGSFSLFTP--ISFANNQLNNPPPSPPPPLQPTPPGASSGNSA 58
+ DLSNN LTGDIP NGSFSLFTP ISFAN +L P SPPPP+ PTPP + N
Sbjct: 161 LQVLDLSNNGLTGDIPVNGSFSLFTPGLISFANTKLTPLPASPPPPISPTPPSPAGSNRI 220
Query: 59 TGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQ 118
TGAIAGGVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQ
Sbjct: 221 TGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQ 280
Query: 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 178
VA+DNFSNRNILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQTEVEMISMAVH
Sbjct: 281 VASDNFSNRNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH 340
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
RNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R++IALG+ARGLAY
Sbjct: 341 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 400
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY
Sbjct: 401 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 460
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE LVD
Sbjct: 461 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 520
Query: 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 418
D++GNYI+EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ
Sbjct: 521 VDLQGNYIDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 580
Query: 419 DFNH-TPHPN-NTWIV-DSTSHIQPDELSGPR 447
DFN+ T HP + WI+ DSTS I+ + SGPR
Sbjct: 581 DFNYPTHHPAVSGWIIGDSTSQIENEYPSGPR 612
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558614|ref|XP_003547599.1| PREDICTED: BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/444 (88%), Positives = 413/444 (93%), Gaps = 1/444 (0%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAG 64
DLSNN L G+IP NGSFSLFTPIS+ NN P P P+ PTPP ASSGNS TGAIAG
Sbjct: 173 DLSNNHLKGEIPVNGSFSLFTPISYQNNLGLIQPKYTPSPVSPTPPPASSGNSNTGAIAG 232
Query: 65 GVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
GVAAGAALLFAAPAIALAYWR+RKP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF
Sbjct: 233 GVAAGAALLFAAPAIALAYWRRRKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 292
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
SN++ILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL
Sbjct: 293 SNKHILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 352
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL W RK+IALG+ARGLAYLHDHCD
Sbjct: 353 RGFCMTPTERLLVYPYMANGSVASCLRERQESQPPLGWPERKRIALGSARGLAYLHDHCD 412
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 413 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 472
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK++KLE LVD+D++G+
Sbjct: 473 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKDRKLETLVDADLQGS 532
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHT- 423
Y +EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE+WE+WQK+E FRQDFN+
Sbjct: 533 YNDEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWEQWQKDETFRQDFNNNI 592
Query: 424 PHPNNTWIVDSTSHIQPDELSGPR 447
HPN WIVDSTSHIQ DELSGPR
Sbjct: 593 HHPNANWIVDSTSHIQADELSGPR 616
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 447 | ||||||
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.816 | 0.584 | 0.830 | 9.6e-174 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.816 | 0.581 | 0.830 | 1.2e-173 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.988 | 0.712 | 0.719 | 1e-169 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.957 | 0.712 | 0.686 | 3.8e-157 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.796 | 0.580 | 0.650 | 3.6e-120 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.814 | 0.575 | 0.596 | 1.2e-117 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.805 | 0.564 | 0.598 | 2.9e-114 | |
| TAIR|locus:2160644 | 614 | AT5G63710 [Arabidopsis thalian | 0.782 | 0.570 | 0.572 | 1.7e-107 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.749 | 0.528 | 0.575 | 2.5e-102 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.664 | 0.458 | 0.639 | 4.1e-102 |
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1596 (566.9 bits), Expect = 9.6e-174, Sum P(2) = 9.6e-174
Identities = 303/365 (83%), Positives = 330/365 (90%)
Query: 83 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 142
+WR+RKP D FFDVPAEEDPEVHLGQLKRFSLRELQVA+D FSN+NILGRGGFGKVYKGR
Sbjct: 261 WWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGR 320
Query: 143 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202
L DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 321 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 380
Query: 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262
NGSVASCLRER SQPPL+W RK+IALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 381 NGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 440
Query: 263 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 441 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 500
Query: 323 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQ 382
GQRAFDLARLANDDDVMLLDWV VD D++ NY E E+EQ+IQVALLCTQ
Sbjct: 501 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQ 560
Query: 383 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDE 442
GSPMERPKMSEVVRMLEGDGLAE+W+EWQK E+ R++ + +P+PN+ WI+DST ++ E
Sbjct: 561 GSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVE 620
Query: 443 LSGPR 447
LSGPR
Sbjct: 621 LSGPR 625
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1595 (566.5 bits), Expect = 1.2e-173, Sum P(2) = 1.2e-173
Identities = 303/365 (83%), Positives = 328/365 (89%)
Query: 83 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 142
+WR+RKP++ FFDVPAEEDPEVHLGQLKRFSLRELQVATD+FSN+NILGRGGFGKVYKGR
Sbjct: 264 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323
Query: 143 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202
L DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383
Query: 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262
NGSVASCLRER SQ PL WS+R+QIALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443
Query: 263 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
FEAVVGDFGLA+LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 444 FEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 503
Query: 323 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQ 382
GQRAFDLARLANDDDVMLLDWV VD D++ NY E EVEQLIQVALLCTQ
Sbjct: 504 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQ 563
Query: 383 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDE 442
SPMERPKMSEVVRMLEGDGLAE+W+EWQK E+ RQ+ + HP + WI+DST ++ E
Sbjct: 564 SSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAME 623
Query: 443 LSGPR 447
LSGPR
Sbjct: 624 LSGPR 628
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1631 (579.2 bits), Expect = 1.0e-169, Sum P(2) = 1.0e-169
Identities = 321/446 (71%), Positives = 349/446 (78%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXX 64
D+SNN+L+GDIP NGSFSLFTPISFA SG
Sbjct: 176 DISNNRLSGDIPVNGSFSLFTPISFANNSLTDLPEPPPTSTSPTPP-PPSGGQMTAAIAG 234
Query: 65 XXXXXXXXXXXXXXXXXXYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
+W +RKP+DHFFDVPAEEDPEVHLGQLKRF+LREL VATDNF
Sbjct: 235 GVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNF 294
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
SN+N+LGRGGFGKVYKGRL DG+LVAVKRLKEERT+GGELQFQTEVEMISMAVHRNLLRL
Sbjct: 295 SNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRL 354
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYP+M NGSVASCLRER + P L+W RK IALG+ARGLAYLHDHCD
Sbjct: 355 RGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCD 414
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
KIIHRDVKAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 415 QKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKS 474
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGN 364
SEKTDVFGYGVMLLELITGQ+AFDLARLANDDD+MLLDWV VD+++EG
Sbjct: 475 SEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGK 534
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHT- 423
Y+E EVEQLIQ+ALLCTQ S MERPKMSEVVRMLEGDGLAERWEEWQKEEM DFN+
Sbjct: 535 YVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQA 594
Query: 424 -PHPNNTWIVD-STSHIQPDELSGPR 447
PH W++ S S I+ D SGPR
Sbjct: 595 YPHAGTDWLIPYSNSLIENDYPSGPR 620
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1511 (537.0 bits), Expect = 3.8e-157, Sum P(2) = 3.8e-157
Identities = 306/446 (68%), Positives = 338/446 (75%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFAXXXXXXXXXXXXXXXXXXXXGASSGNSXXXXXXX 64
D+SNN+L+GDIP NGSFS FT +SFA + SG S
Sbjct: 171 DISNNRLSGDIPVNGSFSQFTSMSFANNKLRPRPASPSP--------SPSGTSAAIVVGV 222
Query: 65 XXXXXXXXXXXXXXXXXXYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNF 124
+W +RK + HF DVPAEEDPEV+LGQ KRFSLREL VAT+ F
Sbjct: 223 AAGAALLFALA-------WWLRRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKF 275
Query: 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
S RN+LG+G FG +YKGRL D +LVAVKRL EERT+GGELQFQTEVEMISMAVHRNLLRL
Sbjct: 276 SKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRL 335
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RGFCMTPTERLLVYP+M NGSVASCLRER + P L+W RK IALG+ARGLAYLHDHCD
Sbjct: 336 RGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCD 395
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
KIIH DVKAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVRGTIGHIAPEYLSTGKS
Sbjct: 396 QKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKS 455
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGN 364
SEKTDVFGYGVMLLELITGQ+AFDLARLANDDD+MLLDWV VD+++EG
Sbjct: 456 SEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGK 515
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHT- 423
Y+E EVEQLIQ+ALLCTQ S MERPKMSEVVRMLEGDGLAERWEEWQKEEM DFN+
Sbjct: 516 YVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQA 575
Query: 424 -PHPNNTWIVD-STSHIQPDELSGPR 447
PH W++ S S I+ D SGPR
Sbjct: 576 YPHAGTDWLIPYSNSLIENDYPSGPR 601
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 3.6e-120, Sum P(2) = 3.6e-120
Identities = 233/358 (65%), Positives = 273/358 (76%)
Query: 91 DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVA 150
D F DV E D + GQLKRF+ RELQ+ATDNFS +N+LG+GGFGKVYKG L D + VA
Sbjct: 257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316
Query: 151 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL 210
VKRL + + GG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYPFM N S+A L
Sbjct: 317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376
Query: 211 RERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270
RE P L+W RK+IALGAARG YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDF
Sbjct: 377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 436
Query: 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 330
GLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +
Sbjct: 437 GLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 496
Query: 331 RLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 390
RL +DDV+LLD V VD +++G YI+EEVE +IQVALLCTQGSP +RP
Sbjct: 497 RLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPV 556
Query: 391 MSEVVRMLEGDGLAERWEEWQKEEMFRQ-DFNHTPHPNNTWIVDSTSHIQPDELSGPR 447
MSEVVRMLEG+GLAERWEEWQ E+ R+ +F + W DS + ELSG R
Sbjct: 557 MSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFD-WGEDSMHNQDAIELSGGR 613
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 1.2e-117, Sum P(2) = 1.2e-117
Identities = 223/374 (59%), Positives = 283/374 (75%)
Query: 83 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 142
+WR R+ + FFDV + DPEV LG LKR++ +EL+ AT++F+++NILGRGG+G VYKG
Sbjct: 260 WWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGH 319
Query: 143 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202
L DG+LVAVKRLK+ GGE+QFQTEVE IS+A+HRNLLRLRGFC + ER+LVYP+M
Sbjct: 320 LNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMP 379
Query: 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262
NGSVAS L++ + +P L+WS RK+IA+G ARGL YLH+ CDPKIIHRDVKAANILLDE+
Sbjct: 380 NGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDED 439
Query: 263 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELIT
Sbjct: 440 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 499
Query: 323 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQ 382
GQ+A D R A+ VML DWV +D D+ + E+E+++QVALLCTQ
Sbjct: 500 GQKALDFGRSAHQKGVML-DWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQ 558
Query: 383 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQD-------FNHTPHPN--NTWIVD 433
+P RPKMSEV++MLEGDGLAERWE Q Q + +P + +I +
Sbjct: 559 FNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQE 618
Query: 434 STSHIQPDELSGPR 447
S+ ++ ELSGPR
Sbjct: 619 SSLVVEAIELSGPR 632
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 2.9e-114, Sum P(2) = 2.9e-114
Identities = 224/374 (59%), Positives = 285/374 (76%)
Query: 83 YWRKRKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 141
+WR+R ++ FFDV EV LG L+RF RELQ+AT+NFS++N+LG+GG+G VYKG
Sbjct: 270 WWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKG 329
Query: 142 RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201
L D ++VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFC+T TE+LLVYP+M
Sbjct: 330 ILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYM 389
Query: 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 261
NGSVAS R +++P L+WS+RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLD+
Sbjct: 390 SNGSVAS----RMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDD 445
Query: 262 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 321
EAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLEL+
Sbjct: 446 YCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELV 505
Query: 322 TGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDM--EGNYIEEEVEQLIQVALL 379
TGQRAF+ + AN VML DWV VD ++ + +Y E E++++++VALL
Sbjct: 506 TGQRAFEFGKAANQKGVML-DWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALL 564
Query: 380 CTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ---DFNHTPHPNNTW--IVDS 434
CTQ P RPKMSEVVRMLEGDGLAE+WE Q+ + + N ++ + + D
Sbjct: 565 CTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDD 624
Query: 435 TSH-IQPDELSGPR 447
+S +Q ELSGPR
Sbjct: 625 SSLLVQAMELSGPR 638
|
|
| TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 1.7e-107, Sum P(2) = 1.7e-107
Identities = 202/353 (57%), Positives = 262/353 (74%)
Query: 86 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 145
+R D FFDV E+D ++ GQLKRFSLRE+Q+ATD+F+ N++G+GGFGKVY+G L D
Sbjct: 251 RRTKYDIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPD 310
Query: 146 GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205
+ VAVKRL + + GGE FQ E+++IS+AVH+NLLRL GFC T +ER+LVYP+M N S
Sbjct: 311 KTKVAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLS 370
Query: 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265
VA LR+ + L+W RK++A G+A GL YLH+HC+PKIIHRD+KAANILLD FE
Sbjct: 371 VAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEP 430
Query: 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 325
V+GDFGLAKL+D THVTT VRGT+GHIAPEYL TGKSSEKTDVFGYG+ LLEL+TGQR
Sbjct: 431 VLGDFGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQR 490
Query: 326 AFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSP 385
A D +RL +++++LLD + VDS++ Y +EVE ++QVALLCTQGSP
Sbjct: 491 AIDFSRLEEEENILLLDHIKKLLREQRLRDIVDSNLT-TYDSKEVETIVQVALLCTQGSP 549
Query: 386 MERPKMSEVVRMLEGDG-LAERWEEWQK-EEMFRQDFNHTPHPNNTWIVDSTS 436
+RP MSEVV+ML+G G LAE+W EW++ EE+ ++ P TW + T+
Sbjct: 550 EDRPAMSEVVKMLQGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETT 602
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 2.5e-102, Sum P(2) = 2.5e-102
Identities = 201/349 (57%), Positives = 254/349 (72%)
Query: 99 EEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER 158
+E+ + LG L+ F+ REL VATD FS+++ILG GGFG VY+G+ DG++VAVKRLK+
Sbjct: 274 QEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVN 333
Query: 159 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP 218
G QF+TE+EMIS+AVHRNLLRL G+C + +ERLLVYP+M NGSVAS L+ ++P
Sbjct: 334 GTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLK----AKP 389
Query: 219 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278
L+W+ RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLDE FEAVVGDFGLAKL+++
Sbjct: 390 ALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNH 449
Query: 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338
+D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG RA + + +
Sbjct: 450 EDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGA 509
Query: 339 MLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
ML +WV VD ++ Y EV +++QVALLCTQ P RPKMSEVV+ML
Sbjct: 510 ML-EWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQML 568
Query: 399 EGDGLAERWEEWQKEEMFRQDFNHTPHPNNTW--IVDSTSHIQPDELSG 445
EGDGLAERW D +H H N ++ I + + Q L G
Sbjct: 569 EGDGLAERWAA-------SHDHSHFYHANMSYRTITSTDGNNQTKHLFG 610
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 4.1e-102, Sum P(2) = 4.1e-102
Identities = 193/302 (63%), Positives = 237/302 (78%)
Query: 106 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ 165
LG L+ F+ REL V TD FS++NILG GGFG VY+G+L DG++VAVKRLK+ G+ Q
Sbjct: 285 LGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQ 344
Query: 166 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR 225
F+ E+EMIS+AVH+NLLRL G+C T ERLLVYP+M NGSVAS L+ S+P L+W++R
Sbjct: 345 FRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLK----SKPALDWNMR 400
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285
K+IA+GAARGL YLH+ CDPKIIHRDVKAANILLDE FEAVVGDFGLAKL+++ D+HVTT
Sbjct: 401 KRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADSHVTT 460
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVX 345
AVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG RA + + + ML +WV
Sbjct: 461 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAML-EWVR 519
Query: 346 XXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 405
+D ++ NY + EV +++QVALLCTQ P RPKMSEVV MLEGDGLAE
Sbjct: 520 KLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLEGDGLAE 579
Query: 406 RW 407
RW
Sbjct: 580 RW 581
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 447 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 9e-51
Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 30/276 (10%)
Query: 129 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FG+VYKG+L VAVK LKE+ ++ +F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
L G C +V +M G + S LR+ +P L+ S AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
IHRD+ A N L+ E + DFGL++ + D + + I +APE L GK
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 304 SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362
+ K+DV+ +GV+L E+ T G++ + ++N++ +L+++K +L Q
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYP--GMSNEE---VLEYLK---NGYRLPQ------- 224
Query: 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
+L + L C P +RP SE+V +L
Sbjct: 225 ---PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 6e-50
Identities = 82/276 (29%), Positives = 131/276 (47%), Gaps = 29/276 (10%)
Query: 129 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FG+VYKG L VAVK LKE+ ++ +F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
L G C ++V +M G + LR+ L+ S AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK- 122
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
IHRD+ A N L+ E + DFGL++ + D + + I +APE L GK
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 304 SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362
+ K+DV+ +GV+L E+ T G+ + ++N + +L+++K K +L +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYP--GMSNAE---VLEYLK---KGYRLPK------- 225
Query: 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
+L ++ L C P +RP SE+V +L
Sbjct: 226 ---PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 6e-49
Identities = 69/194 (35%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
LG GGFG VY R G VA+K +K+E + + E+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
LV + GS+ L+E + L+ +I L GL YLH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 249 HRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 306
HRD+K NILLD + + DFGL+KL+ + + T + GT ++APE L G SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 307 KTDVFGYGVMLLEL 320
K+D++ GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 36/285 (12%)
Query: 128 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FG+VYKG+L VAVK LKE+ ++ F E ++ H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP-----PLNWSVRKQIALGAARGLAY 238
L G C LV +M G + LR+ P L+ A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---A 295
L K +HRD+ A N L+ E+ + DFGL++ + D + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354
PE L G + K+DV+ +GV+L E+ T G + L+N++ +L++++ K +L
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSNEE---VLEYLR---KGYRLP 227
Query: 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ Y +E+ +L+ C Q P +RP SE+V LE
Sbjct: 228 K-------PEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 186
LG G FG VYK + G +VAVK LK+ + + Q + E+ ++ H N++RL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
LV + G + L G PL+ K+IAL RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS 305
IIHRD+K NILLDE + DFGLAK + + +TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 306 EKTDVFGYGVMLLELITGQ 324
K DV+ GV+L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 85/284 (29%), Positives = 128/284 (45%), Gaps = 47/284 (16%)
Query: 130 LGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
LG G FG+VYKG L VAVK LKE ++ +F E ++ H N++RL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
G C +V +M G + LR+ G+ L Q+AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---APEYLST 301
+HRD+ A N L+ E + DFGL++ + D + G I APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLKD 178
Query: 302 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
GK + K+DV+ +GV+L E+ T G++ + G+ E+ LE L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPY-----------------PGMSNEEVLELL---- 217
Query: 361 MEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
+G + +E+ +L+ L C P +RP SE+V L
Sbjct: 218 EDGYRLPRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 6e-47
Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 124 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
+ LG G FGKVY R G LVA+K +K+++ + + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
RL + LV + G + L++RG+ +QI L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLHSK 116
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
I+HRD+K NILLDE+ + DFGLA+ +D +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 303 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362
+ D++ GV+L EL+TG+ F +D + L +K +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFP----GDDQLLELF--------KKIGKPKPPFPPP 219
Query: 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
I E + LI+ LL P +R E ++
Sbjct: 220 EWDISPEAKDLIR-KLLVKD--PEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 128 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLR 185
+LGRG FG VY D G L+AVK ++ EL + E+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 186 GFCMTPTER-LLVY-PFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 240
G + L ++ ++ GS++S L++ G+ P+ +RK QI GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLH 118
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYL 299
+ I+HRD+K ANIL+D + + DFG AK + D + T +VRGT +APE +
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 340
+ D++ G ++E+ TG+ + + L N +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 50/283 (17%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 187
+G+G FGKVY R +DG L +K + E + EV+++ H N+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPP------LNWSVRKQIALGAARGLAYLHD 241
+ +V + G ++ ++++ + P L+W V Q+ L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYLHS 121
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
KI+HRD+K NI L +GDFG++K++ T V GT +++PE L
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQ 176
Query: 302 GKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
K + K+D++ G +L EL T + F+ + L +L
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE---------------------GENLLELALKI 215
Query: 361 MEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
++G Y E+ L+ +LL Q P ERP ++++++
Sbjct: 216 LKGQYPPIPSQYSSELRNLVS-SLL--QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 124 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
F +G+GGFG+VYK R G VA+K +K E + E E++++ H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARGLAYL 239
+ G + E +V F GS+ L+ Q L QIA +GL YL
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ---TLT---ESQIAYVCKELLKGLEYL 114
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEY 298
H + IIHRD+KAANILL + E + DFGL+ L D K + GT +APE
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEV 168
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQ 324
++ K D++ G+ +EL G+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 129 ILGRGGFGKVYKGRLT-DGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
+LG G FG VYKG +G VA+K L+EE + + E +++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLH 240
L G C++ L+ M G + +R SQ LNW V QIA +G++YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIA----KGMSYLE 126
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 299
+ +++HRD+ A N+L+ + DFGLAKL+D + + I +A E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 300 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 328
+ K+DV+ YGV + EL+T G + ++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 24/285 (8%)
Query: 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL--QFQTEVE-MISMAVHR 179
++ LG G FG+VY R D LVA+K L ++ + +F E++ + S+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N+++L F LV ++ GS+ L ++ + PL+ S I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 240 HDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHV-----TTAVRGTIGH 293
H IIHRD+K NILLD + + DFGLAKL+ + + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 294 IAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350
+APE L S +S +D++ G+ L EL+TG F+ + ++ L + L
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTP 233
Query: 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 395
L S I + L++ L P R S +
Sbjct: 234 SLASPLSPS--NPELISKAASDLLKKLL---AKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 66/224 (29%), Positives = 114/224 (50%), Gaps = 17/224 (7%)
Query: 123 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRN 180
N+ +++GRG FG VYKG L G VA+K++ E+ + L+ E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+++ G T ++ + NGS+ +++ G L Q+ +GLAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH 116
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
+ +IHRD+KAANIL ++ + DFG+A ++ + +V GT +APE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRA-FDLA------RLANDDD 337
+S +D++ G ++EL+TG +DL R+ DD
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH 216
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 128 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
++G G FG+V +GRL VA+K LK + L F TE ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
L G +++ +M NGS+ LRE G+ + G A G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEM 125
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPE 297
+HRD+ A NIL++ V DFGL++ ++ + TT +R T APE
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 298 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEQ 355
++ K + +DV+ +G+++ E+++ G+R + D++ + DV+ K + +L
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVI-----KAVEDGYRLPP 229
Query: 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+D L Q+ L C Q ERP S++V L+
Sbjct: 230 PMDCPS----------ALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 79/293 (26%), Positives = 128/293 (43%), Gaps = 30/293 (10%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMA 176
+ LG G FGKV R G VAVK L + F+ E+E++
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 177 VHRNLLRLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 234
H N+++ +G C P R L+ ++ +GS+ L+ + +N + +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICK 120
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IG 292
G+ YL + IHRD+ A NIL++ E + DFGLAK++ + G I
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 293 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD------LARLANDDDVMLLDWVKG 346
APE L T K S +DV+ +GV L EL T L + M++ +
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237
Query: 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
LLKE E+L +EV L++ LC + P +RP ++++ +++
Sbjct: 238 LLKEG--ERLPRPP----SCPDEVYDLMK---LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 91/284 (32%), Positives = 132/284 (46%), Gaps = 39/284 (13%)
Query: 128 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
++G+G FG VY G L D AVK L QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 184 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG--AARGLAYL 239
L G C+ P+E L+V P+M +G + + +R N +V+ I G A+G+ YL
Sbjct: 61 LLGICL-PSEGSPLVVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAP 296
K +HRD+ A N +LDE F V DFGLA+ + +Y H T + + +A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355
E L T K + K+DV+ +GV+L EL+T G + DV D LL+ ++L Q
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--------PDVDSFDITVYLLQGRRLLQ 223
Query: 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E + L +V L C P RP SE+V +E
Sbjct: 224 ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
+G+G FG V G G VAVK LK++ F E +++ H NL++L G +
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 249
+V +M GS+ LR RG++ + + + AL G+ YL + +H
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 250 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 309
RD+ A N+L+ E+ A V DFGLAK V+ T APE L K S K+D
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSD 181
Query: 310 VFGYGVMLLELITGQRA 326
V+ +G++L E+ + R
Sbjct: 182 VWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 124 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
F+ LG G FG+V++G + VA+K LK + + FQ EV+ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGA--ARGLAYLH 240
L C ++ M GS+ + LR GQ P V I + A G+AYL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLP-----VASLIDMACQVAEGMAYLE 121
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
+ IHRD+ A NIL+ E+ V DFGLA+L+ +D ++++ + APE S
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAAS 177
Query: 301 TGKSSEKTDVFGYGVMLLELIT 322
G S K+DV+ +G++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 99/440 (22%), Positives = 188/440 (42%), Gaps = 88/440 (20%)
Query: 5 DLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGAS------SGNS 57
DLS N+L+G+IP N G+ ++ ++N L+ PS L + G++
Sbjct: 553 DLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDT 612
Query: 58 ATGA---------------IAGGVAAGAALLFAAPAIALAYWRKRKP------------- 89
+G I + GA L+ A A + R R
Sbjct: 613 TSGLPPCKRVRKTPSWWFYITCTL--GAFLVLALVAFGFVFIRGRNNLELKRVENEDGTW 670
Query: 90 EDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSL 148
E FFD K ++ ++ + N++ RG G YKG+ + +G
Sbjct: 671 ELQFFDSKV----------SKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQ 717
Query: 149 VAVKRLKE-------ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201
VK + + E G+LQ H N+++L G C + L++ ++
Sbjct: 718 FVVKEINDVNSIPSSEIADMGKLQ------------HPNIVKLIGLCRSEKGAYLIHEYI 765
Query: 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 261
+++ LR L+W R++IA+G A+ L +LH C P ++ ++ I++D
Sbjct: 766 EGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818
Query: 262 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 321
+ E + L L+ ++ ++APE T +EK+D++G+G++L+EL+
Sbjct: 819 KDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELL 872
Query: 322 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI--EEEVEQLIQVALL 379
TG+ D + +++W + + L+ +D + G+ + E+ +++ +AL
Sbjct: 873 TGKSPADAEFGVHGS---IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH 929
Query: 380 CTQGSPMERPKMSEVVRMLE 399
CT P RP ++V++ LE
Sbjct: 930 CTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 129 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGG---ELQ------FQTEVEMISMAVH 178
++G+G +G+VY +T G ++AVK+++ T G Q ++E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
N+++ GF T + ++ GS+ SCLR G+ + L +Q+ GLAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----LEGLAY 123
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPE 297
LH I+HRD+KA N+L+D + + DFG++K D D +++G++ +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 298 YLSTGKS--SEKTDVFGYGVMLLELITGQR 325
+ + S K D++ G ++LE+ G+R
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 80/290 (27%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 130 LGRGGFGKVYKG---RLTDGSL---VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG+G FG VY+G + G VA+K + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRER------GQSQPPLNWSVRKQIALGAARGLA 237
L G T L+V M G + S LR R P Q+A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTTAVRGTIG 292
YL K +HRD+ A N ++ E+ +GDFG+ + + DY K VR
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 293 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352
+APE L G + K+DV+ +GV+L E+ T LA +GL
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT------LAEQP----------YQGLSN--- 227
Query: 353 LEQLVDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E+++ ++G ++ E ++L+++ +C Q +P RP E+V L+
Sbjct: 228 -EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
+G+G FG VYKG L + VAVK + + +F E E++ H N+++L G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARGLAYLHDHCDPKI 247
+V + GS+ + LR++ V+K Q++L AA G+ YL
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLT-----VKKLLQMSLDAAAGMEYLESKN---C 114
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT----IGHIAPEYLSTGK 303
IHRD+ A N L+ E + DFG+++ ++ + T G I APE L+ G+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 304 SSEKTDVFGYGVMLLELITG 323
+ ++DV+ YG++L E +
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 122 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
+ +LG+G G VYK R G + A+K++ + + Q E++ +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+++ G E +V +M GS+A L++ G + V IA +GL YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLH 116
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
IIHRD+K +N+L++ + E + DFG++K+++ T V GT+ +++PE +
Sbjct: 117 T--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
S D++ G+ LLE G+ F L ++ + D
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFEL-----------MQAICDGP 219
Query: 361 ---MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 393
+ E I C Q P +RP +E
Sbjct: 220 PPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 130 LGRGGFGKVYKG-RLTDGSLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLRL 184
LG G FG VY+G L DG AVK + + Q Q + E+ ++S H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 185 RGFCMTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
G + L ++ +V GS+A L++ G P+ +QI LG L YLHD
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR- 121
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STG 302
+HRD+K ANIL+D + DFG+AK + + +G+ +APE + G
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQG 177
Query: 303 KSSEKTDVFGYGVMLLELITGQ 324
D++ G +LE+ TG+
Sbjct: 178 GYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-23
Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 23/270 (8%)
Query: 129 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+LG+G FG+V+KG L D + VAVK KE+ Q +++F +E ++ H N+++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+V + G S LR++ + L + AL AA G+AYL I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 308
HRD+ A N L+ E + DFG+++ D + + I APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 309 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEE 368
DV+ YG++L E F L G+ ++ EQ V+ + ++
Sbjct: 176 DVWSYGILLWE------TFSLGVCP----------YPGMTNQQAREQ-VEKGYRMSCPQK 218
Query: 369 EVEQLIQVALLCTQGSPMERPKMSEVVRML 398
+ + +V C P RPK SE+ + L
Sbjct: 219 CPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 8e-23
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKR--LKEERTQGGELQF---QTEVEMISMAVHRNLL 182
+LG+G +G VY G G L+AVK+ L E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
+ G C+ + F+ GS++S L G P+ KQI G+AYLH++
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNN 121
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-----TAVRGTIGHIAPE 297
C ++HRD+K N++L + DFG A+ + + H T ++ GT +APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQ 324
++ K+D++ G + E+ TG+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 9e-23
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 130 LGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FGKV+ G D LVAVK LKE + F+ E E+++ H N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERG----------QSQPPLNWSVRKQIALGAA 233
G C ++V+ +M +G + LR G L S QIA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGT- 290
G+ YL +HRD+ N L+ + +GDFG++ +D + T V G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVYTTDYYRVGGHT 184
Query: 291 ---IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
I + PE + K + ++DV+ +GV+L E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 9e-23
Identities = 84/276 (30%), Positives = 130/276 (47%), Gaps = 29/276 (10%)
Query: 127 RNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185
++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL++L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
G C ++ FM G++ LRE + + +N V +A + + YL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK--- 123
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKS 304
IHRD+ A N L+ E V DFGL++LM DT+ A + I APE L+ K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 305 SEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363
S K+DV+ +GV+L E+ T G + L+ V LL++ ME
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEK-------GYRMER 226
Query: 364 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E ++ ++ C Q +P +RP +E+ + E
Sbjct: 227 P--EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 9e-23
Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 123 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQT-EVEMISMAVHRN 180
+F N +G+G FG V+K R D + A+K++ + E + E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPPLN-WSVRKQIALGAARGLAY 238
++R + + +V + NG + L+ +RG+ P W QI LG LA+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
LH KI+HRD+K+ N+ LD +GD G+AKL+ T V GT +++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPEL 172
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
+EK+DV+ GV+L E TG+ FD AN+ ++L ++G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPP-------- 220
Query: 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ Y +QL Q+ C +RP +++R
Sbjct: 221 --VSQMY----SQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 44/283 (15%)
Query: 130 LGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185
LG G FG V +G + VAVK LK ++ F E ++ H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL----NWSVRKQIALGAARGLAYLHD 241
G +T ++V GS+ LR+ + +++V QIA G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIA----NGMRYLES 115
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT-IGHIAPEYL 299
+ IHRD+ A NILL + + +GDFGL + L +D +V APE L
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 300 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
T S +DV+ +GV L E+ T G+ + GL + L+++
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPW-----------------AGLSGSQILKKI-- 213
Query: 359 SDMEGNYIEEE---VEQLIQVALLCTQGSPMERPKMSEVVRML 398
D EG +E + + V L C +P +RP + + L
Sbjct: 214 -DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 4e-22
Identities = 74/292 (25%), Positives = 143/292 (48%), Gaps = 37/292 (12%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRL-TDG---SLVAVKRLKEERTQGGELQFQTEVEMI 173
++ + + + ++G G FG+V++G L G VA+K LK T+ F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 174 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL--G 231
H N++RL G +++ +M NG++ LR+ +S + + + G
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRG 115
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRG 289
A G+ YL D +HRD+ A NIL++ E V DFGL++++ D + T+ T+ +
Sbjct: 116 IAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 290 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGL 347
I APE ++ K + +DV+ +G+++ E+++ G+R + D++ + +VM K +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS----NHEVM-----KAI 223
Query: 348 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+L +D + Q+ L C Q RP+ ++V +L+
Sbjct: 224 NDGFRLPAPMDCP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG G +G VYK G +VA+K + + + E+ ++ +++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCD 244
T+ +V + GSV+ ++ ++ L ++IA +GL YLH +
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKT---LT---EEEIAAILYQTLKGLEYLHSN-- 118
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IG---HIAPEYLS 300
K IHRD+KA NILL+EE +A + DFG++ + T A R T IG +APE +
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEVIQ 172
Query: 301 TGKSSEKTDVFGYGVMLLELITG 323
+ K D++ G+ +E+ G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 70/198 (35%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 129 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
I+G G FG V +G T G VAVK +K + T F E +++ H+NL+RL G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+ +V M G++ + LR RG++ + + Q +L A G+ YL K++
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL--QFSLDVAEGMEYLESK---KLV 122
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 308
HRD+ A NIL+ E+ A V DFGLA++ + V+ T APE L K S K+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178
Query: 309 DVFGYGVMLLELITGQRA 326
DV+ YGV+L E+ + RA
Sbjct: 179 DVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 86/291 (29%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 130 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLR 183
LG+G FG V R L D G +VAVK+L+ + L+ F+ E+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69
Query: 184 LRGFCMTPTER--LLVYPFMVNGSVASCL---RERGQSQPPLNWSVRKQIALGAARGLAY 238
+G C + R LV ++ GS+ L RER + L ++ QI +G+ Y
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA--SQIC----KGMEY 123
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAP 296
L + +HRD+ NIL++ E +GDFGL K++ D + V I AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELIT------GQRAFDLARLAND-DDVMLLDWVKGLLK 349
E L+ K S +DV+ +GV+L EL T A + + ND M++ + LLK
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240
Query: 350 EK-KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+L E I +E C P +RP SE+ +E
Sbjct: 241 NNGRLPAPPGCPAEIYAIMKE----------CWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 128 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 185
+G G +G+VYK R G LVA+K+++ E +G + E++++ H N++RL+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 186 GFCMTPTERL-----LVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAY 238
T + +V+ +M + + L ++ + KQ+ GL Y
Sbjct: 65 EIV---TSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK-CYMKQLL----EGLQY 115
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
LH + I+HRD+K +NIL++ + + DFGLA+ +++ T T+ + PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 299 L--STGKSSEKTDVFGYGVMLLELITGQRAF 327
L +T + + D++ G +L EL G+ F
Sbjct: 173 LLGAT-RYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 186
LG+G FGKV R D G L A+K LK+++ + TE ++S H +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 187 FCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIALGAARGLAYLHD 241
+ E+L LV + G + S L + G+ + + +I L L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGR----FSEERARFYAAEIVLA----LEYLHS 111
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
II+RD+K NILLD + + DFGLAK + T GT ++APE L
Sbjct: 112 L---GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 302 GKSSEKTDVFGYGVMLLELITGQRAFD 328
+ D + GV+L E++TG+ F
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 67/282 (23%), Positives = 124/282 (43%), Gaps = 30/282 (10%)
Query: 129 ILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
LGRG FG+V+ + +LV VK L++ + + + +F+ E++M H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 183 RLRGFCMTPTERLLVYPFMVNGS-----VASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
RL G C ++ + G A+ ++ PPL+ + + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
+L + + +HRD+ A N L+ + E V L+K + + + + +APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
+ S K+DV+ +GV++ E+ T Q L++++ V L+ KLE V
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEE-------VLNRLQAGKLELPV 240
Query: 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+L ++ C +P +RP SE+V L
Sbjct: 241 PEGCP--------SRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 75/302 (24%), Positives = 132/302 (43%), Gaps = 59/302 (19%)
Query: 130 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
+G+G FG+V++ R ++VAVK LKEE + + FQ E +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRER------------------GQSQPPLNWSVR 225
L G C L++ +M G + LR R G + PL+ + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYKDTH 282
IA A G+AYL + K +HRD+ N L+ E + DFGL++ DY
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG--QRAFDLARLANDDDVML 340
A+ I + PE + + + ++DV+ YGV+L E+ + Q + +A
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--------- 238
Query: 341 LDWVKGLLKEKKLEQLVDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
E+++ +GN + + +L + LC P +RP + + R+
Sbjct: 239 -------------EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285
Query: 398 LE 399
L+
Sbjct: 286 LQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
LG G FG+V++G + + VAVK LK + F E +++ H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 249
+V M GS+ L+ L + +A A G+AYL IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQ---NYIH 126
Query: 250 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 309
RD+ A N+L+ E V DFGLA+++ + I APE + S K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 310 VFGYGVMLLELIT 322
V+ +G++L E++T
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 127 RNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRL 184
N +G G FGKVY L G L+AVK ++ + + + E++++ + H NL++
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 185 RGFCMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
G R VY FM G++ L L+ V + L GLAYLH
Sbjct: 65 YG---VEVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHS 117
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEY 298
H I+HRD+K ANI LD +GDFG A + T + V+ G ++APE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 299 LSTGKSSEK---TDVFGYGVMLLELITGQRAF 327
++ GK D++ G ++LE+ TG+R +
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 33/279 (11%)
Query: 130 LGRGGFGKVYKG--RLTDGSL--VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185
LG G FG V KG + G VAVK LK+E G+ +F E +++ H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
G C +LV G + L++R + S K++A A G+AYL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK--- 114
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGK 303
+HRD+ A N+LL +A + DFG+++ + + TTA R + APE ++ GK
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 304 SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362
S K+DV+ YGV L E + G + + + + + +L+ ++L +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPY--GEMKGAEVIAMLE------SGERLPR------- 219
Query: 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401
EE +++ + L C + P +RP SE+ D
Sbjct: 220 ---PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 186
LG G FG+V+ G + VA+K LK+ G + F E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHCD 244
+T ++ +M NGS+ L+ + +N K I + A A G+A++
Sbjct: 69 -VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTIN----KLIDMAAQIAEGMAFIERK-- 121
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
IHRD++AANIL+ E + DFGLA+L++ + + I APE ++ G
Sbjct: 122 -NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 305 SEKTDVFGYGVMLLELITGQR 325
+ K+DV+ +G++L E++T R
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 7e-21
Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 36/277 (12%)
Query: 129 ILGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLR 185
+LG+G FG+ +Y+ R D SLV K + R E + E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
M L+ + G++ + + + + +A ++Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 305
I+HRD+K NI L + +GDFG++K++ + + T V GT +++PE K +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 306 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 365
K+D++ G +L EL+T +R FD N LV ++GNY
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLN---------------------LVVKIVQGNY 218
Query: 366 IEEEVEQ----LIQVALLCTQGSPMERPKMSEVVRML 398
V LI + Q P +RP EV+
Sbjct: 219 -TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 186
LG G FG+V+ G + VAVK LK G + F E +++ H L++L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-----GTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHCD 244
C +V +M GS+ L+ + L + + + A A G+AYL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP----QLVDMAAQIAEGMAYLESR-- 122
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPEYLST 301
IHRD+ A NIL+ E + DFGLA+L+ +D TA G I APE +
Sbjct: 123 -NYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEY-TAREGAKFPIKWTAPEAANY 178
Query: 302 GKSSEKTDVFGYGVMLLELIT 322
G+ + K+DV+ +G++L E++T
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 9e-21
Identities = 81/280 (28%), Positives = 133/280 (47%), Gaps = 40/280 (14%)
Query: 128 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
N LG G FG+VY+G TD VAVK L++ T + +F E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRK--QIALGAARGLA 237
+++L G C+ + ++ M G + S LR+ R + P ++++ I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTIG 292
YL IHRD+ A N L+ E+ +GDFGLA+ + YK + G +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLP 176
Query: 293 --HIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 349
+APE L GK + ++DV+ +GV++ E++T GQ+ + L N + +L V
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY--PALNNQE---VLQHVT---A 228
Query: 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 389
+L++ E +++ Q+ C P ERP
Sbjct: 229 GGRLQK----------PENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 78/284 (27%), Positives = 138/284 (48%), Gaps = 41/284 (14%)
Query: 129 ILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
++G G FG+V +GRL VA+K LK T+ F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIAL--GAARGLAYLHD 241
G +++ FM NG++ S LR+ GQ ++V + + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ------FTVIQLVGMLRGIAAGMKYLSE 124
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIG--HIAPE 297
+HRD+ A NIL++ V DFGL++ + D D T+++ G I APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 298 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEQ 355
++ K + +DV+ YG+++ E+++ G+R + D++ + DV+ + ++ +L
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDVI-----NAIEQDYRLPP 232
Query: 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+D L Q+ L C Q RPK ++V L+
Sbjct: 233 PMDCPT----------ALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
LG G FG V+ G+ VA+K ++E E F E +++ H NL++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA----RGLAYLHDHCDP 245
+V +M NG + + LRER + + L + YL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGK-------LGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 305
IHRD+ A N L+ E+ V DFGLA+ + + + + PE + S
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 306 EKTDVFGYGVMLLELITG 323
K+DV+ +GV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-20
Identities = 77/284 (27%), Positives = 136/284 (47%), Gaps = 43/284 (15%)
Query: 129 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
++G G FG+V GRL VA+K LK T+ F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIAL--GAARGLAYLHD 241
G ++V +M NGS+ + LR+ GQ ++V + + + G A G+ YL D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ------FTVIQLVGMLRGIASGMKYLSD 124
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYL 299
+HRD+ A NIL++ V DFGL++++ D + + T + I APE +
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 300 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
+ K + +DV+ YG+++ E+++ G+R + ++N D + ++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPY--WEMSNQDVIKAIE---------------- 223
Query: 359 SDMEGNYIEEEVE---QLIQVALLCTQGSPMERPKMSEVVRMLE 399
EG + ++ L Q+ L C Q ERPK ++V +L+
Sbjct: 224 ---EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 3e-20
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
+G G FG V+ G + VA+K ++E E F E +++ H L++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 190 TPTERLLVYPFMVNGSVASCLR-ERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
+ LV+ FM +G ++ LR +RG+ SQ L + L G+AYL +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN---V 121
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 307
IHRD+ A N L+ E V DFG+ + + +T + + +PE S K S K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 308 TDVFGYGVMLLELIT 322
+DV+ +GV++ E+ +
Sbjct: 182 SDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-----FQTEVEMISMAVHRNLL 182
LG G F Y+ R + G+L+AVK++ R E + + E+ +++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
R+ G + L +M GSV+ L + G +V RGL+YLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 243 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEY 298
+IIHRDVK AN+L+D + + + DFG A + K T + GTI +APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQ 324
L + DV+ G +++E+ T +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKG----RLTDGS--LVAVKRLKEERTQGGELQFQTEVE 171
+V D+ + LG G FG+VY+G R D VAVK L E ++ E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 172 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER--GQSQP-PLNWSVRKQI 228
++S H+N++RL G R ++ M G + S LRE +P L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTT 285
A A+G YL ++ IHRD+ A N LL + A + DFG+A+ + Y+ ++
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYRK 177
Query: 286 AVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 320
R I + PE G + KTDV+ +GV+L E+
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-20
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 129 ILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNL 181
LG G FG+V K + S VAVK LK++ T+ +E+EM+ M H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP-------LNWSVRKQI------ 228
+ L G C +V + +G++ LR R +PP + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR---RPPGEYASPDDPRPPEETLTQKDLV 135
Query: 229 --ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTT 285
A ARG+ +L K IHRD+ A N+L+ E+ + DFGLA+ + + D + TT
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 9e-20
Identities = 58/213 (27%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 129 ILGRGGFGKVYKG-RLTDGSLVAVKRLK--------EERTQGGELQFQTEVEMISMAVHR 179
++G G FG VY G + G L+AVK+++ ++R + E+ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N+++ G + + ++ GSVA+ L G + L + +QI +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-----AVRGTIGHI 294
H+ IIHRD+K ANIL+D + + DFG++K ++ T +++G++ +
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
APE + + K D++ G +++E++TG+ F
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 80/292 (27%), Positives = 134/292 (45%), Gaps = 47/292 (16%)
Query: 130 LGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG+G FG VY+G D + VAVK + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLR------ERGQSQPPLNWSVRKQIALGAARGLA 237
L G L+V M +G + S LR E +PP Q+A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIA 295
YL+ K +HRD+ A N ++ +F +GDFG+ + + Y+ + +G + +A
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355
PE L G + +D++ +GV+L E+ + LA +GL E+ L+
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP-------YQGLSNEQVLKF 233
Query: 356 LVDSDMEGNYI------EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401
+ M+G Y+ E V L++ +C Q +P RP E+V +L+ D
Sbjct: 234 V----MDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 186
LG+GGFG+V ++ G + A K+L ++R + GE E +++ R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGAARGLAYLHDHCD 244
T + LV M G + + G+ P ++ QI G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQR-- 114
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
+I++RD+K N+LLD+ + D GLA ++ K GT G++APE L
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 305 SEKTDVFGYGVMLLELITGQRAF 327
D F G L E+I G+ F
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 57/227 (25%), Positives = 89/227 (39%), Gaps = 48/227 (21%)
Query: 123 NFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
+F ++G+G FGKV + D + A+K + +++ + RN+
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK-------------CVEKGSVRNV 47
Query: 182 LRLRGFCMTPTERLLV----YPFMVNGSVASC----------------LRERGQSQPPLN 221
L ER ++ +PF+VN + LR + +
Sbjct: 48 LN---------ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS 98
Query: 222 WSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281
K L YLH IIHRD+K NILLDE+ + DF +A
Sbjct: 99 EEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT--KVTPD 153
Query: 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
+TT+ GT G++APE L S D + GV E + G+R +
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 129 ILGRGGFGKVYKGRLT--DGSL--VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLR 183
ILG G FG V +G+L+ DGS VAVK +K + E++ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 184 LRGFCMTPTER------LLVYPFMVNGSVAS-CLRERGQSQP---PLNWSVRKQIALGAA 233
L G C + +++ PFM +G + S L R P PL ++ + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK--FMVDIA 123
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRG 289
G+ YL + IHRD+ A N +L E+ V DFGL+K + Y+ + +
Sbjct: 124 LGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KM 177
Query: 290 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 324
+ IA E L+ + K+DV+ +GV + E+ T GQ
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 130 LGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FGKVYKG LT + VA+K LKE + +F+ E E++S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 184 LRGFCMTPTERLLVYPFMVNG------------SVASCLRERGQSQPPLNWSVRKQIALG 231
L G C +++ ++ +G S + L+ S IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 290
A G+ YL H +HRD+ A N L+ E + DFGL++ + D + V +
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 320
+ + PE + GK + ++D++ +GV+L E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 128 NILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLR 185
+G+G FG V K R +DG ++ K + T+ + Q +EV ++ H N++R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 186 GFCMTPTERLLVYPFM---VNGSVAS----CLRERGQSQPPLNWSVRKQIALGAARGLAY 238
+ + + L Y M G +A C +ER + W + Q+ L L
Sbjct: 66 DRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----LYE 120
Query: 239 LH--DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
H ++HRD+K ANI LD +GDFGLAK++ + + T V GT +++P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSP 179
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
E L+ EK+D++ G ++ EL F
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 6e-19
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 18/217 (8%)
Query: 123 NFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 180
+ ++GRG FG V+ R D LV +K++ E+ T+ L Q E +++ + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP----LNWSVRKQIALGAARGL 236
++ + ++V + G++A +++R S L++ V+ +AL
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------ 114
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
++H I+HRD+K NILLD+ V +GDFG++K++ K T V GT +I+
Sbjct: 115 HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYIS 169
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 332
PE ++K+D++ G +L EL + +RAF+ A L
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 130 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FGKV+ D LVAVK LKE ++ FQ E E++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLR---------ERGQSQP--PLNWSVRKQIALGA 232
G C L+V+ +M +G + LR G+ L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTI 291
A G+ YL +HRD+ N L+ + +GDFG+++ + D + V I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
+ PE + K + ++D++ +GV+L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 129 ILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
+LG G FG VYKG + +G V A+K L E ++F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLH 240
L G C++PT + LV M +G + + E SQ LNW V+ A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYL 299
+ +++HRD+ A N+L+ + DFGLA+L++ + + I +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 300 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 328
K + ++DV+ YGV + EL+T G + +D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 186
LG G FG+V+ G + + VAVK LK G + Q E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 187 FCMTPTERLLVYPFMVNGSVASCLR--ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
++ +M GS+ L+ E G+ P QIA G+AY+
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIERK-- 122
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
IHRD++AAN+L+ E + DFGLA++++ + + I APE ++ G
Sbjct: 123 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 305 SEKTDVFGYGVMLLELIT 322
+ K+DV+ +G++L E++T
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 130 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+GRG FG+V+ GRL D + VAVK +E + +F E ++ H N++RL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+V + G + LR G P L Q+ AA G+ YL I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGK 303
HRD+ A N L+ E+ + DFG+++ ++ A G + I APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 304 SSEKTDVFGYGVMLLE 319
S ++DV+ +G++L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 123 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER----TQGGELQFQTEVEMISMAV 177
N+ +LG+G FG+VY D G +AVK++ + T+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 178 HRNLLRLRGFCMTPTERLLVY-PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 236
H +++ G C+ E L ++ +M GSV L+ G L +V ++ G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGV 117
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHI 294
YLH + I+HRD+K ANIL D +GDFG +K + + T +V GT +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELIT 322
+PE +S K DV+ G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 78/299 (26%), Positives = 140/299 (46%), Gaps = 54/299 (18%)
Query: 127 RNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLL 182
++++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRKQIALGA 232
L G C L + +G++ LR+ ++ P S ++ + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 233 --ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 290
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + V+ T
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 181
Query: 291 IGHI-----APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 344
+G + A E L+ + +DV+ YGV+L E+++ G + A +
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY 233
Query: 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV----RMLE 399
+ L + +LE+ ++ D +EV L++ C + P ERP ++++ RMLE
Sbjct: 234 EKLPQGYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 33/279 (11%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
D+ LG G G V K G ++AVK ++ E + + Q E++++
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
++ G + + +M GS+ L+E Q + + +IA+ +GL YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH 117
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEY 298
+ KIIHRDVK +NIL++ + + DFG++ + T V GT ++APE
Sbjct: 118 E--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPER 170
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
+ S K+D++ G+ L+EL TG+ + ND + + L+ +V+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPYP---PENDPPDGIFE---------LLQYIVN 218
Query: 359 SDM----EGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 393
G + + LC P ERP E
Sbjct: 219 EPPPRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 129 ILGRGGFGKVYKG-RLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
+LG G FG VYKG + DG VA+K L+E + + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLH 240
L G C+T T +L V M G + +RE R SQ LNW V QIA +G++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV--QIA----KGMSYLE 126
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 299
+ +++HRD+ A N+L+ + DFGLA+L+D +T + I +A E +
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 300 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 328
+ + ++DV+ YGV + EL+T G + +D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 20/221 (9%)
Query: 129 ILGRGGFGKVYKG-RLTDGSLVAVK-RLKEERTQGGELQFQTEVE-MISMAV--HRNLLR 183
+LG G FG V+KG + +G + + +K + + G FQ + M++M H ++R
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLH 240
L G C + +L V GS+ +R+ S P LNW V QIA +G+ YL
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV--QIA----KGMYYLE 126
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYL 299
+H ++HR++ A NILL + + DFG+A L+ D + + + I +A E +
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 300 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVM 339
G+ + ++DV+ YGV + E+++ G + R D++
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 124 FSNRNILGRGGFGKVYKGR-LTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVH 178
F +LG G FG VYKG + +G VA+K L+E + + E +++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARG 235
++ RL G C+T T +L + M G + +RE SQ LNW V QIA +G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIA----KG 121
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGH 293
+ YL + +++HRD+ A N+L+ + DFGLAKL+ D K+ H + I
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKW 177
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 328
+A E + + ++DV+ YGV + EL+T G + +D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 8e-18
Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 129 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 189 MTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
+ L +V +M GS+ LR RG+S L + +L + YL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 307
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 308 TDVFGYGVMLLELITGQR 325
+DV+ +G++L E+ + R
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 127 RNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185
++G G VY L + VA+KR+ E+ Q + + EV+ +S H N+++
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
+ E LV P++ GS+ ++ + L+ ++ + +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLHSN--- 121
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST 301
IHRD+KA NILL E+ + DFG++ + T VR GT +APE +
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 302 GKS-SEKTDVFGYGVMLLELITG 323
K D++ +G+ +EL TG
Sbjct: 181 VHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 124 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
F+ +G+G FG+VYK +VA+K + E + Q E++ +S +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 183 RLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
+ G +L ++ + GS L+ L+ + I GL YLH+
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE 116
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIAPE 297
IHRD+KAANILL EE + + DFG L M ++T V GT +APE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMAPE 168
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITG 323
+ EK D++ G+ +EL G
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 72/230 (31%), Positives = 102/230 (44%), Gaps = 40/230 (17%)
Query: 99 EEDPEVHLGQLKRFS-LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKE 156
++DPE K F+ LRE+ G G FG VY R +VA+K++
Sbjct: 10 KDDPE------KLFTDLREI-------------GHGSFGAVYFARDVRTNEVVAIKKMSY 50
Query: 157 ERTQGGELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 213
Q E ++Q EV + H N + +G + LV + + GS + L
Sbjct: 51 SGKQSNE-KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH 108
Query: 214 GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273
+ PL I GA +GLAYLH H IHRD+KA NILL E + DFG A
Sbjct: 109 ---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA 162
Query: 274 KLMDYKDTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLEL 320
L+ ++ V GT +APE + G+ K DV+ G+ +EL
Sbjct: 163 SLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 130 LGRGGFGKV--YKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
LG G FGKV Y + G +VAVK LK E Q ++ E+ ++ H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 185 RGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GLAYL 239
+G C + L+ ++ GS+ L P + Q+ L A + G+AYL
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--------PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIA 295
H IHRD+ A N+LLD + +GDFGLAK + + H VR + A
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPVFWYA 178
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELIT 322
E L K S +DV+ +GV L EL+T
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 42/288 (14%)
Query: 130 LGRGGFGKVYKG---RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+G G FGKV G R + V VK L+ T +L F EV+ H N+L+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 187 FCMTPTERLLVYPFMVNGSVASCLR-----ERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
C+ LLV F G + + LR +Q V +++A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMACEVASGLLWLHQ 118
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEY- 298
IH D+ N L + +GD+GLA L Y + + T + +APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 299 ------LSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKE 350
L ++K++++ GV + EL T + + DL+ D+ V+ K +++E
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS----DEQVL-----KQVVRE 225
Query: 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
+ + +L ++ Y + E V C P RP EV +L
Sbjct: 226 QDI-KLPKPQLDLKYSDRWYE----VMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 129 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMIS-MAVHRNLLRL 184
I+G G F V + A+K L + + + + E E+++ + H +++L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 185 RGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
+ E L V + NG + +R+ G L+ + A L YLH
Sbjct: 68 Y-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLHSK- 121
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------------YKDTHVT 284
IIHRD+K NILLD++ + DFG AK++D K+
Sbjct: 122 --GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
+ GT +++PE L+ + + +D++ G ++ +++TG+ F
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 120 ATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK--RLKEERTQGGELQFQTEVEMI-SM 175
T F ++G G +GKVYK R G LVA+K + E+ E + + E ++
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKY 59
Query: 176 AVHRNLLRLRG--FCMTPT----ERLLVYPFMVNGSV---ASCLRERGQSQPPLNWSVRK 226
+ H N+ G P + LV GSV LR++G+ +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK------EE 113
Query: 227 QIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283
IA RGLAYLH++ K+IHRD+K NILL + E + DFG++ +D
Sbjct: 114 WIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 284 TTAVRGTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQ 324
T + GT +APE ++ + + + DV+ G+ +EL G+
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 77/297 (25%), Positives = 137/297 (46%), Gaps = 45/297 (15%)
Query: 118 QVATDNFSNRNILGRGGFGKVY----KGRLTDG--SLVAVKRLKEERTQGGELQFQTEVE 171
+VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 172 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE--------RGQSQPPLNWS 223
++ +++RL G L++ M G + S LR Q+ P L
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283
+ Q+A A G+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + Y+ +
Sbjct: 122 I--QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYY 175
Query: 284 TTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
+G + ++PE L G + +DV+ +GV+L E+ T LA
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP----- 221
Query: 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEE---VEQLIQVALLCTQGSPMERPKMSEVV 395
+G+ E+ L + MEG +++ + L ++ +C Q +P RP E++
Sbjct: 222 --YQGMSNEQVLRFV----MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 129 ILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
LG G FGKV K + VAVK LKE + +E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP--------------------PLNW 222
+L G C LL+ + GS+ S LRE + P L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 223 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282
A +RG+ YL + K++HRD+ A N+L+ E + + DFGL++ + +D++
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 283 VTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
V + R + +A E L + ++DV+ +GV+L E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
+G G +G VYK R G +VA+K++K ++G E++++ H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
+ LV+ FM + + +++R Q L S+ K +GLA+ H H I
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYLSTG 302
+HRD+K N+L++ E + DFGLA+ Y VT R APE L
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYR------APELLLGD 173
Query: 303 KS-SEKTDVFGYGVMLLELITGQRAF 327
K S D++ G + EL++ + F
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 35/284 (12%)
Query: 130 LGRGGFGKVYKGRLT-DGSL--VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 185
LG G FG V +G+L D S+ VAVK +K E++ F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 186 GFCMTPTER------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLA 237
G C+ E +++ PFM +G + S L P + + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAP 296
YL IHRD+ A N +L+E V DFGL+K + D + + + + IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355
E L+ + K+DV+ +GV + E+ T GQ + ++ + D+++ + +L+Q
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLR---QGNRLKQ 235
Query: 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
D ++ L + C +P +RP + LE
Sbjct: 236 PPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-17
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 249
+V +M NG + + LRE G+ P S ++ G+AYL + IH
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 250 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV--RGTIGHIAPEYLSTGKSSEK 307
RD+ A N L+D++ V DFGL++ + D T++V + + PE L K S K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 308 TDVFGYGVMLLELIT-GQRAFDL 329
+DV+ +GV++ E+ + G+ ++
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 190 TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
E + +V +M GS+ L+ G+ L +A A G+AY+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 124
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 308
HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 309 DVFGYGVMLLELITGQR 325
DV+ +G++L EL T R
Sbjct: 185 DVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 124 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHR 179
FS+ +G G FG VY R + + +VA+K++ Q E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N ++ RG + LV + + GS + L + PL + GA +GLAYL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL 131
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY- 298
H H +IHRDVKA NILL E +GDFG A +M + V GT +APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 299 --LSTGKSSEKTDVFGYGVMLLEL 320
+ G+ K DV+ G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 9/215 (4%)
Query: 123 NFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 180
+F LG+G +G VYK RL+D A+K + +Q E+ +++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
++ + + + +V + G ++ + +R + + + +I + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
+ KI+HRD+K+ANILL +GD G++K++ K T + GT ++APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWK 174
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 335
S K+D++ G +L E+ T F+ AR D
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 30/254 (11%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH---RNLLRL 184
++GRG +G VY+G+ + G +VA+K + + Q EV ++S N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
G + ++ + GSV + ++ ++ ++ +R+ + L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV-- 120
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
+IHRD+KAANIL+ + DFG+A L++ + +T V GT +APE ++ GK
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 305 SE-KTDVFGYGVMLLELITGQ---------RAFDL------ARLANDDDVMLL-DWVKGL 347
+ K D++ G+ + E+ TG RA L RL ++ LL ++V
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238
Query: 348 LKEKKLEQLVDSDM 361
L E+ E+L ++
Sbjct: 239 LDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
LG+G FG+V+ G + VA+K LK T E F E +++ H L+ L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPE-AFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 190 TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
E + +V FM GS+ L+E L V +A A G+AY+ I
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIERM---NYI 124
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 308
HRD++AANIL+ + + DFGLA+L++ + + I APE G+ + K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 309 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEE 368
DV+ +G++L EL+T R G++ + LEQ V+ +
Sbjct: 185 DVWSFGILLTELVTKGRVP----------------YPGMVNREVLEQ-VERGYRMPCPQG 227
Query: 369 EVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E L ++ LC + P ERP + LE
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 129 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 185
I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 186 GFCMT-----PTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYL 239
CMT P + + M G + L + G S+ + + + I GL ++
Sbjct: 60 -VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-----GLEHM 113
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 300 STGKSSEKT-DVFGYGVMLLELITGQRAF 327
G + + + D F G ML +L+ G F
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G G +G VYK R + G LVA+K +K E E Q E+ M+ H N++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGSY 69
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCDP 245
+ + +V + GS+ + ++ PL+ QIA +GLAYLH+
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLS---ELQIAYVCRETLKGLAYLHET--- 120
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH---IAPEYL-- 299
IHRD+K ANILL E+ + + DFG++ + T T A R + IG +APE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL----TA-TIAKRKSFIGTPYWMAPEVAAV 175
Query: 300 -STGKSSEKTDVFGYGVMLLELITGQ 324
G K D++ G+ +EL Q
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 186
LG G FG+V+ + VAVK +K G + F E ++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 187 FCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHC 243
+T ++ FM GS+ L+ + G QP + K I A A G+A++
Sbjct: 69 -VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQP-----LPKLIDFSAQIAEGMAFIEQR- 121
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 304 SSEKTDVFGYGVMLLELITGQR 325
+ K+DV+ +G++L+E++T R
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 123 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRN 180
F N +G G +G VY+ R T G +VA+K+++ + + G + E+ ++ H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 181 LLRLRGFCMTPTERLLVYPFMVNG----SVASCLRERGQSQPPLNWSVRKQIALGAARGL 236
++ L+ + L F+V +AS L P + S K + L RGL
Sbjct: 68 IVELKEVV---VGKHLDSIFLVMEYCEQDLASLLDN---MPTPFSESQVKCLMLQLLRGL 121
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
YLH++ IIHRD+K +N+LL ++ + DFGLA+ +T V T+ + AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 297 EYL-STGKSSEKTDVFGYGVMLLELITGQ 324
E L + D++ G +L EL+ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 45/287 (15%)
Query: 130 LGRGGFGKVYKGRLTDG--SLVAVKRL----------KEERTQGGELQFQTEVEMISMAV 177
LG G FG VYK R + +L+A+K + K ER + +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66
Query: 178 -HRNLLRLRGFCMTPTERLLVYPFMVNGS----VASCLRERGQSQPPLN-WSVRKQIALG 231
H N++R +RL + ++ G+ + L+E+ Q W++ Q+ L
Sbjct: 67 RHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291
L YLH + +I+HRD+ NI+L E+ + + DFGLAK ++ +T+ V GTI
Sbjct: 126 ----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTI 177
Query: 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351
+ PE + EK DV+ +G +L ++ T Q F ML L K
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------ML------SLATK 224
Query: 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
+E + + EG Y E+V +I C RP + +V M+
Sbjct: 225 IVEAVYEPLPEGMY-SEDVTDVITS---CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 130 LGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FGKV+ D LVAVK LK+ T FQ E E+++ H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 71
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALG 231
G C ++V+ +M +G + LR G Q++ L S IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 290
A G+ YL +HRD+ N L+ +GDFG+++ + D + V
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
I + PE + K + ++DV+ +GV+L E+ T
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 121 TDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
+ + N +G G G+VYK G VA+K+++ + Q EL E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIIN-EILIMKDCKHP 75
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA---RGL 236
N++ + E +V +M GS+ + Q+ +N QIA +GL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEP---QIAYVCREVLQGL 129
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
YLH +IHRD+K+ NILL ++ + DFG A + + + + V GT +AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQ 324
E + K D++ G+M +E+ G+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 129 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 185
I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 186 GFCM-----TPTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYL 239
CM TP + + M G + L + G S+ + + + I GL ++
Sbjct: 60 -VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL-----GLEHM 113
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 300 STGKSSEKT-DVFGYGVMLLELITGQRAF 327
G + + + D F G ML +L+ G F
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 9e-16
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
LG G FG+V+ G + VAVK LK T E F E +++ H L++L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPE-SFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 190 TPTERL-LVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
E + +V +M GS+ L++ R P L +A A G+AY+
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAAGMAYIERM--- 121
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 305
IHRD+++ANIL+ + + DFGLA+L++ + + I APE G+ +
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 306 EKTDVFGYGVMLLELITGQR 325
K+DV+ +G++L EL+T R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 129 ILGRGGFGKV----YKGRLTDGSLVAVKRLKE----ERTQGGELQFQTEV-EMISMAVHR 179
+LGRG FGKV YK G L A+K LK+ R + L + + E + H
Sbjct: 6 VLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI-ALGAARGLAY 238
L+ L T V + G + + S+P R A GL Y
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVVLGLQY 116
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPE 297
LH++ KI++RD+K N+LLD E + DFGL K M + D T+ GT +APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPE 171
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
L+ + D +G GV++ E++ G+ F
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 130 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FGKV+ D LVAVK LK+ + F E E+++ H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 71
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERG-------QSQPP--LNWSVRKQIALGAAR 234
G C+ ++V+ +M +G + LR G + P L S IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGH 293
G+ YL +HRD+ N L+ E +GDFG+++ + D + V I
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
+ PE + K + ++DV+ GV+L E+ T
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGF 187
LG G FGKVYK + G A K ++ E EL+ F E++++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 188 CMTPTERLLVYPFMVNGSVASCLR--ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
+ ++ F G++ S + ERG ++P + + V +Q+ L +LH H
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQML----EALNFLHSH--- 122
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
K+IHRD+KA NILL + + + DFG+ AK T GT +APE ++
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETF 180
Query: 305 SE-----KTDVFGYGVMLLEL 320
+ K D++ G+ L+EL
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 130 LGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
+ +G +G+V+ K + T G + A+K +K+ Q E ++ ++ ++ +
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 188 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
++ LV ++ G +AS L G L+ V + L YLH +
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHSN--- 112
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAK-------LMDYKDTHVTTAVRGTIGHIAPEY 298
IIHRD+K NIL+D + DFGL+K + D + GT +IAPE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 299 LSTGKSSEKTDVFGYGVMLLELITG 323
+ S+ D + G +L E + G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGF 187
+G G G V+K + G VA+K++ R +GG Q E++ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
+ +LV +M ++ LR+ + PL + K +G+AY+H + I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 306
+HRD+K AN+L+ + + DFGLA+L ++ + + T + APE L K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 307 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
D++ G + EL+ G F ++D+ L
Sbjct: 181 GVDLWAVGCIFAELLNGSPLF-----PGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 130 LGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
LG G FGKV R G VAVK LK E + E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 185 RGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
+G C L+ F+ +GS+ L +++ +N + + A+ +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYLS 300
+ +HRD+ A N+L++ E + +GDFGL K ++ + T + + APE L
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 301 TGKSSEKTDVFGYGVMLLELIT 322
K +DV+ +GV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 118 QVATDNFSNRNILGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTE 169
+V D LG G FG+V K + + VAVK LK + T+ +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 170 VEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER----------GQSQP 218
+EM+ M H+N++ L G C ++ + G++ LR R P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 219 PLNWSVRKQI--ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276
S + + A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 277 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
+ D + TT R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 3e-15
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 124 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT----EVEMISMAVH 178
+ LG G +G VYK R G +VA+K+++ + + G + E+ ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKH 57
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
N+++L T + LV+ + + + L +R PL+ ++ K I RGLAY
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAY 113
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
H H +I+HRD+K NIL++ + + DFGLA+ T V T+ + APE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEI 169
Query: 299 L------STGKSSEKTDVFGYGVMLLELITGQ 324
L ST D++ G + E+ITG+
Sbjct: 170 LLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 130 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 180
LG G FG+V K + VAVK LK++ T +E+EM+ M H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---------------LNWSVR 225
++ L G C ++ + G++ LR R +PP L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRAR---RPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VT 284
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + D + T
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
T R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 130 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 180
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQI 228
++ L G C ++ + G++ LR R + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 287
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 288 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
R + +APE L + ++DV+ +GV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 30/188 (15%)
Query: 128 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHR 179
+G G +G VYK R L G VA+K+++ ++ G E+ ++E H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61
Query: 180 NLLRLRGFCMTP-TER----LLVYPFMVNGSVASCLR---ERGQSQPPLNWSVRKQIALG 231
N++RL C P T+R LV+ V+ +A+ L + G + + +Q+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKD-LMRQLL-- 117
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291
RG+ +LH H I+HRD+K NIL+ + + + DFGLA++ Y T+V T+
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVTL 170
Query: 292 GHIAPEYL 299
+ APE L
Sbjct: 171 WYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 130 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRN 180
LG G FG+V K R VAVK LK+ T +E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QI 228
++ L G C ++ + G++ LR R P + + K
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 287
A ARG+ YL + IHRD+ A N+L+ E+ + DFGLA+ + D + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 288 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
R + +APE L + ++DV+ +G+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 130 LGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
LG FGK+YKG L LVA+K LK+ +FQ E +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCL-------------RERGQSQPPLNWSVRKQIALG 231
G +++ ++ G + L E G + L+ IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 290
A G+ YL H +H+D+ A NIL+ E+ + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
I + PE + GK S +D++ +GV+L E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 116 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMI 173
E + D R +LG+G +G VY R L+ +A+K + E ++ +Q E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALH 59
Query: 174 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER----GQSQPPLNWSVRKQIA 229
S HRN+++ G + + GS+++ LR + ++ + + KQI
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT-KQI- 117
Query: 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAV 287
GL YLHD+ +I+HRD+K N+L++ + VV DFG +K + + T
Sbjct: 118 ---LEGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP-CTETF 169
Query: 288 RGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 327
GT+ ++APE + G D++ G ++E+ TG+ F
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 31/272 (11%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
LG G FG V+ G+ VA+K + E E F E +++ H L++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 190 TPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+V FM NG + + LR+R G+ + S+ + + G+ YL + I
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVC----EGMEYLERN---SFI 122
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 307
HRD+ A N L+ V DFG+ + + D + +++ + + PE + K S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 308 TDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366
+DV+ +GV++ E+ T G+ F + +N + V+ + + +L + + +
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPF--EKKSN------YEVVEMISRGFRLYR---PKLASMTV 230
Query: 367 EEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
E V C P RP +E++R +
Sbjct: 231 YE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 107 GQLKRFSLRELQVATDN---FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG 162
G LK + EL D F++ +G G FG VY R + +VA+K++ Q
Sbjct: 7 GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 163 ELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP 219
E ++Q EV+ + H N + +G + LV + + GS + L + P
Sbjct: 67 E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH---KKP 121
Query: 220 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279
L I GA +GLAYLH H +IHRD+KA NILL E + + DFG A +
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178
Query: 280 DTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLEL 320
++ V GT +APE + G+ K DV+ G+ +EL
Sbjct: 179 NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 129 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT-QGGELQF-QTEVEMISMAVHRNLLRLR 185
+LG+G FGKV L L AVK LK++ Q +++ TE ++++A L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
C +RL VNG L Q + + A GL +LH+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER--- 115
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
II+RD+K N+LLD E + DFG+ K + T T+ GT +IAPE LS
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPY 173
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDD 337
D + GV+L E++ GQ F+ +D+D
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFE----GDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 124 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
F+ +G+G FG+VYKG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
R G + T+ ++ ++ GS L+ PL + I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE 120
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
+ IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 303 KSSEKTDVFGYGVMLLELITGQ 324
K D++ G+ +EL G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 60/204 (29%), Positives = 108/204 (52%), Gaps = 27/204 (13%)
Query: 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANIL 258
FM GS+ ++ G P+ + +IA+ GL YL++ H +I+HRD+K +NIL
Sbjct: 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNIL 136
Query: 259 LDEEFEAVVGDFGLA-KLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 316
++ + + DFG++ +L++ DT V GT +++PE + GK + K+DV+ G+
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 317 LLELITGQRAFDLARLAND--DDVM-LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQL 373
++EL G+ F + + +D DD M +LD ++ +++E +L SD E++
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-PRLPSSDF-----PEDLRDF 245
Query: 374 IQVALLCTQGSPMERPKMSEVVRM 397
+ LL P ERP ++ M
Sbjct: 246 VDACLLKD---PTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 63/198 (31%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 130 LGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRLR 185
+G G FG VY +VAVK++ Q E ++Q EV+ + H N + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
G + LV + + GS + L + PL I GA +GLAYLH H
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTG 302
+IHRD+KA NILL E + + DFG A ++ V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 303 KSSEKTDVFGYGVMLLEL 320
+ K DV+ G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 130 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG G + VYKGR LTD +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
T LV+ ++ + + L + G S +N K RGL Y H K+
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 306
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 307 KTDVFGYGVMLLELITGQRAF 327
+ D++G G + E+ TG+ F
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 129 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHRNLLRLR 185
+LG+G FGKV RL G L AVK LK++ Q +++ TE ++S+A + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG---------- 235
C +RL VNG L + ++K AR
Sbjct: 62 YCCFQTPDRLFFVMEFVNGG-------------DLMFHIQKSRRFDEARARFYAAEITSA 108
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
L +LHD II+RD+K N+LLD E + DFG+ K + T+ GT +IA
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIA 164
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338
PE L D + GV+L E++ G F+ N+DD+
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---EVEMISMAV 177
+ + ++G G +G V K R G +VA+K+ KE E +T EV+++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
H N++ L+ LV+ + V ++ L PP +VR I + +A
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEY-VERTLLELLEASPGGLPPD--AVRSYI-WQLLQAIA 114
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
Y H H IIHRD+K NIL+ E + DFG A+ + + T T + APE
Sbjct: 115 YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 298 YL----STGKSSEKTDVFGYGVMLLELITGQRAF 327
L + GK DV+ G ++ EL+ G+ F
Sbjct: 172 LLVGDTNYGKP---VDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 59/221 (26%), Positives = 110/221 (49%), Gaps = 11/221 (4%)
Query: 123 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
NF LG G + VYKGR T G +VA+K + + +G E+ ++ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
+RL T + +LV+ +M + + + G + L+ + K +G+A+ H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
+ +++HRD+K N+L+++ E + DFGLA+ + V T+ + AP+ L
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 302 GKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
++ S D++ G ++ E+ITG+ F N++D +L
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLF---PGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 68/282 (24%), Positives = 121/282 (42%), Gaps = 21/282 (7%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
+ + LG G G V K RL + ++ A+K + + + Q E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 181 LLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
+++ G + + + + GS+ S ++ + + V +IA +GL+Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPE 297
LH KIIHRD+K +NILL + + + DFG++ +L++ T GT ++APE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPE 173
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
+ S +DV+ G+ LLE+ + F + ++ + ++ E L
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPE-LK 229
Query: 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
D G EE + I+ C + P RP MLE
Sbjct: 230 DEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPW---DMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRG 186
++G G +G+VYKGR + G L A+K + + T+ E + + E+ M+ + HRN+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 187 FCMTPT------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+ + + LV F GSV ++ + +W I RGLA+LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLH 138
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 194
Query: 301 TGKSSEKT-----DVFGYGVMLLELITG 323
++ + T D++ G+ +E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 124 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
+ G + T+ ++ ++ GS L E G PL+ + I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL-EPG----PLDETQIATILREILKGLDYLHSE 120
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLST 301
K IHRD+KAAN+LL E E + DFG+A + DT + GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 302 GKSSEKTDVFGYGVMLLELITGQ 324
K D++ G+ +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
LG G FGKVYK + + +A ++ E +++ + E+E+++ H +++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 190 TPTERLLVYPFMVNGSVASCLRE--RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
+ ++ F G+V + + E RG ++P + R+ + L YLH KI
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSM---KI 131
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYL--ST 301
IHRD+KA N+LL + + + DFG++ K + +D+ + GT +APE + T
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 302 GKSSE---KTDVFGYGVMLLEL 320
K + K D++ G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLK------EERTQGGELQFQTEVEMISMAVHRNLL 182
LG G FG VY R G LVA+K++K EE E++ + + H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS-----LRKLNEHPNIV 61
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
+L+ E V+ +M G++ +++R P + SV + I +GLA++H H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH 118
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL--S 300
HRD+K N+L+ + DFGLA+ + + + T V T + APE L S
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRS 173
Query: 301 TGKSSEKTDVFGYGVMLLELITGQ 324
T SS D++ G ++ EL T +
Sbjct: 174 TSYSS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 122 DNFSNRNILGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS- 174
+N S LG G FGKV + +D + VAVK LK +E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN--WSVRKQIALGA 232
+ H N++ L G C L++ + G + + LR + +S L S Q+A
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA--- 151
Query: 233 ARGLAYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT 290
+G+A+L +C IHRD+ A N+LL + DFGLA+ +M+ + V R
Sbjct: 152 -KGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
+ +APE + + ++DV+ YG++L E+ +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 129 ILGRGGFGKVYKGRLT--DGSL--VAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLR 183
+LG+G FG V + +L DGS VAVK LK + ++ +F E + H N+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 184 LRGFCM--TPTERL----LVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARG 235
L G + RL ++ PFM +G + + L + P ++ + + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHI 294
+ YL IHRD+ A N +L+E V DFGL+K + D + A + + +
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 327
A E L+ + +DV+ +GV + E++T GQ +
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 123 NFSNRNILGRGGFGKVY----KGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISM-A 176
NF +LG G +GKV+ G G L A+K LK+ Q + T E + A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 177 VHRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 234
V R L+ L T T+ L+ ++ G + + L +R VR IA
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIA-EIVL 116
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 294
L +LH II+RD+K NILLD E V+ DFGL+K ++ + GTI ++
Sbjct: 117 ALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 295 APEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 327
APE + G + D + GV+ EL+TG F
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 123 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL----KEERTQGGELQFQTEVEMISMAV 177
N+ +LGRG FG+VY D G +AVK++ + T + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 178 HRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
H +++ G P E+ L +M GS+ L+ G + +QI +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QG 118
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGH 293
++YLH + I+HRD+K ANIL D +GDFG +K + +V GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
++PE +S K DV+ ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 124 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
+ G + T+ ++ ++ GS LR G ++ K+I +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEIL----KGLDYLHSE 120
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
K IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 303 KSSEKTDVFGYGVMLLELITGQ 324
K D++ G+ +EL G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 7e-14
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRG 186
++G G +G+VYKGR + G L A+K + + T E + + E+ M+ + HRN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 187 FCMTPT------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+ + LV F GSV ++ + W I RGL++LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH 128
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 184
Query: 301 TGKSSE-----KTDVFGYGVMLLELITG 323
++ + K+D++ G+ +E+ G
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 129 ILGRGGFGKVYKGRLTD-GSLVAVKRLK---EERTQGGELQ-FQTEVEMISMAVHRNLLR 183
+LG+G FG+VY D G +AVK+++ E E+ + E++++ +H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 184 LRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
G P ER L M GS+ L+ G + +QI G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYL 299
+ I+HRD+K ANIL D +GDFG +K + T +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 300 STGKSSEKTDVFGYGVMLLELIT 322
S K D++ G ++E++T
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG----------ELQFQTEVEMISMAVH 178
LG G + VYK R G +VA+K++K + E++ E++ H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGA 232
N++ L + LV+ FM + ++++ S+ K L
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMT 111
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 292
RGL YLH + I+HRD+K N+L+ + + DFGLA+ + +T V T
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 293 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338
+ APE L + D++ G + EL+ + F L D D+
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF----LPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 74/302 (24%), Positives = 133/302 (44%), Gaps = 49/302 (16%)
Query: 117 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-----VAVKRLKEERTQGGELQ---FQT 168
+ ++ D + ++L G FG+++ G L D V VK +K+ E+Q
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQ 57
Query: 169 EVEMISMAVHRNLLRLRGFCMTPTERLLV-YPFMVNGSVASCLRERGQSQPPLNWSVRKQ 227
E ++ H+N+L + C+ E V YP+M G++ L++ + ++ Q
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 228 ----IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYK- 279
+A+ A G++YLH +IH+D+ A N ++DEE + + D L++ MDY
Sbjct: 118 QLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 280 --DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 336
D + +A E L + S +DV+ +GV+L EL+T GQ +
Sbjct: 175 LGDNE-----NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY--------V 221
Query: 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
++ + L +L Q ++ ++L V C P ERP S++V+
Sbjct: 222 EIDPFEMAAYLKDGYRLAQPINCP----------DELFAVMACCWALDPEERPSFSQLVQ 271
Query: 397 ML 398
L
Sbjct: 272 CL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 130 LGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 186
LG+GGFG+V ++ G + A K+L ++R + GE E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGAARGLAYLHDHCD 244
+ T LV M G + + G+ + + QI G LH H
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI------LHLH-S 113
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
I++RD+K N+LLD++ + D GLA ++ KD T GT G++APE L
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 305 SEKTDVFGYGVMLLELITGQRAF 327
S D F G + E++ G+ F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 123 NFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 179
+ +G G FGK+Y K + +D +K + + E + + EV +++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERG---QSQPPLNWSVRKQIALGAARG 235
N++ +V + G + + R+RG L+W V QI+LG
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG---- 113
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 294
L ++HD KI+HRD+K+ NI L + A +GDFG+A+ ++ T V GT ++
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYL 169
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
+PE + KTD++ G +L EL T + F+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 114 LRELQVATDNFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLKEERTQGGELQFQTEVEM 172
L L TD + +G+G +GKVYK DGSL AVK L E++ + + +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72
Query: 173 ISMAVHRNLLRLRGFC-----MTPTERLLVYPFMVNGSVASCLR---ERGQSQPPLNWSV 224
S+ H N+++ G + + LV GSV ++ GQ L+ ++
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR---LDEAM 129
Query: 225 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 284
I GA GL +LH++ +IIHRDVK NILL E + DFG++ +
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 285 TAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITG 323
T+V GT +APE ++ + + + DV+ G+ +EL G
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 65/206 (31%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 130 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEM-ISMAVH-RNLLRLRG 186
LG+GGFG+V ++ G L A K+L ++R + + VE I VH R ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQP----PLNWSVRKQIALGAARGLAYLHDH 242
T T+ LV M G + + + P P QI G L +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQR 116
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEYLST 301
+II+RD+K N+LLD + + D GLA +L D + T GT G +APE L
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQG 171
Query: 302 GKSSEKTDVFGYGVMLLELITGQRAF 327
+ D F GV L E+I + F
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 130 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG G + V+KGR LT +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
T LV+ ++ + + L G N K RGL+Y H KI
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHN---VKIFMFQLLRGLSYCHKR---KI 124
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 306
+HRD+K N+L++E+ E + DFGLA+ + V T+ + P+ L + + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 307 KTDVFGYGVMLLELITGQRAF 327
D++G G +L E+ TG+ F
Sbjct: 184 PIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 51/200 (25%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
LG G FGKVYK + + ++A ++ + +++ + E+++++ H N+++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 249
++ F G+V + + E + PL + + L YLH++ KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 250 RDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 305
RD+KA NIL + + + DFG++ + + +D+ + GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 306 E-----KTDVFGYGVMLLEL 320
+ K DV+ G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 130 LGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+G G FGKV G + G + V VK L+ + +++F E + H NLL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
C T LLV F G + LR R + + +++A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGK 303
IH D+ N LL + +GD+GL+ YK+ + T + + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHN-KYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 304 S-------SEKTDVFGYGVMLLEL 320
+++++V+ GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 130 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG G + V+KGR LT+ +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
T LV+ ++ + + + + G N K RGLAY H K+
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN---VKIFLYQILRGLAYCHRR---KV 125
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 306
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 307 KTDVFGYGVMLLELITGQRAF 327
+ D++G G + E+ +G+ F
Sbjct: 185 QIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-----MDY 278
+ KQI GL YLH +IIHRDVK NI +++ + +GD G A+
Sbjct: 162 IEKQIL----EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214
Query: 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 321
+ GT+ APE L+ K + K D++ G++L E++
Sbjct: 215 -------GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 61/278 (21%), Positives = 120/278 (43%), Gaps = 22/278 (7%)
Query: 123 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAVHR 179
NF +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N+++ + E +V G ++ ++ + + + + + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
H +++HRD+K AN+ + +GD GL + K T + V GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359
+ K+D++ G +L E+ Q F D + L KK+EQ
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLC------KKIEQCDYP 226
Query: 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
+ ++ EE+ QL+ +C P +RP ++ V +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 74/279 (26%), Positives = 130/279 (46%), Gaps = 43/279 (15%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLR- 185
++G+G +G+V R TDG +K+L E + + E +++S H N++ R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 186 ----GFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPP---LNWSVRKQIALGAARGLA 237
+ +V F G + L+E +G+ P + W V QIA+ L
Sbjct: 67 SWEGEDGLL----YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV--QIAMA----LQ 116
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
YLH+ I+HRD+K N+ L VGD G+A++++ + +T + GT +++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
S + K+DV+ G + E+ T + AF+ A D + ++ ++G KL
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFN----AKDMNSLVYRIIEG-----KLPP-- 221
Query: 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
M +Y E E LI +L + P +RP + ++R
Sbjct: 222 ---MPKDYSPELGE-LIA-TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 121 TDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
NF +LG+G FGKV R L A+K LK++ + T VE +A+
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 180 N---LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
L +L C +RL V ++ G + +++ G+ + P +I++G
Sbjct: 59 KPPFLTQLHS-CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG---- 113
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
L +LH II+RD+K N++LD E + DFG+ K D T GT +IA
Sbjct: 114 LFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-DGVTTRTFCGTPDYIA 169
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
PE ++ + D + YGV+L E++ GQ FD
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK--RLKEERTQGGELQFQTEVEMISMAVH 178
D F +G G +G+VYK R D G LVA+K RL E+ +G + E++++ H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNH 65
Query: 179 RNLLRLRGFCMTPTERL----------LVYPFM---VNGSVASCLRERGQSQPPLNWSVR 225
RN++ L+ + L LV+ +M + G + S L + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH---IKSFM 122
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285
KQ+ GL Y H +HRD+K +NILL+ + + + DFGLA+L + +++ T
Sbjct: 123 KQL----LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 286 AVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
T+ + PE L + DV+ G +L EL T + F
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 123 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK----EERTQGGELQFQTEVEMISMAV 177
N+ +LG+G FG+VY D G +A K+++ T + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 178 HRNLLRLRGFCMTPTERLLV--YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
H +++ G E+ L +M GSV L+ G L SV ++ G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEG 118
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGH 293
++YLH + I+HRD+K ANIL D +GDFG +K + T +V GT
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
++PE +S K DV+ G ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 71/295 (24%), Positives = 136/295 (46%), Gaps = 46/295 (15%)
Query: 128 NILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLR 183
+++G G FG+V + + L A+K LKE ++ F E+E++ + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRK--QIALG 231
L G C + + G++ LR+ ++ P + ++ Q A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 290
A G+ YL + + IHRD+ A N+L+ E + + DFGL++ ++ +V T R
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 349
+ +A E L+ + K+DV+ +GV+L E+++ G + A + + L +
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ 233
Query: 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV----RMLEG 400
++E+ + D +EV +L++ C + P ERP +++ RMLE
Sbjct: 234 GYRMEKPRNCD-------DEVYELMR---QCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 78/294 (26%), Positives = 139/294 (47%), Gaps = 46/294 (15%)
Query: 128 NILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLR 183
+++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRK--QIALG 231
L G C L + +G++ LR+ ++ P S ++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 290
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ ++ +V T R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 349
+ +A E L+ + +DV+ YGV+L E+++ G + A + + L +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ 226
Query: 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV----RMLE 399
+LE+ ++ D +EV L++ C + P ERP ++++ RMLE
Sbjct: 227 GYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 124 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 180
F +LG+GGFG+V ++ G + A K+L+++R + GE E +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GLA 237
++ L T LV M G + + G++ + AA GL
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEICCGLE 116
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
LH +I++RD+K NILLD+ + D GLA + + GT+G++APE
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPE 171
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+ + + D + G +L E+I GQ F
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 122 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
D++ LG G + VYKG+ +G LVA+K ++ + +G E ++ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
++ L T LV+ + V+ + + + P N K RGL+Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPEN---VKLFLFQLLRGLSYIH 120
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YL 299
I+HRD+K N+L+ + E + DFGLA+ +H + T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLL 176
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAF 327
+ + S D++G G + +E+I G AF
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 129 ILGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRL 184
++G+G FGKV R +DGS AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
T + V ++ G + L RER +P + A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-----YAAEVASAIGYLHSL- 115
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 302
II+RD+K NILLD + V+ DFGL K ++ ++T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 303 KSSEKTDVFGYGVMLLELITGQRAF 327
D + G +L E++ G F
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 63/250 (25%), Positives = 119/250 (47%), Gaps = 41/250 (16%)
Query: 107 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 165
GQ L +L+ + +G G G+VYK R G ++AVK+++ RT E
Sbjct: 7 GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKEEN 57
Query: 166 FQT--EVEMISMAVHR--NLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPL 220
+ +++++ + H +++ G+ +T ++ + M ++CL + + Q P+
Sbjct: 58 KRILMDLDVVLKS-HDCPYIVKCYGYFITDSDVFICMELM-----STCLDKLLKRIQGPI 111
Query: 221 NWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDY 278
+ ++ + + L YL + H +IHRDVK +NILLD + DFG++ +L+D
Sbjct: 112 PEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168
Query: 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEK----TDVFGYGVMLLELITGQRAFD------ 328
K +A G ++APE + + K DV+ G+ L+EL TGQ +
Sbjct: 169 K-AKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225
Query: 329 --LARLANDD 336
L ++ ++
Sbjct: 226 EVLTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 130 LGRGGFGKVY------------KGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 172
LG G FG+V+ K + + LVAVK L+ + + F EV++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 173 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER-------GQSQPPLNWSVR 225
+S N+ RL G C ++ +M NG + L++ + L++S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTH 282
+A A G+ YL +HRD+ N L+ + + + DFG+++ + DY
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR-- 187
Query: 283 VTTAVRGT----IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
V+G I +A E + GK + K+DV+ +GV L E++T
Sbjct: 188 ----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 33/274 (12%)
Query: 127 RNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185
+ ILG G G VYK L ++AVK + + T + Q +E+E++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK---------- 55
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ----IALGAARGLAYLHD 241
C +P F V ++ C + + + IA+ +GL YL
Sbjct: 56 --CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWS 113
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
KI+HRDVK +N+L++ + + DFG++ + ++ T V GT ++APE +S
Sbjct: 114 L---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISG 167
Query: 302 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361
+ +DV+ G+ +EL G+ + N +M L + L+ +VD D
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPL---------QLLQCIVDEDP 217
Query: 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 395
+ + E+ + C + P ERP ++
Sbjct: 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 179
D + N + G +G VY+ R G +VA+K+LK E+ +G + E+ ++ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 180 NLLRLRGFCM--TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
N++ ++ + + +V ++ + + S + + P S K + L G+A
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVA 120
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIG 292
+LHD+ I+HRD+K +N+LL+ + DFGLA+ L Y VT R
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR---- 173
Query: 293 HIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
APE L + S D++ G + EL+T + F
Sbjct: 174 --APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 35/167 (20%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRL-- 184
LG G FG+VYK R + G +VA+K++ E+ G + E++++ H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLID 74
Query: 185 ------RGFCMTPTERLLVYPFMV--------NGSVASCLRERGQSQPPLNWSVRKQIAL 230
+V P+M N SV L S K L
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------------LTESQIKCYML 122
Query: 231 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277
G+ YLH++ I+HRD+KAANIL+D + + DFGLA+ D
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVH 178
T+ + + +G G FG V R G VA+K++ K T + E++++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
N++ L ++P E + ++ + L R PL + RGL Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKY 123
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
+H ++HRD+K +NIL++E + + DFGLA++ +D +T V T + APE
Sbjct: 124 VHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYV-STRYYRAPEI 176
Query: 299 LST-GKSSEKTDVFGYGVMLLELITGQRAF 327
+ T K + D++ G + E++ G+ F
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 129 ILGRGGFGKVYKGRLTDGS-LVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNL 181
+LG+G FGKV L + A+K LK++ + E M+ V H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD---DVECTMVERRVLALAWEHPFL 58
Query: 182 LRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA--RGLA 237
L FC T+ L V ++ G + ++ G+ + + A GL
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR------FDEARARFYAAEIICGLQ 110
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
+LH II+RD+K N+LLD++ + DFG+ K + +T GT +IAPE
Sbjct: 111 FLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPE 166
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
L K +E D + +GV+L E++ GQ F
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 130 LGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 186
+G G FGK + K + DG +K + + E + + EV ++S H N+++ +
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 187 FCMTPTERLLVYPFMVNGSVASCL-RERG---QSQPPLNWSVRKQIALGAARGLAYLHDH 242
+V + G + + +RG L+W V QI L L ++HD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV--QICLA----LKHVHDR 120
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
KI+HRD+K+ NI L ++ +GDFG+A++++ T + GT +++PE
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 303 KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 334
+ K+D++ G +L E+ T + AF+ + N
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 123 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 180
NF +G G +G VYK R G +VA+K+++ + T+G E+ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAY 238
+++L T + LV+ F+ L++ + P + + K +GLA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIGH 293
H H +++HRD+K N+L++ E + DFGLA+ + Y VT R
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR----- 167
Query: 294 IAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAF 327
APE L K S D++ G + E++T + F
Sbjct: 168 -APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH 178
D+F LG G FG+V R G A+K L + + E ++ H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIALGAAR 234
L+ L G + LV ++ G + S LR+ G+ P + + Q+ L
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR--FPEPVA--RFYAAQVVLA--- 113
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 294
L YLH D I++RD+K N+LLD + + DFG AK + + T + GT ++
Sbjct: 114 -LEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYL 165
Query: 295 APEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
APE + + GK+ D + G+++ E++ G F DD+ + +
Sbjct: 166 APEIILSKGYGKAV---DWWALGILIYEMLAGYPPFF------DDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
N +G G G VYK G L A+K + Q E+E++ H N+++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
E ++ FM GS L + V +QI G+AYLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLADVARQIL----SGIAYLHRR---H 188
Query: 247 IIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
I+HRD+K +N+L++ + DFG LA+ MD ++ V GTI +++PE ++T
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTD 243
Query: 303 KSSEK-----TDVFGYGVMLLELITGQRAFDLAR 331
+ D++ GV +LE G+ F + R
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 32/225 (14%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG----ELQFQTEVEMISMA 176
D + +G G +GKVYK R G LVA+K+ + E + G L+ + ++M+S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 177 VHRNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 229
++ ++RL + E LV+ ++ + PL K
Sbjct: 61 IY--IVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAK-----LMDYKDTHV 283
+G+A+ H H ++HRD+K N+L+D++ + + D GL + + Y V
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 284 TTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 327
T R APE L S D++ G + E+ Q F
Sbjct: 174 TLWYR------APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 123 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
+F+ +LG+G FGKV R L A+K LK++ + Q + +M V + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD------VIIQDDDVECTM-VEKRV 53
Query: 182 LRLRG---------FCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 231
L L G C +RL V ++ G + +++ G+ + P +IA+G
Sbjct: 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG 113
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291
L +LH II+RD+K N++LD E + DFG+ K + T GT
Sbjct: 114 ----LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRTFCGTP 165
Query: 292 GHIAPE---YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
+IAPE Y GKS D + +GV+L E++ GQ FD
Sbjct: 166 DYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 71/248 (28%), Positives = 114/248 (45%), Gaps = 31/248 (12%)
Query: 129 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRG 186
+LG+G FGKV L G AVK LK++ + T VE +A+ N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 187 FCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--GLAYLHDH 242
+C T+ L V F+ G + ++++G+ + + + A GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR------FDLYRATFYAAEIVCGLQFLHSK 115
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
II+RD+K N++LD + + DFG+ K + D +T GT +IAPE L
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGL 171
Query: 303 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD--------WVKGLLKEKK-- 352
K + D + +GV+L E++ GQ F DD+ L + + + + KE K
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFH-----GDDEDELFESIRVDTPHYPRWITKESKDI 226
Query: 353 LEQLVDSD 360
LE+L + D
Sbjct: 227 LEKLFERD 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 30/281 (10%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAV 177
NF +G+G F VYK L DG +VA+K+++ E E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAA 233
H N+++ + E +V G ++ ++ + + + W Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
L ++H +I+HRD+K AN+ + +GD GL + K T + V GT +
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353
++PE + + K+D++ G +L E+ Q F D + L KK+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLC------KKI 220
Query: 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
E+ + ++ EE+ L+ C P +RP +S V
Sbjct: 221 EKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 12/210 (5%)
Query: 123 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHR 179
+F+ +LG+G FGKV R L A+K LK++ Q +++ E +++++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 180 NLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
L C +RL V ++ G + +++ G+ + P +IA+G L +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
LH II+RD+K N++LD E + DFG+ K + D T GT +IAPE
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEI 172
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
++ + D + +GV+L E++ GQ F+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 124 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 180
F +LG+GGFG+V ++ G + A KRL+++R + GE E +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
++ L T LV M G + + G P ++ AA L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFE---EERALFYAAEILCGLE 116
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
D ++RD+K NILLD+ + D GLA + + GT+G++APE L+
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAF 327
+ + D +G G ++ E+I GQ F
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 129 ILGRGGFGKVYKGRL--TDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHRNLLRL 184
+LG+G FGKV L TD + A+K LK++ Q ++ TE ++++A L
Sbjct: 2 VLGKGSFGKVMLAELKGTD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
C +RL VNG L + Q + + A L +LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGD---LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
+I+RD+K NILLD E + DFG+ K TT GT +IAPE L +
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEY 173
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338
D + GV++ E++ GQ F+ N+DD+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFE---ADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 48/185 (25%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 148 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 207
LVAVK L+ + T+ F E++++S + N++RL G C++ ++ +M NG +
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 208 SCLRER--------GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259
L +R + P ++ + +A+ A G+ YL +HRD+ N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 260 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVML 317
+ + DFG+++ + Y + R I +A E + GK + +DV+ +GV L
Sbjct: 163 GNHYTIKIADFGMSRNL-YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 318 LELIT 322
E+ T
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 25/232 (10%)
Query: 130 LGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAV---HRNLLR 183
+G G +GKV+K R G VA+KR++ + +G L EV ++ H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 184 LRGFCM---TPTERLLVYPF-MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
L C T E L F V+ + + L + +P + K + RGL +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
H H +++HRD+K NIL+ + + DFGLA++ ++ T+V T+ + APE L
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVL 181
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAF----DLARLANDDDVMLL----DW 343
+ D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 129 ILGRGGFGKVYKGRL--TDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 184
++GRG + KV RL T+ + A+K +K+E E QTE + A + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTE-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN---WSVRKQIALGAARGLAYLHD 241
C RL VNG +R + P + +S +AL YLH+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE 114
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 302 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353
D + GV++ E++ G+ FD+ +++ D D++ ++ EK++
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 1e-11
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 48/225 (21%)
Query: 124 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---------EVEMI 173
+ +G G +G V G VA+K++ F E++++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53
Query: 174 SMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 227
H N++ L + P +V M + L + +S PL +
Sbjct: 54 RHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQY 107
Query: 228 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH----- 282
RGL YLH +IHRD+K +NIL++ + + DFGLA+ +D +
Sbjct: 108 FLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 283 ---VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITG 323
VT R APE LS+ + ++ D++ G + EL+T
Sbjct: 165 EYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 129 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
+G G FG VY+G VAVK K + +F E ++ H ++++L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 185 RGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
G ++ + P G + S L+ S L+ + + + LAYL
Sbjct: 73 IGVITENPVWIVMELAPL---GELRSYLQVNKYS---LDLASLILYSYQLSTALAYLESK 126
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
+ +HRD+ A N+L+ +GDFGL++ ++ + + + + I +APE ++
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 303 KSSEKTDVFGYGVMLLE-LITGQRAFDLARLANDDDVMLLD 342
+ + +DV+ +GV + E L+ G + F + N+D + ++
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPF--QGVKNNDVIGRIE 222
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 130 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG G + VYKGR LT LVA+K ++ E +G E ++ H N++ L
Sbjct: 13 LGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCD 244
T LV+ ++ + + + G N VR Q+ RGLAY H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN--VRLFLFQLL----RGLAYCHQR-- 122
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYL 299
+++HRD+K N+L+ E E + DFGLA+ Y + VT R P+ L
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVL 175
Query: 300 --STGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 335
ST S+ D++G G + E+ TG+ F + D
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 130 LGRGGFGKVYKGRL-TDGSLVAVKRLKE----ERTQGGELQFQTEVEMISMAVHRNLLRL 184
LG GGFG+V ++ + A+K +K+ E Q + +E E++ H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ--QEHIFSEKEILEECNHPFIVKL 58
Query: 185 -RGFCMTPTERLLVY---PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
R F ++ +Y + + G + + LR+RG + + YLH
Sbjct: 59 YRTF----KDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLH 110
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYL 299
+ II+RD+K N+LLD + DFG AK L + T T GT ++APE +
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEII 164
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
D + G++L EL+TG+ F +D+D M
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFG----EDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 124 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 180
F + +LG+GGFG+V ++ G + A K+L+++R + GE E ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL-GAARGLAYL 239
++ L T LV M G + + G N +Q A+ AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG------NPGFDEQRAIFYAAELCCGL 115
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG---TIGHIAP 296
D +I++RD+K NILLD+ + D GLA + +T VRG T+G++AP
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAP 170
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
E ++ K + D +G G ++ E+I GQ F
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 39/93 (41%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHI 294
LAYLH IIHRDVK NI LDE AV+GDFG A KL + DT GT+
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+PE L+ KTD++ G++L E+
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 124 FSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHR 179
F + +LG+GGFG+V + R T G + A K+L+++R + GE E +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GL 236
++ L T LV M G + + G ++ AA GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----EERAVFYAAEITCGL 115
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
LH +I++RD+K NILLD+ + D GLA ++ + GT+G++AP
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAP 170
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
E + + + D +G G ++ E+I G+ F
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 123 NFSNRNILGRGGFGKVYKGRLTDG----SLVAVKRLKEER-TQGGELQFQTEVEMISMAV 177
NF +LG G +GKV+ R G L A+K LK+ Q + T E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 178 HRN---LLRLRGFCMTPTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGA 232
R L+ L T T+ L+ ++ G + + L RER + Q QI G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-------EVQIYSGE 113
Query: 233 -ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291
L +LH II+RD+K NILLD V+ DFGL+K + + GTI
Sbjct: 114 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 292 GHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 327
++AP+ + G + D + GV++ EL+TG F
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 59/165 (35%), Positives = 80/165 (48%), Gaps = 24/165 (14%)
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIG 292
LA H H +IHRD+K+ANILL +GDFG +K+ Y T V GT
Sbjct: 154 LAVHHVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSKM--YAATVSDDVGRTFCGTPY 210
Query: 293 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352
++APE S+K D+F GV+L EL+T +R FD N ++VM K L +
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVMH----KTL--AGR 261
Query: 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
+ L S I E+ Q I ALL P RP S+++ M
Sbjct: 262 YDPLPPS------ISPEM-QEIVTALLS--SDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 124 FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRN 180
+ N ++G G +G V K + + G +VA+K+ E+ ++ + E+ M+ H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
L+ L LV+ F+ + + L + + L+ S ++ RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTHVTTAVRGTIGHIA 295
H IIHRD+K NIL+ + + DFG A+ + Y D T R A
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR------A 168
Query: 296 PEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 327
PE L K D++ G ++ E++TG+ F
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMAVHRNLLR 183
++G+G FGKV + DG AVK L+++ + + + + V ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQI-ALGAARGLAYLHD 241
L T + V ++ G + L RER +P R + A A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP------RARFYAAEIASALGYLHS 114
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLS 300
II+RD+K NILLD + V+ DFGL K +++ T T+ GT ++APE L
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLR 169
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAF 327
D + G +L E++ G F
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 146 GSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203
G VA+K L+ + + +F+ E + + H N++ L P L V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---D 260
G LRE + L ++ L LA H+ I+HRD+K NI++
Sbjct: 63 GRT---LREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 261 EEFEAVVGDFGLAKLM-DYKDTHVTTAVR-----GTIGHIAPEYLSTGKSSEKTDVFGYG 314
A V DFG+ L+ +D V T R GT + APE L + +D++ +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 315 VMLLELITGQRAFDLARLA-------NDDDVMLLDWVKGL 347
++ LE +TGQR A +A + DV L W+ G
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH 216
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 130 LGRGGFGKVYKG--RLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
LG G FG V KG ++ + VA+K LK E + + E E++ + ++R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR--KQIALGAARGLAYLHDHCD 244
C E L++ M +G + + + ++ V Q+++G + YL
Sbjct: 63 VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEGK-- 114
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLSTG 302
+HRD+ A N+LL + A + DFGL+K + D++ +A + + APE ++
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 303 KSSEKTDVFGYGVMLLELIT-GQRAF 327
K S ++DV+ YG+ + E + GQ+ +
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAV---HRNLLRL 184
+G G +G VYK R G VA+K ++ + + G L EV ++ H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDH 242
C T +V V LR PP L K + RGL +LH +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
C I+HRD+K NIL+ + + DFGLA++ + T V T+ + APE L
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQS 182
Query: 303 KSSEKTDVFGYGVMLLEL 320
+ D++ G + E+
Sbjct: 183 TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 187
+G G +G VYK R L G L AVK +K E G + Q E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
++ + + + GS+ G PL+ + +GLAYLH
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLSTGK 303
+HRD+K ANILL + + + DFG+A + T A R GT +APE + K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 304 S---SEKTDVFGYGVMLLELITGQRA-FDL 329
+ ++ D++ G+ +EL Q FDL
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 123 NFSNRNILGRGGFGKVYKGRLTDG----SLVAVKRLKEER-TQGGELQFQTEVEMISMAV 177
NF +LG G +GKV+ R G L A+K L++ Q + T E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 178 HRN---LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 234
R L+ L T + L+ ++ G + + L +R N+S +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEI 114
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 294
LA H H I++RD+K NILLD E V+ DFGL+K ++ T + GTI ++
Sbjct: 115 ILALEHLH-KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 295 APEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDL 329
APE + G + D + G+++ EL+TG F L
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 53/223 (23%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEV------------------- 170
LG+G F K++KG ++ E GEL +TEV
Sbjct: 3 LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49
Query: 171 -EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNW--SVRKQ 227
M+S H++L+ G C+ E ++V ++ GS+ + L++ + ++W V KQ
Sbjct: 50 ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQ 108
Query: 228 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 287
+A L +L D + H +V A N+LL E + G+ KL D ++ V
Sbjct: 109 LAW----ALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITV 158
Query: 288 RGT------IGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITG 323
I + PE + ++ S D + +G L E+ +G
Sbjct: 159 LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 129 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE--MISMA-VHRNLLRL 184
+LG+G FGKV+ L A+K LK++ + T VE ++S+A H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 185 RGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
+C T+ L V ++ G + ++ + P +I G L +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK 115
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
I++RD+K NILLD + + DFG+ K D T GT +IAPE L
Sbjct: 116 ---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQ 171
Query: 303 KSSEKTDVFGYGVMLLELITGQRAF 327
K + D + +GV+L E++ GQ F
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 61/287 (21%)
Query: 129 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
ILG G FG++ +G L S VA+ L+ + F E + H N++RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
G ++V +M NG++ S LR+ GQ L + G A G+ YL +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEM- 126
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLST 301
+H+ + A +L++ + + F +L + K + T + G + APE +
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 302 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
S +DV+ +G+++ E+++ G+R + W D
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPY---------------W----------------D 211
Query: 361 MEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEV 394
M G + + VE L Q+ L C Q ERP+ S++
Sbjct: 212 MSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 122 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
DNF +G G G V + + G LVAVK++ + Q EL F EV ++ H N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 78
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
++ + + E +V F+ G++ + + +N + L + L+ LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLH 133
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
+IHRD+K+ +ILL + + DFG + K+ ++ GT +APE +S
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELIS 189
Query: 301 TGKSSEKTDVFGYGVMLLELITGQ 324
+ D++ G+M++E++ G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 123 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
N +G G G V + G VAVK++ + Q EL F EV ++ H N+
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNI 78
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARGLAY 238
+ + + E +V F+ G++ + ++ QIA L + L++
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSF 130
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
LH +IHRD+K+ +ILL + + DFG + K+ ++ GT +APE
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEV 186
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+S + D++ G+M++E++ G+ +
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+G G +G V+K R + G +VA+K+ E+ ++ + E+ M+ H NL+ L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHPNLVNLIE 67
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
+ LV+ + + + L E ++ + + K+I + + + H H
Sbjct: 68 VFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---N 120
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSS 305
IHRDVK NIL+ ++ + + DFG A+++ T V T + APE L +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYG 179
Query: 306 EKTDVFGYGVMLLELITGQ 324
DV+ G + EL+TGQ
Sbjct: 180 PPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQFQTEVEMI----SMAVHRNLLR 183
+G+G FG+VY+ R D + A+K L K+E E+ I + ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
L+ T ++ LV +M G + L++ G+ ++ L L +LH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA----LEHLHKY- 115
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
I++RD+K NILLD + DFGL+K + D T GT ++APE L K
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 304 SSEK-TDVFGYGVMLLELITGQRAF 327
K D + GV++ E+ G F
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 75/287 (26%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 130 LGRGGFGKVYKGRLTDGSLVA---VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+G G FGKV + + VA VK LK + + +F + + + H N+L+ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRE----RGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
C+ LLV+ + G + S L + R SQ L +++A A G+ ++H H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAAGVTHMHKH 118
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT------AVRGTIGHIAP 296
+H D+ N L + VGD+G+ YK+ ++ T +R +
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 297 EY---LSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR--LANDDDVMLLDWVKGLLKEK 351
E+ L T + ++ ++V+ GV L EL F+ A ++ D +L+ V +K++
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQPYSHLSDREVLNHV---IKDQ 225
Query: 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
++ +L +E Y E E L Q L SP +R EV R+L
Sbjct: 226 QV-KLFKPQLELPYSERWYEVL-QFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 12/229 (5%)
Query: 129 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV-HRNLLRL 184
++GRG + KV L + A+K +K+E E QTE + A H L+ L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
T + V F+ G L Q Q L + + + L +LH+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGD----LMFHMQRQRKLPEEHARFYSAEISLALNFLHER-- 115
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353
D + GV++ E++ G+ FD+ ++++ D D++ ++ EK++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 10/179 (5%)
Query: 146 GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205
G VAVK++ + Q EL F EV ++ H N++ + + E +V F+ G+
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265
+ + + +N + L R L+YLH+ +IHRD+K+ +ILL +
Sbjct: 106 LTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
+ DFG + K+ ++ GT +APE +S + D++ G+M++E+I G+
Sbjct: 158 KLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 120 ATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 178
A ++ N LG G + VYKG +G LVA+K + + +G E ++ H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
N++ L T V+ +M ++ G P ++VR RGLAY
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHP---YNVR-LFMFQLLRGLAY 118
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
+H I+HRD+K N+L+ E + DFGLA+ ++ V T+ + P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174
Query: 299 L--STGKSSEKTDVFGYGVMLLELITGQRAF 327
L +T SS D++G G + +E++ GQ AF
Sbjct: 175 LLGATDYSSA-LDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNL 181
+G G +G VYK R G +VA+K+++ E G E+ E+ H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP--PLNWSVRKQIALGAARGLAYL 239
+RL + + LV+ F + L++ S P L+ + K +G+AY
Sbjct: 61 VRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIG 292
H H +++HRD+K N+L+D E + DFGLA+ + Y TH VT R
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYR---- 166
Query: 293 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 327
APE L + S D++ G + E++ + F
Sbjct: 167 --APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 44/215 (20%)
Query: 132 RGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
+G FG VY K R T G A+K LK+ +MI+ N+ R M
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKS-------------DMIAKNQVTNVKAERAIMM 51
Query: 190 TPTE-----RL-----------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 233
E +L LV ++ G AS ++ G P +W+ KQ
Sbjct: 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL--PEDWA--KQYIAEVV 107
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
G+ LH IIHRD+K N+L+D+ + DFGL++ V GT +
Sbjct: 108 LGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDY 159
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
+APE + + +D + G ++ E + G F
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRL-KEERTQGGELQFQTEV 170
+ +L++ ++F ++GRG FG+V R V A+K L K E + + F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 171 EMISMAVHRN---LLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWS-- 223
I MA H N +++L ++ L V +M G + + + P W+
Sbjct: 94 RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARF 146
Query: 224 --VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 280
+AL A + + IHRDVK N+LLD+ + DFG MD +
Sbjct: 147 YTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMD-ANG 196
Query: 281 -THVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 327
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 44/247 (17%)
Query: 127 RNILGRGGFGKVY--------------------KGRLTDGSLVAVKRLKEERTQGGELQF 166
+ LG G FG+V+ KGR LVAVK L+ + + F
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66
Query: 167 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER------------- 213
EV+++S N++RL G C+ ++ +M NG + L
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 214 GQSQ--PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271
+ P +++S +AL A G+ YL +HRD+ N L+ E + DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 272 LAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329
+++ + Y + R I +A E + GK + +DV+ +GV L E++ +
Sbjct: 184 MSRNL-YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 330 ARLANDD 336
L ++
Sbjct: 243 GELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 129 ILGRGGFGKVY-KGRLTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMAVHRNLLR 183
++G+G FGKV R DG AVK L+++ R + + + V ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 184 LRGFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
L + TE+L VNG RER +P + + A L YLH
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE-----IASALGYLHS 114
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLS 300
I++RD+K NILLD + V+ DFGL K + DT TT GT ++APE +
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIR 169
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAF 327
D + G +L E++ G F
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 12/228 (5%)
Query: 129 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLR 185
++GRG + KV RL + + A+K +K+E E QTE + A L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
C T RL + VNG L Q Q L + A L +LH+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGD---LMFHMQRQRKLPEEHARFYAAEICIALNFLHER--- 115
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 305
II+RD+K N+LLD + + D+G+ K T+ GT +IAPE L +
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 306 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353
D + GV++ E++ G+ FD+ + ++ D+ D++ ++ EK +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI--ITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 50/231 (21%)
Query: 129 ILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLR 183
++G+GG G+VY D VA+K+++E+ ++ L+ F E ++ + +H ++
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 184 LRGFCMTPTERLLVY---PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA------- 233
+ C ++ VY P++ ++ S L+ Q + S+ K++A +
Sbjct: 67 VYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKE-----SLSKELAEKTSVGAFLSI 118
Query: 234 -----RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----------- 277
+ Y+H ++HRD+K NILL E V+ D+G A
Sbjct: 119 FHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 278 ------YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
Y + + GT ++APE L +SE TD++ GV+L +++T
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 19/207 (9%)
Query: 129 ILGRGGFGKVY---KGRLTD-GSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLR 183
+LG+G FGKV+ K D G L A+K LK+ + ++ + E ++++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
L T + L+ F+ G + + L +E ++ + + + ++AL L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-AELALA----LDHLHSL 117
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDTHVTTAVRGTIGHIAPEYLS 300
II+RD+K NILLDEE + DFGL+K + K + + GT+ ++APE ++
Sbjct: 118 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVN 171
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAF 327
++ D + +GV++ E++TG F
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 123 NFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRN 180
+F LG G FG+V + G A+K L K E + ++Q + + I M +
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 181 LL--RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
+ + F + F+V G + + LR+ G+ + ++ L Y
Sbjct: 79 FIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEY 133
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
LH D II+RD+K N+LLD + V DFG AK K T + GT ++APE
Sbjct: 134 LHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAPEV 186
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+ + + D + GV+L E I G F
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G G G V R G VAVK + + Q EL F EV ++ H+N++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+ E ++ F+ G++ + SQ LN + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 308
HRD+K+ +ILL + + DFG + KD ++ GT +APE +S +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 309 DVFGYGVMLLELITGQ 324
D++ G+M++E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLK---------EERTQGGE--LQFQT--EVEMI 173
LG G +GKV K T G +VA+K++K ++R G + F T E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 174 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 233
+ H N++ L + LV M AS L++ + L S K I L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LMDYKDTHVTTAV 287
GL LH +HRD+ ANI ++ + + DFGLA+ D T
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 288 RG-------TIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 327
R T+ + APE L K D++ G + EL+TG+ F
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEER-TQGGELQFQ-TEVEMISMAVHRNLLRLR 185
+LG+G FGKV R G A+K LK+E E+ TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 186 GFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
+ +RL NG RER S+ + + ++ L YLH C
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALGYLHS-C 114
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
D +++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 D--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 304 SSEKTDVFGYGVMLLELITGQRAF 327
D +G GV++ E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 53/226 (23%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
LGRG +G V K R + G+++AVKR++ V S R L+ L
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR------------ATVN--SQEQKRLLMDL-DIS 53
Query: 189 MTPTERLLVYPFMVN--------GSVASCLR--------------ERGQSQPPLNWSVRK 226
M R + P+ V G V C+ ++G + P +
Sbjct: 54 M----RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPE---DILG 106
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286
+IA+ + L YLH +IHRDVK +N+L++ + + DFG++ + D+ T
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTI 162
Query: 287 VRGTIGHIAPEYLSTGKSSE----KTDVFGYGVMLLELITGQRAFD 328
G ++APE ++ + + K+DV+ G+ ++EL TG+ +D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 127 RNILGRGGFGKVYKGRLTDGS----LVAVKRLKEE---RTQGGELQFQTEVEMISMAVHR 179
+LG+GG+GKV++ R G+ + A+K LK+ R Q + E ++ H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
++ L T + L+ ++ G + L G +I+L L +L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHL 116
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
H II+RD+K NILLD + + DFGL K ++ T VT GTI ++APE L
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEIL 172
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAF 327
+ D + G ++ +++TG F
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 130 LGRGGFGKVY------------KGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 172
LG G FG+V+ K D S LVAVK L+E+ + F E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 173 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPP------LNWSVR 225
+S N++RL C+T ++ +M NG + L R Q +++S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285
+A A G+ YL +HRD+ N L+ + + + DFG+++ + Y +
Sbjct: 133 IFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YSGDYYRI 188
Query: 286 AVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
R I ++ E + GK + +DV+ +GV L E++T
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 42/225 (18%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EVE 171
D + N + +G G +G+V T G VA+K+L FQ+ E+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYRELR 66
Query: 172 MISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWSV 224
++ H N++ L TP L LV M + + ++ L+
Sbjct: 67 LLKHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLM-GADLNNIVK-----CQKLSDDH 119
Query: 225 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HV 283
+ + RGL Y+H IIHRD+K +NI ++E+ E + DFGLA+ D + T +V
Sbjct: 120 IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV 176
Query: 284 TTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
T + APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 177 ATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 128 NILGRGGFGKVYKGR-LTDGSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185
+G+G FG+V+K R +VA+K+ L E +G + E++++ + H N++ L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 186 GFCMTPTER--------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
C T LV+ F + +A L S K++ GL
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS---NKNVKFTLSEIKKVMKMLLNGLY 133
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274
Y+H + KI+HRD+KAANIL+ ++ + DFGLA+
Sbjct: 134 YIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 130 LGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRG 186
+G+G FGKV + R D + A+K +++ T E +A ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
+P + LV F+ G + L+ G+ + S + L LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR----FDLSRARFYTAELLCALENLHKF---N 113
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
+I+RD+K NILLD + + DFGL KL + KD T GT ++APE L ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 307 KTDVFGYGVMLLELITG 323
D + GV+L E++TG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 57/278 (20%), Positives = 118/278 (42%), Gaps = 22/278 (7%)
Query: 123 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAVHR 179
NF +GRG F +VY+ L D VA+K+++ E E++++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N+++ + E +V G ++ ++ + + + + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
H +++HRD+K AN+ + +GD GL + K T + V GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359
+ K+D++ G +L E+ Q F D + L +K+EQ
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLFSLC------QKIEQCDYP 226
Query: 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
+ + E++ +L+ +C P +RP + V ++
Sbjct: 227 PLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 64/288 (22%), Positives = 126/288 (43%), Gaps = 58/288 (20%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRG- 186
+GRG FG V K G+++AVKR++ + + + +++++ + +++ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 187 --------FCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 234
CM ++ Y + V + S + E + +IA+ +
Sbjct: 72 LFREGDCWICMELMDISLDKF--YKY-VYEVLKSVIPEE----------ILGKIAVATVK 118
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 293
L YL + + KIIHRDVK +NILLD + DFG++ +L+ D+ T G +
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPY 173
Query: 294 IAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAF----------------DLARLAN 334
+APE + ++DV+ G+ L E+ TG+ + D L+N
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233
Query: 335 DDDVM----LLDWV-KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVA 377
++ ++++ L+K++ +E +I++ E+ + VA
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVA 281
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 15/217 (6%)
Query: 115 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL--VAVKRLKEERT--QGGELQFQTEV 170
R+ ++ ++F+ LG G FG+V + VA+KR ++ + Q +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 171 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 230
++++ H + L G + LV F++ G + LR + + QI L
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 231 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 290
YL I++RD+K N+LLD++ + DFG AK++D + T + GT
Sbjct: 143 I----FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGT 191
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+IAPE L + D + G+ + E++ G F
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 131 GRGGFGKVYKGRL---TDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLR 185
GRG +G+VYK + DG A+K+ K ++ Q + E+ ++ H N++ L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 186 GFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
+ ++ L++ + + R + + S+ K + G+ YLH +
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128
Query: 244 DPKIIHRDVKAANILL--DEEFEAVV--GDFGLAKLMD------YKDTHVTTAVRGTIGH 293
++HRD+K ANIL+ + VV GD GLA+L + V TI +
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV----TIWY 181
Query: 294 IAPEYLSTGKSSEKT-DVFGYGVMLLELIT 322
APE L + K D++ G + EL+T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQFQTEVE 171
+R+LQ+ +++ ++GRG FG+V R V +L K E + + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 172 MISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNW----SVR 225
I MA + ++ FC ++ L V +M G + + + P W +
Sbjct: 95 DI-MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAE 150
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 284
+AL A + +IHRDVK N+LLD+ + DFG MD
Sbjct: 151 VVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 285 TAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 327
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 85/347 (24%), Positives = 132/347 (38%), Gaps = 91/347 (26%)
Query: 129 ILGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNL 181
+LG G FGKV + + + + VAVK LKE T +E++ +I + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 182 LRLRG--------------FCM---------------------TPTERLLVYPF------ 200
+ L G FC +P +R
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 201 --MVNGSVASCLRER------GQSQPPLN----WSVRKQI------ALGAARGLAYLHDH 242
+ AS L R G + PP W + + ARG+ +L
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLS 300
K IHRD+ A NILL E + DFGLA+ + YKD + R + +APE +
Sbjct: 194 ---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSARLPLKWMAPESIF 249
Query: 301 TGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359
+ ++DV+ +GV+L E+ + G + G+ ++ Q +
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPY-----------------PGVQINEEFCQRLKD 292
Query: 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAER 406
E ++ ++ L C QG P ERP S +V +L GD L E
Sbjct: 293 GTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 132 RGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFC 188
RG FGKVY GR + L AVK +K+ + Q + E ++A+ ++ ++ L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+ LV +++ G V S L G + K I+ A L YLH H II
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EVALALDYLHRH---GII 126
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKL 275
HRD+K N+L+ E + DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 40/150 (26%), Positives = 76/150 (50%), Gaps = 15/150 (10%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
+G G +G V+K + + +VA+KR++ ++ +G E+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 188 CMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
+ + LV+ + + SC G P + S Q+ +GLA+ H H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLL----KGLAFCHSH-- 118
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAK 274
++HRD+K N+L+++ E + DFGLA+
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMA 176
++ D+F + LG G G V+K L+ ++L E Q E++++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 177 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 236
++ G + E + M GS+ L++ G+ + + ++++ +GL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGL 116
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIA 295
YL + KI+HRDVK +NIL++ E + DFG++ +L+D + + GT +++
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 170
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
PE L S ++D++ G+ L+E+ G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
+G G +G VYK R +A+K+++ E+ +G E+ ++ H N++RL+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR--KQIALGAARGLAYLHDHCDP 245
+ LV+ ++ L++ S P + R K RG+AY H H
Sbjct: 70 VHSEKRLYLVFEYL-----DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH--- 121
Query: 246 KIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
+++HRD+K N+L+D A+ + DFGLA+ T V T+ + APE L +
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRH 180
Query: 305 -SEKTDVFGYGVMLLELITGQRAF 327
S D++ G + E++ + F
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDG---------SLVAVKRLKEERTQGGELQFQTEVEM 172
D+ +G G FG+V+ R ++ V RLK+E+ E +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRV 54
Query: 173 ISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 230
+ H ++RL F +R L + ++ G + S LR G+ + S A
Sbjct: 55 LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYAS 108
Query: 231 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRG 289
L YLH +I++RD+K NILLD+E + DFG AK L D T + G
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCG 160
Query: 290 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
T ++APE + + ++ D + G+++ E++ G F
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 67/296 (22%), Positives = 100/296 (33%), Gaps = 44/296 (14%)
Query: 129 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 187
+ K + T +LVAVK++ + +L+ Q E+ H N+L
Sbjct: 9 CFEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-T 66
Query: 188 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDP 245
L +V P M GS L+ L I L Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSKGF-- 122
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI------APEYL 299
IHR VKA++ILL + + V+ + M + +PE L
Sbjct: 123 --IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 300 STGKS--SEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGL---LKEKKL 353
+EK+D++ G+ EL G F D+ MLL+ V+G L +K
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDM-----PATQMLLEKVRGTVPCLLDKST 235
Query: 354 EQLVDSDMEGNYIEEEV----------------EQLIQVALLCTQGSPMERPKMSE 393
L + M + E E Q LC Q P RP S+
Sbjct: 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 46/201 (22%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 130 LGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+G+G G V+ D G VA+K++ ++ EL E+ ++ + N++
Sbjct: 27 IGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLD 83
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
+ E +V ++ GS+ + E + + R+ + + L +LH + +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---Q 135
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
+IHRD+K+ N+LL + + DFG + + + +T V GT +APE ++
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 307 KTDVFGYGVMLLELITGQRAF 327
K D++ G+M +E++ G+ +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 130 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G+G G VY + G VA+K++ ++ EL E+ ++ + N++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 308
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 309 DVFGYGVMLLELITGQRAF 327
D++ G+M +E++ G+ +
Sbjct: 197 DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 36/232 (15%)
Query: 116 ELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTE 169
E+ ++T F LG FGKVYKG L VA+K LK++ +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 170 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS------------- 216
M S H N++ L G +++ + + + L R
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 217 ---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273
+P + QIA G+ +L H ++H+D+ N+L+ ++ + D GL
Sbjct: 119 STLEPADFVHIVTQIA----AGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 274 KLM---DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
+ + DY + + I ++PE + GK S +D++ YGV+L E+ +
Sbjct: 172 REVYAADYYKLMGNSLL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 129 ILGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
++G G FG+ + + +D A+K ++ ++ + E +++ H N++ +
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 187 FCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPP---LNWSVRKQIALGAARGLAYLHDH 242
+V + G + ++ +RG+ P L W V Q+ LG H H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV--QMCLGVQ------HIH 117
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
+ +++HRD+K+ NI L + + +GDFG A+L+ + T V GT ++ PE
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 303 KSSEKTDVFGYGVMLLELITGQRAF 327
+ K+D++ G +L EL T + F
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 185
++G+G FGKV R + AVK L+++ + E +E ++ V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 186 GFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
F ++L +NG RER +P + A A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----YAAEIASALGYLHSL- 115
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
I++RD+K NILLD + V+ DFGL K + + T+ GT ++APE L
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 304 SSEKTDVFGYGVMLLELITGQRAF 327
D + G +L E++ G F
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 69/239 (28%), Positives = 105/239 (43%), Gaps = 39/239 (16%)
Query: 130 LGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 185
+GRG VY R T G+LV V+ E L+ Q EV + H N++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
T + ++ PFM GS S L+ G S+ ++ I GA RGL YLH +
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSE-----ALIGNILFGALRGLNYLHQN 120
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------YKDTHVTTAVRGTI 291
IHR++KA++IL+ + +V GL+ L Y +T+V +
Sbjct: 121 ---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---L 172
Query: 292 GHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGL 347
++PE L + K+D++ G+ EL TG+ F D+ R MLL +KG
Sbjct: 173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-----MLLQKLKGP 226
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLR 185
+LG+G FGKV R G A+K LK+E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 186 GFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
T V ++ G + L RER S+ + + ++ L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-----ALDYLHSG-- 114
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
KI++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
D +G GV++ E++ G+ F N D L + + L+++ K + + +D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLFELI--LMEDIKFPRTLSAD 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
+G G +G VYKGR G +VA+K+++ E +G E+ ++ H N++ L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 188 CMTPTERLLVYPF--MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
M + L++ F M L + L S QI G + + H
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG----ILFCHSR--- 120
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKS 304
+++HRD+K N+L+D + + DFGLA+ V T T+ + APE L + +
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 305 SEKTDVFGYGVMLLELITGQRAF 327
S D++ G + E+ T + F
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMA 176
++ D+F + LG G G V K + L+ ++L E Q E++++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 177 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 236
++ G + E + M GS+ L+E + + + ++++ RGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGL 116
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIA 295
AYL + +I+HRDVK +NIL++ E + DFG++ +L+D + + GT +++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 170
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
PE L S ++D++ G+ L+EL G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 21/199 (10%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G G +G VYK R + G L A+K +K E + + Q E+ M+ H N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+ + + F GS+ G PL+ S ++ +GL YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST--- 301
HRD+K ANILL + + DFG++ + T A R GT +APE +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 302 GKSSEKTDVFGYGVMLLEL 320
G ++ D++ G+ +EL
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----HVTTAVRG 289
RGL Y+H +IHRD+K +N+L++E+ E +GDFG+A+ + T +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-A 173
Query: 290 TIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELI 321
T + APE LS + + D++ G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
R + YLH++ +IIHRD+KA NI ++ + +GDFG A + + GTI
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
APE L+ D++ G++L E+ T
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 32/98 (32%), Positives = 58/98 (59%), Gaps = 7/98 (7%)
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTT 285
+I++ RGL YL + KI+HRDVK +NIL++ E + DFG++ +L+D +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN 156
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 323
+ GT +++PE L + ++D++ G+ L+E+ G
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 130 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G+G G VY + G VA+K++ ++ EL E+ ++ H N++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 137
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 308
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 309 DVFGYGVMLLELITGQ 324
D++ G+M +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 130 LGRGGFGKVYKG---RLTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLR 185
LG G FG V KG VAVK LK + + + E ++ + ++R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----------QIALGAARG 235
G C + L++ L E G PLN ++K ++ + G
Sbjct: 63 GICEAESWMLVME-----------LAELG----PLNKFLQKNKHVTEKNITELVHQVSMG 107
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGH 293
+ YL + +HRD+ A N+LL + A + DFGL+K + + + G +
Sbjct: 108 MKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 327
APE ++ K S K+DV+ +GV++ E + GQ+ +
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G+G G VY + G VA++++ ++ EL E+ ++ + N++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 308
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 309 DVFGYGVMLLELITGQRAF 327
D++ G+M +E+I G+ +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 130 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERT------QGGE--LQFQTEVEMISMAVHRN 180
LG+G F +YKG L L V +E L F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
L++L G C+ E ++V ++ G + L + L+W + +A A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNN-VSLHWKL--DVAKQLASALHYLE 118
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVR-GTIGHIAPE 297
D K++H +V NIL+ G KL D T ++ R I IAPE
Sbjct: 119 DK---KLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPE 174
Query: 298 YLSTGKSS--EKTDVFGYGVMLLEL 320
+ G++S D + +G LLE+
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 25/176 (14%)
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 290
ARG+ +L K IHRD+ A NILL E + DFGLA+ + YKD R
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLP 238
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 349
+ +APE + + ++DV+ +GV+L E+ + G + G+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-----------------PGVQI 281
Query: 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 405
+++ + + E ++ + L C +P +RP SE+V +L GD L E
Sbjct: 282 DEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL-GDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 22/182 (12%)
Query: 152 KRLKEERTQGGE---LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV--------YPF 200
+RL +R + G +Q + E+ + H N+L++ + ++ Y F
Sbjct: 193 ERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSF 252
Query: 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 260
M + + PL R I + Y+HD K+IHRD+K NI L+
Sbjct: 253 MYDEAFD-------WKDRPLLKQTRA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 261 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 320
+ + V+GDFG A + + GT+ +PE L+ E TD++ G++LL++
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 321 IT 322
++
Sbjct: 362 LS 363
|
Length = 501 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 122 DNFSNRNILGRGGFG--KVYKGRLTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAV 177
+F ++++GRG FG +V + + T G + A+K +K+ E F+ E +++S++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 178 HRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARG 235
+ +L+ + + L LV + G + S L R Q + ++ L
Sbjct: 60 SPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA---- 114
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
+H +HRD+K N+L+D + DFG A + + GT +IA
Sbjct: 115 ---IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 296 PEYLSTGKSSEKT------DVFGYGVMLLELITGQRAF 327
PE L+T K D + GV+ E+I G+ F
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 33/85 (38%), Positives = 50/85 (58%), Gaps = 5/85 (5%)
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG 302
K++HRD+K+ANI L +GDFG +K Y D+ V ++ GT ++APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 303 KSSEKTDVFGYGVMLLELITGQRAF 327
+ S+K D++ GV+L EL+T R F
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 6e-08
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 133 GGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MIS--MAVHRNLLRLRGF 187
G FGKV K + T V K +K + F +E M+ M + N ++L
Sbjct: 27 GKFGKVSVLKHKPTQKLFV-QKIIKAK-------NF-NAIEPMVHQLMKDNPNFIKLYYS 77
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
T +L+ ++ +G L + + + L+ + K+I L LH H I
Sbjct: 78 VTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NI 130
Query: 248 IHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
IH D+K N+L D + + + D+GL K++ + GT+ + +PE +
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIKGHNYDV 185
Query: 307 KTDVFGYGVMLLELITGQRAFDLARLANDDDVML 340
D + GV+ EL+TG+ F D+D L
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFK-----EDEDEEL 214
|
Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLK------EERTQGGELQFQTEVEMISMAVHRNLL 182
+G G F +V K + G A+K +K E+ E+Q + ++ H N+L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ-----ALRRLSPHPNIL 61
Query: 183 RLRGFCM-TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLA 237
RL T RL LV+ M + ++ ++ R + P V+ Q+ + L
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK--RVKSYMYQLL----KSLD 114
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
++H + I HRD+K NIL+ ++ + DFG + + K + T T + APE
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPE 168
Query: 298 -YLSTGKSSEKTDVFGYGVMLLELIT 322
L+ G K D++ G + E+++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 45/257 (17%)
Query: 130 LGRGGFGKV-YKGRLTDGSLVAVKRLKEERTQGGEL---QFQTEVEMISMAVHRNLLRLR 185
+G G +G V G+ VA+K+L R EL + E+ ++ H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 186 GFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
TP L LV PFM + ++ S+ + + V + + +GL Y
Sbjct: 81 D-VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQML-----KGLKY 133
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAP 296
+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R AP
Sbjct: 134 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYR------AP 184
Query: 297 EY-LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-----E 350
E L+ ++ D++ G ++ E++TG+ F +D LD + ++K
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK----GHDH----LDQLMEIMKVTGTPS 236
Query: 351 KKLEQLVDSDMEGNYIE 367
K+ Q + S+ NY++
Sbjct: 237 KEFVQKLQSEDAKNYVK 253
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 16/211 (7%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 190 TPTER----LLVYPFMVNGSVASCLRERGQSQPPLNW--SVRKQIALGAARGLAYLHDHC 243
+ ++R L Y + R ++ P+ S+ K + G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 244 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 297
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 298 YLSTGKSSEKT-DVFGYGVMLLELITGQRAF 327
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 16/214 (7%)
Query: 121 TDNFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
+D + +G+G +GKV+K +GS AVK L E++ + + + +++ H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHP 75
Query: 180 NLLRLRGF-----CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 234
N+++ G + LV GSV ++ + + + I A
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 294
GL +LH + K IHRDVK NILL E + DFG++ + T+V GT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 191
Query: 295 APEYLSTGKS-----SEKTDVFGYGVMLLELITG 323
APE ++ + + DV+ G+ +EL G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGEL------QFQTEVEMISMAVHRNLL 182
LG+G FG VY + D VA +RLK + GEL Q E +++S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL------NWSVRKQIALGAARGL 236
+ + ++ + + L E + L W + Q+ L G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI--QLLL----GV 119
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
Y+H +I+HRD+KA NI L +GDFG+++L+ + T GT +++P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSP 174
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
E L K+D++ G +L E+ AF
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 186
LG+G +G VYK + +KE R + E +F E++++ AV ++ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMA--MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
+ +M GS+ L G + + V ++I +GL +L + +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEYLSTGK 303
IIHRDVK N+L++ + + DFG++ + V + + IG ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 304 SSE------KTDVFGYGVMLLELITG 323
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 129 ILGRGGFGKV--YKGRLTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRL 184
+LG+G FGKV K + T G A+K LK+E + TE ++ + H L L
Sbjct: 2 LLGKGTFGKVILVKEKAT-GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
+ T V + G + L RER S+ + + ++ L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALDYLH--S 113
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
+ +++RD+K N++LD++ + DFGL K KD GT ++APE L
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 304 SSEKTDVFGYGVMLLELITGQRAF 327
D +G GV++ E++ G+ F
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 130 LGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQT---------EVEMISMAV 177
+G G FG V+ +TD G VA+K++ FQ E++M+
Sbjct: 8 IGYGAFGVVWS--VTDPRDGKRVALKKMPN--------VFQNLVSCKRVFRELKMLCFFK 57
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
H N+L P ++V + S L + S PL+ K RGL
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
YLH I+HRD+K N+L++ + DFGLA++ + ++ T T + APE
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 298 YLSTGKS-SEKTDVFGYGVMLLELITGQRAF 327
L + + D++ G + EL+ + F
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 35/122 (28%), Positives = 62/122 (50%), Gaps = 7/122 (5%)
Query: 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRDVKAANILLDE 261
S + + S P L+ + + A+G+ +L +C IHRDV A N+LL +
Sbjct: 193 QSSDSKDEEDTEDSWP-LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTD 247
Query: 262 EFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 320
A + DFGLA+ +M+ + V R + +APE + + ++DV+ YG++L E+
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
Query: 321 IT 322
+
Sbjct: 308 FS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 28/171 (16%)
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 290
A+G+ +L K IHRD+ A NILL E + DFGLA+ + YKD R
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLP 244
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350
+ +APE + + ++DV+ +GV+L E+ F L A+ + +D
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLG--ASPYPGVKID-------- 288
Query: 351 KKLEQLVDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
E+ EG + + ++ Q L C G P +RP SE+V L
Sbjct: 289 ---EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ + D +T V T +
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 294 IAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
RGL Y+H ++HRD+K +N+LL+ + + DFGLA+ K +T V T +
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 294 IAPEYLSTGKSSEKT---DVFGYGVMLLELITGQRAF 327
APE L SE T DV+ G + EL+ + F
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 292
RGL Y+H ++HRD+K AN+ ++ E+ +GDFGLA+++D +H G +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 293 --HIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+ +P LS ++ D++ G + E++TG+ F
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 9e-07
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK----LMDYKDTHVTTAVRG 289
+ L Y+H +IHRD+K +NILL+ + + DFGLA+ L + + V T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 290 TIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAF 327
T + APE L ST + ++ D++ G +L E++ G+ F
Sbjct: 175 TRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQFQTEVE 171
+R+L++ +++ ++GRG FG+V R V +L K E + + F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 172 MISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNW----SVR 225
I MA + ++ F +R L V +M G + + + P W +
Sbjct: 95 DI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAE 150
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-- 283
+AL A + + IHRDVK N+LLD+ + DFG M+ K+ V
Sbjct: 151 VVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRC 200
Query: 284 TTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 327
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 59/259 (22%), Positives = 94/259 (36%), Gaps = 82/259 (31%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMA 176
D+F ++GRG FG+V+ R G + A+K L++ R Q + E ++++ A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADA 58
Query: 177 VHRNLLRLRGFC-MTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI------ 228
+++L + E L LV +M G + +N +RK +
Sbjct: 59 DSPWIVKL--YYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETA 103
Query: 229 ---------ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279
AL + L + IHRD+K NIL+D + + DFGL K
Sbjct: 104 RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCK--KMN 152
Query: 280 DTHVTTAVR------------------------------GTIGHIAPEYLSTGKS-SEKT 308
GT +IAPE L G +
Sbjct: 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLEC 211
Query: 309 DVFGYGVMLLELITGQRAF 327
D + GV+L E++ G F
Sbjct: 212 DWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 190 TPTER----LLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDHC 243
+ +R L Y + R ++ P L + K + G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 244 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 297
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 298 YLSTGKSSEKT-DVFGYGVMLLELITGQRAF 327
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK--EERTQGGELQFQTEVEMISMAVH 178
+ F ++G G +G V K R + +VA+K+ K EE + E + E++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
N++ L+ + LV+ + V ++ L E PP VR I + + +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEY-VEKNMLELLEEMPNGVPPEK--VRSYI-YQLIKAIHW 115
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPE 297
H + I+HRD+K N+L+ + DFG A+ L + + + T V T + +PE
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPE 171
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
L + D++ G +L EL GQ F
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ D + T T +
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 294 IAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
APE L+ ++ D++ G ++ EL+ G+ F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGT 290
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D + H +T V T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-AT 172
Query: 291 IGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAF 327
+ APE + K K D++ G +L E+++ + F
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
L YLH +++RD+K N++LD++ + DFGL K D GT ++A
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
PE L D +G GV++ E++ G+ F
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 51/271 (18%), Positives = 110/271 (40%), Gaps = 38/271 (14%)
Query: 138 VYKGRLTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195
+YKG + V ++ K+ L + E++ + N+L++ GF + + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 255
++ LRE + L++ + +A+ +GL L+ + ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSV 152
Query: 256 NILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAV---RGTIGHIAPEYLSTGKSSEKTD 309
+ L+ E ++ + GL K++ +K+ V V + I EY K D
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKN--VNFMVYFSYKMLNDIFSEYT------IKDD 204
Query: 310 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEE 369
++ GV+L E+ TG+ F+ N L K++ L+ + + +
Sbjct: 205 IYSLGVVLWEIFTGKIPFE-----N-------------LTTKEIYDLIINKNNSLKLPLD 246
Query: 370 VEQLIQ-VALLCTQGSPMERPKMSEVVRMLE 399
I+ + CT ++RP + E++ L
Sbjct: 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQ-FQTEVEMISMAVH 178
++F ++GRG FG+V +L + V ++ K E + E F+ E +++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---PLNWSVRKQIALGAARG 235
+ + L LV + V G + + L + P + IA+ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGTIGHI 294
L Y +HRD+K NIL+D + DFG KLM+ + AV GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 295 APEYLST-----GKSSEKTDVFGYGVMLLELITGQRAF 327
+PE L GK + D + GV + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 24/170 (14%)
Query: 233 ARGLAYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGT 290
A+G+++L +C IHRD+ A NILL + DFGLA+ + +V R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 349
+ +APE + + ++DV+ YG++L E+ + G + G+
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-----------------PGMPV 322
Query: 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ K +++ E ++ + C P++RP ++V+++E
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 130 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEV---------EMISMAVHR 179
+G G +G V G VA+K+L FQ+E+ ++ H
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP--------FQSEIFAKRAYRELTLLKHMQHE 74
Query: 180 NLLRLRG-FCMTPTER-----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 233
N++ L F + LV P+M + S+ + + V + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQML----- 127
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTI 291
GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--- 181
Query: 292 GHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 327
APE L+ ++ D++ G ++ E++TG+ F
Sbjct: 182 ---APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----G 302
+HRD+K N+LLD + DFG M+ T ++ GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 303 KSSEKTDVFGYGVMLLELITGQRAF 327
K + D + GV + E++ G+ F
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 17/164 (10%)
Query: 164 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWS 223
L F ++S H +L + G C+ +E ++V F+ +G + CLR + + + P+ W
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-KEKGRVPVAWK 119
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283
+ +A A L+YL D ++H +V A NILL + + G + + D V
Sbjct: 120 I--TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG---LAE-GTSPFIKLSDPGV 170
Query: 284 TTAVRG------TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLEL 320
+ I IAPE + G S S D + +G LLE+
Sbjct: 171 SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 33/230 (14%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLRG 186
+G+GG+G+V+ + D G +VA+KR+K+ TE ++++ L++L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI-----ALGAARGLAYLHD 241
L ++ G + L G R + A+ A L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS---EDHARFYMAEMFEAVDALHELGY--- 122
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYL 299
IHRD+K N L+D + DFGL+K + VT A V G+ ++APE L
Sbjct: 123 ------IHRDLKPENFLIDASGHIKLTDFGLSKGI------VTYANSVVGSPDYMAPEVL 170
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM--LLDWVKGL 347
D + G ML E + G F + ++ L W + L
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS---GSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGT 290
R L Y+H + HRD+K NIL + + + + DFGLA++ + DT T T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169
Query: 291 IGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAF 327
+ APE + K + D++ G + E++TG+ F
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-----STG 302
+HRD+K N+LLD+ + DFG + T + GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 303 KSSEKTDVFGYGVMLLELITGQRAF 327
+ + D + GV + E++ G+ F
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTAVRG 289
GL Y+H ++HRD+K N+L++ + E + DFGLA+ +T V
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 290 TIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
T + APE LS ++ DV+ G +L EL+ + F
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 66/237 (27%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 186
LG+G G+V+ RL G L A+K L K+E + ++ + TE E+++ H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--------GLAY 238
T T LV + G + L Q QP K ++ AR L Y
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLL----QRQP------GKCLSEEVARFYAAEVLLALEY 118
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR---------- 288
LH I++RD+K NILL E ++ DF L+K D + V+ A+R
Sbjct: 119 LHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 289 ------------------GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
GT +IAPE +S D + G++L E++ G F
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDG-SLVAVKRLKEE----RTQGGELQFQTEVEMISMA 176
++F ++ G +G VY R + A+K++ ++ R Q Q E ++++ A
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ--IQQVFVERDILTFA 58
Query: 177 VHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 234
N + FC T+R L V ++ G A+ L+ G L + +
Sbjct: 59 --ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVL 112
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDY----------KDTH 282
L YLH++ I+HRD+K N+L+ + DFGL+K LM KDT
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 283 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 323
+ V GT +IAPE + + D + G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 27/147 (18%), Positives = 53/147 (36%), Gaps = 17/147 (11%)
Query: 133 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL--RLRGFCMT 190
G +VY D V LK ++ + EV ++ + + L ++ +
Sbjct: 9 GLTNRVYLLGTKDEDYV----LKINPSREKGADREREVAILQLLARKGLPVPKVLASGES 64
Query: 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 250
L+ ++ G++ ++ ++ IA A LA LH + H
Sbjct: 65 DGWSYLLMEWI-----------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 251 DVKAANILLDEEFEAVVGDFGLAKLMD 277
D+ NIL+D+ + D+ A
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 128 NILGRGGFGKVYKGRLTDGS-LVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185
NI+G G FG VY+ D S VA+K+ L++ + + EL + H N++ L+
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN------HINIIFLK 125
Query: 186 GFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
+ T + L V + +V ++ ++ L + K + R LAY
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHI--- 294
+H I HRD+K N+L+D + + DFG AK + A + ++ +I
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------LAGQRSVSYICSR 234
Query: 295 ---APEYLSTGKSSEKT--DVFGYGVMLLELITGQRAF 327
APE L G ++ T D++ G ++ E+I G F
Sbjct: 235 FYRAPE-LMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 27/94 (28%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-- 290
ARG+ +L +HRD+ A N+LL + + DFGLA+ + + +V+ +G+
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 291 --IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
+ +APE + + +DV+ YG++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 294
G+ +LH IIHRD+K +NI++ + + DFGLA+ + T T +
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
APE + E D++ G ++ EL+ G F
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 2/79 (2%)
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLS 300
H + IIHRD+K N+L++ + +GDFG A T + GT+ APE L+
Sbjct: 277 HGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA 335
Query: 301 TGKSSEKTDVFGYGVMLLE 319
+ D++ G+++ E
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.002
Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 45/236 (19%)
Query: 130 LGRGGFGKVY--KGRLTDG----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
+G G FG+V+ K + T ++ + LKE Q EV ++ H+N++R
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS----QLVIEVNVMRELKHKNIVR 76
Query: 184 -LRGFCMTPTERL-LVYPFMVNG----SVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
+ F ++L ++ F G ++ C + G+ + + +Q+ LA
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL----HALA 132
Query: 238 YLHDHCD----PKIIHRDVKAANILLDEEFE-----------------AVVGDFGLAKLM 276
Y H+ D +++HRD+K NI L A +GDFGL+K +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 277 DYKDTHVTTAVRGTIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDLA 330
+ + + GT + +PE L T +K+D++ G ++ EL +G+ F A
Sbjct: 193 GIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246
|
Length = 1021 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 19/100 (19%)
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LM-DYKDTHVTTAV 287
G+ +LH IIHRD+K +NI++ + + DFGLA+ +M Y VT
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 183
Query: 288 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
R APE + E D++ G ++ E+I G F
Sbjct: 184 R------APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 130 LGRGGFGKVYKGRLTDGS------------LVAVKRLKEERTQGGELQFQTEVEMISMAV 177
LGRG ++Y G L + + ++ + + L F M+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---PLNWSVRKQIALGAAR 234
H++++ L G C+ E ++V F+ G + L +S P + V KQ+ A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL----AS 116
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGT--- 290
L+YL D ++H +V NILL E + G+ G KL D +T R
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAR--EGIDGECGPFIKLSD-PGIPITVLSRQECVE 170
Query: 291 -IGHIAPEYLSTGKS-SEKTDVFGYGVMLLEL 320
I IAPE + K+ S D + +G L E+
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 447 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.16 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.51 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.3 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.67 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.46 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.41 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.39 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.27 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.89 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.5 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.48 | |
| PLN02236 | 344 | choline kinase | 96.47 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.34 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.28 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.16 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.13 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.98 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.7 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 95.55 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.42 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.37 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.22 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.22 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.34 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 93.12 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=430.04 Aligned_cols=290 Identities=53% Similarity=0.893 Sum_probs=255.0
Q ss_pred CccccCHHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeee
Q 013238 108 QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187 (447)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 187 (447)
..+.|+++++..+|++|...+.||+|+||.||+|...+|..||||++....... ..+|.+|++++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999999999999887655432 4569999999999999999999999
Q ss_pred eecCC-cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 013238 188 CMTPT-ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 188 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
|.+.+ +.+||||||++|+|.++|+..... +++|..|.+|+.++|+||+|||+.+.+.|+|||||++|||||+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 499999999999999999886544 699999999999999999999999988999999999999999999999
Q ss_pred EeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 267 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 267 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
|+|||+++..............||.+|+|||++..+..+.|+||||||++|+||+||+.+.+... ......+.+|+..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHHH
Confidence 99999997554312211111169999999999999999999999999999999999999887533 2334459999999
Q ss_pred HhhccccccccccccC-CCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 347 LLKEKKLEQLVDSDME-GNYIE-EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
.+....+.+++|+.+. ..... .+...+..++.+|++.+|.+||+|.+|++.|+.+.
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9998899999999987 55554 68889999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=383.51 Aligned_cols=256 Identities=32% Similarity=0.511 Sum_probs=209.5
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCC-cceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 200 (447)
.+...+.||+|+||+||+|.+.....||||++...... .....|.+|+.++.+++|||||+++|+|.+.. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34444569999999999999975444999999754322 22568999999999999999999999999887 78999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCCCCCEEECCCC-cEEEeecCCccccCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-IIHRDVKAANILLDEEF-EAVVGDFGLAKLMDY 278 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~ 278 (447)
+++|+|..+++.. ....+++..+..++.+||+||.|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999874 234599999999999999999999999 7 99999999999999998 999999999987543
Q ss_pred CCCceeeccccccCcccccccc--CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.. ...+...||..|||||++. ...|+.|+||||||+++|||+||+.||.... ....... +
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~--------~~~~~~~---------v 258 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA--------PVQVASA---------V 258 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHH---------H
Confidence 32 2333367999999999999 5699999999999999999999999996421 1111111 1
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.....+...+..+...+..+|..||+.||..||++.+++..|+.+
T Consensus 259 ~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 259 VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 112222333344677899999999999999999999999999963
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=364.59 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=212.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-cceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 200 (447)
+.+..+.||+|..|+||++.++ +++.+|+|.+.........+++.+|+++++..+||+||.++|.|.... +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4445678999999999999987 688999999977777777789999999999999999999999999988 49999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|.+|+|..++...+ .+++.....|+.+|++||.|||+ + +|+||||||+||||+..|++||||||.++.+...
T Consensus 160 MDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999998753 38999999999999999999996 6 9999999999999999999999999999876544
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ........+.+.....+..
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~pp------- 299 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPP------- 299 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCC-------
Confidence 445567999999999999999999999999999999999999999643 1222333333333332211
Q ss_pred ccCCCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 360 DMEGNYIE-EEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 360 ~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...+. .+..++..++..||++||.+|||+.|+++
T Consensus 300 ---P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 ---PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ---CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11222 35677999999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=385.34 Aligned_cols=259 Identities=30% Similarity=0.455 Sum_probs=218.0
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+....+...+.||+|.||.||.|.+.....||+|.++... .....|.+|+++|++++|+|||+++|+|..+...+|||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 3334444557799999999999999877799999997653 23457889999999999999999999999988999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|||+.|+|.++|+.... ..+.....+.++.|||+||+||+++ ++|||||.++||||+++..+||+||||++....
T Consensus 281 E~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999987332 3488999999999999999999999 999999999999999999999999999996554
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
..........-+..|+|||.+..+.++.|||||||||+||||+| |+.||.. ....+.+ +.+
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--------msn~ev~----------~~l 417 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--------MSNEEVL----------ELL 417 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC--------CCHHHHH----------HHH
Confidence 44444444445778999999999999999999999999999999 8888843 2222222 234
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
+...+...+..++..+.++|..||..+|++|||++.+...|+...
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 444455566778889999999999999999999999999998753
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=412.50 Aligned_cols=374 Identities=24% Similarity=0.421 Sum_probs=258.9
Q ss_pred CCeeeCCCCcccccCCCCCCCCCCCccccccCCCCCCCCCCCCCCCCCCCCCCCCCCccchhhHHHHHHHHHHHHHHHHH
Q 013238 1 MNCRDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIA 80 (447)
Q Consensus 1 l~~~~ls~N~lsG~iP~~~~~~~~~~~s~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (447)
|..||+|+|+++|.+|..+++..+...++.||...++++++.. .++............+++++ ++++++++++++.
T Consensus 573 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~---~~~c~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 648 (968)
T PLN00113 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG---LPPCKRVRKTPSWWFYITCT-LGAFLVLALVAFG 648 (968)
T ss_pred cCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC---CCCCccccccceeeeehhHH-HHHHHHHHHHHHH
Confidence 5678888888888888888888888888888876554321111 01111111111111222222 2222222222333
Q ss_pred HHHHhcCCCCCCCCCCCCCCC-ccc---ccCCccccCHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEec
Q 013238 81 LAYWRKRKPEDHFFDVPAEED-PEV---HLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLK 155 (447)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~ 155 (447)
++++|+++.... .....+.. ... .....+.++++++ ...+...+.||+|+||.||+|... ++..||||++.
T Consensus 649 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~ 724 (968)
T PLN00113 649 FVFIRGRNNLEL-KRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN 724 (968)
T ss_pred HHHHHhhhcccc-cccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEcc
Confidence 333333321110 00000000 000 0001122333333 346778889999999999999974 78999999986
Q ss_pred cccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHH
Q 013238 156 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235 (447)
Q Consensus 156 ~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~ 235 (447)
..... ...|++.+++++||||++++|+|.+....++||||+++|+|.++++. ++|..+..++.|+++|
T Consensus 725 ~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~ 792 (968)
T PLN00113 725 DVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKA 792 (968)
T ss_pred CCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHH
Confidence 43321 23468889999999999999999999999999999999999999952 7899999999999999
Q ss_pred HHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHH
Q 013238 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 315 (447)
Q Consensus 236 l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~ 315 (447)
|+|||..+.++++||||||+||+++.++..++. ||........ ....++..|+|||++.+..++.++|||||||
T Consensus 793 L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gv 866 (968)
T PLN00113 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGL 866 (968)
T ss_pred HHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHH
Confidence 999997666699999999999999999888875 6655432211 1224788999999999999999999999999
Q ss_pred HHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 013238 316 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSE 393 (447)
Q Consensus 316 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 393 (447)
++|||+||+.||+.. .........|++..........++|+.+.. .....+...+.+++.+||+.||++||||.+
T Consensus 867 vl~el~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e 943 (968)
T PLN00113 867 ILIELLTGKSPADAE---FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943 (968)
T ss_pred HHHHHHhCCCCCCcc---cCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence 999999999999532 123445777777666555555666665543 234566778899999999999999999999
Q ss_pred HHHHHhcCCC
Q 013238 394 VVRMLEGDGL 403 (447)
Q Consensus 394 vl~~L~~~~~ 403 (447)
+++.|+.+.-
T Consensus 944 vl~~L~~~~~ 953 (968)
T PLN00113 944 VLKTLESASR 953 (968)
T ss_pred HHHHHHHhhc
Confidence 9999997643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=353.91 Aligned_cols=199 Identities=27% Similarity=0.476 Sum_probs=180.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|...+.||+|.||+||+|+++ ++..||||.+.+.. .......+..|+.+|+.++|||||.+++++..++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57888888999999999999986 58999999997764 44455568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC------CcEEEeecCCc
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLA 273 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgl~ 273 (447)
||.||+|..+++.++. +++...+.++.|||.||++||++ +||||||||.||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998753 89999999999999999999999 99999999999999765 45899999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
+.+. ........+|++-|||||++...+|+.|+|+||+|+|||+|++|+.||+.
T Consensus 163 R~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9876 34445667899999999999999999999999999999999999999963
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=359.72 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=208.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc------hHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG------GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++++..... ......+|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3466788899999999999999865 69999999997654322 2234679999999999999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEee
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGD 269 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kl~D 269 (447)
..|+||||++||+|.+.+-..+. +.+..-+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999977653 67777899999999999999999 99999999999999766 8899999
Q ss_pred cCCccccCCCCCceeeccccccCccccccccCCCC---CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 270 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 270 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
||+|+... ....+...+||+.|.|||++.+... ..+.|+||+||+||-+++|..||.... ....+.
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~----~~~sl~----- 391 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY----TDPSLK----- 391 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc----CCccHH-----
Confidence 99999865 4556677899999999999977643 458899999999999999999996321 111111
Q ss_pred HhhccccccccccccC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 347 LLKEKKLEQLVDSDME--GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
+++...+.. ........++..++|.+||..||++|||+.|+++.=.
T Consensus 392 -------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 392 -------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred -------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 122222221 2234556778899999999999999999999987533
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=370.75 Aligned_cols=248 Identities=27% Similarity=0.468 Sum_probs=209.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEE-CCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.+|...++||+|+|.+||.++. .+|+.||+|++.+... ......+.+|+++.+.+.|||||+++++|.+.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999998 6899999999976432 334556889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|+|..++|..+++.+. ++++.+++.++.||+.||.|||++ +|+|||||..|+|++++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998543 499999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.... ....+||+.|+|||++....++..+||||+||++|.|++|++||+... ++..+..-+..+.
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------vkety~~Ik~~~Y-- 235 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------VKETYNKIKLNEY-- 235 (592)
T ss_pred cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------HHHHHHHHHhcCc--
Confidence 5433 445789999999999999999999999999999999999999996421 1111111111111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+........+||.++|+.||.+|||+++|+.
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112233445778899999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=385.97 Aligned_cols=264 Identities=28% Similarity=0.474 Sum_probs=221.8
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 190 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 190 (447)
.++...+....+.||+|.||+||+|+.. +...||||.++.........+|++|++++..++|||||+|+|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3445566677788999999999999854 3568999999988777678899999999999999999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQS----------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 260 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~ 260 (447)
.+..++|+|||..|||.++|..+... ..+++..+.+.|+.|||.||.||-++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 99999999999999999999764321 33589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCceee-ccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcc
Q 013238 261 EEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDV 338 (447)
Q Consensus 261 ~~~~~kl~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~ 338 (447)
++..|||+|||+++.....+..... ...-..+|||||.+..+++|++||||||||+|||+++ |+.||....
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS------- 710 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS------- 710 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-------
Confidence 9999999999999976554443322 3335679999999999999999999999999999998 999985321
Q ss_pred cHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 339 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.++.++.+.+..+ -..+..++..++.||..||+.+|.+||++.||-..|+..
T Consensus 711 ----------n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 711 ----------NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ----------hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 1122222222222 456777889999999999999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=343.17 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=207.7
Q ss_pred CCCCCCeeeecCCeEEEEEEE-CCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeee-eecCCc-ceEEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGF-CMTPTE-RLLVY 198 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~ 198 (447)
+|.+.++||+|.||+||++.. .+|..+|.|.++-... ......+..|+.+|++++|||||+++++ +...++ .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 456668899999999999985 4799999999974432 3345568899999999999999999984 444555 78999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|+|.+|+|..+++.......-+++..+|+++.|++.||..+|++... -|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999988777777799999999999999999999994321 39999999999999999999999999999886
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.... .....+|||.||+||.+.+..|+.||||||+||++|||+.-..||... .+.+.-+. +.+
T Consensus 180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~K------I~q-- 242 (375)
T KOG0591|consen 180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKK------IEQ-- 242 (375)
T ss_pred chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHH------HHc--
Confidence 5443 345567999999999999999999999999999999999999999642 12222111 111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
.....-........+..++..|+..||..||+.-.+++.+.
T Consensus 243 -gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 243 -GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11111112456788999999999999999998544444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=342.58 Aligned_cols=245 Identities=27% Similarity=0.344 Sum_probs=203.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
..++|+..++||+|+||+|+.++.. +++.+|+|++++..... .......|..+|..++||+||+++..+++...+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3568999999999999999999865 58999999998765433 34568889999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
|++|+.||.|..+|++.+. +++..++.+++.|+.||.|||++ +||||||||+|||||.+|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999987653 89999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.. ........+||+.|||||++.+..|+..+|+||+|+++|||++|..||...+ ...+.......+
T Consensus 176 ~~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~~k----- 241 (357)
T KOG0598|consen 176 LK-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILKGK----- 241 (357)
T ss_pred cc-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhcCc-----
Confidence 32 3334455789999999999999999999999999999999999999996422 223333332222
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 390 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 390 (447)
+ ...+.-......+++...++.||.+|..
T Consensus 242 ----~-~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ----L-PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ----C-CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 0 0111112345778888999999999974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=363.99 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=219.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
....+.++||.|.||.|++|.++- ...||||.++....+..+.+|+.|..+|.++.||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345567899999999999998762 4589999999988888888999999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
.|||++|+|..+|+.+.+. +.+.++..++.+||.||+||-+. ++|||||..+||||+.+..+|++|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999988754 88999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeecccc--ccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 278 YKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 278 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.......+...| ..+|.|||.+.-.+++.+||||||||++||.++ |.+||-.. .- .+..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--------SN----------QdVI 844 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------SN----------QDVI 844 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--------ch----------HHHH
Confidence 554333333323 578999999999999999999999999999887 99998421 11 1122
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..++...+-..+.+++..|.+||+.||++|-.+||.+.+++..|++.
T Consensus 845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 22333444455677889999999999999999999999999999984
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=333.05 Aligned_cols=263 Identities=25% Similarity=0.374 Sum_probs=211.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
..+.|+..+.||.|..++||+|.+. .++.||||++..+.+......+.+|+..++.++||||+.++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3568999999999999999999865 689999999998888777778999999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
.||.+|++.+.+...-.. .+++..+..|+.++++||.|||.+ |.+|||||+.||||+++|.+||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999875443 399999999999999999999999 999999999999999999999999998765543
Q ss_pred CCCcee---eccccccCccccccccC--CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 279 KDTHVT---TAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 279 ~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
...+.. ...+||++|||||++.. ..|+.|+|||||||+..||.+|..||...... ..+.. . +.. ..
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm----kvLl~---t-Lqn-~p 249 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM----KVLLL---T-LQN-DP 249 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH----HHHHH---H-hcC-CC
Confidence 332211 44579999999999644 36899999999999999999999999632110 00100 0 110 00
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....-..+..+........+.+++..||+.||.+|||+.++++
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0001112222233445568999999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=339.00 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=204.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC--cceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 198 (447)
.++...+.||+|+||+||++...+ |...|||.+....... ...+.+|+.+|++++|||||+.+|...... .++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 356677899999999999999764 8999999997653322 456889999999999999999999755444 588999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeecCCccccC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMD 277 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~ 277 (447)
||+++|+|.+++...+. ++++..+..++.||++||+|||++ +++||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999988764 399999999999999999999999 9999999999999999 7999999999998765
Q ss_pred C--CCCceeeccccccCccccccccCCC-CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 278 Y--KDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 278 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
. ..........||+.|||||++..+. ...++|||||||++.||+||+.||... .....++.......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~--- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGRED--- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccC---
Confidence 3 2223344567999999999998643 345999999999999999999999531 11111111111111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..+..+........+++.+|++.||.+|||+.++++..--
T Consensus 240 ------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 240 ------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1113334455668889999999999999999999985443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=351.17 Aligned_cols=264 Identities=28% Similarity=0.458 Sum_probs=205.5
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEE------CCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
.+..++|++.++||+|+||.||+|.. .+++.||||++...........+.+|++++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 45667899999999999999999974 135689999997654444455788999999999 89999999998876
Q ss_pred CC-cceEEEecccCCcchhhhhhcCC------------------------------------------------------
Q 013238 191 PT-ERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------ 215 (447)
Q Consensus 191 ~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 215 (447)
.+ ..+++|||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 57899999999999999875321
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc-eeeccccc
Q 013238 216 ----SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 290 (447)
Q Consensus 216 ----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt 290 (447)
...++++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 123588889999999999999999999 9999999999999999999999999999865322211 12223456
Q ss_pred cCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHH
Q 013238 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEE 369 (447)
Q Consensus 291 ~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 369 (447)
..|+|||++.+..++.++|||||||++|||++ |..||..... .. ........... ...+...
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~---~~~~~~~~~~~----------~~~~~~~ 302 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NE---EFCQRLKDGTR----------MRAPENA 302 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cH---HHHHHHhcCCC----------CCCCCCC
Confidence 78999999999999999999999999999997 9999953211 10 11111111100 0111223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 370 VEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 370 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+.+++.+||+.||.+|||+.++++.|+..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 45688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.52 Aligned_cols=242 Identities=27% Similarity=0.465 Sum_probs=205.4
Q ss_pred CCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCC
Q 013238 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 125 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
..++-||+|+.|.||+|++. ++.||||+++... +.+++-|++++|+||+.+.|+|....-+++|||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 34567999999999999997 5789999886432 35788899999999999999999988899999999999
Q ss_pred cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCcee
Q 013238 205 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 284 (447)
Q Consensus 205 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 284 (447)
.|..+|+... ++.......|..+||.||.|||.+ .|||||||+-||||..+..+||+|||-++..... ...
T Consensus 198 qL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 198 QLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred cHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 9999998754 478888999999999999999999 9999999999999999999999999999876543 334
Q ss_pred eccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCC
Q 013238 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364 (447)
Q Consensus 285 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 364 (447)
..++||..|||||++.+.+.++|+||||||||||||+||.-||...+. .-.+..+-...+.-.
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-----------------sAIIwGVGsNsL~Lp 331 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-----------------SAIIWGVGSNSLHLP 331 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-----------------heeEEeccCCccccc
Confidence 556799999999999999999999999999999999999999953110 011222222333444
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 365 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.+..+++-+.-|+++||+..|..||++++++..|+-.
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 5667778888899999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=321.53 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=203.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
+.|+.+.++|+|+||+||+++.+ +|+.||||++..... +...+-.++|+++|+++.|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788889999999999999987 599999999965433 3334457899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
||+. ++.+-|+.... .++...+++++.|++.|+.|+|++ +++||||||+||||+.+|.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9977 44444444322 388999999999999999999999 999999999999999999999999999998764
Q ss_pred CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh---------
Q 013238 280 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 349 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 349 (447)
.+..++..+.|.+|.|||.+.+ -.|....||||+||++.||++|.+.|... .+.+..-.+...+.
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~-----SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR-----SDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc-----chHHHHHHHHHHHcccCHHHHHH
Confidence 4555666778999999999987 68999999999999999999999988431 12221111111111
Q ss_pred ---ccccccccccccC-----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 ---EKKLEQLVDSDME-----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 ---~~~~~~~~d~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
......+.-+... ....+.....+++++..|++.||.+|++-++++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111111 0112233456899999999999999999998875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=348.52 Aligned_cols=265 Identities=26% Similarity=0.423 Sum_probs=214.0
Q ss_pred ccCHHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeee
Q 013238 111 RFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCM 189 (447)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 189 (447)
+.+..++++..+.+.+...||+|.||+||+|.+.+ .||||+++.... .+..+.|++|+.++++-+|.||+-+.|+|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 34567788888888899999999999999999863 499999976543 334567999999999999999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEee
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 269 (447)
.+.. .+|..+|+|.+|..+++.... .++......|+.||++||.|||.+ +|||||||+.|||+.+++.|||+|
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEec
Confidence 8877 999999999999999997653 489999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCC-CCceeeccccccCccccccccC---CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 270 FGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 270 fgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
|||+..-..- .........|...|||||++.. .+|+..+||||||+++|||+||..||... . .
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~---~--------- 598 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-N---R--------- 598 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-C---h---------
Confidence 9998643221 1112223347788999999864 47899999999999999999999999621 0 0
Q ss_pred HHhhccccccccccccC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 346 GLLKEKKLEQLVDSDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
+..+..+-...+. ......+.+.+.+|+..||..++++||++.+|+..|+..
T Consensus 599 ----dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 599 ----DQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ----hheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 1111111111111 123445677899999999999999999999999977753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=342.26 Aligned_cols=289 Identities=23% Similarity=0.348 Sum_probs=221.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 196 (447)
..+|..++.||.|+|++|++|+.. .++.||||++.+.... ...+.+..|-+.|.+| .||.|++|+-.|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 458899999999999999999865 6899999999765322 2233567788888888 79999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
|+||+++|+|.++|+..+. +++...+.++.+|+.||+|||++ |||||||||+|||||++|++||+|||.|+.+
T Consensus 152 vLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999988753 89999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCc----------e--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 277 DYKDTH----------V--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 277 ~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
...... . ....+||..|.+||++..+..+..+|||+||||||.|+.|.+||...+ +....+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----eyliFq-- 297 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----EYLIFQ-- 297 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----HHHHHH--
Confidence 643221 1 144789999999999999999999999999999999999999996422 111111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCchhhHHHHHhhhhhccCCC
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGDGLAERWEEWQKEEMFRQDFNH 422 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~~~~~~~~~~~~~~~~ 422 (447)
..++ ++-. ++....+...+|+.+.|..||.+|+|..++-+ +++++.++. .+.+.++.
T Consensus 298 -kI~~-------l~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n---------lw~~~PP~ 356 (604)
T KOG0592|consen 298 -KIQA-------LDYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN---------LWQQTPPK 356 (604)
T ss_pred -HHHH-------hccc----CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh---------hhhcCCCc
Confidence 1110 1112 22233466888999999999999999977665 334433322 45555554
Q ss_pred -CCCCCCcccc-cCCCcccCCccC
Q 013238 423 -TPHPNNTWIV-DSTSHIQPDELS 444 (447)
Q Consensus 423 -~~~~~~~~~~-~~~~~~~~~~~~ 444 (447)
-|+...+... +.++...++|.+
T Consensus 357 l~py~p~~~~s~e~~s~~~~~~~~ 380 (604)
T KOG0592|consen 357 LQPYKPATSISPEYYSAYTPLEPG 380 (604)
T ss_pred ccCCCCcccCCcccCcccccccCC
Confidence 4444444433 333444444433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=338.39 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=209.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 196 (447)
.+.|+.+++||+|.||.||+|+.. +|+.||+|++..+.. +.......+|+.+|++++||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 456888899999999999999864 799999999986653 33455678999999999999999999998876 68899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
|+|||+. +|.-++...+. .+++.+++.++.|++.||.|+|++ +|+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999976 88888876443 399999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
........+..+-|.+|.|||.+.|. .|+.+.|+||.||||.||++|++.|... .+......+..+........
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-----tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-----TEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-----cHHHHHHHHHHHhCCCChhc
Confidence 87777777888899999999998875 6899999999999999999999998531 22222222222211111000
Q ss_pred c----------cccccC-----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 L----------VDSDME-----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~----------~d~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+ +.+... .+.........++|+..+|..||.+|.|+.++++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 000000 0001223456788999999999999999998886
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=374.68 Aligned_cols=261 Identities=30% Similarity=0.455 Sum_probs=215.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC--Cc----EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTD--GS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
...+.+..+.||+|.||.||.|.+.+ |. .||||.++.........+|.+|..+|+.++|||||+++|+|.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 35667778899999999999998653 33 5999999888778888899999999999999999999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 194 RLLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
.++++|||++|+|..+|++.+. ....++..+.+.++.+||+|+.||+++ ++|||||..+|+||+....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 9999999999999999987522 234589999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCceeecc-ccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHh
Q 013238 271 GLAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
|+|+.+...+....... .-...|||||.+..+.++.|+|||||||+|||++| |..||..- .-.+......
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~--------~n~~v~~~~~ 918 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--------SNFEVLLDVL 918 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc--------chHHHHHHHH
Confidence 99995543333222222 34578999999999999999999999999999999 88888421 1111112222
Q ss_pred hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 349 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
... +-..+..+++.++++|.+||+.+|++||++..+++.++.+
T Consensus 919 ~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 919 EGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred hCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 222 2234566788899999999999999999999999977764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=308.32 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=210.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|...++||+|.||+||+|++. +|+.||||+++..... .......+|++.|+.++|+||+.+++++.......+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46778889999999999999865 7999999999865433 334568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
||+. +|...++.... .++...++.++.++++||+|||++ .|+||||||.|+|++++|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9955 89999976543 489999999999999999999999 9999999999999999999999999999988654
Q ss_pred CCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
..... ..+.|.+|.|||.+.|. .|+...|+||.|||+.||+-|.+-|.. ..+.+....+...+......++-+
T Consensus 155 ~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG-----~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 155 NRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG-----DSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred Ccccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC-----CchHHHHHHHHHHcCCCCcccCcc
Confidence 44333 33579999999988775 689999999999999999998876632 233344444444444444333322
Q ss_pred cccC--------------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 359 SDME--------------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 359 ~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
-.-. ......+....++++..++..||.+|+|+.|+++.
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 2111 11223345667999999999999999999988753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=338.18 Aligned_cols=264 Identities=24% Similarity=0.327 Sum_probs=208.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCC-cceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT-ERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 196 (447)
..++|...++||.|.||.||+|+.. +|..||||+++.......+-.-++|+..|++++ |||||++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4568888899999999999999865 689999999987654433444678999999999 999999999998877 8999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||| ..+|.++++.+ ..++++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+
T Consensus 88 VfE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 99999 55999999876 34699999999999999999999999 9999999999999999889999999999976
Q ss_pred CCCCCceeeccccccCcccccccc-CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
..... .+..+.|.+|.|||++. .+.|+.+.||||+|||++|+.+-++.|-+.+ +.+..-.+-..+.......
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-----E~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-----EIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-----HHHHHHHHHHHhCCCcccc
Confidence 54433 45567899999999875 5678999999999999999999999884321 1111111112221111111
Q ss_pred ccc------------cccCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 356 LVD------------SDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 356 ~~d------------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+.. +...+ ...........+++.+|++.||.+|||+.+.++.
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 00111 1123366778999999999999999999999873
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=314.26 Aligned_cols=238 Identities=24% Similarity=0.348 Sum_probs=199.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|+..+.||.|+||+|.+++.+ +|..+|+|++.+...- .......+|..+|+.+.||+++++.+.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357888899999999999999976 6899999999765432 2234577899999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||.+||.|..+++..+. +++..++.++.+|+.||+|||+. +|++|||||+|||||.+|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999987653 89999999999999999999999 99999999999999999999999999999764
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. ....+||+.|+|||++....++.++|.|||||++|||+.|..||..... .. ..+.++
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~---------iY~KI~ 254 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQ---------IYEKIL 254 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HH---------HHHHHH
Confidence 32 5567899999999999999999999999999999999999999953211 11 111122
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMER 388 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 388 (447)
...+ .++......+.+|+...++.|-.+|
T Consensus 255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2221 2334445567888888889998888
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.13 Aligned_cols=269 Identities=23% Similarity=0.367 Sum_probs=220.4
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
+++.+...+.++||+|.||.|.++....+.+||||.++.......+.+|.+|+++|.+++||||+.++|+|..++..+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 45566778889999999999999999888999999999988888888999999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
+|||++|+|.+++..+.... +.-.....|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||+++.+.
T Consensus 614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999998764322 34555677999999999999998 99999999999999999999999999999665
Q ss_pred CCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh--CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 278 YKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 278 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
..+.. .....+-..+|||+|.+..++++.++|||+||+++||+++ ...||.... +...++-...+++.....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-----~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-----DEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-----HHHHHHhhhhhcCCCCcc
Confidence 44433 3334456789999999999999999999999999999865 778885311 111222222333322222
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
.+ ...+.-++..++++|..||..+-.+|||++++...|.+..
T Consensus 764 ~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 VV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 21 1234456778999999999999999999999999988654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=342.58 Aligned_cols=259 Identities=21% Similarity=0.328 Sum_probs=212.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
..|....+||+|..|.||.|... +++.||||++...... ...-+.+|+.+|+..+|+|||++++.+...++.|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 46777789999999999999854 6889999999765433 344578999999999999999999999888999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
|++|+|.+.+.... +++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999997654 89999999999999999999999 99999999999999999999999999998876544
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc-c
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD-S 359 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~ 359 (447)
. .....+||+.|||||++....|..|.||||||++++||+-|.+||-... . + +.++ -+.+ .
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~----P---l----rAly------LIa~ng 485 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN----P---L----RALY------LIATNG 485 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC----h---H----HHHH------HHhhcC
Confidence 4 3445569999999999999999999999999999999999999993211 0 0 0000 0001 1
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCchhh
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGDGLAERW 407 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~ 407 (447)
...-.........+.+++.+||+.|+.+|+++.|||+ +|......++-
T Consensus 486 ~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL 535 (550)
T KOG0578|consen 486 TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSL 535 (550)
T ss_pred CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHh
Confidence 1112234445667899999999999999999999998 66555544443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=336.05 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=211.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|...+.||+|.||+||+|+-+ +.+.||+|.+.+... +.....+.+|+++++.++||||+.++++|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999866 588999999976543 3344568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.| +|..+|...+. ++++.+..++.+++.||.|||++ +|+|||+||.|||++.+|.+|++|||+++.+..
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9966 99999987653 89999999999999999999999 999999999999999999999999999998764
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.....+.+.||+.|||||++.+..|+..+|+||+|||+||+.+|++||-. .++...++....+..
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a--------~si~~Lv~~I~~d~v------- 217 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA--------RSITQLVKSILKDPV------- 217 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------HHHHHHHHHHhcCCC-------
Confidence 44556777899999999999999999999999999999999999999943 123344444433321
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+.+....+..++...+.+||..|.|..+++.
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 123355667888999999999999999998875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=326.92 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=204.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.++|++.+.||+|+||.||+|.+. .+..||+|.++..........+.+|+.++.+++||||+++++++......++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888899999999999999753 3568999999865444445578899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999987643 2489999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
............++..|+|||++.+..++.++|||||||++||+++ |..||.... ..+......+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--------~~~~~~~~~~~----- 224 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--------GQDVIKAVEDG----- 224 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHHCC-----
Confidence 2221111112234678999999999999999999999999999775 999995311 11111111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.....+..++..+.+++.+||+.+|.+|||+.++++.|++
T Consensus 225 -----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 225 -----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0111122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=332.01 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=213.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
..|+..+.||+|.||.||+|.+. .++.||+|++..+..+.....+++|+.++..++++||.++++.+.....++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35777789999999999999875 68899999998877777777899999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
|.||++.+.|+... .+.+..+.-|+.+++.||.|||++ +.+|||||+.|||+..+|.+|++|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999997643 247778888899999999999999 99999999999999999999999999998776544
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
... ...+||+.|||||++.+..|+.|+||||||++.+||++|.+|+... ...+..-++-..
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~------------------hPmrvlflIpk~ 226 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL------------------HPMRVLFLIPKS 226 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc------------------CcceEEEeccCC
Confidence 443 5567999999999999889999999999999999999999999421 111222222222
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEG 400 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 400 (447)
-.+.....+...+.+++..||+.||+.|||+.++++ ++..
T Consensus 227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 222223355667999999999999999999999997 5555
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=333.91 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=204.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc----chHHHHHHHHHHHHhcC-CCceeeEeeeeecCC
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT 192 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 192 (447)
...++|...+.||+|.||+|++|... +++.||+|++...... .....+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999865 6899999977653111 23445778999999999 999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeecC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFG 271 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg 271 (447)
..++||||+.+|+|.+++...+ ++.+.....++.|++.|++|+|++ +|+||||||+|||+|.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999998733 388899999999999999999999 99999999999999999 999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCC-CC-chhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ........
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki-- 235 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKI-- 235 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHH--
Confidence 999764 2333455567999999999999877 74 78999999999999999999996411 11111111
Q ss_pred ccccccccccccCCCCcHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 EKKLEQLVDSDMEGNYIEEE-VEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..... ..+... ...+..++.+|+..||.+|+|+.+++.
T Consensus 236 -------~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 236 -------RKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -------hcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11111 111112 567889999999999999999999983
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=343.51 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=205.3
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEE------CCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
.+..++|+..+.||+|+||.||+|.. .++..||||+++..........+.+|+.++..+ +||||++++++|..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34456788899999999999999963 235689999997554444455688999999999 89999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCC------------------------------------------------------
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQS------------------------------------------------------ 216 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 216 (447)
....++||||+++|+|.+++......
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 99999999999999999998653210
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 217 -----------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 217 -----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
...+++..++.++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 12478899999999999999999999 9999999999999999999999999999865432
Q ss_pred CCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 280 DTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 280 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... .......++. ...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~----~~~~~~~~~~----~~~----- 334 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP----VDSKFYKMIK----EGY----- 334 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC----chHHHHHHHH----hCc-----
Confidence 2211 122234667999999999999999999999999999998 888885311 1111111111 110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
....+......+.+++.+||+.||++|||+.+|++.|++
T Consensus 335 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 ----RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 000111123568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=328.87 Aligned_cols=266 Identities=24% Similarity=0.388 Sum_probs=204.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-----------------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceee
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD-----------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 183 (447)
.++|...+.||+|+||.||++.+.+ +..||+|.+...........+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578888999999999999997532 34699999976544444567899999999999999999
Q ss_pred EeeeeecCCcceEEEecccCCcchhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 013238 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ---------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248 (447)
Q Consensus 184 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 248 (447)
+++++...+..+++|||+.+|+|.+++..... ....+++..++.++.||+.||.|||+. +++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999998999999999999999998865321 113478889999999999999999999 999
Q ss_pred ecCCCCCCEEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh--CCC
Q 013238 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQR 325 (447)
Q Consensus 249 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~ 325 (447)
||||||+|||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 1222345788999999988899999999999999999987 556
Q ss_pred CcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 326 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 326 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
||... ........+.......... . .......++..+.+++.+||+.+|.+|||+.+|.+.|++
T Consensus 241 p~~~~-----~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGEL-----TDEQVIENAGEFFRDQGRQ-V-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcC-----CHHHHHHHHHHHhhhcccc-c-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 66421 1111222222221111100 0 001112334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=343.91 Aligned_cols=265 Identities=29% Similarity=0.425 Sum_probs=213.3
Q ss_pred HHHHHHHhhCCCCCCeeeecCCeEEEEEEECC--C--cE-EEEEEecc--ccccchHHHHHHHHHHHHhcCCCceeeEee
Q 013238 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLTD--G--SL-VAVKRLKE--ERTQGGELQFQTEVEMISMAVHRNLLRLRG 186 (447)
Q Consensus 114 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 186 (447)
...++...++....++||+|+||.||+|++.. + .. ||||..+. ........+|..|.+++++++|||||+++|
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 33455566677777999999999999998753 2 23 89999985 344556678999999999999999999999
Q ss_pred eeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 013238 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 187 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
++......++|||+|.||+|.++|+.... .++..++..++.+.|.||+|||++ +++||||..+|+|++.++.+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 99999999999999999999999987654 389999999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCCCceee-ccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHH
Q 013238 267 VGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 267 l~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 344 (447)
|+|||+++.... ..... ...-..+|+|||.+....++.++|||||||++||+++ |..||.... ..+..
T Consensus 303 ISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~--------~~~v~ 372 (474)
T KOG0194|consen 303 ISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK--------NYEVK 372 (474)
T ss_pred eCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC--------HHHHH
Confidence 999999986431 11111 1235679999999999999999999999999999998 888985321 11111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
... +....+...+...+..+..++.+||..+|++||||.++.+.|+...-
T Consensus 373 ~kI---------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 373 AKI---------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred HHH---------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 111 11122223333456678889999999999999999999999987543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=320.31 Aligned_cols=264 Identities=28% Similarity=0.399 Sum_probs=194.9
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHH--hcCCCceeeEeeeeecCC----cceE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS--MAVHRNLLRLRGFCMTPT----ERLL 196 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~l 196 (447)
.....++||+|+||.||+|.+. ++.||||++.... ...|++|-++++ .+.|+||+++++.-.... +++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3444577999999999999996 5899999996533 346777777766 467999999998755433 7899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH------CDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
|++|.+.|+|.++|..+. ++|....+|+..+++||+|||+. .+|.|+|||||++||||.+|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999998764 89999999999999999999975 3678999999999999999999999999
Q ss_pred CCccccCCCCCc-eeeccccccCccccccccCCCC------CchhhhHHHHHHHHHHHhCCCCccc--------ccccC-
Q 013238 271 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKS------SEKTDVFGYGVMLLELITGQRAFDL--------ARLAN- 334 (447)
Q Consensus 271 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~------~~~sDvwSlG~il~elltg~~p~~~--------~~~~~- 334 (447)
|+|..+...... .....+||.+|||||++.+... -.+.||||+|.|||||++...-++. +....
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999887644322 2233679999999999976532 2468999999999999996654421 10000
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
+....+ +-++..+-.++....+...... ...+..+.+.+..||..||+.|.|+.=|.+.+..
T Consensus 441 G~hPt~-e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 441 GNHPTL-EEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred cCCCCH-HHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 000111 1122222222211111111111 1356778999999999999999999877766654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=325.07 Aligned_cols=262 Identities=15% Similarity=0.250 Sum_probs=203.3
Q ss_pred CCccccCHHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCceeeE
Q 013238 107 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRL 184 (447)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l 184 (447)
.+++.+...++ +......||+|++|.||+|.+ +|+.||||.++....... ...+.+|++++.+++||||+++
T Consensus 10 ~~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 10 NDIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred CcceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 34445555555 222236799999999999998 588999999976433221 3467899999999999999999
Q ss_pred eeeeec----CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 013238 185 RGFCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 260 (447)
Q Consensus 185 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~ 260 (447)
+|++.+ ....+++|||+++|+|.+++.... .+++.....++.+++.||.|||+.. +++||||||+||+++
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~ 157 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVT 157 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEEC
Confidence 999876 346789999999999999997643 4889999999999999999999732 788999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCceeeccccccCccccccccC--CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcc
Q 013238 261 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338 (447)
Q Consensus 261 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 338 (447)
+++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~------- 226 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT------- 226 (283)
T ss_pred CCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-------
Confidence 99999999999998653221 12347889999999976 678999999999999999999999996321
Q ss_pred cHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 339 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..+......... .....+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 227 -~~~~~~~i~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 227 -TKEIYDLIINKN---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred -HHHHHHHHHhcC---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111111111111 01111123456789999999999999999999999999863
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.44 Aligned_cols=264 Identities=25% Similarity=0.412 Sum_probs=205.4
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
....++|...+.||+|+||.||+|... ++..||||.++..........+.+|+++++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345668889999999999999998742 24579999997654444455688999999999 89999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCC-------------------------------------------------------
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------- 215 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 215 (447)
....++||||+.+|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998864211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc-e
Q 013238 216 -----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-V 283 (447)
Q Consensus 216 -----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~ 283 (447)
...++++..++.++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 112478889999999999999999999 9999999999999999999999999999765332211 1
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 362 (447)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..... ..... ...
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~----~~~~~---------~~~ 333 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFY----KMVKR---------GYQ 333 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHH----HHHHc---------ccC
Confidence 112234567999999998899999999999999999997 9999953210 00111 11111 000
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 363 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+......+.+++.+||+.||.+|||+.+|++.|++.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111235688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=325.55 Aligned_cols=281 Identities=21% Similarity=0.252 Sum_probs=214.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999976 688999999864322 123346788999999999999999999999989999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999987643 388999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~------- 214 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILAGK------- 214 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-------
Confidence 2 123458999999999999889999999999999999999999995311 111111111110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhcCCCchhhHHHHHhhhhhccCCCCCCCCCccccc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVD 433 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (447)
. ..+......+.+++.+||+.||.+||+ +.++++.-.-.. ..|..........+..+...+.+.||+++
T Consensus 215 --~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 288 (291)
T cd05612 215 --L--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS--VDWDDVPQRKLKPPIVPKVSHDGDTSNFD 288 (291)
T ss_pred --c--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC--CCHHHHhcCCCCCCEeCCCCCcccccccc
Confidence 0 111122346889999999999999995 777765422211 12333333333333444456666666665
Q ss_pred C
Q 013238 434 S 434 (447)
Q Consensus 434 ~ 434 (447)
+
T Consensus 289 ~ 289 (291)
T cd05612 289 D 289 (291)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=335.11 Aligned_cols=279 Identities=27% Similarity=0.391 Sum_probs=233.4
Q ss_pred HHHHHHHhhCCCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 114 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
.++++....+.....+||.|.||.||.|.++. ...||||.++.+..+ ..+|+.|..+|+.+.|||+|+++|+|....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 36677777778888999999999999999874 678999999876543 457999999999999999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..|+|.|||..|+|.++|+...... ++...++.++.||..||.||..+ ++|||||..+|+|+.++..+|++|||+
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~e--v~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSE--VPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhh--cchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999998865443 77788899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++++............-.+.|.|||.+.-..++.|+|||+|||+|||+.| |..||... ++ .
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--------dl----------S 473 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DL----------S 473 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--------cH----------H
Confidence 99987655544444445778999999999999999999999999999998 98888431 12 2
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhhHHHHHhhhhh
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFR 417 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~ 417 (447)
.+..+++...+.+.+..|+..+++||..||+.+|.+||++.|+-+.++..--..+.+...+.+.-.
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keLgk 539 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKELGK 539 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHHhh
Confidence 233445555666677788899999999999999999999999999999864444444444444333
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=321.80 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=206.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
++|+..+.||+|+||.||+|.... ...||+|.+...........+.+|++.+..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998643 25799999876544444557889999999999999999999999888899
Q ss_pred EEEecccCCcchhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 013238 196 LVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 263 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~ 263 (447)
++|||+++++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998764211 13588999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHH
Q 013238 264 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 264 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 341 (447)
.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--------~~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--------NQ 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence 999999999976533221 12223346788999999988899999999999999999998 999985311 11
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
+..... .. ......+...+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 234 ~~~~~i-~~---------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIEMI-RS---------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHH-Hc---------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 11 11112233456779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.72 Aligned_cols=249 Identities=29% Similarity=0.510 Sum_probs=194.7
Q ss_pred CCeeeecCCeEEEEEEEC-----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 127 RNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
.+.||.|.||.||+|.+. .+..|+||.++..........+.+|++.+++++||||++++|++......++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 257899999976555555678999999999999999999999999888899999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++|+|.++|.... ...+++..+..|+.||+.||+|||++ +++|+||+++||++++++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999998862 23489999999999999999999999 999999999999999999999999999987632221
Q ss_pred -ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 282 -HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 282 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
...........|+|||.+.+..++.++||||||+++|||++ |+.||... ...++.........
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~~~~~~------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKLKQGQR------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHHHTTEE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccccccc-------
Confidence 12222346778999999999889999999999999999999 67887421 22222223222211
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
......+...+.+++..||+.+|.+|||+.++++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222356688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=334.10 Aligned_cols=243 Identities=27% Similarity=0.374 Sum_probs=201.0
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 194 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 194 (447)
..-++|...++||+|.||+|+++..+ +++.+|||.+++... .+.....+.|-.++...+ ||.+++++..++..++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34568999999999999999999987 588999999987653 233445777877777665 99999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
|+||||+.||++..+.+.. .+++..+..+++.|+.||.|||++ +|||||||.+|||||.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999955554432 399999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
..-. ....++..+||+.|||||++.+..|+.+.|+|||||+||||+.|..||...+ + +
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-----E----------------e 574 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-----E----------------E 574 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-----H----------------H
Confidence 6432 3335667899999999999999999999999999999999999999996311 1 1
Q ss_pred cccccccC--CCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 355 QLVDSDME--GNYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 355 ~~~d~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
++.|..+. ..++.....+...++.+++..+|++|.-+
T Consensus 575 e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11222111 12344556678889999999999999876
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=319.48 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=205.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..++|+..++||+|++|.||+|...++..||+|.+..... ....+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 4567888999999999999999988888899999865322 24568899999999999999999999998899999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++..... ..+++..++.++.+++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999876432 2478899999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.........++..|+|||++.+..++.++||||||+++|+|+| |+.||.... ...... .......
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~---~~~~~~~------ 222 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-----NSDVMS---ALQRGYR------ 222 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-----HHHHHH---HHHcCCC------
Confidence 2222222335678999999988889999999999999999998 999985311 111111 1111100
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..........+.+++.+||+.+|++|||++++++.|+.
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 ----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.79 Aligned_cols=270 Identities=24% Similarity=0.394 Sum_probs=227.6
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEEECC---C--cEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeee
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD---G--SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 187 (447)
+..++++..+..+..++||.|.||.||+|.+.+ | --||||.-+.+...+....|+.|.-++++++||||++++|+
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 344455666667777899999999999998753 2 35899999887777777789999999999999999999999
Q ss_pred eecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEE
Q 013238 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 267 (447)
Q Consensus 188 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl 267 (447)
|.+ ...|+|||.++.|.|..+|+.+..+ ++......++.||+.||+|||+. ++|||||..+|||+....-+||
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence 975 5679999999999999999987654 88899999999999999999999 9999999999999999999999
Q ss_pred eecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHH
Q 013238 268 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 268 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
+|||+++.+........+...-...|||||.+.-.+++.+||||.|||.+||+++ |..||...
T Consensus 533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv---------------- 596 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV---------------- 596 (974)
T ss_pred cccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc----------------
Confidence 9999999887766555554455778999999999999999999999999999987 99999531
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhh
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 407 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 407 (447)
+.......++..-+...++.|+..|+.+|.+||..+|.+||++.++...|+.+..++..
T Consensus 597 --kNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 597 --KNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred --cccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 12222333344444456778889999999999999999999999999999987665544
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=316.98 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=202.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
++|+..+.||+|+||.||++...++..+|+|.+.... .....+..|++++++++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4677888999999999999998888889999886432 22446888999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++|+|.+++..... .+++..++.++.+++.||+|||++ +++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999875432 388999999999999999999999 999999999999999999999999999876533222
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.+........ ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~~~---~~~-- 222 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRGFR---LYR-- 222 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCC---CCC--
Confidence 22222235668999999988889999999999999999999 899985311 1122222211111 000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
+......+.+++.+||+.+|.+|||+.++++.|.
T Consensus 223 -----~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 -----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112346899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=307.69 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=203.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccch-HHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 197 (447)
+.|+..+.|++|+||.||+|+++ +++.||+|+++.+..... ...-++|+.+|.+++|||||.+.++.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35666788999999999999986 689999999986543222 33568999999999999999999987643 568999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
||||+. +|..+++... +++...+++.+..|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999976 9999998765 4699999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc-
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ- 355 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 355 (447)
.. ....+..+-|.+|.|||.+.+. .|+++.|+||+|||+.||+++++.|.. ..+.+..+.+...+....-..
T Consensus 229 sp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G-----~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 229 SP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG-----KSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred CC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC-----CchHHHHHHHHHHhCCCccccC
Confidence 43 3445667789999999998775 589999999999999999999998853 223333333333332111110
Q ss_pred --cccc------c--------cCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 --LVDS------D--------MEGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 --~~d~------~--------~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+... . +...+... ..+.-++++...+..||.+|-|+.+.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000 0 00011111 2356678899999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=320.64 Aligned_cols=249 Identities=20% Similarity=0.303 Sum_probs=198.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
...++|+.+..||+|+||.||+|+-+ +|..+|+|++++... ......+..|-.+|....+++||+++..|++...+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 45679999999999999999999865 699999999986543 223446788899999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
|||||++||++..+|...+ .|++..++.++.+++.|+..||.. |++||||||+|+|||..|++||+||||+..
T Consensus 218 LiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999997654 499999999999999999999999 999999999999999999999999999853
Q ss_pred cCCC----------------------C-C-----c------------------eeeccccccCccccccccCCCCCchhh
Q 013238 276 MDYK----------------------D-T-----H------------------VTTAVRGTIGHIAPEYLSTGKSSEKTD 309 (447)
Q Consensus 276 ~~~~----------------------~-~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~sD 309 (447)
+... + . . .....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 3210 0 0 0 011235999999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 013238 310 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 389 (447)
Q Consensus 310 vwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 389 (447)
+||||||+||||.|.+||...... .....+..|...+... .......+..++|.+|+. ||.+|.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQ-ETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhc
Confidence 999999999999999999642110 0111122332211111 111122567888889888 999998
Q ss_pred C
Q 013238 390 K 390 (447)
Q Consensus 390 t 390 (447)
-
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 7
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=325.05 Aligned_cols=200 Identities=26% Similarity=0.374 Sum_probs=175.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||.||++... +|..+|+|.+...........+.+|+++++.++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999976 5889999999765444445578999999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++|+|.+++.... .+++..+..++.+++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997643 3889999999999999999999862 6999999999999999999999999998755322
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12234589999999999999999999999999999999999999953
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.19 Aligned_cols=263 Identities=22% Similarity=0.361 Sum_probs=206.4
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 190 (447)
.+..++|.+.++||+|+||.||+|... .+..||||++...........+.+|+++++++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 445678999999999999999999853 134799999976544444557899999999996 9999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCC-------------------------------------------------------
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------- 215 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 215 (447)
....++|||||++|+|.+++.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998865321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 013238 216 -------------------------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 258 (447)
Q Consensus 216 -------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nil 258 (447)
....+++..++.++.|++.||+|||+. +++||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012478888999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCC
Q 013238 259 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 336 (447)
Q Consensus 259 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~ 336 (447)
+++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~---- 345 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV---- 345 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----
Confidence 999999999999999865332221 1122346778999999999899999999999999999997 9999853110
Q ss_pred cccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..... ...... ............+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 346 ~~~~~----~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 346 DSTFY----NKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred hHHHH----HHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 00000 111110 0111122345678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.38 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=206.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+..++|+..+.||+|++|.||+|...+++.||+|.++.... ....+.+|++++++++|+||+++++++...+..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 34567888999999999999999987788899999875432 2456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999997643 23489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
...........+..|+|||++.+..++.++||||||+++|||++ |+.||.... . ...........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~---~~~~~~~~~~~------ 221 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----N---AEVLQQVDQGY------ 221 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----H---HHHHHHHHcCC------
Confidence 22111111223457999999998899999999999999999999 999985311 1 11111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
...........+.+++.+||+.+|.+||++.++++.|+.
T Consensus 222 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 ----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 001112234678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=332.69 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=205.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
-|..++.||.|+.|.|.+|++. +|+.+|||++.+.. .......+.+|+-+|+.+.|||++++++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4677889999999999999865 79999999997652 22234468899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++|.|.+++...+ ++.+.+..+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|..- .
T Consensus 93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe--~ 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE--V 163 (786)
T ss_pred ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc--c
Confidence 999999999997765 489999999999999999999999 9999999999999999999999999999763 2
Q ss_pred CCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
........+|++.|.|||++.+.+| ..++||||.|||||.|+||+.||+..+ -..+...|+. +.
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LLlKV~~----G~------ 228 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLLLKVQR----GV------ 228 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHHHHHHc----Cc------
Confidence 3444556689999999999999988 679999999999999999999996321 1111111111 00
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
-+.+.....+..+|+.+|+..||..|.|++||++.
T Consensus 229 ----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 ----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 01123334567889999999999999999999984
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=315.13 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=206.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.++|+..+.||+|+||.||+|.... ...||||.++..........+.+|+.+++.++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4578889999999999999998752 457999998765555555678899999999999999999999998889999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
+|||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999876432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 277 DYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 277 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||... . .............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-----~---~~~~~~~~~~~~~-- 226 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-----S---NQDVIKAVEDGYR-- 226 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-----C---HHHHHHHHHcCCC--
Confidence 4222221 112234678999999998899999999999999999998 99998421 1 1111111111100
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 227 --------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 --------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=317.37 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=198.4
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
|+..+.||+|+||.||++... +|+.||+|.+...... .....+.+|++++..++|+|++++.+++.+.+..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999864 6899999998654322 2234577899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++|+|..++..... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.++|+|||++......
T Consensus 82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 999999988765332 2489999999999999999999999 9999999999999999999999999999865322
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||..... . .....+.......
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~-~~~~~~~~~~~~~--------- 220 (285)
T cd05631 156 -ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE----R-VKREEVDRRVKED--------- 220 (285)
T ss_pred -CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc----c-hhHHHHHHHhhcc---------
Confidence 222344689999999999999999999999999999999999999963211 1 0111111111000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
...........+.+++.+||+.||.+||+ ++++++
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01112223456889999999999999997 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=318.73 Aligned_cols=261 Identities=25% Similarity=0.409 Sum_probs=204.3
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
+..++|+..+.||+|+||.||+|... .+..||||.+...........+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999753 246799999865433334456889999999999999999999999888
Q ss_pred cceEEEecccCCcchhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQS------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998764321 22467889999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHH
Q 013238 267 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 267 l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 344 (447)
|+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.... .....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~~ 231 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQVL 231 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999987543322211 111235678999999998899999999999999999999 788885311 11111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
....... .. .........+.+++.+||+.+|++|||+.++++.|++
T Consensus 232 ~~~~~~~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVMEGG-LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHcCC-cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111110 00 0111234568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=316.96 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=198.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999876 68899999997554433444678899999999999999999999988889999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+. |+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 96 48988886543 2378899999999999999999999 99999999999999999999999999997643222
Q ss_pred CceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh----------
Q 013238 281 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 349 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 349 (447)
. ......++..|+|||++.+ ..++.++|||||||++|||+||+.||..... ............
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-----KEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChHHhhcc
Confidence 2 1223457899999998865 5689999999999999999999999953211 011111111000
Q ss_pred --ccccccccccccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 --EKKLEQLVDSDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 --~~~~~~~~d~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.........+...... .........+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000011111100000 0112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=318.60 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=206.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|.+.+.||+|+||.||+|...+ +..||||.++..........+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3467778899999999999998642 4789999997655444456789999999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 013238 195 LLVYPFMVNGSVASCLRERGQ----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 264 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~ 264 (447)
+++|||+++++|.+++...+. ....+++..+..++.+++.||.|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999976432 223478999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHH
Q 013238 265 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 265 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 342 (447)
++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||.... . .+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-----~---~~ 232 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-----N---EE 232 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-----H---HH
Confidence 99999999875432221 11122335678999999999999999999999999999998 999985311 1 11
Q ss_pred HHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 343 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.+.... .... ..........+.+++.+||+.||.+|||+.||++.|++
T Consensus 233 ~~~~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 VIECIT-QGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHH-cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111 1110 11112234668999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=296.58 Aligned_cols=265 Identities=25% Similarity=0.316 Sum_probs=211.8
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEE-ECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC-----C
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----T 192 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 192 (447)
+..++|++.+.||+|+|+-||+++ ..++..+|+|++.... .......++|++..++++|||++++++++... .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 456789999999999999999998 4578999999998765 34455678999999999999999999887543 3
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
+.|++++|...|+|.+.++.....+..+++.+++.|+.+|++||++||+. .+.+.||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 48999999999999999998877777799999999999999999999998 23499999999999999999999999999
Q ss_pred ccccCCCCCc--------eeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHH
Q 013238 273 AKLMDYKDTH--------VTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 273 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 341 (447)
+....-.... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+..... +.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-Gg----- 249 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GG----- 249 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CC-----
Confidence 8754321111 112234688999999885 445689999999999999999999999743221 10
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.-.-.+....+.........+.+.+++.+|++.||.+||++.+++..++.
T Consensus 250 ---------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 250 ---------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ---------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 11111222222222233367889999999999999999999999998875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=318.91 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=197.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||.||+|... +++.||||.+...........+.+|+++++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999976 6889999999755433334467789999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+. ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 67877776543 2388899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc-----
Q 013238 280 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL----- 353 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 353 (447)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ........+.........
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK----DIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc----cHHHHHHHHHHHhCCCChhhccc
Confidence 2 12233457899999999865 457899999999999999999999996321 111111111111000000
Q ss_pred ----ccccccccC---CCCcH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 ----EQLVDSDME---GNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ----~~~~d~~~~---~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
......... ..... .....+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000 00000 01245778999999999999999999885
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=324.43 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=202.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCc----EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
..+|+..+.||+|+||.||+|.+. ++. .||+|.++..........+.+|+.+++.++|+||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 346888999999999999999864 333 48999987554444456788999999999999999999998764 578
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++++|+++|+|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 9999999999999987643 2378999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcee-eccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 276 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 276 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
......... ....++..|+|||++.+..++.++||||||+++|||++ |+.||+... ..++.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~~~~~~~~--- 227 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISSILEKG--- 227 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHhCC---
Confidence 653332211 11224668999999999999999999999999999998 999985311 11111111111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
........+...+.+++.+||+.+|.+|||+.+++..|....
T Consensus 228 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000111123356889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=328.23 Aligned_cols=263 Identities=29% Similarity=0.441 Sum_probs=204.2
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
++..++|++.+.||+|+||.||+|... +++.||+|+++..........+..|++++.++ +|+||++++++|..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 445678999999999999999999642 25789999997554433445678899999999 89999999998875
Q ss_pred C-CcceEEEecccCCcchhhhhhcCCC-----------------------------------------------------
Q 013238 191 P-TERLLVYPFMVNGSVASCLRERGQS----------------------------------------------------- 216 (447)
Q Consensus 191 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 216 (447)
. ...+++|||+++++|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 4678999999999999988643210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce-eecccccc
Q 013238 217 ----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTI 291 (447)
Q Consensus 217 ----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~ 291 (447)
..++++..+..++.||+.||+|||++ +|+||||||+|||+++++.++|+|||++..+....... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 12589999999999999999999999 99999999999999999999999999998654322211 22234567
Q ss_pred CccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHH
Q 013238 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEV 370 (447)
Q Consensus 292 ~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 370 (447)
.|+|||++.+..++.++|||||||++|||++ |..||.... ....+ ... ..... ....+....
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~----~~~~~---~~~-~~~~~---------~~~~~~~~~ 302 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ----IDEEF---CRR-LKEGT---------RMRAPEYAT 302 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC----ccHHH---HHH-HhccC---------CCCCCccCC
Confidence 8999999999999999999999999999998 999985311 00011 111 11110 011112234
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 371 EQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 371 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..+.+++.+||+.+|.+||++.++++.|++
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=317.49 Aligned_cols=268 Identities=18% Similarity=0.241 Sum_probs=200.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|++.+.||+|+||.||++... +++.||+|++..... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999986 578999999875432 2234467889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|++++.+..+.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987766544322 2488999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCC-------CcccHHHHHHHHhhccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 352 (447)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||........ .................
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 33233344589999999999988899999999999999999999999953211000 00000000011111111
Q ss_pred cccccccccCC------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEG------NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
......+.... .........+.+++.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11100000000 001123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=315.72 Aligned_cols=255 Identities=29% Similarity=0.412 Sum_probs=203.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..+|...+.||+|++|.||+|... .++.||+|.+.... .....+.+|+++++.++|+||+++++++......+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345777889999999999999875 48899999986432 224468889999999999999999999999899999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++..... ..+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999865432 3489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||... ...+........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--------~~~~~~~~~~~~-------- 221 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVYELLEKG-------- 221 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHCC--------
Confidence 2221122224567999999998899999999999999999998 89998531 111111111111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.........+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 222 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 222 --YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 1111122234668999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.99 Aligned_cols=258 Identities=25% Similarity=0.333 Sum_probs=201.8
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-------------chHHHHHHHHHHHHhcCCCceeeE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------------GGELQFQTEVEMISMAVHRNLLRL 184 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l 184 (447)
..-+.|++.+.||+|.||.|-+|... +++.||||++.+.... .......+|+.+|+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34468999999999999999999876 6899999999653211 112367899999999999999999
Q ss_pred eeeeecC--CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 013238 185 RGFCMTP--TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262 (447)
Q Consensus 185 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~ 262 (447)
+++..++ +..|||+|||..|.+...=. ..+.+++.++++++.+++.||.|||.+ +|+||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9998765 57899999999887654321 122289999999999999999999999 99999999999999999
Q ss_pred CcEEEeecCCccccCCCC----CceeeccccccCccccccccCCC----CCchhhhHHHHHHHHHHHhCCCCcccccccC
Q 013238 263 FEAVVGDFGLAKLMDYKD----THVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLAN 334 (447)
Q Consensus 263 ~~~kl~Dfgl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltg~~p~~~~~~~~ 334 (447)
|++||+|||.+....... ........||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--- 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--- 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence 999999999998653221 11223357999999999987743 3678899999999999999999994211
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.. . ....++...+......+..+.+.+|+.++|.+||+.|.+..+|......
T Consensus 324 -----~~----~-----l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 324 -----EL----E-----LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred -----HH----H-----HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11 1 1122333333333333556778999999999999999999999877654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=326.53 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=211.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCceeeEeeeeecCCc-ceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-RLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 198 (447)
++|...+++|+|+||.++.++.+ ++..+++|.+....... .+.....|+.+++++.|||||.+.+.+...+. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999999876 57899999997655332 33467889999999999999999999998887 89999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
+||+||+|.+.+...++ .-+++..++.++.|++.|+.|||++ +|+|||||+.|||++.++.++|+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999987653 3489999999999999999999998 999999999999999999999999999999876
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
... ......||+.||.||.+.+.+|..|+|||||||++|||++-+++|+..++ ...+-..... .
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~-----~-- 222 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRG-----L-- 222 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhc-----c--
Confidence 543 33446699999999999999999999999999999999999999975322 1111111111 1
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
....+......+..++..|++.+|..||++.+++..
T Consensus 223 ---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122344456778999999999999999999999986
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=312.77 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=201.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
++|+..+.||+|++|.||+|...++..+|+|.+..... ....+.+|+.++.+++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 46778889999999999999987777799999865332 2346889999999999999999999998888899999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
.+|+|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999876432 489999999999999999999999 999999999999999999999999999876543222
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+...........
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~------- 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--------NSETVEKVSQGLRL------- 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHhcCCCC-------
Confidence 22222235678999999988889999999999999999998 999985311 11111111111100
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
.........+.+++.+||+.+|.+|||+.+++..|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=312.65 Aligned_cols=262 Identities=20% Similarity=0.313 Sum_probs=209.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||.||+|... +++.||||.+.... .......+.+|+++++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999875 68999999886432 2233446888999999999999999999999889999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.........+++..++.++.+++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998875443344588999999999999999999999 999999999999999999999999999886543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||... ......+.......
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~------~~~~~~~~~~~~~~-------- 223 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLFSLCQKIEQC-------- 223 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc------cccHHHHHHHHhcC--------
Confidence 2211 12235788999999998888999999999999999999999998531 11112222111110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
.............+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 224 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 -DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0111112234567899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=328.21 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=193.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|+||.||+|... +++.||||.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556788999999999999876 68999999996654444455788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.+|+|.... ...+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 256778889999999999999999 99999999999999999999999999998654322
Q ss_pred CceeeccccccCccccccccC-----CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
. ......|+..|+|||++.. ...+.++|||||||++|||++|+.||..... ..............
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~---- 292 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMSQ---- 292 (353)
T ss_pred c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhccC----
Confidence 1 1233468999999998743 2345689999999999999999999962111 11111111110000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
...........+.+++.+||+.||++|||+.|+++.
T Consensus 293 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122334568999999999999999999999873
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=322.75 Aligned_cols=242 Identities=23% Similarity=0.288 Sum_probs=194.4
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
+.||+|+||.||++... +|+.||+|+++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 689999999975432 222345778999999999999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCcee
Q 013238 205 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 284 (447)
Q Consensus 205 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 284 (447)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 9999887543 488999999999999999999999 9999999999999999999999999998753222 1222
Q ss_pred eccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCC
Q 013238 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364 (447)
Q Consensus 285 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 364 (447)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... +. .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~~-------~~----~ 213 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------EI----R 213 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcC-------CC----C
Confidence 33468999999999999999999999999999999999999995311 11111111110 00 1
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 365 YIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 365 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
.+......+.+++.+||+.||.+|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1122345688999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=321.38 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=175.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
..++|+..++||+|+||.||++... ++..+|+|.+...........+.+|+++++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999976 588899998876544444557889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+|+|.+++.... .+++..+..++.+++.||.|||+.. +++|+||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999997543 3788999999999999999999742 699999999999999999999999999875432
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 12234588999999999988899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=309.74 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=196.6
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
+.||+|+||.||+|... +++.+|+|.+...........+.+|+++++.++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 68899999886554444455788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCcee-e
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-T 285 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~ 285 (447)
.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99986532 2488999999999999999999999 999999999999999999999999999875432111110 1
Q ss_pred ccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCC
Q 013238 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364 (447)
Q Consensus 286 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 364 (447)
....+..|+|||.+.+..++.++||||||+++|||++ |..||..... ......... .....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~~----------~~~~~ 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQ----------GVRLP 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHHc----------CCCCC
Confidence 1123456999999998899999999999999999998 8888853110 011111100 01111
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 365 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
........+.+++.+||+.+|++|||+.+|++.|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 12233457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=315.87 Aligned_cols=266 Identities=27% Similarity=0.370 Sum_probs=200.7
Q ss_pred CCCCeeeecCCeEEEEEEE-----CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceEE
Q 013238 125 SNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 197 (447)
Q Consensus 125 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 197 (447)
...+.||+|+||+||++.+ .+++.||+|.++..........+.+|+++++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988753 257789999997654433455788999999999999999999988654 357899
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+.+++|.+++... .+++..++.++.|++.||.|||++ +++||||||+|||+++++.++|+|||++....
T Consensus 87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998653 289999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc--eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 278 YKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 278 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
..... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+...... ..................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccccccchhhhhh
Confidence 32211 111223566799999998888999999999999999999999998532100 0000000000000011111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..+..............+.+++.+||+.+|++|||++++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111112223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=315.28 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=207.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
...+|+..++||.|+||.||+|...++..+++|.+..... .....+..|+.+++.++|+||+++++++......+++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4567888899999999999999988889999999875433 223468889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++..... ..+++..++.++.+++.||.|||++ +++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999976432 3489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ..+........
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~-------- 220 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITAG-------- 220 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHHhC--------
Confidence 211 123335678999999988899999999999999999998 899995321 11111111111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
............+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 --YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111122334668899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=323.76 Aligned_cols=254 Identities=20% Similarity=0.250 Sum_probs=202.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||.||+|... +++.||||++...... .....+..|++++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 5889999999754321 23346788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... .+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997543 388999999999999999999999 999999999999999999999999999975432
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
......|++.|+|||++.+..++.++|||||||++|||++|..||.... ..+......... ....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~---~~~~ 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST--------PNETWENLKYWK---ETLQ 218 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC--------HHHHHHHHHhcc---cccc
Confidence 2233458999999999999999999999999999999999999995321 111111111100 0011
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
..............+.+++.+||+.+|.+|||+.++++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000011234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=311.70 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=203.7
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..++|++.+.||+|++|.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 4567888999999999999999988888899999875433 2346889999999999999999999874 456899999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+++|.+++.... ...+++..++.++.+++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999987542 23489999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~-------- 219 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NREVLEQVERG-------- 219 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcC--------
Confidence 2222222235668999999988889999999999999999999 888985311 11111111111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
............+.+++.+||+.+|.+|||+.++++.|++
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 --YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111122334569999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=325.80 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=197.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|+++++.++||||+++++++...+..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999976 588999999965421 122346788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999987643 378899999999999999999999 999999999999999999999999999986533
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.. ....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ...........
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~-------- 230 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKILAG-------- 230 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHhcC--------
Confidence 21 23458999999999999999999999999999999999999995311 11111111111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
.. ..+......+.+++.+||+.||.+||+ +.+++.
T Consensus 231 -~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 231 -RL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -Cc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 011112345789999999999999997 455554
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=311.07 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=200.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
.+|+..+.||+|+||.||++...++..+|+|.+..... ....+.+|+++++.++|+||+++++++...+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 35778889999999999999987777899999864322 2346788999999999999999999999888999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99999999876432 489999999999999999999999 999999999999999999999999999876532221
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... . .+........
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~---~~~~~~~~~~---------- 217 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-----N---SEVVESVSAG---------- 217 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-----H---HHHHHHHHcC----------
Confidence 11111223457999999998899999999999999999999 899985311 0 1111111111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
............+.+++.+||+.+|++|||+.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00111122455799999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=319.76 Aligned_cols=264 Identities=28% Similarity=0.427 Sum_probs=208.0
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECC------CcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 189 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 189 (447)
+.+..++|+..+.||+|+||.||++...+ ...+|+|.+...........+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34556788889999999999999998642 3679999987654444445688899999999 7999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 257 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Ni 257 (447)
.....+++|||+++|+|..+++... .....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9899999999999999999987532 2234589999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCC
Q 013238 258 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 335 (447)
Q Consensus 258 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~ 335 (447)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 239 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 239 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC----
Confidence 99999999999999998654322111 112234568999999988899999999999999999997 988884211
Q ss_pred CcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 336 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..+........ .....+......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 240 ----~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 ----VEELFKLLKEG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHHHHHHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111111 11111223345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.13 Aligned_cols=248 Identities=30% Similarity=0.439 Sum_probs=198.9
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcch
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 207 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 207 (447)
++||+|+||.||+|...++..+|+|.+...........+.+|+++++.++|+||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876554444556889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeecc
Q 013238 208 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 287 (447)
Q Consensus 208 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 287 (447)
+++.... ..+++..+..++.+++.||.|||++ +++|+||+|+||++++++.+||+|||++..............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9886543 2378999999999999999999999 999999999999999999999999999875432222111222
Q ss_pred ccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCc
Q 013238 288 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366 (447)
Q Consensus 288 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 366 (447)
.++..|+|||++.+..++.++||||||+++|++++ |..||.... ............ .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--------~~~~~~~~~~~~----------~~~~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT--------NQQAREQVEKGY----------RMSCP 216 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHHcCC----------CCCCC
Confidence 34567999999998899999999999999999998 999985311 111111111110 01111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 367 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 367 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
......+.+++.+||+.+|++|||+.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=293.49 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=207.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
+-++|++++.||+|.||.||.|+.+ ++-.||+|++.+... .....++.+|+++-+.++||||+++++++.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3468899999999999999999865 578999999975432 2234578899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
++||..+|+|...|...... .+++.....++.|+|.||.|+|.. +|+||||||+|+|++..+.+||+|||.+..-
T Consensus 100 ilEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999854432 488889999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
. .......+||..|.+||...+..++...|+|++|++.||++.|..||+... .. ..+..-...++
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~----etYkrI~k~~~ 239 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HS----ETYKRIRKVDL 239 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hH----HHHHHHHHccc
Confidence 3 333455679999999999999999999999999999999999999996321 11 11111111111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. .+........++|.+|+..+|.+|.+..|++..
T Consensus 240 ~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 K-------FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred c-------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 123334557889999999999999999998764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.50 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=195.9
Q ss_pred eeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 130 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
||+|+||.||++... +++.||+|.+.... .......+.+|++++..++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 57899999986532 222334677899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeec
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 286 (447)
.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99987543 388999999999999999999999 99999999999999999999999999987543222 22234
Q ss_pred cccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCc
Q 013238 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366 (447)
Q Consensus 287 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 366 (447)
..||+.|+|||++.+..++.++|||||||++|||++|+.||... ............. ...+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~--------~~~~~~~~~~~~~-----------~~~~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE--------NVNEMYRKILQEP-----------LRFP 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC--------CHHHHHHHHHcCC-----------CCCC
Confidence 56899999999999999999999999999999999999999531 1112222221110 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 367 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 367 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
......+.+++.+||+.||.+||++..+.+.|.-.-+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~ 250 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCc
Confidence 2234568899999999999999876555555554333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=315.41 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=208.6
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC-----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec-CC
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PT 192 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 192 (447)
+..++|...+.||+|+||.||+|...+ +..|++|++...........+.+|+.+++.++|+|++++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456788899999999999999999765 688999998765444445678899999999999999999998876 46
Q ss_pred cceEEEecccCCcchhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQS----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 268 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 268 (447)
..+++++|+.+++|.+++...... ...+++..++.++.+++.||+|||+. +++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998764322 14589999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHH
Q 013238 269 DFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 269 Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.... ..++...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~ 231 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--------PFEMAAY 231 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--------HHHHHHH
Confidence 999998654332221 122335678999999988889999999999999999999 999995311 1111111
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...... ......+...+.+++.+||+.+|++|||+.++++.|+..
T Consensus 232 ~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 232 LKDGYR----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred HHcCCC----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111 011122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=311.16 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=203.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..++|++.++||+|+||.||+|.+.++..||+|.+..... ....+.+|+++++.++|+||+++++++. ....+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 3467899999999999999999987767899999975332 2346889999999999999999999864 456799999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+|+|.+++.... ...+++..++.++.+++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999997542 22478999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.........++..|+|||+..+..++.++||||||+++|||+| |..||.... . ..........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----~---~~~~~~~~~~-------- 219 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----N---REVLDQVERG-------- 219 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----h---HHHHHHHhcC--------
Confidence 3222222345678999999988899999999999999999999 888885311 0 0111111100
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
............+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 220 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 220 --YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0111123345678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.71 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=205.1
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+..++|+..++||+|+||.||+|...+++.||+|.+..... ....+.+|+++++.++|+|++++++++ ..+..+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEE
Confidence 44678899999999999999999988889999999875432 234688999999999999999999986 456789999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+++|.+++..... ..+++..+..++.+++.||+|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999865432 3488999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.+........
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~----- 221 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--------NPEVIQNLERGYR----- 221 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--------hHHHHHHHHcCCC-----
Confidence 22222223345678999999988889999999999999999999 999995311 1111111111100
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..........+.+++.+||+.+|++|||++++++.|+.
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 -----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111234569999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=308.67 Aligned_cols=261 Identities=21% Similarity=0.330 Sum_probs=210.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|++|.||+|... +|+.||+|.++... .......+.+|++++++++|+|++++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 78999999886432 2223456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|..++.........+++..++.++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876544445689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+........ .
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~------ 224 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEKC-D------ 224 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhcC-C------
Confidence 3222 222347889999999988889999999999999999999999985321 1122221111110 0
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
............+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00111123456788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=337.25 Aligned_cols=266 Identities=22% Similarity=0.277 Sum_probs=215.8
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCC-cEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeee-eec-----
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDG-SLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGF-CMT----- 190 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~----- 190 (447)
+...++++.+.|.+|||+.||+|.+..+ ..||+|++-.. .+.....+.+|+++|++|. |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 4455778889999999999999998765 99999999766 4555667899999999998 9999999993 221
Q ss_pred -CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEee
Q 013238 191 -PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269 (447)
Q Consensus 191 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 269 (447)
.-+.+|.||||.+|.|-++++.+.... |++.++++|+.++++|+++||.. .+.|||||||.+||||+.+++.||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 135689999999999999999875544 99999999999999999999996 66799999999999999999999999
Q ss_pred cCCccccCCCCCce--------eeccccccCccccccc---cCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcc
Q 013238 270 FGLAKLMDYKDTHV--------TTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338 (447)
Q Consensus 270 fgl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 338 (447)
||.+.......... .-...-|+.|+|||.+ .+...++|+|||+|||+||-||....||+..
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s-------- 261 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES-------- 261 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC--------
Confidence 99986432221110 0012358899999976 5778899999999999999999999999632
Q ss_pred cHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhhHH
Q 013238 339 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEE 409 (447)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 409 (447)
-...+++....-...+.+...|.+||..||+.||.+||++.+|+..+-.+.-.+++-.
T Consensus 262 -------------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 262 -------------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred -------------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 1234455444444446788899999999999999999999999998887665555443
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.03 Aligned_cols=265 Identities=21% Similarity=0.336 Sum_probs=206.4
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeee
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM 189 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 189 (447)
+++..++|.+.+.||+|+||.||+|++. .+..||+|+++..........+..|++++.++. |+||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3455667888899999999999999853 246899999976544444456889999999997 999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCC------------------------------------------------------
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------ 215 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 215 (447)
.....++||||+.+|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 98899999999999999999875321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 013238 216 ----------------------------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 255 (447)
Q Consensus 216 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~ 255 (447)
....+++..+..++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 113467888899999999999999998 9999999999
Q ss_pred CEEECCCCcEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCccccccc
Q 013238 256 NILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 333 (447)
Q Consensus 256 Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~ 333 (447)
|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999976432211 11122346788999999998889999999999999999998 8889853110
Q ss_pred CCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 334 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.+......... .....+......+.+++.+||+.+|.+||++++|++.|++.
T Consensus 348 -------~~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 -------NEQFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred -------hHHHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 01111111111 01111122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.80 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEE-----CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
++|+..+.||+|+||.||+|.. ..+..+++|.+...........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677788999999999999974 24678999999765444444578899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 013238 197 VYPFMVNGSVASCLRERGQ-------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 263 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~ 263 (447)
+|||+.+++|.+++..... ....+++..+..++.+++.||+|||++ +++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999854321 123478899999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHH
Q 013238 264 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 264 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 341 (447)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--------~~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--------NQ 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence 999999999976533221 11222335678999999988889999999999999999998 988984211 01
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
...... ...... .........+.+++.+||+.+|.+||++.++++.|..
T Consensus 234 ~~~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMV-RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHH-HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 111100 1111234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=314.26 Aligned_cols=261 Identities=27% Similarity=0.420 Sum_probs=206.3
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
+..++|+..+.||+|+||.||+|...+ +..||+|.+...........+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 345678889999999999999998642 36899999875544444557889999999999999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQS------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
..+++|||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 999999999999999998764321 22478899999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHH
Q 013238 267 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 267 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 344 (447)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++||++| |+.||... . ..+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-----~---~~~~~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-----S---NEEVL 231 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC-----C---HHHHH
Confidence 999999876543221 11222346778999999988889999999999999999998 99998521 1 11111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..... .. ....+......+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 232 ~~~~~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 KFVID-GG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHhc-CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111 10 011112235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=314.50 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=202.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
+|+..+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 2357899988765444444578899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 013238 197 VYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~N 256 (447)
++||+.+++|.+++..... ...++++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999998865321 123588999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccC
Q 013238 257 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 334 (447)
Q Consensus 257 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~ 334 (447)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 99999999999999999765332221 1122235678999999988889999999999999999998 999985311
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+.++ ... .............+.+++.+||+.+|.+||++.++++.|+++
T Consensus 235 --~~~~~~~----~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 235 --PERLFNL----LKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --HHHHHHH----HhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1111111 111 011111222345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.40 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=200.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-C--cEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD-G--SLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 197 (447)
++|+..+.||+|+||.||+|...+ + ..+++|.++..........+.+|++++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999998753 3 347888887544444445688999999999 799999999999988899999
Q ss_pred EecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 198 YPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
+||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999965431 113488999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHH
Q 013238 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 344 (447)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.... ..+..
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--------~~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--------CAELY 228 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 999999986432111 1111123457999999988899999999999999999997 999995321 11111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
...... ............+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus 229 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 229 EKLPQG----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 111111223456889999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=324.23 Aligned_cols=261 Identities=20% Similarity=0.239 Sum_probs=195.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..+|+..+.||+|+||.||++... +++.||+|.... ..+.+|+++++.++||||+++++++......++++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 457999999999999999999875 688999996532 246789999999999999999999998889999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
++ .++|..++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 164 ~~-~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RY-KTDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cC-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 99 468888876532 388999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCC---cccHHHHHHHHhhcc-----
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD---DVMLLDWVKGLLKEK----- 351 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~----- 351 (447)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||-........ ...+...+.......
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 222333456999999999999999999999999999999999999886321110000 000110100000000
Q ss_pred ----cccccc---------ccccCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 352 ----KLEQLV---------DSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 352 ----~~~~~~---------d~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...... .+.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 000000 001123457889999999999999999999985
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.48 Aligned_cols=259 Identities=26% Similarity=0.372 Sum_probs=203.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
.+++|.+.+.||+|++|.||+|.+.+ +..||+|.+...........+..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999998753 567899988755444445568899999999999999999999998888
Q ss_pred ceEEEecccCCcchhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEE
Q 013238 194 RLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 267 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kl 267 (447)
.+++|||+++++|.+++...... ...+++..+..++.||+.||+|||++ +++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 99999999999999998765321 22489999999999999999999999 999999999999998754 5999
Q ss_pred eecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHH
Q 013238 268 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 268 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||..... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVME 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 9999998653222111 111123467999999998899999999999999999997 9999853111 11111
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
...... ....+......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 233 ~~~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111 11112223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.78 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=197.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCc----EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
++|+..+.||+|+||+||+|.+. +++ .+++|.+...........+..|+..++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 56788899999999999999874 344 4788887543333333467778888999999999999998754 45789
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
++||+++|+|.+++..... .+++..++.++.||+.||+|||++ +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999976432 489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 277 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 277 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+++ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~----~~~~-- 228 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-----PHEVPDLL----EKGE-- 228 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH----HCCC--
Confidence 432221 1223346778999999998899999999999999999998 999985311 11111111 1110
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
... ....+...+.+++.+||..+|.+|||+.++++.|...
T Consensus 229 ~~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 229 RLA-------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred cCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 000 0111234578899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=307.71 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=197.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----cceE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERLL 196 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 196 (447)
.|...+++|+|+||.||+|... +++.||||++..+..- -.+|+++|+++.|||||++..++.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4566789999999999999975 5789999999765432 246899999999999999998876432 2348
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeecCCccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 275 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~ 275 (447)
|||||+. +|.++++........++...++-+..||++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999966 99999986544445588888999999999999999998 99999999999999976 9999999999998
Q ss_pred cCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
+......... ..|..|.|||.+.+. .|+.+.||||.||++.||+-|+.-|... .....+...+ .++.....+
T Consensus 176 L~~~epniSY--icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~----s~~dQL~eIi-k~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEPNISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD----SSVDQLVEII-KVLGTPTRE 248 (364)
T ss_pred eccCCCceeE--EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC----CHHHHHHHHH-HHhCCCCHH
Confidence 8766555333 358899999998775 6899999999999999999999999531 1122222222 222222222
Q ss_pred cccc----------cccCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 355 QLVD----------SDMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 355 ~~~d----------~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
++.. +.+.. -.......+..+++.++++.+|.+|.++.|++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 2111 11111 122334567899999999999999999998875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=317.95 Aligned_cols=242 Identities=23% Similarity=0.288 Sum_probs=193.3
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
+.||+|+||.||++... +|+.||+|.+..... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 689999999975432 222345678999999999999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCcee
Q 013238 205 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 284 (447)
Q Consensus 205 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 284 (447)
+|..++.... .+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9998886543 489999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred eccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCC
Q 013238 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364 (447)
Q Consensus 285 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 364 (447)
....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~~~~~~-------~~---- 213 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE-------IR---- 213 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCC-------CC----
Confidence 33458999999999999999999999999999999999999995311 111111111100 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 365 YIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 365 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
.+......+.+++.+||+.||.+|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1112345688999999999999998 7777765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=326.58 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=201.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|.+.+.||+|+||+||+|... +++.||||++..... ......+..|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999976 689999999975432 123446888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++... ..+++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999765 2489999999999999999999998 999999999999999999999999999976543
Q ss_pred CC----------------------------CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccc
Q 013238 279 KD----------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 330 (447)
Q Consensus 279 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~ 330 (447)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 01122345899999999999999999999999999999999999999532
Q ss_pred cccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 013238 331 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVRM 397 (447)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 397 (447)
. ............ ..............+.+++.+|++ +|.+||+ +.++++.
T Consensus 234 ~--------~~~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 T--------LQETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred C--------HHHHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 111111111100 000000011134568889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=313.50 Aligned_cols=263 Identities=26% Similarity=0.429 Sum_probs=205.6
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 191 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 191 (447)
++..++|++.+.||+|+||.||+|... .+..||+|.+...........+.+|+..++.++|+||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 356788999999999999999999753 24579999886544333445678899999999999999999999988
Q ss_pred CcceEEEecccCCcchhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQ------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
...+++|||+.+|+|.+++..... ......+..+..++.|++.||.|||++ +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 899999999999999999976432 123467788899999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHH
Q 013238 266 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 343 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 343 (447)
+|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence 999999987543222111 112234678999999998899999999999999999998 788885311 1111
Q ss_pred HHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 344 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 344 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.......... .........+.+++.+||+.+|.+|||+.++++.|++.
T Consensus 231 ~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 LKFVMDGGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111111110 01112245799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=315.45 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=205.8
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
....++|...+.||+|+||.||++... .+..+|||.++..........+.+|+++++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345578999999999999999999742 24579999987654444445788999999999 79999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
.+..+++|||+.+|+|.++++.... ..+++..++.++.+++.||+|||++ +++|+||||+|||++.++.++|+||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999975432 2389999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHh
Q 013238 271 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 271 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
|+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...... ..
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~~~~----~~ 257 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSKFYK----LI 257 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHHHHH----HH
Confidence 999765432211 1122335678999999999899999999999999999998 9999853110 001111 11
Q ss_pred hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 349 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
... ............+.+++.+||+.+|++|||+.++++.|++
T Consensus 258 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 258 KEG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred HcC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 111 0111111223568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=307.09 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=201.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
.++|+..+.||+|++|.||++....+..+|+|.+..... ....+.+|+++++.++|+|++++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 456888899999999999999987777899998865332 2346888999999999999999998874 4568999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.+++|.+++.... ...+++..+..++.+++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997643 23478999999999999999999999 99999999999999999999999999997654332
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
........++..|+|||...+..++.++||||||+++|||++ |+.||.... .. +.........
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~---~~~~~~~~~~-------- 220 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----NR---EVLEQVERGY-------- 220 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HH---HHHHHHHcCC--------
Confidence 222222335678999999988899999999999999999999 899985311 11 1111111110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
...........+.+++.+||+.+|.+||++++++++|+.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 --RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011122334668999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=319.16 Aligned_cols=252 Identities=25% Similarity=0.309 Sum_probs=196.3
Q ss_pred CCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccc---cchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 194 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 194 (447)
+|++.+.||+|+||.||+++.. +++.||+|++..... ......+..|++++..++ |+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999753 578999999865321 122345778999999994 99999999999988999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999987543 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
..............||..|+|||++.+. .++.++|||||||++|||+||+.||..... ..............
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~--- 226 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE----RNTQSEVSRRILKC--- 226 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC----CCCHHHHHHHHhcC---
Confidence 6543333333345689999999999765 478899999999999999999999963211 11111111111110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
+..+ .......+.+++.+||+.||.+|| +++++++
T Consensus 227 ----~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 ----DPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 112334578899999999999999 5666664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=314.36 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=202.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECC------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
+|+..+.||+|+||.||+|...+ +..||+|+++..........+..|+.++..++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46667889999999999998642 478999999755433334568889999999999999999999999899999
Q ss_pred EEecccCCcchhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 013238 197 VYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 264 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~ 264 (447)
++||+.+++|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 1123488899999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHH
Q 013238 265 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 265 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 342 (447)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||... ...+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------CHHH
Confidence 99999999886533221 11222345778999999988889999999999999999998 88888531 1112
Q ss_pred HHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 343 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
+........ . ......+...+.+++.+||+.+|.+||++.++++.|+.
T Consensus 235 ~~~~i~~~~-~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQ-V---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222211111 0 11122345668899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=313.05 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=204.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 457888899999999999999752 24568999886543 23345688999999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 195 LLVYPFMVNGSVASCLRERGQ---------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
+++|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999875431 223489999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHH
Q 013238 266 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 343 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 343 (447)
+|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.... ....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--------~~~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEV 231 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence 9999999975532221 11122235678999999998899999999999999999998 899985321 1111
Q ss_pred HHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 344 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 344 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
....... .... ........+.+++.+||+.||.+|||+.+++..|+++.
T Consensus 232 ~~~i~~~-~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 232 IECITQG-RVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHHHcC-CcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111 1000 01122356899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=309.25 Aligned_cols=257 Identities=26% Similarity=0.447 Sum_probs=204.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CC---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+...........+..|+++++.++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999875 23 37999998755434445578899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
+|||+++++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999987543 2489999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCceeec--cccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 277 DYKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 277 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
.......... ...+..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~~~~~i~~~~-- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHEVMKAINDGF-- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhcCC--
Confidence 4332221111 123457999999988889999999999999999997 999995311 112222221110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 --------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111122346689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=308.15 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=206.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+..++|++.+.||+|++|.||+|...++..+|||.+..... ....+.+|++++++++|+|++++++++......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678999999999999999999988788899999875432 3456889999999999999999999998888999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++..... ..+++..+..++.+++.||.|||++ +++|+||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999976432 3489999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||... .. ...........
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-----~~---~~~~~~~~~~~------ 221 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-----TN---REVLEQVERGY------ 221 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-----CH---HHHHHHHHcCC------
Confidence 22111112224568999999998889999999999999999998 99998421 11 11111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
........+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ----RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111224568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=306.92 Aligned_cols=250 Identities=21% Similarity=0.351 Sum_probs=209.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-CCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
..+|++.+.||+|.||+|-+|.. ..|+.||||.+++...... ...+.+|+++|+.++||||+.++++|.+.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788888999999999999985 5799999999987654433 34578999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||..+|.|.+++..++. +++.+...++.||+.|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999987654 99999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.......++|++-|.+||++.+.+| .+..|-||||++||.|+.|.-||+.- +....+++..... .
T Consensus 205 --~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQIs~Ga-Y--- 270 (668)
T KOG0611|consen 205 --DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQISRGA-Y--- 270 (668)
T ss_pred --cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHhhccc-c---
Confidence 3444566789999999999999988 67899999999999999999999642 2333333322211 1
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
. .++.+....-||.+||..||..|-|+.+|...-.
T Consensus 271 r--------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 271 R--------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred c--------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1 1112334667899999999999999999987654
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=327.70 Aligned_cols=255 Identities=21% Similarity=0.268 Sum_probs=200.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
..++|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568889999999999999999876 588999999964321 2223357789999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998653 278888999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeccccccCccccccccCC----CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~ 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMDHKN 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCC
Confidence 43322222345689999999998653 47889999999999999999999995321 1111112111110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 397 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 397 (447)
. +...........+.+++.+||+.+|.+ |+|+.++++.
T Consensus 265 ~-------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 S-------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred c-------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 000001123456788999999999987 9999998775
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=306.12 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=195.2
Q ss_pred eeeecCCeEEEEEEEC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCc
Q 013238 129 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
.||+|+||.||+|.+. ++..||+|.+...........+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 355799999976544444556889999999999999999999875 456799999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCcee-
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT- 284 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~- 284 (447)
|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987533 2489999999999999999999999 999999999999999999999999999976543322111
Q ss_pred -eccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccC
Q 013238 285 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362 (447)
Q Consensus 285 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 362 (447)
....++..|+|||++.+..++.++||||||+++||+++ |..||.... ..++........ .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~----------~ 216 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--------GPEVMSFIEQGK----------R 216 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHHCCC----------C
Confidence 11123568999999988889999999999999999996 999995321 111111111111 1
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 363 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+..+...+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111223356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.44 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=204.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 192 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 192 (447)
..++|.+.+.||+|+||+||+|... +|+.||||.+..... ......+.+|+..+..++|+|++++.+.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999865 689999999865432 233446788999999999999999887765322
Q ss_pred ---cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEee
Q 013238 193 ---ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269 (447)
Q Consensus 193 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 269 (447)
..++||||+++|+|.+++........++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 25799999999999999987655555699999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCC-CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh
Q 013238 270 FGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 270 fgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||... .....+....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------~~~~~~~~~~ 258 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEEVMHKTL 258 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHh
Confidence 99998654322 12223456899999999999999999999999999999999999999532 1122222221
Q ss_pred hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 349 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
... . ...+......+.+++.+||+.||.+|||+.++++.
T Consensus 259 ~~~-----~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR-----Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC-----C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 110 0 01112234568899999999999999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=310.67 Aligned_cols=262 Identities=25% Similarity=0.387 Sum_probs=192.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC--CCcEEEEEEeccccccc-hHHHHHHHHHHHHhc---CCCceeeEeeeeec-----
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT----- 190 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 190 (447)
++|+..+.||+|+||.||+|... +++.||+|.++...... ....+.+|+++++.+ .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46889999986543222 233456677766655 69999999998852
Q ss_pred CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
....+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345789999995 689888865432 2489999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|+++..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.... .......+......
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~-----~~~~~~~i~~~~~~ 227 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVIGL 227 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC-----HHHHHHHHHHHhCC
Confidence 999765432 22334458999999999988899999999999999999999999996321 11111111111000
Q ss_pred c---ccc-------cccccccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 K---KLE-------QLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ~---~~~-------~~~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ... ......... .........+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000 000000000 001123355789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=309.18 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=194.3
Q ss_pred eeecCCeEEEEEEEC-CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 130 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
||+|+||+||++... +++.+|+|.+....... ....+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 68899999986543221 224567899999999999999999999988899999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeec
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 286 (447)
...+.........+++..++.++.||+.||.|||++ +|+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444445689999999999999999999999 999999999999999999999999999976543222 1223
Q ss_pred cccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCc
Q 013238 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366 (447)
Q Consensus 287 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 366 (447)
..|++.|+|||++.+..++.++||||||+++|||++|+.||..... ........... .... ....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~---------~~~~--~~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRI---------LNDS--VTYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc----chhHHHHHHhh---------cccC--CCCc
Confidence 4589999999999999999999999999999999999999953111 10111111111 1110 0112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 367 EEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 367 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
......+.+++.+||+.||.+|| |++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 23456688999999999999999 5565554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=317.65 Aligned_cols=246 Identities=25% Similarity=0.329 Sum_probs=192.7
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||.||++... +++.||+|+++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999876 588999999975432 22234577888988888 699999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 99998886542 489999999999999999999999 9999999999999999999999999998743211 122
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||..|+|||++.+..++.++|||||||++|||++|+.||+.............++.......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC--
Confidence 2334689999999999999999999999999999999999999974332222222222332222221111 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
+......+.+++.+||+.||.+|||+
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11223458889999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=319.71 Aligned_cols=262 Identities=20% Similarity=0.346 Sum_probs=193.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----cce
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 195 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 195 (447)
+|+..+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777889999999999999975 689999999864322 223346889999999999999999999876432 469
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||+. ++|.+++.... .+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999994 68888886542 389999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC--ceeeccccccCccccccccC--CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc-
Q 013238 276 MDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE- 350 (447)
Q Consensus 276 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 350 (447)
...... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~ 227 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGTP 227 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCC
Confidence 432211 11233468999999999866 6789999999999999999999999953211 1111111111000
Q ss_pred ----------cccccccc---cccCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 351 ----------KKLEQLVD---SDMEGN---YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 351 ----------~~~~~~~d---~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
......+. ...... ........+.+++.+||+.||.+|||+.++++.
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 000000 001123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=317.06 Aligned_cols=262 Identities=28% Similarity=0.402 Sum_probs=205.0
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC--------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 189 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 189 (447)
+..++|.+.+.||+|+||.||++... +...+|+|.+...........+..|++++..+ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33567999999999999999999753 23579999997654444445688899999999 7999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 257 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Ni 257 (447)
..+..++||||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 99999999999999999999976432 123488999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCC
Q 013238 258 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 335 (447)
Q Consensus 258 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~ 335 (447)
+++.++.+||+|||++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~----- 246 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----- 246 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-----
Confidence 99999999999999987553221111 111224568999999998889999999999999999998 88888421
Q ss_pred CcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 336 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+........ .....+......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 247 ---~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 247 ---PVEELFKLLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred ---CHHHHHHHHHcC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111111111 01111223345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=317.53 Aligned_cols=246 Identities=25% Similarity=0.329 Sum_probs=191.2
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||.||++... +++.||+|.++..... .....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 5789999999764322 2233567788887766 799999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 99988876542 489999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...............++.........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 2334689999999999999999999999999999999999999964222222222222222222111111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
..+......+.+++.+||+.||.+|||+
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1112234557899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=315.91 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=206.6
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC--------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 189 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 189 (447)
+..++|.+.+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45678888999999999999999742 24579999987554444455788999999999 8999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 257 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Ni 257 (447)
.....+++|||+.+|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999976432 123478899999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCC
Q 013238 258 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 335 (447)
Q Consensus 258 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~ 335 (447)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----- 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----- 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----
Confidence 99999999999999998664322221 122235678999999988889999999999999999998 78887421
Q ss_pred CcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 336 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...++......... ..........+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 244 ---~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 244 ---PVEELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred ---CHHHHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 12222222211111 111123446688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=317.06 Aligned_cols=243 Identities=25% Similarity=0.296 Sum_probs=194.6
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
+.||+|+||.||++... +|+.||+|++..... ......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 689999999975432 223346788999999999999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCcee
Q 013238 205 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 284 (447)
Q Consensus 205 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 284 (447)
+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 9998886542 489999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred eccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCC
Q 013238 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364 (447)
Q Consensus 285 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 364 (447)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... +..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~~~-------~~~---- 213 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------DIK---- 213 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhccC-------Ccc----
Confidence 33468999999999999899999999999999999999999995311 11111111110 001
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 013238 365 YIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 397 (447)
Q Consensus 365 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 397 (447)
.+......+.+++.+||+.||.+|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1112345688999999999999997 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.78 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=201.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-C-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-D-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
.|...+.||+|++|.||+|... + ++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4788899999999999999864 3 6788888764432 22334577899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++|+|.+++........++++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998876544445689999999999999999999999 99999999999999999999999999998654322
Q ss_pred C-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 281 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 281 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~-~~----- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGK-YD----- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-CC-----
Confidence 1 12334568999999999999999999999999999999999999995311 112222211111 00
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+......+.+++.+||+.+|.+|||+.+++.
T Consensus 290 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 ----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011123356889999999999999999999875
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=309.97 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=202.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCc----EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.++|+..++||+|+||+||+|... +|+ .||+|.+...........+.+|..++..+.|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457888899999999999999854 444 4899998765554455678899999999999999999999875 4578
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++++|+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999987543 2489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 276 MDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 276 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||+... ......++.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~----~-- 227 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLLEK----G-- 227 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHC----C--
Confidence 64322211 111234678999999988899999999999999999998 899985311 1111111111 1
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
............+.+++.+||+.||++||++.++++.|+....
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 228 -------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0011112234568899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.32 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=198.8
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
+....++|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+|+++++.++||||+++++++.+...
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445678999999999999999999976 588999999864321 2223457789999999999999999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999998653 278889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCC----CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..........
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~~ 261 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIMD 261 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHHh
Confidence 87643332223345699999999998654 37889999999999999999999995321 1111111111
Q ss_pred ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHH
Q 013238 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPM--ERPKMSEVVRM 397 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~ 397 (447)
.... +...........+.+++..|++.++. .|+|+.++++.
T Consensus 262 ~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1100 00011112244567788888875554 38899988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.99 Aligned_cols=253 Identities=20% Similarity=0.271 Sum_probs=200.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|...+.||+|+||+||++... +|+.||+|.++.... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999876 688999999975432 223446788999999999999999999999989999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997652 2489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccCcccccccc------CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.... .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--------SAKTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 3333333346899999999986 4567889999999999999999999995311 1111122211111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... .........+.+++..|++ +|.+|||+.+++.
T Consensus 227 ~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1100 0011234557888999998 9999999998875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=307.25 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=204.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-C---CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-D---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.++|++.+.||+|+||.||+|... + +..+|+|.++..........+..|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888899999999999999864 2 347999998765444445578899999999999999999999998899999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
+|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997643 2488999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceeec--cccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 277 DYKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 277 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
.......... ..++..|+|||++.+..++.++||||||+++||+++ |..||.... . .+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-----~---~~~~~~~~~~~~- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-----N---QDVIKAIEEGYR- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-----H---HHHHHHHhCCCc-
Confidence 4433222221 123467999999998889999999999999999886 999985311 0 111111111100
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.......+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ---------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011122345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=306.37 Aligned_cols=260 Identities=21% Similarity=0.329 Sum_probs=207.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|++|.||++... +++.+|||.+..... ......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 36777889999999999999964 789999998864322 223346888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++.........+++..++.++.+++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999876444445689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.... .....++..|+|||++.+..++.++||||||+++|+|++|..||.... .....+..... ....
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~------~~~~ 225 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIE------QCDY 225 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc------chHHHHhhhhh------cCCC
Confidence 2221 223457889999999988889999999999999999999999985311 11111111111 0011
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
+ ..........+.+++.+||+.+|++|||+.+|++.+.+
T Consensus 226 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 P---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred C---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1 11112345678899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=303.95 Aligned_cols=250 Identities=29% Similarity=0.460 Sum_probs=203.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
.++|+..+.||+|++|.||+|... |+.||+|.+..... ....+.+|+.+++.++|+||+++++++......+++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457888899999999999999875 78899999976543 345788999999999999999999999988899999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999976542 2489999999999999999999999 99999999999999999999999999998653221
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
. ....+..|+|||++.+..++.++||||||+++|||++ |..||.... ..+........
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~--------- 215 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPHVEKG--------- 215 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHhcC---------
Confidence 1 2234668999999988889999999999999999997 999985311 11111111111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
............+.+++.+||+.+|++|||+.+++.+|+.
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111112234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=318.82 Aligned_cols=247 Identities=23% Similarity=0.278 Sum_probs=198.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC--CcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.++|...+.||+|+||.||+|.+.+ +..||+|.+..... ......+.+|++++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578888999999999999998653 36899999864322 2233467889999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+.+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999997643 388999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--------~~~~~~~i~~~~----- 244 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--------PLLIYQKILEGI----- 244 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC--------HHHHHHHHhcCC-----
Confidence 422 123468999999999998889999999999999999999999995311 111111111110
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 397 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 397 (447)
. ..+......+.+++.+|++.||.+|+ |++++++.
T Consensus 245 ----~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ----I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 01111234578899999999999995 78877654
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=311.95 Aligned_cols=266 Identities=23% Similarity=0.389 Sum_probs=202.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC---------------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD---------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 185 (447)
.++|++.+.||+|+||.||++...+ ...||+|.++..........+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578889999999999999987532 2358999997654444455788999999999999999999
Q ss_pred eeeecCCcceEEEecccCCcchhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 013238 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQ--------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 257 (447)
Q Consensus 186 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Ni 257 (447)
+++......++||||+.+++|.+++..... ....+++..++.++.+++.||+|||++ +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865321 112478899999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh--CCCCcccccccC
Q 013238 258 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLAN 334 (447)
Q Consensus 258 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~p~~~~~~~~ 334 (447)
++++++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--- 237 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--- 237 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---
Confidence 9999999999999999765332211 1122335678999999988889999999999999999998 566774311
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
................ .... .......+..+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus 238 --~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 --DEQVIENTGEFFRNQG-RQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --hHHHHHHHHHhhhhcc-cccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111111100 0000 01111234579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=304.48 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=194.0
Q ss_pred eeeecCCeEEEEEEEC---CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCC
Q 013238 129 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
.||+|+||.||+|.+. ++..+|+|+++..... .....+..|+.+++.+.|+||+++++++. ....+++|||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 5788999998654322 23456889999999999999999999875 45678999999999
Q ss_pred cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCcee
Q 013238 205 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 284 (447)
Q Consensus 205 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 284 (447)
+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999986532 388999999999999999999999 999999999999999999999999999986643332211
Q ss_pred --eccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 285 --TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 285 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
....++..|+|||.+....++.++||||||+++|||++ |..||.... ...+.... ... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~i-~~~---------~ 215 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--------GNEVTQMI-ESG---------E 215 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-HCC---------C
Confidence 11224578999999988889999999999999999998 999995321 11111111 111 0
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
....+......+.+++.+||+.||++||++.+|.+.|++
T Consensus 216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111122234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=311.78 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=205.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
..++|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++|+||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567889999999999999999863 4678999998765444445568899999999999999999999998889
Q ss_pred ceEEEecccCCcchhhhhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 013238 194 RLLVYPFMVNGSVASCLRERGQ------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 255 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~ 255 (447)
.+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999875321 123478899999999999999999999 9999999999
Q ss_pred CEEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCccccccc
Q 013238 256 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 333 (447)
Q Consensus 256 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~ 333 (447)
||++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~--- 236 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM--- 236 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---
Confidence 999999999999999998754322211 1112224567999999988899999999999999999997 88888421
Q ss_pred CCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 334 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
...+........ ... .........+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 237 -----~~~~~~~~~~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 -----AHEEVIYYVRDG-NVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----CHHHHHHHHhcC-CCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111222221111 110 1111234668999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=324.66 Aligned_cols=253 Identities=19% Similarity=0.264 Sum_probs=193.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.|+.++.||+|+||+||+|... +++.||||++..... ......+.+|++++..++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999875 588999999975432 2233468889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999987643 388999999999999999999999 9999999999999999999999999997543110
Q ss_pred CC----------------------------------------------ceeeccccccCccccccccCCCCCchhhhHHH
Q 013238 280 DT----------------------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 313 (447)
Q Consensus 280 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 313 (447)
.. .......||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00122468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHH--ccCCCCCCCCCH
Q 013238 314 GVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALL--CTQGSPMERPKM 391 (447)
Q Consensus 314 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~ 391 (447)
||++|||++|+.||..... ........... ..............+.+++.+ |+..++..||++
T Consensus 235 G~il~elltG~~Pf~~~~~--------~~~~~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTP--------TETQLKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCH--------HHHHHHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999953211 00000111000 000000001122345566665 566777789999
Q ss_pred HHHHHH
Q 013238 392 SEVVRM 397 (447)
Q Consensus 392 ~evl~~ 397 (447)
.++++.
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=317.74 Aligned_cols=242 Identities=25% Similarity=0.338 Sum_probs=193.0
Q ss_pred CeeeecCCeEEEEEEEC----CCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 128 NILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+.||+|+||.||++... +++.||+|.++.... ......+..|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 578999999975322 22234577899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.+++|.+++.... .+.+..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999987643 378888999999999999999999 99999999999999999999999999987533222
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~---------~ 216 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKG---------K 216 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcC---------C
Confidence 22233468999999999998889999999999999999999999995321 11111121111 0
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
. ..+......+.+++.+||+.+|.+|| ++.++++
T Consensus 217 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 L--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0 11112235688999999999999999 7777766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=314.62 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=200.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCc--EEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 197 (447)
++|+..+.||+|+||.||+|... ++. .+++|.++..........+.+|++++.++ +|+||+++++++...+..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 47788899999999999999875 344 46888776544444455788899999999 899999999999999999999
Q ss_pred EecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 198 YPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999976432 123588999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHH
Q 013238 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 344 (447)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||.... ..+..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY 233 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--------hHHHH
Confidence 999999986422111 1111124567999999988889999999999999999998 999985311 11111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...... ............+.+++.+||+.+|++||++.++++.|+.+
T Consensus 234 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 00011112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=311.38 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=203.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.+|...+.||+|+||.||++... ++..+++|.+.... ......+.+|++.+++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777889999999999999743 34568899886443 223346889999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 013238 196 LVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 263 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~ 263 (447)
+||||+++++|.+++..... ....+++..++.++.+++.||+|||++ +++||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999976431 123488999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHH
Q 013238 264 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 264 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 341 (447)
.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||+| |+.||.... ..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------~~ 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--------NT 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HH
Confidence 999999999975533221 11222346778999999999999999999999999999999 999985321 11
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
+.+.... ..... ......+..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 233 ~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 233 EVIECIT-QGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHHHh-CCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 11110 11122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=309.08 Aligned_cols=266 Identities=23% Similarity=0.382 Sum_probs=206.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-----------------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceee
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD-----------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 183 (447)
.++|++.+.||+|+||.||++...+ +..||+|.+...........+.+|++++..++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999987642 24689999876654445567889999999999999999
Q ss_pred EeeeeecCCcceEEEecccCCcchhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 013238 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ-------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256 (447)
Q Consensus 184 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~N 256 (447)
+++++......+++|||+.+++|.+++..... ....+++..++.++.|++.||+|||++ +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999998999999999999999999876542 122589999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh--CCCCccccccc
Q 013238 257 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLA 333 (447)
Q Consensus 257 ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~p~~~~~~~ 333 (447)
|++++++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~--- 237 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL--- 237 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc---
Confidence 9999999999999999876533221 12223346778999999988889999999999999999998 66777421
Q ss_pred CCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 334 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..................... .......+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 238 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 --TDQQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --ChHHHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111111110100 11112234679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=322.02 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=197.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|+||+||+|... +++.||||++..... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999976 589999999975422 222345778999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999987643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-------------------------------------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHH
Q 013238 279 KDTH-------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 321 (447)
Q Consensus 279 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell 321 (447)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011235899999999999999999999999999999999
Q ss_pred hCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 013238 322 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK---MSEVVRM 397 (447)
Q Consensus 322 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 397 (447)
+|..||.... ................. .. .......+.+++.+|+. +|.+|++ +.++++.
T Consensus 234 ~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~-----~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDN--------PQETYRKIINWKETLQF-----PD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCC--------HHHHHHHHHcCCCccCC-----CC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999995321 11111111111000000 00 01123457788888886 9999998 7777663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=305.84 Aligned_cols=256 Identities=23% Similarity=0.421 Sum_probs=203.9
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+..++|...+.||+|+||.||++...++..+|+|.+.... .....+.+|+++++.++|+|++++.+++.. ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 4557888999999999999999998777889999886532 223468889999999999999999999877 7789999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++.... ...+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999997643 23478899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
..........++..|+|||++....++.++|+||||+++|+++| |+.||.... ......+.. ..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~---~~------- 219 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALE---RG------- 219 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHh---CC-------
Confidence 32222222335677999999988889999999999999999999 899985311 111111111 10
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
............+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 ---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=310.47 Aligned_cols=239 Identities=24% Similarity=0.343 Sum_probs=187.3
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHh-cCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||.||+|... +++.||+|.++.... ......+..|.+++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 578999999975432 1222344556666654 4799999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999886543 388999999999999999999999 99999999999999999999999999997543222 22
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~-----------~~ 213 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--------EDELFDSILND-----------RP 213 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-----------CC
Confidence 334568999999999999899999999999999999999999995321 11111111110 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMSE 393 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 393 (447)
..+......+.+++.+||+.||.+||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 111123355788999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=300.33 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=204.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCc-eeeEeeeeecCC------
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPT------ 192 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 192 (447)
..|...++||+|+||+||+|+.. +|+.||+|++..... +.......+|+-+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45666678999999999999865 689999999986654 334445789999999999999 999999998876
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++|+||+ .-+|..++.........++...++.++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 778999999 5599999987653323477789999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
|+..... ....+..++|.+|.|||++.+. .|+...||||+|||+.||++++..|.... +......+...+...
T Consensus 167 Ara~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s-----e~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS-----EIDQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHHHcCCC
Confidence 9965432 2235556689999999999887 68999999999999999999999885321 122222222222222
Q ss_pred cccccc------ccc--cC----C-CCcH---HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 KLEQLV------DSD--ME----G-NYIE---EEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ~~~~~~------d~~--~~----~-~~~~---~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
....+- +.. .. . .... .......+++.+|++.+|.+|.|+..++..
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111110 000 00 0 0001 111367899999999999999999998875
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.01 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=195.9
Q ss_pred CCCCeeeecCCeEEEEEEECC-Cc--EEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC------Ccc
Q 013238 125 SNRNILGRGGFGKVYKGRLTD-GS--LVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 194 (447)
Q Consensus 125 ~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 194 (447)
.+.+.||+|+||.||+|...+ +. .+|+|.++.... ......+..|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999998764 33 689998865432 22345688899999999999999999987532 246
Q ss_pred eEEEecccCCcchhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 195 LLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
+++|||+.+|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998875332 1223489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 273 AKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 273 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~ 230 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSEIYDYLRQG 230 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHcC
Confidence 98654322211 112235678999999999899999999999999999999 788885311 11111111111
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
... .........+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 110 0111234568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=321.59 Aligned_cols=200 Identities=22% Similarity=0.342 Sum_probs=172.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|+||+||++... +++.||+|++..... ......+..|++++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999875 588999999965322 222345778999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997643 489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCC
Q 013238 279 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324 (447)
Q Consensus 279 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~ 324 (447)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346899999999999999999999999999999999999
Q ss_pred CCcc
Q 013238 325 RAFD 328 (447)
Q Consensus 325 ~p~~ 328 (447)
.||.
T Consensus 234 ~Pf~ 237 (363)
T cd05628 234 PPFC 237 (363)
T ss_pred CCCC
Confidence 9995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=314.62 Aligned_cols=263 Identities=26% Similarity=0.420 Sum_probs=204.7
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC--------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeee
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 188 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 188 (447)
....++|.+.+.||+|+||.||++... ....+|+|.++..........+..|+++++.+ +|+||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344568888999999999999999742 24578999987654444445688899999998 699999999999
Q ss_pred ecCCcceEEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 013238 189 MTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256 (447)
Q Consensus 189 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~N 256 (447)
......+++|||+.+|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 988889999999999999999976431 123588999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccC
Q 013238 257 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 334 (447)
Q Consensus 257 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~ 334 (447)
||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--- 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--- 241 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---
Confidence 999999999999999998654322111 111224467999999988889999999999999999999 888884311
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..+..... .... ...........+.+++.+||+.+|.+|||+.++++.|++.
T Consensus 242 -----~~~~~~~~-~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 242 -----VEELFKLL-REGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred -----HHHHHHHH-HcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111111 1110 0111122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=312.25 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=190.8
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHH---HhcCCCceeeEeeeeecCCcceEE
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMI---SMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
|++.+.||+|+||.||+|... +++.||||.++.... ......+..|.+++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999875 589999999975421 12223455565544 567899999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|...+... .+++..++.++.||+.||+|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999998887542 389999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~------ 217 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIVNDE------ 217 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC------
Confidence 222 22234568999999999999999999999999999999999999995321 111111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+||+ +.++++
T Consensus 218 -~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -V----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 011123456789999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=303.56 Aligned_cols=248 Identities=29% Similarity=0.463 Sum_probs=196.9
Q ss_pred CeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
++||+|+||.||+|.+.. +..+|+|.+...........+..|+++++.+.|+|++++++++. ....+++|||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997642 26899999976654444567889999999999999999999875 4567999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997643 489999999999999999999999 99999999999999999999999999998664333221
Q ss_pred eec--cccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 284 TTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 284 ~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
... ..++..|+|||.+.+..++.++||||||+++|||++ |..||.... ......++. ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~~---~~~~-------- 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAMLE---SGER-------- 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHH---cCCc--------
Confidence 111 123467999999998899999999999999999998 999995321 111111111 1110
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..........+.+++.+||+.+|.+|||+.+|++.|+++
T Consensus 217 --~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 --LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=310.82 Aligned_cols=242 Identities=26% Similarity=0.360 Sum_probs=192.1
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||+||++... +++.||||.++.... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 578999999975432 22234566788888777 699999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|...+.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 99998886543 489999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~~~~-------~---- 213 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSILEDE-------V---- 213 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCC-------C----
Confidence 233458999999999999999999999999999999999999995321 111111111110 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKM-----SEVVR 396 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 396 (447)
..+......+.+++.+||+.||.+|||+ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1111234568899999999999999999 76665
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=318.89 Aligned_cols=263 Identities=27% Similarity=0.420 Sum_probs=201.4
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEE------CCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecC
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 191 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 191 (447)
...++|++.+.||+|+||.||+|.. .+++.||||+++..........+.+|++++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4567899999999999999999973 246789999997654443445688899999999 689999999988754
Q ss_pred -CcceEEEecccCCcchhhhhhcCCC------------------------------------------------------
Q 013238 192 -TERLLVYPFMVNGSVASCLRERGQS------------------------------------------------------ 216 (447)
Q Consensus 192 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 216 (447)
...+++|||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4578999999999999998653210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc-eeec
Q 013238 217 ---------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTA 286 (447)
Q Consensus 217 ---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~ 286 (447)
...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12368888899999999999999999 9999999999999999999999999998764322211 1122
Q ss_pred cccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCC
Q 013238 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 365 (447)
Q Consensus 287 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 365 (447)
..++..|+|||.+.+..++.++||||||+++|||++ |..||..... . ............ ...
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~---~~~~~~~~~~~~----------~~~ 303 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----D---EEFCRRLKEGTR----------MRA 303 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----c---HHHHHHHhccCC----------CCC
Confidence 235678999999988899999999999999999997 8989853110 0 011111111100 000
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 366 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 366 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
+......+.+++..||+.+|.+|||+.+|++.|+..
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=303.33 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=200.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc----hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
++|...+.||+|++|.||++... +++.+|+|.+....... ....+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999865 58999999986443211 22457889999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
++||+++++|.+++.... .+++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999887543 378899999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCcee--eccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 277 DYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 277 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
........ ....++..|+|||++.+..++.++||||||+++|||++|+.||.... . . ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~--~-~~~~~~~~----- 221 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-----A--M-AAIFKIAT----- 221 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-----h--H-HHHHHHhc-----
Confidence 33221111 23447789999999999889999999999999999999999995311 0 0 10111110
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
..............+.+++.+||+.+|.+|||+.++++.
T Consensus 222 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 ----QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111222344568899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=308.66 Aligned_cols=266 Identities=23% Similarity=0.378 Sum_probs=203.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-----------------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceee
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-----------------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 183 (447)
.++|++.+.||+|+||.||++... ++..+|+|.+...........+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999998532 234689999976544444567889999999999999999
Q ss_pred EeeeeecCCcceEEEecccCCcchhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 013238 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQS-------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256 (447)
Q Consensus 184 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~N 256 (447)
+++++...+..+++|||+.+++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998764321 12377889999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh--CCCCccccccc
Q 013238 257 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLA 333 (447)
Q Consensus 257 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--g~~p~~~~~~~ 333 (447)
||+++++.++|+|||+++.+...... ......++..|+|||...++.++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-- 238 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC--
Confidence 99999999999999999765332211 1122234678999999888889999999999999999998 677874311
Q ss_pred CCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 334 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
................. ... ......+...+.+++.+||+.||.+|||+.+|++.|++
T Consensus 239 ---~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 ---DEQVIENTGEFFRDQGR-QVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---hHHHHHHHHHHHhhccc-ccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111111000 000 01112234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.90 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=195.6
Q ss_pred CeeeecCCeEEEEEEECC-Cc--EEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLTD-GS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||.||+|...+ +. .+++|.++..........+.+|++++.++ .||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998753 43 46888887544444455788999999999 799999999999998899999999999
Q ss_pred CcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 204 GSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 204 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
|+|.+++..... ....+++..++.++.+++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999876431 123478999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
++........ ......+..|+|||++....++.++||||||+++|||++ |..||.... ..+........
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYEKLPQG 227 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--------HHHHHHHHhCC
Confidence 9863221111 111223567999999988889999999999999999997 999995311 11111111111
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.. ..........+.+++.+||+.+|.+|||+.+++..|+++
T Consensus 228 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 011112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.07 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=199.6
Q ss_pred CCCCCeeeecCCeEEEEEEECC----CcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCc-----
Q 013238 124 FSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 193 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 193 (447)
|.+.+.||+|+||.||+|.... +..||+|.++..... .....+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998642 367999998754332 233468899999999999999999998865443
Q ss_pred -ceEEEecccCCcchhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 194 -RLLVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 194 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
.+++|||+++|+|..++..... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999998865422 223589999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHh
Q 013238 271 GLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 271 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
|+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||... .. .+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-----~~---~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-----EN---HEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----CH---HHHHHHHH
Confidence 9998654332211 111234678999999988889999999999999999999 88888431 11 11111111
Q ss_pred hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 349 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.... ...+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 230 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNR----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCC----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 111223456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=306.37 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=199.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
+|+..++||+|+||.||++... +++.||+|.+...... .....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999875 6889999999654322 223456789999999999999999999998889999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++|+|..++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886532 23489999999999999999999999 9999999999999999999999999999765322
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||.... .......+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~-----~~~~~~~~~~~~~~--------- 219 (285)
T cd05605 156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK-----EKVKREEVERRVKE--------- 219 (285)
T ss_pred C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc-----hhhHHHHHHHHhhh---------
Confidence 1 1223458899999999998889999999999999999999999996311 11111111111100
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 397 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 397 (447)
............+.+++.+||+.||.+|| ++.++++.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00112223456688999999999999999 77777554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=302.89 Aligned_cols=261 Identities=24% Similarity=0.277 Sum_probs=207.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
..++|+..+.||+|.-|+||++.+.+ +..+|+|++.+.... ....+.+.|-++|+.++||.++.|++.+..+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34566777889999999999999874 689999999766433 223467789999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
+||||+||+|..+++.+... .+++..++.++..|+-||+|||-. |||+|||||+||||.++|++.|+||.|+...
T Consensus 155 ~meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999998875443 499999999999999999999999 9999999999999999999999999987543
Q ss_pred CCC---------------------------------CC----------------------ceeeccccccCccccccccC
Q 013238 277 DYK---------------------------------DT----------------------HVTTAVRGTIGHIAPEYLST 301 (447)
Q Consensus 277 ~~~---------------------------------~~----------------------~~~~~~~gt~~y~aPE~~~~ 301 (447)
... .. ......+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 110 00 01123458999999999999
Q ss_pred CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHcc
Q 013238 302 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCT 381 (447)
Q Consensus 302 ~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl 381 (447)
...+.++|+|+|||++|||+.|..||.... ....+. .++...+.-.........+.+||.+.|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~----~~~Tl~-------------NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSN----NKETLR-------------NIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCC----chhhHH-------------HHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999996422 222222 222222222222245567889999999
Q ss_pred CCCCCCCCC----HHHHHH--HHhcCC
Q 013238 382 QGSPMERPK----MSEVVR--MLEGDG 402 (447)
Q Consensus 382 ~~dP~~RPt----~~evl~--~L~~~~ 402 (447)
.+||++|.. +.||-+ ++++..
T Consensus 373 vKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred ccChhhhhccccchHHhhcCccccCCC
Confidence 999999998 555544 344443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.04 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=202.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||+|++|.||++... +++.|++|.+.... .......+..|+++++.++|+|++++++++...+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999875 68899999986432 233445688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++.... ...+++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 23589999999999999999999999 99999999999999999999999999988654332
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ...........
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~---------- 216 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRG---------- 216 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC----------
Confidence 22 223457889999999999899999999999999999999999995321 11111111110
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
............+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0111122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=311.11 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=190.4
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||.||++... +++.||+|++...... .....+..|..++.++ +|+||+.+++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 5789999999764322 2234577888888877 599999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99998886542 489999999999999999999999 99999999999999999999999999987532211 22
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......++..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~---------- 220 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITD--NPDMNTEDYLFQVILEKPI---------- 220 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCC--CcccccHHHHHHHHHhCCC----------
Confidence 2345689999999999999999999999999999999999999963211 1111112222222111110
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
..+......+.+++.+||+.||.+|+++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 0111223457889999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.60 Aligned_cols=238 Identities=28% Similarity=0.388 Sum_probs=189.3
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||+||+|+.. +++.||||++..... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 588999999975432 22334566788888766 699999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99999886543 388999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~---------~-- 213 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE---------V-- 213 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCC---------C--
Confidence 233468999999999999899999999999999999999999995321 111112211110 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMS 392 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 392 (447)
..+......+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 01112345688999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=306.18 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=201.3
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-C---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTD-G---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+|+..+.||+|+||.||+|.... + ..||||.+...........+..|+.+++.++||||+++.+++......+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998753 3 3699999876544444567899999999999999999999999888999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+++|.+++..... .+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999876432 388999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCce--eeccc--cccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 279 KDTHV--TTAVR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 279 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
..... ..... .+..|+|||.+.+..++.++||||||+++|||++ |..||.... ......++. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i~---~~~-- 228 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAIE---QDY-- 228 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHHH---cCC--
Confidence 22111 11111 2357999999998899999999999999999886 999985311 111111111 110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
........+..+.+++.+||+.+|.+||++.+++..|+..
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011122345688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=310.33 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=191.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCC-ceeeEeeeeecCCcceEEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 198 (447)
+|+..+.||+|+||.||+|... +++.||||++..... ......+..|.+++..+.|+ +|+.+++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999876 578999999975432 22334577888899888765 5788888888888999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999886543 378999999999999999999999 999999999999999999999999999875322
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
... ......||..|+|||++.+..++.++|||||||++|||+||+.||.... ..+.........
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~~------- 217 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSIMEHN------- 217 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-------
Confidence 222 2233468999999999999999999999999999999999999995311 111111111110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
...+......+.+++.+||+.||.+|++.
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01111234568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=316.22 Aligned_cols=267 Identities=27% Similarity=0.394 Sum_probs=207.9
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC--------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeee
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 188 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 188 (447)
++...+|++.+.||+|+||.||++... .+..||+|.++..........+.+|++++.++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 444567889999999999999999742 12368999887554444455788999999999 799999999999
Q ss_pred ecCCcceEEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 013238 189 MTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256 (447)
Q Consensus 189 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~N 256 (447)
......+++|||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 998899999999999999999876421 223488999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccC
Q 013238 257 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 334 (447)
Q Consensus 257 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~ 334 (447)
||++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---- 240 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---- 240 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC----
Confidence 999999999999999997654322111 111224567999999999999999999999999999998 88888421
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCch
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 405 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 405 (447)
...++........ ...........+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus 241 ----~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 241 ----PVEELFKLLKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ----CHHHHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1222222221111 11111223456889999999999999999999999998765433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=300.20 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=198.3
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcch
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 207 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 207 (447)
++||+|++|.||++...+++.||+|.+...........+.+|+++++.+.|+||+++++++......+++|||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987789999999876544434557889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCcee-ec
Q 013238 208 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TA 286 (447)
Q Consensus 208 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~ 286 (447)
+++..... .+++..+..++.+++.||+|||++ +++||||+|+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99865432 478999999999999999999999 999999999999999999999999999876432111111 11
Q ss_pred cccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCC
Q 013238 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 365 (447)
Q Consensus 287 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 365 (447)
..++..|+|||.+.+..++.++||||||+++|||+| |..||.... ........ .. ......
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--------~~~~~~~~-~~---------~~~~~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--------NQQTRERI-ES---------GYRMPA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--------HHHHHHHH-hc---------CCCCCC
Confidence 223567999999988899999999999999999999 888884311 01111111 00 001111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 366 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 366 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
+......+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 22334579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=316.47 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=201.4
Q ss_pred HHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeec
Q 013238 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 190 (447)
Q Consensus 114 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 190 (447)
+.++....++|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+|..+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455667789999999999999999999976 588999999864321 2223457789999999999999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
....++||||+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998653 278888999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCC----CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 99987643332223345699999999998654 37889999999999999999999996321 1111111
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRML 398 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 398 (447)
.........+ .........+.+++..|++.++.. |+++.++++..
T Consensus 259 i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 259 IMNHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHcCCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111110000 011123455778889999844432 67888887754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=306.34 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=203.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
..++|...+.||+|+||.||+|...+ ...|+||.............+.+|+.+++.+.|+||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34568888999999999999998643 246899988765444445578899999999999999999998865 5578
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++|||+++|+|.+++.... ..+++..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 9999999999999997543 2489999999999999999999999 999999999999999999999999999886
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.............++..|+|||.+....++.++||||||+++|||++ |..||.... ...... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~---~~~~~~~~- 227 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-----NNDVIG---RIENGERL- 227 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHH---HHHcCCcC-
Confidence 54332222222234568999999988889999999999999999986 999995321 111111 11111100
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCc
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLA 404 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 404 (447)
.........+.+++.+||..+|.+|||+.+++..|+....+
T Consensus 228 ---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 ---------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11122345688999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.19 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=196.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----cce
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 195 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 195 (447)
+|+..+.||+|+||.||++... +|+.||||++..... ......+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 689999999864322 223446789999999999999999999988766 689
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||+. ++|...+... ..+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 5777777543 2489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.............++..|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-----IQQLDLITDLLGTPSLE 227 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHcCCCCHH
Confidence 543333333334578899999998774 478999999999999999999999964211 11111111110000000
Q ss_pred c-----------ccccccCC-------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 355 Q-----------LVDSDMEG-------NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 355 ~-----------~~d~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. +....... .........+.+++.+||+.||.+|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 00000000 0111224568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=315.26 Aligned_cols=243 Identities=23% Similarity=0.279 Sum_probs=193.1
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
+.||+|+||.||++... +|+.||+|.+..... ......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 689999999975432 222345678999999999999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 205 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 205 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
+|..++.... .+++..++.++.||+.||+|||+ . +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 9998886543 48999999999999999999997 6 99999999999999999999999999987532221 12
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ........... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~~-------~~~~-- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------EIRF-- 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhcC-------CCCC--
Confidence 233458999999999999999999999999999999999999995311 11111111100 0001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 397 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 397 (447)
+......+.+++.+||+.||.+|+ ++.++++.
T Consensus 216 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 --PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112235688899999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=298.89 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=200.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecc-ccccchHHHHHHHHHHHHhcCCCceeeEeeeeec-----CC
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PT 192 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 192 (447)
....|...+.||+|++|.|+.+... +|+.||||++.. .......++-.+|+..++.++|+||+.+.+++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666788999999999999876 689999999973 2334445577899999999999999999998765 24
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..|+|+|+| +.+|...++... .++......++.|+++||+|+|+. +|+||||||+|+|++.++.+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 679999999 668998887643 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC-CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 273 AKLMDYK-DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 273 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|+..... .....+..+.|.+|.|||++.. ..|+.+.||||.|||+.||++|+..|.+.+ .....+.+...+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-----~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-----YVHQLQLILELLGT 246 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-----hHHHHHHHHHhcCC
Confidence 9977532 1223345568999999998754 579999999999999999999999995321 11122221111111
Q ss_pred c---ccccc--------ccc-ccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 K---KLEQL--------VDS-DMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ~---~~~~~--------~d~-~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. .+..+ +.. ..... ..+......++++.+||..||.+|+|++|.++
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1 01111 100 00000 01123355789999999999999999999886
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.59 Aligned_cols=251 Identities=32% Similarity=0.482 Sum_probs=203.2
Q ss_pred CeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||.||+|.... +..+++|.+...........+.+|++.+..++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998763 7889999997665444456788999999999999999999999998899999999999
Q ss_pred CcchhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 204 GSVASCLRERGQS-----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 204 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
++|.+++...... ...+++..++.++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875221 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 279 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 279 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... .......++..|+|||.+.+..++.++||||||+++|||++ |..||... ...+.........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~----- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--------SNEEVLEYLRKGY----- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC-----
Confidence 321 11223447889999999988889999999999999999999 69998532 1111112211110
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
...........+.+++.+||+.+|.+|||+.++++.|+
T Consensus 225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112223567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.91 Aligned_cols=260 Identities=21% Similarity=0.306 Sum_probs=190.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 191 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 191 (447)
..+|+..+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457889999999999999999875 58899999885432 1345799999999999999998876432
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeec
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDF 270 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Df 270 (447)
...++||||+++ +|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999964 77777765433344689999999999999999999999 999999999999999665 7999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.... ....+...+. ...
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~----~~~~~~~i~~-~~~ 288 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS----SVDQLVRIIQ-VLG 288 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH-HhC
Confidence 99986543221 2234578999999998664 68999999999999999999999995321 0011111111 000
Q ss_pred ccccc----------c-----ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 EKKLE----------Q-----LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 ~~~~~----------~-----~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..... . +....+....+......+.+++.+||+.||.+|||+.++++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000 0 00000000011123456889999999999999999999885
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=311.31 Aligned_cols=248 Identities=23% Similarity=0.277 Sum_probs=191.1
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHH-HHHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEV-EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||+||+|... +++.||+|++..... ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 578899999965322 11222344444 356788999999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 99999887543 377888889999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~---------~-- 213 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKP---------L-- 213 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCC---------c--
Confidence 234468999999999999999999999999999999999999995311 111111111110 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
.........+.+++.+||+.+|.+||++.+.+..+.+..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 011123456888999999999999999886555444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.05 Aligned_cols=264 Identities=26% Similarity=0.389 Sum_probs=203.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--Ccc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 194 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 194 (447)
..|...+.||+|+||.||++.+. ++..||+|.++..........+.+|+++++.++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34677889999999999999742 47889999997654444455789999999999999999999998775 567
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
+++|||+++++|.+++.... ..+++..++.++.+++.||+|||++ +++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 89999999999999986542 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccccccc-------CCCcccHHHHHH
Q 013238 275 LMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA-------NDDDVMLLDWVK 345 (447)
Q Consensus 275 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~ 345 (447)
........ ......++..|+|||++.+..++.++||||||+++|||+|++.|....... .........++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65433221 112334677899999998888999999999999999999987765321000 000111111111
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.. .... ...........+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 238 ~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VL-EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 1110 0011122456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.96 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=195.1
Q ss_pred eeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 130 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
||+|+||.||++... +|+.||+|.+...... .....+..|++++++++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 5899999999643221 2233456799999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeec
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 286 (447)
..++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++...... .....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeec
Confidence 988865432 3488999999999999999999999 9999999999999999999999999998765432 22233
Q ss_pred cccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCc
Q 013238 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366 (447)
Q Consensus 287 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 366 (447)
..|+..|+|||++.+..++.++|||||||++|||++|+.||.... ............... .... ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~---------~~~~-~~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK----EKVAKEELKRRTLED---------EVKF-EH 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc----chhhHHHHHHHhhcc---------cccc-cc
Confidence 458999999999998889999999999999999999999995311 111111111111111 0000 01
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 367 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 367 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
......+.+++.+||+.||.+||++.|+++.+..
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 1234568899999999999999999887755544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=306.99 Aligned_cols=241 Identities=24% Similarity=0.337 Sum_probs=189.2
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHh-cCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||+||+|... +++.||||.++.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 478999999975431 2223345667777765 5899999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 99999987532 388999999999999999999999 999999999999999999999999999875322221 2
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~-------~~~--- 214 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEELFQSIRMD-------NPC--- 214 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-------CCC---
Confidence 233468999999999999899999999999999999999999995321 11111111100 011
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVV 395 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 395 (447)
.+......+.+++.+||+.||.+||++. ++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1112334578899999999999999997 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.46 Aligned_cols=251 Identities=17% Similarity=0.282 Sum_probs=201.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
+|+..+.||+|+||.||++... +++.+|+|.++..........+..|+.+++.++|+|++++.+.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999876 688999999865444444556788999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++++|.+++.... ...+++..++.++.+++.||.|||++ +++|+||||+||++++++.++++|||++........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999886532 23478999999999999999999999 999999999999999999999999999876543221
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
......++..|+|||++.+..++.++|+||||+++|+|++|..||.... .......... ....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVCQ-GSYK------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHhc-CCCC-------
Confidence 2223458889999999998889999999999999999999999995311 1111111111 1100
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.........+.+++.+||+.||.+|||+.+++..
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=303.79 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=198.3
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
+|+..+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++...+..+++|||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999864 688999999865543444456889999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++++|..+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999986542 267888999999999999999999 99999999999999999999999999997653221
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||....... .......+........ ...+
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~------~~~~ 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ-GSLMPLQLLQCIVDED------PPVL 220 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccc-cccchHHHHHHHhccC------CCCC
Confidence 223458899999999999899999999999999999999999996421110 0111111111111100 0011
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
. .......+.+++.+||+.+|.+||+++++++.-.
T Consensus 221 ~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 221 P---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred C---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 0 1112345889999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=304.43 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=203.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
++|+..+.||+|+||.||+|+.. +.+.+++|.+...........+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999864 246799998865443334457889999999999999999999999888999
Q ss_pred EEEecccCCcchhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 196 LVYPFMVNGSVASCLRERGQSQ-----PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
+||||+++|+|.+++....... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997654221 2589999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhh
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.... . ...+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-----~---~~~~~~~~- 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-----D---EEVLNRLQ- 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----h---HHHHHHHH-
Confidence 9987543222222233346778999999988888999999999999999999 788884211 1 11111111
Q ss_pred ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..... ..........+.+++.+||+.+|.+|||+.+++..|.+
T Consensus 233 ~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 01110 01112234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=323.04 Aligned_cols=253 Identities=17% Similarity=0.236 Sum_probs=194.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|+||+||++... +++.||||.+..... ......+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999875 688999999865321 222346788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999987543 488999999999999999999999 999999999999999999999999999863211
Q ss_pred CCCc----------------------------------------------eeeccccccCccccccccCCCCCchhhhHH
Q 013238 279 KDTH----------------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 312 (447)
Q Consensus 279 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 312 (447)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001235899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCC---C
Q 013238 313 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER---P 389 (447)
Q Consensus 313 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---P 389 (447)
|||++|||++|..||.... ..+............. +.. .......+.+++.+|+. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~-----~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSEN--------SHETYRKIINWRETLY-----FPD--DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCC--------HHHHHHHHHccCCccC-----CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 9999999999999995311 0111111111000000 000 01123457788888987 67665 5
Q ss_pred CHHHHHHH
Q 013238 390 KMSEVVRM 397 (447)
Q Consensus 390 t~~evl~~ 397 (447)
|+.++++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 88888774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=297.26 Aligned_cols=265 Identities=25% Similarity=0.348 Sum_probs=197.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHH--HhcCCCceeeEeeeeecC----Ccc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMI--SMAVHRNLLRLRGFCMTP----TER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~~~~~~~----~~~ 194 (447)
.....+.+.||+|.||.||+|.+. |+.||||++.... +..+.+|.+++ ..++|+||+.+++.-..+ .++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345677789999999999999997 7889999996432 33556666665 468999999999876544 357
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCceecCCCCCCEEECCCCcEEEee
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-----HCDPKIIHRDVKAANILLDEEFEAVVGD 269 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~D 269 (447)
|||.+|.+.|||.++|... .++....++++..+|.||++||. +.+|.|.|||||+.||||.+++.+.|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 8999999999999999874 38899999999999999999995 3578999999999999999999999999
Q ss_pred cCCccccCCCCCc---eeeccccccCccccccccCCCC------CchhhhHHHHHHHHHHHhC----------CCCcccc
Q 013238 270 FGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGKS------SEKTDVFGYGVMLLELITG----------QRAFDLA 330 (447)
Q Consensus 270 fgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~~sDvwSlG~il~elltg----------~~p~~~~ 330 (447)
+|||......... .....+||.+|||||++...-. -..+||||||.|+||++.. +.||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999765433221 2345679999999999965421 3468999999999999852 2444321
Q ss_pred cccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 331 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
-..+. + .+-++..+-..++...+..+ -...+.+..+.++|..||..||..|-|+-.+-+.|.++.
T Consensus 440 Vp~DP---s-~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 440 VPSDP---S-FEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCC---C-HHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 11111 1 11111111111111111111 124578889999999999999999999998888887654
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=311.08 Aligned_cols=243 Identities=25% Similarity=0.335 Sum_probs=191.9
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
++||+|+||.||+|... +++.||+|++..... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 578999999975432 22233566788888765 799999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|...+.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99998886543 388999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~~----------- 213 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDDV----------- 213 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCC-----------
Confidence 233458999999999999899999999999999999999999996321 1111222211110
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERP-------KMSEVVRM 397 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~ 397 (447)
..+......+.+++.+||+.||.+|| ++.++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01111235688999999999999999 67777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=308.12 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=197.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|...+.||+|+||.||+|... +++.||+|.++..........+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999876 57889999997654444444677899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.+ +|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 965 7887776543 2378899999999999999999999 99999999999999999999999999987543322
Q ss_pred CceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc---------
Q 013238 281 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE--------- 350 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 350 (447)
. ......++..|+|||++.+ ..++.++||||||+++|||+||+.||...... ............
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhh
Confidence 2 1222347889999998865 46789999999999999999999999532110 111111110000
Q ss_pred ---cccccccccccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 ---KKLEQLVDSDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ---~~~~~~~d~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........+..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000000 00122345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=312.84 Aligned_cols=239 Identities=26% Similarity=0.332 Sum_probs=191.7
Q ss_pred CeeeecCCeEEEEEEE----CCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEeccc
Q 013238 128 NILGRGGFGKVYKGRL----TDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 202 (447)
+.||+|+||.||++.. .+|+.||+|++...... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 25789999999754322 223456789999999999999999999999999999999999
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 282 (447)
+|+|.+++.... .+++..++.++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 999999986532 489999999999999999999999 99999999999999999999999999987653322 2
Q ss_pred eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccC
Q 013238 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362 (447)
Q Consensus 283 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 362 (447)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~~~---------~- 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILKAK---------L- 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHcCC---------C-
Confidence 2334568999999999998889999999999999999999999995321 111111111110 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 013238 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSE 393 (447)
Q Consensus 363 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 393 (447)
..+......+.+++.+||+.||.+|||+.+
T Consensus 216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111123456889999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=305.77 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=200.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.++...++||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46777889999999999999642 35678999886432 333457889999999999999999999999988999
Q ss_pred EEEecccCCcchhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 013238 196 LVYPFMVNGSVASCLRERGQ-----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 264 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~ 264 (447)
++|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999876432 113488999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHH
Q 013238 265 AVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 265 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 342 (447)
+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.... . .+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~---~~ 232 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-----N---TE 232 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-----H---HH
Confidence 999999998755322211 1122234678999999999999999999999999999998 899984211 0 11
Q ss_pred HHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 343 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.......... ..........+.+++.+||+.||.+||++.+|++.|+.
T Consensus 233 ~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AIECITQGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHcCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111111100 01111234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=300.59 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=199.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeee-cCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 199 (447)
.++|...+.||+|+||.||++... |..+|+|.++... ....+.+|+.++++++|+|++++++++. ..+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 357888899999999999999875 7789999986432 2346889999999999999999999765 4456899999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++..... ..+++..++.++.+++.||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999876432 2488999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+........
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~~~-------- 215 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPRVEKG-------- 215 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhcC--------
Confidence 1 12234568999999988889999999999999999998 99998531 112222211111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
............+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 --YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01111122345688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=300.58 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=200.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
.+|+..+.||+|+||.||++...++..+|+|.+..... ....+.+|+++++.++|+|++++++++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 46777889999999999999887788999998864332 2346889999999999999999999998888999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
.+++|.+++..... ++++..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999875432 378999999999999999999999 999999999999999999999999999875532221
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ............ ....+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~---~~~~~- 223 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETINAGF---RLYKP- 223 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHhCCC---CCCCC-
Confidence 11112234568999999998899999999999999999998 999985311 111222211110 11111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
......+.+++.+||+.+|.+|||+.++++.|.
T Consensus 224 ------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 ------RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=307.34 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=189.0
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHh-cCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||.||+|... +|+.||+|.++.... ......+..|..++.. .+|+||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 588999999975432 2223345667777765 4899999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 99999886542 388999999999999999999999 99999999999999999999999999987432222 22
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ........... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--------~~~~~~~~~~~-------~~~--- 214 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--------EDELFESIRVD-------TPH--- 214 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-------CCC---
Confidence 334568999999999999999999999999999999999999995311 11111111110 011
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVV 395 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 395 (447)
.+......+.+++.+||+.||.+||++. +++
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 -YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111334578899999999999999984 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=310.27 Aligned_cols=241 Identities=24% Similarity=0.303 Sum_probs=188.5
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHH-HHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||+||+|... +|+.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999976 689999999965422 112234445544 46789999999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 99999886543 488999999999999999999999 9999999999999999999999999998753222 122
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-------~~~~- 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKP-------LRLK- 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCC-------CCCC-
Confidence 333468999999999999999999999999999999999999995311 111222211110 0011
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 395 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 395 (447)
......+.+++.+||+.||.+||++.+.+
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 217 ---PNISVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 11245688999999999999999986333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=302.92 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=199.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--Ccc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 194 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 194 (447)
.+|++.+.||+|+||.||++... ++..||+|.+.... ......+.+|+++++.++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46788899999999999999742 47899999986543 23345688999999999999999999987543 467
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 89999999999999986543 2389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcee--eccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccccccc-----CC--CcccHHHHHH
Q 013238 275 LMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA-----ND--DDVMLLDWVK 345 (447)
Q Consensus 275 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~-----~~--~~~~~~~~~~ 345 (447)
.......... ....++..|+|||++.+..++.++||||||+++|||++|..++...... .. ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 6643322111 1112345699999998888999999999999999999988775321100 00 0000000000
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.. +...............+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 237 ~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 EL---------LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HH---------HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11 111111111122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=301.25 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=198.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 457889999999999999999974 688999999864422 223457789999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++.... ++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 999999999886532 488999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.. ......++..|+|||.+. ...++.++||||||+++|||++|+.||....... .... ......
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-----------~~~~-~~~~~~ 226 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----------ALFL-MSKSNF 226 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-----------hhee-eecCCC
Confidence 21 122335788999999874 3457889999999999999999999984311000 0000 000000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
..+.. .........+.+++.+||+.+|++|||++++++.|
T Consensus 227 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 01112345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.65 Aligned_cols=200 Identities=25% Similarity=0.358 Sum_probs=170.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
+|+..++||+|+||+||+|... +++.||+|.+..... ......+.+|+++++.++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999875 588999999965322 2233467889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999987643 378899999999999999999999 9999999999999999999999999997532110
Q ss_pred CC----------------------------------------------ceeeccccccCccccccccCCCCCchhhhHHH
Q 013238 280 DT----------------------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 313 (447)
Q Consensus 280 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 313 (447)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00 00112458999999999999999999999999
Q ss_pred HHHHHHHHhCCCCccc
Q 013238 314 GVMLLELITGQRAFDL 329 (447)
Q Consensus 314 G~il~elltg~~p~~~ 329 (447)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (382)
T cd05625 235 GVILYEMLVGQPPFLA 250 (382)
T ss_pred hHHHHHHHhCCCCCCC
Confidence 9999999999999953
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.33 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=191.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+|+..+.||+|+||.||+|... +++.||+|.+..... ......+..|..++..+ .|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999876 578999999975432 12223456677777766 5899999999999989999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|...+.... .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999998886543 388999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ............
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~i~~~~------- 217 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN------- 217 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-------
Confidence 22 22234568999999999999999999999999999999999999996321 111111111110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
...+......+.+++.+|++.+|.+|++.
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01112234568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=300.23 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=191.5
Q ss_pred CeeeecCCeEEEEEEECC---CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCC
Q 013238 128 NILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
+.||+|+||.||+|...+ +..+|+|.++..........+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 45799999876554444457888999999999999999999999888999999999999
Q ss_pred cchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 205 SVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 205 sL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
+|.+++...... ....++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999764321 22467788889999999999999999 99999999999999999999999999987543222111
Q ss_pred -eeccccccCccccccccCC-------CCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 284 -TTAVRGTIGHIAPEYLSTG-------KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 284 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||.... ....... ... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~~~~~~~---~~~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS-----DEQVLTY---TVR-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHH---Hhh-cccC
Confidence 1223467889999998643 35789999999999999996 999995321 0111110 011 0111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
...++.+. ......+.+++..|| .+|++|||+++|+..|+
T Consensus 229 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 112345778899999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=335.80 Aligned_cols=260 Identities=23% Similarity=0.306 Sum_probs=201.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..++||+|+||.||+|... +|+.||+|++..... ......+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999876 589999999975432 223456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 199 PFMVNGSVASCLRERGQ-------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
||+++|+|.+++..... .....++..++.++.||++||+|||++ +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999865311 122366778899999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC-----------------ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccC
Q 013238 272 LAKLMDYKDT-----------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 334 (447)
Q Consensus 272 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~ 334 (447)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 9986521110 011224589999999999999999999999999999999999999953110
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEG 400 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 400 (447)
.... ... .+.++. ........+..+.+++.+||+.||.+|| +++++++.|+.
T Consensus 237 ---~ki~-------~~~---~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 237 ---RKIS-------YRD---VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred ---hhhh-------hhh---hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 000 000000 0001122345688899999999999996 56777777665
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=300.06 Aligned_cols=249 Identities=30% Similarity=0.432 Sum_probs=198.8
Q ss_pred CeeeecCCeEEEEEEECC--C--cEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLTD--G--SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|++|.||+|.+.+ + ..||||.+...........+.+|+.++++++|+||+++++++.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 36899999776544445578899999999999999999999888 888999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc-
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 282 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 282 (447)
++|.+++..... ..+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999977542 3589999999999999999999999 9999999999999999999999999999876432221
Q ss_pred -eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 283 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 283 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
......++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+......... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~--~------ 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--------SGSQILKKIDKEG--E------ 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHhcC--C------
Confidence 1112346788999999998899999999999999999999 99998531 1111111111100 0
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
........+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 -RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00111223466889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.65 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=195.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecC------
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP------ 191 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 191 (447)
+++.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+|++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 5667888899999999999999875 58899999986532 2334678899999888 699999999998753
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
...+++|||+.+++|.+++..... ..+++..++.++.|++.||+|||++ +++|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 357899999999999999876432 3488999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||..... ..... .
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~-~ 227 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF-L 227 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHH-H
Confidence 9976543222 223345888999999986 33578899999999999999999999953110 00000 0
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. .... .... ........+.+++.+||+.+|.+|||+.++++
T Consensus 228 ~-~~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 I-PRNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred H-hcCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 0000 0011 11123356889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.76 Aligned_cols=252 Identities=20% Similarity=0.266 Sum_probs=193.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
+|++.+.||+|+||.||+++.. +++.||||.+..... ......+.+|++++..++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999875 588999999864321 2223457889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999997643 378899999999999999999999 9999999999999999999999999997532110
Q ss_pred CC------------------------------------------ceeeccccccCccccccccCCCCCchhhhHHHHHHH
Q 013238 280 DT------------------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 317 (447)
Q Consensus 280 ~~------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 317 (447)
.. .......||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 001124689999999999999999999999999999
Q ss_pred HHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 013238 318 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP---KMSEV 394 (447)
Q Consensus 318 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~ev 394 (447)
|||++|+.||.... ..+.......... .............+.+++.+|+ .+|.+|+ |+.++
T Consensus 235 yell~G~~Pf~~~~--------~~~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 235 YEMLVGQPPFLADT--------PAETQLKVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eehhhCCCCCCCCC--------HHHHHHHHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999996321 1111111111000 0000001112334566666665 4999999 78888
Q ss_pred HHH
Q 013238 395 VRM 397 (447)
Q Consensus 395 l~~ 397 (447)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=321.91 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=205.6
Q ss_pred CCCCCeeeecCCeEEEEEEEC--CCc--EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 124 FSNRNILGRGGFGKVYKGRLT--DGS--LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
....++||+|.||.|++|.++ +|+ .||||.++..........|.+|+..|.+++|+|+++|+|+..+ ....||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344578999999999999876 344 6899999877655556689999999999999999999999877 67889999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
.++.|+|.+.|+. .....|.......++.|||.||.||.++ ++|||||..+|+||-....+||+||||.+.+...
T Consensus 191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999988 3344688999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCce--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 280 DTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 280 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
+... .....-...|+|||.+....++-++|||+|||+||||+| |..||-.. .-.+ +-+.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--------~g~q----------IL~~ 327 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--------RGIQ----------ILKN 327 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--------CHHH----------HHHh
Confidence 4332 222335678999999999999999999999999999999 88888431 1111 1222
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 395 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 395 (447)
+|..-.-..+..+.++++++|+.||..+|.+|||+..+.
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 333333345667889999999999999999999999997
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=299.97 Aligned_cols=250 Identities=32% Similarity=0.441 Sum_probs=191.7
Q ss_pred CeeeecCCeEEEEEEEC----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec-CCcceEEEeccc
Q 013238 128 NILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPFMV 202 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 202 (447)
+.||+|+||.||+|... ++..+|+|.+...........+.+|+.+++.++|||++++++++.. .+..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998654333344568889999999999999999998764 456789999999
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 282 (447)
+|+|.+++..... ...+..+..++.+++.||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999975432 267788889999999999999999 9999999999999999999999999999754322111
Q ss_pred ---eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhC-CCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 283 ---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 283 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
......++..|+|||.+.+..++.++||||||+++|||++| ..||... ...+..........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--------~~~~~~~~~~~~~~------ 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------DSFDITVYLLQGRR------ 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHhcCCC------
Confidence 11122356789999999888999999999999999999995 4555321 11222222211110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.......+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 221 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 ----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=300.42 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=202.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
..|+..+.||.|+||.||+|... ++..||+|.+...........+.+|+++++.++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677788999999999999875 58899999987554444455788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++... ++++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999988642 378899999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
. ......++..|+|||++.+..++.++|+||||+++|||++|+.||..... ..... .+...
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--------~~~~~----------~~~~~ 216 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--------MRVLF----------LIPKN 216 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh--------HhHhh----------hhhcC
Confidence 1 12233578899999999888899999999999999999999999853210 00000 00111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
............+.+++.+||+.+|.+||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1122334456778999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=307.81 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=199.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCc----EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.++|+..+.||+|+||.||+|... +|. .+|+|.+...........+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356778889999999999999864 343 57899887654444445688899999999999999999998754 467
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++++|+++|+|.+++..... .+++..++.++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999875432 378999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 276 MDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 276 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
........ .....++..|+|||++.+..++.++||||||+++|||++ |..||.... .....+++. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~~ 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLLE----KGER 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH----CCCC
Confidence 54322211 112235678999999998899999999999999999997 899985311 111111111 1100
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
......+...+.+++..||..+|.+||++.++++.|+.+
T Consensus 230 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ---------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001112335688999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=302.03 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=201.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||.|++|.||+|... +++.+|+|.+...........+.+|+++++.++|+|++++.+++.+....++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999976 58899999987654344445688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++... ++++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 489999999999999999999999 99999999999999999999999999998765332
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
. ......++..|+|||++.+..++.++||||||+++|+|+||+.||..... ......... ... +.
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~~~-~~~-----~~ 217 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFLIPK-NNP-----PS 217 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHHhhh-cCC-----CC
Confidence 2 12233578889999999988899999999999999999999999953210 111111110 000 11
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+... .....+.+++.+||..+|++|||++++++
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 13456889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=308.48 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=193.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||.||+++.. +++.||+|.+.... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999976 58899999996432 1222345788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999997532 2388999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeccccccCccccccccC-----CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKEH 226 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCc
Confidence 33222233458999999999863 457889999999999999999999995311 11111121111110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQ--GSPMERPKMSEVVRM 397 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 397 (447)
..+ . .........+.+++.+|+. .++..||++.++++.
T Consensus 227 ~~~-----~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQF-----P-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccC-----C-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 110 0 0011123456667776664 344457888888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=301.82 Aligned_cols=252 Identities=30% Similarity=0.481 Sum_probs=197.2
Q ss_pred CeeeecCCeEEEEEEECC-------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 128 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+.||+|+||.||+|+..+ +..+|||.+...........+.+|+++++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886554334455788999999999999999999999988899999999
Q ss_pred ccCCcchhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-----cEEEeecCC
Q 013238 201 MVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-----EAVVGDFGL 272 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgl 272 (447)
+++++|.+++..... ....+++..++.++.+++.||+|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999976432 123478999999999999999999999 999999999999999887 899999999
Q ss_pred ccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 273 AKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 273 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
+......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... . .+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-----~---~~~~~~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----N---QEVLQHVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-----H---HHHHHHHhcC
Confidence 8755322211 1122235678999999999999999999999999999998 999985311 1 1111111000
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
. ........+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 230 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 011122335678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=304.69 Aligned_cols=249 Identities=19% Similarity=0.317 Sum_probs=199.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
.+|+..+.||+|++|.||+|... +++.|++|.+...... ....+.+|+++++.+.|+|++++++.+......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 47888899999999999999864 6889999998754433 235678899999999999999999999988899999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998643 378899999999999999999999 99999999999999999999999999987643322
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+.. ...... +
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~-~~~~~~------~- 234 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYL-IATNGT------P- 234 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHH-HhcCCC------C-
Confidence 11 2223578899999999888899999999999999999999999953211 011110 000000 0
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...........+.+++.+||..+|.+|||+.++++
T Consensus 235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 00112233456889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=305.53 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=200.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|+||.||++... ++..+|+|.+...........+.+|++++..++||||+++++++...+..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999875 57889999987554333445688899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ +++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997642 4889999999999999999999732 8999999999999999999999999998754321
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc--------
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-------- 352 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 352 (447)
......++..|+|||++.+..++.++||||||+++|+|++|+.||..... .....+.........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-----hhHHHhhcCccccccccCCcccc
Confidence 12234578899999999888899999999999999999999999853211 001000000000000
Q ss_pred ----------------cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 353 ----------------LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 353 ----------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
...+................+.+++.+||+.+|++|||+.++++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000000011344688999999999999999999998863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=299.35 Aligned_cols=279 Identities=22% Similarity=0.262 Sum_probs=209.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 198 (447)
++|+..+.||.|++|.||++... +++.+|+|.+...........+.+|+++++.++|+||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999985 58899999987654444456788999999999999999999988654 3578999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998765443344588999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||+....... ...+........ ....+.+
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~ 230 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL---GPIELLSYIVNM-PNPELKD 230 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC---ChHHHHHHHhcC-Cchhhcc
Confidence 221 123467889999999988999999999999999999999999974322111 111221111110 1111110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCchhhHHHHHh
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGDGLAERWEEWQKE 413 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~~~~~~~ 413 (447)
. . .........+.+++.+||+.+|.+|||+.|+++ .+....-+..+.+.+.+
T Consensus 231 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~~~~ 284 (287)
T cd06621 231 E-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKFVA 284 (287)
T ss_pred C-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchhhHHHHHH
Confidence 0 0 000123466899999999999999999999998 44443333333333333
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=302.93 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=202.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-Cc----EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD-GS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.++|+..+.||+|+||.||+|...+ |. .+|+|.+...........+.+|+++++.++|+|++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4567888999999999999998642 32 5899988766544445678899999999999999999999887 7889
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++|||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999876432 389999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceee-ccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 276 MDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 276 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
.......... ...++..|+|||.+....++.++||||||+++||+++ |+.||+... ..++.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLEKGER- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhCCCC-
Confidence 6533222111 1223568999999988889999999999999999998 999995321 1112111111100
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+..+...+.+++.+||..+|.+|||+.++++.|+..
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 ---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011111234588999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=306.71 Aligned_cols=273 Identities=23% Similarity=0.334 Sum_probs=202.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999876 57899999987554444445677899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+. ++|..++..... .+++..++.++.|+++||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 588888865432 488999999999999999999999 99999999999999999999999999987543222
Q ss_pred CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh----------
Q 013238 281 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 349 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 349 (447)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.||..... ............
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCChhhchhh
Confidence 1 12223468899999988654 578899999999999999999999953211 111111111100
Q ss_pred --ccccccccccccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhh
Q 013238 350 --EKKLEQLVDSDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 407 (447)
Q Consensus 350 --~~~~~~~~d~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 407 (447)
.........+..... ........+.+++.+|++.||.+|||+.++++.-.-..++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~ 296 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI 296 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence 000000000000000 0112244578999999999999999999998754444444443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=308.03 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=211.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccc--hHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcce
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQG--GELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 195 (447)
..+.|++.+.||+|.||.||++..+. |+.+|+|.+.+..... ....+.+|+.+|+++. |||||.+.+++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34578888999999999999999874 9999999997765433 3357899999999999 999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC----CcEEEeecC
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFG 271 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg 271 (447)
+|||++.||.|.+.+... .+++.....++.|++.+++|||+. +|+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999776 289999999999999999999999 99999999999999543 579999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.... ...... .....
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~----~~~~~~----~i~~~- 253 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET----EFEIFL----AILRG- 253 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC----hhHHHH----HHHcC-
Confidence 9998765 455666789999999999999999999999999999999999999996421 111111 11110
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+................+++..|+..||..|+|+.++++.
T Consensus 254 ------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 ------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1123334455567778899999999999999999999994
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.70 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=198.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555677999999999999875 578899999875544444457889999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++++|.+++... ++++..+..++.++++||.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988542 388999999999999999999999 999999999999999999999999999876543221
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
......++..|+|||++.+..++.++||||||+++|||++|+.|+..... .. .... .. ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~~---~~~~-~~---------~~~ 217 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-----MR---VLFL-IP---------KNS 217 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-----hh---HHhh-hh---------cCC
Confidence 11223478899999999988899999999999999999999999853110 00 0000 00 000
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
...........+.+++.+||+.+|.+|||+.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111122334568899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=275.68 Aligned_cols=268 Identities=23% Similarity=0.391 Sum_probs=207.5
Q ss_pred CCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEEecccCC
Q 013238 127 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
+..||.|..|.||++.+. +|...|||.+.........++++..++++.+-. .|.||+.+|+|......++.||.| ..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 345999999999999976 589999999987777666777888888876654 899999999999999999999998 44
Q ss_pred cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCcee
Q 013238 205 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 284 (447)
Q Consensus 205 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 284 (447)
.+..++.... .++++..+-++...+++||.||.+++ +|+|||+||+|||+|+.|.+|++|||++..+-.+ ...
T Consensus 176 C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAh 248 (391)
T KOG0983|consen 176 CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAH 248 (391)
T ss_pred HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--ccc
Confidence 5666665543 35899999999999999999999887 9999999999999999999999999999876433 333
Q ss_pred eccccccCccccccccC---CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 285 TAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 285 ~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
+...|.+.|||||.+.- ..|+.++||||||+.|+||.||..||..-. .+ .+.+...+.++. +.+
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~----td---Fe~ltkvln~eP------P~L 315 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK----TD---FEVLTKVLNEEP------PLL 315 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC----cc---HHHHHHHHhcCC------CCC
Confidence 44568999999999864 368899999999999999999999996421 11 122222222111 122
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--H-hcCCCchhhHHHHHhhhhh
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM--L-EGDGLAERWEEWQKEEMFR 417 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L-~~~~~~~~~~~~~~~~~~~ 417 (447)
... ......+.+++..||+.|+.+||...++++. + .=...+.+..+|+...+-.
T Consensus 316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~~ 372 (391)
T KOG0983|consen 316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVMAK 372 (391)
T ss_pred Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHHhc
Confidence 211 1145668899999999999999999999873 2 2234456667777766543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.19 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=201.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|++|.||+|...+ ++.+++|.+..... ...+.+|+++++.++|+|++++++++......++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 578888999999999999999864 78999999865432 45788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.+++|.+++.... ..+++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999986543 3489999999999999999999999 99999999999999999999999999988654332
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.||...... ...... ... ..
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~~~~-~~~-------~~ 216 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIFMI-PNK-------PP 216 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhhhhh-ccC-------CC
Confidence 1 222334788999999999889999999999999999999999999632110 000000 000 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............+.+++.+||+.+|.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 001112223456899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=306.88 Aligned_cols=246 Identities=23% Similarity=0.304 Sum_probs=189.7
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHH-HHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
++||+|+||.||+|+.. +++.||+|.+..... ......+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 588999999865432 122234455554 57889999999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|...+.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99988886532 378888999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~---------~~-- 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHK---------PL-- 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcC---------CC--
Confidence 233458999999999998899999999999999999999999995321 11111111111 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHhc
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVVRMLEG 400 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~L~~ 400 (447)
..+......+.+++.+||+.+|.+||++. ++++.++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 11112345688999999999999999874 34444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=298.78 Aligned_cols=253 Identities=29% Similarity=0.441 Sum_probs=198.2
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccchHH-HHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 124 FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
|+..+.||+|+||+||+++... ++.+|+|.+.......... ...+|+.++..++|+||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4566889999999999999874 6789999997664433222 3456999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
.+++|.+++.... .+++..++.++.|+++||++||++ +++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998332 389999999999999999999999 99999999999999999999999999997542 222
Q ss_pred ceeeccccccCcccccccc-CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......++..|+|||++. +..++.++||||+|+++|+|++|..||... ................. ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-----~~~~~~~~~~~~~~~~~----~~~~ 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-----NSDDQLEIIEKILKRPL----PSSS 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-----SHHHHHHHHHHHHHTHH----HHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-----cchhhhhhhhhcccccc----cccc
Confidence 3344456899999999998 788999999999999999999999999642 00111111111111000 0000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.........+.+++.+||+.||++|||+.++++
T Consensus 224 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 ---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011267999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=308.24 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=191.4
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHH-HHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||+||+|... +|+.+|+|++..... ......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 689999999965422 122234455554 46779999999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... ++++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99998886532 488999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ............ .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~-------~~~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKP-------LVLRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCC-------ccCCC
Confidence 234468999999999999999999999999999999999999995311 111111111110 00111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.....+.+++.+|++.+|.+||++++.++.+...
T Consensus 218 ----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 218 ----GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred ----CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 1234578899999999999999997555544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=302.49 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=204.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec--CCcc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 194 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 194 (447)
++|...+.||+|+||.||++... ++..+|||.+...........+.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777789999999999999854 3678999999765443345578999999999999999999999877 5578
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
+++|||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCC-------cccHHHHHH
Q 013238 275 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-------DVMLLDWVK 345 (447)
Q Consensus 275 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~ 345 (447)
......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......... ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765222211 11123456799999998889999999999999999999999998532111000 000111111
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
. .. ..........+...+.+++.+||+.+|.+|||+.+|+++|+.+
T Consensus 238 ~-~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 L-LK---------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred H-HH---------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 11 1111111223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.62 Aligned_cols=266 Identities=21% Similarity=0.254 Sum_probs=194.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 192 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 192 (447)
..++|+..+.||+|+||.||++... +|+.||||.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999875 588999999965422 233446778999999999999999999886443
Q ss_pred -cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 193 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 193 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
..++||||+.+ +|...+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999965 56655532 278889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccC----------CCcccHH
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN----------DDDVMLL 341 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~----------~~~~~~~ 341 (447)
+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||....... .......
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99754321 12233458899999999999999999999999999999999999996321100 0000000
Q ss_pred HH----HHHHhhcc-cc-----ccccccc-cC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 342 DW----VKGLLKEK-KL-----EQLVDSD-ME--GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 342 ~~----~~~~~~~~-~~-----~~~~d~~-~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+. +....... .. .+..... .. ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00000000 00 0000000 00 00011123567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.58 Aligned_cols=263 Identities=19% Similarity=0.221 Sum_probs=194.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++......+++|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 346888899999999999999976 478899996432 135689999999999999999999998899999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
++ .++|..++.... .++++..++.|+.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KY-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 99 568888876532 2489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCc---ccHHHHHHHHhh-ccccc
Q 013238 280 DTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD---VMLLDWVKGLLK-EKKLE 354 (447)
Q Consensus 280 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~ 354 (447)
... ......||..|+|||++.+..++.++|||||||++|||++|..++-......... ..+...+..... .....
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 211 1223468999999999999999999999999999999999887652211100001 111111111000 00000
Q ss_pred cc----------------cccccCCCCc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 355 QL----------------VDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 355 ~~----------------~d~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.. ..+....... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0000000000 0122357889999999999999999999874
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=297.79 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECC--CcEEEEEEecccc---------ccchHHHHHHHHHHHHh-cCCCceeeEeeeeec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEER---------TQGGELQFQTEVEMISM-AVHRNLLRLRGFCMT 190 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 190 (447)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... .......+..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999764 6889999885321 11222346678887764 799999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988654333445899999999999999999999631 8999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ...........
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~~~~ 228 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVEA 228 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHHhhc
Confidence 9998654332 2334458889999999998889999999999999999999999985321 11111111111
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
..... ........+.+++.+||+.||++||++.|+..+++
T Consensus 229 -~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 -VYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -cCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000 01122356889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=294.16 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=189.8
Q ss_pred eeeecCCeEEEEEEECCC---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCc
Q 013238 129 ILGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
.||+|+||.||++...++ ..+++|.+...........+.+|+++++.++||||+++++.+......+++|||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 34667776554433445578899999999999999999999999899999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC-Ccee
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 284 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 284 (447)
|.+++..........++..++.++.||+.||+|||+. +++||||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986543334467788889999999999999999 99999999999999999999999999986432111 1112
Q ss_pred eccccccCccccccccC-------CCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 285 TAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 285 ~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
....++..|+|||++.. ..++.++||||||+++|||++ |..||... ...+........ ....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--------~~~~~~~~~~~~-~~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--------SDREVLNHVIKD-QQVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHhh-ccccc
Confidence 23457889999998753 235789999999999999997 56677421 111222222221 11222
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
.++.+... ....+.+++..|| .+|.+|||+++|++.|.
T Consensus 230 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222222 3355778888999 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=302.70 Aligned_cols=264 Identities=23% Similarity=0.295 Sum_probs=201.4
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee-
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM- 189 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~- 189 (447)
.++.+..+.++|+..+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34445567789999999999999999999875 57899999886432 2234577899999998 6999999999874
Q ss_pred ----cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 190 ----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 190 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
.....+++|||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 33567999999999999998865433344588999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCceeeccccccCccccccccC-----CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccH
Q 013238 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 340 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 340 (447)
+|+|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-------- 234 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------- 234 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--------
Confidence 9999999876543221 1223358899999998853 4578899999999999999999999853210
Q ss_pred HHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 341 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 341 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
.......... ......+ .......+.+++.+||+.+|++|||+.++++.+
T Consensus 235 ~~~~~~~~~~-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 235 MRALFKIPRN-PPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hHHHhhcccc-CCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000000000 0000000 111234688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.07 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=189.2
Q ss_pred eeeecCCeEEEEEEECC---CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCc
Q 013238 129 ILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
.||+|+||.||+|...+ ...+++|.+...........+.+|++.++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 357888887655444445568889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce-
Q 013238 206 VASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV- 283 (447)
Q Consensus 206 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 283 (447)
|.+++...... ....++...+.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765432 22356788899999999999999999 99999999999999999999999999986533221111
Q ss_pred eeccccccCccccccccC-------CCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 284 TTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.... . .+......... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~---~~~~~~~~~~~-~~~ 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-----D---EQVLKQVVREQ-DIK 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-----H---HHHHHHHhhcc-Ccc
Confidence 122335678999998743 356889999999999999999 778884211 0 11111111111 011
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
+..+. ........+.+++..|| .||.+|||+.+|++.|.
T Consensus 230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 12223455677888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=295.50 Aligned_cols=252 Identities=31% Similarity=0.480 Sum_probs=201.3
Q ss_pred CCCCCeeeecCCeEEEEEEECC-----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 124 FSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+++.+.||.|+||.||++...+ +..||+|.+...........+..|++++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566889999999999998763 38899999976654435567889999999999999999999999989999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999998764321 189999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
..........++..|+|||.+.+..++.++||||||+++++|++ |..||... ...+..........
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~----- 222 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------SNEEVLEYLKKGYR----- 222 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhcCCC-----
Confidence 32222212236789999999988889999999999999999998 78888531 11111111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
..........+.+++.+||+.+|.+|||+.++++.|
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011112456689999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=308.57 Aligned_cols=256 Identities=20% Similarity=0.283 Sum_probs=194.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|...+.||+|+||.||+++.. +++.||+|.+.... .......+..|..++..++|+||+.+++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999976 57889999986532 1222335778899999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999976432 388999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCceeeccccccCccccccccC-----CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
..........|++.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCCCc
Confidence 33323333568999999999875 467889999999999999999999995311 11111111111100
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 397 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 397 (447)
.. + ..........+.+++.+|+..++.. |++++++++.
T Consensus 227 ~~-----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 FQ-----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cc-----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0 0111123456778888888765443 4567666643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=301.10 Aligned_cols=260 Identities=24% Similarity=0.393 Sum_probs=204.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||+||++... +++.||+|.+...........+.+|+++++.++|+||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356777889999999999999875 5889999998765444445678899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|..++...+ ++++..+..++.+++.||.|||+.. +++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999886532 4899999999999999999999732 8999999999999999999999999998654221
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCC---CcccHHHHHHHHhhccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND---DDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 356 (447)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ......+++........
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 230 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP---- 230 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC----
Confidence 1 1234588999999999888899999999999999999999999964221110 01111222222211110
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
+.+ ........+.+++.+||+.||.+|||+.|+++..
T Consensus 231 --~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 --PRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 1112445688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=296.77 Aligned_cols=251 Identities=24% Similarity=0.422 Sum_probs=198.6
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-----cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
+|...+.||+|+||.||+|...+++.+|+|.+..... ......+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999988889999999864321 11224588899999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
+||+++++|.+++.... ++++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999996543 378999999999999999999999 99999999999999999999999999987543
Q ss_pred CCC-----CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 278 YKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 278 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
... ........++..|+|||++.+..++.++||||||+++|+|++|+.||..... ..... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~-~~~~~-- 223 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMF-YIGAH-- 223 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHHH-Hhhhc--
Confidence 211 1112234578899999999988899999999999999999999999953110 00000 00000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. ..+ .........+.+++.+||+.+|.+|||+.++++
T Consensus 224 -~~-~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 -RG-LMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -cC-CCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 001 111223456889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=308.23 Aligned_cols=243 Identities=24% Similarity=0.339 Sum_probs=191.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 198 (447)
+|+..+.||+|+||.||+|... +|+.||+|++..... ......+..|.+++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677789999999999999875 688999999975432 222345677888888776 567788999888888999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|..++.... .+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999886543 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.. .......||..|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~~------- 217 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--------EDELFQSIMEHN------- 217 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-------
Confidence 21 12233458999999999999899999999999999999999999995321 111111111110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 392 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 392 (447)
. ..+......+.+++.+||+.+|.+|++..
T Consensus 218 --~--~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 --V--SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred --C--CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0 11112335678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.50 Aligned_cols=251 Identities=27% Similarity=0.377 Sum_probs=197.0
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
|+..+.||+|+||.||++... +++.||+|.+....... ....+..|+.+++.++|+|++.+.+.+...+..+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999876 68899999986543222 233567899999999999999999999988999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998865432 3488999999999999999999999 99999999999999999999999999987543221
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... .. ............. .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~----~~-~~~~~~~~~~~~~--~------ 221 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK----KK-IKREEVERLVKEV--Q------ 221 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC----cc-chHHHHHhhhhhh--h------
Confidence 1223458999999999999999999999999999999999999996311 00 0001111111100 0
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
..........+.+++.+||+.||.+||| +.++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 --EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0111123455889999999999999999 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=300.16 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=195.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHH-HHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|+..+.||+|+||.||++... +|+.||+|+++..........+..|+.. ++..+|+|++++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999976 5899999999765433334455666664 566789999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|++ |+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 995 6888888664434456899999999999999999999854 7999999999999999999999999998765321
Q ss_pred CCceeeccccccCccccccccC----CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.... . .. +.+.......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~--~~-~~~~~~~~~~---- 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK----T--PF-QQLKQVVEEP---- 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc----c--CH-HHHHHHHhcC----
Confidence 1 1222347889999998865 446889999999999999999999995211 0 00 1111111100
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... ........+.+++.+||+.+|.+|||+.++++
T Consensus 225 --~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 --SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 01123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=299.89 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=199.9
Q ss_pred cCHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee
Q 013238 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 189 (447)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 189 (447)
.++.++..+.+.|+..+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +|+|++++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 345555567788999999999999999999975 58899999885432 2234577888888888 6999999999885
Q ss_pred c------CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 013238 190 T------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 263 (447)
Q Consensus 190 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~ 263 (447)
. ....+++|||+.+|+|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 3 3467899999999999999876432 2478888999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCCceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcc
Q 013238 264 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338 (447)
Q Consensus 264 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 338 (447)
.++|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||......
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----- 232 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----- 232 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-----
Confidence 999999999875432221 122345788999999875 345788999999999999999999999532100
Q ss_pred cHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 339 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.-.... ................+.+++.+||+.||.+|||+.++++
T Consensus 233 ---~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 ---RALFLI---------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---hhhhhH---------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000 0000001111223456899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=295.90 Aligned_cols=240 Identities=23% Similarity=0.359 Sum_probs=186.1
Q ss_pred CeeeecCCeEEEEEEECC-------------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 128 NILGRGGFGKVYKGRLTD-------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
+.||+|+||.||+|.... ...|++|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 358999999999997532 2358889876533 23344678889999999999999999999998999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-------EEE
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-------AVV 267 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~-------~kl 267 (447)
+++|||+++|+|..++.... .++++..++.++.||++||+|||++ +++||||||+|||++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999998886533 2489999999999999999999999 9999999999999987664 899
Q ss_pred eecCCccccCCCCCceeeccccccCcccccccc-CCCCCchhhhHHHHHHHHHHH-hCCCCcccccccCCCcccHHHHHH
Q 013238 268 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELI-TGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 268 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
+|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||..... .+. .
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~-~ 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEK-E 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHH-H
Confidence 999998754322 1234778899999886 466899999999999999998 58888743110 000 0
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
...... .. ........+.+++.+||+.||.+||++.++++.|+
T Consensus 220 ~~~~~~---------~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEGQ---------CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhcC---------cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111100 00 01112356889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=282.84 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=200.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccch-------HHHHHHHHHHHHhc-CCCceeeEeeeeecCC
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMA-VHRNLLRLRGFCMTPT 192 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 192 (447)
+.|...+.||+|..++|.++..+ +|...|+|++........ ...-..|+.+|+++ .||+|+.+.+++..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 46778889999999999998765 688899999864332211 12345688899887 4999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++|+|.|+.|.|.++|...- .+++.....|+.|+.+|+.|||.+ +||||||||+|||+|++.++||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999997643 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccC------CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
++.+.. +......+||++|+|||.+.- ..|+...|+||+|+|+|.|+.|.+||..-.. .+ .++.
T Consensus 170 a~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------ml--MLR~ 239 (411)
T KOG0599|consen 170 ACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------ML--MLRM 239 (411)
T ss_pred eeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HH--HHHH
Confidence 998754 444567789999999998842 3578899999999999999999999942110 00 0011
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... .-........+......+++.+||+.||.+|.|++|+++
T Consensus 240 ImeG-------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEG-------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhc-------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1110 011223334556677889999999999999999999886
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=315.88 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=211.0
Q ss_pred CCCCeeeecCCeEEEEEEEC-C----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 125 SNRNILGRGGFGKVYKGRLT-D----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 125 ~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
...++||+|+||+||+|.+- . ..+||||++......+...+++.|.-.|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 44578999999999999853 3 34799999988777777788999999999999999999999998766 789999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
||+.|+|.++++..+. ++.....+.|..|||+||.|||.+ ++|||||..+||||.+-..+||+|||+++.+...
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999988654 488899999999999999999999 9999999999999999999999999999988765
Q ss_pred CCceeec-cccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 280 DTHVTTA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 280 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
....... ..-.+.|||-|.+....|+.++|||||||++||++| |..|++... ...+.+++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~------------------~~eI~dll 913 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP------------------AEEIPDLL 913 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC------------------HHHhhHHH
Confidence 5443222 223568999999999999999999999999999998 999986421 11222333
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
....+-..++.+..++..+|.+||..|+..||+++++...+.+
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 3333344566777889999999999999999999999987765
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.11 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=194.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..++||+|+||.||+++.. +++.+|+|.+.+... ......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999976 478899999864321 222334778899999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999976432 388999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||... ...+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~--------~~~~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC--------CHHHHHHHHhCCCcc
Confidence 3322233346899999999986 346788999999999999999999999532 112222222111100
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQG--SPMERPKMSEVVRM 397 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~ 397 (447)
.. . ..........+.+++.+|+.. ++..|+++.++++.
T Consensus 227 ~~-----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQ-----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc-----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0 011112344567777777754 44446888888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=294.24 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=203.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||.|+||.||.++.. +++.+++|.+.... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999999999865 58899999986543 233445688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++.... ...+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997653 23489999999999999999999999 99999999999999999999999999998654333
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
. ......++..|+|||.+.+..++.++||||||+++|||++|..||.... ..+......... ..
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~-~~------ 219 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQGN-YT------ 219 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCC-CC------
Confidence 2 2233458899999999988889999999999999999999999995311 112222211110 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
.........+.+++.+||+.+|.+|||+.++++.+
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123345688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=296.31 Aligned_cols=258 Identities=23% Similarity=0.340 Sum_probs=197.9
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
++.+++++.....||+|+||.||+|... ++..|++|.+..... .....+.+|+++++.++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3445666666778999999999999865 577899998865432 23446889999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeecCCcc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAK 274 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~ 274 (447)
+++||+++++|.+++...... ...++..+..++.|++.||+|||+. +++||||||+||+++. ++.++|+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999999764221 1127888899999999999999999 9999999999999976 6799999999987
Q ss_pred ccCCCCCceeeccccccCccccccccCCC--CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
....... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||..... .....+......
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--- 228 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-----PQAAMFKVGMFK--- 228 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-----hhhhHhhhhhhc---
Confidence 6532221 122234788999999986644 78899999999999999999999853110 000000000000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.....+......+.+++.+||+.+|.+|||+.+++.
T Consensus 229 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 --------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011112234456889999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=316.03 Aligned_cols=200 Identities=23% Similarity=0.359 Sum_probs=172.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|+||.||++... +++.||+|++..... ......+..|++++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999876 588999999964321 223346778999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999987543 388999999999999999999999 999999999999999999999999999875421
Q ss_pred CCC----------------------------------ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCC
Q 013238 279 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324 (447)
Q Consensus 279 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~ 324 (447)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0011346899999999999999999999999999999999999
Q ss_pred CCcc
Q 013238 325 RAFD 328 (447)
Q Consensus 325 ~p~~ 328 (447)
.||.
T Consensus 234 ~Pf~ 237 (360)
T cd05627 234 PPFC 237 (360)
T ss_pred CCCC
Confidence 9995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=298.91 Aligned_cols=261 Identities=25% Similarity=0.322 Sum_probs=190.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-hHHHHHHHHHHHHhc---CCCceeeEeeeeecC-----C
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMTP-----T 192 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~ 192 (447)
+|+..+.||+|+||+||+|... +++.||+|.++...... ....+.+|+++++.+ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999876 68899999987543222 223455677666554 799999999987642 3
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 4689999996 488888865432 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
+....... ......++..|+|||++.+..++.++|||||||++|||++|+.||.... ....+.... .......
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~----~~~~~~~~~-~~~~~~~ 227 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS----EADQLGKIF-DLIGLPP 227 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC----HHHHHHHHH-HHhCCCC
Confidence 97654221 1223457889999999998899999999999999999999999985311 111111111 1100000
Q ss_pred ccc----------ccccccC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQ----------LVDSDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~----------~~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
... ....... ..........+.+++.+||+.||.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000000 0011123456789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=308.51 Aligned_cols=266 Identities=20% Similarity=0.223 Sum_probs=194.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC------
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 191 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 191 (447)
..++|+..+.||+|+||.||++... .++.||||.+..... ......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 588999999975432 22344677899999999999999999987643
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
...+++|||+.+ +|...+.. .+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 246899999965 66666542 278899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCC----------Cccc--
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND----------DDVM-- 339 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~----------~~~~-- 339 (447)
+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99864322 122334589999999999998999999999999999999999999953211000 0000
Q ss_pred --HHHHHHHHhhc-cccccccccc------c--CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 340 --LLDWVKGLLKE-KKLEQLVDSD------M--EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 340 --~~~~~~~~~~~-~~~~~~~d~~------~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+...+...... .....+..+. . ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000 0000000000 0 000111224567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=299.01 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=195.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||+|++|.||+|... +++.||+|.+...... .....+.+|+.++..++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999975 6889999998654322 2334678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+. ++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 688888765432 23589999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh----------
Q 013238 281 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 349 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 349 (447)
.......++..|+|||++.+. .++.++||||||+++|+|+||+.||..... .............
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE----IDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHhCCCChhhhhcch
Confidence 122233468899999988654 578999999999999999999999953210 0000000000000
Q ss_pred -ccccccccccccC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 -EKKLEQLVDSDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 -~~~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............. ..........+.+++.+||+.||.+|||+.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 0001113456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=302.99 Aligned_cols=199 Identities=22% Similarity=0.298 Sum_probs=164.2
Q ss_pred CCCeeeec--CCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 126 NRNILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 126 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
+.++||+| +|++||++... +|+.||+|++...... .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 68999999875 6899999999765332 23345778999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++|+|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865432 2488999999999999999999999 999999999999999999999999986543221111
Q ss_pred c------eeeccccccCccccccccC--CCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 282 H------VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 282 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112236678999999976 4588999999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=294.91 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=201.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec--CCcceEEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVY 198 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 198 (447)
+|+..+.||.|+||.||++... +++.+|+|.+..... ......+..|+++++.++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999865 678999999865432 2334568889999999999999999998764 34578999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-----~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
||+++++|.+++........++++..++.++.+++.||.||| +. +++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999775444456999999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ......... ..
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~-- 225 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASKIK-EG-- 225 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHHHh-cC--
Confidence 876543321 223458899999999998889999999999999999999999996321 111111111 11
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
............+.+++.+||+.+|.+|||+.+|++.
T Consensus 226 -------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 -------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111222345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=299.72 Aligned_cols=248 Identities=19% Similarity=0.315 Sum_probs=199.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
.+|+..+.||+|++|.||++... +++.||+|.+...... ....+.+|+.+++.++|+||+++++++......++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 57888999999999999999864 6899999998654322 334678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++... .+++..+..++.+++.||.|||+. +++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998643 378899999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc-cc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV-DS 359 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~ 359 (447)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... . ...... ..
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~---~--------------~~~~~~~~~ 231 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---R--------------ALYLIATNG 231 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc---h--------------heeeeccCC
Confidence 21 22235788999999999988999999999999999999999999532110 0 000000 00
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.............+.+++.+||+.+|.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000112223455788999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=305.42 Aligned_cols=193 Identities=25% Similarity=0.393 Sum_probs=164.3
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
....+|+..+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 44567999999999999999999976 4778999975432 234689999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
||++ .++|.+++.... .++++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9999 568888886533 3489999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~ 327 (447)
.. .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 209 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 1122345899999999999999999999999999999999865554
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=285.04 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=203.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.+.|++.+.||+|.|+.|+++... +|+.+|+|++....- ...-..+.+|+.+.+.++||||+++.+...+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 356777788999999999998754 689999998864322 224557889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeecCCccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKL 275 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~ 275 (447)
|+|.|++|..-+-.+. -.++..+-.++.||+++|.|+|.+ +|||||+||.|+++-. .--+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999977665542 267888889999999999999999 9999999999999954 33599999999998
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
+. +........||+.|||||++...+|+..+|||+.|+|||-|+.|..||.... .-.+. +....
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-----~~rly---e~I~~------ 226 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLY---EQIKA------ 226 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-----HHHHH---HHHhc------
Confidence 76 5566677789999999999999999999999999999999999999995311 00111 11110
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
-+..+.+...+...+...+++.+||..||.+|.|+.|.++
T Consensus 227 -g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 227 -GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0112223344555667888999999999999999988775
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=307.91 Aligned_cols=198 Identities=23% Similarity=0.287 Sum_probs=166.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC------
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 191 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 191 (447)
..++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999875 588999999975432 23344677899999999999999999987543
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
...++||||+.+ +|...+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 346899999965 67666642 278889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
+++..... .......+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 99865322 122334589999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=294.49 Aligned_cols=247 Identities=30% Similarity=0.457 Sum_probs=197.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
++|+..+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.+++.++|+|++++++++.. +..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECC
Confidence 4688889999999999999975 57889999986532 23468899999999999999999998865 4579999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
.+++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999976432 3488999999999999999999999 99999999999999999999999999987543211
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+........
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~---------- 213 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVKECVEKG---------- 213 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHHHHHhCC----------
Confidence 11224567999999988899999999999999999998 999985321 11111111111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.........+..+.+++.+||+.+|.+||++.+++..|+.
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111112234668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=292.16 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=201.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|++|.||+|... +++.+++|.+...... ....+.+|+++++.++|+||+++++++......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 357888899999999999999875 5788999999754332 44578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+++|.+++.... .++++..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999999887642 2488999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeeccccccCccccccccCC---CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .-...... ...
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--------~~~~~~~~----~~~ 221 (262)
T cd06613 155 IA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--------RALFLISK----SNF 221 (262)
T ss_pred hh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh----ccC
Confidence 21 12234578899999999776 7899999999999999999999999532100 00000000 000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... ..........+.+++.+||+.+|.+|||+.+++.
T Consensus 222 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 PPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 1122334567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=294.35 Aligned_cols=249 Identities=23% Similarity=0.408 Sum_probs=197.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc--------hHHHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
+|...+.||+|++|.||+|... +++.+|+|.+....... ....+.+|+++++.++|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677789999999999999875 57899999886443211 12357889999999999999999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.+++|||+++++|.+++.... .+++..+..++.+++.||+|||+. +++||||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997643 378899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC-----ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh
Q 013238 274 KLMDYKDT-----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 274 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
+....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..-+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------LQAIFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--------HHHHHHHh
Confidence 86642111 111123478899999999988899999999999999999999999963210 00011100
Q ss_pred hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 349 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ... ...+......+.+++.+||+.+|.+||++.++++
T Consensus 226 ~------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E------NAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c------cCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 011 1112234466889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=296.96 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=193.5
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
|+..+.||+|+||+||++... +++.+|+|.+...... .....+.+|+++++.++|+|++.+.+.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 6889999998654322 2233567899999999999999999999988999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.+++|..++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988865432 3489999999999999999999999 99999999999999999999999999987643221
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.... ................
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~----~~~~~~~~~~~~~~~~--------- 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK----EKVKREEVDRRVLETE--------- 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhhhccc---------
Confidence 1223458999999999998899999999999999999999999995311 0000111111111000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 392 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 392 (447)
..........+.+++..||+.||.+|||+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 011122344578899999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.03 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=198.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC--Ccc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 194 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 194 (447)
...++|++.+.||+|+||+||++... ++..+|+|.+..... ......+..|+.++..++||||+++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999976 577899999865432 22345688999999999999999999988643 457
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCceecCCCCCCEEECC---------
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD----PKIIHRDVKAANILLDE--------- 261 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~ivH~dlk~~Nill~~--------- 261 (447)
++||||+.+|+|.++|.........+++..++.|+.||+.||.|||+... .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999997654334469999999999999999999998521 25999999999999964
Q ss_pred --------CCcEEEeecCCccccCCCCCceeeccccccCccccccccC--CCCCchhhhHHHHHHHHHHHhCCCCccccc
Q 013238 262 --------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLAR 331 (447)
Q Consensus 262 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~p~~~~~ 331 (447)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2348999999998653222 2233468999999999854 458899999999999999999999995311
Q ss_pred ccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 332 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....++..+.... .+. .......+.++|..||+.+|.+|||+.+++.
T Consensus 248 -------~~~qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 -------NFSQLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred -------cHHHHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1122222211111 000 0112356889999999999999999999984
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=300.58 Aligned_cols=249 Identities=18% Similarity=0.309 Sum_probs=199.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
.+|+..+.||.|++|.||+|... +++.|++|.+..... .....+.+|+++++.++|+|++++++++......++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 46888899999999999999864 689999999865432 2345678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.+++|..++... .+++..+..++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988643 388999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ........... ...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~~~~~~~~-~~~----- 234 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNG-TPE----- 234 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcC-Ccc-----
Confidence 21 2234578899999999988899999999999999999999999953211 01111111000 000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..........+.+++.+||..+|.+|||+.+++.
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0111223456888999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=311.20 Aligned_cols=262 Identities=22% Similarity=0.265 Sum_probs=196.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
...+|++.+.||+|+||.||++... .+..||+|.+.... ...+|+++++.++|+||+++++++......++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3467999999999999999999753 35789999886432 34689999999999999999999998889999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
+||++. ++|..++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 6888888432 3489999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 277 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 277 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+...++.+ ......-
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~-~~~~~~~ 313 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCM-QVHPLEF 313 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHh-ccCcccc
Confidence 433221 2223468999999999999999999999999999999999999995422111 011111111110 0000000
Q ss_pred c-------------cccccCCCCc-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 356 L-------------VDSDMEGNYI-------EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 356 ~-------------~d~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. .......... ......+.+++.+||..||++|||+.+++..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000000 0123457789999999999999999999875
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=292.86 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=199.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec-CCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 199 (447)
.|+..+.||+|++|.||++... +++.+|+|.+..... ......+.+|++++++++|+|++++.+.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999876 578899999865432 2334467889999999999999999988764 345789999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++.... ..++++..++.++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987642 23489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
. .......++..|+|||++.+..++.++||||||+++++|++|+.||.... ........... ..
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~~-~~------ 219 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIEG-KL------ 219 (257)
T ss_pred C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc-CC------
Confidence 2 22233457889999999999999999999999999999999999985311 11111111111 10
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
..........+.+++.+||+.+|.+|||+.++++.
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122344678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=293.00 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=192.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCceeeEeeeeecC--Ccc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 194 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 194 (447)
.+|+..+.||+|+||.||+|... ++..|++|.+..... ......+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999875 588999999864321 12234578899999999999999999988653 567
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999987543 378899999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCC--CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 275 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 275 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||.... ....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--------~~~~~~~~~~--- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--------AMAAIFKIAT--- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--------hHHHHHHHhc---
Confidence 653211 111122347889999999998889999999999999999999999995311 0111111100
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.......+......+.+++ .||..+|.+|||+++|++
T Consensus 224 ------~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 ------QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0011111222334455555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=298.83 Aligned_cols=255 Identities=21% Similarity=0.342 Sum_probs=200.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|+||.||++... ++..||+|.+...........+.+|++++++++|+||+++++.+...+..+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999976 68999999987544333445788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|..++.... ....+++..+..++.+++.||.|||+.+ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999998887532 1235899999999999999999999632 89999999999999999999999999987543221
Q ss_pred CceeeccccccCccccccccCCC------CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||.... ............
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~------ 223 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-----YANIFAQLSAIV------ 223 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-----hhhHHHHHHHHh------
Confidence 12234788999999986543 4789999999999999999999995311 111111111111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+. ............+.+++.+||+.+|.+||++.+++..
T Consensus 224 ---~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 ---DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 10 0111223355678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=299.53 Aligned_cols=196 Identities=23% Similarity=0.373 Sum_probs=159.0
Q ss_pred CCeeeecCCeEEEEEEEC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec--CCcceEEEecc
Q 013238 127 RNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPFM 201 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 201 (447)
.++||+|+||+||+|... +++.+|+|.+..... ...+.+|+++++.++||||+++++++.. ....+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 357999999999999864 467899999865322 2356789999999999999999998864 34578999998
Q ss_pred cCCcchhhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEEEeecCC
Q 013238 202 VNGSVASCLRERGQ-----SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGL 272 (447)
Q Consensus 202 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl 272 (447)
. ++|..++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 588777654321 123488999999999999999999999 99999999999999 4667899999999
Q ss_pred ccccCCCCC--ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 273 AKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 273 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 986543221 122334689999999998774 589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=294.55 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=203.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
+|+..+.||+|++|.||++... +++.+|+|.+...........+.+|+++++.++|+||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677788999999999999986 588999999976654455567889999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
.+++|.+++.... .++++..+..++.+++.||+|||+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999997653 358899999999999999999999 8 99999999999999999999999999987543221
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.+........ +.
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~------~~ 223 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---PPDGIFELLQYIVNEPP------PR 223 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---ccccHHHHHHHHhcCCC------CC
Confidence 11 14578899999999999999999999999999999999999953211 11112222222211110 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+ ........+.+++.+||..+|.+|||+.+++..
T Consensus 224 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 L---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 011145568899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=296.72 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=197.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.+.|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++|+|++++++.+......++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 357888999999999999999976 48899999986542 2334568889999999999999999999998899999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|..++.+... .+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999888765432 389999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.. ......++..|+|||++. ...++.++|||||||++|||++|..||.... .............
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~-- 232 (292)
T cd06644 164 LQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEP-- 232 (292)
T ss_pred cc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--------HHHHHHHHhcCCC--
Confidence 11 122334788999999985 3446889999999999999999999985311 0111111111100
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+.. .........+.+++.+||+.+|++||++.++++
T Consensus 233 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 ----PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 111223346889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=292.52 Aligned_cols=238 Identities=24% Similarity=0.382 Sum_probs=187.9
Q ss_pred CeeeecCCeEEEEEEECCCc-----------EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 128 NILGRGGFGKVYKGRLTDGS-----------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976422 5788877544322 4578899999999999999999999988 77899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-------cEEEee
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-------EAVVGD 269 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~D 269 (447)
||||+.+|+|.+++..... .+++..+..++.||+.||+|||++ +++||||||+||+++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999999976542 488999999999999999999999 999999999999999888 799999
Q ss_pred cCCccccCCCCCceeeccccccCccccccccCC--CCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHH
Q 013238 270 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 270 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||..... ..+...
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--------~~~~~~ 218 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--------SEKERF 218 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--------hhHHHH
Confidence 999986533 1223467789999999876 78999999999999999999 5777743210 011111
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
..... .... .....+.+++.+||..+|.+|||+.++++.|+
T Consensus 219 ~~~~~--------~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQH--------RLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCC--------CCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 10000 0000 01167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=293.28 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=201.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||+|+||.+|++... +|+.||+|.+..... ......+.+|+++++.++|+||+++.+++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 688999999865422 22344688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.+++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999998875432 2478999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
. ......|+..|+|||++.+...+.++|+||||+++++|++|+.||.... ..+.+.......
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~--------- 217 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGS--------- 217 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCC---------
Confidence 1 1122347888999999998889999999999999999999999985311 112222211111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...........+.+++.+||+.+|.+||++.+|++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01112233556899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=318.56 Aligned_cols=202 Identities=23% Similarity=0.338 Sum_probs=162.7
Q ss_pred HHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC------CCceeeEeee
Q 013238 115 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNLLRLRGF 187 (447)
Q Consensus 115 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~ 187 (447)
+++....++|++.++||+|+||+||+|... +++.||||+++.... ....+..|++++..++ |.+++.++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 334556788999999999999999999875 578899999964321 1223455666666654 4458888888
Q ss_pred eecC-CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---
Q 013238 188 CMTP-TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF--- 263 (447)
Q Consensus 188 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~--- 263 (447)
+... ...++||+++ +++|.+++...+ .+++..++.|+.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccc
Confidence 8764 4678999988 778888886543 4899999999999999999999732 899999999999998765
Q ss_pred -------------cEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 264 -------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 264 -------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999876422 122345689999999999999999999999999999999999999964
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=298.97 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=201.0
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
.+.++..+.++|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++..
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 33444556788999999999999999999875 68899999986432 2234577888888888 79999999999875
Q ss_pred C-----CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 191 P-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 191 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
. ...++||||+++++|.++++........+++..++.++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 357899999999999998875433344589999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCceeeccccccCccccccccCC-----CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccH
Q 013238 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 340 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 340 (447)
||+|||++......... .....++..|+|||++... .++.++|||||||++|||++|+.||.... .
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~--------~ 238 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH--------P 238 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc--------H
Confidence 99999998765432211 1223578899999987543 36889999999999999999999985311 0
Q ss_pred HHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 341 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 341 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
..-+...... ....+ .........+.+++.+||+.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~-~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 239 VKTLFKIPRN-PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHHhcC-CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0111111100 00001 0112234568999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=291.69 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=203.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||.|++|+||+|... ++..+++|++...........+.+|++.++.++|+|++++++.+...+..+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999865 57899999997654444556789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 12489999999999999999999999 99999999999999999999999999987654332
Q ss_pred Cc---eeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 281 TH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 281 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.. ......|+..|+|||++... .++.++|+||||+++|+|++|+.||..... ..... .....
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~----~~~~~------ 222 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP----MKVLM----LTLQN------ 222 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh----hhhHH----HHhcC------
Confidence 22 12233578899999998777 789999999999999999999999953211 00011 11110
Q ss_pred cccccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........ ........+.+++.+||+.||.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00111111 11234566889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=294.35 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=199.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
-|...+.||+|+||.||+|... ++..+|+|.+...........+.+|++.+..++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667788999999999999865 688999999865443344456888999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
.+++|..++... .+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999988642 388999999999999999999999 999999999999999999999999999876543221
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
......++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......... ..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~-~~--------- 217 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--------PMKVLFLIPK-NN--------- 217 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--------hHHHHHHHhc-CC---------
Confidence 1222357889999999988888999999999999999999999985311 1111111110 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
...........+.+++.+||+.+|.+||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011112234568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=301.95 Aligned_cols=257 Identities=24% Similarity=0.283 Sum_probs=199.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|++|.||++... +++.+|+|.+....... ....+..|+++++.++|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999876 48999999997643322 3446888999999999999999999999989999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987542 23589999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc----------------------------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccc
Q 013238 279 KDTH----------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 330 (447)
Q Consensus 279 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~ 330 (447)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 011234788999999999888999999999999999999999999532
Q ss_pred cccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 331 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.. . ..... +.+..............+.+++.+||+.+|.+|||....++.+..
T Consensus 236 ~~----~----~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NR----D----ETFSN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ch----H----HHHHH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 0 00011 111111111111145679999999999999999994444443333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=294.89 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=199.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCC-----
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT----- 192 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 192 (447)
++++|+..+.||+|++|.||+|... +++.+++|.+..... ....+.+|+++++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999985 578999999865432 234688999999998 6999999999987644
Q ss_pred -cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 193 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 193 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
..+++|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 37999999999999999876543334589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccC-----CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
++........ ......++..|+|||++.. ..++.++||||||+++|+|++|+.||.... .. .....
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~----~~~~~ 229 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH----PM----RALFK 229 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc----hH----HHHHH
Confidence 9876533222 1223447889999998754 346788999999999999999999995211 00 00111
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... .. . ...........+.+++.+||..||++|||+.++++
T Consensus 230 ~~~~-~~-----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRN-PP-----P--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhcc-CC-----C--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1110 00 0 01112224567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=295.51 Aligned_cols=239 Identities=25% Similarity=0.367 Sum_probs=184.0
Q ss_pred eeeecCCeEEEEEEECC-------------------------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceee
Q 013238 129 ILGRGGFGKVYKGRLTD-------------------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 183 (447)
.||+|+||.||+|.... ...|++|.+..... .....+.+|+.+++.++|+||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999997421 23588998865432 23346778899999999999999
Q ss_pred EeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 013238 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 263 (447)
Q Consensus 184 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~ 263 (447)
+++++......++||||+++|+|..++..... .+++..+..++.|++.||+|||++ +++||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 99999999999999999999999998865322 478999999999999999999999 999999999999997644
Q ss_pred -------cEEEeecCCccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHH-hCCCCcccccccC
Q 013238 264 -------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELI-TGQRAFDLARLAN 334 (447)
Q Consensus 264 -------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell-tg~~p~~~~~~~~ 334 (447)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-- 227 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence 3899999988643221 11246788999998865 56799999999999999985 69999853110
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
.....+ .... ..... .....+.+++.+||+.+|.+|||+.++++.|.
T Consensus 228 ---~~~~~~----~~~~-------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 ---SEKERF----YEKK-------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHH----HHhc-------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 011111 1100 00111 11235889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=295.43 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=196.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346777788999999999999865 588999999865432 223457789999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++...+ .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 87 FCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred ccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 999999999986543 489999999999999999999999 9999999999999999999999999998765422
Q ss_pred CCceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.. ......|+..|+|||++. ...++.++|||||||++|+|++|..||..... ... +....... .
T Consensus 160 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~----~~~----~~~~~~~~----~ 226 (267)
T cd06645 160 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP----MRA----LFLMTKSN----F 226 (267)
T ss_pred cc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc----hhh----HHhhhccC----C
Confidence 21 122345889999999874 45678899999999999999999999842110 000 00000000 0
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+.... .......+.+++.+||+.+|++|||+.++++
T Consensus 227 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000000 0112345889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=303.73 Aligned_cols=260 Identities=22% Similarity=0.273 Sum_probs=192.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecC-----
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP----- 191 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 191 (447)
...++|...+.||+|+||.||+|... +++.||||.+...... .....+.+|+++++.++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999865 6789999998654322 2234577899999999999999999887532
Q ss_pred -CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 192 -TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 192 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
...+++++++ +++|..++... .+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 78888877532 389999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
|+++..... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...+..+. ....
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~-~~~~ 233 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY----IDQLKRIM-EVVG 233 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHH-HHhC
Confidence 999865432 223458999999999876 5689999999999999999999999953210 00000000 0000
Q ss_pred ccc-----------ccccccc--ccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 EKK-----------LEQLVDS--DMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 ~~~-----------~~~~~d~--~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
... ....... ..... ........+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000000 00000 00011234779999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=290.76 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=198.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
+|+..+.||+|++|.||+|... +++.|++|.+..... ......+.+|+++++.++|+|++++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999976 789999999864321 22345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
+||+++++|.+++.... ++++..++.++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999987542 488999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCceeeccccccCccccccccCCC-CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ..............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~--- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKEL--- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccC---
Confidence 322 223345788999999987766 8999999999999999999999995321 11111111110000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..........+.+++.+||+.+|.+|||+.++++
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1111223456888999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=295.21 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=194.7
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEeccc
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 202 (447)
|+..+.||+|+||.||++... ++..+++|.+.... ......+.+|+++++.++|+|++++++++......+++|||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 566788999999999999976 47788999885432 2334468889999999999999999999999999999999999
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 282 (447)
+++|..++.... .++++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 999988876532 2489999999999999999999999 99999999999999999999999999987543221 1
Q ss_pred eeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 283 VTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 283 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
......++..|+|||++. +..++.++|||||||++|||++|+.||.... ....+......... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~~-~~- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPP-TL- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhcCCC-CC-
Confidence 122345888999999884 3456789999999999999999999985311 11111111111000 00
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.........+.+++.+||+.+|.+|||+.++++.
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111234568899999999999999999988753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=296.39 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=199.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|++.+.||.|++|.||++... ++..+|+|.+.... ......+..|++++++++|+||+++++++......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 456888889999999999999875 58899999986542 2234468889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++.... .++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999987643 2489999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
... .....++..|+|||.+. ...++.++||||||+++|||++|+.||.... .............
T Consensus 157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~-- 225 (280)
T cd06611 157 LQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--------PMRVLLKILKSEP-- 225 (280)
T ss_pred ccc-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--------HHHHHHHHhcCCC--
Confidence 221 22334788999999875 3456789999999999999999999995321 1111111111000
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+.+ .........+.+++..||+.+|.+||++.++++.
T Consensus 226 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 1112234568899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.47 Aligned_cols=263 Identities=23% Similarity=0.294 Sum_probs=197.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|+..+.||+|++|.||+|... +|+.||+|++..... ......+.+|+++++.++|+|++++++++......+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 589999999865432 2233457889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|..++.... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887765432 389999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHH----------h
Q 013238 280 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL----------L 348 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~ 348 (447)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ........... .
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD----VDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChHHhhhc
Confidence 21 1222347788999999876 4578999999999999999999999953211 00011110000 0
Q ss_pred hccc-cccccccccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 349 KEKK-LEQLVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 349 ~~~~-~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... ......+...... .......+.+++.+||+.+|++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 0000000000000 1122466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.57 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=195.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|++|.||+|... +++.||||.+...........+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999976 68899999987544333334567899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+. ++|.+++..... .+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 489888865432 488999999999999999999999 99999999999999999999999999987543221
Q ss_pred CceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc---ccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK---KLEQL 356 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 356 (447)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||..... ............... .....
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD----VEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHhcCCCChhhhhhh
Confidence 1 1122236788999999875 4578999999999999999999999953210 000110000000000 00000
Q ss_pred ------ccccc---CCC----C--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 ------VDSDM---EGN----Y--IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ------~d~~~---~~~----~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..... ... . .......+.+++.+||+.+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000 0 0001256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=290.67 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=194.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCceeeEeeeeecC--Ccc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 194 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 194 (447)
.+|+..+.||+|+||.||++... ++..||||.+..... ......+.+|+.+++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 588999998854321 12234678899999999999999999987664 456
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
+++|||+++++|.+++.... .+++...+.++.+++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 79999999999999987543 378888999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCC--ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 275 LMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 275 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
....... .......++..|+|||++.+..++.++||||||+++|||++|+.||.... ..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~-~~~~---- 222 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAI-FKIA---- 222 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHH-HHHh----
Confidence 5432111 11223457889999999988889999999999999999999999995310 00110 1110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
........+......+.+++.+||. +|.+||+++++++.
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 -----TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0011112233445567788888985 99999999998863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=293.29 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=200.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|++.+.||+|++|.||+|... +|+.||+|++..... ......+.+|+.+++.++|+|++++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999975 689999999875543 23345788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+ +++|.+++.... .++++..++.++.||++||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987543 3489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc-------
Q 013238 281 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK------- 352 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 352 (447)
........++..|+|||.+.+. .++.++||||||+++|||++|..+|... .................
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE-----NDIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC-----CHHHHHHHHHHHcCCCChHHHhhc
Confidence 2223334588899999998654 4689999999999999999998777431 11111111111111000
Q ss_pred -----cccccccccCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 353 -----LEQLVDSDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 353 -----~~~~~d~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
...+....... ....+....+.+++.+||+.+|.+|||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0011234778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=307.89 Aligned_cols=245 Identities=30% Similarity=0.423 Sum_probs=197.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.|..++.||.|+||.||.|.+. +.+.||||++.-...... -.++..|+..|..++|||.|.+.|+|......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4777788999999999999865 688999999964433222 2368899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|| -|+-.+++.-.. .|+.+..+..|..+.++||+|||++ +.||||||..|||+++.|.|||+|||.+....+.
T Consensus 107 YC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99 557778776654 3589999999999999999999999 9999999999999999999999999999766543
Q ss_pred CCceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
..++||+.|||||++. .+.|+-++|||||||+..||.-.++|+=..+ -+..++. +.+-
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----------AMSALYH---IAQN 240 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYH---IAQN 240 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----------HHHHHHH---HHhc
Confidence 3467999999999884 5789999999999999999999999962211 0111111 1111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
-.+.+. ..+-...+..++..||++-|.+|||..++++
T Consensus 241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 112222 3344566888999999999999999988776
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=296.50 Aligned_cols=262 Identities=21% Similarity=0.305 Sum_probs=194.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||+|++|.||+|... +|+.+|+|.+..... ......+.+|+++++.++|+|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999976 688999999865322 22234577899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+. ++|.+++.... ..+++..++.++.||++||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 57877776432 2489999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc------c
Q 013238 281 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK------L 353 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 353 (447)
. ......++..|+|||++.+. .++.++|||||||++|||+||..|+.... ................. .
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC----CHHHHHHHHHHHhCCCChHHhHHh
Confidence 1 12233478899999998765 46899999999999999999999863211 10001111100000000 0
Q ss_pred cccccc----ccCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVDS----DMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d~----~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.+..+. .... .........+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0000 011123456789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=292.66 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=197.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC---CCceeeEeeeeecCCcceEEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 198 (447)
.|+..+.||+|+||.||+|... +++.+|+|.+...........+.+|+++++.+. |+|++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677789999999999999974 689999999876544444556888999998886 999999999999888999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++... ++++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988643 489999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.... .....|+..|+|||.+.++ .++.++||||||+++|+|++|..||..... ...... .... .
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~-~~~~-----~ 218 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMML-IPKS-----K 218 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhc-cccC-----C
Confidence 3322 2233588899999988654 468899999999999999999999953211 111100 0000 0
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.+.+... .....+.+++.+||+.||.+||++.+++.
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0111111 13456889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=292.98 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=196.4
Q ss_pred CCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 013238 124 FSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 192 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 192 (447)
|.+.+.||+|+||.||+|... +++.||||.+..... ......+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999854 368899999975432 223446888999999999999999999886532
Q ss_pred cceEEEecccCCcchhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
..+++++|+.+|+|..++..... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 23688999999999888754321 122478899999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHh
Q 013238 271 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 271 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
|+++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||.... ......+ ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~~---~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNY---LI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHHH---HH
Confidence 999865432211 1122235678999999988889999999999999999999 888885311 1111111 11
Q ss_pred hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 349 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..... .........+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 230 ~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 01112345799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=294.79 Aligned_cols=240 Identities=23% Similarity=0.354 Sum_probs=186.1
Q ss_pred CeeeecCCeEEEEEEECC--------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 128 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
+.||+|+||.||+|.... ...+++|.+.... ......+..|..+++.+.|||++++++++......++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 369999999999998642 2348888875432 2233467889999999999999999999999889999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--------EEEeecC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--------AVVGDFG 271 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg 271 (447)
|+.+|+|..++..... .+++..++.++.||+.||+|||+. +++||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999976532 488999999999999999999999 9999999999999987765 6899999
Q ss_pred CccccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCC-CCcccccccCCCcccHHHHHHHHhh
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQ-RAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
++...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+.... ..... ....
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~--------~~~~~-~~~~ 219 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD--------SQKKL-QFYE 219 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc--------HHHHH-HHHH
Confidence 88654321 223478899999999764 5789999999999999999985 5553210 00110 0111
Q ss_pred ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
. . ...+......+.+++.+||+.+|++|||++++++.|+
T Consensus 220 ~---------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D---------R--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c---------c--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 0111112356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=290.51 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=197.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc---------chHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ---------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
+|...+.||+|++|.||+|... +|+.+|+|.++..... .....+..|+++++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999865 6889999988542211 11235778999999999999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++||||+.+++|.+++.... ++++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999987652 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-ceeeccccccCccccccccCCC--CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 273 AKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 273 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
++....... .......++..|+|||.+.... ++.++|+||||+++||+++|..||.... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--------AIAAMFKLGN 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--------hHHHHHHhhc
Confidence 976432211 1122345788999999987654 7899999999999999999999984211 0111111111
Q ss_pred ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.. ................+.+++.+||+.+|.+|||+.++++.
T Consensus 227 ~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KR-----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cc-----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 00111111112335678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.67 Aligned_cols=237 Identities=23% Similarity=0.266 Sum_probs=181.6
Q ss_pred eeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhc---CCCceeeEeeeeecCCcceEEEecccC
Q 013238 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA---VHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 130 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
||+|+||+||+|... +++.||||++...... .....+..|..++... .||||+++++++......++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 5899999998643221 1122344566666554 699999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99998886543 388999999999999999999999 99999999999999999999999999987533222 22
Q ss_pred eeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccC
Q 013238 284 TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 362 (447)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||.... ............ ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~-------~~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAFGK-------VRFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHcCC-------CCCC
Confidence 2345689999999998765 47899999999999999999999995311 111111111100 0111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 013238 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMS 392 (447)
Q Consensus 363 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 392 (447)
. ......+.+++.+||+.||.+||++.
T Consensus 218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 K---NVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred C---ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 1 11234578899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=297.01 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=210.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
+-|...+.||+|.|.+|-+|++- +|..||||++.+..... ....+.+|+..|+..+|||||++|++......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777788999999999999853 79999999998765433 34468899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcEEEeecCCccccCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~ 278 (447)
.-.+|+|.+++-.+.. .+.+....+++.||+.|+.|+|.. .+|||||||+||.+. +-|-+||+|||++..+.+
T Consensus 98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999977643 389999999999999999999999 999999999999775 568899999999976543
Q ss_pred CCCceeeccccccCccccccccCCCCC-chhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
+......+|+..|-|||++.+..|+ ++.||||||||||.|++|+.||+..+ +.+.+.-++
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-----------------DSETLTmIm 232 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-----------------DSETLTMIM 232 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-----------------chhhhhhhh
Confidence 4445566899999999999998885 68899999999999999999997432 123344445
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
|... ..+.....++.++|..||..||++|.|.++++..
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 5432 4456677889999999999999999999998764
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=295.96 Aligned_cols=262 Identities=23% Similarity=0.363 Sum_probs=197.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|+..+.||+|++|.||+|... +++.||+|.+....... ....+.+|+++++.++|+||+++++++......+++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999986 58899999986543222 34467889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+++|..+.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99998888776543 2389999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHH-----------
Q 013238 280 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL----------- 347 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 347 (447)
. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.... ......-....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS-----DIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc-----hHHHHHHHHHHhCCCchhhHHH
Confidence 2 22223347889999999875 457889999999999999999999985311 00000000000
Q ss_pred hhccc-cccccccccCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 348 LKEKK-LEQLVDSDMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 348 ~~~~~-~~~~~d~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..... ......+.... .........+.+++.+||+.+|.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 00000000000 001123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=292.14 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=194.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
+++|...+.||+|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++.+++......+++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467888999999999999999875 5889999999755444444467789999999999999999999998889999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+. ++|.+++.... ..+.+..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 67776665432 2377888899999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH-----------HH
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-----------GL 347 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~ 347 (447)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.||+..... ...+...+. ..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHHHHHHcCCCChhhhhhh
Confidence 11 12223468899999998764 5788999999999999999999999632110 000000000 00
Q ss_pred hhccccccccccccCCCC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 348 LKEKKLEQLVDSDMEGNY------IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 348 ~~~~~~~~~~d~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.................. .......+.+++.+|++.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000000 0011346788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=289.01 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=205.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
+|+..+.||+|++|.||+|... +++.|+||++...........+.+|++.+..++|+|++++++++......+++|||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6788899999999999999987 489999999976544344567889999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
++++|.+++... .++++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999764 348999999999999999999999 8 99999999999999999999999999998664333
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+.........
T Consensus 155 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~--------- 219 (264)
T cd06623 155 DQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGP--------- 219 (264)
T ss_pred Ccc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCC---------
Confidence 221 233478899999999998999999999999999999999999954211 11122222211110
Q ss_pred cCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 361 MEGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 361 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. ...... ....+.+++.+||+.+|.+|||+.++++.
T Consensus 220 ~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 P-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 111112 45679999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.00 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=198.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||+|++|.||++... +++.+|+|.+..... ......+.+|+++++.++|+|++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 688999999865432 22345688999999999999999999999888899999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeecCCccccCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~ 279 (447)
+++++|.+++.... ...+++..++.++.++++||+|||++ +++|+||+|+||+++++ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997643 23488999999999999999999999 99999999999999865 46899999999865432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+...... ...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~~~~~-~~~----- 219 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------LPALVLKIMSG-TFA----- 219 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------hHHHHHHHHhc-CCC-----
Confidence 21 222457889999999998889999999999999999999999995321 11111111110 000
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.........+.+++.+||+.+|.+|||+.++++
T Consensus 220 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 ----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=295.05 Aligned_cols=195 Identities=24% Similarity=0.382 Sum_probs=158.0
Q ss_pred CeeeecCCeEEEEEEEC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec--CCcceEEEeccc
Q 013238 128 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPFMV 202 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 202 (447)
.+||+|+||.||+|... ++..||+|.+..... ...+.+|+++++.++||||+++++++.. ....+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999865 357899998865322 2357789999999999999999998854 456789999985
Q ss_pred CCcchhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEEEeecCCc
Q 013238 203 NGSVASCLRERG-----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 273 (447)
Q Consensus 203 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 273 (447)
++|.+++.... .....+++..++.++.|++.||.|||+. +++||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 47777764321 1123488999999999999999999999 99999999999999 56779999999999
Q ss_pred cccCCCCCc--eeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 274 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 274 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
+........ ......+|..|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 865432211 12234578999999998764 579999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=289.40 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=199.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|...+.||+|++|.||+|... +++.|++|.++..... .....+..|+++++.++|+||+++++++...+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999865 6889999998755432 2455788999999999999999999999988999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++.... .+++..++.++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987542 378899999999999999999999 99999999999999999999999999988764333
Q ss_pred Ccee---eccccccCccccccccCCC---CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 281 THVT---TAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 281 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.... ....++..|+|||++.+.. .+.++||||||+++|||++|+.||.... ... ....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~----~~~---~~~~~~~-~~~-- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD----NEF---QIMFHVG-AGH-- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc----chH---HHHHHHh-cCC--
Confidence 2211 1245788999999998766 7899999999999999999999995321 000 0000000 000
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...+. ........+.+++.+||+.+|.+|||+.+++.
T Consensus 224 ---~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00010 01112456789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=294.51 Aligned_cols=257 Identities=22% Similarity=0.344 Sum_probs=194.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|...+.||+|+||.||++... +++.+|+|.+...........+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999875 589999999976544444557888999999986 99999999999988899999999
Q ss_pred ccCCcchhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 201 MVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 201 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
+. +++.++.... ......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4555543221 111235899999999999999999999743 8999999999999999999999999998754322
Q ss_pred CCceeeccccccCccccccccCC---CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.. .....|+..|+|||++.+. .++.++||||||+++|||++|+.||.... ...+.+.......
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~----- 227 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGD----- 227 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCC-----
Confidence 21 1223478899999998776 68899999999999999999999995321 1111111111100
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.+.+...........+.+++.+||+.+|.+|||+.+|++.
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111112345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.51 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=199.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|+..+.||+|++|.||+|... +++.||+|.++.... ......+.+|+++++.++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999976 588999999865432 2234568899999999999999999999999889999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.++.+..+.... ..+++..++.++.+|+.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99887766555432 2388999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh---------
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 349 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 349 (447)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ............
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhh
Confidence 33223334578899999999888 789999999999999999999999853211 111100000000
Q ss_pred ---ccccc--cccccccC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 ---EKKLE--QLVDSDME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 ---~~~~~--~~~d~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..... +..+.... ..........+.+++.+||+.+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00000000 0011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=300.08 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=200.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccc-cccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 197 (447)
....|+++++||+||.+.||++...+.+.+|+|++... ........|..|++.|.+++ |.+||++++|-..++..|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34568888999999999999999888788888887543 33444556999999999996 99999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||- .-+|..+|++..... ..| .++.+..|++.|+.++|.+ ||||.||||.|+|+-+ |.+||+|||+|..+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~~--~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSID--PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhccCCC--chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9987 569999998765432 334 7889999999999999999 9999999999999986 589999999999876
Q ss_pred CCCCce-eeccccccCccccccccCC-----------CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 278 YKDTHV-TTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 278 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
...... ....+||+.||+||.+... ..+.++||||||||||+|+.|+.||... .+.+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----------~n~~- 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----------INQI- 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------HHHH-
Confidence 554433 3456799999999988532 2467899999999999999999999631 1111
Q ss_pred HHhhccccccccccccCCCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIE-EEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.++..+.++...-+++. .....+.++|..||+.||.+|||+.+||+
T Consensus 580 -----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 -----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 23344555533222211 11122999999999999999999999998
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=293.04 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=197.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|++|.||++... +++.+|+|.+..... ......+.+|+++++++.||||+++++++......+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999876 589999999865332 223446888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999987653 488999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... ...........
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-------- 213 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKILEG-------- 213 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcC--------
Confidence 3 223458899999999988888999999999999999999999995321 01111111110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
. ...+......+.+++.+||+.+|.+|+ +++++++
T Consensus 214 -~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 -K--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -C--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 011112245688999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.63 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=203.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
+..+.|+.-++||+|+||.||-+... +|+.+|.|.+.+.+.. ..+...++|-.+|.+++.+.||.+-..+.+.+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 44567888899999999999999865 6999999999765432 23445678999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+|+..|+||+|.-+|.+.+. +.+++..+..++.+|+.||.+||+. +||+|||||+|||+|+.|+++|+|+|+|..
T Consensus 262 lVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999988764 4599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
+... ......+||.+|||||++.+..|+...|+|||||+||||+.|+.||.... ++...+
T Consensus 337 i~~g--~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K------------------eKvk~e 396 (591)
T KOG0986|consen 337 IPEG--KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK------------------EKVKRE 396 (591)
T ss_pred cCCC--CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh------------------hhhhHH
Confidence 6433 33444579999999999999999999999999999999999999996421 111111
Q ss_pred cccccc---CCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 013238 356 LVDSDM---EGNYIEEEVEQLIQVALLCTQGSPMERPKMS 392 (447)
Q Consensus 356 ~~d~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 392 (447)
-+|.+. ...++....+...++....|+.||.+|..-+
T Consensus 397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 112111 1233445556667777777899999997654
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=293.53 Aligned_cols=247 Identities=28% Similarity=0.400 Sum_probs=194.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+.|...+.||+|+||.||+|... +++.||+|.+..... ......+.+|+++++.++|||++++.+++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999875 688999999864322 222346888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+. |+|.+++.... .++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 57777665432 2489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
. ....++..|+|||++. ...++.++||||||+++|||+||+.||..... ..........
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~~~----- 229 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQN----- 229 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHhcC-----
Confidence 2 1234788999999874 45678899999999999999999999853210 0111111000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.............+.+++.+||+.+|.+||++.+++..
T Consensus 230 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 ----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00001112245568999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=292.87 Aligned_cols=251 Identities=19% Similarity=0.307 Sum_probs=199.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|...+.||+|+||.||++... +++.||+|.+..... .....+.+|+.+++.++|||++++++++...+..++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 367888899999999999999864 678899999864332 223467889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++... .+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 97 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999998653 278899999999999999999999 9999999999999999999999999988755433
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
... .....++..|+|||.+.+..++.++||||||+++|++++|+.||...... ..+..... ..
T Consensus 169 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--------~~~~~~~~--------~~ 231 (293)
T cd06647 169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIAT--------NG 231 (293)
T ss_pred ccc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------hheeehhc--------CC
Confidence 222 22335788999999998888999999999999999999999999632110 00000000 00
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.............+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011122234568889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=288.77 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=199.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-----chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
+|+..+.||+|++|.||++... +++.+|+|.+...... .....+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777889999999999999864 6889999998643321 123468899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeecCCccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKL 275 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~ 275 (447)
||||+++++|.+++.... ++++..++.++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999987543 488999999999999999999999 999999999999998776 599999999876
Q ss_pred cCCCCCc---eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 276 MDYKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 276 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~---- 224 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIA---- 224 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHh----
Confidence 5432111 11223578899999999888899999999999999999999999953211 11111111110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........+......+.+++.+||+.+|.+|||+.++++
T Consensus 225 -----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 -----SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001112233344567889999999999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=292.02 Aligned_cols=259 Identities=20% Similarity=0.272 Sum_probs=201.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|+||.||++... .++.|++|.+..... ......+.+|+++++.++|+||+++++.+...+..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999876 478999999865432 222346778999999999999999999999888999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++.... ++++..+..++.+++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999996643 488999999999999999999999 999999999999999999999999999864211
Q ss_pred CCC--------------ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 279 KDT--------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 279 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
... .......++..|+|||.+.+..++.++||||||+++|||++|..||... ...++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--------~~~~~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--------TPEELF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHH
Confidence 100 0011234678899999998888999999999999999999999999521 111111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
....... ...+. ........+.+++.+||+.+|.+||++.++.+.|+..-+
T Consensus 226 ~~~~~~~----~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 226 GQVISDD----IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred HHHHhcc----cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 1111110 00000 011234568899999999999999998888888877433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=296.42 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=195.0
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEeccc
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 202 (447)
|.....||+|+||.||++... ++..||||.+.... ......+.+|+..++.++|+|++++++.+...+..+++|||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 333466999999999999875 58899999986433 2334468899999999999999999999999999999999999
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 282 (447)
+++|.+++... .+++..++.++.+|+.||.|||++ +++||||||+||++++++.++|+|||++.........
T Consensus 103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 99999987542 378999999999999999999999 9999999999999999999999999998754322221
Q ss_pred eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccC
Q 013238 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362 (447)
Q Consensus 283 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 362 (447)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||.... . ...+.... ........
T Consensus 175 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~---~~~~~~~~------~~~~~~~~ 239 (292)
T cd06658 175 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-----P---LQAMRRIR------DNLPPRVK 239 (292)
T ss_pred -CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHH------hcCCCccc
Confidence 222457889999999988889999999999999999999999995311 0 11111110 01111111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 363 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. .......+.+++.+||..||.+|||+.++++.
T Consensus 240 ~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 D--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 11223457789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=291.11 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=195.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||.|++|.||+|... +++.||||.+..... ......+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999876 688999999865432 22234688899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+. ++|..++..... ..+++..++.++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 688888865432 3489999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeccccccCccccccccCCC-CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc--------
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-------- 351 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 351 (447)
. ......++..|+|||++.+.. ++.++||||||+++|||+||+.||.... ................
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHhCCCChhhhhhhh
Confidence 1 122234678899999887654 5889999999999999999999995311 1111111111000000
Q ss_pred -------ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 352 -------KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 352 -------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.......... ..........+.+++.+||+.||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0000112345778999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=291.13 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=197.3
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
+|...+.||+|++|.||+|... +++.||||.+...... .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999975 6899999999754332 1234567899999999999999999999998899999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+ +++|.+++.... ..+++..++.++.||++||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999987543 2489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc-----
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK----- 351 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 351 (447)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|.... ...............
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-----DIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-----cHHHHHHHHHHcCCCchhhh
Confidence 3322 1222346778999998865 457899999999999999999987774311 111111110000000
Q ss_pred ----ccccccccccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 ----KLEQLVDSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ----~~~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
............. ........+.+++.+||+.+|.+|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 112234678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.84 Aligned_cols=266 Identities=25% Similarity=0.391 Sum_probs=215.7
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEEC----C----CcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEee
Q 013238 116 ELQVATDNFSNRNILGRGGFGKVYKGRLT----D----GSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRG 186 (447)
Q Consensus 116 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~ 186 (447)
.+++..++..+.+.||+|.||.|++|... . ...||||.++..........+..|+++++.+. |+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45666677777789999999999999743 1 45799999998777766778999999998874 999999999
Q ss_pred eeecCCcceEEEecccCCcchhhhhhcC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 013238 187 FCMTPTERLLVYPFMVNGSVASCLRERG---QS-------Q--PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 254 (447)
Q Consensus 187 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~ 254 (447)
.|......++|+||+..|+|..+|+..+ .. . ..+.....+.++.|||.||+||++. +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999899999999999999999998876 10 1 2388999999999999999999999 999999999
Q ss_pred CCEEECCCCcEEEeecCCccccCCCCCceeecccc--ccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCccccc
Q 013238 255 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 331 (447)
Q Consensus 255 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~ 331 (447)
+|||+.++..+||+|||+++..............+ ...|||||.+....++.++|||||||+||||+| |..||...
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~- 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI- 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-
Confidence 99999999999999999999654444333222222 456999999999999999999999999999999 88888420
Q ss_pred ccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 332 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
....+.+. .+....+...+..+...++++|+.||+.+|++||++.++.+.|+..
T Consensus 526 ------~~~~~l~~----------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 ------PPTEELLE----------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ------CcHHHHHH----------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 00111111 1222233344555677899999999999999999999999999983
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=287.58 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=203.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||+|++|.||++... +++.+++|.+..... ......+..|+++++.++|+||+++.+++......+++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999865 678999999875432 23344677899999999999999999999988999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++.........+++..++.++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999877544445689999999999999999999999 9999999999999999999999999999876443
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ........ .. .
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~-~~---------~ 216 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--------MQDLRYKV-QR---------G 216 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-hc---------C
Confidence 1222347889999999999889999999999999999999999995321 11111111 11 1
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
............+.+++.+||+.+|.+|||+.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112223455679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=290.20 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=196.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 197 (447)
++|+..+.||+|++|.||+|... +++.+|+|.++..... .....+.+|++++.+++||||+++++++... ...+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999986 5889999999754322 2233567899999999999999999998877 789999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+. ++|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||++++++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 589888865432 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh-------
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK------- 349 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 349 (447)
.... ......++..|+|||.+.+. .++.++||||||+++|||++|..||..... ......+.....
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-----IDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchHHH
Confidence 4321 12223468889999988764 468999999999999999999999953211 000000000000
Q ss_pred ----------ccccccccccccCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 ----------EKKLEQLVDSDMEGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 ----------~~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...........+....... ....+.+++.+||+.+|++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000111111111 3556889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=305.70 Aligned_cols=244 Identities=26% Similarity=0.422 Sum_probs=197.2
Q ss_pred eeeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcch
Q 013238 129 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 207 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 207 (447)
+||+|.||+||.|++.+ ...+|||-+...... ...-+..|+.+-+.++|.|||+++|.+...+..-+.||..+||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 59999999999999764 567899998654332 2335889999999999999999999999888888999999999999
Q ss_pred hhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcEEEeecCCccccCCCCCcee
Q 013238 208 SCLRERGQSQPPL--NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVT 284 (447)
Q Consensus 208 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~ 284 (447)
++|+..-+ |+ .+.++-.+..||++||.|||++ .|||||||-+||||+ -.|.+||+|||-++.+..- .-.+
T Consensus 661 sLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~T 733 (1226)
T KOG4279|consen 661 SLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCT 733 (1226)
T ss_pred HHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cccc
Confidence 99986433 35 7888999999999999999999 999999999999996 4789999999999877533 2334
Q ss_pred eccccccCccccccccCC--CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccC
Q 013238 285 TAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362 (447)
Q Consensus 285 ~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 362 (447)
....||..|||||++..+ .|..++|||||||++.||.||++||-.... . ...-+-.+++ ...
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs--p---qAAMFkVGmy-----------KvH 797 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS--P---QAAMFKVGMY-----------KVH 797 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC--h---hHhhhhhcce-----------ecC
Confidence 455699999999999765 478999999999999999999999953211 0 0000001111 112
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 363 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+..+.+.......++++|+.++|.+||++.++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 3456666778889999999999999999999986
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=304.16 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=195.7
Q ss_pred CCeeeecCCeEEEEEEEC-CCcEEEEEEec---cccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc--ceEEEec
Q 013238 127 RNILGRGGFGKVYKGRLT-DGSLVAVKRLK---EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--RLLVYPF 200 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 200 (447)
..+||+|+|-+||+|.+. +|..||--.++ .........+|..|+.+|+.|+|+||++++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999876 47667644443 22333344679999999999999999999999987665 6689999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeecCCccccCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~ 279 (447)
+..|+|..+++..+. ++...++.|+.||++||.|||++ .|+|+|||||-+||||+. .|.|||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999988764 78889999999999999999997 668999999999999975 589999999999876543
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
. .....|||.|||||++. ..|++..||||||++++||+|+..||.. ......+...|..-.+...+..+.|
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQIYKKV~SGiKP~sl~kV~d- 270 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQIYKKVTSGIKPAALSKVKD- 270 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHHHHHHHcCCCHHHhhccCC-
Confidence 3 23367999999999986 7899999999999999999999999952 1111222222222222222222222
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGD 401 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 401 (447)
..+.++|.+|+.. ..+|||+.|+|. +|...
T Consensus 271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 271 -----------PEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -----------HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 3478899999998 999999999997 55543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=287.07 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=204.3
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEeccc
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 202 (447)
|.+.++||+|+||.||+|.++ .|+.+|||.+..+. ...++..|+.++.+...+++|+++|.+.....+|+|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 555678999999999999876 69999999987543 34568899999999999999999999999999999999999
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 282 (447)
.|+..+.++.+.. ++.+.++..++...++||+|||.. .-+|||||..|||++.+|.+||+|||.+..+...- .
T Consensus 112 AGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A 184 (502)
T KOG0574|consen 112 AGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A 184 (502)
T ss_pred CCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence 9999999987653 599999999999999999999998 88999999999999999999999999998764322 2
Q ss_pred eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc--ccc
Q 013238 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV--DSD 360 (447)
Q Consensus 283 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~ 360 (447)
....+.||+-|||||++..-.|+.++||||||+...||..|++||... +....++ -..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI--------------------HPMRAIFMIPT~ 244 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI--------------------HPMRAIFMIPTK 244 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc--------------------cccceeEeccCC
Confidence 234456999999999999999999999999999999999999999521 1111111 111
Q ss_pred cCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
-.. ..+..-...+.+++..||-++|++|-|+.++++
T Consensus 245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 111 224455678999999999999999999998887
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=288.60 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=197.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
+|+..+.||.|++|.||+|... +|..||||.++..........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999986 588999999976544444456778999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
.+ +|.+++..... ..++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 88888765432 23589999999999999999999999 999999999999999999999999999975533221
Q ss_pred ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc---ccccc-
Q 013238 282 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK---KLEQL- 356 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~- 356 (447)
......++..|++||++.+. .++.++||||||+++|+|++|+.||..... .............. ....+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-----EDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHHHhCCCChhhHHHHh
Confidence 12223468899999988664 568899999999999999999999963211 00000000000000 00000
Q ss_pred ----cccccC-------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 ----VDSDME-------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ----~d~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...... ..........+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=289.99 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=201.7
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
..+.|+..+.||+|++|.||++... ++..+++|.+..... ....+..|+++++.++|+|++++++.+......++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 3456777889999999999999987 688999999975433 3456888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998754 2489999999999999999999998 999999999999999999999999998875443
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... .....
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~--- 235 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLITT-KGIPP--- 235 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-cCCCC---
Confidence 221 11223477899999999888899999999999999999999999853110 011111100 00000
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..........+.+++.+||+.+|.+|||+.++++
T Consensus 236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 ----LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0111123456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=291.04 Aligned_cols=245 Identities=21% Similarity=0.301 Sum_probs=194.3
Q ss_pred CCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCc
Q 013238 127 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
...||+|+||.||++... +++.||+|.+..... .....+.+|+.++..++|||++++++++...+..+++|||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 346999999999999875 688999999865432 234467889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceee
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 285 (447)
|..++... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 99877542 388999999999999999999999 999999999999999999999999999875433221 122
Q ss_pred ccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCC
Q 013238 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 365 (447)
Q Consensus 286 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 365 (447)
...++..|+|||++.+..++.++||||||+++|||++|+.||.... . .+.+..... ..... ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~---~~~~~~~~~-~~~~~-------~~~ 239 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-----P---VQAMKRLRD-SPPPK-------LKN 239 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHhc-cCCCC-------ccc
Confidence 3458899999999998889999999999999999999999995311 1 111111111 00000 001
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 366 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 366 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11223458889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=287.23 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=199.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||+|+||.||++... +|..+|+|.+...... .....+.+|+++++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999976 5788999998654221 2344678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeecCCccccCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 279 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 279 (447)
+++++|.+++..... ..+++..++.++.++++||.|||+. +++|+||+|+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999876432 2479999999999999999999999 999999999999999886 4699999998765432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.. ......|+..|+|||++.+..++.++|+||||+++|||++|..||.... ...++....... ..
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-----~~- 220 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQGY-----FA- 220 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhccc-----CC-
Confidence 22 2222347889999999988889999999999999999999999985321 122222211111 00
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.........+.+++.+||+.+|++|||+.++++.
T Consensus 221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111233568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=286.30 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=192.1
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecC--CcceEEEe
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLVYP 199 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 199 (447)
|+..+.||+|+||.||+|... +++.+|+|.++............+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999875 588999999876533333334557888888885 99999999999877 78899999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+. ++|.+.+.... ..+++..++.++.|++.||+|||+. +++||||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 57877776532 2489999999999999999999999 9999999999999999 99999999999865432
Q ss_pred CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc--------
Q 013238 280 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------- 350 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 350 (447)
... ....++..|+|||++.+ ..++.++|||||||++|||++|..||.... ......+.......
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-----ELDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-----HHHHHHHHHHHcCCCCHHHHHh
Confidence 221 22347889999997644 557889999999999999999999995321 11111111111110
Q ss_pred ---cccccccccccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 ---KKLEQLVDSDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ---~~~~~~~d~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........+..... ........+.+++.+||+.+|.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 01134577999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=281.31 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+++++.++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4677789999999999999986 688999999976543 33457889999999999999999999999989999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987643 3489999999999999999999998 999999999999999999999999999876654322
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||.... .......... ........
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~~~~--- 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--------PMKALFKIAT-NGPPGLRN--- 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHh-cCCCCcCc---
Confidence 233457889999999988889999999999999999999999995321 0111111100 00000000
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.......+.+++.+||+.||++|||+.++++
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 ----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112456899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=284.74 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=194.7
Q ss_pred eeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 130 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
||.|++|.||++... +++.+|+|.+...... .....+.+|+++++.++|+||+++++++.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 4889999999754322 3345688999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeec
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 286 (447)
.+++.... .+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997643 388999999999999999999998 99999999999999999999999999998664332 1223
Q ss_pred cccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCc
Q 013238 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366 (447)
Q Consensus 287 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 366 (447)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........... .......+
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~---------~~~~~~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILK---------GNGKLEFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhc---------cCCCCCCC
Confidence 3578899999999888899999999999999999999999964211 11222222111 01111122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 367 EEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 367 ~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
......+.+++.+||+.+|.+||+ +.|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 222567999999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=283.89 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=204.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|...+.||.|++|.||++... +++.+++|++..... ......+.+|+++++.++|+|++++.+.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999976 588999999975433 23445688999999999999999999999888999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++.........+++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543335699999999999999999999999 99999999999999999999999999997654432
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......|+..|+|||.+.+..++.++||||||+++++|++|+.||.... ........... ...
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~------ 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKG-QYP------ 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcC-CCC------
Confidence 12233457889999999988889999999999999999999999995321 11111111111 111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+......+.+++.+||+.+|.+|||+.++++
T Consensus 222 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 ---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111133456889999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=287.55 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=193.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcC-CCceeeEeeeeecCCc-----
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE----- 193 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 193 (447)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+++++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999976 6899999998654322 22346788999999995 6999999999876655
Q ss_pred ceEEEecccCCcchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeecC
Q 013238 194 RLLVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFG 271 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 271 (447)
.+++|||+.+ +|.+++...... ...+++..++.++.||++||.|||++ +++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 788887654332 34589999999999999999999999 9999999999999998 8999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
++......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......... ....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~-~~~~ 230 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFK-LLGT 230 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHH-HhCC
Confidence 98765332211 122346788999998865 4578999999999999999999999953110 000000000 0000
Q ss_pred cccc---cccc-------cccC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 KKLE---QLVD-------SDME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ~~~~---~~~d-------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... .... +... ..........+.+++.+||+.||.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0000 0000 0001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=297.24 Aligned_cols=263 Identities=20% Similarity=0.329 Sum_probs=194.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Ccc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 194 (447)
+++|++.+.||+|++|.||+|... +|+.||+|.+...........+.+|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 68999999986543333445678899999999999999999887643 346
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++++||+. ++|...+... .+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 89999996 4777776542 389999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCc--eeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 275 LMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 275 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
........ ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ......+...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~ 229 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTP 229 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCC
Confidence 65332211 1122457889999998754 5689999999999999999999999953211 11111111111100
Q ss_pred c---cccccccc-------c--CCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 K---LEQLVDSD-------M--EGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ~---~~~~~d~~-------~--~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. ...+.+.. . .... .......+.+++.+||+.+|.+|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000000 0 0000 01224568899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=287.63 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=196.0
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceEEEe
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYP 199 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 199 (447)
|+..+.||+|++|.||+|... +++.+|+|.+.... .......+.+|+++++.++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556788999999999999976 48899999997653 222344678899999999999999999999887 78999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|++ ++|.+++.... ..+++..++.++.+|+.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 996 48888876542 3489999999999999999999999 9999999999999999999999999999866544
Q ss_pred CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc---c
Q 013238 280 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---Q 355 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 355 (447)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... .......+.......... .
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST-----ELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCchhhccc
Confidence 3222333446788999998765 457899999999999999999999995321 111111111110000000 0
Q ss_pred ccc--------------cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVD--------------SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+ ..+.......+...+.+++.+||+.+|.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00000000112567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=311.24 Aligned_cols=273 Identities=20% Similarity=0.261 Sum_probs=187.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC--CcEEEEEEe--------------ccc--cccchHHHHHHHHHHHHhcCCCce
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRL--------------KEE--RTQGGELQFQTEVEMISMAVHRNL 181 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~--------------~~~--~~~~~~~~~~~e~~~l~~l~h~ni 181 (447)
..++|++.+.||+|+||+||++.... +...++|.+ .+. ........+.+|++++..++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987542 222222211 000 011123457889999999999999
Q ss_pred eeEeeeeecCCcceEEEecccCCcchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 013238 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 260 (447)
Q Consensus 182 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~ 260 (447)
+++++++...+..+++++++. ++|..++...... ........++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999984 5777766443211 12234566778999999999999999 999999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccH
Q 013238 261 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 340 (447)
Q Consensus 261 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 340 (447)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++..... ......+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~-~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG-GKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC-CCHHHHH
Confidence 999999999999987654333333345689999999999999999999999999999999998764321110 0001111
Q ss_pred HHHHHHHhh-cc-------cccccccccc---CCCCcH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 341 LDWVKGLLK-EK-------KLEQLVDSDM---EGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 341 ~~~~~~~~~-~~-------~~~~~~d~~~---~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
...+..... .. .+.+.++... ...... .....+.+++.+||+.||.+|||+.|++..
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111110000 00 0000000000 000000 112346778999999999999999999873
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=291.07 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=194.0
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
|...+.||+|+||.||++... ++..+|+|.+..... ......+..|+++++.++|+|++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999875 588999999864322 22234688899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+. |+|.+.+.... .++++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 57777765432 2489999999999999999999999 9999999999999999999999999998754322
Q ss_pred CceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
....++..|+|||++. .+.++.++||||||+++|||++|+.||.... ............
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~------ 240 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE------ 240 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhcc------
Confidence 2234788999999874 4568899999999999999999999985311 111111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
............+.+++.+||+.+|.+||++.++++.+..
T Consensus 241 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 ---SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0011112234568899999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=299.14 Aligned_cols=196 Identities=24% Similarity=0.349 Sum_probs=167.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC------CCceeeEeeeeecCCcc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNLLRLRGFCMTPTER 194 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~ 194 (447)
-+|++.+.||+|.||.|-+|.+. +++.||||+++....- ..+-..|+.+|..++ --|+|++++++.-.++.
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 38889999999999999999865 6999999999765322 234567888888886 34699999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC--CcEEEeecCC
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGL 272 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl 272 (447)
+||+|.+ .-+|.++++.+.-. +++...++.++.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.
T Consensus 264 ciVfELL-~~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999 56999999987644 499999999999999999999999 99999999999999654 4699999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
++...... . ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|..
T Consensus 338 Sc~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 338 SCFESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 98654322 2 33467789999999999999999999999999999999887743
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=283.60 Aligned_cols=267 Identities=25% Similarity=0.324 Sum_probs=218.7
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEee
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 186 (447)
...++.+..++++...++-+|.||.||+|.+. +.+.|.+|.++....+-....++.|--++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 36677788889999999999999999999654 345688898887777666667888999999999999999999
Q ss_pred eeecC-CcceEEEecccCCcchhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 013238 187 FCMTP-TERLLVYPFMVNGSVASCLRERGQ----SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 261 (447)
Q Consensus 187 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~ 261 (447)
++... ...++++.++.-|+|..+|...+. ..+.++..+...++.|++.|++|||++ +++|.||..+|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 98764 567899999999999999984322 223477788889999999999999999 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCceee-ccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCccc
Q 013238 262 EFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVM 339 (447)
Q Consensus 262 ~~~~kl~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~ 339 (447)
..++||+|-.+++.+.+.+....+ ....+..||+||.+....|+.++||||||++||||+| |+.|+... +
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI--------D 503 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI--------D 503 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc--------C
Confidence 999999999999977666654333 2335778999999999999999999999999999998 89998431 1
Q ss_pred HHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 340 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..+....+.++.++ ..+.+++++++.+|.-||...|++||++++++..|.+
T Consensus 504 PfEm~~ylkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 504 PFEMEHYLKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHHHHHhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 22222222223332 3355678889999999999999999999999999874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=291.11 Aligned_cols=270 Identities=23% Similarity=0.304 Sum_probs=194.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC---CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--Ccce
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT---DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERL 195 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 195 (447)
+|+..+.||+|++|.||+|... +++.||+|.+.... .......+.+|+++++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999975 37899999997632 122234577899999999999999999999887 7789
Q ss_pred EEEecccCCcchhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC----CCcEEEeec
Q 013238 196 LVYPFMVNGSVASCLRERGQSQ-PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE----EFEAVVGDF 270 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 270 (447)
+||||+++ +|.+++....... ..+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 6766665433222 3689999999999999999999999 9999999999999999 999999999
Q ss_pred CCccccCCCCC--ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCc-----ccHHH
Q 013238 271 GLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-----VMLLD 342 (447)
Q Consensus 271 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~-----~~~~~ 342 (447)
|++........ .......++..|+|||++.+. .++.++||||||+++++|++|+.||.......... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543222 112223478889999988664 57899999999999999999999996432211000 00001
Q ss_pred HHHHHh-----------hccccccccccccCCCCc----H-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 343 WVKGLL-----------KEKKLEQLVDSDMEGNYI----E-------EEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 343 ~~~~~~-----------~~~~~~~~~d~~~~~~~~----~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.+..+- .........+........ . .....+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 100000 000000000000000000 0 23356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=285.31 Aligned_cols=243 Identities=27% Similarity=0.343 Sum_probs=185.2
Q ss_pred eeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHH---HhcCCCceeeEeeeeecCCcceEEEeccc
Q 013238 129 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMI---SMAVHRNLLRLRGFCMTPTERLLVYPFMV 202 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 202 (447)
.||+|+||.||++... +++.+|+|.+...... .....+.+|..++ ...+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 5889999998654322 1122334444433 34479999999999998889999999999
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 282 (447)
+++|..++.... .+++..+..++.|++.||.|||+. +++|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999886543 489999999999999999999999 99999999999999999999999999987543222
Q ss_pred eeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 283 VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 283 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|..||...... .... ...... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~-~~~~~~----------~~ 214 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHE-IDRMTL----------TV 214 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CHHH-HHHHhh----------cC
Confidence 122358999999999864 56789999999999999999999999632110 1111 111100 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 397 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 397 (447)
....+......+.+++.+||+.||.+|| |++++++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1112223446688999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=287.69 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=197.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC----
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT---- 192 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 192 (447)
...++|++.+.||+|+||.||+|... +|+.||+|.++.... ......+.+|+++++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 588999999975432 223346778999999999999999999887654
Q ss_pred ------cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 013238 193 ------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 193 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
..++++||+++ ++...+... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 68899999976 666666543 22489999999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 267 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 267 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-----~~~~~~~~~ 231 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-----ELAQLELIS 231 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHH
Confidence 99999998664433222222345778999998865 357889999999999999999999996321 111111111
Q ss_pred HHhhcccc---ccccc--------ccc-----CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 346 GLLKEKKL---EQLVD--------SDM-----EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 346 ~~~~~~~~---~~~~d--------~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........ ..+.. ... ........+..+.+++.+||+.+|.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111000 00000 000 00001112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=279.60 Aligned_cols=243 Identities=27% Similarity=0.340 Sum_probs=197.4
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
+..++|..+++||+|.||+|.+++-+ +++.+|+|+++++..... ...-+.|-.+|+..+||.+..+...++..+.++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 34578888999999999999999865 699999999987754332 234567889999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||..||.|.-+|...+ .+++...+.+-..|+.||.|||++ +||+||||.+|.|+|.+|++||+|||+++.
T Consensus 245 FVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999999887643 388888889999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
- ..........+||+.|+|||++....|..+.|+|.+||++|||++|+.||..- +. .++.+
T Consensus 318 ~-I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-----dh-------------~kLFe 378 (516)
T KOG0690|consen 318 E-IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-----DH-------------EKLFE 378 (516)
T ss_pred c-ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-----ch-------------hHHHH
Confidence 3 23445567788999999999999999999999999999999999999999531 11 11111
Q ss_pred ccc-cccCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 013238 356 LVD-SDMEGNYIEEEVEQLIQVALLCTQGSPMERP 389 (447)
Q Consensus 356 ~~d-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 389 (447)
++- ..+ .++.........++...|..||.+|.
T Consensus 379 LIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 379 LILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHhhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 110 111 12222233455667778899999996
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=287.16 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=197.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
.|...+.||+|++|.||++... +++.+++|.+.... ......+.+|+.+++.++|+|++++++++...+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 3455678999999999999865 68899999885432 223445788999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
.+++|.+++... ++++..+..++.+++.||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 99 EGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 999999998762 388999999999999999999999 999999999999999999999999998875432222
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~~~~~~~------~~~~ 235 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMKRIRDNL------PPKL 235 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHhcC------CCCC
Confidence 1223458889999999988889999999999999999999999985311 111222111110 0000
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ........+.+++.+||+.+|++|||+.++++
T Consensus 236 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 K--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred c--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 11113456899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=287.19 Aligned_cols=248 Identities=24% Similarity=0.309 Sum_probs=199.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
+|+..+.||.|+||.||++... +++.||+|.+...... .....+.+|++++++++||||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777889999999999999976 5889999999754322 234578899999999999999999999998999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+++|..++... .++++..+..++.++++||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998764 2488999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ............
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~--------- 216 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR------TIRDQIRAKQET--------- 216 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc------cHHHHHHHHhcc---------
Confidence 2 22234578899999999888899999999999999999999999964211 011111111111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKM--SEVV 395 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 395 (447)
.....+......+.+++.+||+.||.+||++ ++++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011122234678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=286.38 Aligned_cols=262 Identities=22% Similarity=0.316 Sum_probs=195.0
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
|+..+.||.|++|.||+|... +|..||+|++...... .....+.+|+++++.++|+|++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999875 6899999998754322 22346788999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
. ++|.+++..... ..+++..++.++.|+++||+|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 4 689988865432 3489999999999999999999999 999999999999999999999999999976533221
Q ss_pred ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc--------c
Q 013238 282 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--------K 352 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 352 (447)
. .....++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ...+........... .
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHHhhhhhh
Confidence 1 1223467889999988664 568999999999999999999999953211 001111111000000 0
Q ss_pred ccccccc--ccC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDS--DME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~--~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+.... ... ..........+.+++.+||+.+|.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 000 0011122356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.54 Aligned_cols=256 Identities=22% Similarity=0.388 Sum_probs=194.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 198 (447)
.++|+..+.||+|++|.||+|...+ ++.||||.++..........+..|++++.+.. |+||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4567888999999999999999874 89999999976543334445667777666665 999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+. ++|.+++..... ++++..+..++.+++.||+|||+.. +++||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9984 577776655322 5899999999999999999999732 899999999999999999999999999876533
Q ss_pred CCCceeeccccccCccccccccCCC----CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ..+......... ..
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~-~~ 237 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKILQEE-PP 237 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHHHHHHhcCC-CC
Confidence 221 12234778999999987654 78899999999999999999999953110 011111111111 00
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
... ........+.+++.+||+.||.+|||+.++++.--
T Consensus 238 -----~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 238 -----SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -----CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 000 01123456899999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=282.23 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=195.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--Ccc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 194 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 194 (447)
.+|+..+.||+|++|.||+|... +++.||+|.+.... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999875 58899999875321 122334688899999999999999999988764 457
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++++||+++++|.+++.... ++++..++.++.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999986542 378899999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCC--CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 275 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 275 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
...... ........++..|+|||++.+..++.++||||||+++|+|++|+.||.... .... +...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~-~~~~----- 221 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAA-IFKI----- 221 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHH-HHHH-----
Confidence 653211 111123457889999999998889999999999999999999999995311 0001 1111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.........+....+.+.+++.+||+ +|..|||+.+++.
T Consensus 222 ----~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ----ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111112233445668899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=286.59 Aligned_cols=260 Identities=18% Similarity=0.228 Sum_probs=182.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccch-H---------HHHHHHHHHHHhcCCCceeeEe
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGG-E---------LQFQTEVEMISMAVHRNLLRLR 185 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-~---------~~~~~e~~~l~~l~h~niv~l~ 185 (447)
..++|.+.++||+|+||+||+|...+ +..+|+|.......... + .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34678999999999999999998764 34566665432211100 0 0112233445667899999999
Q ss_pred eeeecCC----cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 013238 186 GFCMTPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 261 (447)
Q Consensus 186 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~ 261 (447)
+.+.... ..+++++++. .++.+.+.... ..++..++.++.|++.||+|||+. +++||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8765443 2367777763 35555554322 256788899999999999999999 9999999999999999
Q ss_pred CCcEEEeecCCccccCCCCCc------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCC
Q 013238 262 EFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 335 (447)
Q Consensus 262 ~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~ 335 (447)
++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~--- 238 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH--- 238 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc---
Confidence 999999999999865422211 11223589999999999999999999999999999999999999964211
Q ss_pred CcccHHHHH-HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 336 DDVMLLDWV-KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 336 ~~~~~~~~~-~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
........ .... .++...... .......+.+++..||+.+|++||++.++++.|+
T Consensus 239 -~~~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 -NGNLIHAAKCDFI-----KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -chHHHHHhHHHHH-----HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111100 0110 111111111 1122466889999999999999999999998874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=278.56 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=202.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceEEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 198 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 198 (447)
+|...+.||+|++|.||+|... +++.|++|.+..... ......+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999986 688999999865432 23345688999999999999999999999887 7889999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+++|.+++.... .+++..++.++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999987653 589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.... ......++..|+|||.+.+...+.++||||||+++++|++|..||.... ...........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~-------- 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGS-------- 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccc--------
Confidence 3321 1223457889999999988889999999999999999999999996421 11111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.......+......+.+++.+|++.+|.+||++.++++
T Consensus 219 -~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 -SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111122233567999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=316.72 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=188.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 191 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 191 (447)
..+|+.++.||+|+||.||+++.+ ||+.||||++...........+.+|+..+++++|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 457888899999999999999987 89999999998665444555688999999999999999987422100
Q ss_pred --------------------------------------------------------------------------------
Q 013238 192 -------------------------------------------------------------------------------- 191 (447)
Q Consensus 192 -------------------------------------------------------------------------------- 191 (447)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 013238 192 -------------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240 (447)
Q Consensus 192 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH 240 (447)
..+|+-||||+..+|.++++.+.-. -.....++++.+|++||+|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHH
Confidence 0126778888887777777654321 146778999999999999999
Q ss_pred hCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC-----------------CCCCceeeccccccCccccccccCC-
Q 013238 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------------YKDTHVTTAVRGTIGHIAPEYLSTG- 302 (447)
Q Consensus 241 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~- 302 (447)
+. |+|||||||.|||+|+++.|||+|||+++... .......+..+||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998621 0011133455799999999999764
Q ss_pred --CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC--CCcHHHHHHHHHHHH
Q 013238 303 --KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG--NYIEEEVEQLIQVAL 378 (447)
Q Consensus 303 --~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~li~ 378 (447)
+|+.|+|+||||||++||+. ||... +-+...+..+.+..+.. .+..+....=.++|.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----------------MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS----------------MERASILTNLRKGSIPEPADFFDPEHPEEASLIR 852 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCch----------------HHHHHHHHhcccCCCCCCcccccccchHHHHHHH
Confidence 49999999999999999996 56431 11111122222222221 123334445567899
Q ss_pred HccCCCCCCCCCHHHHHH
Q 013238 379 LCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 379 ~cl~~dP~~RPt~~evl~ 396 (447)
++++.||.+|||+.|+|.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=293.00 Aligned_cols=266 Identities=20% Similarity=0.247 Sum_probs=195.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecC------
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 191 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 191 (447)
..++|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 68999999986432 222334577899999999999999999987643
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
...++||||+. ++|.+.+... ++...+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 24689999995 5787777532 78889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccC----------CCcccHH
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN----------DDDVMLL 341 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~----------~~~~~~~ 341 (447)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... .......
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986543221 223347889999999999999999999999999999999999995321100 0000000
Q ss_pred HHH----HHHhhcc------ccccccccccC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 342 DWV----KGLLKEK------KLEQLVDSDME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 342 ~~~----~~~~~~~------~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
... ....... ...++...... ..........+.+++.+||+.||.+|||+.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000 00000000000 00011235567899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=288.03 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=191.1
Q ss_pred Ceeeec--CCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
..||+| +||+||++... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 89999999875 689999999875432 22345688899999999999999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc-
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 282 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 282 (447)
++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876532 2488999999999999999999999 9999999999999999999999999865322111100
Q ss_pred -e----eeccccccCccccccccCC--CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH---------
Q 013238 283 -V----TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG--------- 346 (447)
Q Consensus 283 -~----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 346 (447)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||..... ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR----TQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh----HHHHHHHhcCCCCCCcccc
Confidence 0 0011245679999998764 478999999999999999999999953210 0000000000
Q ss_pred -------H-------h---------hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 347 -------L-------L---------KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 347 -------~-------~---------~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. . .......+.+..+.......+...+.+++.+||+.||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0 0000000111111112233456778999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=287.01 Aligned_cols=263 Identities=25% Similarity=0.348 Sum_probs=194.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 196 (447)
.++|+..+.||+|+||.||+|... +|+.||+|.++..... .....+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999975 5899999998654322 2233466899999999999999999998754 45799
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+. ++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 47888876543 3489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc--
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL-- 353 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 353 (447)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... .......+.........
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-----EIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCChhh
Confidence 433211 122235778999999865 457899999999999999999999995321 11111111111100000
Q ss_pred ----------ccccccccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 ----------EQLVDSDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ----------~~~~d~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............ .......+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000 0112456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=283.39 Aligned_cols=242 Identities=26% Similarity=0.344 Sum_probs=188.9
Q ss_pred eeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 130 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
||+|+||+||++... +|+.+|+|.+..... ......+..|+++++.++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 688999999865321 22233567899999999999999999999988999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeec
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 286 (447)
.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..... ......
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccc
Confidence 999876543 3489999999999999999999999 999999999999999999999999999876532 112223
Q ss_pred cccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCc
Q 013238 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366 (447)
Q Consensus 287 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 366 (447)
..++..|+|||++.+..++.++||||||+++|+|++|+.||..... ........... .. ......
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~---------~~--~~~~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE----KVEKEELKRRT---------LE--MAVEYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc----cccHHHHHhcc---------cc--ccccCC
Confidence 3477899999999888899999999999999999999999953211 00111110000 00 001112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH
Q 013238 367 EEEVEQLIQVALLCTQGSPMERPKMSE 393 (447)
Q Consensus 367 ~~~~~~l~~li~~cl~~dP~~RPt~~e 393 (447)
......+.+++.+||+.+|.+||+..+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 223556889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=324.96 Aligned_cols=253 Identities=27% Similarity=0.370 Sum_probs=199.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-CCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+-++....+||.|.||.||-|.. .+|...|+|-++..... ..-....+|+.++..++|||+|+++|+=..++..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34666778999999999999985 46999999988644332 22335778999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|||.+|+|.+.++..+. .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999976543 67777788889999999999999 999999999999999999999999999987754
Q ss_pred CCCc---eeeccccccCccccccccCC---CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 279 KDTH---VTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 279 ~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
.... ......||+.|||||++.+. ....+.||||+|||+.||+||++||...+ .+|. -+++-
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---------ne~a-IMy~V-- 1454 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---------NEWA-IMYHV-- 1454 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---------chhH-HHhHH--
Confidence 4211 12234699999999999764 35678999999999999999999996421 1111 11110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
...-.+..+......-.+++..|+..||.+|.++.|+++.
T Consensus 1455 -----~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 -----AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 0111123333455667789999999999999998877653
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=283.27 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=196.2
Q ss_pred eeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 130 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
||+|+||.||++... +|+.+++|.+..... ......+.+|++++++++|+|++++++.+......+++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999865432 13344688899999999999999999999888899999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC-----
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----- 281 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----- 281 (447)
.+++.... .+++..++.++.||++||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997643 489999999999999999999999 999999999999999999999999999875433211
Q ss_pred --ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 282 --HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 282 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.......++..|+|||.+.+...+.++||||||+++|+|++|..||.... .......... .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~-------- 216 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILN-G-------- 216 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-C--------
Confidence 12223447889999999988889999999999999999999999995321 1111111111 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.............+.+++.+||+.+|.+|||+..+.+.|+--
T Consensus 217 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 217 KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 000000111246689999999999999999997777777643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=299.20 Aligned_cols=201 Identities=29% Similarity=0.408 Sum_probs=173.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC------Ccce
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERL 195 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 195 (447)
.+...+.||+|+||.||+|+.+ +|+.||||.++............+|++++++++|+|||+++++=.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455678999999999999965 79999999998876666667788999999999999999999875433 3568
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CC--cEEEeecC
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EF--EAVVGDFG 271 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~--~~--~~kl~Dfg 271 (447)
++||||.+|+|...|+..... ..+++...+.++.+++.||.|||++ +|+||||||.||++-. +| .-||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999999876433 3599999999999999999999999 9999999999999843 23 47999999
Q ss_pred CccccCCCCCceeeccccccCcccccccc-CCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
.|+.++.. ......+||..|++||.+. .+.|+..+|.|||||++|+++||..||..
T Consensus 170 ~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 170 AARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99987543 3667788999999999998 47889999999999999999999999964
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=285.31 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=192.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc-----
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 193 (447)
-++|+..+.||+|+||.||+|... +++.||||.+..... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357888999999999999999876 689999999864432 2223356689999999999999999999876543
Q ss_pred ---ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 194 ---RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 194 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
.++||||+. ++|...+.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 489999995 57877776532 2489999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCc---eeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 271 GLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 271 gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.... .......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-----~~~~~~~~~~ 238 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-----EQHQLTLISQ 238 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHH
Confidence 999765432221 11223467889999988665 46889999999999999999999985321 1111111111
Q ss_pred Hhh---ccccc-----ccccc-ccCCCC---------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 347 LLK---EKKLE-----QLVDS-DMEGNY---------IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 347 ~~~---~~~~~-----~~~d~-~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
... ..... ...+. ...... .......+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 110 00000 00000 000000 0011245678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=283.49 Aligned_cols=262 Identities=21% Similarity=0.292 Sum_probs=193.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|+..+.||+|.+|.||+|... +|+.||+|.+...... .....+.+|+++++.++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999976 6889999998654322 223467889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeecCCccccCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~ 278 (447)
|+. ++|.+++..... ..+++..++.++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 578777754332 2367888899999999999999999 9999999999999985 56799999999976533
Q ss_pred CCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. .......++..|+|||++.+. .++.++||||||+++|+|+||+.||..... ....... ....... .....
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~----~~~~~~~-~~~~~~~-~~~~~ 228 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE----IDELFKI-FRILGTP-NEETW 228 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH-HHHhCCC-Chhhc
Confidence 21 112223467899999988664 578999999999999999999999953110 0000000 0000000 00000
Q ss_pred c------------cccCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 D------------SDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d------------~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+ +..... ........+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000 01122355889999999999999999999986
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=286.87 Aligned_cols=249 Identities=28% Similarity=0.388 Sum_probs=193.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.|...+.||+|++|.||+|... +++.+|+|.+.... .......+.+|+++++.++|+|++++.+++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3556678999999999999975 57889999986432 22223467789999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+. |+|.+.+.... .++++..+..++.+++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 68877765432 2488999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
....++..|+|||.+. ...++.++|||||||++|+|++|+.||.... ............
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~----- 230 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE----- 230 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHHhhcC-----
Confidence 2234788999999874 3567889999999999999999999984311 011111111100
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
............+.+++.+||+.+|.+||++.++++...-
T Consensus 231 ----~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 231 ----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred ----CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 0011112334568899999999999999999999986443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=285.35 Aligned_cols=258 Identities=24% Similarity=0.310 Sum_probs=187.3
Q ss_pred eeeecCCeEEEEEEECCCcEEEEEEeccc-cccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcch
Q 013238 129 ILGRGGFGKVYKGRLTDGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 207 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 207 (447)
.+|.|+++.|+++.. +++.||||++... ........+..|+++++.++|+||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344444545555444 5899999999754 23334457889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC------
Q 013238 208 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------ 281 (447)
Q Consensus 208 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~------ 281 (447)
+++..... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 88 DLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99976532 2388999999999999999999999 999999999999999999999999998865432111
Q ss_pred ceeeccccccCccccccccCC--CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh----hcc----
Q 013238 282 HVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL----KEK---- 351 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~---- 351 (447)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||.... ......+...... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP----ATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCccccccCchhh
Confidence 111223467789999998763 57889999999999999999999996321 0011111110000 000
Q ss_pred ---cccc----ccccc----cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 352 ---KLEQ----LVDSD----MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 352 ---~~~~----~~d~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... ..+.. ............+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 00000 001112234467889999999999999999999887
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=282.50 Aligned_cols=265 Identities=26% Similarity=0.361 Sum_probs=195.6
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEEecc
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
|++.+.||+|++|+||+|... +++.|+||++.............+|+..+.+++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999986 478899999876543333334567899999999 999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
+|+|.+.+.... ...+++..++.++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889998887643 23489999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCC--------CcccHHHHHHHHhhccc
Q 013238 282 HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND--------DDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 352 (447)
.....++..|+|||++.+ ..++.++|+||||+++|||++|+.||........ .......|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122347889999998754 4578999999999999999999999853211000 00000011111110111
Q ss_pred cccccccccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....+...... .........+.+++.+||+.+|.+|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 11110000000 000112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=283.01 Aligned_cols=259 Identities=25% Similarity=0.315 Sum_probs=201.3
Q ss_pred CCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccc---cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 194 (447)
+|+..+.||+|++|.||++... +++.||||.++.... ......+..|++++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667789999999999999753 468899999864322 22234578899999999 599999999999888889
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+.+|+|.+++.... .+++..++.++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999886532 488999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCceeeccccccCccccccccCCC--CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||.... ...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~----~~~~~~~~~~~~~~~-- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG----EQNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc----ccchHHHHHHHHHcc--
Confidence 65443332233345788999999987665 7889999999999999999999995311 111111221221111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
.. .........+.+++.+||+.+|++|||+.++.+.|+..-+
T Consensus 228 -----~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 228 -----KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred -----CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 01 1111233557889999999999999999999988887544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=280.25 Aligned_cols=260 Identities=23% Similarity=0.304 Sum_probs=197.2
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
|+..+.||+|++|.||++... +++.+++|.+...... .....+..|+++++.++|+||+++++++......++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999875 6889999998654322 23456788999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
.+ +|..++.... .++++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 65 8888876643 2489999999999999999999999 99999999999999999999999999987664432
Q ss_pred ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc---ccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKLEQLV 357 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 357 (447)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||..... ..........+.. .....+.
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-----IDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCchHhcccch
Confidence 122223477889999998776 789999999999999999999999853211 0010000000000 0000000
Q ss_pred c---------cccC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 D---------SDME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d---------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+ +... ..........+.+++.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0000 0112234577999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=276.68 Aligned_cols=248 Identities=26% Similarity=0.444 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|+..+.||+|.+|.||++... +++.|++|.+...... .....+.+|++++.+++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777889999999999999876 5789999999765432 2344688999999999999999999999988899999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++++|.+++... .++++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998764 2489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.. .....++..|+|||...+..++.++||||||+++|+|++|..||.... ..... ..... ..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~-~~~~~-~~-------- 215 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAAL-FRIVQ-DD-------- 215 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHH-HHHhc-cC--------
Confidence 22 223457889999999988888999999999999999999999985311 01111 11100 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...........+.+++.+||+.+|++|||+.+++.
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01111223456889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=280.85 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=195.8
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
+|.+.+.||+|+||.||++.... +..+++|.++... .......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998753 4456666654321 122334567789999999999999999999888889999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876444445699999999999999999999999 9999999999999986 569999999987654
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||... ............
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~------- 220 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--------NFLSVVLRIVEG------- 220 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcC-------
Confidence 3221 222345788999999998888899999999999999999999998521 111111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............+.+++.+||+.+|++||++.++++
T Consensus 221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 ---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011122344567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=275.38 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=189.7
Q ss_pred HHHHhhCCCCCCee--eecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHh-cCCCceeeEeeeeecCC
Q 013238 117 LQVATDNFSNRNIL--GRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 117 ~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~ 192 (447)
.....++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|+..... .+|+|++++++.+...+
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 33344667777766 99999999999875 67889999986532211 12222222 26999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeecC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFG 271 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg 271 (447)
..++||||+++++|.+++.... ++++..++.++.|+++||.|||+. +++||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999997643 589999999999999999999999 999999999999999998 99999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++....... ...++..|+|||++.+..++.++||||||+++|||++|+.||.... ........+.... ..
T Consensus 156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~--~~ 225 (267)
T PHA03390 156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEELDLESLLKRQ--QK 225 (267)
T ss_pred cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---cchhhHHHHHHhh--cc
Confidence 987654321 2347889999999999899999999999999999999999996321 1111122221111 00
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVR 396 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 396 (447)
. ..........+.+++.+||+.+|.+||+ ++++++
T Consensus 226 --------~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 --------K--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------c--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 0111234556899999999999999996 588774
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=278.49 Aligned_cols=246 Identities=21% Similarity=0.259 Sum_probs=188.7
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHH-HHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|++|.||+|... +++.||+|.+...... .....+..|..+ .....|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 5889999998654321 112233444443 3456899999999999998999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
++|.+++.... ++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997543 488999999999999999999999 999999999999999999999999999875432
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....++..|+|||.+.+..++.++||||||+++|||++|..||.... ........... ... ...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~------~~~ 214 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--------PDAVFDNILSR-RIN------WPE 214 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhc-ccC------CCC
Confidence 122347889999999988888999999999999999999999995311 11111111110 000 001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.........+.+++.+||+.+|.+|||+.++.+.|.-
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1111234668999999999999999988777666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=284.01 Aligned_cols=245 Identities=28% Similarity=0.402 Sum_probs=191.1
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
|...+.||+|+||+||+|+.. +++.|++|.+..... ......+.+|+++++.++|+|++++++++.+....+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999875 588999999864322 22234678899999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+. |+|.+++.... .++++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 57777775432 2489999999999999999999999 999999999999999999999999999864321
Q ss_pred CceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.....|+..|+|||++. ...++.++||||||+++|||++|..||.... ....+....... ..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~-~~--- 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQND-SP--- 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcC-CC---
Confidence 12345788999999984 4567889999999999999999999985311 111111111110 00
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
..........+.+++.+||+.+|.+||++.++++.
T Consensus 239 -----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 -----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223458889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=292.61 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=206.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccch-HHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
...|.+.+.||+|.|++|.+|+.. ++..||||.+.+...... ...+.+|+++++.++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 357888899999999999999875 689999999977654332 345789999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+|.+.+++...+. ..+.....++.|+..|++|||++ .|+|||||.+||||+.+..+||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999988765 44578888999999999999999 999999999999999999999999999998763
Q ss_pred CCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.......+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+...+ ..+-
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---------------------k~Lr 264 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---------------------KELR 264 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---------------------cccc
Confidence 344556679999999999999877 6899999999999999999999974221 1111
Q ss_pred ccccCCCC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 358 DSDMEGNY--IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 358 d~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
+..+.+.+ +.....++-+++++++-.+|.+|++++++..--..
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 11111111 11223457778889999999999999988765443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=280.85 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=194.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccc---cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 194 (447)
+|+..+.||+|+||.||++... +|+.||+|++..... ......+.+|++++..+ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999999863 688999999865322 12234678899999999 599999999999888889
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+++++|.+++.... ++++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999987542 478899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCC--CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|..||.... .......+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSE- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC----ccccHHHHHHHhhccC-
Confidence 6543322222334578899999998753 46789999999999999999999995311 1111222222221110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
...+......+.+++.+||+.+|.+|| ++.+++.
T Consensus 229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011122345688999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=277.93 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=192.4
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-hHHHHHHHHHHHHhc---CCCceeeEeeeeecCCc-----
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMTPTE----- 193 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 193 (447)
|+..+.||+|+||.||+|+.. +++.+|+|.++...... ....+.+|++++.++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556788999999999999987 48999999997543322 233456677766555 69999999999987766
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.+++|||+. ++|.+++..... ..+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 488888865432 2489999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
........ .....++..|+|||++.+..++.++||||||+++|||++|+.||.... .......+..........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS----EADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC----hHHHHHHHHHHcCCCChH
Confidence 76543321 122346888999999999899999999999999999999999985311 111111111111000000
Q ss_pred c---------cccccccC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 E---------QLVDSDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~---------~~~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ........ ..........+.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000000 0111233466789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=285.16 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=191.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 192 (447)
.++|+..+.||+|++|.||+|... +++.+|+|.+....... ....+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999976 58899999986543222 2335678999999999999999998875443
Q ss_pred --cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 193 --ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 193 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
..+++|+|+.+ +|...+.... ..+++..++.++.|+++||+|||++ +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35899999964 6666665432 2489999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCc----------eeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCccc
Q 013238 271 GLAKLMDYKDTH----------VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339 (447)
Q Consensus 271 gl~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~ 339 (447)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-----~~ 234 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-----ID 234 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-----HH
Confidence 999765432211 11223467889999987654 578999999999999999999999853211 11
Q ss_pred HHHHHHHHhhcc---------cccccc----ccccCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 340 LLDWVKGLLKEK---------KLEQLV----DSDMEGN---YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 340 ~~~~~~~~~~~~---------~~~~~~----d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....+....... ...... ....... ........+.+++.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111100000 000000 0000000 00112256889999999999999999998875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=298.03 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=196.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+.|+++..||.|+||.||+|..++ +-..|-|.+... .......++-|+++|....||+||++++.|.-.+.+|++.||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 456666779999999999998774 444566766433 233345688999999999999999999998889999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
|.||.....+-..+ .++.+..+..++.+++.||.|||++ +|+|||||..|||++-+|.++|+|||.+.... ..
T Consensus 111 C~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-ST 183 (1187)
T ss_pred cCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hH
Confidence 99999988876543 3499999999999999999999999 99999999999999999999999999885432 12
Q ss_pred CceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
......+.||++|||||+.. ..+|+.++||||||++|.||..+.+|-...+.. ..+-..-+ .....
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--------RVllKiaK-SePPT 254 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAK-SEPPT 254 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--------HHHHHHhh-cCCCc
Confidence 22344566999999999864 568999999999999999999999987432110 00000000 00011
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+ -.+......+.+++..||..||..||++.++++.
T Consensus 255 L-------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 255 L-------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred c-------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1 1233455678899999999999999999998863
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=289.21 Aligned_cols=264 Identities=20% Similarity=0.324 Sum_probs=196.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec----CCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 194 (447)
.++|+..+.||+|++|.||+|... +|+.||+|++..... ......+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368899999999999999999875 589999999875432 2234467789999999999999999988753 3457
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+. ++|.+++.... .+++..++.++.||+.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 89999995 68888876432 389999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCc---eeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 275 LMDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 275 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~-----~~~~~~~~~~~g~ 230 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY-----VHQLKLILSVLGS 230 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh-----HHHHHHHHHHhCC
Confidence 65432211 1123457889999998865 4588999999999999999999999953211 0111111110000
Q ss_pred -----------ccccccccc-ccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 351 -----------KKLEQLVDS-DMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 351 -----------~~~~~~~d~-~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.......+. ..... ........+.+++.+||+.+|.+|||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000 00000 012235678999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=283.99 Aligned_cols=243 Identities=21% Similarity=0.340 Sum_probs=192.7
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
.+||+|+||.||++... +++.||||.+.... ......+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 56999999999999875 68899999885432 23345688899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeec
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 286 (447)
.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9887542 378999999999999999999999 999999999999999999999999999875533221 1233
Q ss_pred cccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCc
Q 013238 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366 (447)
Q Consensus 287 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 366 (447)
..++..|+|||.+.+..++.++||||||+++|+|++|..||.... . ...+...... ...... ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~-----~---~~~~~~~~~~------~~~~~~--~~ 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----P---LKAMKMIRDN------LPPKLK--NL 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHhh------CCcccC--Cc
Confidence 457889999999988888999999999999999999999985311 1 1111111000 001100 01
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 367 EEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 367 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112345788999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=286.31 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=195.8
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec-CCcc
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTER 194 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 194 (447)
...+++|+..+.||.|+||.||++... +++.||||++..... ......+..|++++..++|||++++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345778999999999999999999866 689999998864322 2234567789999999999999999998875 4578
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++++||+ +++|..++... ++++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 66888887542 378888899999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCC-------CcccHHHHHHH
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLDWVKG 346 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~-------~~~~~~~~~~~ 346 (447)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ......++...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 122346788999998766 5689999999999999999999999953211000 00000011111
Q ss_pred HhhccccccccccccCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 347 LLKEKKLEQLVDSDMEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
........-+.........+ ......+.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11110000000000000111 1134678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=279.17 Aligned_cols=242 Identities=27% Similarity=0.355 Sum_probs=184.5
Q ss_pred eeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHH---HHHHhcCCCceeeEeeeeecCCcceEEEeccc
Q 013238 129 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEV---EMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 202 (447)
.||+|+||.||++... +++.||+|.+...... .....+..|. ..++...|+||+.+.+++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 5889999998654322 1112233333 34445679999999999999999999999999
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 282 (447)
+|+|..++.... .+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999998886432 489999999999999999999999 999999999999999999999999999875432221
Q ss_pred eeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 283 VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 283 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
....|+..|+|||++.++ .++.++||||||+++|||++|+.||...... ..... ...... ....
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~------~~~~- 217 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEI-DRMTLT------MAVE- 217 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHHH-HHHhhc------cCCC-
Confidence 223588999999998754 6889999999999999999999999642111 00010 000000 0111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
.+......+.+++.+|+..+|.+|| ++.++++
T Consensus 218 ---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 ---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1112346688999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.06 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=194.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhc-CCCceeeEeeeeecC--Ccc
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP--TER 194 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 194 (447)
..++|+..+.||+|+||.||+|... +++.+|+|++.... .......+.+|+.+++.+ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999976 58899999885432 222234567899999999 999999999988653 357
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+. ++|..++... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 5888887653 378999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----ceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh-
Q 013238 275 LMDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL- 348 (447)
Q Consensus 275 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 348 (447)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-----~~~~~~~~~~~ 230 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-----NQLEKIIEVIG 230 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhC
Confidence 6543321 12223457889999998765 45788999999999999999999999532110 0000000000
Q ss_pred ----------hccccccccc----cccC--CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 349 ----------KEKKLEQLVD----SDME--GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 349 ----------~~~~~~~~~d----~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.......+++ .... ..........+.+++.+||+.+|.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000110 0000 00111134668999999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.25 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=197.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----cce
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 195 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 195 (447)
+|.+.+.||+|++|.||+|... +++.+|||.+..... ......+.+|+++++.++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5778899999999999999976 489999999875432 333456888999999999999999999987765 789
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++|+|+. ++|.+++.... ++++..++.++.+++.||+|||+. +++|+||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58888886533 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 276 MDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 276 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ......+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-----IDQLNLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHhcCCCC
Confidence 654321 112233478899999999887 789999999999999999999999953211 001111111000000
Q ss_pred -----------ccccccc-ccCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 -----------LEQLVDS-DMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 -----------~~~~~d~-~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....+.. .... .........+.+++.+||+.+|.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000000 0000 001123466889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=273.98 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=196.7
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHH-hcCCCceeeEeeeeecCCcceEEEecc
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
.+.+..||.|.||+|++-.++ .|+..|||+++.........+++.|.+... .-+.||||+++|.+..++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 334456999999999999876 699999999988777666778889998654 456899999999999999999999999
Q ss_pred cCCcchhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 202 VNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 202 ~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
.-+|..+.... ......+++..+..|....+.||.||.... .|+|||+||+|||+|..|.+||||||++..+..+
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 44666544321 112234889999999999999999999876 8999999999999999999999999999765432
Q ss_pred CceeeccccccCccccccccC--CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
-..+...|...|||||.+.. ..|+.+|||||||++|+|+.||+.|++.. .+..+-+.......... +.
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-------~svfeql~~Vv~gdpp~-l~- 291 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-------DSVFEQLCQVVIGDPPI-LL- 291 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-------HHHHHHHHHHHcCCCCe-ec-
Confidence 22334458889999999854 35899999999999999999999999531 11223333332221111 11
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...........+.+++..|+.+|-.+||...++.+
T Consensus 292 ---~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 ---FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ---CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11122345667999999999999999999998876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=282.07 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=199.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 197 (447)
++|...+.||+|++|.||++... +++.||+|.+..... ......+..|.+++.+++ |+||+++++++......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999876 689999999865322 223346788999999998 99999999999988999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+.+++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997643 489999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCC-------------------ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcc
Q 013238 278 YKDT-------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338 (447)
Q Consensus 278 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 338 (447)
.... .......++..|+|||++.+..++.++||||||++++++++|+.||.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~- 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----E- 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----H-
Confidence 3221 12223347889999999988889999999999999999999999996421 0
Q ss_pred cHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 013238 339 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM----SEVVR 396 (447)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 396 (447)
......... .....+......+.+++.+||+.+|.+|||+ .++++
T Consensus 228 --~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 --YLTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 011111110 0011112224568999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=311.23 Aligned_cols=293 Identities=20% Similarity=0.260 Sum_probs=221.1
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeee
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCM 189 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 189 (447)
.+.++....++|+++++||+|+||.|..++.+ +++.||.|++.+... ......|..|-++|...+.+-|+.+...|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35667778899999999999999999999986 588999999976322 233446888899999999999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEee
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 269 (447)
+..++|+|||||+||+|-.++.... ++++..++.++..|+-||.-||+. |+|||||||+|||||..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999997764 489999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCceeeccccccCcccccccc----C-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 270 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS----T-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 270 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
||.+-.+.....-.....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||.... +++-.
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY 290 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETY 290 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHH
Confidence 9999887765555566678999999999984 3 578999999999999999999999996422 22222
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHhcCCCchhhHHHHHhhhhhccCC
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK---MSEVVRMLEGDGLAERWEEWQKEEMFRQDFN 421 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~ 421 (447)
...+..+....+-+ ..+......+||.+.+. +|..|.. +.++-. +.|=+...|..=.+-.....+
T Consensus 291 ~KIm~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~----HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 291 GKIMNHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN----HPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred HHHhchhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh----CccccCCChhhhhhcCCCCCC
Confidence 22222221111111 11233445556555443 7888887 555443 333222222222334455555
Q ss_pred CCCCCCCcccc
Q 013238 422 HTPHPNNTWIV 432 (447)
Q Consensus 422 ~~~~~~~~~~~ 432 (447)
++..+.-|.+|
T Consensus 359 evssd~DTsnF 369 (1317)
T KOG0612|consen 359 EVSSDDDTSNF 369 (1317)
T ss_pred cCCCCCccccc
Confidence 56666666655
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=287.49 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=194.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Cc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 193 (447)
.++|...+.||+|+||+||++... +++.||||.+.... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888899999999999999865 68999999986532 222234567899999999999999999987643 34
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++++||+. ++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 6888887643 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh---
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 349 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 349 (447)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ............
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 229 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLGSPS 229 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCC
Confidence 8654322 22223347889999998865 4688999999999999999999999953210 000000000000
Q ss_pred --------cccccccccc---ccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 350 --------EKKLEQLVDS---DMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 350 --------~~~~~~~~d~---~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.......... .... .........+.+++.+||+.+|.+|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 0000 0011234668899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=284.41 Aligned_cols=268 Identities=21% Similarity=0.248 Sum_probs=196.4
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 190 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 190 (447)
...++....++|...+.||+|+||.||++... +++.||+|++..... ......+.+|++++..++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 44556677899999999999999999999864 688999999875322 2223457789999999999999999998754
Q ss_pred C------CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 013238 191 P------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 264 (447)
Q Consensus 191 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~ 264 (447)
. ...+++++++ +++|.+++... .+++..++.++.|+++||+|||+. +++||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3357788876 78888877542 388999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHH
Q 013238 265 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 343 (447)
Q Consensus 265 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 343 (447)
+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ....+...
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~----~~~~~~~~ 230 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD----HIDQLKLI 230 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH
Confidence 999999998754321 223357889999998866 567889999999999999999999994311 00001100
Q ss_pred HHHH----------hhccccccc---cccccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 344 VKGL----------LKEKKLEQL---VDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 344 ~~~~----------~~~~~~~~~---~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.... +........ +...... .........+.+++.+|++.||.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 000000000 0000000 0000123457899999999999999999988865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=276.54 Aligned_cols=260 Identities=26% Similarity=0.347 Sum_probs=196.5
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
|+..+.||+|.+|.||+|+.. +++.+|+|.+..... ......+..|+++++.++|+|++++++++.+....+++|||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999976 489999999976532 223346778999999999999999999999989999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
. ++|.+++.... ..+++..++.++.+++.||+|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999997653 2489999999999999999999999 999999999999999999999999999986543322
Q ss_pred ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc--------
Q 013238 282 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-------- 352 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 352 (447)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||.... ................
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-----EIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHHHhCCCcHHHHHhhc
Confidence 12223357789999998776 78999999999999999999999985321 1111111111100000
Q ss_pred ----ccccccccc---CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 ----LEQLVDSDM---EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ----~~~~~d~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
......... ...........+.+++.+||+.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 00001112467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=283.46 Aligned_cols=262 Identities=24% Similarity=0.310 Sum_probs=192.9
Q ss_pred hCCCC-CCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-------------hHHHHHHHHHHHHhcCCCceeeEee
Q 013238 122 DNFSN-RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------------GELQFQTEVEMISMAVHRNLLRLRG 186 (447)
Q Consensus 122 ~~~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~l~~ 186 (447)
++|.. .+.||+|+||+||+|... +++.||||.+....... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45553 467999999999999876 68999999986432221 0124678999999999999999999
Q ss_pred eeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 013238 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 187 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
++...+..+++|||+. |+|.+++.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 68988886532 388999999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCC-------------CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccc
Q 013238 267 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARL 332 (447)
Q Consensus 267 l~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~ 332 (447)
|+|||++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~- 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN- 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999987654111 1111223367889999998764 46899999999999999999999995321
Q ss_pred cCCCcccHHHHHHHHhhccccc---ccc--------ccccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 333 ANDDDVMLLDWVKGLLKEKKLE---QLV--------DSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~---~~~--------d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.......+.......... +.. ...... .........+.+++.+||+.+|.+|||+.+++.
T Consensus 239 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 ----EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ----HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111111111100000 000 000000 001123456889999999999999999999986
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=282.07 Aligned_cols=258 Identities=21% Similarity=0.305 Sum_probs=189.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 192 (447)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468888999999999999999875 689999999865322 222345788999999999999999999886542
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++++||+. .+|..++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4589999985 36655542 1388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh---
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL--- 348 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 348 (447)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...........
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 234 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGVP 234 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCC
Confidence 8754321 122346788999999876 4688999999999999999999999963211 00000000000
Q ss_pred --------hccccccccc--cccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 349 --------KEKKLEQLVD--SDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 349 --------~~~~~~~~~d--~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.......... +...... .......+.+++.+||+.||.+|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 0000000 01123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=281.36 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=193.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 192 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 192 (447)
..++|...+.||+|++|.||++... ++..||||++..... ......+.+|+++++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999865 689999999864322 222345778999999999999999999887543
Q ss_pred -cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 193 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 193 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
..++||+|+ +++|..++... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 348999999 77888887532 389999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCC-------CcccHHHH
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLDW 343 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~-------~~~~~~~~ 343 (447)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .......+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99764322 122346889999999876 4588999999999999999999999953210000 00000001
Q ss_pred HHHHhhccccccccc--cccCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 344 VKGLLKEKKLEQLVD--SDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 344 ~~~~~~~~~~~~~~d--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....... ....... +.... .........+.+++.+|++.||.+|||+.+++.
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSE-DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcch-hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0000000 00000 001123345889999999999999999999885
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=287.14 Aligned_cols=298 Identities=22% Similarity=0.289 Sum_probs=220.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCc-EEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGS-LVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.++..+..||-|+||.|-++...... .+|+|++++...- ........|-.+|...+.+.||+++-.+.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566677999999999999876433 4899988765432 22345677889999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|-|-||.|+..|+.++. ++..+.+.++..+++|+.|||++ +||+|||||+|+++|.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999988764 88889999999999999999999 999999999999999999999999999998754
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. ..+-..+||+.|.|||++.+..++.++|.||||+++|||++|++||...+.. ...+. .++.
T Consensus 573 g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-----ktYn~---ILkG-------- 634 (732)
T KOG0614|consen 573 G--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-----KTYNL---ILKG-------- 634 (732)
T ss_pred C--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-----HHHHH---HHhh--------
Confidence 3 3345578999999999999999999999999999999999999999753321 11111 1111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHhcCCCch--hhHHHHHhhhhhccCCCCCCCCCcccccCC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM-SEVVRMLEGDGLAE--RWEEWQKEEMFRQDFNHTPHPNNTWIVDST 435 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~evl~~L~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (447)
.-...++........++|.+.+..+|.+|... ..=+.-++++.+=+ +|.-...-.....-.+.+.+|--+..+|.+
T Consensus 635 -id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~ 713 (732)
T KOG0614|consen 635 -IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNF 713 (732)
T ss_pred -hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCC
Confidence 11112233344556778888889999999761 11122222222211 222233344444455555555555566555
Q ss_pred ----CcccCCccCC
Q 013238 436 ----SHIQPDELSG 445 (447)
Q Consensus 436 ----~~~~~~~~~~ 445 (447)
.-+-|+|+||
T Consensus 714 p~dnd~pppde~SG 727 (732)
T KOG0614|consen 714 PPDNDEPPPDELSG 727 (732)
T ss_pred CcccCCCCchhccc
Confidence 2334589998
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=260.58 Aligned_cols=253 Identities=24% Similarity=0.273 Sum_probs=194.1
Q ss_pred hhCCCCC-CeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecC----Cc
Q 013238 121 TDNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP----TE 193 (447)
Q Consensus 121 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 193 (447)
+++|.+. ++||-|-.|.|..+..+ +++.+|+|++.... ...+|++.-.+. .|+|||.+++++.+. .-
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3445443 57999999999999876 68999999986432 245777776555 499999999988653 34
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeec
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 270 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 270 (447)
+.+|||.|+||.|...++.++.. ++++.++.+|+.||+.|+.|||+. +|.||||||+|+|... +..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 57999999999999999887643 599999999999999999999999 9999999999999964 456999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|+|+.... .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||.. ......... ++.....
T Consensus 209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS----~hg~aispg-Mk~rI~~ 281 (400)
T KOG0604|consen 209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS----NHGLAISPG-MKRRIRT 281 (400)
T ss_pred ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc----cCCccCChh-HHhHhhc
Confidence 99986432 2233445679999999999999999999999999999999999999952 111111000 0110000
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
-.-.+.........+...++|..+|..+|.+|.|+.+++..
T Consensus 282 ------gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 282 ------GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ------cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 01112233455667778889999999999999999999863
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=284.86 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=188.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC---------
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--------- 191 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 191 (447)
.+|...+.||.|+||.||+|... +|..||+|.+..... .....+.+|+++++.++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999875 588999999865433 3344678899999999999999998766543
Q ss_pred -----CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcE
Q 013238 192 -----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEA 265 (447)
Q Consensus 192 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~-~~~~~ 265 (447)
...+++|||+. ++|.+++... .+++..++.++.||+.||.|||+. +++||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 34689999996 5888877532 388999999999999999999999 999999999999997 45678
Q ss_pred EEeecCCccccCCCCCc--eeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHH
Q 013238 266 VVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 342 (447)
+|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~----~~~~~ 230 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL----EQMQL 230 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence 99999999765322111 1122346888999998754 56788999999999999999999999532110 00000
Q ss_pred HHHHHh--hcccccc--------ccccccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 343 WVKGLL--KEKKLEQ--------LVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 343 ~~~~~~--~~~~~~~--------~~d~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...... ....... .......... .......+.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0000000 0000000000 0123356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=268.33 Aligned_cols=237 Identities=29% Similarity=0.331 Sum_probs=191.0
Q ss_pred eeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 130 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 130 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
||+|++|.||++... +++.+|+|.+...... .....+..|+++++.++|+|++++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 5889999998764332 2344688899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeec
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 286 (447)
.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99997643 389999999999999999999998 99999999999999999999999999987654322 12233
Q ss_pred cccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCc
Q 013238 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366 (447)
Q Consensus 287 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 366 (447)
..++..|+|||...+...+.++|+||||+++|+|++|..||..... ......... .. ...+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~---------~~--~~~~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK---------DP--LRFP 213 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc---------CC--CCCC
Confidence 4578899999999888889999999999999999999999953210 111111111 00 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH
Q 013238 367 EEEVEQLIQVALLCTQGSPMERPKMSE 393 (447)
Q Consensus 367 ~~~~~~l~~li~~cl~~dP~~RPt~~e 393 (447)
......+.+++.+||..||++|||+.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 122466889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=283.25 Aligned_cols=259 Identities=23% Similarity=0.317 Sum_probs=193.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc----
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE---- 193 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 193 (447)
..++|+..+.||+|++|.||+|... +++.||||++..... ......+.+|+.+++.++|+|++++.+++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567889999999999999999976 578999999865322 2223457789999999999999999987765544
Q ss_pred --ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 194 --RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 194 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
.++|+||+ +++|.+++... ++++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 67998888642 489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-----~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-----IDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCC
Confidence 99865322 222347888999998865 3678999999999999999999999953110 0001100000000
Q ss_pred -----------ccccccccc---ccCCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 -----------KKLEQLVDS---DMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 -----------~~~~~~~d~---~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
......... ...... .......+.+++.+||+.+|.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 000000 0112467899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=276.66 Aligned_cols=285 Identities=19% Similarity=0.250 Sum_probs=199.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-C--CcEEEEEEecccccc-chHHHHHHHHHHHHhc-CCCceeeEeeeeecC----Cc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-D--GSLVAVKRLKEERTQ-GGELQFQTEVEMISMA-VHRNLLRLRGFCMTP----TE 193 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 193 (447)
+|+..+.||+|+||.||++... . +..||+|.+...... .....+.+|++++.++ .|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677789999999999999975 3 678999998653222 2234577899999988 599999999875432 44
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.+++++|+. ++|..++... ..+++..++.++.||+.||.|||+. +++||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678889885 6888888543 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---eeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHH-------
Q 013238 274 KLMDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD------- 342 (447)
Q Consensus 274 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~------- 342 (447)
+........ ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||..... .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~ 227 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLNQILQVLG 227 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHHHHHHHhC
Confidence 765422111 1122358889999998765 4689999999999999999999999853210 00000
Q ss_pred -----HHHHHhhcccccccc---ccccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhhHHHH
Q 013238 343 -----WVKGLLKEKKLEQLV---DSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQ 411 (447)
Q Consensus 343 -----~~~~~~~~~~~~~~~---d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~ 411 (447)
++...... ...... ...... .........+.+++.+||+.||.+|||+.+++.. +|
T Consensus 228 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~-----------~~- 294 (332)
T cd07857 228 TPDEETLSRIGSP-KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH-----------PY- 294 (332)
T ss_pred CCCHHHHHhhhhh-hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC-----------hh-
Confidence 00000000 000000 000000 0001123568899999999999999999998632 22
Q ss_pred HhhhhhccCCCCCCCCCcccccCC
Q 013238 412 KEEMFRQDFNHTPHPNNTWIVDST 435 (447)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~~ 435 (447)
+..+++ ....+.|+.+|.++-+
T Consensus 295 -~~~~~~-~~~~~~~~~~~~~~~~ 316 (332)
T cd07857 295 -LAIWHD-PDDEPVCQKPFDFSFE 316 (332)
T ss_pred -hhhhcC-ccccccccccccCCcc
Confidence 122333 4446667777766543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=262.93 Aligned_cols=205 Identities=26% Similarity=0.375 Sum_probs=169.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-----CcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeec-CCc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 193 (447)
...|+....||+|.+|.||+|.-.+ ...+|||+++..... .......+|+.+++.++|+|++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568889999999999999996432 236899999866432 223457789999999999999999998887 677
Q ss_pred ceEEEecccCCcchhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC----CcEEEe
Q 013238 194 RLLVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVG 268 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~----~~~kl~ 268 (447)
.++++||.+. +|+..++-.+.. ...++...++.|+.||+.|+.|||++ =|+||||||.||||..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999977 888888654322 24588999999999999999999999 79999999999999877 999999
Q ss_pred ecCCccccCCCCCc--eeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 269 DFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 269 Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
|+|+++.+...-.. ....++-|.+|.|||.+.+. .|+.+.||||.|||+.||+|-.+.|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999987543221 23345679999999998876 579999999999999999998888753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=263.56 Aligned_cols=219 Identities=21% Similarity=0.177 Sum_probs=174.4
Q ss_pred cCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcchhhhh
Q 013238 133 GGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 211 (447)
Q Consensus 133 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 211 (447)
|.+|.||++... +++.+|+|.+.... .+..|...+....|||++++++++......+++|||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999975 68899999996543 12344455556679999999999999999999999999999999986
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeecccccc
Q 013238 212 ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291 (447)
Q Consensus 212 ~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~ 291 (447)
... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 543 389999999999999999999999 9999999999999999999999999987654322 12233567
Q ss_pred CccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHH
Q 013238 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE 371 (447)
Q Consensus 292 ~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 371 (447)
.|+|||.+.+..++.++||||+|+++|||++|+.|+...... .... .. ...+.....
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------------~~~~-----~~----~~~~~~~~~ 203 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------------INTH-----TT----LNIPEWVSE 203 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------------cccc-----cc----cCCcccCCH
Confidence 899999998888899999999999999999999887421100 0000 00 011112345
Q ss_pred HHHHHHHHccCCCCCCCCCH
Q 013238 372 QLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 372 ~l~~li~~cl~~dP~~RPt~ 391 (447)
.+.+++.+|++.||.+|||+
T Consensus 204 ~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHHccCCHHHhcCC
Confidence 68889999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=244.12 Aligned_cols=213 Identities=23% Similarity=0.367 Sum_probs=178.2
Q ss_pred cCHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHh-cCCCceeeEeeeee
Q 013238 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCM 189 (447)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~ 189 (447)
+....+++..++...+..||+|++|.|-+-++. +|...|+|++..........++++|+++..+ ...|.+|.++|...
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 344446677777778888999999999888764 7999999999877666666678888887654 46999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEee
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 269 (447)
.....++.||.| .-+|..+-...-.....+++..+-+|+..++.||.|||++. .++|||+||+||||+.+|++|+||
T Consensus 116 regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 999999999999 55888776665445556999999999999999999999987 899999999999999999999999
Q ss_pred cCCccccCCCCCceeeccccccCccccccccC----CCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 270 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 270 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
||++..+..+.. .+...|...|||||.+.. ..|+.++||||||+.+.||.+++.||+.
T Consensus 193 FGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 193 FGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred cccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 999987643322 222458889999998853 3689999999999999999999999963
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.27 Aligned_cols=146 Identities=32% Similarity=0.455 Sum_probs=129.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|.+.+.||+|+||.||+|.+. +++.||||+++.... ......+..|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999986 688999999975432 222346888999999999999999999999889999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
||+.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987543 378899999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=233.87 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=193.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+|...++||+|.+|+|++|+.. +++.||+|+++.+... .......+|+-+++.+.|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3455678999999999999865 5889999999765433 3344678999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
| ..+|..+.....+ .++....+.++.|+++||.|+|++ ++.|||+||.|.||+.+|++|++|||+++.++...
T Consensus 83 c-dqdlkkyfdslng---~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred h-hHHHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9 4588888766443 388899999999999999999999 99999999999999999999999999999876432
Q ss_pred CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc----
Q 013238 281 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---- 354 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 354 (447)
......+.|.+|.+|.++.+. -|++..|+||.|||+.|+.. |++.|.. .+....+. .+...+......
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg----~dvddqlk-rif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLK-RIFRLLGTPTEDQWPS 229 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC----CcHHHHHH-HHHHHhCCCccccCCc
Confidence 334455679999999999876 47899999999999999987 5555532 11111111 111111111111
Q ss_pred --cccccccCCCCc---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 355 --QLVDSDMEGNYI---------EEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 355 --~~~d~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.+-|......++ +.....-.+++...+.-+|.+|.++++.++
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111111111 111223356777778889999999988765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=268.29 Aligned_cols=299 Identities=23% Similarity=0.318 Sum_probs=211.5
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchH--HHHHHHHHHHHhc-CCCceeeEeeeeecCCcc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGE--LQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 194 (447)
+-..+|..+.+||+|+||+|.+|.-+ +.+.+|||+++++...... .--+.|-++|... +-|.++++...++.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 33457888999999999999999865 4788999999876543221 1223456666655 467888898888999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
|+||||+.||+|--.+++.+. +.+..+..++..||-||-+||++ +|++||||.+|||+|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999999988765 66677888999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.-- -....+...+||+.|+|||++.-.+|+..+|+|||||+||||+.|+.||+..+ +..+. .
T Consensus 499 Eni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD-----E~elF------------~ 560 (683)
T KOG0696|consen 499 ENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----EDELF------------Q 560 (683)
T ss_pred ccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC-----HHHHH------------H
Confidence 532 23344556789999999999999999999999999999999999999997421 11111 1
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHhcCCC--chhhHHHHHhhhhhccCCCCCCCCCccc
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS-EVVRMLEGDGL--AERWEEWQKEEMFRQDFNHTPHPNNTWI 431 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~L~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (447)
.+.+.. -.++.....+...+....+.+.|.+|.... +--+-+....+ .-.|++....++...-.+...+.-..-+
T Consensus 561 aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eN 638 (683)
T KOG0696|consen 561 AIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAEN 638 (683)
T ss_pred HHHHcc--CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhh
Confidence 111111 123333445566677778899999996431 11122222222 1233333333333333333323344455
Q ss_pred ccCCCcccCCccC
Q 013238 432 VDSTSHIQPDELS 444 (447)
Q Consensus 432 ~~~~~~~~~~~~~ 444 (447)
+|..+-.++-+|.
T Consensus 639 FD~~Ft~~~~~lT 651 (683)
T KOG0696|consen 639 FDKFFTREPTDLT 651 (683)
T ss_pred hhHHHhcCCCCCC
Confidence 5555555554443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=283.74 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=206.9
Q ss_pred HHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee---
Q 013238 115 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM--- 189 (447)
Q Consensus 115 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--- 189 (447)
+.+...++.|++.+.||.|.+|.||+++.. +++.+|+|++...... ..+.+.|.++++.. .|||++.++|++.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 333445678999999999999999999854 6899999998765443 33566788888766 5999999999886
Q ss_pred --cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEE
Q 013238 190 --TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 267 (447)
Q Consensus 190 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl 267 (447)
.++++|||||||.+|+..++++... ...+.|..+..|+..++.|+.+||.+ .++|||||-.|||++.++.+||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 3578999999999999999998866 44599999999999999999999999 9999999999999999999999
Q ss_pred eecCCccccCCCCCceeeccccccCccccccccCC-----CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHH
Q 013238 268 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 268 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 342 (447)
.|||.+..++...... ....||+.|||||++.-. .|+..+|+||||++..||.-|.+|+-..
T Consensus 165 vDFGvSaQldsT~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm------------ 231 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM------------ 231 (953)
T ss_pred eeeeeeeeeecccccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc------------
Confidence 9999998876544433 334599999999998533 4677899999999999999999998421
Q ss_pred HHHHHhhccccccc-cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 343 WVKGLLKEKKLEQL-VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 343 ~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.....+..+ -++...-..+..-.+.+.++|..||.+|-..||++.++++
T Consensus 232 -----HPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 232 -----HPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -----chhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111111111 1222223345667788999999999999999999998876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=279.81 Aligned_cols=240 Identities=23% Similarity=0.287 Sum_probs=190.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHh-cCCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++.|+....+|.|+|+.|-++... +++..++|++.+... .-.+|+.++.+ -.|+|++++.+.+.+..+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567888888999999999999865 678899999976522 22356655444 46999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE-CCCCcEEEeecCCccccC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgl~~~~~ 277 (447)
|.+.++-|.+.+.... .....+..|+.+|+.|+.|||++ |++||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998877775433 22367778999999999999999 99999999999999 699999999999998765
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. ....+-|..|.|||++....++.++||||||++||+|++|+.||... ..+ . ++.
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~----P~~---~-------------ei~ 523 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH----PAG---I-------------EIH 523 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC----Cch---H-------------HHH
Confidence 43 22224578899999999999999999999999999999999999631 111 1 111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.....+.+.........+|+.+||+.||.+||+|.++...
T Consensus 524 ~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 524 TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1111222234445667889999999999999999998763
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=254.62 Aligned_cols=266 Identities=21% Similarity=0.283 Sum_probs=196.2
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEE-ECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeec
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 190 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 190 (447)
.+.++...++ +.||+|+++.|.-++ ..+|..+|||++.+. ....+.+..+|++++...+ |+||+.+++++.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3455555554 679999999999887 567999999999776 3344557889999998886 9999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEE
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVV 267 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kl 267 (447)
+...|+|||-|.||.|...++++.. +++.++.++..+|+.||.|||.+ ||.||||||+|||..+... +||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999987653 89999999999999999999999 9999999999999976544 899
Q ss_pred eecCCccccCCCC------CceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCC
Q 013238 268 GDFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 336 (447)
Q Consensus 268 ~Dfgl~~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~ 336 (447)
+||.+........ .-.....+|+..|||||+.. ...|+.+.|.||||+|||-|++|..||......+..
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 9999875432211 11122345888999999763 335789999999999999999999999643222111
Q ss_pred ---cccHHHHHHHHhhccccccccccc--cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 337 ---DVMLLDWVKGLLKEKKLEQLVDSD--MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 337 ---~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+......-..++. .+-+.. +...........-.+++...+..++.+|.++.++++
T Consensus 301 WdrGe~Cr~CQ~~LFe-----sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFE-----SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHH-----HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111111111111 010110 111112223344566777788899999999988877
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=262.59 Aligned_cols=260 Identities=23% Similarity=0.282 Sum_probs=198.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC--CCc----eeeEeeeeecCC
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRN----LLRLRGFCMTPT 192 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~n----iv~l~~~~~~~~ 192 (447)
.+.+|.+...+|+|.||.|-.+.+. .+..||||+++.-. .-....+-|++++.++. -|+ ++.+.+++.-.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 4778999999999999999999865 47899999997532 22334567899998884 222 677888888889
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC------------
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD------------ 260 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~------------ 260 (447)
+.++|+|.+ |-++.++|..+. ..+++...+..|+.|++++++|||+. +++|.||||+|||+.
T Consensus 165 hiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 999999998 779999998754 34699999999999999999999999 999999999999993
Q ss_pred --------CCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccc
Q 013238 261 --------EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 332 (447)
Q Consensus 261 --------~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~ 332 (447)
++..++++|||.|...... ...++.|..|.|||++.+..++..+||||+||||+|+.||...|+.
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt--- 311 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT--- 311 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc---
Confidence 1345899999999864322 2455689999999999999999999999999999999999999963
Q ss_pred cCCCcccHHHHHHHHhh-----------------ccccc-----------ccccccc----CCCCcHHHHHHHHHHHHHc
Q 013238 333 ANDDDVMLLDWVKGLLK-----------------EKKLE-----------QLVDSDM----EGNYIEEEVEQLIQVALLC 380 (447)
Q Consensus 333 ~~~~~~~~~~~~~~~~~-----------------~~~~~-----------~~~d~~~----~~~~~~~~~~~l~~li~~c 380 (447)
.++......++..+. ...+. .+.+... .....+.+...|++|+..|
T Consensus 312 --Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 312 --HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred --CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 122222222222111 11000 0000000 0112345667799999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 013238 381 TQGSPMERPKMSEVVR 396 (447)
Q Consensus 381 l~~dP~~RPt~~evl~ 396 (447)
|..||.+|+|+.|++.
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999886
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=283.80 Aligned_cols=264 Identities=19% Similarity=0.199 Sum_probs=170.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-C----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeee------e
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-D----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF------C 188 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~ 188 (447)
..++|...+.||+|+||.||+|.+. + +..||||++...... . .... +.+....+.++..+... +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e-~~~~--e~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--E-IWMN--ERVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--H-HHHH--HHHHhhchhhHHHHHHhhhccccc
Confidence 4678999999999999999999976 4 689999988643211 1 1111 11122222222222111 2
Q ss_pred ecCCcceEEEecccCCcchhhhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 013238 189 MTPTERLLVYPFMVNGSVASCLRERGQS----------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 252 (447)
Q Consensus 189 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dl 252 (447)
......++||||+.+++|.+++...... ........+..++.|++.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 3456789999999999999988653210 00112345668999999999999999 9999999
Q ss_pred CCCCEEECC-CCcEEEeecCCccccCCCCCceeeccccccCccccccccCC----------------------CCCchhh
Q 013238 253 KAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG----------------------KSSEKTD 309 (447)
Q Consensus 253 k~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 309 (447)
||+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986543333333445689999999965322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCcccccc-----cCCCcccHHHHHHHHhhccccccccccccCC--CCcHHHHHHHHHHHHHccC
Q 013238 310 VFGYGVMLLELITGQRAFDLARL-----ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG--NYIEEEVEQLIQVALLCTQ 382 (447)
Q Consensus 310 vwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~li~~cl~ 382 (447)
||||||+||||+++..+++.... ..........|....... ....+.. ...........+++.+||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999998776542100 000011122221111000 0000000 0001112235689999999
Q ss_pred CCCCCCCCHHHHHHH
Q 013238 383 GSPMERPKMSEVVRM 397 (447)
Q Consensus 383 ~dP~~RPt~~evl~~ 397 (447)
.||.+|||+.++++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999983
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=271.67 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=193.6
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCc
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
++||+|.||+||-|+.+ +|+.||||++.+.+-. ..+.++.+|+.+|..+.||.||.+.-.|...+..++|||-+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 78999999999999975 7999999999876543 345578899999999999999999999999999999999995 45
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeecCCccccCCCCCc
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~~ 282 (447)
..+++-.... ..+++...+.++.||+.||.|||.+ +|+|+||||+|||+.+. -.+||+|||+|+.+... .
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 5555433222 2389999999999999999999999 99999999999999643 47999999999987543 3
Q ss_pred eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccC
Q 013238 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362 (447)
Q Consensus 283 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 362 (447)
....++||+.|+|||++.++.|+..-|+||.|+|+|--++|..||... .++.+-++.. .+ ...
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-------EdIndQIQNA-------aF---MyP 784 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-------EDINDQIQNA-------AF---MYP 784 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-------cchhHHhhcc-------cc---ccC
Confidence 455678999999999999999999999999999999999999999531 1111111110 00 011
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 363 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.....+.....+++|...|+..-.+|-|.+.-+.
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2334445566788888888888889988766543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=267.08 Aligned_cols=202 Identities=24% Similarity=0.360 Sum_probs=171.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-CCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
..-|..++.||-|+||.|.++.- .+...+|.|.+.+... .......+.|-++|.....+-||+|+..|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34577788999999999999974 3467899999975432 22334577889999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|+|++||++-.+|.+.+. +.+..++.++..+.+|+++.|.. |+|||||||+|||||.+|++||+||||+.-+.
T Consensus 708 MdYIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999987654 88899999999999999999999 99999999999999999999999999985431
Q ss_pred CCCC-------------------------c----------------eeeccccccCccccccccCCCCCchhhhHHHHHH
Q 013238 278 YKDT-------------------------H----------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 316 (447)
Q Consensus 278 ~~~~-------------------------~----------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~i 316 (447)
.... . .....+||+.|+|||++....++..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1000 0 0112459999999999999999999999999999
Q ss_pred HHHHHhCCCCccc
Q 013238 317 LLELITGQRAFDL 329 (447)
Q Consensus 317 l~elltg~~p~~~ 329 (447)
||||+.|+.||-.
T Consensus 861 l~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLA 873 (1034)
T ss_pred HHHHhhCCCCccC
Confidence 9999999999953
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=253.78 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=192.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec--------CC
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------PT 192 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~ 192 (447)
.|+...+||+|.||.|++|+.+ +|+.||+|++-.+.. ..-.....+|+++|..+.|+|++.++++|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4566678999999999999876 478889887754322 2223456789999999999999999998863 23
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..|+||.+|+. +|..+|.+... .++..++.+++.++..||.|+|+. .|+|||+|+.|+||+.+|.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 46899999966 88888866533 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---eeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh
Q 013238 273 AKLMDYKDTH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 273 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
++.+...... ..+..+.|.+|.+||.+.+. .|+++.|||..|||+.||.||.+-+... .++.....+..+.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn-----teqqql~~Is~Lc 245 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN-----TEQQQLHLISQLC 245 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC-----hHHHHHHHHHHHh
Confidence 9876543321 23445569999999988765 6899999999999999999999887531 1122222222221
Q ss_pred hcc-----------ccccccc-cccCCCC---cHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 349 KEK-----------KLEQLVD-SDMEGNY---IEEE------VEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 349 ~~~-----------~~~~~~d-~~~~~~~---~~~~------~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
... .+.+.+. +.+.... ..+- ....++++..++..||.+|+++++++..
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 110 0011110 0011000 0111 1246788888999999999999998863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=254.36 Aligned_cols=239 Identities=31% Similarity=0.410 Sum_probs=190.9
Q ss_pred CCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcchhhhhh
Q 013238 134 GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE 212 (447)
Q Consensus 134 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 212 (447)
+||.||+|... +|+.+++|++...........+.+|++.+++++|+|++++.+++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997654433256788999999999999999999999988899999999999999999876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccC
Q 013238 213 RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 292 (447)
Q Consensus 213 ~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~ 292 (447)
... +++..++.++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 432 78999999999999999999999 99999999999999999999999999998764332 2233457889
Q ss_pred ccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHH
Q 013238 293 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ 372 (447)
Q Consensus 293 y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 372 (447)
|++||.+.+..++.++||||||+++++|++|..||... .. .......... ..... ..........
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~----~~---~~~~~~~~~~-~~~~~-------~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD----DQ---LLELFKKIGK-PKPPF-------PPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----Cc---HHHHHHHHhc-cCCCC-------ccccccCCHH
Confidence 99999998888899999999999999999999998531 01 1111111111 00000 0000003456
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 013238 373 LIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 373 l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=272.54 Aligned_cols=264 Identities=22% Similarity=0.252 Sum_probs=180.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEE-----------------CCCcEEEEEEeccccccc-------------hHHHHHHH
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRL-----------------TDGSLVAVKRLKEERTQG-------------GELQFQTE 169 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~e 169 (447)
..++|++.++||+|+||+||+|.. .+++.||||++....... .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235689999986432211 01123346
Q ss_pred HHHHHhcCCCce-----eeEeeeeec--------CCcceEEEecccCCcchhhhhhcCC--------------------C
Q 013238 170 VEMISMAVHRNL-----LRLRGFCMT--------PTERLLVYPFMVNGSVASCLRERGQ--------------------S 216 (447)
Q Consensus 170 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 216 (447)
+.++.+++|.++ ++++++|.. ....++||||+.+++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776654 567777653 3567999999999999999875321 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCcccc
Q 013238 217 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296 (447)
Q Consensus 217 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP 296 (447)
...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788999999999999999999 999999999999999999999999999975433222111222347899999
Q ss_pred ccccCCCC----------------------CchhhhHHHHHHHHHHHhCCC-CcccccccCCC----cccHHHHHHHHhh
Q 013238 297 EYLSTGKS----------------------SEKTDVFGYGVMLLELITGQR-AFDLARLANDD----DVMLLDWVKGLLK 349 (447)
Q Consensus 297 E~~~~~~~----------------------~~~sDvwSlG~il~elltg~~-p~~~~~~~~~~----~~~~~~~~~~~~~ 349 (447)
|.+..... ..+.||||+||++++|++|.. ||......+.. ...+..|.. ..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hc
Confidence 98754321 134699999999999999875 66422111100 011111110 00
Q ss_pred ccccccccccccCCCCcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 013238 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP---MERPKMSEVVR 396 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~ 396 (447)
. ................+++.+++..+| .+|+|+.|+++
T Consensus 458 ~--------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 G--------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred c--------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 011111122234567788888888765 68999999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=262.02 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=194.7
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc------hHHHHHHHHHHHHhcCCCceeeEeeeeec-C
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG------GELQFQTEVEMISMAVHRNLLRLRGFCMT-P 191 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~ 191 (447)
..++|-.+.+||+|+|+.||+|.+- ..+.||||+-....... -.+...+|..+-+.+.||.||++++++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3466777889999999999999854 57889999875332211 12346689999999999999999999864 5
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEe
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVG 268 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 268 (447)
+..+-|+|||+|.+|.-+|++... +++.++..|+.||+.||.||.+. .++|+|-||||.|||+.+ .|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 678899999999999999987653 78999999999999999999986 668999999999999954 5789999
Q ss_pred ecCCccccCCCCCc------eeeccccccCccccccccCC----CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcc
Q 013238 269 DFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338 (447)
Q Consensus 269 Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 338 (447)
|||+++.++..... .+....||.+|++||++.-+ ..+.|.||||.|||+|.++.|+.||... ....
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn----qsQQ 691 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN----QSQQ 691 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc----hhHH
Confidence 99999988754332 34455799999999988533 4688999999999999999999999631 1111
Q ss_pred cHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 013238 339 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 395 (447)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 395 (447)
..+....+....+..+. .-+........+|.+||++.-++|....++.
T Consensus 692 -------dILqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 -------DILQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------HHHhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111111111111111 1122334566789999999999998776664
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=248.43 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=199.4
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccch--HHHHHHHHHHHHhc-CCCceeeEeeeeecCCcc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 194 (447)
+..++|...++||+|+|.+|..+++. +.+.+|+|+++++-.... ..=.+.|-.+.... +||.+|-+..+++....+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 44578999999999999999999876 578999999986543222 22245565555544 699999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++|.||.+||+|--.+++.+ .++++.+..+...|.-||.|||++ ||++||||.+|+|+|..|++||+|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 99999999999988776543 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.- ......+...+||+.|+|||++.+..|....|+|+||++++||+.|+.||+...+ +..+.+-.+++....-++.+.
T Consensus 400 e~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm-~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 400 EG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM-DNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred cC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC-CCcccchhHHHHHHHhhhccc
Confidence 53 2344556678899999999999999999999999999999999999999987553 334444455544443332211
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 390 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 390 (447)
- +.........++..-|++||.+|..
T Consensus 478 i----------prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 I----------PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred c----------cceeehhhHHHHHHhhcCCcHHhcC
Confidence 1 1111223445667778999999853
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=275.89 Aligned_cols=246 Identities=27% Similarity=0.364 Sum_probs=183.8
Q ss_pred CCCCCeeeecCCeE-EEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEecc
Q 013238 124 FSNRNILGRGGFGK-VYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 124 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
|...+++|.|+.|+ ||+|.+. |+.||||++-.+. .....+|+..+..- .|||||++++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44556789998765 7999986 7899999985432 33567899988876 4999999999888889999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---C--CcEEEeecCCcccc
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---E--FEAVVGDFGLAKLM 276 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgl~~~~ 276 (447)
..+|.++++..........-...+.++.|+++||++||+. +||||||||.||||+. + .+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5699999987411111112145577889999999999998 9999999999999976 3 57899999999988
Q ss_pred CCCCCce--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhC-CCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 277 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 277 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
....... .....||-+|+|||++....-+.++|||||||++|+.++| .+||...... ..+.+.. ...+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R------~~NIl~~---~~~L 732 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER------QANILTG---NYTL 732 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh------hhhhhcC---ccce
Confidence 7554332 3345699999999999999889999999999999999985 9999531100 0000000 0000
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+ ....++ ...+||.+|++.+|..||++.+|+.
T Consensus 733 ~~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VHL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 001111 5778999999999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=241.05 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=197.1
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-----cceE
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERLL 196 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 196 (447)
.+..+-||-|+||.||.+.+. +|+.||.|++..... -...+.+.+|++++..++|.|++..+++.+-.. +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344577999999999999875 799999999864321 223456789999999999999999988866442 4577
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
+.|.| ..+|...+- +..+++...++-++.||++||+|||+. +|.||||||.|.|++.+..+||+|||+++..
T Consensus 135 ~TELm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 88887 446666653 445688899999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
...+...++..+-|..|.|||++.+. .|+.+.||||.|||+.|++..+-.|+... .....+.+..++.....+.
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-----PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-----PIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-----hHHHHHHHHHHhCCCcHHH
Confidence 77777777777789999999999876 58999999999999999999888885321 1122233333332222221
Q ss_pred c-----------cccccCC-C--------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 356 L-----------VDSDMEG-N--------YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 356 ~-----------~d~~~~~-~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
+ +....+. . -.......-..+.+.++..||.+|.+..+.+..+..
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 1 1111100 0 011222335567778889999999999988876544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=226.44 Aligned_cols=212 Identities=35% Similarity=0.521 Sum_probs=183.0
Q ss_pred eeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcchh
Q 013238 130 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 208 (447)
Q Consensus 130 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 208 (447)
||+|.+|.||++...+ ++.+++|.+...........+.+|++.++.+.|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999999765443234578899999999999999999999998889999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeecCCccccCCCCCceeecc
Q 013238 209 CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAV 287 (447)
Q Consensus 209 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~ 287 (447)
++.... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987643 2488999999999999999999999 9999999999999999 89999999999986543321 12223
Q ss_pred ccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCc
Q 013238 288 RGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366 (447)
Q Consensus 288 ~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 366 (447)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 467889999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 367 EEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 367 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
..+.+++..|++.+|.+||++.++++.+
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3488899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=240.93 Aligned_cols=132 Identities=23% Similarity=0.358 Sum_probs=111.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-----C---CceeeEeeeeec-
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----H---RNLLRLRGFCMT- 190 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~- 190 (447)
..+|...++||.|.|++||++.+. +.+.||+|+.+... .-....+.|+++|+.++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 478999999999999999999865 67899999997532 22335678999988764 3 359999998864
Q ss_pred ---CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 013238 191 ---PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259 (447)
Q Consensus 191 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill 259 (447)
..+.+||+|++ |.+|..++......+ ++...+++|+.||+.||.|||.+| +|+|.||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999999 779999988765443 889999999999999999999999 99999999999999
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=230.44 Aligned_cols=254 Identities=19% Similarity=0.295 Sum_probs=189.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeee-eecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGF-CMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 198 (447)
+.|.+.+.+|+|.||.+-++.++ ..+.+++|.+..... ...+|.+|...--.+ .|.||+.-+++ ++..+..++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 56888899999999999999986 577899999876533 345688888754333 59999988776 45567778999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCcEEEeecCCcccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLM 276 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~ 276 (447)
||++.|+|.+.+...+ +.+...+.++.|+++|+.|||++ ++||||||.+||||- +..++||||||+.+..
T Consensus 102 E~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999887654 78889999999999999999999 999999999999993 3458999999998754
Q ss_pred CCCCCceeeccccccCccccccccCC-----CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
+. ......-+..|.+||.+... ...+.+|||.||++++.++||+.||+.....+...+....|......
T Consensus 174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 32 12222345679999977543 24678999999999999999999998665555555555555443221
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.+. .......+.+.++-.+-+..++++|=-..++.++...
T Consensus 248 --------~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 248 --------ALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred --------cCc-hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 111 1112234456777778889999999555555444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=222.38 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=189.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCC--cceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT--ERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~l 196 (447)
.++|++.+++|+|.++.|+.|.. .+.+.++||+++.-. .+.+.+|+.+|..+. ||||+.++++..++. ...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45788889999999999999984 468899999997643 346789999999998 999999999988754 4679
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeecCCccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 275 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~ 275 (447)
++||..+.+...+.. .++...+..++.+++.||.|+|+. ||+|||+||.|++||.. ..++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 999998877666543 377788899999999999999999 99999999999999865 4699999999988
Q ss_pred cCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
..+.. .....+.+..|--||.+-. ..|+..-|+|||||+|..|+..+.||=.. .+....++..++ .+....+.
T Consensus 183 YHp~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG---~dN~DQLVkIak-VLGt~el~ 256 (338)
T KOG0668|consen 183 YHPGK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG---HDNYDQLVKIAK-VLGTDELY 256 (338)
T ss_pred cCCCc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC---CCCHHHHHHHHH-HhChHHHH
Confidence 65433 2333446778899998865 45788899999999999999999998321 111112222111 11111111
Q ss_pred cc-------cccccC----------------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 355 QL-------VDSDME----------------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 355 ~~-------~d~~~~----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. +|+... .+...-...+.++++.+.|..|-++|+|++|.+.
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 10 111111 0001112355778888899999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=229.61 Aligned_cols=263 Identities=22% Similarity=0.247 Sum_probs=191.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecC------Cc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TE 193 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 193 (447)
.+|.....+|.|.. .|..+.+. .++.||+|++.... .....++..+|+.++..++|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46667778999988 66666544 58899999986442 223345678899999999999999999988643 35
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.|+|||+| ..+|...+... ++-.++..|+.|+++|++|||+. +|+||||||+||++..++.+||.|||++
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 68999999 56888887632 67788999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccc----------cCCCccc----
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL----------ANDDDVM---- 339 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~----------~~~~~~~---- 339 (447)
+.-+.. ...+..+.|..|.|||++.+-.+.+.+||||+||++.||++|+..|.+... -...+..
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 864332 345666789999999999998899999999999999999999988843110 0000000
Q ss_pred HHHHHHHHhhcccccc-------ccccccCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 340 LLDWVKGLLKEKKLEQ-------LVDSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 340 ~~~~~~~~~~~~~~~~-------~~d~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+...++.++....-.+ +-|..... +...-......+++.+||-.||++|.+++++|+.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111111111000000 00111110 1112234457789999999999999999999873
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=245.20 Aligned_cols=196 Identities=23% Similarity=0.332 Sum_probs=166.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-------hHHHHHHHHHHHHhcC---CCceeeEeeeeecC
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAV---HRNLLRLRGFCMTP 191 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 191 (447)
+|+..+.+|.|+||.|++|.++ +...|+||.+.+++.-. .....-.|+.+|+.++ |+||+++++++.++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5788899999999999999987 45678999987664211 1113556999999998 99999999999999
Q ss_pred CcceEEEecc-cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 192 TERLLVYPFM-VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 192 ~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
+..|++||-. ++-+|.+++... +.+++.+.+.|+.||+.|+++||++ +|||||||-+||.++.+|-+||+||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 9999999965 456888888654 3489999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD 328 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~ 328 (447)
|.+....... ....+||..|.|||++.+..| ...-|||++|++||.++....||.
T Consensus 715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987654332 334569999999999999887 667899999999999999988884
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=222.48 Aligned_cols=199 Identities=34% Similarity=0.515 Sum_probs=170.1
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEeccc
Q 013238 124 FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 202 (447)
|...+.||+|++|.||++...+ ++.+++|.+...........+.+|++.+.+++|+|++++++++......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999875 889999999765433235578889999999999999999999998889999999999
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 282 (447)
+++|.+++...... +++..+..++.+++.++.+||+. +++|+||+++||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998764321 78899999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeeccccccCccccccc-cCCCCCchhhhHHHHHHHHHHHhCCCCcc
Q 013238 283 VTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFD 328 (447)
Q Consensus 283 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltg~~p~~ 328 (447)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22233477889999998 66677889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=250.09 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=197.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
..++|+....+|+|.+|.||++++. +++..|+|.++.+.... ....+.|+-+++..+|+||+.++|.+...+..++.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3467888999999999999999976 68999999998765332 234678899999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|||.+|+|++.-+..+ ++++.++..+....++||+|||+. +-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 9999999999876543 588999999999999999999999 889999999999999999999999999876543
Q ss_pred CCCceeeccccccCccccccc---cCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
... ......||+.|||||+. ..+.|..++|||++|+...|+---..|.-. .....-+ .+. .+.
T Consensus 165 ti~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd--------lhpmr~l-~Lm-TkS--- 230 (829)
T KOG0576|consen 165 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD--------LHPMRAL-FLM-TKS--- 230 (829)
T ss_pred hhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc--------cchHHHH-HHh-hcc---
Confidence 322 23445699999999976 456789999999999999999876666310 0000000 000 000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..++.-. .....-...+.++++.|+..+|++|||++.+++
T Consensus 231 ~~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0111100 011223455888999999999999999987766
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=232.91 Aligned_cols=202 Identities=22% Similarity=0.262 Sum_probs=166.7
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC------CCceeeEeeeee
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNLLRLRGFCM 189 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~ 189 (447)
-++...+|......|+|-|++|.+|.+. .|+.||||++...... .+.=+.|+++|++|+ --+.++++-.|.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3566788999999999999999999976 4889999999754321 223357899999885 346788888888
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEe
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVG 268 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~ 268 (447)
..+++|||+|-+ ..+|.++|...+. ...|....+..++.|+.-||..|... +|+|.||||+||||++. ..+|||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 889999999988 5699999988754 33588889999999999999999997 99999999999999876 468999
Q ss_pred ecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcc
Q 013238 269 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328 (447)
Q Consensus 269 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~ 328 (447)
|||.|....... . +..-.+.-|.|||++.|.+|+...|+||.||+||||.||+-.|.
T Consensus 580 DfGSA~~~~ene--i-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 580 DFGSASFASENE--I-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred cCcccccccccc--c-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 999997654322 1 12223557999999999999999999999999999999999884
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=260.69 Aligned_cols=195 Identities=14% Similarity=0.100 Sum_probs=136.3
Q ss_pred hcCC-CceeeEeeeee-------cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 013238 175 MAVH-RNLLRLRGFCM-------TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246 (447)
Q Consensus 175 ~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 246 (447)
.++| .||+++++++. .....++++|++ +++|.++|.... .++++..++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3445 57777777762 223466778887 669999997532 3489999999999999999999999 9
Q ss_pred ceecCCCCCCEEECCCC-------------------cEEEeecCCccccCCCCC---------------ceeeccccccC
Q 013238 247 IIHRDVKAANILLDEEF-------------------EAVVGDFGLAKLMDYKDT---------------HVTTAVRGTIG 292 (447)
Q Consensus 247 ivH~dlk~~Nill~~~~-------------------~~kl~Dfgl~~~~~~~~~---------------~~~~~~~gt~~ 292 (447)
|+||||||+||||+..+ .+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 455666666543211000 00111347888
Q ss_pred ccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHH
Q 013238 293 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ 372 (447)
Q Consensus 293 y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 372 (447)
|||||++.+..++.++|||||||+||||++|..|+.... .....+... ...+. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~---------~~~~~-----~~~~~~~ 240 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR---------VLPPQ-----ILLNWPK 240 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh---------hcChh-----hhhcCHH
Confidence 999999999999999999999999999999988874210 000011000 01110 0111234
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 013238 373 LIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 373 l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...++.+||+.+|.+|||+.++++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 567888999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=203.82 Aligned_cols=166 Identities=22% Similarity=0.279 Sum_probs=124.8
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|.+++...+ .++++..++.++.|++.||.|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68889887643 2499999999999999999999998 5 999999999999999 99988654322
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
..|++.|+|||++.+..++.++|||||||++|||+||+.||..... .......+....... +.. ..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~-------~~~-~~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPAD-------DPR-DR 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccC-------Ccc-cc
Confidence 2488999999999999999999999999999999999999953211 011111111111100 000 00
Q ss_pred CCcHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 364 NYIEEEVE--QLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 364 ~~~~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
........ .+.+++.+||+.+|.+|||+.++++.+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11122222 58999999999999999999999998765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=218.32 Aligned_cols=197 Identities=26% Similarity=0.398 Sum_probs=163.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 193 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 193 (447)
...+.|...++||.|.|++||++.+. .++.||+|.+...... ..+..|+++|..+. +.||+++.+.+...+.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 44567888999999999999999754 3678999999754433 35789999999886 9999999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeecCC
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGL 272 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl 272 (447)
..+|+||++.....++... ++...+..++..++.||+++|.+ |||||||||+|+|.+.. +.-.|.|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 9999999999988888764 67888999999999999999999 99999999999999754 5678999999
Q ss_pred ccccCCC------------------C-------------------------CceeeccccccCccccccccCCC-CCchh
Q 013238 273 AKLMDYK------------------D-------------------------THVTTAVRGTIGHIAPEYLSTGK-SSEKT 308 (447)
Q Consensus 273 ~~~~~~~------------------~-------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~s 308 (447)
+...+.. . ........||++|.|||++.... -+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 8621100 0 00111235999999999987654 58899
Q ss_pred hhHHHHHHHHHHHhCCCCcc
Q 013238 309 DVFGYGVMLLELITGQRAFD 328 (447)
Q Consensus 309 DvwSlG~il~elltg~~p~~ 328 (447)
||||.|+|++-+++++.||-
T Consensus 260 Diws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ceeeccceeehhhccccccc
Confidence 99999999999999999983
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=202.32 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=187.6
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCc
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
..+|.+...|..|+|+++. ..+++|++.... .......|..|+-.++.+.||||++++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 3458889999999999974 456677775432 22234478999999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceee
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 285 (447)
|..+|+.... -..+..+..+++.++++|++|||+.. +-|.---|.+..++||++.+++|+ .+-.++.... .
T Consensus 274 lynvlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsfqe-----~ 344 (448)
T KOG0195|consen 274 LYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE-----V 344 (448)
T ss_pred HHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeeeec-----c
Confidence 9999987543 34677888999999999999999973 334445789999999999988864 1111111001 1
Q ss_pred ccccccCccccccccCCCC---CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccC
Q 013238 286 AVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362 (447)
Q Consensus 286 ~~~gt~~y~aPE~~~~~~~---~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 362 (447)
...-.+.||+||.++..+. -.++|+|||++++||+.|...||........ -..+.-..++
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-----------------gmkialeglr 407 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-----------------GMKIALEGLR 407 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----------------hhhhhhcccc
Confidence 1123678999999987654 4578999999999999999999953221111 1112223344
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 363 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...++.....+.++|.-|++.||.+||.++.++-+||+.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 445556667799999999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=209.82 Aligned_cols=167 Identities=22% Similarity=0.219 Sum_probs=129.3
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC--CCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCceee-Eeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLR-LRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~ 190 (447)
....++|...+.||+|+||+||+|.+. +++.+|||++.... .......+.+|+++++.++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999865 57788999875331 1223446899999999999999985 4432
Q ss_pred CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCEEECCCCcEEEee
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGD 269 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dl-k~~Nill~~~~~~kl~D 269 (447)
+..++||||+++++|... .. .. ...++.++++||.|||++ +|+|||| ||+|||++.++.+||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence 457999999999998632 11 11 146788999999999999 9999999 99999999999999999
Q ss_pred cCCccccCCCCCce-------eeccccccCccccccccCC
Q 013238 270 FGLAKLMDYKDTHV-------TTAVRGTIGHIAPEYLSTG 302 (447)
Q Consensus 270 fgl~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 302 (447)
||+++.+....... .....+++.|+|||.+...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99998765432111 1234578899999998644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-23 Score=200.95 Aligned_cols=260 Identities=18% Similarity=0.211 Sum_probs=190.8
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC--cEEEEEEeccccccchHHHHHHHHHHHHhcCC----CceeeEeeee-ecCCcce
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDG--SLVAVKRLKEERTQGGELQFQTEVEMISMAVH----RNLLRLRGFC-MTPTERL 195 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~ 195 (447)
+|.+.+.||+|+||.||++..... ..+|+|........... .+..|..++..+.. .++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 788999999999999999997653 47888887665433332 56778888877763 5788888888 4677889
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-----CcEEEeec
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDF 270 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Df 270 (447)
+||+.+ |.+|.++..... ...++..+...|+.|++.+|.+||+. |++||||||.|+++... ..+.|.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999988 889999876554 34599999999999999999999999 99999999999999765 46899999
Q ss_pred CCcc--ccCCCCCc------e-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHH
Q 013238 271 GLAK--LMDYKDTH------V-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 271 gl~~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 341 (447)
|+++ ........ . ....+||.+|+++.+..+...+.+.|+||++.++.|++.|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~ 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence 9998 32212211 1 1234599999999999999999999999999999999999999954221110 1
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
.-+....... .... ........+.++...+-..+..++|....+...|.+...
T Consensus 247 ~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 247 SKFEKDPRKL----LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHHHHhhhh----cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 1111111110 1110 111122334455555556899999999999998766433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-22 Score=188.60 Aligned_cols=262 Identities=28% Similarity=0.372 Sum_probs=196.0
Q ss_pred CCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCC-ceeeEeeeeecCCcceEEEec
Q 013238 124 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 200 (447)
|...+.||.|.||.||++... ..+++|.+....... ....+.+|...+..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999987 788999997665544 356789999999999988 799999999766668999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeecCCccccCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 279 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 279 (447)
+.++++.+++...... ..+.......++.+++.++.|+|+. +++|||+||+||+++..+ .++++|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776654321 2488899999999999999999999 999999999999999998 7999999999855433
Q ss_pred CCc-----eeeccccccCccccccccC---CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 280 DTH-----VTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 280 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||...... ..............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~ 231 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP 231 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC
Confidence 322 2345569999999999987 57889999999999999999999997532110 00111111111111
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. . .................+.+++..|+..+|..|.+..+....
T Consensus 232 ~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 T-P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred C-c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 0 000000000002223567888889999999999998877764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-24 Score=217.10 Aligned_cols=254 Identities=19% Similarity=0.241 Sum_probs=182.0
Q ss_pred CCCeeeecCCeEEEEEEEC-CCcEEEEEEeccc--cccc---hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 126 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEE--RTQG---GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 126 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..+++|.|.+|.|+..... .....+.|.+... .... ....+..|+.+-..+.|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4577999999977776543 2333444433211 1111 11125556666778899999888777766665555699
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
||++ +|..++.... .+....+..++.|++.|++|||+. |+.|||+|++|++++.+|.+||+|||.+..+...
T Consensus 402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9999987652 277888899999999999999999 9999999999999999999999999999876544
Q ss_pred CC---ceeeccccccCccccccccCCCCCc-hhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 280 DT---HVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 280 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
.. ......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||..+...+... .......+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----------~~~~~~~~ 543 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----------KTNNYSDQ 543 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----------hhhccccc
Confidence 33 3455567999999999999998865 6799999999999999999997543322110 00000000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.....-........+.....++.++|+.+|.+|-|+.+|++.
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000011223445567789999999999999999998763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-22 Score=179.97 Aligned_cols=200 Identities=19% Similarity=0.278 Sum_probs=167.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEE-ECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 198 (447)
.-+|.++++||+|.||..+.|+ +-+++.||||.-... ...-++..|....+.+. .+.|..++.+..+.-...||+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 3478899999999999999998 447999999975432 22336778888888775 688998888888888899999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-----CcEEEeecCCc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDFGLA 273 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfgl~ 273 (447)
|.+ |-+|.+++.-.+. .++..++..++.|++.-++|+|++ .+|+|||||+|+||..- ..+.++|||+|
T Consensus 104 dLL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 998 8899888766544 389999999999999999999999 99999999999999643 35899999999
Q ss_pred cccCCCCC------ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccc
Q 013238 274 KLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 330 (447)
Q Consensus 274 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~ 330 (447)
+....... .......||.+||+-....+..-+.+-|+=|||-++++.+-|..||+..
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 87643322 2234456999999999999999999999999999999999999999753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=174.95 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=189.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEE-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CceeeEeeeeecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 197 (447)
..++|..+++||+|+||.+|.|.. .+|..||||.-..... .-++..|..+...+++ ..|..+..+..+.....+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 456799999999999999999984 5799999998654332 2256778888888875 5577778888888899999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeecCCcc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAK 274 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~ 274 (447)
|+.+ |-+|.+++.-... .++..+++.++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||+++
T Consensus 90 MdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9998 8899888765433 388899999999999999999999 99999999999999643 458899999998
Q ss_pred ccCCCCCc------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh
Q 013238 275 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 275 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
........ ......||.+|.+-....+..-+.+.|+=|+|.+|.++.-|..||+....... .+.... .
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKyEk-I 236 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKYEK-I 236 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHHHH-H
Confidence 65432221 22334589999998888888888999999999999999999999975322111 000001 1
Q ss_pred hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 349 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.+.+....+.. + +...+.++.-.+..|-..--.+-|....+-+.+.-
T Consensus 237 ~EkK~s~~ie~-L----C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 237 SEKKMSTPIEV-L----CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HHhhcCCCHHH-H----hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 11111111111 1 12233456667777877778888887766655443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=192.57 Aligned_cols=216 Identities=23% Similarity=0.379 Sum_probs=162.4
Q ss_pred HhcCCCceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-eecCC
Q 013238 174 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI-IHRDV 252 (447)
Q Consensus 174 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i-vH~dl 252 (447)
+.+.|.|+.+++|.+.+....+.|.+||..|+|.+.+..... .+++.....++.+|+.||+|||+. .| .|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~---~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI---KLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc---CccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 467899999999999999999999999999999999987433 389999999999999999999997 44 99999
Q ss_pred CCCCEEECCCCcEEEeecCCccccCC-CCCceeeccccccCccccccccCCC-------CCchhhhHHHHHHHHHHHhCC
Q 013238 253 KAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGK-------SSEKTDVFGYGVMLLELITGQ 324 (447)
Q Consensus 253 k~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlG~il~elltg~ 324 (447)
+++|+++|....+||+|||+...... .............-|.|||.+.+.. .+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999876532 1111111122345699999987641 467899999999999999999
Q ss_pred CCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 325 RAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 325 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
.||+........ ..+...++. .......+.+... .+....+..++.+||..+|.+||+++++-..++.+.-
T Consensus 156 ~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999753322221 122222222 0111111111111 1333468999999999999999999999998887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=171.70 Aligned_cols=140 Identities=17% Similarity=0.189 Sum_probs=107.4
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccc-h------------------------HHHHHHHHHHHHhcCCCce
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-G------------------------ELQFQTEVEMISMAVHRNL 181 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~e~~~l~~l~h~ni 181 (447)
...||+|++|.||+|...+|+.||||+++...... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998889999999997542210 0 0122458889999887776
Q ss_pred eeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecCCCCCCEEEC
Q 013238 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRDVKAANILLD 260 (447)
Q Consensus 182 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~dlk~~Nill~ 260 (447)
.....+.. ...++||||++++++....... .+++......++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 43332222 2348999999887766543222 2488899999999999999999 688 999999999999998
Q ss_pred CCCcEEEeecCCcccc
Q 013238 261 EEFEAVVGDFGLAKLM 276 (447)
Q Consensus 261 ~~~~~kl~Dfgl~~~~ 276 (447)
++.++|+|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=207.28 Aligned_cols=260 Identities=23% Similarity=0.254 Sum_probs=188.3
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHH---HHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++...+.||++.|=+|.+|++.+|. |+||++-+....-....+.+ |++ ...++|||.+++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4556678999999999999998877 88999865543333333333 444 566789999998877666777788888
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC--
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-- 277 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-- 277 (447)
|... +|.+.+..+ +-+...+.+-|+.|++.||.-+|.. +|+|||||.+||||+.=.-+.|+||...+...
T Consensus 102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 8844 788777443 3367788889999999999999999 99999999999999998899999998765332
Q ss_pred CCCCce----eeccccccCccccccccCC-----------CCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHH
Q 013238 278 YKDTHV----TTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 278 ~~~~~~----~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 341 (447)
...... .........|+|||.+... ..+++-||||+||++.||++ |+++|.....-......
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~-- 251 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN-- 251 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC--
Confidence 111111 1112234579999987431 14678999999999999988 78899643221110000
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhhHHH
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEW 410 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 410 (447)
....++++... +...+..++..|++.||.+|.++++.|+.-.+..+++.+...
T Consensus 252 --------~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~F 304 (1431)
T KOG1240|consen 252 --------ADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSF 304 (1431)
T ss_pred --------ccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHH
Confidence 00111111110 012478899999999999999999999999999999988764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-22 Score=176.18 Aligned_cols=174 Identities=10% Similarity=0.095 Sum_probs=133.1
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchH--HH------HHHHHHHHHhcCCCceeeEeeeeec
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE--LQ------FQTEVEMISMAVHRNLLRLRGFCMT 190 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~e~~~l~~l~h~niv~l~~~~~~ 190 (447)
+..++|+..+++|.|+||.||++.. ++..+|||.+......... .. +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 5578999999999999999999766 5678999999755432221 11 5789999999999999999887553
Q ss_pred C--------CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 013238 191 P--------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262 (447)
Q Consensus 191 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~ 262 (447)
. ...+++|||++|.+|.++.. ++. ....+++.+|..+|+. +++|||++|+||+++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 2 35789999999999977632 222 2455889999999999 99999999999999998
Q ss_pred CcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh
Q 013238 263 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322 (447)
Q Consensus 263 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt 322 (447)
| ++|+|||........... ..++....+..++|+||||+.+..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 999999988644211100 013334456678999999998776543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=166.08 Aligned_cols=140 Identities=19% Similarity=0.208 Sum_probs=109.9
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccc--------------------h-----HHHHHHHHHHHHhcCCCce
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG--------------------G-----ELQFQTEVEMISMAVHRNL 181 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~e~~~l~~l~h~ni 181 (447)
.+.||+|++|.||+|...+|+.||||+++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999997542110 0 1123578889999999987
Q ss_pred eeEeeeeecCCcceEEEecccCCcchhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEE
Q 013238 182 LRLRGFCMTPTERLLVYPFMVNGSVASC-LRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILL 259 (447)
Q Consensus 182 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill 259 (447)
.....+... ..++||||++++++... +.. ..++......++.+++.++.+||+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 544433332 35899999988755433 322 136788899999999999999999 8 99999999999999
Q ss_pred CCCCcEEEeecCCccccC
Q 013238 260 DEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 260 ~~~~~~kl~Dfgl~~~~~ 277 (447)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=173.68 Aligned_cols=232 Identities=23% Similarity=0.311 Sum_probs=144.7
Q ss_pred CCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCC----------CceeeEeeeee---
Q 013238 126 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH----------RNLLRLRGFCM--- 189 (447)
Q Consensus 126 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~--- 189 (447)
..+.||.|+++.||.+.+. +|+.+|+|++..... ....+.+.+|.-....+.+ -.++-.++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3567999999999999987 589999999864432 2223445555544433222 11221122111
Q ss_pred ------cC---C-----cceEEEecccCCcchhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 013238 190 ------TP---T-----ERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 252 (447)
Q Consensus 190 ------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dl 252 (447)
.. . +.+++|+-+ .++|..++.. .......+....++.+..|+++.+++||+. |++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11 1 235677777 6688777543 222222345566677889999999999999 9999999
Q ss_pred CCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccC--------CCCCchhhhHHHHHHHHHHHhCC
Q 013238 253 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQ 324 (447)
Q Consensus 253 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il~elltg~ 324 (447)
+|+|++++.+|.++|+||+.....+. .......+..|.+||.... -.++.+.|.|+||+++|.|.+|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999987764322 2221335678999997643 24688999999999999999999
Q ss_pred CCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 013238 325 RAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER 388 (447)
Q Consensus 325 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 388 (447)
.||+.......... .+ .... +.++.+..+|..+|+.||.+|
T Consensus 248 lPf~~~~~~~~~~~---------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW---------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG---------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc---------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99974322211110 11 1122 667789999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=175.91 Aligned_cols=199 Identities=22% Similarity=0.282 Sum_probs=137.5
Q ss_pred cCCCceeeEeeeeecC---------------------------CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHH
Q 013238 176 AVHRNLLRLRGFCMTP---------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 228 (447)
Q Consensus 176 l~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i 228 (447)
.+|||||++.++|.+. ...|+||... ..+|..++..+. .+.....-|
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~~~ 346 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGRVI 346 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHHHH
Confidence 3599999998876421 2347888777 348888886543 556677788
Q ss_pred HHHHHHHHHHHHhCCCCCceecCCCCCCEEE--CCCC--cEEEeecCCccccCCCC-----CceeeccccccCccccccc
Q 013238 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILL--DEEF--EAVVGDFGLAKLMDYKD-----THVTTAVRGTIGHIAPEYL 299 (447)
Q Consensus 229 ~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfgl~~~~~~~~-----~~~~~~~~gt~~y~aPE~~ 299 (447)
+.|+++|+.|||.+ +|.|||+|++|||| |+++ .+.|+|||++-..+... ....-...|.-..||||+.
T Consensus 347 laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 99999999999999 99999999999998 4444 46799999875432211 1111223467789999988
Q ss_pred cCCC------CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHH
Q 013238 300 STGK------SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQL 373 (447)
Q Consensus 300 ~~~~------~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 373 (447)
...+ .-.|+|.|+.|.+.||+++...||..- .+. .++.....+---+ ..+..++..+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-----Gem--------~L~~r~Yqe~qLP----alp~~vpp~~ 486 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-----GEM--------LLDTRTYQESQLP----ALPSRVPPVA 486 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCccccc-----chh--------eechhhhhhhhCC----CCcccCChHH
Confidence 5432 245899999999999999999999531 110 1111111111111 2233344557
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 374 IQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 374 ~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.+++...++.||++|++.+-....|+-
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHHH
Confidence 888899999999999998777666653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.7e-20 Score=159.90 Aligned_cols=184 Identities=17% Similarity=0.083 Sum_probs=137.0
Q ss_pred CCCeeeecCCeEEEEEEECCCcEEEEEEeccccccc---hHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEEecc
Q 013238 126 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG---GELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 126 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
....|++|+||+|+.+.. .+.+++.+.+.....-. ....+.+|+++++++. |+++++++++ +..+++|+|+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 346799999999997766 57888888776543311 1224789999999995 5778888886 4469999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
.|.+|...+.. . ...++.+++++|.++|++ ||+|||| ||.|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99888654311 1 135678899999999999 9999999 7999999999999999999998654322
Q ss_pred Cc----e--------eeccccccCccccccccCC-CCC-chhhhHHHHHHHHHHHhCCCCcc
Q 013238 281 TH----V--------TTAVRGTIGHIAPEYLSTG-KSS-EKTDVFGYGVMLLELITGQRAFD 328 (447)
Q Consensus 281 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlG~il~elltg~~p~~ 328 (447)
.. . ......++.|+.|+...-. ..+ ...+.++-|.-+|.++|+..+.-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0 0112256777788754322 233 56788999999999999998873
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-21 Score=186.13 Aligned_cols=234 Identities=26% Similarity=0.268 Sum_probs=178.0
Q ss_pred eeecCCeEEEEEEE----CCCcEEEEEEeccccccchH-HHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEEecccC
Q 013238 130 LGRGGFGKVYKGRL----TDGSLVAVKRLKEERTQGGE-LQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 130 lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+|+|.||.|+++.- ..|..+|.|.+++....... .....|-.++...+ ||.++++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999998742 24778899988654322211 13445667777777 99999999999999999999999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|...+.... .+.+.....+...++-++.++|.. +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 82 g~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccccCC----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99998886543 367777888888999999999999 9999999999999999999999999999865322221
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
+||..|||||++. .+..++|.||||++++||+||..||.. +.+...++. ..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~-----------~~ 204 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKA-----------EL 204 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhh-----------cc
Confidence 7899999999997 677889999999999999999999953 112222211 11
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHhc
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKM--SEVVRMLEG 400 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~~L~~ 400 (447)
..+........+++..++..+|..|--. +.+.+..+.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h 243 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH 243 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence 2234444556667777778899999765 344444443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-20 Score=192.23 Aligned_cols=201 Identities=21% Similarity=0.260 Sum_probs=158.2
Q ss_pred HHHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC---CCceeeEeeeeecC
Q 013238 115 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTP 191 (447)
Q Consensus 115 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 191 (447)
.+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-. |--=.+++.+|+ -+-|..+...+.-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 34566678899999999999999999998889999999876543221 111122333333 22344444444556
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-------CCCc
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-------EEFE 264 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~-------~~~~ 264 (447)
+..++|+||.+.|+|.++++.. ..++|..+..++.|++..+..||.. +|||+||||+|+||. +...
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 7789999999999999999843 3489999999999999999999999 999999999999993 2345
Q ss_pred EEEeecCCccccC-CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCC
Q 013238 265 AVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 326 (447)
Q Consensus 265 ~kl~Dfgl~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p 326 (447)
++|+|||.+..+. ..+.......++|-.+-.+|...|..++...|.|.|+.+++-||.|+..
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 8999999986543 2333456667789999999999999999999999999999999999743
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=154.42 Aligned_cols=136 Identities=21% Similarity=0.230 Sum_probs=103.9
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-----CCCceeeEeeeeecCC---cc
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLRGFCMTPT---ER 194 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~ 194 (447)
+...+.||+|+||.||. .. ++.. +||++..... .....+.+|+.+++.+ .||||++++|++.+.. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34457899999999996 43 3444 6998865422 2345689999999999 5799999999998763 32
Q ss_pred e-EEEec--ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceecCCCCCCEEECC----CCcEE
Q 013238 195 L-LVYPF--MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL-AYLHDHCDPKIIHRDVKAANILLDE----EFEAV 266 (447)
Q Consensus 195 ~-lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~ivH~dlk~~Nill~~----~~~~k 266 (447)
+ +|+|| +.+|+|.+++.+.. +++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 3 78999 55799999996532 4444 35577777777 999999 9999999999999974 34799
Q ss_pred EeecCCc
Q 013238 267 VGDFGLA 273 (447)
Q Consensus 267 l~Dfgl~ 273 (447)
|+||+-+
T Consensus 150 LiDg~G~ 156 (210)
T PRK10345 150 VCDNIGE 156 (210)
T ss_pred EEECCCC
Confidence 9995443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=155.24 Aligned_cols=142 Identities=14% Similarity=0.094 Sum_probs=109.6
Q ss_pred CCCCCCeeeecCCeEEEEEE--ECCCcEEEEEEeccccccc-----------------------hHHHHHHHHHHHHhcC
Q 013238 123 NFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQG-----------------------GELQFQTEVEMISMAV 177 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~ 177 (447)
.|.+.+.||+|++|.||+|. ..+|+.||+|+++...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 4579999999987432100 1123567999999887
Q ss_pred CCc--eeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCCC
Q 013238 178 HRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-IIHRDVKA 254 (447)
Q Consensus 178 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivH~dlk~ 254 (447)
+.. +..++++ ...++||||+.+++|....... ..+.......++.+++.++.+||++ + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3344443 2458999999998887654222 1255666788999999999999999 8 99999999
Q ss_pred CCEEECCCCcEEEeecCCcccc
Q 013238 255 ANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 255 ~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.4e-18 Score=151.49 Aligned_cols=135 Identities=20% Similarity=0.320 Sum_probs=112.7
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccc-------hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+.||+|++|.||+|.. .|..+++|......... ....+.+|++++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57789999865432211 123477899999999999988777777777888999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++|++|.+++.... . .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886421 2 7788999999999999999 999999999999999 78999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-19 Score=171.27 Aligned_cols=174 Identities=25% Similarity=0.367 Sum_probs=129.5
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++.|++|...+|.++|..+... ...++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 468999999999999999765433 347889999999999999999 6 899999999999999999999999999
Q ss_pred ccccCCCC-----CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHH
Q 013238 273 AKLMDYKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 273 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
........ ....+...||..||+||.+.+..|+.++||||||+||+|++. =...++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------------- 465 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------------- 465 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------
Confidence 87654433 223444569999999999999999999999999999999997 2222221
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 394 (447)
.....++-|..+...+..+. ..=..++.+++...|.+||++.++
T Consensus 466 ---~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 ---IATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ---HHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 11122222222221111111 123467888999999999954443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=148.54 Aligned_cols=138 Identities=20% Similarity=0.153 Sum_probs=107.9
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCcEEEEEEecccccc---------------------chHHHHHHHHHHHHhcCCCc-
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---------------------GGELQFQTEVEMISMAVHRN- 180 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~h~n- 180 (447)
.|...+.||+|+||.||++...+|+.||||++...... ........|+..+..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 47778899999999999999888999999987643210 01123567888888887774
Q ss_pred -eeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 013238 181 -LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259 (447)
Q Consensus 181 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill 259 (447)
+...++ ....+++|||+++++|...... .....++.+++.++.++|+. +++|+||+|.||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 444433 2456899999999988765421 23457888999999999998 99999999999999
Q ss_pred CCCCcEEEeecCCccccC
Q 013238 260 DEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 260 ~~~~~~kl~Dfgl~~~~~ 277 (447)
++++.++|+|||++....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=148.29 Aligned_cols=131 Identities=18% Similarity=0.302 Sum_probs=105.7
Q ss_pred eeeecCCeEEEEEEECCCcEEEEEEeccccccc-------hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 129 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
.||+|++|.||+|.. +|..+++|......... ....+.+|++++..+.|+++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 46789999865432111 1235678999999999887655555555667789999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 0 7889999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=168.26 Aligned_cols=137 Identities=18% Similarity=0.277 Sum_probs=110.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEe-ccc-ccc-----chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL-KEE-RTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~-~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
..|...+.||+|+||+||+|.+.+.. +++|+. .+. ... .....+.+|++++..++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44566789999999999999876443 444432 221 111 1124578899999999999998888777777788
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999998875 2467899999999999999 99999999999999 67799999999997
Q ss_pred c
Q 013238 275 L 275 (447)
Q Consensus 275 ~ 275 (447)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.4e-18 Score=173.61 Aligned_cols=210 Identities=21% Similarity=0.307 Sum_probs=139.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..+|+.++.|..|++|.||.++++ ..+.+|+| +++... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc--cccccCCccee-----------------
Confidence 357899999999999999999876 36778884 332211 1110 22222233322
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+-...++..+. ++... +.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++.....
T Consensus 136 ----gDc~tllk~~g~----lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP----LPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhcccCCC----Ccchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 454555544321 22222 6789999999 9999999999999999999999999998754211
Q ss_pred C--------------CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 280 D--------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 280 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
. ......++||+.|.|||++....|...+|+|++|+|+||.+-|+.||... ..+..+ .
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd----tpeelf----g 268 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD----TPEELF----G 268 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC----CHHHHH----h
Confidence 1 01123457999999999999999999999999999999999999999531 111111 1
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
.++.+... + .+.......+..+++.+.|+.+|.+|--.
T Consensus 269 ~visd~i~--w------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 269 QVISDDIE--W------PEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhhhhhcc--c------cccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 11111100 0 01111223446677778889999999543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.6e-15 Score=128.51 Aligned_cols=134 Identities=18% Similarity=0.136 Sum_probs=112.3
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC--CceeeEeeeeecCCcceEEEecccCC
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..+.| .++.+++++....+..+++|||+.++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4679999999999999864 7899999865433 3468889999999876 58889988887778899999999887
Q ss_pred cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 205 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 205 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
.+..+ +......++.++++++++||.....+++|+|++|.||++++.+.+++.|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76654 4456678889999999999986444799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-15 Score=134.48 Aligned_cols=137 Identities=20% Similarity=0.210 Sum_probs=97.2
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccchH-HH----------------------HHHHHHHHHhcCCCc--e
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE-LQ----------------------FQTEVEMISMAVHRN--L 181 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-~~----------------------~~~e~~~l~~l~h~n--i 181 (447)
.+.||+|+||+||+|...+|+.||||++......... .. ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998653221110 00 134555555554332 3
Q ss_pred eeEeeeeecCCcceEEEecccCCcchh-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEE
Q 013238 182 LRLRGFCMTPTERLLVYPFMVNGSVAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILL 259 (447)
Q Consensus 182 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill 259 (447)
.+.++. ...+++|||++++.+.. .+.... .. .....++.+++.++.++|. . +++|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 34689999999865432 122111 11 5567899999999999999 7 99999999999999
Q ss_pred CCCCcEEEeecCCccccC
Q 013238 260 DEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 260 ~~~~~~kl~Dfgl~~~~~ 277 (447)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.9e-17 Score=166.07 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=184.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC--CcEEEEEEecccc-ccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEER-TQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 197 (447)
..|...+.||+|.|+.|-...... ...+|+|.+.... ..........|..+-..+. |.|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 356666779999999998887543 4456777665432 1222223444666666666 99999999999999999999
Q ss_pred EecccCCcchhhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecCCCCCCEEECCCC-cEEEeecCCcc
Q 013238 198 YPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 274 (447)
Q Consensus 198 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~ 274 (447)
.+|..++++...+ +.... ..+......++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999988 43321 2455566778999999999999 77 999999999999999999 99999999998
Q ss_pred ccCC--CCCceeecccc-ccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 275 LMDY--KDTHVTTAVRG-TIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 275 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
.... .........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++.+..... ....|....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~~~~~--- 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSWKSNK--- 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceeecccc---
Confidence 7665 22333444567 9999999999885 457789999999999999999999976443221 111111110
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
................++..+++..+|..|.+.+++..
T Consensus 248 --------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 --------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00001111222334667777888899999999877654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.4e-15 Score=134.57 Aligned_cols=136 Identities=18% Similarity=0.192 Sum_probs=103.7
Q ss_pred CCeee-ecCCeEEEEEEECCCcEEEEEEeccccc------------cchHHHHHHHHHHHHhcCCCce--eeEeeeeecC
Q 013238 127 RNILG-RGGFGKVYKGRLTDGSLVAVKRLKEERT------------QGGELQFQTEVEMISMAVHRNL--LRLRGFCMTP 191 (447)
Q Consensus 127 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 191 (447)
...|| .|+.|+||.+... +..++||.+..... ......+.+|++++..+.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999885 67789998853210 1123457889999999998875 6666664432
Q ss_pred C-c---ceEEEecccC-CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 013238 192 T-E---RLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 192 ~-~---~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
. . .++|||++++ .+|.+++... +++.. .+.+++.+|.+||+. ||+|+||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 2 2599999997 6888887542 24443 356789999999999 999999999999999999999
Q ss_pred EeecCCccc
Q 013238 267 VGDFGLAKL 275 (447)
Q Consensus 267 l~Dfgl~~~ 275 (447)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.2e-15 Score=135.20 Aligned_cols=206 Identities=18% Similarity=0.288 Sum_probs=142.8
Q ss_pred HHHHHHhcCCCceeeEeeeeecC-----CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013238 169 EVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243 (447)
Q Consensus 169 e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~ 243 (447)
-+..+-.+.|.|||+++.|+.+. ....++.|||..|++..+|++.......+......+|+.||+.||.|||+ |
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 34556677799999999887653 34679999999999999999877766678889999999999999999999 5
Q ss_pred CCCceecCCCCCCEEECCCCcEEEeecCCccccCCC----CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHH
Q 013238 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK----DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 319 (447)
Q Consensus 244 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~e 319 (447)
.|.|+|+++.-+.|++..+|-+|++----.. .... .........+-++|.|||.=...+.+.++|||+||+..+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 7889999999999999999988875322111 1100 0111122236789999998766777889999999999999
Q ss_pred HHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 320 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 320 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
|..|..--.. ......++. ........+...+ =..++..|++..|..||+|++++..
T Consensus 275 mailEiq~tn-----seS~~~~ee-----~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 275 MAILEIQSTN-----SESKVEVEE-----NIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHheeccCC-----Ccceeehhh-----hhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 9876532111 000000000 0000000001111 1235678999999999999988753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.9e-13 Score=134.25 Aligned_cols=141 Identities=23% Similarity=0.255 Sum_probs=99.1
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccch---------------------------------------HHHHHH
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---------------------------------------ELQFQT 168 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 168 (447)
+.||+|++|.||+|++.+|+.||||+.+......- +..+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999865421100 012334
Q ss_pred HHHHHHhc----CCCceeeEeeeee-cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 013238 169 EVEMISMA----VHRNLLRLRGFCM-TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR-GLAYLHDH 242 (447)
Q Consensus 169 e~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~~ 242 (447)
|...+.++ .|.+-+.+-.++. .....++||||++|++|.++....... . .+..++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHhC
Confidence 44444443 2333333333332 234579999999999999876542111 2 23456666555 46788988
Q ss_pred CCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 243 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|++|+|++|.||++++++.++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.8e-14 Score=138.08 Aligned_cols=249 Identities=21% Similarity=0.190 Sum_probs=177.7
Q ss_pred hCCCCCCeeee--cCCeEEEEEEE--C-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcc
Q 013238 122 DNFSNRNILGR--GGFGKVYKGRL--T-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 194 (447)
Q Consensus 122 ~~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 194 (447)
..|.....+|. |.+|.||.+.. . ++..+|+|.-+.... ......-.+|+....+++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45566677999 99999999987 3 578899998433221 122223345666666664 99999988888888899
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEee
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR----GLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGD 269 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~D 269 (447)
++-.|++ +.+|..+.+..... ++....+.++.+..+ ||.++|+. +++|-|+||.||++..+ ...+++|
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~---~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNF---LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeeccc-cchhHHhhhccccc---CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 9999999 57888888765442 556666777777777 99999999 99999999999999999 8899999
Q ss_pred cCCccccCCCCCc----eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 270 FGLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 270 fgl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
||+...+....-. ......|...|++||.. .+.++..+|+|++|.++.+..++......... ..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---~~-------- 334 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN---SS-------- 334 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC---CC--------
Confidence 9999877544311 11222477789999987 55778899999999999999998776632100 00
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..++-...+..++.......+...+.++++.+|..|++.+.+..
T Consensus 335 -------W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 -------WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -------ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111111222233333445666888999999999999775543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.3e-12 Score=124.56 Aligned_cols=236 Identities=17% Similarity=0.166 Sum_probs=157.7
Q ss_pred CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHH
Q 013238 144 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWS 223 (447)
Q Consensus 144 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 223 (447)
.++.+|.|...+.... .......+-++.++.++||||++++.........|+|+|.+. -|..++.+. ...
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 3678888888765443 333456778889999999999999999999999999999873 455666553 356
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCC
Q 013238 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303 (447)
Q Consensus 224 ~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 303 (447)
.....+.||+.||.|||+.| +++|++|.-+.|+|+..|+.||++|.++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 67778899999999999877 999999999999999999999999998764332221 001111122466666543322
Q ss_pred CCchhhhHHHHHHHHHHHhCCCCcccc-cccCCCc-ccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHcc
Q 013238 304 SSEKTDVFGYGVMLLELITGQRAFDLA-RLANDDD-VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCT 381 (447)
Q Consensus 304 ~~~~sDvwSlG~il~elltg~~p~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl 381 (447)
-..|.|-|||+++|++.|..+-... ....... ..+..+.+.+...+ .. . ...++++..|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~---------~~------r-~n~~~~~~~~~ 243 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATE---------LK------R-PNKLRFILECR 243 (690)
T ss_pred --cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhcccc---------cc------c-cchhhHHHHHH
Confidence 3469999999999999993322110 0000000 00000001110000 00 0 01566777788
Q ss_pred CCCCCCCCCHHHHHHHHhcCCCchhhHHH
Q 013238 382 QGSPMERPKMSEVVRMLEGDGLAERWEEW 410 (447)
Q Consensus 382 ~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 410 (447)
......|=-+-+++.+|+...+++.-++.
T Consensus 244 ~~~gff~n~fvd~~~fLeel~lks~~eK~ 272 (690)
T KOG1243|consen 244 LLGGFFRNDFVDTLLFLEELRLKSVEEKQ 272 (690)
T ss_pred hccccccchHHHHHHHHHhcccCcHHHHH
Confidence 88888888889999999998887665553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=3e-12 Score=111.00 Aligned_cols=130 Identities=20% Similarity=0.170 Sum_probs=94.8
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCcee-eEeeeeecCCcceEEEecccCCcc
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
+.|+.|.++.||++... +..+++|....... ....+..|.+.+..+.+.+++ +++.+. ....++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 56889999999999875 77899998765432 122467788888887655544 344433 3346899999999887
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 207 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 207 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
.... . ....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 0 11245678899999999982 12359999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.4e-13 Score=132.97 Aligned_cols=146 Identities=22% Similarity=0.244 Sum_probs=94.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccc---------------------------------hH----
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQG---------------------------------GE---- 163 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~---- 163 (447)
..|+. +.||+|++|.||+|++.+ |+.||||+.+...... -.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 679999999999999987 9999999997542110 00
Q ss_pred --HHHHHHHHHHHhc----CCCceeeEeeeeec-CCcceEEEecccCCcchhh--hhhcCCCCCCCCHHHHHHHHHHHHH
Q 013238 164 --LQFQTEVEMISMA----VHRNLLRLRGFCMT-PTERLLVYPFMVNGSVASC--LRERGQSQPPLNWSVRKQIALGAAR 234 (447)
Q Consensus 164 --~~~~~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~~ 234 (447)
..+.+|...+.++ .+.+.+.+-.++.+ ....++||||+.|+.+.++ +...+.....+....+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 1233444444333 24444444444433 4567899999999999774 2222211111222222233333
Q ss_pred HHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeecCCccccCC
Q 013238 235 GLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDFGLAKLMDY 278 (447)
Q Consensus 235 ~l~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl~~~~~~ 278 (447)
+... |++|+|+||.||+++.++ ++++.|||+...++.
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3345 999999999999999988 999999999987643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.8e-11 Score=103.07 Aligned_cols=137 Identities=15% Similarity=0.119 Sum_probs=97.9
Q ss_pred CeeeecCCeEEEEEEECC-------CcEEEEEEeccccc---------------------cchHHHH----HHHHHHHHh
Q 013238 128 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERT---------------------QGGELQF----QTEVEMISM 175 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~----~~e~~~l~~ 175 (447)
..||.|.-+.||.|...+ +..+|||+.+.... ......+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 569999999999998653 47899998853210 0111222 378888888
Q ss_pred cCC--CceeeEeeeeecCCcceEEEecccCCcchh-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecC
Q 013238 176 AVH--RNLLRLRGFCMTPTERLLVYPFMVNGSVAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRD 251 (447)
Q Consensus 176 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~d 251 (447)
+.. -++..++++ ...++||||+.++.+.. .+... .++......+..+++.+|..| |.. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 753 455556654 56799999997654422 22221 244556677889999999999 787 999999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccC
Q 013238 252 VKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 252 lk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|++.||++++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-10 Score=105.55 Aligned_cols=143 Identities=20% Similarity=0.235 Sum_probs=107.8
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC--CceeeEeeeeecC---CcceEEEeccc
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTP---TERLLVYPFMV 202 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~ 202 (447)
+.|+.|..+.||++...+|+.+++|.............+..|.+++..+.+ .++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999999877788999998654322233467889999988875 3456677766553 25689999999
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--------------------------------------- 243 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------- 243 (447)
|.++...+.. ..++......++.+++++|+.||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888876532 13666777777888888888887421
Q ss_pred --------------CCCceecCCCCCCEEECC--CCcEEEeecCCccc
Q 013238 244 --------------DPKIIHRDVKAANILLDE--EFEAVVGDFGLAKL 275 (447)
Q Consensus 244 --------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~ 275 (447)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-11 Score=120.97 Aligned_cols=248 Identities=19% Similarity=0.171 Sum_probs=168.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC--CCcEEEEEEeccccccchHH-HHHHHHHHHHhc-CCCceeeEeeeeecCCcce
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQGGEL-QFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 195 (447)
...+|..+..||.|.|+.|+..... ++..+++|.+.+.......+ .-..|+.+...+ .|.+++.....+...+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888889999999999988643 57889999886654332221 223444444444 4888888777666667778
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeecCCcc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAK 274 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~ 274 (447)
+--|||+++++.....-. ..++...++.+..+++.++.++|+. .++|+|+||+||++..+ +..+++|||++.
T Consensus 343 ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 999999999887666222 2277788899999999999999998 99999999999999886 788999999987
Q ss_pred ccCCCCCceeeccccccCcc--ccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHI--APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
.+...... .....++. +++......+..+.|++|||.-+.|.+++..--... .+|
T Consensus 416 ~~~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----------~~~--------- 472 (524)
T KOG0601|consen 416 RLAFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----------VQS--------- 472 (524)
T ss_pred ccceeccc----ccccccccccchhhccccccccccccccccccccccccCcccCccc----------ccc---------
Confidence 43222111 11223344 555556667889999999999999999987543210 000
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..+...... ... .....+..+...+...++..||.+.++....+-
T Consensus 473 -~~i~~~~~p-~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 473 -LTIRSGDTP-NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -eeeeccccc-CCC-chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 001111000 001 111345556666778999999998887765543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.3e-10 Score=105.21 Aligned_cols=290 Identities=15% Similarity=0.151 Sum_probs=181.6
Q ss_pred CCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHh-cCCCceeeEeee------eecCCc-ceEE
Q 013238 126 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGF------CMTPTE-RLLV 197 (447)
Q Consensus 126 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~------~~~~~~-~~lv 197 (447)
..+.||+|+-+.+|-.---.+ .+-|+......... ...++.|.. -.||-+-.=+.+ .-+... .-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhc--hhheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 346799999999986532212 34566654322111 122333333 235433221111 011222 4567
Q ss_pred EecccCCcchhhh-h--hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 198 YPFMVNGSVASCL-R--ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 198 ~e~~~~gsL~~~l-~--~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
|..+.+..--..+ . .++.+.+...|...++++..++.+.+-||.. |.+-+|+.++|+|+.+++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 7777654222222 1 1334556689999999999999999999999 99999999999999999999998865443
Q ss_pred ccCCCCCceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhC-CCCcccccccCCCcccHH-HHHHHH
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLL-DWVKGL 347 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~-~~~~~~ 347 (447)
.. .........+|...|++||.-. +...+...|-|.||+++++++.| ++||...........-+. +.....
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32 2334445566899999999654 33457789999999999999886 999975433222211111 111111
Q ss_pred hhccccccccccccC---CCCc-HHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHhcCCCchhhHHHHHhhhhhccCC
Q 013238 348 LKEKKLEQLVDSDME---GNYI-EEEVEQLIQVALLCTQG--SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFN 421 (447)
Q Consensus 348 ~~~~~~~~~~d~~~~---~~~~-~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~ 421 (447)
+....-. ..... ...+ .-....+.-+-.+|+.. ++.-|||++-++..|......-..|-...++.|....-
T Consensus 244 f~ya~~~---~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~hl~ 320 (637)
T COG4248 244 FAYASDQ---RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPVHLT 320 (637)
T ss_pred eeechhc---cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccCCCC
Confidence 1100000 00010 1111 11223344455566643 46799999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 013238 422 HTPHPNNT 429 (447)
Q Consensus 422 ~~~~~~~~ 429 (447)
.||-|..+
T Consensus 321 ~CPwCa~~ 328 (637)
T COG4248 321 DCPWCALD 328 (637)
T ss_pred CCchhhhc
Confidence 99999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.3e-10 Score=94.55 Aligned_cols=132 Identities=20% Similarity=0.305 Sum_probs=97.3
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccc-------hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
..+++|+-+.++.+.+. |..+++|.-....... ......+|..++.++.--.|.-..=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 4456666543222111 122456788888887655554444455678888999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
.+|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888654 134556666778889999 999999999999998875 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.2e-09 Score=105.39 Aligned_cols=171 Identities=20% Similarity=0.254 Sum_probs=128.1
Q ss_pred CCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec----CCcceEEEecccC-Ccch
Q 013238 134 GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPFMVN-GSVA 207 (447)
Q Consensus 134 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~ 207 (447)
.-.+.|++... +|..|++|+++..+..... ....-+++++++.|.|+|++.+++.. +...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34678888754 7999999999654433221 12345788999999999999998763 4567899999976 4666
Q ss_pred hhhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 208 SCLRERG-----------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 208 ~~l~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
+.-.... ......++..+|.++.|+..||.++|+. |+..+-|.+.+|+++.+.+++|...|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 5432211 1234578899999999999999999999 9999999999999999999999998887765
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCC
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 326 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p 326 (447)
...... .+ .--.+-|.=.||.+++.|.||..-
T Consensus 444 ~~d~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPTE---------------PL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCCc---------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 433211 01 112357999999999999998643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.2e-10 Score=92.68 Aligned_cols=144 Identities=18% Similarity=0.253 Sum_probs=103.5
Q ss_pred CCCeeeecCCeEEEEEEECCCcEEEEEEecccccc-------chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 126 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 126 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
....|-+|+-+.|+++.+. |+.+.||.-...... -...+..+|...+.++.--.|....-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999986 777777754322211 12335678888888876555544444566777788999
Q ss_pred ecccC-CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEeecCCcc
Q 013238 199 PFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAK 274 (447)
Q Consensus 199 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~ 274 (447)
||+++ -++.+++...... .........++..|-+.+.-||.. +++|+||..+||++..++. +.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 3677777654322 122233367778888899999999 9999999999999976553 5899999986
Q ss_pred c
Q 013238 275 L 275 (447)
Q Consensus 275 ~ 275 (447)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.9e-11 Score=126.22 Aligned_cols=251 Identities=19% Similarity=0.201 Sum_probs=162.6
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
....+.+.+.+-+-+|.++.+..+.-. .|...++|......... .......+-.+.-..++|.++....-+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345566777777888999998877643 34444444443211100 000111222222223456666554444456778
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
+++++|+.+++|...|+... +.+..-.......+.++++|||+. .+.|+|++|.|+++..+++.+++|||...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence 99999999999999998765 244444455566677899999998 79999999999999999999999998432
Q ss_pred ccCCC---------------------C---------CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCC
Q 013238 275 LMDYK---------------------D---------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324 (447)
Q Consensus 275 ~~~~~---------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~ 324 (447)
..... . ........+|+.|.+||...+......+|+|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 21100 0 01122345899999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccHHHHHHHHhhccccccccccccCC-CCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 013238 325 RAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMS 392 (447)
Q Consensus 325 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 392 (447)
.||...... .....+....... ...........+++...+..+|.+|-.+.
T Consensus 1033 pp~na~tpq-----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQ-----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchh-----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999642211 0011111111111 11223334466677777788999998776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.5e-09 Score=93.27 Aligned_cols=126 Identities=21% Similarity=0.220 Sum_probs=82.1
Q ss_pred EEEEEEECCCcEEEEEEecccccc-------------------------chHHHHHHHHHHHHhcCCC--ceeeEeeeee
Q 013238 137 KVYKGRLTDGSLVAVKRLKEERTQ-------------------------GGELQFQTEVEMISMAVHR--NLLRLRGFCM 189 (447)
Q Consensus 137 ~V~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 189 (447)
.||.|...+|..+|||..+..... .......+|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999988999999998532100 0112467799999999765 45666654
Q ss_pred cCCcceEEEeccc--CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceecCCCCCCEEECCCCcEE
Q 013238 190 TPTERLLVYPFMV--NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY-LHDHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 190 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~y-LH~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
....+||||++ |..+..+.... ++......++.+++..+.. +|.. |++|+||++.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 35689999998 54554433221 1123455677777776655 4677 99999999999999988 999
Q ss_pred EeecCCcccc
Q 013238 267 VGDFGLAKLM 276 (447)
Q Consensus 267 l~Dfgl~~~~ 276 (447)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.3e-08 Score=94.24 Aligned_cols=141 Identities=14% Similarity=0.092 Sum_probs=98.6
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccc----------hHHHHHHHHHHHHhcCCCc--eeeEeeeeec-----
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG----------GELQFQTEVEMISMAVHRN--LLRLRGFCMT----- 190 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~----- 190 (447)
+.+-......|.+..+ +|+.+.||+........ ....+.+|...+.++...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4454445556777766 57889999774332111 1113678888887774333 2334444432
Q ss_pred CCcceEEEecccCC-cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-------C
Q 013238 191 PTERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-------E 262 (447)
Q Consensus 191 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-------~ 262 (447)
....++|+|++++. +|.+++..... .+.+......++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999875 78888754321 2355677788999999999999999 9999999999999975 4
Q ss_pred CcEEEeecCCcc
Q 013238 263 FEAVVGDFGLAK 274 (447)
Q Consensus 263 ~~~kl~Dfgl~~ 274 (447)
..+.++||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 679999999875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=6.2e-09 Score=93.39 Aligned_cols=136 Identities=21% Similarity=0.162 Sum_probs=96.9
Q ss_pred CCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc---------------------cchHHHHHHHHHHHHhcCCC--c
Q 013238 124 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT---------------------QGGELQFQTEVEMISMAVHR--N 180 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~--n 180 (447)
..+...||-|.-+.||.|...+|.++|||.-+..++ .-.....++|.+.|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445678999999999999999999999997643221 01223567899999888544 4
Q ss_pred eeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 013238 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 260 (447)
Q Consensus 181 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~ 260 (447)
+.+.+++ +...+||||.+|-.|...- ++......++..|++-+.-+-.. |+||+|++.-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 5555543 5568999999886655432 11222334444444544444455 999999999999999
Q ss_pred CCCcEEEeecCCccc
Q 013238 261 EEFEAVVGDFGLAKL 275 (447)
Q Consensus 261 ~~~~~kl~Dfgl~~~ 275 (447)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.2e-10 Score=111.60 Aligned_cols=150 Identities=17% Similarity=0.311 Sum_probs=102.2
Q ss_pred HHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC--------ceeeccccccCccccccccC
Q 013238 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--------HVTTAVRGTIGHIAPEYLST 301 (447)
Q Consensus 230 ~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~ 301 (447)
.+++.|+.|+|... ++||++|.|++|.++.++..||+.|+.+........ ...........|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999875 999999999999999999999999998764432111 11111123457999999999
Q ss_pred CCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHc
Q 013238 302 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLC 380 (447)
Q Consensus 302 ~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~c 380 (447)
...+.++|+||+|+++|.+.. |+.-+... ...... ......+..-...+....+.++.+-+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-----~~~~~~----------~~~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN-----GGLLSY----------SFSRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhcc-----CCcchh----------hhhhcccccccccccccCcHHHHHHHHHH
Confidence 888999999999999999984 55444321 011111 11111111111122344556688888889
Q ss_pred cCCCCCCCCCHHHHHH
Q 013238 381 TQGSPMERPKMSEVVR 396 (447)
Q Consensus 381 l~~dP~~RPt~~evl~ 396 (447)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.4e-07 Score=82.85 Aligned_cols=104 Identities=20% Similarity=0.209 Sum_probs=79.5
Q ss_pred HHHHHHHHHHhcCCC--ceeeEeeeeecC----CcceEEEecccCC-cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 013238 165 QFQTEVEMISMAVHR--NLLRLRGFCMTP----TERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237 (447)
Q Consensus 165 ~~~~e~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~ 237 (447)
...+|...+..+... .....+++.... ...++|+|++++. +|.+++..... .+......++.+++..++
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence 467788777666422 244455555432 2347999999874 78888876332 455667889999999999
Q ss_pred HHHhCCCCCceecCCCCCCEEECCCC---cEEEeecCCccc
Q 013238 238 YLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKL 275 (447)
Q Consensus 238 yLH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~ 275 (447)
-||.. ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.1e-07 Score=92.11 Aligned_cols=142 Identities=19% Similarity=0.217 Sum_probs=91.5
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccch---------------------------------------HHHHHH
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---------------------------------------ELQFQT 168 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 168 (447)
+-|+.++-|.||+|++.+|+.||||+.+....+.- +..+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56889999999999999999999999865421100 011223
Q ss_pred HHHHHHhc----CCCceeeEeeeeec-CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 013238 169 EVEMISMA----VHRNLLRLRGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG-LAYLHDH 242 (447)
Q Consensus 169 e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~-l~yLH~~ 242 (447)
|...+.++ ....-+.+=.++.+ .....++|||+.|-.+.+....... .++.. .++..++++ +.-+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k---~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRK---ELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHH---HHHHHHHHHHHHHHHhc
Confidence 33333332 22222333333332 4677999999999888887432221 14433 333333332 2223334
Q ss_pred CCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 243 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|+.|.|..|.||+++.+|++.+.|||+...++.
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.3e-06 Score=76.81 Aligned_cols=138 Identities=20% Similarity=0.165 Sum_probs=99.9
Q ss_pred eeecCCeEEEEEEECCCcEEEEEEeccccc-----cchHHHHHHHHHHHHhcCCCc--eeeEeeeee-c--C--CcceEE
Q 013238 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERT-----QGGELQFQTEVEMISMAVHRN--LLRLRGFCM-T--P--TERLLV 197 (447)
Q Consensus 130 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~-~--~--~~~~lv 197 (447)
-|+|+-+-|++..+. |..+-+|+-..... +.....|.+|+..+..+...+ +.++. ++. . . -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 456888889998775 45788888752211 334567999999988875333 44444 222 1 1 235789
Q ss_pred EecccC-CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--EEEeecCCcc
Q 013238 198 YPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK 274 (447)
Q Consensus 198 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~ 274 (447)
+|-+.+ -+|.+++..... .+.+...+..++.+++..++-||+. |+.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 578888755332 2356777889999999999999999 9999999999999986667 9999998665
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.9e-06 Score=76.87 Aligned_cols=153 Identities=20% Similarity=0.228 Sum_probs=97.5
Q ss_pred CHHHHHHHhhCCCCCC---eeeecCCeEEEEEEECCCcEEEEEEeccccccc------------------hHHH-----H
Q 013238 113 SLRELQVATDNFSNRN---ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG------------------GELQ-----F 166 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~---~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------~~~~-----~ 166 (447)
++..+.....+..+.. .|++|.-..||+|...++..+|||+++.....- .... .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3444444444444444 466777888999998889999999986432110 0011 2
Q ss_pred HHHHHHHHhcC--CCceeeEeeeeecCCcceEEEecccCC-cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013238 167 QTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243 (447)
Q Consensus 167 ~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~ 243 (447)
..|+..|.++. +-.+.+.+++ ....+||||+... .-.-.|... ++.......+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHhc
Confidence 34566665553 2333333433 3457999999553 112222221 1333356677778888888887633
Q ss_pred CCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 244 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
++||+||+.-|||+. ++.+.|+|||-+....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 7899999999887544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.4e-06 Score=76.45 Aligned_cols=139 Identities=13% Similarity=0.127 Sum_probs=83.4
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc--eeeEeeeeecCCcceEEEecccCCc
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+++....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 24567788876433 2334678898888775433 4566777766667789999998863
Q ss_pred -chhhh---------------------hhcCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCceec
Q 013238 206 -VASCL---------------------RERGQSQPPLNWSVRK-QIAL----------GAAR-GLAYLHDH-CDPKIIHR 250 (447)
Q Consensus 206 -L~~~l---------------------~~~~~~~~~l~~~~~~-~i~~----------~i~~-~l~yLH~~-~~~~ivH~ 250 (447)
+...+ +...... ....... .+.. .+.. ...+|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 21111 1110011 1111110 0000 0111 12223221 13367999
Q ss_pred CCCCCCEEECCCCcEEEeecCCccc
Q 013238 251 DVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 251 dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
|+.|.||++++++ +.++||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999988 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.6e-06 Score=72.29 Aligned_cols=139 Identities=12% Similarity=0.113 Sum_probs=89.5
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHH--------HHHHHHHHHHhcCCCc---eeeEeee
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL--------QFQTEVEMISMAVHRN---LLRLRGF 187 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~e~~~l~~l~h~n---iv~l~~~ 187 (447)
+...+|...+++-......|.+-.. +|..+++|..+......... ...+.+..+.+++... ...++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4456777777787777777777666 46889999886543221110 1223344333333222 2222222
Q ss_pred ee-----cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 013238 188 CM-----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262 (447)
Q Consensus 188 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~ 262 (447)
.. -....+++|||++|..|.++.. ++. .++..+++++.-||.. |++|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 21 1234568999999988776642 222 2445667889999999 99999999999999966
Q ss_pred CcEEEeecCCcc
Q 013238 263 FEAVVGDFGLAK 274 (447)
Q Consensus 263 ~~~kl~Dfgl~~ 274 (447)
+ +++.||+..+
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 4 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.9e-07 Score=92.72 Aligned_cols=181 Identities=21% Similarity=0.159 Sum_probs=128.7
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc-eeeEeeeeecCCcceEEEecccCC-c
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVYPFMVNG-S 205 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-s 205 (447)
+-+++|+++++++.+....+....+.+... ....-++++|.+.+||| .+..++-+..+...++.++++.++ +
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 347889999999887654444556655433 23456789999999999 666677666777888999999776 2
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceee
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 285 (447)
-..-... ....+.......+...-+++++|||+. .=+|+| ||+..+ +..+.+||+....+.... ...
T Consensus 322 ~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 322 SALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred ccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 2111111 111133333444555567889999987 558888 777766 578999999987665443 233
Q ss_pred ccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCc
Q 013238 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327 (447)
Q Consensus 286 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~ 327 (447)
...+++.|+|||+.....+..+.|+|++|.-..+|.-|-.|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 455899999999999999999999999998777777776664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.4e-05 Score=84.56 Aligned_cols=150 Identities=12% Similarity=0.197 Sum_probs=92.3
Q ss_pred CCeeeecCCeEEEEEEECCC---cEEEEEEeccccccchHHHHHHHHHHHHhcC-CCce--eeEeeeeecC---CcceEE
Q 013238 127 RNILGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNL--LRLRGFCMTP---TERLLV 197 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 197 (447)
.+.++.|.++.+|+....++ ..+++|+............+.+|.++++.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 35688999999999887653 3677787654332223346889999998885 6654 7778887664 467899
Q ss_pred EecccCCcchhh-----------------------hhhcCCC-------CCCCCH--HHHHHHH---------------H
Q 013238 198 YPFMVNGSVASC-----------------------LRERGQS-------QPPLNW--SVRKQIA---------------L 230 (447)
Q Consensus 198 ~e~~~~gsL~~~-----------------------l~~~~~~-------~~~l~~--~~~~~i~---------------~ 230 (447)
|||++|..+.+. |+..... ..+..+ ..+..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999987653321 1111100 011111 1111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCceecCCCCCCEEECC-CCc-EEEeecCCcccc
Q 013238 231 GAARGLAYLHDHCD--------PKIIHRDVKAANILLDE-EFE-AVVGDFGLAKLM 276 (447)
Q Consensus 231 ~i~~~l~yLH~~~~--------~~ivH~dlk~~Nill~~-~~~-~kl~Dfgl~~~~ 276 (447)
.+...+.+|..+.. +.++|+|+++.||+++. ++. .-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 13344567754322 35999999999999985 334 569999987654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.2e-05 Score=80.51 Aligned_cols=141 Identities=21% Similarity=0.237 Sum_probs=89.0
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccc------------------------------------hHHHHHHHHH
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG------------------------------------GELQFQTEVE 171 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------------------~~~~~~~e~~ 171 (447)
+-||.-+.|.||+|++++|+.||||+-+..-... .+.+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5689999999999999999999999876432111 0112333443
Q ss_pred HH----HhcCCCc---eeeEeeeeec-CCcceEEEecccCCcchhhh--hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013238 172 MI----SMAVHRN---LLRLRGFCMT-PTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGAARGLAYLHD 241 (447)
Q Consensus 172 ~l----~~l~h~n---iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~ 241 (447)
.. ..+.|-+ -|.+=.++.+ .....|+||||+|..+.+.- ...+ ++...+.. .+.++ |++.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~~i~~---~l~~~--~~~q 316 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-----ISPHDILN---KLVEA--YLEQ 316 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-----CCHHHHHH---HHHHH--HHHH
Confidence 32 2233444 1222223322 35679999999998887653 3332 44444333 33332 2222
Q ss_pred CCCCCceecCCCCCCEEECC----CCcEEEeecCCccccCC
Q 013238 242 HCDPKIIHRDVKAANILLDE----EFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 242 ~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfgl~~~~~~ 278 (447)
-...|++|+|-.|.||+++. ++.+.+-|||+...+..
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 12228999999999999984 67899999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.4e-05 Score=72.75 Aligned_cols=143 Identities=17% Similarity=0.181 Sum_probs=81.7
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCC--ceeeEeeeeec---CCcceEEEeccc
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR--NLLRLRGFCMT---PTERLLVYPFMV 202 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~ 202 (447)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.++.. ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 568999999999999877 68999987554 2334567788887776533 24556654432 234689999999
Q ss_pred CCcchh----------------hh---hhcCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 013238 203 NGSVAS----------------CL---RERGQSQPPLNWSVR---------KQI------------ALGAAR-GLAYLHD 241 (447)
Q Consensus 203 ~gsL~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~i~~-~l~yLH~ 241 (447)
+..+.. .+ +.......+...... ... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887776 11 111111111111110 000 111222 2333332
Q ss_pred C----CCCCceecCCCCCCEEEC-CCCcEEEeecCCcc
Q 013238 242 H----CDPKIIHRDVKAANILLD-EEFEAVVGDFGLAK 274 (447)
Q Consensus 242 ~----~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~ 274 (447)
. ....++|+|+.+.||+++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 234799999999999999 66677899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.2e-05 Score=72.22 Aligned_cols=140 Identities=16% Similarity=0.083 Sum_probs=82.6
Q ss_pred eeecCC-eEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEEecccCCcch
Q 013238 130 LGRGGF-GKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVA 207 (447)
Q Consensus 130 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 207 (447)
|..|.. ..||+.... +..+.+|+..... ...+.+|++++..+. +--+.+++++....+..++||++++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444544 788998764 4678888875432 224567888777663 334556777766666789999999987766
Q ss_pred hhh-------------------hhcCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhC----
Q 013238 208 SCL-------------------RERGQSQPPLNWS--VRKQIAL--------------------GAARGLAYLHDH---- 242 (447)
Q Consensus 208 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~l~yLH~~---- 242 (447)
... +.......++... ....... .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1110001111100 0000000 011112222111
Q ss_pred CCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 243 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23469999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=2e-05 Score=69.01 Aligned_cols=105 Identities=19% Similarity=0.174 Sum_probs=81.7
Q ss_pred HHHHHHHHhcCC-CceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 013238 167 QTEVEMISMAVH-RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245 (447)
Q Consensus 167 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~ 245 (447)
..|.-++..+++ +++.+++|+| ..+++.||...+++...-... ...-..+|..+.+|+.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 457778888876 6899999998 347899999877665321000 0011268999999999999999999985444
Q ss_pred CceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 246 ~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
.+.-.|++++|+-+++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6788999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.1e-05 Score=64.21 Aligned_cols=127 Identities=15% Similarity=0.191 Sum_probs=87.3
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceee-EeeeeecCCcceEEEecccCCc
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR-LRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gs 205 (447)
.+.|++|.+|.||++.+. |..+|+|+-+.+ .....++.|.+++..+.-.++.+ ++.| +..++.|||..|-.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~ 98 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcc
Confidence 467999999999999997 457888876543 33457889999998887666544 4443 23345599998878
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC-CCCEEECCCCcEEEeecCCccc
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVK-AANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
|.++-... +... +..+++.---|... ||-|+.|+ |...+|..++.+.|+||.-|..
T Consensus 99 L~~~~~~~-------~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG-------DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc-------cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 77665321 1222 33445554445555 99999997 5555555555999999998863
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00023 Score=62.75 Aligned_cols=134 Identities=23% Similarity=0.333 Sum_probs=90.8
Q ss_pred CCCeeeecCCeEEEEEEECCCcEEEEEEecccc---------------ccchHHHHHHHHHHHHhcC------CCceeeE
Q 013238 126 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER---------------TQGGELQFQTEVEMISMAV------HRNLLRL 184 (447)
Q Consensus 126 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------h~niv~l 184 (447)
....||+|+.-.||.- .++....||++.... ......+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3467999999999863 445567888887654 1112345666776655554 8889999
Q ss_pred eeeeecCCcceEEEecccC------CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 013238 185 RGFCMTPTERLLVYPFMVN------GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 258 (447)
Q Consensus 185 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nil 258 (447)
+|+..+....-+|+|...+ -+|.+++.... ++. ...+. +-+-..||-++ +|+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEE
Confidence 9999998888999998643 25666664332 444 33333 33445778787 8999999999999
Q ss_pred ECCCC----cEEEee-cCCc
Q 013238 259 LDEEF----EAVVGD-FGLA 273 (447)
Q Consensus 259 l~~~~----~~kl~D-fgl~ 273 (447)
+.... .+.|+| ||..
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEecCCCceEEEEEeCCCCc
Confidence 95432 466776 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00027 Score=66.95 Aligned_cols=79 Identities=14% Similarity=0.068 Sum_probs=56.1
Q ss_pred CCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC---CceeeEeeeeec---CCcceEE
Q 013238 124 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH---RNLLRLRGFCMT---PTERLLV 197 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv 197 (447)
....+.||.|..+.||+....++ .+++|..+... ....+..|.+.++.+.- ..+.+++++|.. .+..++|
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 33446799999999999987655 46677753311 22367889998887753 357778887754 3568999
Q ss_pred EecccCCcc
Q 013238 198 YPFMVNGSV 206 (447)
Q Consensus 198 ~e~~~~gsL 206 (447)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.87 E-value=7.5e-05 Score=79.59 Aligned_cols=197 Identities=20% Similarity=0.196 Sum_probs=136.2
Q ss_pred HHHHHHHHHhcCCCceeeEeeeeecCCc----ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013238 166 FQTEVEMISMAVHRNLLRLRGFCMTPTE----RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241 (447)
Q Consensus 166 ~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~ 241 (447)
...|++.+.++.|+|++.+++|...... ..+..+++..-++...+.... .++....+.+..++.+||+|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH
Confidence 4457778889999999999998765432 234557888888887776543 37788888899999999999999
Q ss_pred CCCCCceecCCCCC---CEEECCCCcEEEe--ecCCccccCCCCCceeeccccccCccccccccCCCCCc--hhhhHHHH
Q 013238 242 HCDPKIIHRDVKAA---NILLDEEFEAVVG--DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE--KTDVFGYG 314 (447)
Q Consensus 242 ~~~~~ivH~dlk~~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwSlG 314 (447)
. ...|.-+..+ +.-.+..+.+.++ ||+.++......... ...-+..|.|+|......+.. ..|+|.+|
T Consensus 305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHH
Confidence 8 6666666555 5555677777777 888887654332221 122345678888776665544 47999999
Q ss_pred HHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 013238 315 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394 (447)
Q Consensus 315 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 394 (447)
..+..+..|..+-..... ...+++. .. ...+.+...+|+..++++|+++.++
T Consensus 380 ll~~~~~~~~~i~~~~~~--------------------~~~~l~~----~~----~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV--------------------PVSLLDV----LS----TSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHhhhhhcCcccccccc--------------------hhhhhcc----cc----chhhhhhhhhhcchhhhhccchhhh
Confidence 999999988765432110 0001111 00 0146777889999999999999999
Q ss_pred HHHHh
Q 013238 395 VRMLE 399 (447)
Q Consensus 395 l~~L~ 399 (447)
+...-
T Consensus 432 l~~~f 436 (1351)
T KOG1035|consen 432 LTHPF 436 (1351)
T ss_pred hhchh
Confidence 87544
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00026 Score=64.69 Aligned_cols=32 Identities=28% Similarity=0.438 Sum_probs=26.7
Q ss_pred CCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 244 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
.+.++|+|+.+.||+++++...-|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 34689999999999999776567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00036 Score=63.69 Aligned_cols=142 Identities=15% Similarity=0.183 Sum_probs=80.5
Q ss_pred CeeeecCCeEEEEEEECC--CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc-eeeEeeeeecCCcceEEEecccCC
Q 013238 128 NILGRGGFGKVYKGRLTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
+.|..|-...+|+....+ +..+++|........ .....+|+.++..+.... ..++++.+. ..++|||++|.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 457788889999998764 678889977543211 112346787777774333 334444322 24899999887
Q ss_pred cchhh-----------------hhhcCCCC-------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 013238 205 SVASC-----------------LRERGQSQ-------PPL-NWSVRKQIAL----------------------GAARGLA 237 (447)
Q Consensus 205 sL~~~-----------------l~~~~~~~-------~~l-~~~~~~~i~~----------------------~i~~~l~ 237 (447)
++... ++...... ... .+..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65321 11111110 011 1222212211 1111111
Q ss_pred HH----HhC-CCCCceecCCCCCCEEECC-CCcEEEeecCCccc
Q 013238 238 YL----HDH-CDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKL 275 (447)
Q Consensus 238 yL----H~~-~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~ 275 (447)
.| ... ....++|+|+.+.|||+++ ++.+.++||..+..
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 22 111 2337999999999999998 57899999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00085 Score=58.76 Aligned_cols=126 Identities=25% Similarity=0.334 Sum_probs=86.0
Q ss_pred hCCCCCCeeeecCC-eEEEEEEECCCcEEEEEEeccc---c-------cc----------chHHHHHHHHHHHHhcC---
Q 013238 122 DNFSNRNILGRGGF-GKVYKGRLTDGSLVAVKRLKEE---R-------TQ----------GGELQFQTEVEMISMAV--- 177 (447)
Q Consensus 122 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~~---~-------~~----------~~~~~~~~e~~~l~~l~--- 177 (447)
.+++.++.||.|.- |.||+++.. |+.+|+|.+..- . .. .....|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78889999999999 999999985 779999994210 0 00 00123777888777665
Q ss_pred CCce--eeEeeeeecCC------------------cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 013238 178 HRNL--LRLRGFCMTPT------------------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237 (447)
Q Consensus 178 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~ 237 (447)
+.++ ++.+||..-.. ...+|.||.+... .+.... +.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHHHHHH
Confidence 4455 88888863220 1235666654432 123333 344556678
Q ss_pred HHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 238 yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.+|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 89998 9999999999987 3489999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00046 Score=63.89 Aligned_cols=139 Identities=14% Similarity=0.068 Sum_probs=78.1
Q ss_pred eeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCce-eeEeeeeecCCcceEEEecccCCcchh
Q 013238 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFMVNGSVAS 208 (447)
Q Consensus 130 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 208 (447)
+..|-.+.+|+... ++..+++|........- .....+|.++++.+....+ .+++..+ ..++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 55688889999874 46678888764332111 0134678888877754333 2334332 2479999998876542
Q ss_pred h-----------------hhhcCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCCceecCCCCCC
Q 013238 209 C-----------------LRERGQSQPPLNWSV-RKQIALGA---------ARGLAYLHDH-----CDPKIIHRDVKAAN 256 (447)
Q Consensus 209 ~-----------------l~~~~~~~~~l~~~~-~~~i~~~i---------~~~l~yLH~~-----~~~~ivH~dlk~~N 256 (447)
. ++.......+++... +..+..++ ...+..+-.. ....++|+|+.+.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111111222221 11111111 1112222211 12368999999999
Q ss_pred EEECCCCcEEEeecCCccc
Q 013238 257 ILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 257 ill~~~~~~kl~Dfgl~~~ 275 (447)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.001 Score=65.06 Aligned_cols=75 Identities=15% Similarity=0.111 Sum_probs=51.7
Q ss_pred CeeeecCCeEEEEEEECCC-cEEEEEEecccc------ccchHHHHHHHHHHHHhcC---CCceeeEeeeeecCCcceEE
Q 013238 128 NILGRGGFGKVYKGRLTDG-SLVAVKRLKEER------TQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 197 (447)
+.||.|.+..||++...+| +.++||.-.... ..-...+...|.+.|..+. -.++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998876 489999854221 1122335666777776642 3456667766 44667899
Q ss_pred EecccCC
Q 013238 198 YPFMVNG 204 (447)
Q Consensus 198 ~e~~~~g 204 (447)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00067 Score=64.28 Aligned_cols=143 Identities=16% Similarity=0.092 Sum_probs=83.1
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc--eeeEeee------eecCCcceEEE
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGF------CMTPTERLLVY 198 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~ 198 (447)
.+.|..|....+|+....+ ..+++|+... . ....+..|++++..+.+.. +.+++.. ....+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~-~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK-V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC-C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3457778888999987654 4688898754 1 1234566777776664332 3344331 12234568999
Q ss_pred ecccCCcchh----h----------hhhcCCC-C------CCCCHHHHH----------HHHHHHHHHHHHHHh----CC
Q 013238 199 PFMVNGSVAS----C----------LRERGQS-Q------PPLNWSVRK----------QIALGAARGLAYLHD----HC 243 (447)
Q Consensus 199 e~~~~gsL~~----~----------l~~~~~~-~------~~l~~~~~~----------~i~~~i~~~l~yLH~----~~ 243 (447)
+|++|..+.. . ++..... . ....|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998876532 0 1111000 0 011222111 011123344555543 12
Q ss_pred CCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 244 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
..+++|+|+.|.||++++++.+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3479999999999999998777899999775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.003 Score=60.55 Aligned_cols=31 Identities=26% Similarity=0.284 Sum_probs=26.7
Q ss_pred CCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 244 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
..+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4489999999999999976556899999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00024 Score=65.92 Aligned_cols=135 Identities=17% Similarity=0.136 Sum_probs=91.7
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCcEEEEEEecccccc---------------------chHHHHHHHHHHHHhcCC-Cc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---------------------GGELQFQTEVEMISMAVH-RN 180 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~h-~n 180 (447)
-+..++.||-|.-+.+|.+.+.+|++.++|.-+..++. -.+....+|+..|+.+.. ..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 35677899999999999999999999999865422110 012235567777776642 22
Q ss_pred -eeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 013238 181 -LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259 (447)
Q Consensus 181 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill 259 (447)
+.+.++ .+..++|||++.+-.|...-+-. +... +...+..-+.-|-.+ |+||+|..--||++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-------d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVE-------DPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecC-------ChHH---HHHHHHHHHHHHHHc---CceecccchheeEE
Confidence 222332 34568999999887766543221 2222 333333445567777 99999999999999
Q ss_pred CCCCcEEEeecCCcc
Q 013238 260 DEEFEAVVGDFGLAK 274 (447)
Q Consensus 260 ~~~~~~kl~Dfgl~~ 274 (447)
++++.++++||--..
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999997554
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0023 Score=60.68 Aligned_cols=142 Identities=18% Similarity=0.236 Sum_probs=95.7
Q ss_pred CCCeeeecCCeEEEEEEECCCcEEEEEEecccc--------------------ccchHHH-----HHHHHHHHHhcCCCc
Q 013238 126 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER--------------------TQGGELQ-----FQTEVEMISMAVHRN 180 (447)
Q Consensus 126 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------~~~~~~~-----~~~e~~~l~~l~h~n 180 (447)
+..+|..|.-..||.+.-.+|..+|||+++... +...... ...|+..|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346788899999999999999999999985321 0111111 345677777775444
Q ss_pred eeeEeeeeecCCcceEEEecccCCcc-hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 013238 181 LLRLRGFCMTPTERLLVYPFMVNGSV-ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259 (447)
Q Consensus 181 iv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill 259 (447)
|...--+.. ....|||+|+..... .-.|.. -.++...+..+-.+++.-|.-|-..| ++||.||+--|+|+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 322111111 234799999953221 112222 23666777788888888899998888 99999999999999
Q ss_pred CCCCcEEEeecCCccccC
Q 013238 260 DEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 260 ~~~~~~kl~Dfgl~~~~~ 277 (447)
.+ |.+.|+|.+-+...+
T Consensus 299 hd-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVEHD 315 (520)
T ss_pred EC-CEEEEEEccccccCC
Confidence 86 589999998876443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0014 Score=62.28 Aligned_cols=141 Identities=23% Similarity=0.244 Sum_probs=81.2
Q ss_pred CeeeecCCeEEEEEEECC-------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCce-eeEeeeeecCCcceEEEe
Q 013238 128 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 199 (447)
+.+..|-...+|+....+ ++.+++|+...... ......+|.+++..+....+ .++++++. ..+|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence 346677788999988654 47889998754321 11245677777776653333 33444442 246899
Q ss_pred cccCCcchhh-----------------hhhcCCCC-------CCCCHHHHHHH--------------------------H
Q 013238 200 FMVNGSVASC-----------------LRERGQSQ-------PPLNWSVRKQI--------------------------A 229 (447)
Q Consensus 200 ~~~~gsL~~~-----------------l~~~~~~~-------~~l~~~~~~~i--------------------------~ 229 (447)
|++|..+... +|...... .+.-+..+..+ .
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9988766431 11111110 00111111111 1
Q ss_pred HHHHHHHHHHHh------CCCCCceecCCCCCCEEECCC----CcEEEeecCCcc
Q 013238 230 LGAARGLAYLHD------HCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAK 274 (447)
Q Consensus 230 ~~i~~~l~yLH~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~ 274 (447)
..+...+.+|.. .....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 122222334432 234578999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.32 E-value=5.3e-05 Score=82.61 Aligned_cols=160 Identities=13% Similarity=0.014 Sum_probs=114.2
Q ss_pred HHHHHHHhcCCCceeeEeeeee--cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 013238 168 TEVEMISMAVHRNLLRLRGFCM--TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-- 243 (447)
Q Consensus 168 ~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-- 243 (447)
.|.+-++...|+++.....=.. ...+.+..++|+.+|.+.+.+-......++++..-+.....+.+....-.|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444455667888765443222 234668999999999999998776555555555544443333344555555432
Q ss_pred CCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhC
Q 013238 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 323 (447)
Q Consensus 244 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg 323 (447)
..-.+|+++|+-|.+|+.+..+|++++|+.+.... .....+...+++.|++|+....-.++.++|+|..|+.+|+..-|
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 22468999999999999999999999999984332 22233444578889999998888899999999999999999999
Q ss_pred CCCcc
Q 013238 324 QRAFD 328 (447)
Q Consensus 324 ~~p~~ 328 (447)
..+|-
T Consensus 1437 n~~fi 1441 (2724)
T KOG1826|consen 1437 NAYFI 1441 (2724)
T ss_pred cHHHH
Confidence 88873
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.011 Score=56.27 Aligned_cols=144 Identities=15% Similarity=0.130 Sum_probs=80.0
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc--eeeEeeee------ecCCcceEEE
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFC------MTPTERLLVY 198 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~ 198 (447)
.+.++.|....+|+....+| .+++|+...... ...+..|.+++..+.... +.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 35577787789999876555 577887754321 223445566665553222 33333321 1234568999
Q ss_pred ecccCCcchhh--------------hhhcCCCC-CC-------CCHHHHH------------HHHHHHHHHHHHHHh---
Q 013238 199 PFMVNGSVASC--------------LRERGQSQ-PP-------LNWSVRK------------QIALGAARGLAYLHD--- 241 (447)
Q Consensus 199 e~~~~gsL~~~--------------l~~~~~~~-~~-------l~~~~~~------------~i~~~i~~~l~yLH~--- 241 (447)
+|++|..+... ++...... .+ -.|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99988554211 11111100 00 0111100 001123334555542
Q ss_pred -CCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 242 -HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 242 -~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
....+++|+|+.+.||++++++...|.||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234589999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0048 Score=58.28 Aligned_cols=148 Identities=19% Similarity=0.216 Sum_probs=82.5
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEecc-ccccchHHHHHHHHHHHHhcCCC--ceeeEeeeeecCC--cceEEEeccc
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHR--NLLRLRGFCMTPT--ERLLVYPFMV 202 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~--~~~lv~e~~~ 202 (447)
+.+..|....+|..... ++.++++ ... ...........+|+++++.+.-- -+...+++|.+.. ..+.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 33444544555555544 6778888 331 22333344567788888776421 2333466666554 6699999998
Q ss_pred CCcchhhhhhcCCC--------------------------C-------CC-CCHHHHHHHHH--------HHHHHHHHHH
Q 013238 203 NGSVASCLRERGQS--------------------------Q-------PP-LNWSVRKQIAL--------GAARGLAYLH 240 (447)
Q Consensus 203 ~gsL~~~l~~~~~~--------------------------~-------~~-l~~~~~~~i~~--------~i~~~l~yLH 240 (447)
|..+.+.+...... . .+ ..|...+..+. ....-..||+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 85443332211000 0 00 00111110000 0112234444
Q ss_pred hCC-----CCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 241 DHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 241 ~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
.+. .+.++|+|+.+.|++++.++-+=+.||+++..-+
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 332 2479999999999999999889999999987644
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0053 Score=57.53 Aligned_cols=73 Identities=21% Similarity=0.269 Sum_probs=46.2
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC---CCceeeEeeeeecCCcceEEEecccC
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
.+.++.|....+|+.. .+++.+.||.-... ....|..|.+-|+.+. --.+.+++++....+..+++|||++.
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 3568889999999987 56788999987522 2235778888777773 45577788888777778999999977
Q ss_pred C
Q 013238 204 G 204 (447)
Q Consensus 204 g 204 (447)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.013 Score=54.71 Aligned_cols=31 Identities=29% Similarity=0.482 Sum_probs=26.0
Q ss_pred CCceecCCCCCCEEECCCCc-EEEeecCCccc
Q 013238 245 PKIIHRDVKAANILLDEEFE-AVVGDFGLAKL 275 (447)
Q Consensus 245 ~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~ 275 (447)
+.++|+|+++.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.037 Score=53.22 Aligned_cols=73 Identities=14% Similarity=0.029 Sum_probs=46.1
Q ss_pred eeeecCCeEEEEEEECCC-cEEEEEEeccc------cccchHHHHHHHHHHHHhcC--CC-ceeeEeeeeecCCcceEEE
Q 013238 129 ILGRGGFGKVYKGRLTDG-SLVAVKRLKEE------RTQGGELQFQTEVEMISMAV--HR-NLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 198 (447)
.||.|....||++...+| +.|+||.-... ..+-...+...|.+.|.... -| .+.+++.+ ++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998654 57999986422 11222334445666665542 23 34445543 556667999
Q ss_pred ecccC
Q 013238 199 PFMVN 203 (447)
Q Consensus 199 e~~~~ 203 (447)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.069 Score=52.34 Aligned_cols=74 Identities=12% Similarity=0.033 Sum_probs=48.4
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccc------cchHHHHHHHHHHHHhcC---CCceeeEeeeeecCCcceEE
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT------QGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 197 (447)
.+.||.|....||+.... +..++||+-..... .....+-..|.+.|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 356899999999998875 45688998752211 112223334555555443 356777888775 557889
Q ss_pred EecccC
Q 013238 198 YPFMVN 203 (447)
Q Consensus 198 ~e~~~~ 203 (447)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.036 Score=53.69 Aligned_cols=140 Identities=16% Similarity=0.160 Sum_probs=78.5
Q ss_pred eeeecCCeEEEEEEECC-----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCcee-eEeeeeecCCcceEEEeccc
Q 013238 129 ILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPFMV 202 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~ 202 (447)
.|..|-...+|+....+ ++.|++|+...... . .....+|..++..+...++. ++++.+.. ..|.+|++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~ 116 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-L-FFDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIH 116 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-e-eechHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeC
Confidence 45567888999987532 36788998755321 1 11235677777776544433 34454422 25899987
Q ss_pred CCcchhh-----------------hhhcCCCC--CCCCHHHHHHHHHH-----------------HHHHHHHHH----h-
Q 013238 203 NGSVASC-----------------LRERGQSQ--PPLNWSVRKQIALG-----------------AARGLAYLH----D- 241 (447)
Q Consensus 203 ~gsL~~~-----------------l~~~~~~~--~~l~~~~~~~i~~~-----------------i~~~l~yLH----~- 241 (447)
+.+|... +|...... .+..+..+..+..+ +...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 11111111 11223333333211 111122222 1
Q ss_pred CCCCCceecCCCCCCEEECC-CCcEEEeecCCcc
Q 013238 242 HCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAK 274 (447)
Q Consensus 242 ~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~ 274 (447)
.....++|+|+++.||++++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12336899999999999986 4689999998875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.01 Score=58.69 Aligned_cols=49 Identities=16% Similarity=0.211 Sum_probs=38.4
Q ss_pred HHHHHHHHHHHhcCCCceeeEeeeeecCC-cceEEEecccCCcchhhhhhc
Q 013238 164 LQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPFMVNGSVASCLRER 213 (447)
Q Consensus 164 ~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~ 213 (447)
.++.-...+++.+.|+|+...+.+..... ...+|||++ +.+|.+.+..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 45667788999999999999988876543 357889998 66888888654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.07 Score=50.82 Aligned_cols=29 Identities=34% Similarity=0.408 Sum_probs=25.4
Q ss_pred CCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 245 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999998 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.044 Score=52.77 Aligned_cols=142 Identities=15% Similarity=0.178 Sum_probs=77.8
Q ss_pred CeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCcee-eEeeeeecCCcceEEEeccc
Q 013238 128 NILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPFMV 202 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~ 202 (447)
+.|..|-...+|+....+ +..|++|+...... ......+|..+++.+..-++- ++++++. . .+|.+|++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i~~fi~ 93 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG-N---GMIQSFIN 93 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC-C---cEeehhhc
Confidence 345567788899887543 23788888754322 112345677777777644443 4455442 2 25888987
Q ss_pred CCcchhh-----------------hhhcCCCC--CCCCHHHHHHHHHHH----------------------HHHHHHHHh
Q 013238 203 NGSVASC-----------------LRERGQSQ--PPLNWSVRKQIALGA----------------------ARGLAYLHD 241 (447)
Q Consensus 203 ~gsL~~~-----------------l~~~~~~~--~~l~~~~~~~i~~~i----------------------~~~l~yLH~ 241 (447)
+..|... +|...... .+-.|..+..+..++ ..-+..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 7655310 11111110 111233332222221 111111111
Q ss_pred -----CCCCCceecCCCCCCEEECC-CCcEEEeecCCccc
Q 013238 242 -----HCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKL 275 (447)
Q Consensus 242 -----~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~ 275 (447)
.....++|+|+.+.||++++ ++.++++||..+..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11224799999999999975 57899999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.033 Score=49.28 Aligned_cols=150 Identities=14% Similarity=0.138 Sum_probs=86.6
Q ss_pred CCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCcchhhhhhc
Q 013238 134 GFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 213 (447)
Q Consensus 134 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 213 (447)
+..+.-.++.+-|. ..+|++......-...-+..+..+++++. .|+++..- +....-++.|+|..-
T Consensus 74 gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~--------- 139 (308)
T PF07387_consen 74 GNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI--------- 139 (308)
T ss_pred CceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc---------
Confidence 34444444443333 45666654433323345677888888763 46666521 223345888888331
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCc
Q 013238 214 GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293 (447)
Q Consensus 214 ~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 293 (447)
.....-.|..+ +.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|-+.-.. .+.-|
T Consensus 140 -------~i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~ 197 (308)
T PF07387_consen 140 -------KINFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNM 197 (308)
T ss_pred -------ccchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeE
Confidence 11111222222 3667778864 34899999999999999999999999875421 01112
Q ss_pred cccccccCCCCCchhhhHHHHHHHHHHHh
Q 013238 294 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 322 (447)
Q Consensus 294 ~aPE~~~~~~~~~~sDvwSlG~il~ellt 322 (447)
.--| -...+.++.+-+|=.-+++++.
T Consensus 198 vN~~---Y~~lT~~aE~~~fv~s~l~~v~ 223 (308)
T PF07387_consen 198 VNIE---YESLTQEAEVKVFVKSCLKLVE 223 (308)
T ss_pred Eeee---ccccChHHHHHHHHHHHHHHHH
Confidence 2211 1123566777777666666665
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.11 Score=46.39 Aligned_cols=75 Identities=13% Similarity=0.179 Sum_probs=50.3
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhc---CCCceeeEeeeeecCCcceEEEecccCC
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA---VHRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
+.+..|.--..|+..+ +..++.||+-... ....|..|+.-|..+ +--++.+++.+..+.+..|+|+||++-+
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~~----~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQRE----QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecchh----hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 4455566666666655 3567888865322 123566777655544 4456777888888889999999999987
Q ss_pred cch
Q 013238 205 SVA 207 (447)
Q Consensus 205 sL~ 207 (447)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 665
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.27 Score=47.06 Aligned_cols=140 Identities=16% Similarity=0.224 Sum_probs=78.5
Q ss_pred eeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC---CCceee---Eeeeee--cCC--cceEEEe
Q 013238 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLR---LRGFCM--TPT--ERLLVYP 199 (447)
Q Consensus 130 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~---l~~~~~--~~~--~~~lv~e 199 (447)
|.+ .-..+|+....+|+. ++|+.... .. ..++..|++.+..+. .+-.++ +-|-.. -.. ..+.+++
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~--~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WT--RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CC--HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 556789988877766 88988765 22 234555666665553 121122 222111 123 5678999
Q ss_pred cccCCcchh-h--------------hhhcCCC----C----CCCCHHH----H---------HHHHHHHHHHHHHHHhCC
Q 013238 200 FMVNGSVAS-C--------------LRERGQS----Q----PPLNWSV----R---------KQIALGAARGLAYLHDHC 243 (447)
Q Consensus 200 ~~~~gsL~~-~--------------l~~~~~~----~----~~l~~~~----~---------~~i~~~i~~~l~yLH~~~ 243 (447)
|++|..+.. . |+..... . ....|.. . .....++...+..+.+..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887772 1 1111000 0 0123321 0 012233344444444332
Q ss_pred ----CCC---ceecCCCCCCEEECCCCc-EEEeecCCcc
Q 013238 244 ----DPK---IIHRDVKAANILLDEEFE-AVVGDFGLAK 274 (447)
Q Consensus 244 ----~~~---ivH~dlk~~Nill~~~~~-~kl~Dfgl~~ 274 (447)
... +||+|+.+.||+++.+.. +.+.||+.+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 223 899999999999999875 8899999875
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.32 Score=46.70 Aligned_cols=72 Identities=18% Similarity=0.124 Sum_probs=41.8
Q ss_pred cCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCC--ceeeEe---e--eeecCCcceEEEecccCCc
Q 013238 133 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR--NLLRLR---G--FCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 133 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~gs 205 (447)
+.-..||+....+|..+++|..+.... ....+..|++.+..+... .++... | +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 445789999887788899998764331 233455666666554311 122211 1 1122345678899987754
Q ss_pred c
Q 013238 206 V 206 (447)
Q Consensus 206 L 206 (447)
.
T Consensus 114 ~ 114 (325)
T PRK11768 114 P 114 (325)
T ss_pred C
Confidence 3
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.0096 Score=62.44 Aligned_cols=36 Identities=28% Similarity=0.551 Sum_probs=20.4
Q ss_pred CCeeeCCCCcccccCCCC-CCCCCCCccccccCCCCC
Q 013238 1 MNCRDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 36 (447)
Q Consensus 1 l~~~~ls~N~lsG~iP~~-~~~~~~~~~s~~~n~~~~ 36 (447)
|..||||+|+|+|.+|.. +.+..+..+.+.+|.+.+
T Consensus 468 L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g 504 (623)
T PLN03150 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504 (623)
T ss_pred CCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc
Confidence 445666666666666653 445555555555555543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.11 Score=50.81 Aligned_cols=74 Identities=12% Similarity=0.137 Sum_probs=47.1
Q ss_pred CeeeecCCeEEEEEEECC-CcEEEEEEeccc-----cccchHHHHHHHHHHHHhcC--CC-ceeeEeeeeecCCcceEEE
Q 013238 128 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEE-----RTQGGELQFQTEVEMISMAV--HR-NLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 198 (447)
+.||.|.-.-||++...+ ++.|+||.-... ...-...+..-|.+.|+... -| .+.+++.+ ++....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 568999999999999753 567999976422 11222334555666666542 33 35556544 455667888
Q ss_pred ecccC
Q 013238 199 PFMVN 203 (447)
Q Consensus 199 e~~~~ 203 (447)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 88854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.26 Score=54.72 Aligned_cols=32 Identities=34% Similarity=0.450 Sum_probs=26.7
Q ss_pred CCCceecCCCCCCEEECCCC--cEE-EeecCCccc
Q 013238 244 DPKIIHRDVKAANILLDEEF--EAV-VGDFGLAKL 275 (447)
Q Consensus 244 ~~~ivH~dlk~~Nill~~~~--~~k-l~Dfgl~~~ 275 (447)
..++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 44799999999999999875 555 999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.07 Score=50.86 Aligned_cols=53 Identities=25% Similarity=0.255 Sum_probs=46.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 220 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 220 l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
..+.+...++.+.+..+.-+..+. ..-|||+.-.||||+ +|++.|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 467888888888888777777765 789999999999999 99999999999984
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.19 Score=47.87 Aligned_cols=32 Identities=19% Similarity=0.288 Sum_probs=28.3
Q ss_pred CCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 244 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
..+++|+|+.+.|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999987763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.44 Score=46.72 Aligned_cols=74 Identities=14% Similarity=0.204 Sum_probs=43.6
Q ss_pred CeeeecCCeEEEEEEECCC--cE-----EEEEEeccccccchHHHHHHHHHHHHhcCCCceee-EeeeeecCCcceEEEe
Q 013238 128 NILGRGGFGKVYKGRLTDG--SL-----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR-LRGFCMTPTERLLVYP 199 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e 199 (447)
+.|..|-.+.+|++...++ .. |.++..... . .......+|+++++.+...++-+ +++.+. .++++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-N-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-C-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 3455688899999976532 22 444432111 1 11113456888888887555544 444432 369999
Q ss_pred cccCCcch
Q 013238 200 FMVNGSVA 207 (447)
Q Consensus 200 ~~~~gsL~ 207 (447)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99887664
|
|
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=93.12 E-value=0.029 Score=30.07 Aligned_cols=17 Identities=47% Similarity=0.743 Sum_probs=15.1
Q ss_pred CCeeeCCCCcccccCCCC
Q 013238 1 MNCRDLSNNKLTGDIPTN 18 (447)
Q Consensus 1 l~~~~ls~N~lsG~iP~~ 18 (447)
|..||||+|+|+ .||..
T Consensus 2 L~~Ldls~n~l~-~ip~~ 18 (22)
T PF00560_consen 2 LEYLDLSGNNLT-SIPSS 18 (22)
T ss_dssp ESEEEETSSEES-EEGTT
T ss_pred ccEEECCCCcCE-eCChh
Confidence 678999999999 89865
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 447 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-179 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-171 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-35 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 632 bits (1632), Expect = 0.0
Identities = 305/326 (93%), Positives = 317/326 (97%)
Query: 93 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVK 152
FFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL DG+LVAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 153 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE 212
RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRE
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 213 RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272
R +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 332
AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 333 ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 392
ANDDDVMLLDWVKGLLKEKKLE LVD D++GNY +EEVEQLIQVALLCTQ SPMERPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 393 EVVRMLEGDGLAERWEEWQKEEMFRQ 418
EVVRMLEGDGLAERWEEWQKEEMFRQ
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 444 bits (1144), Expect = e-156
Identities = 113/314 (35%), Positives = 173/314 (55%), Gaps = 22/314 (7%)
Query: 99 EEDPEVHLGQLKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVK 152
+ EV + FS EL+ T+NF R N +G GGFG VYKG + + + VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 153 RLKEERTQG---GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASC 209
+L + QF E+++++ H NL+ L GF + LVY +M NGS+
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 210 LRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269
L PPL+W +R +IA GAA G+ +LH++ IHRD+K+ANILLDE F A + D
Sbjct: 121 LSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 270 FGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
FGLA+ + + T +T+ + GT ++APE L G+ + K+D++ +GV+LLE+ITG A D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 329 LARLANDDDVMLLDWVKGLLKEKK-LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME 387
R + +LLD + + E+K +E +D M + VE + VA C +
Sbjct: 236 EHR----EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNK 290
Query: 388 RPKMSEVVRMLEGD 401
RP + +V ++L+
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-143
Identities = 115/306 (37%), Positives = 173/306 (56%), Gaps = 7/306 (2%)
Query: 97 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE 156
A + + R L +L+ AT+NF ++ ++G G FGKVYKG L DG+ VA+KR
Sbjct: 14 DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73
Query: 157 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS 216
E +QG +F+TE+E +S H +L+ L GFC E +L+Y +M NG++ L
Sbjct: 74 ESSQG-IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 217 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276
++W R +I +GAARGL YLH IIHRDVK+ NILLDE F + DFG++K
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 277 DYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 335
D TH++T V+GT+G+I PEY G+ +EK+DV+ +GV+L E++ + A +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PR 247
Query: 336 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 395
+ V L +W +LEQ+VD ++ E + + A+ C S +RP M +V+
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 396 RMLEGD 401
LE
Sbjct: 308 WKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 2e-80
Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 33/311 (10%)
Query: 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE 171
L + + RG FG V+K +L VAVK + Q Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ--SWQNEYEVY 70
Query: 172 MISMAVHRNLLRLRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 227
+ H N+L+ G + L+ F GS++ L+ ++W+
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 228 IALGAARGLAYLHDH-------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YK 279
IA ARGLAYLH+ P I HRD+K+ N+LL A + DFGLA + K
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 280 DTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 334
T GT ++APE L + + D++ G++L EL + A D +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD--GPVD 243
Query: 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE------QLIQVALLCTQGSPMER 388
+ + + + + ++++V + + + + L + C R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 389 PKMSEVVRMLE 399
V +
Sbjct: 304 LSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-62
Identities = 71/322 (22%), Positives = 115/322 (35%), Gaps = 44/322 (13%)
Query: 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE 171
+ E + DN ++GRG +G VYKG L D VAVK Q F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ----NFINEKN 57
Query: 172 MISMAV--HRNLLRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSV 224
+ + + H N+ R E LLV + NGS+ L +W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 225 RKQIALGAARGLAYLH------DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278
++A RGLAYLH DH P I HRD+ + N+L+ + V+ DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 279 -------KDTHVTTAVRGTIGHIAPEYL-------STGKSSEKTDVFGYGVMLLELITGQ 324
++ + + GTI ++APE L + ++ D++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 325 RAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD-------MEGNYIEEEVEQLIQVA 377
+ + V + ++ LV + V L +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 378 LLCTQGSPMERPKMSEVVRMLE 399
C R +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 3e-62
Identities = 77/314 (24%), Positives = 145/314 (46%), Gaps = 23/314 (7%)
Query: 88 KPEDHFFDVPAEEDPEVHLGQLK-RFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDG 146
K H + + P + ++ + + + + +G G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 147 SLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205
S VAVK L E+ + F EV ++ H N++ G P +V ++ GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265
+ L + G ++ L+ R +A A+G+ YLH + +P I+HR++K+ N+L+D+++
Sbjct: 121 LYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTV 178
Query: 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 325
V DFGL++L + + GT +APE L S+EK+DV+ +GV+L EL T Q+
Sbjct: 179 KVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 326 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 385
+ ++ V + + K ++ + + +V +I+ C P
Sbjct: 238 PW--------GNLNPAQVVAAVGFKCKRLEIPRN------LNPQVAAIIE---GCWTNEP 280
Query: 386 MERPKMSEVVRMLE 399
+RP + ++ +L
Sbjct: 281 WKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-60
Identities = 74/308 (24%), Positives = 129/308 (41%), Gaps = 40/308 (12%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
++GRG FG V K + VA+K+++ E + F E+ +S H N+++L G
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK---AFIVELRQLSRVNHPNIVKLYGA 69
Query: 188 CMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
C+ P E + GS+ + L P + L ++G+AYLH
Sbjct: 70 CLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 244 DPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
+IHRD+K N+LL + + DFG A + T +G+ +APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGS 178
Query: 303 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362
SEK DVF +G++L E+IT ++ FD + + + + + +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPP--LIKN-- 228
Query: 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH 422
+ + +E L+ C P +RP M E+V+++ L + +E + H
Sbjct: 229 ---LPKPIESLMT---RCWSKDPSQRPSMEEIVKIMT--HLMRYFP--GADEPLQYPCQH 278
Query: 423 TPHPNNTW 430
+ P
Sbjct: 279 SLPPGEDG 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-59
Identities = 76/290 (26%), Positives = 134/290 (46%), Gaps = 47/290 (16%)
Query: 128 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL------QFQTEVEMISMAVHRN 180
+G+GGFG V+KGR + D S+VA+K L ++G +FQ EV ++S H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 181 LLRLRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 236
+++L G P E F+ G + L ++ P+ WSV+ ++ L A G+
Sbjct: 85 IVKLYGLMHNPPRMVME------FVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGI 135
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTI 291
Y+ + +P I+HRD+++ NI L E V DFGL++ H + + G
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNF 190
Query: 292 GHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349
+APE + +EK D + + ++L ++TG+ FD + + ++ + +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYSYGKIKFINMIRE 244
Query: 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E + + + +I+ LC G P +RP S +V+ L
Sbjct: 245 EGLRPTIPED------CPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-59
Identities = 78/283 (27%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL---QFQTEVEMISMAVHRNLLRL 184
I+G GGFGKVY+ G VAVK + + + + E ++ +M H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
RG C+ LV F G + L + + + A+ ARG+ YLHD
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 245 PKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
IIHRD+K++NIL+ ++ E + DFGLA+ T +A G +AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA-GAYAWMAP 183
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356
E + S+ +DV+ YGV+L EL+TG+ F + L G+ K +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPF--------RGIDGLAVAYGVAMNKLALPI 235
Query: 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ E +L++ C P RP + ++ L
Sbjct: 236 PST------CPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 72/325 (22%), Positives = 129/325 (39%), Gaps = 42/325 (12%)
Query: 89 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL 148
PE + + A P L+E + + ++G+G FG+VY GR G
Sbjct: 2 PEMNLSLLSARSFPRKA--SQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE- 57
Query: 149 VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 207
VA++ + ER +L+ F+ EV H N++ G CM+P ++ ++
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 208 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 267
S +R+ L+ + +QIA +G+ YLH I+H+D+K+ N+ D + V+
Sbjct: 118 SVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVI 170
Query: 268 GDFGLAKLMD----YKDTHVTTAVRGTIGHIAPEYLSTGKS---------SEKTDVFGYG 314
DFGL + + G + H+APE + S+ +DVF G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 315 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLI 374
+ EL + F + + + L + +E+ ++
Sbjct: 231 TIWYELHAREWPFKT---------QPAEAIIWQMGTGMKPNLSQIG-----MGKEISDIL 276
Query: 375 QVALLCTQGSPMERPKMSEVVRMLE 399
C ERP ++++ MLE
Sbjct: 277 L---FCWAFEQEERPTFTKLMDMLE 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 68/290 (23%), Positives = 109/290 (37%), Gaps = 45/290 (15%)
Query: 128 NILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+LG+G FG+ K G ++ +K L + + F EV+++ H N+L+ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-QRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
+ ++ G++ ++ WS R A A G+AYLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------YKDTHVTTAVRGTIGH 293
IIHRD+ + N L+ E VV DFGLA+LM D V G
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353
+APE ++ EK DVF +G++L E+I A D++
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-------------DYL-------PR 228
Query: 354 EQLVDSDMEGNY---IEEEV-EQLIQVALLCTQGSPMERPKMSEVVRMLE 399
++ G + + C P +RP ++ LE
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-55
Identities = 61/278 (21%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 186
L G+++KGR G+ + VK LK + + F E + + H N+L + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 187 FCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 244
C +P + +M GS+ + L E + ++ S + AL ARG+A+LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 304
P I + + ++++DE+ A + + + +APE L
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPE 185
Query: 305 ---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361
D++ + V+L EL+T + F D+ ++ + E +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPF--------ADLSNMEIGMKVALEGLRPTIPPG-- 235
Query: 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
I V +L++ +C P +RPK +V +LE
Sbjct: 236 ----ISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-54
Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 41/282 (14%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 188
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 189 MTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
P T+ + S+ L IA ARG+ YLH
Sbjct: 90 TAPQLAIVTQ------WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPE---YL 299
IIHRD+K+ NI L E+ +GDFGLA +H + G+I +APE
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--KGLLKEKKLEQLV 357
+ S ++DV+ +G++L EL+TGQ + + + N D ++ + +G L +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQII---EMVGRGSLSPDLSKVRS 252
Query: 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ + +++L+ C + ERP ++ +E
Sbjct: 253 NCP-------KRMKRLMA---ECLKKKRDERPSFPRILAEIE 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 62/298 (20%), Positives = 119/298 (39%), Gaps = 39/298 (13%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 185
+G+G +G+V++G G VAVK E + E E+ + + H N+L
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 186 GFCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 240
MT T+ L+ + GS+ L+ L+ +I L A GLA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 241 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 293
P I HRD+K+ NIL+ + + + D GLA + + GT +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 294 IAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA---RLANDDDVML---L 341
+APE + S ++ D++ +G++L E+ + + + D V
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ ++ ++ + + + + + +L++ C +P R + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 39/298 (13%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 185
+G+G +G+V+ G+ G VAVK E + E E+ + H N+L
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97
Query: 186 GFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 240
+ T+ L+ + NGS+ L+ L+ ++A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 241 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 293
P I HRD+K+ NIL+ + + D GLA V GT +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 294 IAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA---RLANDDDV---MLL 341
+ PE + +S D++ +G++L E+ + + +L D V
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ ++ ++ KKL + + ++ +L+ C +P R V + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 185
+G+G FG+V++G+ G VAVK E + E E+ + H N+L
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 186 GFCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 240
T T+ LV + +GS+ L + + ++AL A GLA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 241 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGTIGH 293
P I HRD+K+ NIL+ + + D GLA D + GT +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 294 IAPEYL------STGKSSEKTDVFGYGVMLLELITGQRAFDLA---RLANDDDV---MLL 341
+APE L +S ++ D++ G++ E+ + +L D V +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ ++ ++ E+KL + + + + ++++ C + R + + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-41
Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 130 LGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+GRG FG+V+ GRL + VAVK +E + +F E ++ H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+V + G + LR G L Q+ AA G+ YL I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA------VRGTIGHIAPEYLSTG 302
HRD+ A N L+ E+ + DFG+++ + + V+ T APE L+ G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWT----APEALNYG 290
Query: 303 KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361
+ S ++DV+ +G++L E + G + +Q +
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPY---------------------PNLSNQQTREFVE 329
Query: 362 EGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+G + + V +L+ C P +RP S + + L+
Sbjct: 330 KGGRLPCPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQ 370
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 55/296 (18%)
Query: 128 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLL 182
ILG G FG V +G L VAVK +K + + E++ F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 183 RLRGFC-----MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARG 235
RL G C + +++ PFM G + + L P + ++ + + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI- 294
+ YL + +HRD+ A N +L ++ V DFGL+K + D + +G I +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 295 ----APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 349
A E L+ + K+DV+ +GV + E+ T G + + N
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY--PGVQN--------------- 255
Query: 350 EKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
++ D + G+ ++ +E+ +++ C + P++RP S + LE
Sbjct: 256 ----HEMYDYLLHGHRLKQPEDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLE 304
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 81/284 (28%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 128 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 184 LRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
L G C+ L+V P+M +G + + +R L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEYL 299
K +HRD+ A N +LDE+F V DFGLA+ M +Y H T + + +A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 300 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
T K + K+DV+ +GV+L EL+T G + + +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYP---------------------DVNTFDITV 243
Query: 359 SDMEGNYIEEEV---EQLIQVALLCTQGSPMERPKMSEVVRMLE 399
++G + + + L +V L C RP SE+V +
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 69/288 (23%), Positives = 111/288 (38%), Gaps = 34/288 (11%)
Query: 128 NILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
LG G FGKV G +VAVK LK + ++ E++++ H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 183 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+ +G C LV ++ GS+ L L A G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 297
IHRD+ A N+LLD + +GDFGLAK + + + APE
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPE 207
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
L K +DV+ +GV L EL+T + L+ + + + +L
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 358 DSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ G + EV L+ C + RP ++ +L+
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILK 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 69/297 (23%), Positives = 121/297 (40%), Gaps = 56/297 (18%)
Query: 128 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLL 182
+LG+G FG V + +L VAVK LK + +++ F E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 183 RLRGFC------MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAAR 234
+L G +++ PFM +G + + L + P N ++ + + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRG 289
G+ YL IHRD+ A N +L E+ V DFGL++ + D + V+
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 290 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 348
A E L+ + +DV+ +GV + E++T GQ + A + N
Sbjct: 206 L----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY--AGIEN-------------- 245
Query: 349 KEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
++ + + GN ++ EEV L+ C P +RP + + LE
Sbjct: 246 -----AEIYNYLIGGNRLKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMELE 294
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-39
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 100 EDP-EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-----VAVKR 153
E P + L LK ++++V LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 154 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 213
L+E + + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 214 GQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270
+ LNW V QIA +G+ YL D +++HRD+ A N+L+ + DF
Sbjct: 111 KDNIGSQYLLNWCV--QIA----KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 161
Query: 271 GLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 324
GLAKL+ ++ ++ A E + + ++DV+ YGV + EL+T G
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 325 R 325
+
Sbjct: 218 K 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 34/289 (11%)
Query: 128 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
LG G FGKV R G VAVK LK E + E+E++ H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 183 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+ +G C L+ F+ +GS+ L + +N + + A+ +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLG 143
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 297
+ +HRD+ A N+L++ E + +GDFGL K + D T + APE
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPE 199
Query: 298 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356
L K +DV+ +GV L EL+T L M+ + + +L
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK---MIGPTHGQM----TVTRL 252
Query: 357 VDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
V++ EG + +EV QL+ C + P R ++ E
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 128 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 184 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
L G C +E L+V P+M +G + + +R L A+G+ +L
Sbjct: 155 LLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 298
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +A E
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 299 LSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
L T K + K+DV+ +GV+L EL+T G + + +
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP---------------------DVNTFDIT 306
Query: 358 DSDMEGNYIEEEV---EQLIQVALLCTQGSPMERPKMSEVVRMLE 399
++G + + + L +V L C RP SE+V +
Sbjct: 307 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-38
Identities = 61/312 (19%), Positives = 124/312 (39%), Gaps = 44/312 (14%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQF-QTEVEMISMAVH 178
NF +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 234
N+++ + E +V G ++ ++ + + + W Q+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--- 148
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 294
L ++H +++HRD+K AN+ + +GD GL + K T + V GT ++
Sbjct: 149 -LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 203
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354
+PE + + K+D++ G +L E+ Q F + ++
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLY--------------- 244
Query: 355 QLVDSDMEGNY--IEEEV--EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEW 410
L + +Y + + E+L Q+ +C P +RP ++ V + A+R
Sbjct: 245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV------AKRMHAC 298
Query: 411 QKEEMFRQDFNH 422
+ +H
Sbjct: 299 TASSLEHHHHHH 310
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-38
Identities = 82/321 (25%), Positives = 131/321 (40%), Gaps = 42/321 (13%)
Query: 128 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
+ LG+G FG V R G+LVAVK+L+ + FQ E++++ ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIV 87
Query: 183 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 237
+ RG P + LV ++ +G + L+ L +S QI +G+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS--QIC----KGME 141
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIA 295
YL + +HRD+ A NIL++ E + DFGLAKL+ + V + I A
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354
PE LS S ++DV+ +GV+L EL T ++ + D L
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP-------ALS 251
Query: 355 QLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 408
+L++ EG + EV +L+ LC SP +RP S + L D L
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQL--DMLWSG-S 305
Query: 409 EWQKEEMFRQDFNHTPHPNNT 429
+ F H +
Sbjct: 306 RGCETHAFTAHPEGKHHSLSF 326
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-38
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 128 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
++G+G FG VY G D + A+K L F E ++ H N+L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 184 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
L G P E ++ P+M +G + +R L ARG+ YL +
Sbjct: 87 LIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE 142
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 298
K +HRD+ A N +LDE F V DFGLA+ + +Y R + A E
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 299 LSTGKSSEKTDVFGYGVMLLELIT 322
L T + + K+DV+ +GV+L EL+T
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-37
Identities = 76/326 (23%), Positives = 131/326 (40%), Gaps = 55/326 (16%)
Query: 98 AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS------LVAV 151
+P +V N + LG G FG+VY+G+++ VAV
Sbjct: 6 HHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 65
Query: 152 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 211
K L E ++ EL F E +IS H+N++R G + R ++ M G + S LR
Sbjct: 66 KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 212 E-RGQSQPPLNWSVRK--QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV- 267
E R + P + ++ +A A G YL ++ IHRD+ A N LL V
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182
Query: 268 --GDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGVMLLEL 320
GDFG+A+ + + +G + PE G + KTD + +GV+L E+
Sbjct: 183 KIGDFGMARDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 321 IT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQL 373
+ G + +N +++++ G ++ V ++
Sbjct: 239 FSLGYMPY--PSKSN-------------------QEVLEFVTSGGRMDPPKNCPGPVYRI 277
Query: 374 IQVALLCTQGSPMERPKMSEVVRMLE 399
+ C Q P +RP + ++ +E
Sbjct: 278 M---TQCWQHQPEDRPNFAIILERIE 300
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-37
Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 38/291 (13%)
Query: 128 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
LG+G FG V R G +VAVK+L+ T+ F+ E+E++ H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 74
Query: 183 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 237
+ +G C + R L+ ++ GS+ L++ + L ++ QI +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--QIC----KGME 128
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHI 294
YL + IHRD+ NIL++ E +GDFGL K++ D I
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWY 184
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354
APE L+ K S +DV+ +GV+L EL T + + +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-----QMIVF 239
Query: 355 QLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
L++ + +E+ ++ C + +RP ++ ++
Sbjct: 240 HLIELLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVD 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 74/300 (24%), Positives = 128/300 (42%), Gaps = 63/300 (21%)
Query: 128 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
LG+G FG VY+G VA+K + E + ++F E ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRER------GQSQPPLNWSVRKQIALGAARG 235
+RL G L++ M G + S LR P + S Q+A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI- 294
+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + D + +G G +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 203
Query: 295 ----APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVMLLDWVK 345
+PE L G + +DV+ +GV+L E+ T LA L+N
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSN----------- 246
Query: 346 GLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
EQ++ MEG ++ + + +L+ +C Q +P RP E++ ++
Sbjct: 247 --------EQVLRFVMEGGLLDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIK 295
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 186
+GRG F VYKG VA L++ + E +F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 187 FCMTPTE---RLLVYP-FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
+ + +++ M +G++ + L+ + V + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR 148
Query: 243 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
P IIHRD+K NI + +V +GD GLA L AV GT +APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 302 GKSSEKTDVFGYGVMLLELITGQ 324
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 66/288 (22%), Positives = 118/288 (40%), Gaps = 32/288 (11%)
Query: 128 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
LG+G FG V R G +VAVK+L+ T+ F+ E+E++ H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 105
Query: 183 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+ +G C + R L+ ++ GS+ L++ + ++ Q +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 297
+ IHRD+ NIL++ E +GDFGL K++ D I APE
Sbjct: 163 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPE 218
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
L+ K S +DV+ +GV+L EL T + ++ +E L
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHLIELL- 276
Query: 358 DSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ +E+ ++ C + +RP ++ ++
Sbjct: 277 ---KNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVD 318
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 67/311 (21%), Positives = 132/311 (42%), Gaps = 43/311 (13%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 179
+ + +G G FGK + DG +K + R E + + EV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP----LNWSVRKQIALGAARG 235
N+++ R +V + G + + + L+W V QI L
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLA---- 137
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
L ++HD KI+HRD+K+ NI L ++ +GDFG+A++++ + GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355
PE + K+D++ G +L EL T + AF+ A ++
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE----AGS-----------------MKN 232
Query: 356 LVDSDMEGNY--IEEEV-EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQK 412
LV + G++ + L + + +P +RP ++ + LE +A+R E++
Sbjct: 233 LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLS 289
Query: 413 EEMFRQDFNHT 423
++ ++F
Sbjct: 290 PQLIAEEFCLK 300
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-36
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 100 EDP-EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS-----LVAVKR 153
E P + L LK ++++V LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 154 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 213
L+E + + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 214 GQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270
+ LNW V QIA +G+ YL D +++HRD+ A N+L+ + DF
Sbjct: 111 KDNIGSQYLLNWCV--QIA----KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 161
Query: 271 GLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 324
GLAKL+ ++ ++ A E + + ++DV+ YGV + EL+T G
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 325 R 325
+
Sbjct: 218 K 218
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 63/292 (21%), Positives = 110/292 (37%), Gaps = 57/292 (19%)
Query: 127 RNILGRGGFGKVYKGRLTDGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FG V +G VA+K LK+ + + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
L G C +LV G + L + + + S ++ + G+ YL +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 129
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLST 301
+HRD+ A N+LL A + DFGL+K + D++ T G + APE ++
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 302 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
K S ++DV+ YGV + E ++ GQ+ +
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYK-------------------------------K 216
Query: 361 MEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEVVRMLE 399
M+G + +EQ L + C +RP V + +
Sbjct: 217 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 128 NILGRGGFGKVYKGRLTDGSL-----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 182
+LG G FG V+KG V +K ++++ + + I H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYL 239
RL G C + LV ++ GS+ +R+ + P LNW V QIA +G+ YL
Sbjct: 79 RLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV--QIA----KGMYYL 131
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHI 294
+H ++HR++ A N+LL + V DFG+A L+ D + + ++
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM---- 184
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELIT-GQR 325
A E + GK + ++DV+ YGV + EL+T G
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 73/296 (24%), Positives = 125/296 (42%), Gaps = 55/296 (18%)
Query: 128 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
LG G FG+VY+G+++ VAVK L E ++ EL F E +IS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRK--QIALGAARGLAY 238
+R G + R ++ M G + S LRE R + P + ++ +A A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVV---GDFGLAKLMDYKDTHVTTAVRGTIGHI- 294
L ++ IHRD+ A N LL V GDFG+A+ + + +G +
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLP 249
Query: 295 ----APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 349
PE G + KTD + +GV+L E+ + G + +N
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSN--------------- 292
Query: 350 EKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+++++ G ++ V +++ C Q P +RP + ++ +E
Sbjct: 293 ----QEVLEFVTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIE 341
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 64/297 (21%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
+F ++G GGFG+V+K + DG +KR+K + + EV+ ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVN 65
Query: 181 LLRLRGF-------------CMTPTERLLVYPFM---VNGSVASCLRERGQSQPP--LNW 222
++ G + ++ ++ M G++ + +R + L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 223 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282
+ +QI G + Y+H K+I+RD+K +NI L + + +GDFGL +
Sbjct: 126 ELFEQITKG----VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR-AFDLARLANDDDVMLL 341
+ GT+ +++PE +S+ ++ D++ G++L EL+ AF+ ++ D
Sbjct: 179 TRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD------ 230
Query: 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
L++ + + D + L+Q P +RP SE++R L
Sbjct: 231 ------LRDGIISDIFDKKE---------KTLLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 66/295 (22%), Positives = 122/295 (41%), Gaps = 51/295 (17%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 179
+++ +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 180 NLLRLRGFCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPPLN----WSVRKQIAL 230
N++R + T L ++V G +AS + + + + L+ V Q+ L
Sbjct: 66 NIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 231 GAARGLAYLHDHCDP--KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 288
L H D ++HRD+K AN+ LD + +GDFGLA+++++ + T V
Sbjct: 123 A----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177
Query: 289 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 348
GT +++PE ++ +EK+D++ G +L EL F A
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT----AFS------------- 220
Query: 349 KEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
++L EG + +E+ ++I RP + E++
Sbjct: 221 ----QKELAGKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG+G FG+V+ G + VA+K LK F E +++ H L++L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
+ +V +M GS+ L+ L V +A A G+AY+
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERM---NY 301
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 307
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 308 TDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 366
+DV+ +G++L EL T G+ + + N + + ++ G +
Sbjct: 362 SDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVE-------------------RGYRM 400
Query: 367 E------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E + L+ C + P ERP + LE
Sbjct: 401 PCPPECPESLHDLM---CQCWRKEPEERPTFEYLQAFLE 436
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 23/232 (9%)
Query: 96 VPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLK 155
+ ++ P ++ + + LG G FG V G+ VA+K +K
Sbjct: 3 LGSKNAP-----STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK 57
Query: 156 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ 215
E E +F E +++ H L++L G C ++ +M NG + + LRE
Sbjct: 58 EGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR- 114
Query: 216 SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275
++ + YL + +HRD+ A N L++++ V DFGL++
Sbjct: 115 --HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 276 MDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
+ D + ++ VR + PE L K S K+D++ +GV++ E+ +
Sbjct: 170 V-LDDEYTSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 71/319 (22%), Positives = 120/319 (37%), Gaps = 72/319 (22%)
Query: 128 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 178
LG G FG+V VAVK LK++ T+ +E+E M + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------ 226
+N++ L G C ++ + G++ LR R ++ + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 287 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDD 336
V+ APE L + ++DV+ +GV++ E+ T L +
Sbjct: 264 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPV-- 311
Query: 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPK 390
E+L EG+ ++ E+ ++ C P +RP
Sbjct: 312 -----------------EELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPT 351
Query: 391 MSEVVRMLEGDGLAERWEE 409
++V L+ EE
Sbjct: 352 FKQLVEDLDRILTLTTNEE 370
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 60/254 (23%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 90 EDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL- 148
+ H + +P+ + +++ ++++G G FG+V K R+ L
Sbjct: 2 KKHHHHHHGKNNPDPTI--YPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR 52
Query: 149 --VAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205
A+KR+KE ++ F E+E + + H N++ L G C L + +G+
Sbjct: 53 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 206 VASCLRERGQSQPPLNWSVRK------------QIALGAARGLAYLHDHCDPKIIHRDVK 253
+ LR+ + +++ A ARG+ YL + IHRD+
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLA 169
Query: 254 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKT 308
A NIL+ E + A + DFGL++ + V+ T+G + A E L+ + +
Sbjct: 170 ARNILVGENYVAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNS 222
Query: 309 DVFGYGVMLLELIT 322
DV+ YGV+L E+++
Sbjct: 223 DVWSYGVLLWEIVS 236
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
+G G FG V+ G + VA+K ++E E F E E++ H L++L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
C+ LV FM +G ++ LR + + L G+AYL + +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTG 302
IHRD+ A N L+ E V DFG+ + + D + ++ V+ +PE S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SPEVFSFS 180
Query: 303 KSSEKTDVFGYGVMLLELIT 322
+ S K+DV+ +GV++ E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-35
Identities = 70/335 (20%), Positives = 122/335 (36%), Gaps = 63/335 (18%)
Query: 84 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 143
+ P D DPE +LK L + + LG G FG V +G
Sbjct: 304 KPRPMPMDTSVFESPFSDPE----ELKDKKLFLKR--DNLLIADIELGCGNFGSVRQGVY 357
Query: 144 TDGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200
VA+K LK+ + + E +++ + ++RL G C +LV
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEM 416
Query: 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 260
G + L + + + S ++ + G+ YL + +HR++ A N+LL
Sbjct: 417 AGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLV 470
Query: 261 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLL 318
A + DFGL+K + D++ T G + APE ++ K S ++DV+ YGV +
Sbjct: 471 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 319 ELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ----- 372
E ++ GQ+ + M+G + +EQ
Sbjct: 531 EALSYGQKPYK-------------------------------KMKGPEVMAFIEQGKRME 559
Query: 373 --------LIQVALLCTQGSPMERPKMSEVVRMLE 399
L + C +RP V + +
Sbjct: 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 59/297 (19%), Positives = 112/297 (37%), Gaps = 44/297 (14%)
Query: 115 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEV 170
R+ ++ + +G G FG V++G VA+K K + +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 171 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 230
+ H ++++L G ++ G + S L+ R L+ + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAY 498
Query: 231 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTA 286
+ LAYL + +HRD+ A N+L+ +GDFGL++ M+ YK +
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVK 345
++ APE ++ + + +DV+ +GV + E++ G + F + N
Sbjct: 556 IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--GVKN----------- 598
Query: 346 GLLKEKKLEQLVDSDMEGNYIEEEV---EQLIQVALLCTQGSPMERPKMSEVVRMLE 399
++ G + L + C P RP+ +E+ L
Sbjct: 599 --------NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 129 ILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
ILG G FG+VY+G T+ VAVK K++ T + +F +E ++ H ++++L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 185 RGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
G PT ++ G + L S L +L + +AYL
Sbjct: 79 IGIIEEEPT--WIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESI- 132
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----VRGTIGHIAPEYL 299
+HRD+ NIL+ +GDFGL++ ++ +D + + ++ +PE +
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 300 STGKSSEKTDVFGYGVMLLELIT 322
+ + + +DV+ + V + E+++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-35
Identities = 69/309 (22%), Positives = 118/309 (38%), Gaps = 72/309 (23%)
Query: 128 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 178
LG G FG+V VAVK LK++ T+ +E+E M + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------ 226
+N++ L G C ++ + G++ LR R ++ + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 287 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDD 336
V+ APE L + ++DV+ +GV++ E+ T L +
Sbjct: 218 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPV-- 265
Query: 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPK 390
E+L EG+ ++ E+ ++ C P +RP
Sbjct: 266 -----------------EELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPT 305
Query: 391 MSEVVRMLE 399
++V L+
Sbjct: 306 FKQLVEDLD 314
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-35
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 129 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
LG G FG V G+ VAVK +KE E +F E + + H L++ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+V ++ NG + + LR G+ L S ++ G+A+L H + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGK 303
HRD+ A N L+D + V DFG+ + + D +V++ V+ + APE K
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 304 SSEKTDVFGYGVMLLELIT 322
S K+DV+ +G+++ E+ +
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 70/304 (23%)
Query: 130 LGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG G FGKV+ + S LVAVK LK+ T FQ E E+++ H ++++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QIALG 231
G C ++V+ +M +G + LR G L + IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----- 286
A G+ YL +HRD+ N L+ +GDFG+++ + D +
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVMLL 341
+R PE + K + ++DV+ +GV+L E+ T + L+N
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSN------- 241
Query: 342 DWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVV 395
++++ +G +E +EV ++ L C Q P +R + E+
Sbjct: 242 ------------TEVIECITQGRVLERPRVCPKEVYDVM---LGCWQREPQQRLNIKEIY 286
Query: 396 RMLE 399
++L
Sbjct: 287 KILH 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 60/302 (19%), Positives = 112/302 (37%), Gaps = 61/302 (20%)
Query: 128 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
LG FGKVYKG L + VA+K LK++ +F+ E + + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QIA 229
+ L G +++ + +G + L R + + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--- 286
A G+ YL H ++H+D+ N+L+ ++ + D GL + + D +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 287 --VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 343
+R APE + GK S +D++ YGV+L E+ + G + + +N
Sbjct: 192 LPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--CGYSN--------- 236
Query: 344 VKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
+ +V+ + V L+ + C P RP+ ++
Sbjct: 237 ----------QDVVEMIRNRQVLPCPDDCPAWVYALM---IECWNEFPSRRPRFKDIHSR 283
Query: 398 LE 399
L
Sbjct: 284 LR 285
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 71/275 (25%), Positives = 119/275 (43%), Gaps = 31/275 (11%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG+G FG+V+ G + VA+K LK F E +++ H L++L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 188 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
+E +V +M GS+ L+ L V +A A G+AY+
Sbjct: 331 V---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERM--- 382
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 305
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 306 EKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
K+DV+ +G++L EL T G+ + + N + + ++ +G ++ +
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVE--RGY----RMPCPPECP---- 490
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E L + C + P ERP + LE
Sbjct: 491 ------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 70/307 (22%), Positives = 119/307 (38%), Gaps = 72/307 (23%)
Query: 130 LGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 180
LG G FG+V + VAVK LK + T+ +E+E M + H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QI 228
++ L G C ++ + G++ L+ R +++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-- 286
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D + T
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 287 ---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDV 338
V+ APE L + ++DV+ +GV+L E+ T L +
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPV---- 299
Query: 339 MLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMS 392
E+L EG+ ++ E+ ++ C P +RP
Sbjct: 300 ---------------EELFKLLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFK 341
Query: 393 EVVRMLE 399
++V L+
Sbjct: 342 QLVEDLD 348
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 62/299 (20%), Positives = 119/299 (39%), Gaps = 42/299 (14%)
Query: 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQ 167
S R+ ++ + +G G FG V++G VA+K K + +F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 168 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 227
E + H ++++L G ++ G + S L+ R L+ +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---YSLDLASLIL 120
Query: 228 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 287
A + LAYL + +HRD+ A N+L+ +GDFGL++ M+ + +
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 288 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 346
+ I +APE ++ + + +DV+ +GV + E++ G + F + N +DV+
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--GVKN-NDVI------- 227
Query: 347 LLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
++E G + + L+ C P RP+ +E+ L
Sbjct: 228 ----GRIEN-------GERLPMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLS 272
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 129 ILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRL 184
LG G FG V KG + VAVK LK E E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDH 242
G C + +LV G + L++ + + Q++ G+ YL +
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH--QVS----MGMKYLEES 136
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLS 300
+HRD+ A N+LL + A + DFGL+K + + + G + APE ++
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 301 TGKSSEKTDVFGYGVMLLELIT-GQR 325
K S K+DV+ +GV++ E + GQ+
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 61/301 (20%)
Query: 128 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
LG G FGKV+ + LVAVK LKE ++ FQ E E+++M H+++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHI 105
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRER-----------GQSQPPLNWSVRKQIAL 230
+R G C L+V+ +M +G + LR + PL +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 231 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTT 285
A G+ YL +HRD+ N L+ + +GDFG+++ + DY
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 344
+R PE + K + ++DV+ +GV+L E+ T G++ + +L+N
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--YQLSN---------- 266
Query: 345 KGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRML 398
+ +D +G +E EV ++ C Q P +R + +V L
Sbjct: 267 ---------TEAIDCITQGRELERPRACPPEVYAIM---RGCWQREPQQRHSIKDVHARL 314
Query: 399 E 399
+
Sbjct: 315 Q 315
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 70/308 (22%)
Query: 128 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 180
LGRG FG+V + VAVK LKE T +E++ +I + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 181 LLRLRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------Q 227
++ L G C P +++ F G++++ LR + P +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 228 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA- 286
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 287 ----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDD 337
++ APE + + ++DV+ +GV+L E+ + L + D++
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEE 259
Query: 338 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKM 391
++L++ G + E+ Q + L C G P +RP
Sbjct: 260 FC-----------RRLKE-------GTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTF 298
Query: 392 SEVVRMLE 399
SE+V L
Sbjct: 299 SELVEHLG 306
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-34
Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 38/302 (12%)
Query: 115 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMI 173
+ + ++ LG GGF V L DG A+KR+ Q E + Q E +M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMH 80
Query: 174 SMAVHRNLLRLRGFCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 229
+ H N+LRL +C+ L+ PF G++ + + L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR- 288
LG RGL +H HRD+K NILL +E + V+ D G A+
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 289 -------GTIGHIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAFDLARLANDDD 337
TI + APE L + +S E+TDV+ G +L ++ G+ +D+
Sbjct: 198 QDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ----- 251
Query: 338 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
KG ++ + + + QL+ + P +RP + ++
Sbjct: 252 -------KGDSVALAVQNQLSIPQSPRH-SSALWQLLNSMM---TVDPHQRPHIPLLLSQ 300
Query: 398 LE 399
LE
Sbjct: 301 LE 302
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 188 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
+ L +V +M GS+ LR RG+S + + + +L + YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYLEGN---N 137
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 193
Query: 307 KTDVFGYGVMLLELIT 322
K+DV+ +G++L E+ +
Sbjct: 194 KSDVWSFGILLWEIYS 209
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 27/274 (9%)
Query: 128 NILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+ LG G +G+VY+G SL VAVK LKE+ + +F E ++ H NL++L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
C ++ FM G++ LRE + + + +A + + YL
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYLEKK---N 338
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
IHR++ A N L+ E V DFGL++LM + I APE L+ K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 307 KTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 365
K+DV+ +GV+L E+ T G + + LL+ K ++E+
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLE--KDY----RMERPEGC------ 444
Query: 366 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E++ ++ C Q +P +RP +E+ + E
Sbjct: 445 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 67/209 (32%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 129 ILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLL 182
LG G FG V +G S VAVK LK + E F EV + HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYL 239
RL G +TP +V GS+ LR+ ++V Q+A G+ YL
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA----EGMGYL 137
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPE 297
+ IHRD+ A N+LL +GDFGL + + D H APE
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 298 YLSTGKSSEKTDVFGYGVMLLELIT-GQR 325
L T S +D + +GV L E+ T GQ
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG G FG+V+ G + VAVK LK+ F E ++ H+ L+RL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAV 76
Query: 188 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 245
T+ ++ +M NGS+ L+ + +N + +A A G+A++ +
Sbjct: 77 V---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL--DMAAQIAEGMAFIEER--- 128
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLS 300
IHRD++AANIL+ + + DFGLA+L+ + + ++ T APE ++
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 183
Query: 301 TGKSSEKTDVFGYGVMLLELIT 322
G + K+DV+ +G++L E++T
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 82/341 (24%), Positives = 135/341 (39%), Gaps = 70/341 (20%)
Query: 83 YWRKRKPEDHFFDVPAE-EDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 141
Y++ + PE F+ P E+P + R RE++ I+G G G+V G
Sbjct: 15 YFQGKLPEPQFYAEPHTYEEPG----RAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYG 68
Query: 142 RLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197
RL VA+K LK T+ F +E ++ H N++RL G ++V
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 257
+M NGS+ + LR + G G+ YL D +HRD+ A N+
Sbjct: 129 TEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNV 182
Query: 258 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFG 312
L+D V DFGL++++ D G G I APE ++ S +DV+
Sbjct: 183 LVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTG--GKIPIRWTAPEAIAFRTFSSASDVWS 239
Query: 313 YGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE 371
+GV++ E++ G+R + +M + VE
Sbjct: 240 FGVVMWEVLAYGERPYW-------------------------------NMTNRDVISSVE 268
Query: 372 Q-------------LIQVALLCTQGSPMERPKMSEVVRMLE 399
+ L Q+ L C +RP+ S++V +L+
Sbjct: 269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 188 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
+ L +V +M GS+ LR RG+S + + + +L + YL +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYLEGN---N 309
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 365
Query: 307 KTDVFGYGVMLLELIT 322
K+DV+ +G++L E+ +
Sbjct: 366 KSDVWSFGILLWEIYS 381
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-34
Identities = 62/261 (23%), Positives = 88/261 (33%), Gaps = 25/261 (9%)
Query: 74 FAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRG 133
+ + +P F A E + R Q +F + LG G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ----SFQRLSRLGHG 68
Query: 134 GFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCM 189
+G+V+K R DG L AVKR + + E+ S H +RL
Sbjct: 69 SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRLEQAWE 127
Query: 190 TPTERLLVYPFM--VNGSVASCLRERGQSQP-PLNWSVRKQIALGAARGLAYLHDHCDPK 246
+Y S+ G S P W + L LA+LH
Sbjct: 128 EGGI---LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LAHLHSQ---G 177
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
++H DVK ANI L +GDFGL + G ++APE L G
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQEGDPRYMAPELLQ-GSYGT 234
Query: 307 KTDVFGYGVMLLELITGQRAF 327
DVF G+ +LE+
Sbjct: 235 AADVFSLGLTILEVACNMELP 255
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 74/356 (20%), Positives = 132/356 (37%), Gaps = 87/356 (24%)
Query: 86 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 145
+ P + +P +P+ L L+ +N +G G FG+V++ R
Sbjct: 21 RLHPNPMYQRMPLLLNPK----------LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70
Query: 146 G------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199
++VAVK LKEE + + FQ E +++ + N+++L G C L++
Sbjct: 71 LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130
Query: 200 FMVNGSVASCLRERGQSQPPLNWSVRK--------------------QIALGAARGLAYL 239
+M G + LR IA A G+AYL
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI----- 294
+ K +HRD+ N L+ E + DFGL++ + D + I
Sbjct: 191 SER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWM 243
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVMLLDWVKGLLK 349
PE + + + ++DV+ YGV+L E+ + +A+
Sbjct: 244 PPESIFYNRYTTESDVWAYGVVLWEIFS------YGLQPYYGMAH--------------- 282
Query: 350 EKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E+++ +GN + E+ L+ LC P +RP + R+L+
Sbjct: 283 ----EEVIYYVRDGNILACPENCPLELYNLM---RLCWSKLPADRPSFCSIHRILQ 331
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG G FG+V+ + VAVK +K F E ++ H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247
T ++ FM GS+ L+ S+ PL + + A G+A++
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQR---NY 305
Query: 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 307
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G + K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 308 TDVFGYGVMLLELIT 322
+DV+ +G++L+E++T
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 75/314 (23%), Positives = 128/314 (40%), Gaps = 77/314 (24%)
Query: 128 NILGRGGFGKVYKGRLTDG------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
LG G FGKV K + VAVK LKE + +E ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--------------- 226
++L G C LL+ + GS+ LRE + P S
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 227 -----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281
A ++G+ YL + K++HRD+ A NIL+ E + + DFGL++ + +D+
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 282 HVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR----- 331
+ V+ + G I A E L + ++DV+ +GV+L E++T L
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYPG 255
Query: 332 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSP 385
+ E+L + G+ +E EE+ +L+ L C + P
Sbjct: 256 IPP-------------------ERLFNLLKTGHRMERPDNCSEEMYRLM---LQCWKQEP 293
Query: 386 MERPKMSEVVRMLE 399
+RP +++ + LE
Sbjct: 294 DKRPVFADISKDLE 307
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 78/333 (23%), Positives = 133/333 (39%), Gaps = 65/333 (19%)
Query: 128 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
++G G FG+V GRL S VA+K LK T+ F E ++ H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
L G ++V +M NGS+ S LR+ + G A G+ YL D
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 301
+HRD+ A NIL++ V DFGL +++ D + + T + I +PE ++
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 302 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
K + +DV+ YG++L E+++ G+R + +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYW-------------------------------E 253
Query: 361 MEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 407
M + + V++ L Q+ L C Q RPK ++V +L+
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD-------- 305
Query: 408 EEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQP 440
+ + + + P+N + S I
Sbjct: 306 KLIRNPGSLKIITSAAARPSNLLLDQSNVDITT 338
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 49/285 (17%)
Query: 128 NILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL++L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLG 76
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
C ++ FM G++ LRE + + + +A + + YL
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYLEKK---N 131
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLST 301
IHRD+ A N L+ E V DFGL++LM DT+ A ++ T APE L+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT----APESLAY 186
Query: 302 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
K S K+DV+ +GV+L E+ T G + + Q+ +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY--PGIDL-------------------SQVYELL 225
Query: 361 MEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ +E E+V +L+ C Q +P +RP +E+ + E
Sbjct: 226 EKDYRMERPEGCPEKVYELM---RACWQWNPSDRPSFAEIHQAFE 267
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 53/248 (21%), Positives = 96/248 (38%), Gaps = 19/248 (7%)
Query: 84 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR- 142
W + E++ V L + + E + +++ +GRG FG+V++ +
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79
Query: 143 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202
G AVK+++ E + E+ + ++ L G + +
Sbjct: 80 KQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262
GS+ +++ G Q L GL YLH +I+H DVKA N+LL +
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYYLGQA-L---EGLEYLHTR---RILHGDVKADNVLLSSD 186
Query: 263 FEAV-VGDFGLAKLMDYKDTHVTTA----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 317
+ DFG A + + + GT H+APE + K D++ M+
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 318 LELITGQR 325
L ++ G
Sbjct: 247 LHMLNGCH 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 70/304 (23%), Positives = 126/304 (41%), Gaps = 57/304 (18%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
+F +LG+G FG+V K R D A+K+++ T+ +EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 180 NLLRLRGF--------CMTPTERLLVYPFMV-----NGSVASCLRERGQSQPP-LNWSVR 225
++R + F+ NG++ + +Q W +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY------- 278
+QI L+Y+H IIHRD+K NI +DE +GDFGLAK +
Sbjct: 123 RQILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 279 -------KDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLA 330
++T+A+ GT ++A E L TG +EK D++ G++ E+I
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FST-- 230
Query: 331 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 390
+ +L L+ +E D + N ++ E +++I+ L+ P +RP
Sbjct: 231 --GMERVNILKK-----LRSVSIE--FPPDFDDNKMKVE-KKIIR-LLIDH--DPNKRPG 277
Query: 391 MSEV 394
+
Sbjct: 278 ARTL 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 62/305 (20%), Positives = 110/305 (36%), Gaps = 67/305 (21%)
Query: 128 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 180
LG G FGKV + VAVK LK + +E++ M + H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----------QIAL 230
++ L G C L++ + G + + LR + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 231 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA---- 286
A+G+A+L IHRDV A N+LL A +GDFGLA+ + ++
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 287 -VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVML 340
V+ APE + + ++DV+ YG++L E+ + L + +
Sbjct: 229 PVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSKFY- 277
Query: 341 LDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEV 394
K ++ +G + + + ++ C P RP ++
Sbjct: 278 ----------KLVK-------DGYQMAQPAFAPKNIYSIM---QACWALEPTHRPTFQQI 317
Query: 395 VRMLE 399
L+
Sbjct: 318 CSFLQ 322
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 54/302 (17%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
+F LGRGGFG V++ + D A+KR++ + + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 181 LLRLRG-------FCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPP---LNWSVR 225
++R VY ++ ++ + R + + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285
QIA + +LH ++HRD+K +NI + VGDFGL MD + T
Sbjct: 125 LQIAEA----VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 286 AVR-----------GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 334
GT +++PE + S K D+F G++L EL+ F
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS----TQ 230
Query: 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
+ V L + L + E ++Q SPMERP+ +
Sbjct: 231 MERVRTL---------TDVRNLKFPPLFTQKYPCEY-VMVQ---DMLSPSPMERPEAINI 277
Query: 395 VR 396
+
Sbjct: 278 IE 279
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 116 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 174
E D +R +LG+G +G VY GR L++ +A+K + E ++ + E+ +
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHK 74
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQIALG 231
H+N+++ G + + GS+++ LR + ++ KQI L
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI-L- 132
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGT 290
GL YLHD+ +I+HRD+K N+L++ + + DFG +K + + T GT
Sbjct: 133 --EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186
Query: 291 IGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQR 325
+ ++APE + G + D++ G ++E+ TG+
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 71/309 (22%)
Query: 128 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 180
LG G FGKV + VAVK LK +E++ + + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------------- 226
++ L G C L++ + G + + LR + S S
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286
+ A+G+A+L IHRD+ A NILL + DFGLA+ + +V
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 287 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDD 336
V+ APE + + ++DV+ YG+ L EL + L + D
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPGMPVDS 255
Query: 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPK 390
K ++ EG + E+ ++ C P++RP
Sbjct: 256 KFY-----------KMIK-------EGFRMLSPEHAPAEMYDIM---KTCWDADPLKRPT 294
Query: 391 MSEVVRMLE 399
++V+++E
Sbjct: 295 FKQIVQLIE 303
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 71/296 (23%), Positives = 129/296 (43%), Gaps = 66/296 (22%)
Query: 129 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
++G G FG+VYKG L S VA+K LK T+ + F E ++ H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
L G +++ +M NG++ LRE+ + + G A G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTA-----VRGTIGHIAPE 297
+HRD+ A NIL++ V DFGL++++ D + TT+ +R T APE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APE 220
Query: 298 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356
+S K + +DV+ +G+++ E++T G+R +
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYW---------------------------- 252
Query: 357 VDSDMEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEVVRMLE 399
++ + + + + + Q+ + C Q RPK +++V +L+
Sbjct: 253 ---ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 61/310 (19%), Positives = 123/310 (39%), Gaps = 60/310 (19%)
Query: 110 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL-KEERTQGGELQFQT 168
+ + + V +S +G GG KV++ + A+K + EE ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 169 EVEMISMAVHRNL--LRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSV 224
E+ ++ + +RL + +T +Y M N + S L+++ P
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---R 129
Query: 225 R---KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYK 279
+ K + + +H H I+H D+K AN L+ + ++ DFG+A M
Sbjct: 130 KSYWKNM----LEAVHTIHQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPD 179
Query: 280 DTHVT-TAVRGTIGHIAPEYL-----------STGKSSEKTDVFGYGVMLLELITGQRAF 327
T V + GT+ ++ PE + S K S K+DV+ G +L + G+ F
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239
Query: 328 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLCTQGS 384
+ + KL ++D + E + E++++ +++ C +
Sbjct: 240 Q-----QIINQI-----------SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRD 280
Query: 385 PMERPKMSEV 394
P +R + E+
Sbjct: 281 PKQRISIPEL 290
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 58/293 (19%)
Query: 129 ILGRGGFGKVYKGRLTDGSL--------VAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
LG+G F K++KG + V +K L + + F M+S H++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKH 73
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
L+ G C+ E +LV F+ GS+ + L++ + + W + ++A A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKL--EVAKQLAAAMHFLE 130
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIG 292
++ +IH +V A NILL E + + D G++ + + +
Sbjct: 131 EN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV-- 184
Query: 293 HIAPEYLSTGKS-SEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 350
PE + K+ + TD + +G L E+ + G + L +
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-----------------ALDSQ 225
Query: 351 KKLEQLVDSDMEGNYIEE----EVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+KL+ + + + E+ LI C P RP ++R L
Sbjct: 226 RKLQFY----EDRHQLPAPKAAELANLI---NNCMDYEPDHRPSFRAIIRDLN 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 65/314 (20%), Positives = 110/314 (35%), Gaps = 76/314 (24%)
Query: 128 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 180
+LG G FGKV S VAVK LKE+ +E++ M + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------------- 226
++ L G C L++ + G + + LR + +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 227 -----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281
A A+G+ +L +HRD+ A N+L+ + DFGLA+ +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 282 HVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR----- 331
+V V+ APE L G + K+DV+ YG++L E+ + L
Sbjct: 228 YVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS------LGVNPYPG 277
Query: 332 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSP 385
+ D + K ++ G ++ EE+ ++ C
Sbjct: 278 IPVDANFY-----------KLIQ-------NGFKMDQPFYATEEIYIIM---QSCWAFDS 316
Query: 386 MERPKMSEVVRMLE 399
+RP + L
Sbjct: 317 RKRPSFPNLTSFLG 330
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 59/292 (20%), Positives = 117/292 (40%), Gaps = 60/292 (20%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNL--LRL 184
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 185 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYL 239
+ +T +Y M N + S L+++ P + K + + +
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---RKSYWKNMLE----AVHTI 124
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAP 296
H H I+H D+K AN L+ + ++ DFG+A M T V + GT+ ++ P
Sbjct: 125 HQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 297 EYL-----------STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345
E + S K S K+DV+ G +L + G+ F + +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI------ 227
Query: 346 GLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEV 394
KL ++D + E + E++++ +++ C + P +R + E+
Sbjct: 228 -----SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 52/281 (18%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG+GGF K ++ D + A K L + + + E+ + H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 79
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 240
GF +V S+ + R P R QI G YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIV----LGCQYLH 132
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
+ ++IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 188
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
S + DV+ G ++ L+ G+ F+ + ++++
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKET--------YLRIKK----- 229
Query: 361 MEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
Y I LIQ +L Q P RP ++E++
Sbjct: 230 --NEYSIPKHINPVAASLIQ-KML--QTDPTARPTINELLN 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 74/275 (26%), Positives = 118/275 (42%), Gaps = 39/275 (14%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGG-ELQFQTEVEMISMAVHRNLLRLRG 186
LG+G F VY+ + G VA+K + K+ + G + Q EV++ H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN-WSVRK---QIALGAARGLAYLHDH 242
+ LV NG + L+ R + P + R QI G+ YLH H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQII----TGMLYLHSH 131
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
I+HRD+ +N+LL + DFGLA + T GT +I+PE +
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS 187
Query: 303 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362
++DV+ G M L+ G+ FD D V L ++V +D E
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD------TDTVKNT-----------LNKVVLADYE 230
Query: 363 G-NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+++ E + LI LL + +P +R +S V+
Sbjct: 231 MPSFLSIEAKDLIH-QLL--RRNPADRLSLSSVLD 262
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 4e-31
Identities = 36/301 (11%), Positives = 75/301 (24%), Gaps = 50/301 (16%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVK--RLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185
L G V+ R + A+K + E ++ + + + + R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 186 GFC--------------------------MTPTERLLVYPFMV--NGSVASCLRERGQSQ 217
LL+ P + S L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 218 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277
+ R A L ++H N+ + + ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 278 YKDTHVTTAVRGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFDLARLAND 335
K A + + E+L+ + + + + G+ + + F L
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 336 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 395
W + L+ + L + + V+ LI L R E +
Sbjct: 302 G-----SWKRPSLRVPGTDSLAFGSCTP--LPDFVKTLIG-RFLNFD--RRRRLLPLEAM 351
Query: 396 R 396
Sbjct: 352 E 352
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 57/292 (19%), Positives = 115/292 (39%), Gaps = 60/292 (20%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNL--LRL 184
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 185 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYL 239
+ +T +Y M N + S L+++ P + K + + +
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---RKSYWKNMLE----AVHTI 171
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAP 296
H H I+H D+K AN L+ + ++ DFG+A M T V + G + ++ P
Sbjct: 172 HQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 297 EYLS-----------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345
E + K S K+DV+ G +L + G+ F + +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI------ 274
Query: 346 GLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEV 394
KL ++D + E + E++++ +++ C + P +R + E+
Sbjct: 275 -----SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 318
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 42/276 (15%)
Query: 130 LGRGGFGKVYKGRLTD-GSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
LG+GGF K ++ D + A K L + + + E+ + H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 240
GF +V S+ + R P R QI G YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIV----LGCQYLH 158
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
+ ++IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 214
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
S + DV+ G ++ L+ G+ F+ + L+ KK E +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKET-----YLRIKKNEYSIPK- 262
Query: 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+I LIQ +L Q P RP ++E++
Sbjct: 263 ----HINPVAASLIQ-KML--QTDPTARPTINELLN 291
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 13/213 (6%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
D++ + ++G G V VA+KR+ E+ Q + E++ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR-KQIAL---GAARGL 236
++ + E LV + GSV ++ + + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH-- 293
YLH + IHRDVKA NILL E+ + DFG++ + VR T +G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 294 -IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
+APE + + K D++ +G+ +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 45/243 (18%), Positives = 76/243 (31%), Gaps = 47/243 (19%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-- 177
T F +G G FG V+K DG + A+KR K+ + Q E+ + AV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLG 68
Query: 178 -HRNLLRLRGFCMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLN----WSVRKQIA 229
H +++R E + GS+A + E + + Q+
Sbjct: 69 QHSHVVRYFSAWA---EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV-------------------GDF 270
G L Y+H ++H D+K +NI + GD
Sbjct: 126 RG----LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDL 329
G + G +A E L + K D+F + ++ +
Sbjct: 179 GHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233
Query: 330 ARL 332
Sbjct: 234 GDQ 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
+ F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 236
+ + G + T+ ++ ++ GS L + QIA +GL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--------QIATILREILKGL 132
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
YLH K IHRD+KAAN+LL E E + DFG+A + T V GT +AP
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQ 324
E + K D++ G+ +EL G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGG-ELQFQTEVEMIS 174
Q A ++F LG+G FG VY R ++A+K L K + + G E Q + EVE+ S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 234
H N+LRL G+ T L+ + G+V L++ + + ++A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--- 121
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 294
L+Y H ++IHRD+K N+LL E + DFG + GT+ ++
Sbjct: 122 -LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC--GTLDYL 174
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
PE + EK D++ GV+ E + G+ F+
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 64/293 (21%), Positives = 110/293 (37%), Gaps = 47/293 (16%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMA 176
V +F +++LG G G + + D VAVKR+ E EV+ +
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESD 75
Query: 177 VHRNLLRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLN-WSVRKQIALGAA 233
H N++R Y + ++ + ++ + L ++ +Q
Sbjct: 76 EHPNVIRYFCTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQT----T 128
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLAKLMD---YKDTHVTT 285
GLA+LH I+HRD+K NIL+ A++ DFGL K + + + +
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 286 AVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 341
GT G IAPE LS + D+F G + +I+ G F
Sbjct: 186 VP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG------KSLQRQA 238
Query: 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
+ + G L+ L + + +LI+ ++ P +RP V
Sbjct: 239 NILLG---ACSLDCLHPEK----HEDVIARELIE-KMIAMD--PQKRPSAKHV 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 43/311 (13%), Positives = 88/311 (28%), Gaps = 74/311 (23%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVK--------------RLKEERTQGGELQ-------- 165
+LG+ + G V ++KEE + L+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 166 -----FQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPFMV--NGSVASCLRERGQS 216
F +++ + ++R+R R +YP M + L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 217 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276
L R Q+ L R LA LH + ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 277 DYKDTHVTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQR 325
+ + G PE + + D + G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 326 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 385
D + +W+ K I + V L++ L
Sbjct: 312 PIT-----KDAALGGSEWIFRSCKN---------------IPQPVRALLE-GFLRYP--K 348
Query: 386 MERPKMSEVVR 396
+R + +
Sbjct: 349 EDRLLPLQAME 359
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 43/254 (16%), Positives = 84/254 (33%), Gaps = 24/254 (9%)
Query: 94 FDVPAEEDPEVHLGQLKRFSL-RELQVATDNFSNRNILGRGGFGKVYKGRLTD------G 146
V + + +L E Q+ + ++LG G F +VY+ D
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 147 SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 206
+K K + Q +E + ++ ++ + +LV G++
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 207 ASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------ 259
+ + + + + A+ + +HD +IIH D+K N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211
Query: 260 -----DEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 313
D + D G + M + + TA T G E LS + + D FG
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 314 GVMLLELITGQRAF 327
+ ++ G
Sbjct: 272 AATVYCMLFGTYMK 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 59/329 (17%), Positives = 112/329 (34%), Gaps = 52/329 (15%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 176
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 177 VHRNLLRLRGFCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPPLN----WSVRKQ 227
H+N+++L T R + ++ GS+ + L E + L V +
Sbjct: 65 NHKNIVKLFAIEEETTTR---HKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRD 120
Query: 228 IALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMDYKDTHV 283
+ G+ +L ++ I+HR++K NI+ D + + DFG A+ ++ D
Sbjct: 121 V----VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQF 172
Query: 284 TTAVRGTIGHIAPEYLSTGKS--------SEKTDVFGYGVMLLELITGQRAFDLARLAND 335
+ GT ++ P+ D++ GV TG F
Sbjct: 173 VSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 336 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 395
+ K ++ + + + E + S + ++ V+
Sbjct: 232 N--------KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
Query: 396 R-MLEGDGLAERWEEWQKEEMFRQDFNHT 423
+LE D + W F Q F T
Sbjct: 284 ANILEADQ-EKCW-------GFDQFFAET 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 51/300 (17%), Positives = 100/300 (33%), Gaps = 53/300 (17%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKRLK----------------EERTQGGELQFQTEVEMI 173
L +G F K+ A+K+ + + + F+ E+++I
Sbjct: 39 LNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 174 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG-----QSQPPLNWSVRK-- 226
+ + L G E ++Y +M N S+ + ++
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 227 -QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285
+ +Y+H+ + I HRDVK +NIL+D+ + DFG ++ M D +
Sbjct: 158 KSVLNS----FSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209
Query: 286 AVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL-- 341
+ GT + PE+ S + K D++ G+ L + F ++ L
Sbjct: 210 SR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVELFN 263
Query: 342 -------DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
++ S N++ E ++ L P ER +
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK-LFLRKN--PAERITSEDA 320
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 48/235 (20%), Positives = 85/235 (36%), Gaps = 23/235 (9%)
Query: 105 HLGQLKRFSLRELQVATDNFSNRNILGRG--GFGKVYKGR-LTDGSLVAVKRLKEERTQG 161
H+ L + + ++G+G V R G V V+R+ E
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 162 GELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL 220
+ F Q E+ + + H N++ R + E +V FM GS + +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GM 125
Query: 221 NWSVRKQIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277
N IA G + L Y+H +HR VKA++IL+ + + + M
Sbjct: 126 N---ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 278 ---YKDTHVTTAVRGTIGHI---APEYLSTGKS--SEKTDVFGYGVMLLELITGQ 324
+ V + ++ + +PE L K+D++ G+ EL G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 42/305 (13%), Positives = 84/305 (27%), Gaps = 63/305 (20%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVK--------------RLKEERTQGGELQ-------- 165
+LG+ + G V ++KEE + L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 166 -----FQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYPFMV--NGSVASCLRERGQS 216
F +++ + ++R+R R +YP M + L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 217 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276
L R Q+ L R LA LH + ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 277 DYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLAR 331
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-- 319
Query: 332 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391
D + +W+ K I + V L++ L + +R
Sbjct: 320 ---DAALGGSEWIFRSCKN---------------IPQPVRALLEGFL---RYPKEDRLLP 358
Query: 392 SEVVR 396
+ +
Sbjct: 359 LQAME 363
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 186
LG+G FG VY R + ++A+K L + + + + Q + E+E+ S H N+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
+ L+ F G + L++ G+ + + +++A L Y H+ K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA----LHYCHER---K 134
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
+IHRD+K N+L+ + E + DFG + T GT+ ++ PE + E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TMC--GTLDYLPPEMIEGKTHDE 191
Query: 307 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
K D++ GV+ E + G FD
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFD------SPSHTET 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 58/335 (17%), Positives = 112/335 (33%), Gaps = 44/335 (13%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 176
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 177 VHRNLLRLRGFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQIALG 231
H+N+++L T R L+ F GS+ + L E + + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG- 123
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDYKDTHVTTAV 287
G+ +L ++ I+HR++K NI+ + + DFG A+ ++ D +
Sbjct: 124 ---GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY 176
Query: 288 RGTIGHIAPEYLSTGKS--------SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
GT ++ P+ D++ GV TG F +
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--- 232
Query: 340 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR-ML 398
K ++ + + + E + S + ++ V+ +L
Sbjct: 233 -----KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 399 EGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVD 433
E D + W F Q F T + ++
Sbjct: 288 EAD-QEKCW-------GFDQFFAETSDILHRMVIH 314
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 56/304 (18%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 180
+ + ILG G G V G VAVKR+ + E++ + H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPN 70
Query: 181 LLRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARG 235
++R T + + N ++ + + S L A G
Sbjct: 71 VIRYYCSETTDRFLYIA---LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 236 LAYLHDHCDPKIIHRDVKAANILLD-------------EEFEAVVGDFGLAKLMD----Y 278
+A+LH KIIHRD+K NIL+ E ++ DFGL K +D
Sbjct: 128 VAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 279 KDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 330
T++ GT G APE L + + D+F G + +++ G+ F
Sbjct: 185 FRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-D 242
Query: 331 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 390
+ + + +++ +G+ +++ L D + E LI ++ P++RP
Sbjct: 243 KYSRESNII-----RGIFSLDEMKCLHDRS-----LIAEATDLIS-QMIDHD--PLKRPT 289
Query: 391 MSEV 394
+V
Sbjct: 290 AMKV 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 65/297 (21%), Positives = 121/297 (40%), Gaps = 37/297 (12%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
+ + LG GGFG V + G VA+K+ ++E + ++ E++++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 180 NLLRLRGFCMTPTE-RLLVYPFMV-----NGSVASCLRERGQSQPPLNWSVR---KQIAL 230
N++ R + P + G + L + +R I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 231 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAV 287
L YLH++ +IIHRD+K NI+L + + + D G AK +D + T V
Sbjct: 133 A----LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV 184
Query: 288 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD----------LARLANDDD 337
GT+ ++APE L K + D + +G + E ITG R F R +++
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 338 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
+++ D + G +K + L + + ++E+ +Q L +R +
Sbjct: 244 IVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 32/240 (13%)
Query: 115 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL---KEERTQGGELQFQTEV 170
+ +++ R +L GGF VY+ + + G A+KRL +EE+ + EV
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR----AIIQEV 76
Query: 171 E-MISMAVHRNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNW 222
M ++ H N+++ E L+ + G + L++ +S+ PL+
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSC 135
Query: 223 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282
+I R + ++H P IIHRD+K N+LL + + DFG A + + +
Sbjct: 136 DTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 283 VTTA-----------VRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFD 328
+A T + PE + + EK D++ G +L L Q F+
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 76/261 (29%), Positives = 111/261 (42%), Gaps = 38/261 (14%)
Query: 87 RKPEDHFFDVPAEEDP-----------EVHLGQLKRFSLRELQVATD---NFSNRNILGR 132
H +D+P E+ G LK + EL D FS+ +G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 133 GGFGKVYKGR-LTDGSLVAVKR--LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189
G FG VY R + + +VA+K+ +++ EV + H N ++ RG +
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCDPK 246
LV + GS + L + PL +IA GA +GLAYLH H
Sbjct: 125 REHTAWLVMEYC-LGSASDLLEVHKK---PLQ---EVEIAAVTHGALQGLAYLHSH---N 174
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
+IHRDVKA NILL E +GDFG A +M ++ V GT +APE + +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQ 229
Query: 307 ---KTDVFGYGVMLLELITGQ 324
K DV+ G+ +EL +
Sbjct: 230 YDGKVDVWSLGITCIELAERK 250
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 130 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 184
LG GG VY D L VA+K + + E F+ EV S H+N++ +
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 185 --RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
E Y M + G L E +S PL+ G+ + H
Sbjct: 77 IDVD-----EEDDCYYLVMEYIEGPT---LSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
D +I+HRD+K NIL+D + DFG+AK + T V GT+ + +PE
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFD 328
+ E TD++ G++L E++ G+ F+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 41/205 (20%), Positives = 77/205 (37%), Gaps = 21/205 (10%)
Query: 130 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
+ GG G +Y +G V +K L + E + ++ VH +++++ F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 188 CMTPTERLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
++V G L+ + P+ ++ L L+YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQS---LKRSKGQKLPVAEAIA--YLLEILPALSYLHSI- 201
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
+++ D+K NI+L EE + + D G ++ + GT G APE +
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPE-IVRTG 252
Query: 304 SSEKTDVFGYGVMLLELITGQRAFD 328
+ TD++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 29/235 (12%)
Query: 107 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 165
L L L+ F ++G G +G+VYKGR + G L A+K + G E +
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEE 65
Query: 166 -FQTEVEMIS-MAVHRNLLR-----LRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQ 217
+ E+ M+ + HRN+ ++ ++L LV F GSV ++
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKG 123
Query: 218 PPLNWSVRKQIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274
L + IA RGL++LH H K+IHRD+K N+LL E E + DFG++
Sbjct: 124 NTLK---EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 324
+D T + GT +APE ++ ++ + K+D++ G+ +E+ G
Sbjct: 178 QLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
+ + LG G FGKVYK + G+L A K ++ + + E + E+E+++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 236
+++L G + ++ F G+V + + E + L QI + L
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLT---EPQIQVVCRQMLEAL 130
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIG 292
+LH +IIHRD+KA N+L+ E + + DFG K + +D+ + GT
Sbjct: 131 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPY 182
Query: 293 HIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 324
+APE + + K D++ G+ L+E+ +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 130 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 184
LG GG +V+ R D VAVK L+ + + F+ E + + H ++ +
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 185 --RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
G TP L Y M V+G LR+ ++ P+ ++ A + L + H
Sbjct: 78 YDTGEAETPAGP-LPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEY 298
+ IIHRDVK ANI++ V DFG+A+ + VT AV GT +++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
++DV+ G +L E++TG+ F
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 28/211 (13%)
Query: 130 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 184
+GRGG G VY+ D VA+K + E + + Q E +++ +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 185 --RGFCMTPTERLLVYPFM--VNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
G +Y M +NG +A+ LR +G PL I L
Sbjct: 100 HDFG-----EIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAA 150
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPE 297
H HRDVK NIL+ + A + DFG+A D +T GT+ ++APE
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPE 205
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
S ++ + D++ +L E +TG +
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 55/229 (24%), Positives = 106/229 (46%), Gaps = 14/229 (6%)
Query: 99 EEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEE 157
+E L + ++ D+F + LG G G V+K G ++A K + E
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69
Query: 158 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ 217
Q E++++ ++ G + E + M GS+ L++ G
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--- 126
Query: 218 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLM 276
+ + ++++ +GL YL + KI+HRDVK +NIL++ E + DFG++ +L+
Sbjct: 127 -RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183
Query: 277 DYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
D ++ V GT +++PE L S ++D++ G+ L+E+ G+
Sbjct: 184 DSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
++ +G+G G VY + G VA++++ ++ EL E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 236
N++ + E +V ++ GS+ + E + QIA + L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------QIAAVCRECLQAL 129
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
+LH + ++IHRD+K+ NILL + + DFG + + + +T V GT +AP
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 185
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQ 324
E ++ K D++ G+M +E+I G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 178
+ F LG G +G VYK G +VA+K++ E Q + E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ----EIIKEISIMQQCDS 83
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARG 235
++++ G T+ +V + GSV+ +R R + L +IA +G
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLT---EDEIATILQSTLKG 137
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
L YLH + IHRD+KA NILL+ E A + DFG+A + T + GT +A
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMA 193
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
PE + + D++ G+ +E+ G+
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 20/229 (8%)
Query: 107 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 165
G+LK + ++ + +GRG +G V K G ++AVKR++ + + Q
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 166 FQTEVEMI-SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP-PLNWS 223
+++++ + +++ G + + M + S + +
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEE 125
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTH 282
+ +I L + L +L + + KIIHRD+K +NILLD + DFG+ +L+D
Sbjct: 126 ILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----- 178
Query: 283 VTTAVRGTIG---HIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQ 324
+ A G ++APE + S ++DV+ G+ L EL TG+
Sbjct: 179 -SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
+ +G G G V R G VAVK + + Q EL EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHF 102
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 236
N++ + + E ++ F+ G++ + + LN +QIA + L
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLN---EEQIATVCEAVLQAL 154
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
AYLH +IHRD+K+ +ILL + + DFG + + V GT +AP
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAP 210
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQ 324
E +S + + D++ G+M++E++ G+
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 15/232 (6%)
Query: 117 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM 175
++V D+ LGRG +G V K R G ++AVKR++ + + +++ ISM
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISM 60
Query: 176 AV--HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 233
+ G + + M + S+ ++ + + +IA+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
+ L +LH +IHRDVK +N+L++ + + DFG++ + D G +
Sbjct: 120 KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPY 175
Query: 294 IAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
+APE ++ + S K+D++ G+ ++EL + F +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQ 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 48/280 (17%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMISM----AVHR 179
LG+GGFG V+ G LTD VA+K R+ + EV ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
++RL + T +LV + + + E+G + Q+ + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAIQH 154
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
H ++HRD+K NIL+D + DFG L+ D T GT + PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GTRVYSPPE 208
Query: 298 YLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356
++S + + V+ G++L +++ G F+ D +++ + L
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEIL-----EAELHFPA---- 254
Query: 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
++ + LI+ L P RP + E++
Sbjct: 255 --------HVSPDCCALIR-RCLAP--KPSSRPSLEEILL 283
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 72/253 (28%), Positives = 113/253 (44%), Gaps = 18/253 (7%)
Query: 94 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK 152
F E D Q K L + ++FS I+GRGGFG+VY R D G + A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 153 RLKEER--TQGGELQFQTE---VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 207
L ++R + GE E + ++S ++ + TP + + M G +
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 208 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 267
L + G +I LG L ++H+ +++RD+K ANILLDE +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILG----LEHMHNR---FVVYRDLKPANILLDEHGHVRI 333
Query: 268 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRA 326
D GLA K H +V GT G++APE L G + + + D F G ML +L+ G
Sbjct: 334 SDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
Query: 327 FDLARLANDDDVM 339
F + + ++
Sbjct: 391 FRQHKTKDKHEID 403
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 14/216 (6%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMIS 174
V + F +LG+GGFG+V ++ G + A K+L+++R + GE E +++
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGA 232
R ++ L T LV M G + + GQ+ P +V +I G
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG- 298
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 292
L LH +I++RD+K NILLD+ + D GLA + T GT+G
Sbjct: 299 ---LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVG 350
Query: 293 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
++APE + + + D + G +L E+I GQ F
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMIS 174
+ D F + +LGRGGFG+V+ ++ G L A K+L ++R + G E ++++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 175 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIA 229
R ++ L + L LV M G + + + P QI
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVR 288
G L +LH II+RD+K N+LLD++ + D GLA L + T
Sbjct: 300 SG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 289 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
GT G +APE L + D F GV L E+I + F
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 63/278 (22%), Positives = 114/278 (41%), Gaps = 46/278 (16%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHR--NL 181
LG GGFG VY G ++D VA+K R+ + + EV ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 182 LRLRGFCMTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+RL + P +L+ + + ERG Q L S Q+ + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRHCH 166
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
+ ++HRD+K NIL+D + + DFG L+ KDT T GT + PE++
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSPPEWI 220
Query: 300 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
+ V+ G++L +++ G F+ +D++++ +G + ++
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII-----RGQVFFRQ------ 264
Query: 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ E + LI+ L P +RP E+
Sbjct: 265 ------RVSSECQHLIR-WCLAL--RPSDRPTFEEIQN 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 178
++ + LG G +G+V R A+K +++ EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 234
N+++L F LV G L + + N + KQ+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQV----LS 147
Query: 235 GLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291
G+ YLH H I+HRD+K N+LL +++ + DFGL+ + +++ GT
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTA 202
Query: 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+IAPE L K EK DV+ GV+L L+ G F
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 64/303 (21%), Positives = 111/303 (36%), Gaps = 44/303 (14%)
Query: 28 SFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKR 87
S +N+ N ++ P + + + A A L + +
Sbjct: 9 SGVDNKFNKERRRARREIRHLP-NLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 88 KPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG--RLTD 145
E+ +F ED K F + ++++GRG V + R T
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGRGVSSVVRRCVHRAT- 118
Query: 146 GSLVAVK-------RLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLV 197
G AVK RL E+ + + E + +A H +++ L + + LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 198 YPFMVNGS-----VAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 251
+ M G L E+ S+ + + +++LH + I+HRD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETR------SIMRSLL----EAVSFLHAN---NIVHRD 225
Query: 252 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 311
+K NILLD+ + + DFG + + + + GT G++APE L K S
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEIL---KCSMDETHP 280
Query: 312 GYG 314
GYG
Sbjct: 281 GYG 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 65/285 (22%), Positives = 119/285 (41%), Gaps = 41/285 (14%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAV 177
+D + + +LG+G FG+V + G AVK + + + + EV+++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAA 233
H N+++L F LV G L + S+ + + +Q+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQV----L 136
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 290
G+ Y+H + KI+HRD+K N+LL ++ + DFGL+ ++ + GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGT 191
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350
+IAPE L G EK DV+ GV+L L++G F+ ++ +L +
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN----GANEYDIL---------K 237
Query: 351 KKLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
K + ++ + E + LI+ +L P R +
Sbjct: 238 KVEKGKYTFELPQWKKVSESAKDLIR-KMLTY--VPSMRISARDA 279
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 51/219 (23%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE 171
+ Q ++ N +G G G+V+K R G ++AVK+++ + + +++
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 172 -MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 230
++ +++ G +T T+ + M + R +G P+ + ++ +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTV 131
Query: 231 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 290
+ L YL + +IHRDVK +NILLDE + + DFG++ + D G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGC 187
Query: 291 IGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 324
++APE + ++ + DV+ G+ L+EL TGQ
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 33/227 (14%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVK---RLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185
LG G +GKV + AVK + K R GE + E++++ H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 186 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--------GLA 237
++ + +MV ++E L+ K+ + A GL
Sbjct: 73 DVLYNEEKQKM---YMVMEYCVCGMQEM------LDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAP 296
YLH I+H+D+K N+LL + G+A+ + + +G+ P
Sbjct: 124 YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 297 EYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
E + S K D++ GV L + TG F+ D++ L
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKL 221
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEER-------TQGGELQFQTEVEMISMAVHRNL 181
LG G FG V+ V VK +K+E+ + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 182 LRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+++ LV +G + + + + PL + +Q+ + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLR 147
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
IIHRD+K NI++ E+F + DFG A ++ + T GTI + APE L
Sbjct: 148 LK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTFC-GTIEYCAPEVLM 202
Query: 301 TGKSSE--KTDVFGYGVMLLELITGQRAFD 328
G + +++ GV L L+ + F
Sbjct: 203 -GNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 40/284 (14%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 178
+ ++ +LG+G FG+V K + AVK + + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 234
N+++L + +V G L + + + + KQ+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVF----S 132
Query: 235 GLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291
G+ Y+H H I+HRD+K NILL +++ + + DFGL+ ++ GT
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA 187
Query: 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351
+IAPE L G EK DV+ GV+L L++G F ++ +L ++
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFY----GKNEYDIL---------KR 233
Query: 352 KLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
D+ I ++ + LI+ +L P R ++
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDLIR-KMLTFH--PSLRITATQC 274
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 54/248 (21%), Positives = 94/248 (37%), Gaps = 44/248 (17%)
Query: 121 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK--------RLKEERTQGGELQFQTEV 170
+N+ + ILGRG V + + T AVK E Q EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 171 E-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VAS-CLRERGQSQPPLNWS 223
+ + ++ H N+++L+ T T LV+ M G L E+
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------K 128
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283
+ + + + LH I+HRD+K NILLD++ + DFG + +
Sbjct: 129 IMRALL----EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEK 179
Query: 284 TTAVRGTIGHIAPEYLSTGKSSEKT------DVFGYGVMLLELITGQRAFDLARLANDDD 337
V GT ++APE + + D++ GV++ L+ G F +
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQ 234
Query: 338 VMLLDWVK 345
+++L +
Sbjct: 235 MLMLRMIM 242
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 65/280 (23%), Positives = 114/280 (40%), Gaps = 51/280 (18%)
Query: 130 LGRGGFGKVYKGR--LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+G+G F KV R LT G VA+K + K + + EV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHC 243
T L+ + G V L G+ + R QI + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE---ARSKFRQIV----SAVQYCHQKR 134
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
I+HRD+KA N+LLD + + DFG + + G + APE GK
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAFC-GAPPYAAPELFQ-GK 188
Query: 304 SSE--KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361
+ + DV+ GV+L L++G FD ++ L +++ +
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKEL--------RERV-------L 227
Query: 362 EGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
G Y + + E L++ L +P++R + ++++
Sbjct: 228 RGKYRIPFYMSTDCENLLKRFL---VLNPIKRGTLEQIMK 264
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 8e-21
Identities = 44/210 (20%), Positives = 78/210 (37%), Gaps = 43/210 (20%)
Query: 203 NGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259
++ + R + + + QIA + +LH ++HRD+K +NI
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLHSK---GLMHRDLKPSNIFF 197
Query: 260 DEEFEAVVGDFGLAKLMDYKDTHVTTAVR-----------GTIGHIAPEYLSTGKSSEKT 308
+ VGDFGL MD + T GT +++PE + S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 309 DVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE 367
D+F G++L EL+ + R+ D ++ K L
Sbjct: 258 DIFSLGLILFELLYSFSTQMERVRIITD------------VRNLKFPLLFT-----QKYP 300
Query: 368 EEVEQLIQVALLCTQGSPMERPKMSEVVRM 397
+E ++Q SP ERP+ ++++
Sbjct: 301 QEH-MMVQ---DMLSPSPTERPEATDIIEN 326
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 121 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK-------RLKEERTQGGELQFQTEVE 171
D + LG G G+V R T VA++ + R L +TE+E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 172 MISMAVHRNLLRLRGFCMTPTERLLVYPFM--VNGS------VAS-CLRERGQSQPPLNW 222
++ H +++++ F Y + + G V + L+E
Sbjct: 193 ILKKLNHPCIIKIKNFFDAED----YYIVLELMEGGELFDKVVGNKRLKEATCK------ 242
Query: 223 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYK 279
Q+ L + YLH++ IIHRD+K N+LL +E+ + DFG +K++
Sbjct: 243 LYFYQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 293
Query: 280 DTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITG 323
+T + + GT ++APE L + + + D + GV+L ++G
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 49/294 (16%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK------------EERTQGGELQFQ 167
+++ LG G +G+V + S A+K +K + + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 168 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WS 223
E+ ++ H N+++L LV F G L E+ ++ + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAAN 150
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 280
+ KQI G+ YLH H I+HRD+K NILL + + DFGL+ +
Sbjct: 151 IMKQI----LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSK 201
Query: 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 340
+ GT +IAPE L K +EK DV+ GV++ L+ G F +D
Sbjct: 202 DYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFG----GQND---- 252
Query: 341 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
+ ++K+ + + + I +E ++LI+ +L +R E
Sbjct: 253 ----QDIIKKVEKGKYYFDFNDWKNISDEAKELIK-LMLTY--DYNKRCTAEEA 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 34/234 (14%)
Query: 113 SLRELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ 167
S RE + LG G FG V+ + G +K + ++R+Q Q +
Sbjct: 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68
Query: 168 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG----------SVASCLRERGQSQ 217
E+E++ H N++++ +V G + L E ++
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 218 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 274
+ KQ+ LAY H ++H+D+K NIL + DFGLA+
Sbjct: 129 ------LMKQMM----NALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
Query: 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
L D H T A GT ++APE + K D++ GV++ L+TG F
Sbjct: 176 LFK-SDEHSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 30/272 (11%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+ L + G + + P Q+ G+ YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLHGI---GIT 127
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGK--S 304
HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE L +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK-RREFH 185
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
+E DV+ G++L ++ G+ +D +D DW +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYL----------NPWK 232
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
I+ L+ L +P R + ++ +
Sbjct: 233 KIDSAPLALLHKIL---VENPSARITIPDIKK 261
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 33/224 (14%)
Query: 120 ATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EV---E 171
AT + +G G +G VYK R G VA+K ++ GG + EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 172 MISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSVRK 226
+ H N++RL C T LV+ + + + + L + P L K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKA--PPPGLPAETIK 123
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTH 282
+ RGL +LH + I+HRD+K NIL+ + DFGLA++ M T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TP 178
Query: 283 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
VT R APE L + D++ G + E+ +
Sbjct: 179 VVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 57/233 (24%), Positives = 110/233 (47%), Gaps = 25/233 (10%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQF-QTEVEMIS 174
V D+F +G+G FGKV + D + A+K + K++ + E++ E++++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 175 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQ-SQPPLNWSVR---KQIA 229
H L+ L + E + +V ++ G + L++ + +V+ ++
Sbjct: 71 GLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE----TVKLFICELV 125
Query: 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 289
+ L YL + +IIHRD+K NILLDE + DF +A ++ + T A G
Sbjct: 126 MA----LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--G 176
Query: 290 TIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQRAFDLARLANDDDVM 339
T ++APE S+ K + + D + GV EL+ G+R + + + +++
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 7e-20
Identities = 52/248 (20%), Positives = 81/248 (32%), Gaps = 53/248 (21%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVK----RLKEERTQGGELQFQTEVEMISMAVHRNLLRL 184
+G+G +G V ++ A+K + + +TEV ++ H N+ RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG------------- 231
LV G + L + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 232 ----------------AAR-------GLAYLHDHCDPKIIHRDVKAANILL--DEEFEAV 266
+ L YLH+ I HRD+K N L ++ FE
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 267 VGDFGLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLEL 320
+ DFGL+K + +TT GT +APE L+T K D + GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 321 ITGQRAFD 328
+ G F
Sbjct: 270 LMGAVPFP 277
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 30/272 (11%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
+ L + G + + P Q+ G+ YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLHGI---GIT 127
Query: 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGK--S 304
HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE L +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK-RREFH 185
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 364
+E DV+ G++L ++ G+ +D +D DW +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYL----------NPWK 232
Query: 365 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
I+ L+ L +P R + ++ +
Sbjct: 233 KIDSAPLALLHKIL---VENPSARITIPDIKK 261
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 48/225 (21%), Positives = 98/225 (43%), Gaps = 18/225 (8%)
Query: 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTE 169
++++++ ++F ++GRG FG+V +L + + A+K L K E + E F+ E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 170 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQ 227
+++ + + L LV + V G + + L + + + P + +
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMARFYLAE 183
Query: 228 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 287
+ + + +H +HRD+K NIL+D + DFG + T ++
Sbjct: 184 MVIA----IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 288 RGTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQRAF 327
GT +I+PE L + + D + GV + E++ G+ F
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 178
+ ++ +LG+G FG+V K + AVK + + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGA 232
N+++L + +V G E ++ + KQ+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVF--- 131
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 289
G+ Y+H H I+HRD+K NILL +++ + + DFGL+ ++T + + G
Sbjct: 132 -SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-G 185
Query: 290 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
T +IAPE L G EK DV+ GV+L L++G F
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFY 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 32/246 (13%)
Query: 97 PAEEDPEVHLGQLKRFSLRELQVATDNFSNR----NILGRGGFGKVYKG--RLTDGSLVA 150
+ K++ + +++ D+ + LG G FG V++ R T G+ A
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT-GNNFA 186
Query: 151 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------ 204
K + E + E++ +S+ H L+ L E +++Y FM G
Sbjct: 187 AKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245
Query: 205 -SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 263
+ + E + +Q+ +GL ++H++ +H D+K NI+ +
Sbjct: 246 ADEHNKMSEDEAVE------YMRQV----CKGLCHMHEN---NYVHLDLKPENIMFTTKR 292
Query: 264 EAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 321
+ DFGL +D V GT APE TD++ GV+ L+
Sbjct: 293 SNELKLIDFGLTAHLD-PKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350
Query: 322 TGQRAF 327
+G F
Sbjct: 351 SGLSPF 356
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 25/239 (10%)
Query: 97 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL- 154
AE P Q + + + ++F ILG G F V R A+K L
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 155 KEERTQGGELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 213
K + ++ + E +++S H ++L + + NG + +R+
Sbjct: 65 KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI 124
Query: 214 GQSQPPLNWSVRK----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269
G + + + +I L YLH IIHRD+K NILL+E+ + D
Sbjct: 125 GS----FDETCTRFYTAEIVSA----LEYLHGK---GIIHRDLKPENILLNEDMHIQITD 173
Query: 270 FGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQ 324
FG AK L + GT +++PE L+ KSS D++ G ++ +L+ G
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS---DLWALGCIIYQLVAGL 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 46/216 (21%), Positives = 84/216 (38%), Gaps = 19/216 (8%)
Query: 121 TDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 175
+ + N +GRG +G+V A K++ + + + +F+ E+E++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKS 62
Query: 176 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
H N++RL T+ LV G + + + + + K +
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL----SA 118
Query: 236 LAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 292
+AY H + HRD+K N L + + DFGLA + GT
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPY 173
Query: 293 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
+++P+ L G + D + GVM+ L+ G F
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 41/229 (17%)
Query: 115 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKR-LKEERTQGGELQFQTEVEMI 173
+ + ++N ++G G FG V++ +L + VA+K+ L+++R + ELQ V+
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK-- 90
Query: 174 SMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRK- 226
H N++ L+ F + ++ LV ++ +V R + + + + K
Sbjct: 91 ----HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKL 145
Query: 227 ---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTH 282
Q+ R LAY+H I HRD+K N+LLD + + DFG AK
Sbjct: 146 YMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK-------- 190
Query: 283 VTTAVRGTIGHI------APEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
+ A + +I APE + + + D++ G ++ EL+ GQ
Sbjct: 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 53/229 (23%), Positives = 86/229 (37%), Gaps = 26/229 (11%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVK----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 183
++G+G F V + G AVK + E + M H +++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAARGLAYL 239
L + +V+ FM + + +R + + +QI L A L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI-LEA---LRYC 146
Query: 240 HDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
HD+ IIHRDVK +LL + +G FG+A + V GT +AP
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
Query: 297 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345
E + + DV+G GV+L L++G F L + +
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFY------GTKERLFEGII 245
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 34/234 (14%)
Query: 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGEL-QFQTE 169
L+E+++ D+F ++GRG F +V ++ G + A+K + K + + GE+ F+ E
Sbjct: 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 170 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 228
+++ R + +L F L LV + V G + + L + G ++I
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFG-----------ERI 159
Query: 229 ALGAAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280
AR + +H +HRD+K NILLD + DFG +
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216
Query: 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG-------YGVMLLELITGQRAF 327
T + GT +++PE L T +G GV E+ GQ F
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVH 178
+ + N ++G G +G V K R G +VA+K+ E ++ E++++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRH 83
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
NL+ L C LV+ F+ + ++ L L++ V ++ G+ +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN---GLDYQVVQKYLFQIINGIGF 139
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGH 293
H H IIHRD+K NIL+ + + DFG A+ + T R
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR----- 191
Query: 294 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
APE L + DV+ G ++ E+ G+
Sbjct: 192 -APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 66/282 (23%), Positives = 102/282 (36%), Gaps = 50/282 (17%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G G FG R LVAVK + ER + Q E+ H N++R +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCDP 245
+TPT ++ + G + + G+ R Q+ G++Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLS----GVSYCHSM--- 135
Query: 246 KIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 303
+I HRD+K N LLD + DFG +K + + V GT +IAPE L +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTV-GTPAYIAPEVLL-RQ 192
Query: 304 --SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361
+ DV+ GV L ++ G F+ D + +K Q + +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRD--------YRKTIQRI---L 235
Query: 362 EGNY-------IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
Y I E LI P R + E+
Sbjct: 236 SVKYSIPDDIRISPECCHLISRIF---VADPATRISIPEIKT 274
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 67/300 (22%), Positives = 105/300 (35%), Gaps = 56/300 (18%)
Query: 127 RNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRL 184
++LG G +V L AVK ++++ + EVE + HRN+L L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLEL 76
Query: 185 RGFCMTPTERLLVYPFMVNGSVASCLRERGQ------SQPPLNWSVRKQIALGAARGLAY 238
F LV+ M GS+ S + +R S V + +A L +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV------VVQDVA----SALDF 126
Query: 239 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV-------TTAVR 288
LH+ I HRD+K NIL ++ + DF L + T
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC- 182
Query: 289 GTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 343
G+ ++APE + D++ GV+L L++G F W
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV------GRCGSDCGW 236
Query: 344 VKGLLKEKKLEQLVDSDMEGNY---------IEEEVEQLIQVALLCTQGSPMERPKMSEV 394
+G L +S EG Y I + LI LL +R ++V
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS-KLLVR--DAKQRLSAAQV 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 121 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK-------RLKEERTQGGELQFQTEVE 171
D + LG G G+V R T VA+K + R L +TE+E
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 172 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVR 225
++ H +++++ F + +V M G L+E
Sbjct: 68 ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKL------YF 120
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 282
Q+ L + YLH++ IIHRD+K N+LL +E+ + DFG +K++ +T
Sbjct: 121 YQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETS 171
Query: 283 VTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVML 317
+ + GT ++APE L + + + D + GV+L
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 7e-19
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 179
+ + +G G +G VYK + + G +VA+KR++ + G + E+ ++ H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHP 79
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N++ L + LV+ FM + L E L S K RG+A+
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHC 135
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGHI 294
H H +I+HRD+K N+L++ + + DFGLA+ TH VT R
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------ 186
Query: 295 APEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
AP+ L K S D++ G + E+ITG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTE 169
+R+L++ +++ ++GRG FG+V R + A+K L K E + + F E
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 170 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR---K 226
++++ A +++L +V +M G + + + + R
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTA 175
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286
++ L L +H IHRDVK N+LLD+ + DFG M+ +
Sbjct: 176 EVVLA----LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 287 VRGTIGHIAPEYLSTGKSSEK----TDVFGYGVMLLELITGQRAF 327
GT +I+PE L + D + GV L E++ G F
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 50/245 (20%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVK-------------------------RLKEERTQGGE 163
+G+G +G V D + A+K + +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 164 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV----NGSVASCLRERGQSQPP 219
Q E+ ++ H N+++L P E L +MV N +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSED 137
Query: 220 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279
+ + G + YLH KIIHRD+K +N+L+ E+ + DFG++
Sbjct: 138 QARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 280 DTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDD 336
D ++ V GT +APE LS + S + DV+ GV L + GQ F D+
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM------DE 243
Query: 337 DVMLL 341
+M L
Sbjct: 244 RIMCL 248
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 30/212 (14%)
Query: 121 TDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMIS 174
+ FS+ LG+G F V + T G A K + ++ + Q + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQI 228
H N++RL + LV+ + G E S +QI
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------HCIQQI 114
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTT 285
+AY H + I+HR++K N+LL + + DFGLA + D+
Sbjct: 115 L----ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWH 165
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 317
GT G+++PE L S+ D++ GV+L
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
F +LG G F +V+ + G L A+K +K+ + + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHE 66
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGAA 233
N++ L + T LV + G E+ S V +Q+
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQVL---- 116
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 290
+ YLH++ I+HRD+K N+L +E + ++ DFGL+K+ ++ ++TA GT
Sbjct: 117 SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GT 170
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVML 317
G++APE L+ S+ D + GV+
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 31/219 (14%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 174
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 228
+H N++ L T+ +L+ + G L E + KQI
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQI 124
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 284
G+ YLH KI H D+K NI+L + + + DFGLA +D
Sbjct: 125 L----DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 323
+ GT +APE ++ + D++ GV+ L++G
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 31/219 (14%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 174
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VAS-CLRERGQSQPPLNWSVRKQI 228
+H N++ L T+ +L+ + G L E + KQI
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQI 124
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 284
G+ YLH KI H D+K NI+L + + + DFGLA +D
Sbjct: 125 L----DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 323
+ GT +APE ++ + D++ GV+ L++G
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 186
LG G FGKV G G VAVK L ++ + ++ + + E++ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
TPT+ +V ++ G + + + G+ + + +QI + Y H H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA----VDYCHRH---M 131
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--S 304
++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE +S G+ +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVIS-GRLYA 188
Query: 305 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
+ D++ GV+L L+ G FD D+ V L
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD------DEHVPTL 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 42/208 (20%), Positives = 79/208 (37%), Gaps = 25/208 (12%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 178
T+ + LG+G F V + + G A + ++ + Q + E + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGA 232
N++RL L++ + G E S +QI
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH------CIQQIL--- 120
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 289
+ + H ++HR++K N+LL + + DFGLA ++ + G
Sbjct: 121 -EAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-G 175
Query: 290 TIGHIAPEYLSTGKSSEKTDVFGYGVML 317
T G+++PE L + D++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 48/241 (19%), Positives = 92/241 (38%), Gaps = 35/241 (14%)
Query: 115 RELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTE 169
++L + F++ +G G + + AVK + + + E E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----E 65
Query: 170 VEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ------SQPPLNW 222
+E++ H N++ L+ +V M G + + + S
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA----- 120
Query: 223 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDY 278
V I + + YLH ++HRD+K +NIL E++ + DFG AK +
Sbjct: 121 -VLFTIT----KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338
++ + T T +APE L D++ GV+L ++TG F +++
Sbjct: 173 ENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
Query: 339 M 339
+
Sbjct: 232 L 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 87.2 bits (215), Expect = 2e-18
Identities = 58/359 (16%), Positives = 109/359 (30%), Gaps = 95/359 (26%)
Query: 94 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNIL--GRGGFGKVYKGRLTDGSLVAV 151
++V + +L++ +L EL+ +N+L G G GK + VA+
Sbjct: 129 YNVSRLQ----PYLKLRQ-ALLELR------PAKNVLIDGVLGSGK---------TWVAL 168
Query: 152 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSV 206
+ Q + ++ +++ C +P L L+Y N
Sbjct: 169 DVCLSYKVQ---CKMDFKIFWLNL----------KNCNSPETVLEMLQKLLYQIDPNW-- 213
Query: 207 ASCLRERGQSQPPLNW-SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265
R S L S++ ++ R L + + ++ +V+ A F
Sbjct: 214 --TSRSDHSSNIKLRIHSIQAEL-----RRLLKSKPYENCLLVLLNVQNAKAW--NAF-- 262
Query: 266 VVGDFGLAKLMDYKDTHVTTAVRG-TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
+ L+ + VT + T HI+ ++ S + ++ LL
Sbjct: 263 ---NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV------KSLLLKYLDC 313
Query: 325 RAFDLARLAND--------------DDVMLLDWVKGLLKEKK-------LEQLVDSDMEG 363
R DL R D + D K + +K L L ++
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 364 NYIE-----EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFR 417
+ I LL + + + VV L L E+ KE
Sbjct: 374 MFDRLSVFPPSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK---QPKESTIS 427
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 48/348 (13%), Positives = 109/348 (31%), Gaps = 89/348 (25%)
Query: 95 DVPAEEDPEVHLGQLKRFSL--RELQVATDNFSNRNILGRGGFGKVYKGRLTDG------ 146
+V ++ + F+L + L + T + L + +
Sbjct: 252 NV---QNAKA----WNAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 147 -SLVA------VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF------------ 187
SL+ + L E + + +I+ ++ L +
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRR----LSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 188 -----CMTPTE------RLLVYPFMVN--GSVASCLRERGQSQPP---LNWSVRKQ-IAL 230
+ P E RL V+P + + S + +N + +
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419
Query: 231 GAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVG----DFGLAKLMDYKDTHVTT 285
+ + + K+ + A + + + + D L Y +H
Sbjct: 420 QPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH--- 476
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL--ITGQ-RAFDLARLAND---DDVM 339
IGH +L + E+ +F ++ L+ + + R A A+ + +
Sbjct: 477 -----IGH----HLKNIEHPERMTLFR--MVFLDFRFLEQKIRHDSTAWNASGSILNTLQ 525
Query: 340 LLDWVKGLL--KEKKLEQLVDS------DMEGNYIEEEVEQLIQVALL 379
L + K + + K E+LV++ +E N I + L+++AL+
Sbjct: 526 QLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM 573
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 26/223 (11%)
Query: 106 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL 164
+G+ F + +DN+ + LG+G F V + T G A K + ++ +
Sbjct: 13 MGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF 72
Query: 165 Q-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQ 217
Q + E + H N++RL + LV+ + G E S
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS- 131
Query: 218 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 274
+QI +AY H + I+HR++K N+LL + + DFGLA
Sbjct: 132 -----HCIQQIL----ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 317
+ D+ GT G+++PE L S+ D++ GV+L
Sbjct: 180 EV--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
+ + + LG G + VYKG+ +LVA+K ++ E +G EV ++ H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
++ L T LV+ ++ + + L + G +N K RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCH 117
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIGH 293
K++HRD+K N+L++E E + DFGLA+ Y + VT R
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYR----- 167
Query: 294 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
P+ L S + D++G G + E+ TG+
Sbjct: 168 -PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 31/219 (14%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 174
D++ LG G F V K R G A K RL R + + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 228
H N++ L T+ +L+ + G L E +Q KQI
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLKQI 117
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 284
G+ YLH +I H D+K NI+L + + + DFG+A ++
Sbjct: 118 L----DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFK 169
Query: 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 323
GT +APE ++ + D++ GV+ L++G
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 40/223 (17%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVH 178
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106
Query: 179 RNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QI 228
N++RLR F + E+ LV ++ +V R +++ L K Q+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV 287
R LAY+H I HRD+K N+LLD + + + DFG AK + + + +
Sbjct: 166 F----RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYI 217
Query: 288 -----RGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
R APE + + DV+ G +L EL+ GQ
Sbjct: 218 CSRYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 43/282 (15%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 186
LG G F K AVK + + E Q E+ + H N+++L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHE 73
Query: 187 FCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
LV + G E S + +++ ++++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY------IMRKLV----SAVSHMH 123
Query: 241 DHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
D ++HRD+K N+L ++ E + DFG A+L + + T T+ + APE
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPE 179
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
L+ E D++ GV+L +++GQ F + D + ++K+ K
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQ-----SHDRSLTCTSAVEIMKKIKKGDF- 233
Query: 358 DSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
EG + +E + LIQ LL P +R KMS +
Sbjct: 234 --SFEGEAWKNVSQEAKDLIQ-GLLTV--DPNKRLKMSGLRY 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 60/308 (19%), Positives = 107/308 (34%), Gaps = 45/308 (14%)
Query: 32 NQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPED 91
+ ++ L S + + + ++
Sbjct: 6 HHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPV----KSKRTSA 61
Query: 92 HFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN------RNILGRGGFGKVYKGR-LT 144
D+PA P F R + ++ ILG G FG+V+K
Sbjct: 62 LAVDIPAPPAP---------FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112
Query: 145 DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 204
G +A K +K + E + + E+ +++ H NL++L + + +LV ++ G
Sbjct: 113 TGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 205 -------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 257
+ L E KQI G+ ++H I+H D+K NI
Sbjct: 172 ELFDRIIDESYNLTELDTI------LFMKQIC----EGIRHMHQM---YILHLDLKPENI 218
Query: 258 LLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 315
L + DFGLA+ + GT +APE ++ S TD++ GV
Sbjct: 219 LCVNRDAKQIKIIDFGLARRYK-PREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGV 276
Query: 316 MLLELITG 323
+ L++G
Sbjct: 277 IAYMLLSG 284
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 122 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGG-------E---LQFQTE 169
+ +G G +GKV+K R G VA+KR++ + + G E L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR---- 66
Query: 170 VEMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSV 224
+ H N++RL C LV+ + + + + L + + P +
Sbjct: 67 --HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE--PGVPTET 121
Query: 225 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKD 280
K + RGL +LH H +++HRD+K NIL+ + + DFGLA++ M
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 281 TH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
T VT R APE L + D++ G + E+ +
Sbjct: 177 TSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 51/249 (20%), Positives = 94/249 (37%), Gaps = 29/249 (11%)
Query: 85 RKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-L 143
+ P+ + +D E+ + ++ Q + D + LG G FG V++
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSV---YDYYDILEELGSGAFGVVHRCVEK 73
Query: 144 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203
G + K + + E+ +++ H L+ L E +L+ F+
Sbjct: 74 ATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 204 G-------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256
G + + E +Q GL ++H+H I+H D+K N
Sbjct: 133 GELFDRIAAEDYKMSEAEVIN------YMRQAC----EGLKHMHEH---SIVHLDIKPEN 179
Query: 257 ILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 314
I+ + + + V DFGLA ++ D V T APE + TD++ G
Sbjct: 180 IMCETKKASSVKIIDFGLATKLN-PDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 315 VMLLELITG 323
V+ L++G
Sbjct: 238 VLGYVLLSG 246
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 4e-18
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 27/217 (12%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVH 178
+ +G G +G V+K + +VA+KR++ + G + E+ ++ H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKH 60
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
+N++RL + + LV+ F + + L+ + K +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGF 116
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTI 291
H ++HRD+K N+L++ E + +FGLA+ + Y + VT R
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYR--- 168
Query: 292 GHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 327
P+ L K S D++ G + EL R
Sbjct: 169 ---PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 4e-18
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 179
+ + +G G +G VYK + G A+K+++ E+ G + T E+ ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHS 60
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N+++L T +LV+ + + + L L K L G+AY
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYC 116
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIG 292
HD +++HRD+K N+L++ E E + DFGLA+ + Y TH VT R
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYR---- 167
Query: 293 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
AP+ L K S D++ G + E++ G
Sbjct: 168 --APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLRG 186
LG G FGKV VA+K + + + ++ + E+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
TPT+ ++V + G + + E+ + +QI + Y H H K
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRH---K 128
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
I+HRD+K N+LLD+ + DFGL+ +M + T+ G+ + APE ++ GK
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVIN-GKLYA 185
Query: 307 --KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
+ DV+ G++L ++ G+ FD D+ + L
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFD------DEFIPNL 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 35/218 (16%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAV 177
+ + +G G +G V+K R G +VA+K+ E + E+ M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK--IALREIRMLKQLK 60
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
H NL+ L LV+ + + +V L + + + K I + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQR---GVPEHLVKSITWQTLQAVN 116
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-----RGTIG 292
+ H H IHRDVK NIL+ + + DFG A+L+ + V R
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR---- 169
Query: 293 HIAPEYL------STGKSSEKTDVFGYGVMLLELITGQ 324
+PE L DV+ G + EL++G
Sbjct: 170 --SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 39/246 (15%)
Query: 102 PEVHLGQLKRFSLRELQVAT--DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEER 158
E S+ AT D + LG G +G+VYK VA+KR++ E
Sbjct: 12 LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH 71
Query: 159 TQGGELQF-QT---EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG 214
+ G T EV ++ HRN++ L+ L++ + + L++
Sbjct: 72 EEEG---VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYM 123
Query: 215 QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----D 269
P ++ V K G+ + H + +HRD+K N+LL + D
Sbjct: 124 DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 270 FGLAKLM-----DYKDTH--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELI 321
FGLA+ + TH +T R PE L + S D++ + E++
Sbjct: 181 FGLARAFGIPIRQF--THEIITLWYR------PPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 322 TGQRAF 327
F
Sbjct: 233 MKTPLF 238
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVH 178
D F + G+G FG V G+ G VA+K+ +++ R + ELQ ++ +++ H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78
Query: 179 RNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----Q 227
N+++L+ + T ER +V ++ ++ C R + Q + K Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 228 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA 286
+ R + LH + HRD+K N+L++E + DFG AK + + +V
Sbjct: 138 LI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 287 V----RGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
R APE + + + D++ G + E++ G+
Sbjct: 193 CSRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 120 ATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 178
++ F LG G + VYKG T G VA+K +K + +G E+ ++ H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGAARGL 236
N++RL T + LV+ FM + + + R G + L ++ K +GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTH--VTTAVRG 289
A+ H++ KI+HRD+K N+L+++ + +GDFGLA+ + + VT R
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYR- 175
Query: 290 TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
AP+ L ++ S D++ G +L E+ITG+
Sbjct: 176 -----APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EVEMISMA 176
+ + LG G F VYK R +VA+K++K + +T E++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 177 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 236
H N++ L + LV+ FM + +++ L S K L +GL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGL 125
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274
YLH H I+HRD+K N+LLDE + DFGLAK
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 31/219 (14%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 174
D + LG G F V K R + G A K R K R + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 228
H N++ L T+ +L+ + G L E ++ KQI
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQI 123
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 284
G+ YLH +I H D+K NI+L + + + DFGLA +D
Sbjct: 124 L----NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFK 175
Query: 285 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 323
GT +APE ++ + D++ GV+ L++G
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 186
LG G FGKV G+ G VAVK L ++ + ++ + + E++ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
TP++ +V ++ G + + + G+ + + +QI G + Y H H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG----VDYCHRH---M 136
Query: 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 306
++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE +S G+
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVIS-GRLYA 193
Query: 307 --KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341
+ D++ GV+L L+ G FD DD V L
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFD------DDHVPTL 224
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 39/226 (17%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EVEMISMA 176
+ +G+G FG+V+K R G VA+K++ E + G F T E++++ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 177 VHRNLLRLRGFCMTPTERL--------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 228
H N++ L C T LV+ F + +A L S K++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRV 129
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-------T 281
GL Y+H + KI+HRD+KAAN+L+ + + DFGLA+ T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 282 H--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
+ VT R PE L + D++G G ++ E+ T
Sbjct: 187 NRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 186
LGRG F V + + G A K L K R Q + E+ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 187 FCMTPTERLLVYPFMVNG--------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
+E +L+ + G +A + E + + KQI G+ Y
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR------LIKQIL----EGVYY 146
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
LH + I+H D+K NILL + + DFG+++ + + + GT ++A
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM-GTPEYLA 201
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITG 323
PE L+ + TD++ G++ L+T
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 64/314 (20%), Positives = 113/314 (35%), Gaps = 59/314 (18%)
Query: 105 HLGQLKRFSLRELQVATDNFSN-----RNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEE 157
H + + ++ + +LG G GKV + G A+K L
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP 66
Query: 158 RTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER----LLVYPFMVNGSVASCLRE 212
+ + EV+ + +++ + L++ M G L
Sbjct: 67 K-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE----LFS 115
Query: 213 RGQSQPPLNWSVR------KQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEF 263
R Q + ++ R + I + +LH H I HRDVK N+L +++
Sbjct: 116 RIQERGDQAFTEREAAEIMRDIG----TAIQFLHSH---NIAHRDVKPENLLYTSKEKDA 168
Query: 264 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 323
+ DFG AK + T T ++APE L K + D++ GV++ L+ G
Sbjct: 169 VLKLTDFGFAKETT--QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
Query: 324 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLC 380
F +N G+ + +L Q + E+ +QLI+ LL
Sbjct: 226 FPPFY----SNTGQ----AISPGMKRRIRLGQY---GFPNPEWSEVSEDAKQLIR-LLLK 273
Query: 381 TQGSPMERPKMSEV 394
T P ER +++
Sbjct: 274 TD--PTERLTITQF 285
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 61/266 (22%), Positives = 108/266 (40%), Gaps = 36/266 (13%)
Query: 86 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 145
K+ E + E L + + S Q+ D F LG G FG+V + +
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 146 -GSLVAVKRL-KEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 202
G+ A+K L K++ + +++ E ++ L++L + +V ++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 203 NGSVASCLRERGQSQPPLNWSVRK----QIALGAARGLAYLHDHCDPKIIHRDVKAANIL 258
G + S LR G+ + + QI L YLH +I+RD+K N+L
Sbjct: 125 GGEMFSHLRRIGR----FSEPHARFYAAQIVLT----FEYLHSL---DLIYRDLKPENLL 173
Query: 259 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGV 315
+D++ V DFG AK + T + GT +APE + + K+ D + GV
Sbjct: 174 IDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA---VDWWALGV 226
Query: 316 MLLELITGQRAFDLARLANDDDVMLL 341
++ E+ G F D + +
Sbjct: 227 LIYEMAAGYPPFF------ADQPIQI 246
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
+D F + LGRG VY+ + A+K LK + +TE+ ++ H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHP 108
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQIALGAA 233
N+++L+ TPTE LV + G V ER + KQI
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD------AVKQIL---- 158
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 290
+AYLH++ I+HRD+K N+L + + DFGL+K+++++ T GT
Sbjct: 159 EAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GT 213
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVML 317
G+ APE L + D++ G++
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 20/228 (8%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 173
++ +F+ +LG+G FGKV L AVK LK++ + T VE +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 174 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 232
L +L C +RL V ++ G + +++ G+ + P +IA+G
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG- 454
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTI 291
L +L II+RD+K N++LD E + DFG+ K + T T GT
Sbjct: 455 ---LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTP 506
Query: 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
+IAPE ++ + D + +GV+L E++ GQ F+ D+D +
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 550
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
+ + LGRG FG V++ + K +K ++ + E+ ++++A HR
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNG-------SVASCLRERGQSQPPLNWSVRKQIALGA 232
N+L L + E ++++ F+ + A L ER S Q+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV------SYVHQVC--- 112
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGT 290
L +LH H I H D++ NI+ + + +FG A+ + +
Sbjct: 113 -EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLF-TA 166
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+ APE S TD++ G ++ L++G F
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 66/279 (23%), Positives = 108/279 (38%), Gaps = 48/279 (17%)
Query: 87 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRN------------ILGRGG 134
H +D+P E+ + + T + ++GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 135 FGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRLRGFCMT 190
+ KV RL + A++ +K+E E + E + H L+ L C
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQ 123
Query: 191 PTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR----------GLAYL 239
RL V + VNG G L + +++Q L L YL
Sbjct: 124 TESRLFFVIEY-VNG---------GD----LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEY 298
H+ II+RD+K N+LLD E + D+G+ K + DT T+ GT +IAPE
Sbjct: 170 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 224
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 337
L D + GV++ E++ G+ FD+ +++ D
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 62/262 (23%), Positives = 102/262 (38%), Gaps = 26/262 (9%)
Query: 87 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD- 145
+P++ P Q+ +F ++G+G FGKV R
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 146 GSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERL-LVYPFM 201
AVK L+++ + + E ++ H L+ L F ++L V ++
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYI 121
Query: 202 VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 258
G + L+ P R +IA L YLH I++RD+K NIL
Sbjct: 122 NGGELFYHLQRERCFLEPR---ARFYAAEIASA----LGYLHSL---NIVYRDLKPENIL 171
Query: 259 LDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 317
LD + V+ DFGL K +++ T T+ GT ++APE L D + G +L
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVL 229
Query: 318 LELITGQRAFDLARLANDDDVM 339
E++ G F + + M
Sbjct: 230 YEMLYGLPPFY----SRNTAEM 247
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 130 LGRGGFGKVYKGR---LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+GRG +G VYK + D A+K+++ G + E+ ++ H N++ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85
Query: 187 FCMTPTERL--LVYPFM---VNGSVASCLRERGQSQP-PLNWSVRKQIALGAARGLAYLH 240
++ +R L++ + + + + +P L + K + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDY---KDTHVTTAVRGTIGH 293
+ ++HRD+K ANIL+ E + D G A+L + + V T +
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 294 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 324
APE L + ++ D++ G + EL+T +
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 48/241 (19%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK---------EERTQGGELQFQ 167
+ + +F LG G FG+V+ R G A+K LK E T
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 168 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK- 226
E M+S+ H ++R+ G + ++ ++ G + S LR+ + P V K
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----VAKF 110
Query: 227 ---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283
++ L L YLH II+RD+K NILLD+ + DFG AK V
Sbjct: 111 YAAEVCLA----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDV 159
Query: 284 TTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 340
T + GT +IAPE +ST KS D + +G+++ E++ G F D + M
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFY------DSNTMK 210
Query: 341 L 341
Sbjct: 211 T 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 173
++ +F+ +LG+G FGKV L AVK LK++ + T VE +
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 174 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 232
L +L C +RL V + VNG G L + +++
Sbjct: 76 LPGKPPFLTQLH-SCFQTMDRLYFVMEY-VNG---------GD----LMYHIQQVGRFKE 120
Query: 233 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 281
GL +L II+RD+K N++LD E + DFG+ K + T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
T GT +IAPE ++ + D + +GV+L E++ GQ F+ D+D +
Sbjct: 178 --TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 229
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 67/259 (25%), Positives = 110/259 (42%), Gaps = 25/259 (9%)
Query: 95 DVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD----GSLVA 150
D + H + + +V +NF +LG G +GKV+ R G L A
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 151 VKRLKEER-TQGGELQFQTEVE-MISMAVHRN--LLRLRGFCMTPTERL-LVYPFMVNGS 205
+K LK+ Q + T E + + ++ L+ L + +L L+ ++ G
Sbjct: 87 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGE 145
Query: 206 VASCLRERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262
+ + L +R + V+ +I L L +LH II+RD+K NILLD
Sbjct: 146 LFTHLSQRERFTEHE---VQIYVGEIVLA----LEHLHKL---GIIYRDIKLENILLDSN 195
Query: 263 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV--FGYGVMLLEL 320
V+ DFGL+K +T GTI ++AP+ + G S V + GV++ EL
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
Query: 321 ITGQRAFDLARLANDDDVM 339
+TG F + N +
Sbjct: 256 LTGASPFTVDGEKNSQAEI 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 64/264 (24%), Positives = 109/264 (41%), Gaps = 26/264 (9%)
Query: 85 RKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT 144
+K+ + F + D + + +V + F +LG+G FGKV +
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 170
Query: 145 D-GSLVAVKRLKEERTQGGELQFQTEVE--MISMAVHRNLLRLRGFCMTPTERL-LVYPF 200
G A+K LK+E + T E ++ + H L L+ + +RL V +
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEY 229
Query: 201 MVNGSVASCL-RERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256
G + L RER S+ R +I L YLH + +++RD+K N
Sbjct: 230 ANGGELFFHLSRERVFSED----RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLEN 279
Query: 257 ILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 315
++LD++ + DFGL K + T GT ++APE L D +G GV
Sbjct: 280 LMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 316 MLLELITGQRAFDLARLANDDDVM 339
++ E++ G+ F D + +
Sbjct: 338 VMYEMMCGRLPFY----NQDHEKL 357
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 27/232 (11%)
Query: 118 QVATDNFSNRNILGRGGFGKVY----KGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 172
+ F +LG+G FGKV+ L A+K LK+ ++ + E ++
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 173 ISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQI 228
+ H +++L + +L L+ F+ G + + L + V+ ++
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED---VKFYLAEL 135
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAV 287
AL L +LH II+RD+K NILLDEE + DFGL+K +D++ +
Sbjct: 136 ALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSF 186
Query: 288 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
GT+ ++APE ++ ++ D + +GV++ E++TG F D
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ----GKDRKET 234
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 73/239 (30%), Positives = 106/239 (44%), Gaps = 42/239 (17%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMA 176
++ DNF +LG+G FGKV R+ + G L AVK LK++ + T E ++
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 177 VHRN---LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 232
+ RN L +L C +RL V F VNG G L + ++K
Sbjct: 79 LARNHPFLTQLF-CCFQTPDRLFFVMEF-VNG---------GD----LMFHIQKSRRFDE 123
Query: 233 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 281
AR L +LHD II+RD+K N+LLD E + DFG+ K + T
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 282 HVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAFDLARLANDDDVM 339
T GT +IAPE L D + GV+L E++ G F+ A ++D +
Sbjct: 181 --TATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFE----AENEDDL 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 55/252 (21%), Positives = 90/252 (35%), Gaps = 41/252 (16%)
Query: 87 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNR-----NILGRGGFGKVYKG 141
+ P PA+ P + LQ+ + + +LG G GKV +
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 142 R-LTDGSLVAVKRL-KEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER---- 194
A+K L + + EVE + +++R+
Sbjct: 82 FNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 195 LLVYPFMVNGSVASCLRERGQSQPPLNWS------VRKQIALGAARGLAYLHDHCDPKII 248
L+V + G L R Q + ++ + K I + YLH I
Sbjct: 135 LIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIG----EAIQYLHSI---NIA 183
Query: 249 HRDVKAANILL-DEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 305
HRDVK N+L + A++ DFG AK +TT T ++APE L K
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPC-YTPYYVAPEVLGPEKYD 241
Query: 306 EKTDVFGYGVML 317
+ D++ GV++
Sbjct: 242 KSCDMWSLGVIM 253
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 36/236 (15%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 173
+ +F ++GRG + KV RL + A+K +K+E E + E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 174 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 232
+ H L+ L C RL V + VNG G L + +++Q L
Sbjct: 65 QASNHPFLVGLH-SCFQTESRLFFVIEY-VNG---------GD----LMFHMQRQRKLPE 109
Query: 233 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 281
L YLH+ II+RD+K N+LLD E + D+G+ K + DT
Sbjct: 110 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 337
T+ GT +IAPE L D + GV++ E++ G+ FD+ +++ D
Sbjct: 167 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 40/238 (16%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE-MISM 175
++ ++F +LG+G FGKV+ A+K LK++ + T VE +
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 176 AVHRN--LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 232
+ L + E L V + +NG G L + ++
Sbjct: 73 LAWEHPFLTHMF-CTFQTKENLFFVMEY-LNG---------GD----LMYHIQSCHKFDL 117
Query: 233 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 281
+R GL +LH I++RD+K NILLD++ + DFG+ K M
Sbjct: 118 SRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174
Query: 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
T GT +IAPE L K + D + +GV+L E++ GQ F D++ +
Sbjct: 175 --TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH----GQDEEEL 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TT 285
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 197 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322
R + +APE + + ++DV+ +GV+L E+ +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 31/108 (28%), Positives = 46/108 (42%), Gaps = 8/108 (7%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MIS 174
D LGRG FG+V + VAVK LKE T +E++ +I
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 175 MAVHRNLLRLRGFCMTPTERLLV-YPFMVNGSVASCLRERGQSQPPLN 221
+ H N++ L G C P L+V F G++++ LR + P
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER-TQGGELQF-QTEVEMIS 174
+V ++F +LG+G FGKV R G A+K L++E E+ TE ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 175 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 233
H L L+ + +RL V + NG G+ L + + ++
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEY-ANG---------GE----LFFHLSRERVFTEE 105
Query: 234 R----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTH 282
R L YLH +++RD+K N++LD++ + DFGL K + T
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 161
Query: 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
GT ++APE L D +G GV++ E++ G+ F D + +
Sbjct: 162 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY----NQDHERL 213
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 29/234 (12%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER-TQGGELQFQTEVE- 171
++ + F +LG+GG+GKV++ R G + A+K LK+ + + T+ E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 172 -MISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVR---K 226
++ H ++ L + +L L+ ++ G + L G
Sbjct: 73 NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT---ACFYLA 128
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTT 285
+I++ L +LH II+RD+K NI+L+ + + DFGL K + T
Sbjct: 129 EISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--TH 179
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
GTI ++APE L + D + G ++ +++TG F +
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT----GENRKKT 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 46/260 (17%), Positives = 93/260 (35%), Gaps = 68/260 (26%)
Query: 117 LQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT-EVEMIS 174
L+ ++ +S LG G FG V + + G A+K++ ++ +++ E++++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------- 226
+ H N+++L + T + P + + G + + V
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 227 ---------------------------------QIALGAARGLAYLHDHCDPKIIHRDVK 253
Q+ R + ++H I HRD+K
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIK 168
Query: 254 AANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV----RGTIGHIAPEYLSTGKS-SEK 307
N+L++ + + + DFG AK + + V R APE + +
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPS 222
Query: 308 TDVFGYGVMLLELITGQRAF 327
D++ G + ELI G+ F
Sbjct: 223 IDLWSIGCVFGELILGKPLF 242
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 23/206 (11%), Positives = 56/206 (27%), Gaps = 48/206 (23%)
Query: 130 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 184
G + ++ D +L VA+ + + ++ + +S + R+
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 185 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
T L+V + G L+E + P ++R A H
Sbjct: 97 LDVVHTRAGGLVV---AEWIRGGS---LQEVADTSPSPVGAIR--AMQSLAAAADAAHRA 148
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
+ + + + + + V+ +
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD- 178
Query: 303 KSSEKTDVFGYGVMLLELITGQRAFD 328
++ + D+ G G L L+ +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLP 203
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 2e-12
Identities = 32/223 (14%), Positives = 55/223 (24%), Gaps = 45/223 (20%)
Query: 107 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF 166
Q + T+ +G G FG+V++ D + VA+K + E
Sbjct: 6 SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 167 QTEVEMISMAV----------------HRNLLRLRGFCM----TPTERLLVYPFM--VNG 204
Q E I + + L P L + G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 205 SVASCLRERGQSQPPL-------------------NWSVRKQIALGAARGLAYLHDHCDP 245
S Q + + + K I LA
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 288
+ HRD+ N+LL + + K + ++
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQT---------EV 170
++ + + G +G V G ++G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 171 EMISMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSV 224
+++ H N+L LR E LV M +A + ++ + ++
Sbjct: 81 RLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQ---RIVISPQH 135
Query: 225 RK----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280
+ I GL LH+ ++HRD+ NILL + + + DF LA+ D
Sbjct: 136 IQYFMYHIL----LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT-AD 187
Query: 281 THVTTAVRGTIGHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+ T V + APE + ++ D++ G ++ E+ + F
Sbjct: 188 ANKTHYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 178
D++ LGRG + +V++ +T+ V VK LK + + + + E++ + ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGG 90
Query: 179 RNLLRLRGFCMTPTERLLVYPFM-VNGSVASCLRERGQSQPPLNWSVR---KQIALGAAR 234
N++ L P R F VN + ++ Q+ + +R +I +
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTD---FKQLYQTLTDYD--IRFYMYEIL----K 141
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGH 293
L Y H I+HRDVK N+++D E + + D+GLA+ + V +
Sbjct: 142 ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYF 196
Query: 294 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 327
PE L + D++ G ML +I + F
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 46/225 (20%), Positives = 84/225 (37%), Gaps = 39/225 (17%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM 83
Query: 188 CMTPTERLLVYPFMVNGSVAS--C---------LRE--RGQSQPPLNWSVRKQIALGAAR 234
+LL + F G L + + KQI+
Sbjct: 84 GANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 235 GLAYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLAKLMDYKDTHVTTAV- 287
GL Y+H C IIH D+K N+L++ + + D G A + D H T ++
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197
Query: 288 ----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
R +PE L D++ ++ ELITG F+
Sbjct: 198 TREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 170
+ N +G G G V VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 171 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 223
++ H+N++ L TP + L +V M + ++ ++ L+
Sbjct: 76 VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELM-DANLCQVIQM------ELDHE 127
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 182
Query: 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
T T + APE + E D++ G ++ E+I G F
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 51/230 (22%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 170
+ + +G G +G V G VA+K+L FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 171 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 223
++ H N++ L TP L LV PFM + +
Sbjct: 75 LLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMG-----LKFSEEK 127
Query: 224 VRK---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280
++ Q+ +GL Y+H ++HRD+K N+ ++E+ E + DFGLA+ D +
Sbjct: 128 IQYLVYQML----KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 281 TH--VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
T VT R APE LS ++ D++ G ++ E++TG+ F
Sbjct: 181 TGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 43/193 (22%), Positives = 66/193 (34%), Gaps = 31/193 (16%)
Query: 130 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEV-------EMISMAVHRNL 181
+G GGFG +Y A +K E + G L + + + I + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 182 LRLRGF-----CMTPTERLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGA 232
L G + Y FMV + + G S Q+ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----FKKSTVLQLGIRM 160
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--THVTTAVR 288
L Y+H++ +H D+KAAN+LL + V D+GL+ Y H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR--YCPNGNHKQYQEN 215
Query: 289 GTIGHI-APEYLS 300
GH E+ S
Sbjct: 216 PRKGHNGTIEFTS 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 38/161 (23%), Positives = 58/161 (36%), Gaps = 32/161 (19%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 186
+LG G GKV + A+K L++ + + EVE + +++R+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 78
Query: 187 FCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGAARGL 236
L+V + G L R Q + ++ R K I +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIG----EAI 130
Query: 237 AYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 274
YLH I HRDVK N+L + DFG AK
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 48/224 (21%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 170
+ N +G G G V VA+K+L FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 171 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 223
++ H+N++ L TP + L LV M + ++ ++ L+
Sbjct: 113 VLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELM-DANLCQVIQM------ELDHE 164
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 165 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 219
Query: 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
T T + APE + E D++ G ++ E++ + F
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 50/230 (21%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 170
+ + N + +G G +G V T G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 171 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 223
++ H N++ L TP L LV M + L + Q +
Sbjct: 80 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 224 VRK---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280
V+ QI RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ +
Sbjct: 134 VQFLIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 281 T--HVTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
T T R APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 187 TGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 35/212 (16%), Positives = 72/212 (33%), Gaps = 51/212 (24%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---------EV 170
D + R+++G G +G V + + +VA+K++ F+ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103
Query: 171 EMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSVR 225
+++ H +++++ + +V R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFR 148
Query: 226 KQIALGAA----------RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275
+ L G+ Y+H I+HRD+K AN L++++ V DFGLA+
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205
Query: 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 307
+DY + + + K
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 170
+ + +G G +G V G+ VA+K+L FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 171 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 223
++ H N++ L TP E L LV PFM + L + + + L
Sbjct: 76 RLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEK-LGED 128
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 282
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T
Sbjct: 129 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 283 -VTTAVRGTIGHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 327
VT R APE L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 186 VVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 59/236 (25%)
Query: 122 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 173
D+ + R ++G+G FG+V K VA+K ++ E Q E+ ++
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-----AEEIRIL 147
Query: 174 SMAVHR------NLLRL------RG-FCMTPTERLLVYPFMVNGSVASCLRE--RGQSQP 218
+ N++ + R CMT E L + L E +
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMT-FELL-----------SMNLYELIKKNKFQ 195
Query: 219 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLM 276
+ + ++ A + L LH + +IIH D+K NILL ++ + V DFG +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC-- 250
Query: 277 DYKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
Y+ V T + R APE + + D++ G +L EL+TG
Sbjct: 251 -YEHQRVYTYIQSRFYR------APEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 56/267 (20%), Positives = 103/267 (38%), Gaps = 64/267 (23%)
Query: 89 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GS 147
H A PE+ GQ F + ++N + +G G +G V
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQ--VFDV------GPRYTNLSYIGEGAYGMVCSAYDNLNKV 53
Query: 148 LVAVKRLKEERTQGGELQFQT---------EVEMISMAVHRNLLRLRGFCMTPTERL--- 195
VA+K++ F+ E++++ H N++ + +
Sbjct: 54 RVAIKKIS---------PFEHQTYCQRTLREIKILLRFRHENIIGIND-IIRAPTIEQMK 103
Query: 196 ---LVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCDPKIIH 249
+V M + L + ++Q N + QI RGL Y+H ++H
Sbjct: 104 DVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL----RGLKYIHS---ANVLH 151
Query: 250 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--------VTTAVRGTIGHIAPEY-LS 300
RD+K +N+LL+ + + DFGLA++ D H T R APE L+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR------APEIMLN 205
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAF 327
+ ++ D++ G +L E+++ + F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 41/182 (22%), Positives = 68/182 (37%), Gaps = 41/182 (22%)
Query: 130 LGRGGFGKVYKGRLTDGSLVAVKR---LKEERTQGGELQFQTEV-------EMISMAVHR 179
+G+GGFG +Y + V +K E + G L + + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 180 NLLRLRGFCM-----TPTERLLVYPFMVNGSVASCLRER-GQS-QPPLNWSVRK------ 226
L+ G + Y FM+ +R G Q + ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMI--------MDRFGSDLQKIYEANAKRFSRKTV 154
Query: 227 -QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--T 281
Q++L L Y+H+H +H D+KA+N+LL+ + V D+GLA Y
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY--RYCPEGV 209
Query: 282 HV 283
H
Sbjct: 210 HK 211
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 38/201 (18%), Positives = 66/201 (32%), Gaps = 45/201 (22%)
Query: 114 LRELQVATDNFSNR----NILGRGGFGKVYKGR---------LTDGSLVAVKRLKEERTQ 160
L V TD + + R G +Y+ ++K ++
Sbjct: 30 LPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL 89
Query: 161 GGELQF-QTEVEMISMAVHRNLLRLRGFCMTPT-----ERLLVYPFMVNGSVASCLRER- 213
E F Q + + + + L + PT Y F+V
Sbjct: 90 FNEQNFFQRAAKPLQVNKWKKLYSTPLLAI-PTCMGFGVHQDKYRFLV--------LPSL 140
Query: 214 GQS-QPPLNWSVRK--------QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 264
G+S Q L+ S + Q+A L +LH++ +H +V A NI +D E +
Sbjct: 141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQ 197
Query: 265 AVV--GDFGLAKLMDYKDTHV 283
+ V +G A Y +
Sbjct: 198 SQVTLAGYGFAFR--YCPSGK 216
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 47/236 (19%), Positives = 91/236 (38%), Gaps = 57/236 (24%)
Query: 122 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 173
+ + +R +++G+G FG+V K + VA+K +K + Q Q EV ++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLL 104
Query: 174 SM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQP 218
+ + ++ L+ C+ E L + L + R +
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLV-FEML-----------SYNLYDLLRNTNFR 152
Query: 219 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLM 276
++ ++ ++ A L +L + IIH D+K NILL + + DFG +
Sbjct: 153 GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC-- 209
Query: 277 DYKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+ + R +PE L D++ G +L+E+ TG+ F
Sbjct: 210 -QLGQRIYQYIQSRFYR------SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 19/104 (18%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTH--------VT 284
RGL Y+H ++HRD+K AN+ ++ E +GDFGLA++MD +H VT
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 285 TAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
R +P LS ++ D++ G + E++TG+ F
Sbjct: 188 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
R + LH +IHRD+K +N+L++ + V DFGLA+++D + + G
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-ESAADNSEPTGQQSG 178
Query: 294 I----------APEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+ APE L++ K S DV+ G +L EL + F
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 44/248 (17%), Positives = 77/248 (31%), Gaps = 71/248 (28%)
Query: 122 DNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEE---RTQGGELQFQTEVEM 172
D R LG G FGKV + S VA+K ++ R + E+ +
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINV 69
Query: 173 ISM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQ 217
+ + + + C+ E L E + +
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIA-FELL-----------GKNTFEFLKENNF 117
Query: 218 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---- 273
P + +A L +LH++ ++ H D+K NIL + + +
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174
Query: 274 -------KLMD-----YKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVM 316
++ D + H TT V R PE + ++ DV+ G +
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCI 228
Query: 317 LLELITGQ 324
L E G
Sbjct: 229 LFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 44/258 (17%), Positives = 80/258 (31%), Gaps = 87/258 (33%)
Query: 122 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 173
+N +G G FG+V + + + AVK ++ + E +++
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-----KIEADIL 85
Query: 174 SM-----AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQPP 219
+ N+++ G C+ E L L E +
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLI-FEPL-----------GPSLYEIITRNNYNG 133
Query: 220 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA------ 273
+ K + + L YL + H D+K NILLD+ +
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 274 -----------KLMD-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSE 306
KL+D +K + + + R APE +
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DV 238
Query: 307 KTDVFGYGVMLLELITGQ 324
+D++ +G +L EL TG
Sbjct: 239 SSDMWSFGCVLAELYTGS 256
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 46/254 (18%), Positives = 89/254 (35%), Gaps = 75/254 (29%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 170
DN+ ++++GRG +G VY + VA+K++ F+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREI 76
Query: 171 EMISMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSV 224
+++ ++RL + P + L +V L
Sbjct: 77 TILNRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEIA---------------DSDLKKLF 120
Query: 225 RKQIALGAA----------RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274
+ I L G ++H+ IIHRD+K AN LL+++ V DFGLA+
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 275 LMDYKDTHVTTAVRGTIGHI---------------------APEYLSTGKS-SEKTDVFG 312
++ + APE + ++ ++ D++
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 313 YGVMLLELITGQRA 326
G + EL+ ++
Sbjct: 238 TGCIFAELLNMLQS 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 49/254 (19%), Positives = 85/254 (33%), Gaps = 83/254 (32%)
Query: 122 DNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEE---RTQGGELQFQTEVEM 172
D S R + LG G FGKV + G VAVK +K ++E+++
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-----RSEIQV 64
Query: 173 ISM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQ 217
+ +++ + C+ E L + +
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIV-FELL-----------GLSTYDFIKENGF 112
Query: 218 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---- 273
P +++A + + +LH + K+ H D+K NIL + + +
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169
Query: 274 -------KLMD-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSEKTDV 310
K++D Y D H +T V R APE + S+ DV
Sbjct: 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYR------APEVILALGW------SQPCDV 217
Query: 311 FGYGVMLLELITGQ 324
+ G +L+E G
Sbjct: 218 WSIGCILIEYYLGF 231
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
+ + YLH ++HRD+K +NILL+ E V DFGL++ +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 294 I--------------------APEY-LSTGKSSEKTDVFGYGVMLLELITGQ 324
APE L + K ++ D++ G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 21/57 (36%), Positives = 24/57 (42%), Gaps = 13/57 (22%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP----PPLQPTPPGASSGNS 57
DLSNN L+G IP G F F P F NN P PL P + G +
Sbjct: 710 DLSNNNLSGPIPEMGQFETFPPAKFLNN---------PGLCGYPLPRCDPSNADGYA 757
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 37/184 (20%), Positives = 54/184 (29%), Gaps = 62/184 (33%)
Query: 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 255
+V+ + G + Q L K+I +GL YLH C +IIH D+K
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPE 176
Query: 256 NILL-------------------------------------------------DEEFEAV 266
NILL E+ +
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 267 VGDFGLAKLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 324
+ D G A + T T R + E L + D++ M EL TG
Sbjct: 237 IADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATGD 290
Query: 325 RAFD 328
F+
Sbjct: 291 YLFE 294
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 11/28 (39%), Positives = 17/28 (60%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANN 32
++S N L G+IP G+ F ++ANN
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANN 301
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 35/166 (21%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGF 187
+G G FG +++G L + VA+K E + Q + E + + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 188 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPL-NWSVRK-------QIALGAARGLAYL 239
+LV + G S L + RK A + +
Sbjct: 75 GQEGLHNVLVIDLL------------GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKD 280
H+ +++RD+K N L+ V DFG+ K Y+D
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FYRD 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 41/183 (22%), Positives = 61/183 (33%), Gaps = 36/183 (19%)
Query: 113 SLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE 171
S+ L V NF +G G FG++ G+ L VA+K E + Q E
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYR 56
Query: 172 MISMAVH-RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL-NWSVRK--- 226
+ ++ F +V + G S L + R
Sbjct: 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL------------GPSLEDLFDLCDRTFSL 104
Query: 227 ----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----DFGLAKLMD 277
IA+ + Y+H +I+RDVK N L+ DF LAK +
Sbjct: 105 KTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--E 159
Query: 278 YKD 280
Y D
Sbjct: 160 YID 162
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 42/167 (25%), Positives = 61/167 (36%), Gaps = 39/167 (23%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G G FG +Y G + G VA+K E + Q E + +++ + G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESK-----IYKMMQGGVGIP 68
Query: 189 MTPTERLLVYPFMVNGS----VASCLRERGQSQPPL-NWSVRK-------QIALGAARGL 236
+ G V L G S L N+ RK +A +
Sbjct: 69 T-------IRWCGAEGDYNVMVMELL---GPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 237 AYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 280
Y+H IHRDVK N L+ + + DFGLAK Y+D
Sbjct: 119 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRD 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 19/159 (11%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRGF 187
+G G FG++Y G + VA+K E + Q E ++ + + +R F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 188 CMTPTERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 246
+ +LV + G S+ + L+ +A + ++H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 247 IIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 282
+HRD+K N L+ + + DFGLAK Y+DT
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRDTS 160
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 447 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.84 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.49 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.22 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.2 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.06 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.5 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.86 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 95.81 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.48 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 95.35 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.72 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.47 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.06 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.52 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.01 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.14 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 89.14 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 87.8 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 83.88 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 82.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 81.12 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=431.28 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=211.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
+++++.++||+|+||+||+|.+. +++.||||+++..........|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566788999999999999863 467899999986655555678999999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 013238 196 LVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 263 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~ 263 (447)
+|||||++|+|.++|..... ....++|..+..|+.|||+||+|||++ +|+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999975431 123589999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHH
Q 013238 264 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 264 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 341 (447)
.+||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||... ...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--------~~~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQ 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--------CHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------CHH
Confidence 999999999986643322 22344569999999999999999999999999999999999 89999531 112
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
+.+....... ....+..++..+.++|.+||+.||.+||||.||++.|+.
T Consensus 255 ~~~~~i~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 255 DVVEMIRNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 2222221111 112233455678999999999999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=428.64 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=210.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|.+.+.||+|+||+||+|++. ++..||||+++... ......|.+|++++++++|||||+++|+|.+.+..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 356778899999999999999864 37789999997543 33456799999999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 195 LLVYPFMVNGSVASCLRERG---------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
++|||||++|+|.++|+..+ .....++|..++.|+.||++||+|||++ +|+||||||+||||++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997643 2234699999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHH
Q 013238 266 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 343 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 343 (447)
||+|||+++......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||... ...+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--------~~~~~ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--------SNNEV 239 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CHHHH
Confidence 999999998664433222 223458999999999999999999999999999999999 89999532 11222
Q ss_pred HHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 344 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 344 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
+........ ...+..++..+.++|.+||+.||.+|||+.+|++.|+.
T Consensus 240 ~~~i~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 240 IECITQGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 222222111 11223345678999999999999999999999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=428.38 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=204.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
++|.+.++||+|+||+||+|++. +++.||||+++.. .......|.+|++++++++|||||+++|+|.+.+..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46677789999999999999864 4788999999754 3344567999999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 013238 196 LVYPFMVNGSVASCLRERGQ-----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 264 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~ 264 (447)
+|||||++|+|.++++.... ...+++|..++.|+.||++||+|||++ +|+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999976532 224699999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHH
Q 013238 265 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 265 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 342 (447)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||... ...+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--------~~~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--------SNTE 268 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--------CHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC--------CHHH
Confidence 99999999987643332 23344569999999999999999999999999999999999 89999532 1112
Q ss_pred HHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 343 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.+.......+ ...+..++..+.++|.+||+.||.+||||.||++.|+.+
T Consensus 269 ~~~~i~~g~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 269 AIDCITQGRE----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHTCC----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCC----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 2222222111 112223456789999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=419.93 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=202.5
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
++..+++.+.++||+|+||+||+|++.+ .||||+++.... ......|.+|++++++++|||||+++|++.+ +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3445678888999999999999998753 599999975432 3334579999999999999999999998864 56899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
|||||++|+|.++|+.... ++++..+..|+.|||+||+|||++ +|+||||||+||||++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999976432 499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CceeeccccccCccccccccC---CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 277 DYKD-THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 277 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
.... ........||+.|||||++.+ ..++.++|||||||+||||+||+.||.... .. ..+........
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-----~~---~~~~~~~~~~~ 254 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-----NR---DQIIFMVGRGY 254 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CH---HHHHHHHHTTC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-----hH---HHHHHHHhcCC
Confidence 4322 223445679999999999864 468999999999999999999999995311 11 11111111110
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..+.+ ......++..+.+++.+||+.||.+||||.+|++.|+.
T Consensus 255 ----~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 255 ----ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp ----CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred ----CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 11223345678999999999999999999999998874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=422.34 Aligned_cols=324 Identities=94% Similarity=1.420 Sum_probs=274.6
Q ss_pred CCCCCCCcccccCCccccCHHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHH
Q 013238 95 DVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 174 (447)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~ 174 (447)
+.+.+..+....+..+.+++.++....++|+..+.||+|+||.||+|...+|+.||||++...........+.+|+++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~ 82 (326)
T 3uim_A 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 82 (326)
T ss_dssp ------------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGG
T ss_pred CCCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHH
Confidence 34556666777888899999999999999999999999999999999988899999999976654444446889999999
Q ss_pred hcCCCceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 013238 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 254 (447)
Q Consensus 175 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~ 254 (447)
.++||||+++++++......++||||+.+|+|.+++........++++..++.++.|++.||+|||+++.++|+||||||
T Consensus 83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 99999999999999999999999999999999999988766666799999999999999999999998777899999999
Q ss_pred CCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccC
Q 013238 255 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 334 (447)
Q Consensus 255 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~ 334 (447)
+|||++.++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||+......
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 99999999999999999998776555555566679999999999988899999999999999999999999998766666
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhhHHHHHhh
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEE 414 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 414 (447)
.......+|+...........+.+..............+.+++.+||+.||.+|||+.+|++.|++....+.|++|.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 322 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEE 322 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC------
T ss_pred ccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHH
Confidence 77788889998888888888888888888888999999999999999999999999999999999999999999999999
Q ss_pred hhhc
Q 013238 415 MFRQ 418 (447)
Q Consensus 415 ~~~~ 418 (447)
+.+|
T Consensus 323 ~~~q 326 (326)
T 3uim_A 323 MFRQ 326 (326)
T ss_dssp ----
T ss_pred hhcC
Confidence 8775
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=425.09 Aligned_cols=270 Identities=27% Similarity=0.396 Sum_probs=219.0
Q ss_pred cCHHHHHHHhhCCCCCCeeeecCCeEEEEEEECC------CcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CceeeE
Q 013238 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRL 184 (447)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l 184 (447)
+...++++..++|++.+.||+|+||+||+|.+.. ++.||||.++..........|.+|++++.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4456778888999999999999999999998642 368999999876655556679999999999976 899999
Q ss_pred eeeeecC-CcceEEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 013238 185 RGFCMTP-TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 251 (447)
Q Consensus 185 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~d 251 (447)
+|+|... +..++|||||++|+|.++|+.... ....+++..+..++.|||+||+|||++ +|+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999976432 134589999999999999999999999 999999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCccc
Q 013238 252 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 329 (447)
Q Consensus 252 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~ 329 (447)
|||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 3345568999999999999999999999999999999998 9999953
Q ss_pred ccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 330 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.. ....+... +... .....+..+...+.++|.+||+.||.+|||+.+|++.|+.+
T Consensus 291 ~~----~~~~~~~~----i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VK----IDEEFCRR----LKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CC----CSHHHHHH----HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----HHHHHHHH----HHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 21 11111111 1111 11112223446689999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=418.57 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=202.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|++++.||+|+||+||+|+.. +|+.||||++..... ......+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999976 689999999975533 2334578999999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
||++|+|.+++..... ..+++..++.|+.||+.||+|||++ +|+||||||+||||+++|.+||+|||+++.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999976432 2478999999999999999999999 9999999999999999999999999999865421
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||... ...+.+........ .
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~~-~----- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--------SMKNLVLKIISGSF-P----- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHTCC-C-----
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCCC-C-----
Confidence 12233456999999999999999999999999999999999999999532 12222222222111 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.........+.+++.+||+.||.+|||+.|+++
T Consensus 244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223456889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=411.58 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=205.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+.|+..+.||+|+||+||+|... +|+.||||++..... .....+.+|+++++.++|||||++++++.+.+..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888899999999999999986 699999999975433 2334678999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
|++|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+++.+....
T Consensus 153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999999753 389999999999999999999999 99999999999999999999999999998765332
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... . ..+......... .+.
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~---~~~~~~~i~~~~------~~~ 289 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----P---PLKAMKMIRDNL------PPR 289 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----C---HHHHHHHHHHSS------CCC
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----C---HHHHHHHHHcCC------CCC
Confidence 2334567999999999999999999999999999999999999999531 1 111111111110 000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..........+.+++.+||+.||.+|||+.|+++
T Consensus 290 --~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112233456889999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=405.84 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=207.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. .......+.+|+++++.++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 68999999997543 2233457899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|||++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998754 389999999999999999999999 999999999999999999999999999997754
Q ss_pred CCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.... ..+.........
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~------ 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKLE------ 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC------
Confidence 332 23445679999999999999999999999999999999999999995321 122222222211
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 395 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 395 (447)
..+ +......+.+++.+||+.||.+|||++|++
T Consensus 251 -~~~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 -YDF----PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCC----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCC----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 011 112234688999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-54 Score=407.78 Aligned_cols=250 Identities=22% Similarity=0.264 Sum_probs=202.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+.|+..++||+|+||+||+|++. +|+.||||+++.... ..+|+.+++.++|||||++++++.+.+..|+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777788999999999999976 689999999975432 24699999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeecCCccccCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 279 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 279 (447)
|++|+|.++++..+ ++++..++.++.||+.||+|||++ +|+||||||+||||+.+| ++||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999998754 399999999999999999999999 999999999999999987 6999999999876533
Q ss_pred CCc----eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 280 DTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 280 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.... ........... .....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~~---~~~~~- 276 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF----RGPLCLKIASE---PPPIR- 276 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC----CSCCHHHHHHS---CCGGG-
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHHHcC---CCCch-
Confidence 211 1233579999999999999999999999999999999999999996421 11112111110 00000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..+......+.+++.+||+.||.+|||+.|+++.|..
T Consensus 277 --------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 --------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp --------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1122234568899999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=402.19 Aligned_cols=245 Identities=25% Similarity=0.372 Sum_probs=195.1
Q ss_pred CCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec----CCcceEEE
Q 013238 125 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 198 (447)
Q Consensus 125 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 198 (447)
+..++||+|+||+||+|.+. ++..||||.+..... ......|.+|++++++++|||||++++++.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999976 588999999975432 3334568999999999999999999999865 24578999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECC-CCcEEEeecCCccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDE-EFEAVVGDFGLAKL 275 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~ 275 (447)
|||++|+|.+++.... ++++..++.++.||+.||+|||++ + |+||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999998653 489999999999999999999998 6 999999999999984 79999999999986
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||... ............... ..
T Consensus 182 ~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~-------~~~~~~~~~i~~~~~-~~ 249 (290)
T 3fpq_A 182 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGVK-PA 249 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTCC-CG
T ss_pred CCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC-------CcHHHHHHHHHcCCC-CC
Confidence 432 23345679999999999865 6999999999999999999999999531 111112122211111 00
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~--------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC--------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01 1112245889999999999999999999876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=406.95 Aligned_cols=268 Identities=22% Similarity=0.292 Sum_probs=200.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC----cceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 197 (447)
++|.+.+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|+|.+.+ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 3567778999999999999998 489999999965321 2223445666667889999999999998654 46899
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
||||++|+|.++|+.. +++|..+.+++.|++.||+|||+++ .++|+||||||+||||+.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999764 3899999999999999999999862 45899999999999999999999999999
Q ss_pred ccccCCCCCce---eeccccccCccccccccCC------CCCchhhhHHHHHHHHHHHhCCCCcccccccCC-------C
Q 013238 273 AKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------D 336 (447)
Q Consensus 273 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~-------~ 336 (447)
++......... .....||+.|||||++.+. .++.++|||||||+||||+||+.||........ .
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98765433221 2235699999999999764 367899999999999999999888753221110 0
Q ss_pred cccHHHHHHHHhhccccccccccccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
............. . ..++.+... ...+....+.++|.+||+.||.+||||.||++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~-~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 235 DPSVEEMRKVVCE-Q----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SCCHHHHHHHHTT-S----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhc-c----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111122111111 1 111211111 12356678999999999999999999999999998643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=412.50 Aligned_cols=249 Identities=21% Similarity=0.321 Sum_probs=206.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+.|+..+.||+|+||+||+|... +|+.||||++..... .....+.+|+++++.++|||||++++++.+.+..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56999999999999999999986 699999999975433 2334688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
|++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+++.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999754 289999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||... . ..+.+....... ...
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~---~~~~~~~i~~~~------~~~ 366 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----P---PLKAMKMIRDNL------PPR 366 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----C---HHHHHHHHHHSC------CCC
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----C---HHHHHHHHHcCC------CCC
Confidence 2 334567999999999999999999999999999999999999999531 1 111111111110 001
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+ .........+.+++.+||+.||.+|||+.|+++
T Consensus 367 ~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 111123456889999999999999999999886
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=391.75 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=190.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||+||+|... +|+.||||++..... ......+.+|+++++.++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999975 689999999975432 233456899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+ +|+|.+++...+ ++++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 789999987653 499999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
. ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||... ............. .
T Consensus 165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------~~~~~~~~i~~~~-~---- 229 (275)
T 3hyh_A 165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------SIPVLFKNISNGV-Y---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC-C----
T ss_pred C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCC-C----
Confidence 2 22344679999999999998876 57999999999999999999999531 1222222221111 0
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. .+......+.+++.+||+.||.+|||++|+++
T Consensus 230 --~----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 --T----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --C----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 11122356889999999999999999999886
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=397.70 Aligned_cols=243 Identities=25% Similarity=0.305 Sum_probs=193.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ......+.+|++++++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 478999999975432 2223367889999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
|||||++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998754 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||... ...+.........
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~----- 242 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--------DRKETMTMILKAK----- 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-----
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc--------CHHHHHHHHHcCC-----
Confidence 4322 2234467999999999999999999999999999999999999999532 1122222222111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
. ..+......+.+++.+||+.||.+|||+
T Consensus 243 --~----~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 --L----GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --C----CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 1112234568899999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=395.67 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=190.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC--------
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-------- 192 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 192 (447)
++|++.+.||+|+||+||+|+.. +|+.||||+++..........+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999976 689999999976555555567899999999999999999999987543
Q ss_pred ----cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 013238 193 ----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 268 (447)
Q Consensus 193 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 268 (447)
..|+|||||.+|+|.+++..... ....++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 25899999999999999986543 22356778899999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCc-----------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCc
Q 013238 269 DFGLAKLMDYKDTH-----------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 337 (447)
Q Consensus 269 Dfgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~ 337 (447)
|||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~------- 230 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ------- 230 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------
Confidence 99999876533221 1233469999999999999999999999999999999996 77421
Q ss_pred ccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 338 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
......+.... +... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~---------~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 MERVRTLTDVR---------NLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHHH---------TTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cHHHHHHHHHh---------cCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111111110 0000 0112233345678999999999999999999886
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=381.63 Aligned_cols=262 Identities=20% Similarity=0.299 Sum_probs=199.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec------CCc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 193 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 193 (447)
++|++.+.||+|+||+||+|... +|+.||||+++.... ......+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 699999999975432 2334568899999999999999999998764 356
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.|+|||||. |+|.+++...+ ++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 799999995 68999886543 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC---CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 274 KLMDYKD---THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 274 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
+.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||... ........+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-----~~~~~l~~I~~~~g 280 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-----NYVHQLQLIMMVLG 280 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-----SHHHHHHHHHHHHC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-----CHHHHHHHHHHhcC
Confidence 8664321 2233456799999999998875 5699999999999999999999999532 11111111111111
Q ss_pred ccccccc-----------ccc--ccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 EKKLEQL-----------VDS--DMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 ~~~~~~~-----------~d~--~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....... +.. ...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1000000 000 000000 0112356789999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=369.78 Aligned_cols=278 Identities=40% Similarity=0.665 Sum_probs=236.8
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
...+++|+..+.||+|+||.||+|...+++.||||++.... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 34567899999999999999999998889999999987543 23345788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|.+++.........+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999977655445699999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC-CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 278 YKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 278 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... .........|.........+.+.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS--SSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC--cHHHHHHHHHhhhccccccHHHh
Confidence 322 222233458999999999998899999999999999999999999996432 22334456666555556666777
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
+++.............+.+++.+||+.||.+|||+.++++.|+..
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 777777777888999999999999999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=376.34 Aligned_cols=196 Identities=23% Similarity=0.403 Sum_probs=168.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcc
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 194 (447)
..++|++.+.||+|+||+||+|+.+ +++.||||.+.... ....+.+|++++..+ +||||+++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999853 46789999986543 234678899999988 699999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeecCCc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 273 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~ 273 (447)
++|||||++|+|.+++. .+++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999984 288999999999999999999999 99999999999999876 79999999999
Q ss_pred cccCCCCC---------------------------ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCC
Q 013238 274 KLMDYKDT---------------------------HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQR 325 (447)
Q Consensus 274 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~ 325 (447)
+....... ......+||+.|+|||++.+. .++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 76532211 112334699999999999776 58999999999999999999999
Q ss_pred Ccc
Q 013238 326 AFD 328 (447)
Q Consensus 326 p~~ 328 (447)
||.
T Consensus 246 Pf~ 248 (361)
T 4f9c_A 246 PFY 248 (361)
T ss_dssp SSS
T ss_pred CCC
Confidence 994
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=388.49 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=206.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|++.+.||+|+||+||+|... +|+.||+|++.... ......+.+|+++|+.++|||||++++++.+....++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999986 69999999996543 2334568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC--CcEEEeecCCccccC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMD 277 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~ 277 (447)
||.+|+|.+++..... .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 235 ~~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999865332 489999999999999999999999 99999999999999854 899999999999765
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.........
T Consensus 309 ~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~~~~------ 372 (573)
T 3uto_A 309 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCD------ 372 (573)
T ss_dssp TT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTC------
T ss_pred CC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHhCC------
Confidence 33 33445579999999999999999999999999999999999999995321 111111211110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..............+.+++.+||+.||.+|||+.|+++
T Consensus 373 -~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 373 -WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111111123456789999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=387.59 Aligned_cols=250 Identities=27% Similarity=0.332 Sum_probs=198.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHH---HHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
-++|++.++||+|+||+||+|+.. +|+.||||++.+... ........+ ++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999976 699999999975432 112222333 35666778999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
|+|||||+||+|..+|...+ .+++..++.++.||+.||.|||++ +|+||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998754 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
...... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... .............
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~~-- 410 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTMA-- 410 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHCC--
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCCC--
Confidence 764332 334579999999999964 57999999999999999999999999642211 1111111111110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
...+......+.+++.+||+.||.+|++ +.|+++
T Consensus 411 ---------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0111223456889999999999999998 566554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=364.52 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=211.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC--------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
..++|++.+.||+|+||.||+|... ++..||||+++..........+.+|+++++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3467888999999999999999852 35679999998765555556789999999999 89999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 258 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nil 258 (447)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999987542 123589999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCC
Q 013238 259 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 336 (447)
Q Consensus 259 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~ 336 (447)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~----- 310 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 310 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----
Confidence 99999999999999986543322 12223346789999999999999999999999999999999 999995321
Q ss_pred cccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.......+. .. .....+..+...+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 311 ~~~~~~~~~---~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 311 VEELFKLLK---EG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GGGHHHHHH---TT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHh---cC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111111 11 11112223445689999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=356.58 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=208.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.++|++.+.||+|+||.||+|.+. .+..||||.++..........+.+|+++++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888899999999999999975 3456999999876555556679999999999999999999999999889999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999975432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 277 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 277 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
...... ......+|..|+|||++.+..++.++||||||+++|||++ |..||.... ..+........
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~~~~~--- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISSVEEG--- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTT---
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHcC---
Confidence 543222 2222346778999999998999999999999999999999 999995311 11111111111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
............+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 271 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 271 -------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111223346689999999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=347.82 Aligned_cols=250 Identities=19% Similarity=0.305 Sum_probs=205.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||+||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 468999999999999999999864 689999999975443 234568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999764 389999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~~------ 234 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTP------ 234 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSC------
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC------
Confidence 32 2334569999999999999999999999999999999999999995311 11111111111100
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...........+.+++.+||+.||.+|||+.++++
T Consensus 235 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 --ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01112233456889999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=341.55 Aligned_cols=283 Identities=39% Similarity=0.631 Sum_probs=228.5
Q ss_pred ccccCHHHHHHHhhCCCCC------CeeeecCCeEEEEEEECCCcEEEEEEecccc---ccchHHHHHHHHHHHHhcCCC
Q 013238 109 LKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVKRLKEER---TQGGELQFQTEVEMISMAVHR 179 (447)
Q Consensus 109 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ 179 (447)
...+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... .......+.+|+++++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4678999999999999887 8999999999999987 57899999986532 223345788999999999999
Q ss_pred ceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 013238 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259 (447)
Q Consensus 180 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill 259 (447)
||+++++++...+..+++|||+++++|.+++..... ..++++..++.++.|++.||+|||++ +++||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999875432 24589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcc
Q 013238 260 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338 (447)
Q Consensus 260 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 338 (447)
+.++.+||+|||++......... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ..
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~ 241 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE----PQ 241 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS----SS
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc----hH
Confidence 99999999999999865433222 2233468999999998865 588999999999999999999999964321 11
Q ss_pred cHHHHHHHHhh-ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 339 MLLDWVKGLLK-EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 339 ~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
....+...... ...+...++..+ ..........+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22222222221 122333333333 3345677888999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=356.02 Aligned_cols=265 Identities=27% Similarity=0.411 Sum_probs=203.0
Q ss_pred HHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 114 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
..++.+..++|++.+.||+|+||+||+|+. +|+.||||++..... ......+.+|++++++++||||+++++++....
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 334445567899999999999999999987 478899999975543 233456889999999999999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCcEEEeec
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999976431 12388999999999999999999999 8 999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+........
T Consensus 184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~~ 254 (309)
T 3p86_A 184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFK 254 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHHS
T ss_pred CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence 9997543221 22234568999999999999999999999999999999999999995321 11111111100
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.. ....+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 255 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 255 CK---------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp CC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 0111222345688999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=352.34 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=207.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|...+.||+|+||+||+|... +++.||+|.+... .......+.+|+++++.++||||+++++++.+....++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 457888899999999999999986 5899999998543 23345578999999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999987432 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCce-------------eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCC-cccHHHHHH
Q 013238 280 DTHV-------------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-DVMLLDWVK 345 (447)
Q Consensus 280 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~ 345 (447)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..|+......... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 11346899999999999999999999999999999999999998542211111 111111111
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
. .. +......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 242 ~-------------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 R-------------YC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp H-------------TC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-------------cC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 00 111224588999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=367.06 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=209.2
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.+..++|...+.||+|+||.||+|.+. +++.||||.++..........+.+|+++++.++||||+++++++......++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344568888999999999999999986 6899999999765443344468899999999999999999999999899999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999976532 389999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcee-eccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 277 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 277 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
........ ....++..|+|||++.+..++.++|||||||++|||+| |..||.... ..+.. ......
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~--------~~~~~-~~~~~~--- 331 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--------NQQTR-EFVEKG--- 331 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--------HHHHH-HHHHTT---
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHcC---
Confidence 32211111 11225678999999998899999999999999999998 999995311 11111 111111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.....+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 332 ------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 332 ------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11111222345688999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=361.97 Aligned_cols=258 Identities=29% Similarity=0.432 Sum_probs=199.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
..++|+..+.||+|+||.||+|... ++..||||.++..........+.+|++++++++||||+++++++......+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999865 467899999976555555567999999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||+++|+|.++++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999997643 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 276 MDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 276 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~~~~i~~~-- 266 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVDEG-- 266 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHHHHHHHTT--
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcC--
Confidence 64332221 112235678999999999999999999999999999998 999995311 11111111111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
............+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 267 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 --------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp --------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11111223346689999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=343.48 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=212.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..++|+..+.||+|+||.||+|...++..||+|++..... ....+.+|++++..++||||+++++++.+....++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 4567888999999999999999998888999999975432 24568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999976532 389999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||.... ............. .
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~---~-- 224 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQGHR---L-- 224 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTCC---C--
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHHHcCCC---C--
Confidence 4333334456778999999998889999999999999999999 999995321 1111111111110 0
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLA 404 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 404 (447)
..+......+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 225 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 -----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 01111235688999999999999999999999999986543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.40 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=209.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..++|+..+.||+|+||.||+|...+++.||+|++..... ....+.+|++++++++||||+++++++.+....++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3467888899999999999999998889999999976432 24568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999976432 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.........++..|+|||++.+..++.++||||||+++|+|++ |+.||.... ..+.........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~~~~~------- 224 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGF------- 224 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTC-------
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhcCc-------
Confidence 2222233446778999999999999999999999999999999 999995311 112222221110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
....+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 225 ---RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0111112245688999999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=372.76 Aligned_cols=270 Identities=27% Similarity=0.392 Sum_probs=218.8
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
+++..++|+..+.||+|+||.||+|.+.. +..||||.++.... ....+.+|++++++++||||++++++|......+
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 34456678888999999999999999874 88999999975432 3457899999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 293 lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccccee
Confidence 99999999999999986432 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.............++..|+|||++.+..++.++|||||||++|||+| |..||.... .......+.
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~~~~--------- 433 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE--------- 433 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHH---------
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH---------
Confidence 64333222233446788999999998899999999999999999999 999995321 111111111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhhHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQ 411 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~ 411 (447)
.......+..+...+.++|.+||+.||.+|||+.+|++.|+.........+..
T Consensus 434 ----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~~~~ 486 (495)
T 1opk_A 434 ----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486 (495)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSCHHHHH
T ss_pred ----cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccccchHH
Confidence 11111222334567899999999999999999999999999976655554433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=360.89 Aligned_cols=270 Identities=27% Similarity=0.400 Sum_probs=215.3
Q ss_pred cCHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeE
Q 013238 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRL 184 (447)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 184 (447)
+...++++..++|++.+.||+|+||.||+|.+. +++.||||+++..........+.+|++++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 456677788899999999999999999999742 46789999998665555556789999999999 78999999
Q ss_pred eeeeecCCc-ceEEEecccCCcchhhhhhcCCC-----------------------------------------------
Q 013238 185 RGFCMTPTE-RLLVYPFMVNGSVASCLRERGQS----------------------------------------------- 216 (447)
Q Consensus 185 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------- 216 (447)
++++...+. .++||||+.+|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999887654 89999999999999999765421
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 217 ---------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 217 ---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12288999999999999999999999 999999999999999999999999999986543322
Q ss_pred -ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 282 -HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 282 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.......||..|+|||++.+..++.++||||||+++|||+| |+.||.... ........ .....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~~~----~~~~~------- 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK----IDEEFCRR----LKEGT------- 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----CSHHHHHH----HHHTC-------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc----hhHHHHHH----HHcCC-------
Confidence 23334558889999999999999999999999999999998 999995321 11111111 11110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
....+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 314 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 314 --RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0111122335688999999999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.58 Aligned_cols=267 Identities=26% Similarity=0.426 Sum_probs=214.8
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeee
Q 013238 116 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 189 (447)
Q Consensus 116 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 189 (447)
.+.+..++|+..+.||+|+||.||+|... +++.||||.++..........+.+|+++++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34455788999999999999999999874 347899999986655555567899999999999999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQS--------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 249 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 249 (447)
.....++||||+++|+|.+++...... ..++++..++.++.||+.||.|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999874321 14689999999999999999999999 9999
Q ss_pred cCCCCCCEEECCCCcEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCc
Q 013238 250 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 327 (447)
Q Consensus 250 ~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~ 327 (447)
|||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999976543221 12233457889999999999999999999999999999999 99999
Q ss_pred ccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 328 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
.... ..+........ ... ..+......+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 278 ~~~~--------~~~~~~~~~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 278 YGMA--------HEEVIYYVRDG-NIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTSC--------HHHHHHHHHTT-CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCC--------hHHHHHHHhCC-CcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 5311 11122221111 110 1112234568999999999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=358.09 Aligned_cols=261 Identities=28% Similarity=0.395 Sum_probs=212.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC--------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
..++|.+.+.||+|+||+||+|... .+..||||+++..........+.+|+++++.+ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4568888999999999999999863 23579999998765555556789999999999 89999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 258 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nil 258 (447)
.+..++||||+.+|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999987542 123589999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCC
Q 013238 259 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 336 (447)
Q Consensus 259 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~ 336 (447)
++.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~------ 297 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------ 297 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------
Confidence 99999999999999986643322 22233457889999999999999999999999999999999 99999531
Q ss_pred cccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+......... ...........+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 298 --~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 298 --PVEELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp --CHHHHHHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHcCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112222221111 1111122345689999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=346.85 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=204.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.++|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357888999999999999999974 799999999975432 233456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999997654 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccCccccccccCCCCC-chhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. ......||+.|+|||++.+..+. .++|||||||++|||++|+.||.... .............
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~----- 231 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRGKY----- 231 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC-----
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-----
Confidence 32 23445699999999999888765 79999999999999999999996321 2222222221110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
..+......+.+++.+||+.||.+|||+.++++.
T Consensus 232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111234558899999999999999999998763
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=344.58 Aligned_cols=250 Identities=23% Similarity=0.288 Sum_probs=204.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|+..+.||+|+||+||+|... +|+.||+|+++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888999999999999999976 68999999997543 223345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997653 389999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 157 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~------ 221 (337)
T 1o6l_A 157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE------ 221 (337)
T ss_dssp CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC------
T ss_pred cC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC------
Confidence 22 222344569999999999999999999999999999999999999995311 111111211111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 397 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 397 (447)
.. .+......+.+++.+||+.||.+|| ++.++++.
T Consensus 222 -~~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 -IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CC----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 00 1112345688999999999999999 88888763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=352.55 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=199.7
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc--hHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcce
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 195 (447)
..++|+..++||+|+||+||+|+.. +++.||+|++++..... ....+..|..++.++ +||||+++++++.+....+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467899999999999999999986 58899999997653222 223477888888776 8999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999997653 389999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.+.........
T Consensus 203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 3222 2234456799999999999999999999999999999999999999964322111111111111111111110
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
..+......+.+++.+||+.||.+||++
T Consensus 280 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 --------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1112234568899999999999999996
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=346.38 Aligned_cols=257 Identities=21% Similarity=0.355 Sum_probs=206.9
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+..++|+..+.||+|+||.||++...++..||||++..... ....+.+|++++..++|+||+++++++.+....++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34568888999999999999999998888999999976432 2456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+++|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999976432 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
..........+|+.|+|||++.+..++.++||||||+++|||+| |+.||.... ..+........
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~~~------- 237 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQG------- 237 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTT-------
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHHhcc-------
Confidence 22222223346788999999998899999999999999999998 999995311 11111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.....+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 238 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 238 ---LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00111112235688999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=359.01 Aligned_cols=260 Identities=27% Similarity=0.376 Sum_probs=209.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|+..+.||+|+||+||+|.+. +++.||||+++..........+.+|+.+++.++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999853 46789999997655555566788999999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEe
Q 013238 195 LLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVG 268 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 268 (447)
++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999999875422 23589999999999999999999999 999999999999999555 59999
Q ss_pred ecCCccccCCC-CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHH
Q 013238 269 DFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 269 Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
|||+++..... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH
Confidence 99999754221 1122233457899999999999999999999999999999998 999995311 1111111
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..... ...........+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 299 i~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 299 VTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 1111222345688999999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=369.59 Aligned_cols=261 Identities=23% Similarity=0.398 Sum_probs=211.8
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 116 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 116 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
++++..++|...+.||+|+||.||+|.+.++..||||+++... .....+.+|+++++.++||||+++++++. ....+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 3455677889999999999999999999888899999997643 23557999999999999999999999986 56789
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 259 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 99999999999999975422 1378899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.............++..|+|||++....++.++|||||||++|||+| |+.||... ...+.........
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i~~~~--- 402 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------SNPEVIRALERGY--- 402 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHHHHHTC---
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCC---
Confidence 54322111222346788999999998999999999999999999999 99999531 1112222211111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
....+..++..+.++|.+||+.||.+|||+.+|++.|+...
T Consensus 403 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 403 -------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11112234567899999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=345.40 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=197.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
+..++|++.+.||+|+||.||+|.+.. +..||+|.+...........+.+|+.+++.++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345688889999999999999998753 45799999876554455567899999999999999999999974 5678
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 99999999999999997653 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
..............+++.|+|||++.+..++.++||||||+++|||++ |..||.... .......+ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-----~~~~~~~i---~~~~~- 235 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRI---ENGER- 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHH---HTTCC-
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-----HHHHHHHH---HcCCC-
Confidence 765433323333446788999999998999999999999999999997 999996321 11111111 11110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111223345688999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=340.25 Aligned_cols=273 Identities=19% Similarity=0.218 Sum_probs=215.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC--cceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 197 (447)
.++|.+.++||+|+||+||+|... +++.||||++...........+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357888999999999999999986 489999999986555555567889999999999999999999988655 67999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEEEeecCCc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 273 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 273 (447)
|||+++++|.+++...... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999865332 2389999999999999999999999 99999999999999 88888999999999
Q ss_pred cccCCCCCceeeccccccCcccccccc--------CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLS--------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
+....... .....||..|+|||++. +..++.++|||||||++|||++|+.||...... ......+.
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~ 237 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMY 237 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG----GGCHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc----chhHHHHH
Confidence 87643322 23346899999999886 577899999999999999999999999642211 11122222
Q ss_pred HHhhccc---ccccc-----------ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 346 GLLKEKK---LEQLV-----------DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 346 ~~~~~~~---~~~~~-----------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
....... ...+. +-.............+.+++.+||+.||.+|||++|+++...+..-
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 2222111 11000 0011123456777889999999999999999999999998876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=343.43 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=205.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.++..++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467889999999999999999975 688999999864332 22345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++++|.+++.... ++++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997654 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ............. ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~-~~~- 232 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQDSV-PNV- 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHSSCC-CCH-
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhccC-CCc-
Confidence 433333444568999999999999999999999999999999999999995321 1111111111100 000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCC
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEGDGL 403 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~ 403 (447)
.. ......+..+.+++.+||+.||.+|| +++++.+.|+...-
T Consensus 233 ~~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 TT----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HH----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ch----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00 01112345688999999999999998 99999999987544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.53 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=212.1
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
+..++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+++++.++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 34678888999999999999999862 357899999976555555567899999999999999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQS--------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 252 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dl 252 (447)
..++||||+.+|+|.+++...... ...+++..++.++.||+.||+|||++ +++||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 999999999999999999875431 23488999999999999999999999 9999999
Q ss_pred CCCCEEECCCCcEEEeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccc
Q 013238 253 KAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 330 (447)
Q Consensus 253 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~ 330 (447)
||+||+++.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998664333221 223346788999999999899999999999999999999 99999532
Q ss_pred cccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 331 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
. .......+.. . ............+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 257 ~-----~~~~~~~~~~----~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 257 P-----PERLFNLLKT----G---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp C-----GGGHHHHHHT----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----HHHHHHHhhc----C---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 1111111111 1 11111223346689999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=349.43 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=201.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999976 68999999997554444445688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999996543 389999999999999999999999 99999999999999999999999999998654222
Q ss_pred C-ceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 281 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 281 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .......+.. .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~----~-------- 224 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKE----K-------- 224 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT---TSHHHHHHHT----T--------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhc----c--------
Confidence 1 22234568999999999987775 7789999999999999999999964211 1111111111 0
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.............+.+++.+||+.||.+|||+.|+++.
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 -KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00001112234567899999999999999999998763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=338.66 Aligned_cols=273 Identities=22% Similarity=0.297 Sum_probs=215.9
Q ss_pred cccCHHHHHHHhhC----------CCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCC
Q 013238 110 KRFSLRELQVATDN----------FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 178 (447)
Q Consensus 110 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h 178 (447)
..++..++..+++. |...+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 35677777766654 556678999999999999987 69999999996543 2334568899999999999
Q ss_pred CceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 013238 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 258 (447)
Q Consensus 179 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nil 258 (447)
|||+++++++......++||||+++++|.+++... .+++..+..++.|++.||.|||++ +++||||||+|||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999998643 389999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcc
Q 013238 259 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 338 (447)
Q Consensus 259 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 338 (447)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------- 245 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------- 245 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------
Confidence 99999999999999987643322 2234569999999999999999999999999999999999999995311
Q ss_pred cHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCchhhH
Q 013238 339 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGDGLAERWE 408 (447)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~~ 408 (447)
............ .+.. .........+.+++.+||+.||.+|||+.++++ .+.+....++..
T Consensus 246 -~~~~~~~~~~~~------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~ 308 (321)
T 2c30_A 246 -PVQAMKRLRDSP------PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLV 308 (321)
T ss_dssp -HHHHHHHHHHSS------CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGGGGH
T ss_pred -HHHHHHHHhcCC------CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcccch
Confidence 111111111111 0000 111223456889999999999999999999998 455555555443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=350.27 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=200.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCc----EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.++|+..+.||+|+||+||+|.+. +++ +||+|.+...........+.+|++++++++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 457888899999999999999865 344 46888886655455566799999999999999999999999875 478
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++++|+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999987543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 276 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 276 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
....... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||.... .......+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~-------- 233 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE-------- 233 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHH--------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC-----HHHHHHHHH--------
Confidence 6543322 2223346889999999999999999999999999999999 999996321 111111111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
..............+.+++.+||+.||.+|||+.++++.|+...
T Consensus 234 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 234 -----KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111122233456889999999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=339.12 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=199.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHh--cCCCceeeEeeeeecC----Ccc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP----TER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~ 194 (447)
.++|+..+.||+|+||+||+|+. +++.||||++.... ...+..|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 56899999999999999999998 58999999986432 3345566666665 7999999999987543 457
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCEEECCCCcEE
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--------DHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 8999999999999999543 3899999999999999999999 77 999999999999999999999
Q ss_pred EeecCCccccCCCCCce---eeccccccCccccccccCC------CCCchhhhHHHHHHHHHHHhC----------CCCc
Q 013238 267 VGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITG----------QRAF 327 (447)
Q Consensus 267 l~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltg----------~~p~ 327 (447)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997654433322 2233689999999999876 445799999999999999999 7777
Q ss_pred ccccccCCCcccHHHHHHHHhhccccccccccccC-CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 328 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME-GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..... .................. +... ..........+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 234 ~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVP---NDPSFEDMRKVVCVDQQR-----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSC---SSCCHHHHHHHHTTSCCC-----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCC---CCcchhhhhHHHhccCCC-----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43211 111111111111111110 1111 012335677899999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=346.77 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=212.5
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEE------CCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
++..++|+..+.||+|+||.||+|.+ .+++.||||.+...........+.+|++++.++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34457888999999999999999985 246789999998665444556789999999999 89999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQS--------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~N 256 (447)
.+..++||||+++|+|.+++...... ..++++..++.++.|++.||+|||++ +++||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 99999999999999999999875421 22589999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccC
Q 013238 257 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 334 (447)
Q Consensus 257 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~ 334 (447)
|+++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--- 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--- 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc---
Confidence 99999999999999999876543332 2233447789999999999999999999999999999999 999995321
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
........+.. . ............+.+++.+||+.||.+|||+.++++.|++
T Consensus 253 -~~~~~~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 253 -VDSKFYKMIKE----G---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp -SSHHHHHHHHH----T---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -chhHHHHHhcc----C---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11111111111 0 0111112234568999999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=352.90 Aligned_cols=267 Identities=24% Similarity=0.367 Sum_probs=210.4
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEE------CCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 189 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 189 (447)
+++..++|+..+.||+|+||.||+|.. .++..||||.+...........+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445667899999999999999999986 235689999997654444456789999999999 8999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQS-------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 250 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~ 250 (447)
..+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999765321 12479999999999999999999999 99999
Q ss_pred CCCCCCEEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcc
Q 013238 251 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 328 (447)
Q Consensus 251 dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~ 328 (447)
||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999866433322 2333457889999999999999999999999999999998 999995
Q ss_pred cccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 329 LARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
... ........+. .. .....+......+.+++.+||+.||.+|||+.++++.|+....
T Consensus 277 ~~~----~~~~~~~~~~----~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 277 GIP----VDANFYKLIQ----NG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp TCC----CSHHHHHHHH----TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCC----cHHHHHHHHh----cC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 321 1111111111 11 1111122234668999999999999999999999999987533
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=346.10 Aligned_cols=270 Identities=26% Similarity=0.314 Sum_probs=205.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc----ce
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----RL 195 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~ 195 (447)
..++|+..+.||+|+||+||+|+.. ++.||||++.... ........|+.++..++||||+++++++..... .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3467888999999999999999886 7899999996542 223356678888999999999999999987543 59
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCceecCCCCCCEEECCCCcEEEe
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-------DPKIIHRDVKAANILLDEEFEAVVG 268 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------~~~ivH~dlk~~Nill~~~~~~kl~ 268 (447)
+||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999999764 2899999999999999999999862 3379999999999999999999999
Q ss_pred ecCCccccCCCCCc-eeeccccccCccccccccCC-----CCCchhhhHHHHHHHHHHHhCCCCcccccccCCC------
Q 013238 269 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDD------ 336 (447)
Q Consensus 269 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~------ 336 (447)
|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999866533222 22335689999999999763 4567889999999999999999999643211100
Q ss_pred --cccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 337 --DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 337 --~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
......+........ ....+.... ........+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKK-KRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSC-CCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhccc-CCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111111111111 010000000 1224566799999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=345.39 Aligned_cols=263 Identities=28% Similarity=0.403 Sum_probs=215.7
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
++..++|+..+.||+|+||.||+|... ++..||+|.+.... .....+.+|+++++.++||||+++++++.+....++
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 345678888999999999999999987 48899999997543 234578899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+.+++|.+++..... ..+++..++.++.+++.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999976433 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
............++..|+|||++.+..++.++||||||+++|+|++ |..||.... .......+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-----~~~~~~~~~~--------- 227 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK--------- 227 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHHT---------
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhc---------
Confidence 6544444444557889999999999999999999999999999999 999995321 1111111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCch
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 405 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 405 (447)
.............+.+++.+||+.||.+|||+.++++.|+....+.
T Consensus 228 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 228 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111122233466899999999999999999999999998754433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=364.26 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=206.2
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
+++..++|+..+.||+|+||.||+|.+.++..||||+++.... ....+.+|++++++++||||+++++++.+ ...++
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 3455678888999999999999999998888899999976432 34578999999999999999999999876 67899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 256 v~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 9999999999999975322 2389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
............++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+........
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i~~~----- 397 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQVERG----- 397 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHTT-----
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcC-----
Confidence 4333222333446789999999999999999999999999999999 99999531 111222221111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
.....+..+...+.++|.+||+.||.+|||+.+|++.|+...
T Consensus 398 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 398 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111122234567899999999999999999999999999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=360.75 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=205.6
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC-cceEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLV 197 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv 197 (447)
+..++|+..+.||+|+||.||+|.+. |+.||||+++... ....+.+|++++++++||||+++++++.... ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 34567888899999999999999986 7899999997643 3457899999999999999999999987765 68999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999987543 2378999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... ....++..|+|||++.+..++.++||||||+++|||+| |+.||.... ...... .....
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-----~~~~~~---~i~~~------ 402 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVP---RVEKG------ 402 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-----TTTHHH---HHHTT------
T ss_pred ccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHH---HHHcC------
Confidence 221 12247889999999999999999999999999999998 999996321 111111 11111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.....+..+...+.++|.+||+.||.+|||+.++++.|+.+
T Consensus 403 ----~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 403 ----YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11122233456789999999999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=352.54 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=208.1
Q ss_pred HHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeec
Q 013238 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 190 (447)
Q Consensus 114 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 190 (447)
+.++....++|+..+.||+|+||+||+|+.. +++.||+|++..... ......+.+|.+++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556789999999999999999999986 588999999965321 1122347789999999999999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
....++||||+++|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999754 289999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCC----CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
|+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSK 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHH
Confidence 999876544333344567999999999997665 7899999999999999999999995321 1122222
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 397 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 397 (447)
........... ........+.+++.+||+.+|.+ ||++.|+++.
T Consensus 285 i~~~~~~~~~p-------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 285 IMNHKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHTHHHHCCCC-------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHhccccccCC-------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 22111000000 00112355888999999999988 9999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=345.35 Aligned_cols=252 Identities=22% Similarity=0.331 Sum_probs=200.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------ 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 193 (447)
.++|+..+.||+|+||.||+|+.. +|+.||||++...........+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357888999999999999999987 7899999999765555556679999999999999999999998865432
Q ss_pred ---------------------------------------------------ceEEEecccCCcchhhhhhcCCCCCCCCH
Q 013238 194 ---------------------------------------------------RLLVYPFMVNGSVASCLRERGQSQPPLNW 222 (447)
Q Consensus 194 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 222 (447)
.++||||+++|+|.+++..... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 6899999999999999987543 234677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC-----------ceeecccccc
Q 013238 223 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-----------HVTTAVRGTI 291 (447)
Q Consensus 223 ~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~gt~ 291 (447)
..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999987654321 1123346899
Q ss_pred CccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHH
Q 013238 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE 371 (447)
Q Consensus 292 ~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 371 (447)
.|+|||++.+..++.++||||||+++|||++|..|+... ......... . ...........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~~-~---------~~~~~~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVRN-L---------KFPLLFTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHHT-T---------CCCHHHHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhhc-c---------CCCcccccCCh
Confidence 999999999999999999999999999999998776321 011111100 0 00111233445
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 372 QLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 372 ~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.+.+++.+||+.||.+|||+.++++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 6789999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=339.74 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=200.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||+||+|...+|+.||+|++...... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4678889999999999999999988999999999754332 234568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+. |+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 997 48888776543 2489999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc-
Q 013238 280 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV- 357 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 357 (447)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .. .....+.............
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~-~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT----DD-DQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----TT-THHHHHHHHHCCCCTTTSGG
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC----hH-HHHHHHHHHHCCCChHHhhh
Confidence 22 2333458999999999876 568999999999999999999999996321 11 1222222211111100000
Q ss_pred --------ccc---cCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 --------DSD---MEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 --------d~~---~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+.. ..... .......+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 00000 1112356889999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=346.21 Aligned_cols=251 Identities=28% Similarity=0.372 Sum_probs=199.1
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 194 (447)
+..++|+..+.||+|+||+||+|+.. +|+.||||+++... .......+.+|.+++..+ +||||+++++++.+....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34568999999999999999999976 58999999997542 222344677899999887 699999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999997753 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~--- 240 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE--- 240 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC---
Confidence 54322 223344569999999999998899999999999999999999999995321 112222222111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM------SEVVR 396 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 396 (447)
. ..+......+.+++.+||+.||.+||++ .++++
T Consensus 241 ------~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ------V--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------C--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------C--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 1111234568899999999999999998 66655
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=335.58 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=194.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|+..+.||+|+||.||+|.+. ++.||||++...... .....+.+|+++++.++||||+++++++......++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888899999999999999985 789999998754322 2235688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--------CCcEEEee
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--------EFEAVVGD 269 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~D 269 (447)
|||+++++|.+++... .+++..++.++.|++.||+|||++...+++||||||+|||++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998542 4899999999999999999999992112999999999999986 77899999
Q ss_pred cCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 270 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 270 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
||++....... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ..........
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--------GLAVAYGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHT
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHhhhc
Confidence 99998654322 223458999999999999999999999999999999999999995311 1111111111
Q ss_pred ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
. .............+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 229 ~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 N---------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp S---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C---------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1 111112223345689999999999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=349.32 Aligned_cols=256 Identities=23% Similarity=0.298 Sum_probs=204.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.++|++.+.||+|+||+||+|... +|+.||||++..... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467899999999999999999876 689999999864321 113457899999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEeecCC
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGL 272 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl 272 (447)
+||||+++|+|.+.+.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988866543344589999999999999999999999 9999999999999987655 99999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ............
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGKY 249 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCCC
Confidence 98765332 22334569999999999999999999999999999999999999995311 111111111100
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. .... ........+.+++.+||+.||.+|||+.++++
T Consensus 250 -~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 -K--MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -C--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -C--CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000 00112456889999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.37 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=199.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 197 (447)
++|+..+.||+|+||.||+|+.. +++.||+|++...... .....+.+|..++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888899999999999999986 5889999999765322 2334578899999887 899999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|..++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999997653 389999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||................+.........
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 222 223445799999999999999999999999999999999999999964221111111111111111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
..+......+.+++.+||+.||.+||++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1112234568899999999999999996
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=344.68 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=204.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-----hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|++.+.||+|+||.||+|... +|+.||+|.+....... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467889999999999999999986 58999999997643321 245788999999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeec
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 270 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df 270 (447)
++||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999996532 489999999999999999999999 999999999999998877 7999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+........
T Consensus 164 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITAV 233 (361)
T ss_dssp SSCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred CCceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence 999876432 22334569999999999999999999999999999999999999995311 11111111111
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. .............+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY-------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC-------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC-------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0000001122356889999999999999999999886
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=340.84 Aligned_cols=258 Identities=27% Similarity=0.438 Sum_probs=208.7
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
+++..++|+..+.||+|+||.||+|...++..||||.+..... ....+.+|+++++.++||||+++++++. .+..++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3445678889999999999999999998888999999975432 3457889999999999999999999876 456899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 9999999999999975321 1389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
............++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.........
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~~---- 227 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERGY---- 227 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTC----
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHhccc----
Confidence 5433323333446788999999988889999999999999999999 999995311 111222211110
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
...........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 228 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 228 ------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 011112234568999999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=339.64 Aligned_cols=266 Identities=25% Similarity=0.408 Sum_probs=203.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEE-----CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--C
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--T 192 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 192 (447)
..++|++.+.||+|+||+||+|++ .+++.||||++.... ......+.+|+++++.++||||+++++++... .
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 346788899999999999999984 258899999997543 33345788999999999999999999998653 5
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 68999999999999999976532 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC--ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccc------cCC-CcccHHHH
Q 013238 273 AKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL------AND-DDVMLLDW 343 (447)
Q Consensus 273 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~------~~~-~~~~~~~~ 343 (447)
+........ .......++..|+|||++.+..++.++||||||+++|||+||..|+..... ... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987643322 122233467789999999999999999999999999999999999854211 000 00001111
Q ss_pred HHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 344 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 344 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
+..... .......+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 241 ~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 LIELLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHh---------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111 1111122233456799999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=338.40 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=195.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-------------------------chHHHHHHHHHHHH
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------------------------GGELQFQTEVEMIS 174 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~ 174 (447)
.++|+..+.||+|+||.||+|... +++.||||++...... .....+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357888999999999999999975 5889999999654311 11235889999999
Q ss_pred hcCCCceeeEeeeeec--CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 013238 175 MAVHRNLLRLRGFCMT--PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 252 (447)
Q Consensus 175 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dl 252 (447)
.++||||+++++++.+ ....++||||+++++|.+++.. .++++..++.++.|++.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 4578999999999999887643 2489999999999999999999999 9999999
Q ss_pred CCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCC---CCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 253 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 253 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987653322 233456999999999997765 37889999999999999999999953
Q ss_pred ccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 330 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. ...+....... ... . .........+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~--------~~~~~~~~~~~-~~~----~----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER--------IMCLHSKIKSQ-ALE----F----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS--------HHHHHHHHHHC-CCC----C----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc--------HHHHHHHHhcc-cCC----C----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 11111111111 100 0 001122356889999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=335.60 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=209.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..++|+..+.||+|+||.||+|...+++.||+|.+..... ....+.+|+++++.++||||+++++++.+.+..+++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3467888899999999999999998888999999976433 23578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++..... .+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999976532 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||.... .............
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~~~~------ 223 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFR------ 223 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC------
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhcCCc------
Confidence 2112223346788999999998899999999999999999999 899995311 1122222211110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 224 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 ----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011112245688999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.50 Aligned_cols=254 Identities=31% Similarity=0.539 Sum_probs=201.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchH------HHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGE------LQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
.++|+..+.||+|+||+||+|.+. +++.||||++......... ..+.+|+++++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888899999999999999985 6899999998654332211 56889999999999999999999986544
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCc-----EE
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFE-----AV 266 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~dlk~~Nill~~~~~-----~k 266 (447)
++||||+++|+|.+++.... .++++..++.++.|++.||+|||++ + ++||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999998886543 3489999999999999999999999 8 999999999999988876 99
Q ss_pred EeecCCccccCCCCCceeeccccccCcccccccc--CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 267 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 267 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
|+|||+++.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.... .......
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~ 239 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS------YGKIKFI 239 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC------CCHHHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc------ccHHHHH
Confidence 999999974332 234456899999999984 4567899999999999999999999996321 1111111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...... .............+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 NMIREE---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHhcc---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111 111112223346689999999999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=336.79 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=204.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
..++|...+.||+|+||.||+|.+.+ +..||+|.+...........+.+|+++++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45688889999999999999998643 346999999876555556678999999999999999999999764 4578
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||+.+++|.+++..... .+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999976532 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.............++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.. ...
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-----~~~~~~~~~~---~~~-- 232 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-----NKDVIGVLEK---GDR-- 232 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----GGGHHHHHHH---TCC--
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-----hHHHHHHHhc---CCC--
Confidence 65433333334457889999999998999999999999999999998 999995311 1111111111 100
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 233 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 --------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 011112345688999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=350.26 Aligned_cols=265 Identities=25% Similarity=0.386 Sum_probs=211.7
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECC-C-----cEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTD-G-----SLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 189 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 189 (447)
+++..++|...+.||+|+||.||+|.... + ..||+|.+...........+.+|+++++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44556789999999999999999998752 2 479999997665555556789999999999 8999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQ----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill 259 (447)
..+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999876421 123589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCc
Q 013238 260 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDD 337 (447)
Q Consensus 260 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~ 337 (447)
+.++.+||+|||++......... ......+|..|+|||++.+..++.++||||||+++|||+| |..||.... ..
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~~ 273 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL----VN 273 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----SS
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc----hh
Confidence 99999999999999865433222 2233446789999999999999999999999999999998 999995321 11
Q ss_pred ccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 338 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
......+.. . .....+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 274 ~~~~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 274 SKFYKLVKD----G---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHH----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhc----C---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111111111 1 00111112245688999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=341.80 Aligned_cols=251 Identities=19% Similarity=0.243 Sum_probs=204.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 357888999999999999999976 58899999986432 234468899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CCcEEEeecCCccccC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 277 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~ 277 (447)
|+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++....
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999996543 2489999999999999999999999 9999999999999987 7899999999998764
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..............
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~---- 221 (321)
T 1tki_A 156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYT---- 221 (321)
T ss_dssp TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC----
T ss_pred CC--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcCCCC----
Confidence 33 23344568999999999998889999999999999999999999995311 11122222111100
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............+.+++.+||+.||.+|||+.|+++
T Consensus 222 ---~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 ---FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000122456889999999999999999999988
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=344.68 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=210.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC--------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 189 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 189 (447)
+..++|+..+.||+|+||.||+|... ++..||||++...........+.+|+++++.+ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34678999999999999999999863 46789999998665555556788999999999 8999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 257 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Ni 257 (447)
..+..++||||+.+|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 999999999999999999999865421 23489999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCC
Q 013238 258 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 335 (447)
Q Consensus 258 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~ 335 (447)
|++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---- 264 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 264 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----
Confidence 9999999999999999876543221 1223346788999999988889999999999999999999 999995311
Q ss_pred CcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 336 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..+.......... ..........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 265 ----~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 ----VEELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ----HHHHHHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCC----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1112111111110 111122345688999999999999999999999999974
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=345.61 Aligned_cols=267 Identities=25% Similarity=0.369 Sum_probs=207.3
Q ss_pred CCCCCeeeecCCeEEEEEEEC-----CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceE
Q 013238 124 FSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 196 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 196 (447)
|+..+.||+|+||+||++.+. +++.||||++...........+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998653 57899999998765555566789999999999999999999999874 56789
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+++|+|.+++.... +++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999997643 89999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 277 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 277 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF---LELIGIAQGQMTVLRLT 261 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHHCSCCHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---hhhhcccccchhHHHHH
Confidence 543322 1223457888999999999899999999999999999999999996421100 00000000000000111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
+.+...............+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11222222222333456799999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=335.99 Aligned_cols=266 Identities=24% Similarity=0.360 Sum_probs=190.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||.||+|... +|+.||+|.++..........+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999875 5899999999765544445578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 200 FMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|+. |+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 699998876432 223589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc---c
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---L 353 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 353 (447)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+........ .
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-----DEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCChhHh
Confidence 3222 22334589999999999764 68999999999999999999999995321 1111111111111000 0
Q ss_pred ccc-----cccccC---CC---------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQL-----VDSDME---GN---------YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~-----~d~~~~---~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+ ...... .. ........+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 000000 00 00112356889999999999999999998875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=344.95 Aligned_cols=271 Identities=25% Similarity=0.391 Sum_probs=216.2
Q ss_pred cCHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEe
Q 013238 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 185 (447)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 185 (447)
+...++++..++|+..+.||+|+||.||+|... +++.||||.+...........+.+|+++++.++|+||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455667789999999999999999999764 36789999997655544556788999999999999999999
Q ss_pred eeeecCCcceEEEecccCCcchhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 013238 186 GFCMTPTERLLVYPFMVNGSVASCLRERG------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259 (447)
Q Consensus 186 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill 259 (447)
+++.+.+..++||||+.+|+|.+++.... ....++++..++.++.|++.||.|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999987632 1123478999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCc
Q 013238 260 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDD 337 (447)
Q Consensus 260 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~ 337 (447)
+.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 245 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------ 245 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------
Confidence 99999999999999865432211 1122346788999999999999999999999999999999 899985311
Q ss_pred ccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 338 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
..+......... . ..........+.+++.+||+.||.+|||+.++++.|+....
T Consensus 246 --~~~~~~~~~~~~-~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 --NEQVLRFVMEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHHHHHHHHTTC-C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111111111 0 01112234568899999999999999999999999998644
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.87 Aligned_cols=264 Identities=24% Similarity=0.392 Sum_probs=194.8
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECC-C---cEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTD-G---SLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 191 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 191 (447)
+.+..++|+..+.||+|+||+||+|.+.. + ..||||.++.... ......+.+|+++++.++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34456789999999999999999998754 3 2799999975432 23345788999999999999999999999876
Q ss_pred Ccc------eEEEecccCCcchhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 013238 192 TER------LLVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 263 (447)
Q Consensus 192 ~~~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~ 263 (447)
... +++|||+.+|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 899999999999999865432 222589999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHH
Q 013238 264 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 264 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 341 (447)
.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .....
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~ 249 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-----NAEIY 249 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-----hHHHH
Confidence 999999999986543322 12223346788999999999999999999999999999999 999996321 11111
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
. ...... ...........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 250 ~---~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 N---YLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp H---HHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 111111 0111222345689999999999999999999999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=359.11 Aligned_cols=264 Identities=19% Similarity=0.281 Sum_probs=209.1
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeee
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCM 189 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 189 (447)
.+.++....++|+..++||+|+||+||+|+.. +++.||+|++..... ......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555666789999999999999999999987 478999999965321 111224788999999999999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEee
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 269 (447)
+....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999997632 2489999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 270 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 270 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~ 290 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETY 290 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHH
Confidence 9999876544444444567999999999986 5678999999999999999999999995321 11111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVR 396 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 396 (447)
......... +.-+. ........+.+++.+||..+|+. ||+++|+++
T Consensus 291 ~~i~~~~~~--~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 291 GKIMNHKER--FQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHTHHHH--CCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred Hhhhhcccc--ccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 122111100 00010 00112355888999999888888 999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=333.09 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=198.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|+||+||+|...+|+.||+|++...... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468888999999999999999988999999999654322 2335688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.+ +|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 8988887543 2489999999999999999999999 99999999999999999999999999998654322
Q ss_pred CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc---c-
Q 013238 281 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---Q- 355 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~- 355 (447)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+.......... .
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHCCCChhhchhh
Confidence 1 22334589999999998764 58999999999999999999999995321 111111111111100000 0
Q ss_pred ----ccccccCC-------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 ----LVDSDMEG-------NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ----~~d~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..++.... .........+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 001123456889999999999999999999876
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.37 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=200.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57888999999999999999974 689999999965422 122346889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+ +|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 789999887653 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+..... .....+.
T Consensus 161 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------------~~~~~i~ 221 (336)
T 3h4j_B 161 G--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----------------NLFKKVN 221 (336)
T ss_dssp S--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----------------TCBCCCC
T ss_pred C--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----------------HHHHHHH
Confidence 2 22234469999999999988776 78999999999999999999999642111 0001111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
... ...+......+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 100 1112223456889999999999999999999876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=333.34 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=203.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC--CcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 197 (447)
.++|...+.||+|+||.||+|.+. ++.||||++..... ......+.+|+++++.++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457888899999999999999985 88999999976532 23345689999999999999999999999877 678999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
|||+++|+|.+++..... .++++..++.++.|++.||+|||++ + ++||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986432 2589999999999999999999998 8 99999999999999999999999988764
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCc---hhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
... ....||+.|+|||++.+..++. ++||||||+++|||++|+.||.... ............
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~- 227 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEG- 227 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHSC-
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhcC-
Confidence 322 2235899999999998765544 8999999999999999999995311 111111111111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
.....+......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 --------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111112233456899999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.77 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=204.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-----chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|...+.||+|+||.||+|... +|+.||+|.+...... .....+.+|+++++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467888999999999999999986 5899999999754322 1345788999999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeec
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 270 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df 270 (447)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999653 2489999999999999999999999 999999999999999887 8999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+........
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~ 232 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV 232 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHT
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHHhc
Confidence 9998764322 2234569999999999999999999999999999999999999995311 11111111110
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. ..............+.+++.+||+.||.+|||+.++++.
T Consensus 233 ~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 N-------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C-------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C-------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000000011123568899999999999999999999873
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=337.92 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=202.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888899999999999999986 689999999965432 223456888999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998753 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-~----- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK-V----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C-----
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcCC-C-----
Confidence 2 233468999999999999999999999999999999999999995311 112222222111 0
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
..+......+.+++.+||+.||.+||+ +.++++
T Consensus 256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111123456889999999999999998 777765
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=337.12 Aligned_cols=291 Identities=24% Similarity=0.311 Sum_probs=198.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc---
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER--- 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 194 (447)
.++|++.+.||+|+||.||+|... +++.||||++...... .....+.+|++++..++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 467889999999999999999974 6899999999764322 2234688999999999999999999998765544
Q ss_pred -eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 195 -LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 195 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
++||||+++++|.+++.... ++++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999997653 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 274 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 274 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCC
Confidence 865433221 2233458999999999999999999999999999999999999995321 111111111111
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHhcCCCchhhHHHHHhhhhhccCCCCCCCCCcc
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR-MLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTW 430 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~-~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (447)
..... .. .......+.+++.+||+.||.+||++.+++. .|.. . ........+....+-
T Consensus 236 ~~~~~---~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~------------~--~~~~~~~~~~~~~~~ 294 (311)
T 3ork_A 236 PIPPS---AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR------------V--HNGEPPEAPKVLTDA 294 (311)
T ss_dssp CCCHH---HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH------------H--HTTCCCSSCCCCCC-
T ss_pred CCCcc---cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH------------H--hcCCCCCCCcccccc
Confidence 10000 00 0112356889999999999999998776664 3221 1 111112222222233
Q ss_pred cccCCCcccCCccCCCC
Q 013238 431 IVDSTSHIQPDELSGPR 447 (447)
Q Consensus 431 ~~~~~~~~~~~~~~~~~ 447 (447)
...+.....+..++|||
T Consensus 295 ~~~~~~~~~~~~~~~pr 311 (311)
T 3ork_A 295 ERTSLLSSAAGNLSGPR 311 (311)
T ss_dssp -----------------
T ss_pred chhhhhhhcccCCCCCC
Confidence 33444666777889997
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=348.61 Aligned_cols=254 Identities=18% Similarity=0.246 Sum_probs=203.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
..++|+..+.||+|+||+||+|... +|+.+|+|++...... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567999999999999999999875 6899999999754432 2345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCcEEEeecCCcc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAK 274 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~ 274 (447)
|||+.+|+|.+.+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999987653 389999999999999999999999 999999999999998 56789999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ............ .
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~-~- 230 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLYQQIKAGA-Y- 230 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTC-C-
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhCC-C-
Confidence 6653322 2334569999999999999999999999999999999999999995311 111111111110 0
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.............+.+++.+||+.||.+|||+.++++
T Consensus 231 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 -----DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0001111223456889999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=343.19 Aligned_cols=270 Identities=26% Similarity=0.402 Sum_probs=215.2
Q ss_pred cCHHHHHHHhhCCCCCCeeeecCCeEEEEEEE------CCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeE
Q 013238 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRL 184 (447)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 184 (447)
+...++.+..++|+..+.||+|+||+||+|.. .+++.||||++...........+.+|++++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45566677788999999999999999999974 246899999998665555556788999999999 69999999
Q ss_pred eeeeecCC-cceEEEecccCCcchhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 013238 185 RGFCMTPT-ERLLVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 251 (447)
Q Consensus 185 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~d 251 (447)
++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987754 489999999999999999875432 22378999999999999999999999 999999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCccc
Q 013238 252 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 329 (447)
Q Consensus 252 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~ 329 (447)
|||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999865433322 2333457889999999999999999999999999999998 9999953
Q ss_pred ccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 330 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.. ...... ........ ..........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 254 ~~----~~~~~~---~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VK----IDEEFC---RRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CC----CSHHHH---HHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----hhHHHH---HHhccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 21 111111 11111110 011112345688999999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.77 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=201.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.++|+..+.||+|+||.||+|.... +..||||.++..........+.+|+++++.++||||+++++++......+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3467777899999999999998652 23699999976555555567899999999999999999999999989999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999997643 2489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc--eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 276 MDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 276 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHCCCc
Confidence 5433221 1122335778999999999999999999999999999999 999995311 1112222211111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 269 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 ----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111122345689999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=335.06 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=205.8
Q ss_pred hhCCCCCC-eeeecCCeEEEEEEEC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.++|.+.+ .||+|+||.||+|.+. ++..||||.++..........+.+|+++++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34565655 8999999999999864 57789999998765555566789999999999999999999998 4566899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999996532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 277 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 277 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
....... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~---~~~i~~~~-- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEV---MAFIEQGK-- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----THHH---HHHHHTTC--
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----HHHH---HHHHhcCC--
Confidence 5333221 122346789999999988889999999999999999998 999995321 1111 11111111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
....+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 231 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111223446789999999999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=368.51 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=207.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..++|++.+.||+|+||.||+|.+.++..||||+++.... ....+.+|++++++++|+||+++++++.+ ...++|||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3455666788999999999999998888899999976432 34578999999999999999999999876 67899999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999975321 2388999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+.........
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--------~~~~~~~~i~~~~------- 481 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQVERGY------- 481 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--------CHHHHHHHHHTTC-------
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCC-------
Confidence 1111222346788999999999999999999999999999999 99999531 1112222211111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
.......+...+.++|.+||+.||.+|||+.+|++.|+..-
T Consensus 482 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 482 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11112234567899999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.15 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=202.2
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCc
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 193 (447)
....++|...+.||+|+||+||+|+.. +|+.||||+++.... ......+..|.+++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999986 589999999975431 22344577888888876 89999999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999997653 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~-- 234 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDN-- 234 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC--
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCC--
Confidence 8543222 22344579999999999999999999999999999999999999995311 111111211111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS-EVV 395 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 395 (447)
.. .+......+.+++.+||+.||.+||++. +++
T Consensus 235 -----~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -----PF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01 1112345688999999999999999997 554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=341.42 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=204.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
..++|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999976 589999999975432 22345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEeecCCcc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAK 274 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~ 274 (447)
|||+.+|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999886542 489999999999999999999999 999999999999998654 59999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ............ .
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~~i~~~~-~- 247 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAGA-Y- 247 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-C-
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC-C-
Confidence 664322 2334569999999999999999999999999999999999999995311 111111111110 0
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.............+.+++.+||+.||.+|||+.++++.
T Consensus 248 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 -----DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00011112234568899999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=340.94 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=202.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|++.+.||+|+||.||++... +++.||+|++.... .......+.+|+++++.++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367888999999999999999976 58899999996543 222345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+.+|+|..++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999997643 489999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeeccccccCccccccccC---CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...............
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~--- 236 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-----STSSKEIVHTFETTV--- 236 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT-----TSCHHHHHHHHHHCC---
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhhcc---
Confidence 32 22344569999999999864 458999999999999999999999996321 111222222211110
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVR 396 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 396 (447)
...+......+.+++.+||+.||.+||+ +.++++
T Consensus 237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111223456899999999999999998 666554
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=331.63 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=199.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|+..+.||+|+||+||+|... +++.||||++...... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999986 5899999999754432 234568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+ +|.+.+.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 5665555432 2489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeeccccccCccccccccCCC-CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc--
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL-- 356 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 356 (447)
. .......||+.|+|||++.+.. ++.++|||||||++|||++|..||-.. .........+............
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~----~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC----SSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC----CCHHHHHHHHHHHhCCCChhhhhh
Confidence 2 2233446899999999997765 799999999999999999998886321 1111111111111111100000
Q ss_pred -c---c---------cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 -V---D---------SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 -~---d---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. + ..............+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0 00000111234456889999999999999999999886
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=334.73 Aligned_cols=246 Identities=26% Similarity=0.352 Sum_probs=203.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|+..+.||+|+||+||+++.. +|+.||+|+++.... ......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999986 689999999975432 12344678899999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997643 389999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~------ 219 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE------ 219 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC------
Confidence 22 234569999999999999999999999999999999999999995311 111122222111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+|| +++++++
T Consensus 220 ---~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 ---L--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---C--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---C--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 01112335688999999999999999 8888875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=345.17 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=201.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcE----EEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.++|+..+.||+|+||+||+|.+. +++. ||+|.+...........+.+|+.+++.++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888899999999999999875 3443 78888755433333345778999999999999999999886 45688
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997642 2488899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 276 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 276 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
....... ......++..|+|||++.+..++.++||||||+++|||+| |+.||.... .......+.. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~---~~~- 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-----LAEVPDLLEK---GER- 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----TTHHHHHHHT---TCB-
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-----HHHHHHHHHc---CCC-
Confidence 6543322 2334457889999999999999999999999999999999 999996321 1111111111 100
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
...+......+.+++.+||+.||.+|||+.++++.|+....
T Consensus 236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01111123347889999999999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=336.43 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=206.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-----CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC--Cc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 193 (447)
.++|+..+.||+|+||.||+|.+ .+++.||||++...........+.+|+++++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34678889999999999999984 358899999998665555556789999999999999999999999876 56
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 7999999999999999966542 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccc------cCCCcccHHHHHH
Q 013238 274 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL------ANDDDVMLLDWVK 345 (447)
Q Consensus 274 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~------~~~~~~~~~~~~~ 345 (447)
......... ......+|..|+|||++.+..++.++||||||+++|||++|..|+..... ...........+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 876544322 22334578889999999999999999999999999999999998753210 0011111111111
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.... .......+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 254 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 254 NTLK---------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHH---------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHh---------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111 111111222344678999999999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=328.84 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=200.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|...+.||+|+||.||++... ++..+|+|++...........+.+|+++++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467888999999999999999975 5889999999876655556788999999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeecCCcccc
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~ 276 (447)
|+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999866433334599999999999999999999999 99999999999999 55688999999999765
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... .......||+.|+|||++. ..++.++||||||+++|||++|+.||.... ..+..............
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKEPNYAV 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCC
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCCccccc
Confidence 432 2233446899999999885 568999999999999999999999995321 11111111111000000
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........+.+++.+||+.||.+|||+.|+++
T Consensus 247 --------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 --------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00012356889999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=341.97 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=200.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCc----EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
.++|+..+.||+|+||.||+|.+. +++ +||+|.+...........+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 457888999999999999999975 344 357887765555555678999999999999999999999998754 78
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++++|+.+|+|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999987533 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 276 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 276 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
....... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~~~~-------- 233 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE-------- 233 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHH--------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHH--------
Confidence 5432221 2223346788999999999999999999999999999999 999996321 111111111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
..............+.+++.+||+.||.+|||+.++++.|+...
T Consensus 234 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 234 -----KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111112223456889999999999999999999999999753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=334.35 Aligned_cols=261 Identities=15% Similarity=0.183 Sum_probs=206.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 197 (447)
..++|+..+.||+|+||.||+|... +++.||||++...... ..+.+|++.+..+ +|+|++++++++......++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3467899999999999999999964 6899999998644322 2477899999998 799999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-----EEEeecCC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGL 272 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl 272 (447)
|||+ +++|.+++.... .++++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 999999998653 2489999999999999999999999 9999999999999987776 99999999
Q ss_pred ccccCCCCCc------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 273 AKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 273 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~ 235 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA--ATNKQKYERIGE 235 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS--CCHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc--cccHHHHHHHHh
Confidence 9876543221 23345689999999999999999999999999999999999999964211 011111111111
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.......... . ......+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 236 ~~~~~~~~~~-----~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 236 KKQSTPLREL-----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHSCHHHH-----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hccCccHHHH-----H----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111111110 0 11235689999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=337.22 Aligned_cols=247 Identities=23% Similarity=0.276 Sum_probs=193.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 196 (447)
..++|+..++||+|+||+||+|... +|+.||||++..... .........|+..+..+ +|+||+++++++.+....++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999987 689999999865432 22233455566555544 89999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+ +++|.+++..... ++++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 7799998877542 499999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .+ ..... ..
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~-~~~~~-~~---- 268 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GW-QQLRQ-GY---- 268 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HH-HHHTT-TC----
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HH-HHHhc-cC----
Confidence 4322 2334458999999999876 78999999999999999999977663211 00 11111 00
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............+.+++.+||+.||.+|||+.++++
T Consensus 269 ----~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 ----LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000011123456899999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=368.08 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=198.2
Q ss_pred eeeecCCeEEEEEEEC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCc
Q 013238 129 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
.||+|+||.||+|.+. ++..||||+++..........+.+|+++++.++||||+++++++.. +..++||||+.+|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4567999999876555556789999999999999999999999876 56899999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce--
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-- 283 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-- 283 (447)
|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 422 L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 999997543 3489999999999999999999999 99999999999999999999999999998764332211
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccccC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 362 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 362 (447)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ..... ....... .
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~~~~~---~~i~~~~----------~ 557 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVM---AFIEQGK----------R 557 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----SHHHH---HHHHTTC----------C
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHH---HHHHcCC----------C
Confidence 122235689999999999999999999999999999998 999995321 11111 1111111 1
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 363 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 363 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
...+..+...+.++|.+||+.||.+|||+.+|++.|+.
T Consensus 558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 12223345679999999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=337.93 Aligned_cols=259 Identities=17% Similarity=0.196 Sum_probs=205.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.++|+..+.||+|+||.||+|... +|+.||||.+...... ..+.+|+++++.+ +|+||+++++++......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 467888999999999999999974 6899999998654322 2478899999999 9999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-----EEEeecCCc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLA 273 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~ 273 (447)
||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 999999998652 2499999999999999999999999 9999999999999999887 999999999
Q ss_pred cccCCCCCc------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHH
Q 013238 274 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 347 (447)
Q Consensus 274 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 347 (447)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i 232 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERYQKI 232 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHHHHH
Confidence 875433221 1234569999999999999999999999999999999999999996421 11222222211
Q ss_pred hhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 348 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 348 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
........ . ..+... .+ .+.+++..||+.||.+||++.+|++.|+..
T Consensus 233 ~~~~~~~~-~-~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 233 GDTKRATP-I-EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHHSC-H-HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhhhccCC-H-HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 11100000 0 000000 12 689999999999999999999999999853
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=353.40 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=207.5
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeee
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCM 189 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 189 (447)
.+++.....++|+..+.||+|+||+||+++.. +|+.||||++++... ......+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555666789999999999999999999986 689999999965321 112234788999999999999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEee
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 269 (447)
+.+..++||||+++|+|.+++...+. .+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999986532 389999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCceeeccccccCcccccccc-------CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHH
Q 013238 270 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 270 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 342 (447)
||+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~ 277 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------TAE 277 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------HHH
Confidence 9999876544333334457999999999987 3568999999999999999999999995321 111
Q ss_pred HHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 013238 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER---PKMSEVVR 396 (447)
Q Consensus 343 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~ 396 (447)
.......... .+.-+. ........+.+++.+||. +|.+| |+++++++
T Consensus 278 ~~~~i~~~~~--~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 TYGKIVHYKE--HLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHhccc--CcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111111100 000010 011234568899999999 99998 58888876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=343.58 Aligned_cols=256 Identities=23% Similarity=0.274 Sum_probs=197.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHH-HHhcCCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.++|+..+.||+|+||+||+|+.. +++.||||++.+.... .....+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357888999999999999999986 5889999999765432 223345566665 467899999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997653 388999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~----- 255 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKP----- 255 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHSC-----
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcc-----
Confidence 322 222344579999999999999999999999999999999999999995321 112222222111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
. .........+.+++.+||+.||.+||++.+.+..+....+
T Consensus 256 ----~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 256 ----L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp ----C--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred ----c--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 0 0111223568899999999999999998765555555443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=332.01 Aligned_cols=262 Identities=27% Similarity=0.430 Sum_probs=196.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
+..++|+..+.||+|+||+||+|+.. ..||||+++.... ......+.+|+++++.++|+||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34678999999999999999999865 3599999975543 23345688999999999999999999965 45668999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+.+++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999996543 3489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC-CceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 278 YKD-THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 278 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
... ........||+.|+|||++. +..++.++||||||+++|||++|+.||.... ....... .......
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~----~~~~~~~ 243 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIE----MVGRGSL 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----CHHHHHH----HHHHTSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----hHHHHHH----Hhccccc
Confidence 322 22233456899999999986 5678899999999999999999999995321 1111111 1111111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
.... ..........+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 244 ~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1100 1112233467899999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=334.30 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=193.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE----CCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
.++|+..+.||+|+||.||+++. .+|+.||+|+++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999987 3689999999976432 2223457789999999999999999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997653 388999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ............
T Consensus 169 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~-- 237 (327)
T 3a62_A 169 KESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKCK-- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTC--
T ss_pred cccccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC--
Confidence 754322 122334568999999999999999999999999999999999999995321 111122221110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+|| ++.++++
T Consensus 238 -------~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -------L--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------C--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------C--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 11112345688999999999999999 6677766
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.74 Aligned_cols=253 Identities=19% Similarity=0.276 Sum_probs=204.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 367899999999999999999976 688999999865432 234468899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CCcEEEeecCCccccC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 277 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~ 277 (447)
|+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999987543 2489999999999999999999999 9999999999999974 5789999999998765
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||.... ....+........
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~~~~----- 267 (387)
T 1kob_A 203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDW----- 267 (387)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCC-----
T ss_pred CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-----
Confidence 332 2333468999999999999999999999999999999999999995321 1111112111100
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.............+.+++.+||+.||.+|||+.++++.
T Consensus 268 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 --EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111112234568899999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=338.21 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=202.1
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 194 (447)
...++|+..+.||+|+||+||+|... +|+.||||+++.... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34568999999999999999999987 478999999975432 22344677899999887 799999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999998653 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~--- 237 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN--- 237 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC---
Confidence 54322 222344569999999999999999999999999999999999999995311 112222222111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+||+ ++++++
T Consensus 238 ------~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 ------V--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------C--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------C--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 111223456889999999999999996 456554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.66 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=196.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCC--CceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l 196 (447)
..++|++.+.||+|+||.||++...+++.||||++..... ......+.+|++++..++| +||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3457888999999999999999988899999999975433 2234568899999999987 999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||| +.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 55889999998643 489999999999999999999999 999999999999997 578999999999876
Q ss_pred CCCCCc-eeeccccccCccccccccC-----------CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 277 DYKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 277 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... .......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh-------hhHHHHH
Confidence 433222 2334569999999999864 67899999999999999999999999531 1111111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
... ++.......+......+.+++.+||+.||.+|||+.++++.
T Consensus 231 ~~~---------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 HAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHH---------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111 11111111122223568899999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=332.64 Aligned_cols=256 Identities=28% Similarity=0.376 Sum_probs=201.5
Q ss_pred CCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc-eEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-LLV 197 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 197 (447)
.|...++||+|+||+||+|.+.+ +..||+|.+...........+.+|+++++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34556889999999999998642 2379999997655545556788999999999999999999999876655 999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997633 3489999999999999999999999 99999999999999999999999999997553
Q ss_pred CCC---CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 278 YKD---THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 278 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
... ........++..|+|||.+.+..++.++||||||+++|+|++|..|+.. ..........+... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~----~~~~~~~~~~~~~~---~--- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR----HIDPFDLTHFLAQG---R--- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT----TSCGGGHHHHHHTT---C---
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc----cCCHHHHHHHhhcC---C---
Confidence 221 1122334578899999999999999999999999999999996666521 11111222211111 0
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111122345688999999999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=345.09 Aligned_cols=271 Identities=19% Similarity=0.220 Sum_probs=212.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC--cceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 197 (447)
.++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457888999999999999999986 489999999986555555567889999999999999999999988755 67999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEEEeecCCc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 273 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 273 (447)
|||+++|+|.+++...... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999765322 2389999999999999999999999 99999999999999 78888999999999
Q ss_pred cccCCCCCceeeccccccCccccccccC--------CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
+..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.+.
T Consensus 164 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~----~~~~~~ 237 (396)
T 4eut_A 164 RELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR----NKEVMY 237 (396)
T ss_dssp EECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT----CHHHHH
T ss_pred eEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc----hHHHHH
Confidence 875432 22234568999999999865 4678899999999999999999999964322111 122222
Q ss_pred HHhhccccc---ccc-----------ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 346 GLLKEKKLE---QLV-----------DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 346 ~~~~~~~~~---~~~-----------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
......... .+. +..............+.+++.+||+.||.+|||+.++++.++.+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 222211110 000 00111233467778899999999999999999999999988774
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=342.14 Aligned_cols=266 Identities=17% Similarity=0.198 Sum_probs=202.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC------CcEEEEEEeccccccch----------HHHHHHHHHHHHhcCCCceee
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGG----------ELQFQTEVEMISMAVHRNLLR 183 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~niv~ 183 (447)
..++|++.+.||+|+||.||+|.+.. ++.||||++........ ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34588999999999999999998764 47899999865432100 112334555677788999999
Q ss_pred EeeeeecC----CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 013238 184 LRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259 (447)
Q Consensus 184 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill 259 (447)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 3479999999 999999997643 2499999999999999999999999 99999999999999
Q ss_pred C--CCCcEEEeecCCccccCCCCCc------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccccc
Q 013238 260 D--EEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 331 (447)
Q Consensus 260 ~--~~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~ 331 (447)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999765432211 1123459999999999999999999999999999999999999996421
Q ss_pred ccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 332 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.............. ..+..+++..+... ..+..+.+++..||+.||.+||++.+|++.|+.
T Consensus 266 ----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 ----KDPKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp ----TCHHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ----cCHHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11222222222111 12233333222111 123568899999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.06 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=202.8
Q ss_pred HHhhCCCCCC-eeeecCCeEEEEEEEC---CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 119 VATDNFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 119 ~~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
+..++|.+.+ .||+|+||.||+|.+. +++.||||+++..... .....+.+|+++++.++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456777777 8999999999999643 4688999999765332 2245788999999999999999999998 5567
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 899999999999999997643 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcee--eccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 274 KLMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 274 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
........... ....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~ 236 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKG 236 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcC
Confidence 87654433221 22336788999999988889999999999999999999 999995321 11111111111
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
. ....+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 237 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 237 E----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1111223346689999999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=337.34 Aligned_cols=264 Identities=27% Similarity=0.333 Sum_probs=205.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec----CCcc
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTER 194 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 194 (447)
..++|+..+.||+|+||.||++... +++.||||++.... ......+.+|+++++.++||||+++++++.. ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4568999999999999999999974 68999999986532 3344578899999999999999999999873 3467
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+.+|+|.+++.........+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999987544445699999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCc--------eeeccccccCccccccccCCC---CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHH
Q 013238 275 LMDYKDTH--------VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 343 (447)
Q Consensus 275 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 343 (447)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ .....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~ 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALA 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---CHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---hhhHH
Confidence 54321110 011234789999999987654 68899999999999999999999964211110 11111
Q ss_pred HHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 344 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 344 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
.. ..............+.+++.+||+.||.+|||+.++++.|+.+.-
T Consensus 260 ~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQ-------------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HH-------------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hh-------------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00 000111112234568999999999999999999999999997643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.76 Aligned_cols=255 Identities=31% Similarity=0.444 Sum_probs=193.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC--C--CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec-CCcceEE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT--D--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLV 197 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 197 (447)
.|...+.||+|+||+||+|.+. + +..||||.++..........+.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556688999999999999864 2 246899998765544556678999999999999999999998765 4578999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997543 2488999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc---eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 278 YKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 278 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
..... ......++..|+|||++.+..++.++||||||+++|||+| |..||... ........+. ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-----~~~~~~~~~~---~~~~- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYLL---QGRR- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CSSCHHHHHH---TTCC-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-----CHHHHHHHHH---cCCC-
Confidence 32211 1223346788999999999999999999999999999999 67777532 1111211111 1110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 315 ---------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011122345689999999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=327.89 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=204.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||.||+|... +++.||||.+...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467888999999999999999986 6899999999765544555678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998653 2489999999999999999999999 9999999999999999999999999999765322
Q ss_pred CC-ceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 280 DT-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 280 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. .......|+..|+|||++.+..+ +.++||||||+++|||++|+.||..... .......+.. ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~----~~~----- 226 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKE----KKT----- 226 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT---TSHHHHHHHT----TCT-----
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHhhh----ccc-----
Confidence 21 12233468999999999987765 7799999999999999999999964211 1111111111 000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...........+.+++.+||+.||.+|||+.++++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00111223456889999999999999999999876
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=350.36 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=195.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
..++|+..+.||+|+||.||+|... +|+.||||++.... .......+.+|+++++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 68999999997542 22223457789999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
||||+++|+|..++.... .+++..++.++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999997653 38999999999999999999998 7 999999999999999999999999999985
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 299 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~---- 365 (446)
T 4ejn_A 299 GIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEE---- 365 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC----
T ss_pred ccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCC----
Confidence 4322 222344679999999999999999999999999999999999999995321 111111111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+|| |+.++++
T Consensus 366 ---~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 ---I----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---C----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 01112335688999999999999999 9999886
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=334.27 Aligned_cols=261 Identities=21% Similarity=0.325 Sum_probs=198.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 47888899999999999999975 68999999997532 2233456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+++|.+++.........+++..++.++.+++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999976443344589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||... .............. ...
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~-~~~---- 256 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEQC-DYP---- 256 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHHTT-CSC----
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc------chhHHHHHHHhhcc-cCC----
Confidence 222 222345899999999999999999999999999999999999999531 11122222221111 110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..........+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 257 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 257 ----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp ----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001112345688999999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=332.71 Aligned_cols=256 Identities=32% Similarity=0.459 Sum_probs=200.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec-CCcceE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLL 196 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 196 (447)
.+|+..+.||+|+||+||+|...+ +..+|+|.+...........+.+|++++++++||||+++++++.. .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467778999999999999998643 236899999765555555678999999999999999999998654 567899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997543 3489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC---ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 277 DYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 277 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||... ........ ......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~~~~---~~~~~~ 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVY---LLQGRR 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-----CTTTHHHH---HHTTCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-----CHHHHHHH---HhcCCC
Confidence 43221 12233457789999999999999999999999999999999 55555321 11111111 111100
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 251 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 251 ----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011112235688999999999999999999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=342.47 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=202.4
Q ss_pred hhCCCCCCeeeec--CCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 121 TDNFSNRNILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.++|++.+.||+| +||+||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678999999999 99999999987 6899999999765432 234568889999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999977532 2489999999999999999999999 9999999999999999999999999988644
Q ss_pred CCCCC------ceeeccccccCccccccccC--CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh
Q 013238 277 DYKDT------HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 277 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||..... .......+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~ 254 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA----TQMLLEKLNGTV 254 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS----TTHHHHC-----
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCCC
Confidence 22111 11122358899999999987 5789999999999999999999999963211 111111000000
Q ss_pred h----c-----cc-------------ccccccc---------ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 349 K----E-----KK-------------LEQLVDS---------DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 349 ~----~-----~~-------------~~~~~d~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. . .. ....... .............+.+++.+||+.||.+|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0 00 0000000 00001122234568899999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=328.92 Aligned_cols=262 Identities=20% Similarity=0.254 Sum_probs=199.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
-++|++.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++..++||||+++++++...+..+++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 357889999999999999999976 68899999997553322 235688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++++|.+++.... ++++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998653 489999999999999999999999 99999999999999999999999999998655
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
...........|+..|+|||++.+..++.++||||||+++|||++|+.||..... ..+..........
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~~--- 253 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQAIPR--- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSCCCC---
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccCCCC---
Confidence 4333333445689999999999999999999999999999999999999963211 1111111111000
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCCch
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEGDGLAE 405 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~ 405 (447)
. ..........+.+++.+||+.||.+|| |++++++.|+......
T Consensus 254 -~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 254 -P---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -G---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -c---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0 001112234588999999999999999 9999999999865443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=334.84 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=196.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
.++|+..+.||+|+||+||+|... ++.||||.+... .....+.+|++++++++||||+++++++. +..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 356788899999999999999985 788999998643 23457889999999999999999999876 458999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-EEEeecCCccccCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-AVVGDFGLAKLMDYK 279 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~ 279 (447)
+++|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999976432 234789999999999999999999932228999999999999998886 799999999754322
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.....||..|+|||++.+..++.++||||||+++|||++|+.||.... ..............
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~-------- 221 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAVHNGT-------- 221 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC------SSHHHHHHHHHTTC--------
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC------ccHHHHHHHHhcCC--------
Confidence 223358999999999999999999999999999999999999996311 11111111111111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 222 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 222 --RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp --CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0111122345688999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=346.15 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=196.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC--CCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 197 (447)
.++|++.+.||+|+||.||++...+++.||||++..... ......+.+|++++..++ |+||+++++++......++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 356899999999999999999988899999999965432 233457889999999997 59999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|| +.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 56889999998653 488999999999999999999999 999999999999996 5799999999998764
Q ss_pred CCCCc-eeeccccccCccccccccC-----------CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 278 YKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 278 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHH
Confidence 33222 2334569999999999865 368899999999999999999999995311 1111112
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
... +.......+......+.+++.+||+.||.+|||+.++++.
T Consensus 279 ~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHh---------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 221 1111111111123568899999999999999999999873
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=340.25 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=189.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
..++|+..+.||+|+||.||+|... +++.||||++.... ....+.+|++++++++||||+++++++......++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3567889999999999999999987 57899999997543 2345788999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeecCCccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKL 275 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~ 275 (447)
||+++|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999986543 489999999999999999999999 9999999999999975 88999999999986
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ........... .
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~---~~~~~~i~~~~-~-- 268 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER----GD---QFMFRRILNCE-Y-- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT----CH---HHHHHHHHTTC-C--
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc----cc---HHHHHHHHhCC-C--
Confidence 5432 22234568999999999999999999999999999999999999995311 11 11111111111 0
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.............+.+++.+||+.||.+|||+.++++.
T Consensus 269 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 ----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011112234568899999999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=339.78 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=202.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcE--EEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSL--VAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 197 (447)
++|+..+.||+|+||.||+|... ++.. +|+|.+...........+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888899999999999999875 4554 4999987654444455688999999999 899999999999999999999
Q ss_pred EecccCCcchhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 198 YPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
|||+++|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997653 2234589999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHH
Q 013238 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 344 (447)
||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+..
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY 251 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHHH
Confidence 999999987432211 1122346789999999988889999999999999999998 999995321 11111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
...... ............+.+++.+||+.||.+|||+.++++.|+.
T Consensus 252 ~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 252 EKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HHGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111111 0111122234568999999999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=340.75 Aligned_cols=261 Identities=22% Similarity=0.217 Sum_probs=200.9
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
....++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 456678999999999999999999975 68899999996542 2234457889999999999999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQS------------------------------------QPPLNWSVRKQIALGAARGL 236 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~l 236 (447)
..++||||+++|+|.+++...... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999988531100 11245778889999999999
Q ss_pred HHHHhCCCCCceecCCCCCCEEECCCC--cEEEeecCCccccCCCCC---ceeeccccccCccccccccC--CCCCchhh
Q 013238 237 AYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLST--GKSSEKTD 309 (447)
Q Consensus 237 ~yLH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~sD 309 (447)
+|||++ +|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 899999999986543221 12334568999999999865 67899999
Q ss_pred hHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 013238 310 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 389 (447)
Q Consensus 310 vwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 389 (447)
|||||+++|||++|+.||.... ..+............ ...........+.+++.+||+.||.+||
T Consensus 259 iwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVN--------DADTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999995321 111222222111100 0011112345688999999999999999
Q ss_pred CHHHHHH
Q 013238 390 KMSEVVR 396 (447)
Q Consensus 390 t~~evl~ 396 (447)
|+.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=341.45 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=194.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||+||++... +++.||||++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467899999999999999999986 689999999965432 23467899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--EEEeecCCccccC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMD 277 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~~~ 277 (447)
|+.+|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999997654 389999999999999999999999 9999999999999987765 9999999997432
Q ss_pred CCCCceeeccccccCccccccccCCCCCch-hhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... ........+.......
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~~~~~~~----- 238 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----EPRDYRKTIQRILSVK----- 238 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTC-----
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc----cHHHHHHHHHHHhcCC-----
Confidence 22 12233458999999999988877655 899999999999999999996421 1122222222222111
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
............+.+++.+||+.||.+|||+.++++.
T Consensus 239 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 ----YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000011123568899999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=339.51 Aligned_cols=247 Identities=29% Similarity=0.422 Sum_probs=198.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+.|+..+.||+|+||+||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999974 6899999999654322 22346889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+. |+|.+++.... .++++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9996 68888876543 2489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ....+........
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~~--- 270 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES--- 270 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC---
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCC---
Confidence 2 2346899999999984 5678999999999999999999999995311 1111111111110
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
+... .......+.+++.+||+.||.+|||+.++++.
T Consensus 271 ---~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ---PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111 11223558899999999999999999999873
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=334.32 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=204.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec--CCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 196 (447)
.++|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888899999999999999986 689999999975432 3334568899999999999999999998754 567899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceecCCCCCCEEECCCCcEEEeecC
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-----IIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
||||+++++|.+++.........+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999987544445699999999999999999999999 7 9999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++....... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ..+....... .
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~-~ 231 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIRE-G 231 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-T
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHHHHhh-c
Confidence 998654322 11223458999999999999899999999999999999999999996321 1111111111 1
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
... ..+......+.+++.+||+.||.+|||+.++++.+..
T Consensus 232 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111 1111234568899999999999999999999987664
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=331.92 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=205.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.+.|+..+.||+|+||.||+|... +++.||||.+...........+.+|+.+++.++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999875 6889999999766555556678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++... ++++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999998642 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 359 (447)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ........... . ..
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~-----~~ 237 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLIPKN-N-----PP 237 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS-C-----CC
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHhhcC-C-----CC
Confidence 21 2233458999999999999999999999999999999999999995311 11111111111 0 01
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 360 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
... ......+.+++.+||+.||.+|||+.++++.
T Consensus 238 ~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 TLE----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCC----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCc----cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111 1223558899999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=337.80 Aligned_cols=267 Identities=18% Similarity=0.202 Sum_probs=199.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccccc----------hHHHHHHHHHHHHhcCCCceeeEee
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQG----------GELQFQTEVEMISMAVHRNLLRLRG 186 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~ 186 (447)
.++|.+.+.||+|+||.||+|... ++..+|||++....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 457888999999999999999975 47789999987543211 1123567888899999999999999
Q ss_pred eeec----CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 013238 187 FCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262 (447)
Q Consensus 187 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~ 262 (447)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9887 67789999999 999999997654 489999999999999999999999 99999999999999888
Q ss_pred C--cEEEeecCCccccCCCCC------ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccC
Q 013238 263 F--EAVVGDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 334 (447)
Q Consensus 263 ~--~~kl~Dfgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~ 334 (447)
+ .+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--- 264 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL--- 264 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT---
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc---
Confidence 7 999999999986542211 11133468999999999999999999999999999999999999995311
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
.................... +..... .......+.+++.+||+.||.+|||+.+|++.|+...+
T Consensus 265 -~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 -KDPVAVQTAKTNLLDELPQS-VLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -TCHHHHHHHHHHHHHTTTHH-HHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -cccHHHHHHHHhhcccccHH-HHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111111111000 000000 00223568999999999999999999999999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=331.26 Aligned_cols=267 Identities=24% Similarity=0.350 Sum_probs=200.2
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHh--cCCCceeeEeeeeecC---
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP--- 191 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~--- 191 (447)
.....++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3445678999999999999999999986 8999999985432 2234455555554 4899999999998876
Q ss_pred -CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCEEECCCCcE
Q 013238 192 -TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 192 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~dlk~~Nill~~~~~~ 265 (447)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+++ .++|+||||||+|||++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 6789999999999999999764 3899999999999999999999762 3479999999999999999999
Q ss_pred EEeecCCccccCCCCCce---eeccccccCccccccccCCCCCch------hhhHHHHHHHHHHHhC----------CCC
Q 013238 266 VVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTGKSSEK------TDVFGYGVMLLELITG----------QRA 326 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlG~il~elltg----------~~p 326 (447)
||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||+|| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997654332221 123468999999999987766554 9999999999999999 555
Q ss_pred cccccccCCCcccHHHHHHHHhhccccccccccccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 327 FDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
|..... ........ ......... .+..... ....+...+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 262 ~~~~~~---~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 262 YHDLVP---SDPSYEDM-REIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTTSC---SSCCHHHH-HHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhhcC---CCCchhhh-HHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 532111 11111111 111111111 1111110 1236778899999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.02 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=200.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-C-------cEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD-G-------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
.++|...+.||+|+||+||+|.... + ..||+|.+.... ......+.+|+++++.++||||+++++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4678888999999999999998653 3 479999996543 334457899999999999999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--------
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-------- 264 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~-------- 264 (447)
..++||||+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999976432 389999999999999999999999 9999999999999998887
Q ss_pred EEEeecCCccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHH
Q 013238 265 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 343 (447)
Q Consensus 265 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 343 (447)
+||+|||++..... .....++..|+|||++.+ ..++.++||||||+++|||++|..|+... ......
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~ 227 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA-------LDSQRK 227 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc-------cchHHH
Confidence 99999999875422 122347889999999987 67899999999999999999965554211 111111
Q ss_pred HHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCc
Q 013238 344 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLA 404 (447)
Q Consensus 344 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 404 (447)
........... . .....+.+++.+||+.||.+|||+.++++.|+.+--+
T Consensus 228 ~~~~~~~~~~~--------~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 228 LQFYEDRHQLP--------A----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHHHTTCCCC--------C----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HHHhhccCCCC--------C----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11111111110 0 1123488999999999999999999999999986543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.16 Aligned_cols=269 Identities=26% Similarity=0.360 Sum_probs=208.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-----CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec--CCc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 193 (447)
.++|+..+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+++++.++|+||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 46788889999999999999984 358899999997543 3334568999999999999999999998874 456
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 7899999999999999976432 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccccccc------CCCcccHHHHHH
Q 013238 274 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA------NDDDVMLLDWVK 345 (447)
Q Consensus 274 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~ 345 (447)
......... ......+|..|+|||++.+..++.++||||||+++|+|++|+.||...... ..........+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 253 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL- 253 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH-
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH-
Confidence 876543322 122334788899999999988999999999999999999999998542210 00000000001
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCch
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 405 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 405 (447)
.+.+...............+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 254 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 254 --------LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp --------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred --------HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111111112223334567899999999999999999999999999875433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.23 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=204.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
..++|+..+.||+|+||.||+|.+. +++.||||.+...........+.+|+.+++.++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4578999999999999999999842 4778999999765555556678899999999999999999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEE
Q 013238 194 RLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVV 267 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl 267 (447)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||++ +++||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999875432 23489999999999999999999999 9999999999999984 456999
Q ss_pred eecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHH
Q 013238 268 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 268 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
+|||++........ .......+++.|+|||++.+..++.++||||||+++|||+| |+.||.... ......
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLE 256 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHHHHH
Confidence 99999875432221 22233457889999999999999999999999999999998 999995311 111111
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
....... ..........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 257 ~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 257 FVTSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCCC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1111110 11112234568899999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=335.91 Aligned_cols=265 Identities=26% Similarity=0.435 Sum_probs=198.9
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec
Q 013238 116 ELQVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 190 (447)
Q Consensus 116 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 190 (447)
++.+..++|...+.||+|+||.||+|... ++..||||.+..... ......+.+|++++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34456678999999999999999999864 245899999975432 2334568899999999999999999999887
Q ss_pred CCc-----ceEEEecccCCcchhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 013238 191 PTE-----RLLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 263 (447)
Q Consensus 191 ~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~ 263 (447)
... .++||||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 543 499999999999999985432 2234599999999999999999999999 999999999999999999
Q ss_pred cEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHH
Q 013238 264 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 264 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 341 (447)
.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||.... .....
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~ 259 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-----NHEMY 259 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHHH
Confidence 999999999986543221 11223346789999999999999999999999999999999 889985321 11111
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.. ..... ...........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 260 ~~---~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 DY---LLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HH---HHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11111 1111223345689999999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=331.25 Aligned_cols=268 Identities=23% Similarity=0.307 Sum_probs=208.6
Q ss_pred CHHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHh--cCCCceeeEeeeeec
Q 013238 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMT 190 (447)
Q Consensus 113 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~ 190 (447)
.+.-.....++|...+.||+|+||.||+|+.. |+.||||++... ....+.+|.+++.. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 33344566789999999999999999999984 899999999643 23457788888877 789999999999987
Q ss_pred CC----cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCEE
Q 013238 191 PT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--------DHCDPKIIHRDVKAANIL 258 (447)
Q Consensus 191 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~dlk~~Nil 258 (447)
.. ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 75 789999999999999999764 3899999999999999999999 77 9999999999999
Q ss_pred ECCCCcEEEeecCCccccCCCCCc---eeeccccccCccccccccCCC------CCchhhhHHHHHHHHHHHhC------
Q 013238 259 LDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITG------ 323 (447)
Q Consensus 259 l~~~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltg------ 323 (447)
++.++.+||+|||++......... ......||+.|+|||++.+.. ++.++||||||+++|||+||
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876543322 123346899999999997763 34789999999999999999
Q ss_pred ----CCCcccccccCCCcccHHHHHHHHhhccccccccccccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013238 324 ----QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 398 (447)
Q Consensus 324 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 398 (447)
..||..... .......+........ ..+.+... ........+.+++.+||+.||.+|||+.+|++.|
T Consensus 260 ~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 260 HEDYQLPYYDLVP---SDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCCCCTTTTTSC---SSCCHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccccCccccCc---CcccHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 667743211 1112222222221111 11111111 1235677899999999999999999999999999
Q ss_pred hcC
Q 013238 399 EGD 401 (447)
Q Consensus 399 ~~~ 401 (447)
+.+
T Consensus 332 ~~i 334 (342)
T 1b6c_B 332 SQL 334 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=323.57 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=200.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
..++|+..+.||+|+||.||+|... ++..||+|++..... ......+.+|+++++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467888999999999999999876 577999999865432 2234568899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999997653 389999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ..+.........
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~----- 223 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVE----- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTC-----
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhCC-----
Confidence 322 2233468999999999999999999999999999999999999995321 111111111100
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
...+......+.+++.+||+.||.+|||+.++++.
T Consensus 224 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111234568899999999999999999999973
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=326.12 Aligned_cols=249 Identities=26% Similarity=0.424 Sum_probs=182.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|+..+.||+|+||.||+|... +|+.||||.+..... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888899999999999999974 689999999965432 122356889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++.... .++++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999997643 3489999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.... .....|++.|+|||++.+..++.++||||||+++|||++|+.||....... ....+..
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------------~~~~~~~ 226 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----------------TLNKVVL 226 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCS
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----------------HHHHHhh
Confidence 2221 223458999999999999899999999999999999999999996421110 0000110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
... ..+......+.+++.+||+.||.+|||+.++++
T Consensus 227 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 ADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 111123456889999999999999999999886
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=336.48 Aligned_cols=244 Identities=23% Similarity=0.278 Sum_probs=201.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-------chHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 191 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 191 (447)
..++|+..+.||+|+||+||+|... +++.||||++...... .....+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999875 6889999999754321 1222467899999999999999999999999
Q ss_pred CcceEEEecccCC-cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 192 TERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 192 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
+..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999987643 489999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
|++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 99987643322 233468999999999988877 8899999999999999999999953110
Q ss_pred ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
....... .+......+.+++.+||+.||.+|||+.++++.
T Consensus 236 ------~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ------TVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------GTTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------HHhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 011123568899999999999999999999884
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=349.92 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=205.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|...+.||+|+||.||+|+.. +|+.||+|++..... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999986 689999999975432 22345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|..++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999987654455699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ................
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~----~~~~~~~~~~~i~~~~------ 409 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQA------ 409 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT----CCCCHHHHHHHHHHCC------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc----cchhHHHHHHHHhhcc------
Confidence 3322 2233469999999999999999999999999999999999999996421 1112222222222111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 392 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 392 (447)
...+......+.+++.+||+.||.+||++.
T Consensus 410 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 -----VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred -----cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 011122345688999999999999999763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=324.12 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=203.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999976 588999999975443 223456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEeecCCccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 275 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~ 275 (447)
||+.+++|.+.+.... .+++..++.++.|++.||.|||++ +++||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999887653 389999999999999999999999 9999999999999987655 99999999976
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ........... ...
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~-~~~- 225 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAG-AYD- 225 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT-CCC-
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--------hhHHHHHHHhc-ccc-
Confidence 54322 2234568999999999999999999999999999999999999995311 11111111111 000
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............+.+++.+||+.||.+|||+.++++
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000111123456889999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.37 Aligned_cols=201 Identities=25% Similarity=0.388 Sum_probs=161.7
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCC--cc
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT--ER 194 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~ 194 (447)
..++|+..+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999875 68999999986442 2233456788999999997 999999999987544 67
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+. ++|..++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999996 6899988763 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC--------------------CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 275 LMDYK--------------------DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 275 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 65321 1112334569999999999976 6789999999999999999999999953
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=338.06 Aligned_cols=209 Identities=22% Similarity=0.292 Sum_probs=180.6
Q ss_pred ccccCHHHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-----CCcee
Q 013238 109 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----HRNLL 182 (447)
Q Consensus 109 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv 182 (447)
...+++++.....++|.+.++||+|+||+||+|... +++.||||++... ......+..|++++..+. ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345566666667889999999999999999999985 6889999999642 223345678999998886 99999
Q ss_pred eEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-
Q 013238 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE- 261 (447)
Q Consensus 183 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~- 261 (447)
++++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 9999999999999999999 9999999987543 2489999999999999999999999 9999999999999976
Q ss_pred ------------------------CCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHH
Q 013238 262 ------------------------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 317 (447)
Q Consensus 262 ------------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 317 (447)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999864332 2334689999999999999999999999999999
Q ss_pred HHHHhCCCCccc
Q 013238 318 LELITGQRAFDL 329 (447)
Q Consensus 318 ~elltg~~p~~~ 329 (447)
|||++|+.||..
T Consensus 250 ~ell~g~~pf~~ 261 (360)
T 3llt_A 250 AELYTGSLLFRT 261 (360)
T ss_dssp HHHHHSSCSCCC
T ss_pred HHHHHCCCCCCC
Confidence 999999999953
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.60 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=197.1
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc----cchHHHHHHHHHHHHhc---CCCceeeEeeeeec
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMA---VHRNLLRLRGFCMT 190 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~ 190 (447)
...++|+..+.||+|+||+||+|... +++.||||++..... ......+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 35678999999999999999999974 689999999964332 11123566777776665 49999999999976
Q ss_pred CC-----cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 191 PT-----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 191 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
.. ..+++|||+. ++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 54 4689999996 699999976543 2489999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~ 232 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-----EADQLGKIF 232 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-----HHHHHHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH
Confidence 999999998654322 2344568999999999999999999999999999999999999995321 111111111
Q ss_pred HHhhcccccccc------ccccCC--CC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 346 GLLKEKKLEQLV------DSDMEG--NY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 346 ~~~~~~~~~~~~------d~~~~~--~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..........+. ...... .. .......+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111100000000 000000 00 0123456889999999999999999999876
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=338.04 Aligned_cols=246 Identities=23% Similarity=0.270 Sum_probs=194.0
Q ss_pred CCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccCCc
Q 013238 127 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 567999999999999975 689999999976432 334578899999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE--CCCCcEEEeecCCccccCCCCCce
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 999886543 2389999999999999999999999 99999999999999 677899999999998764332 2
Q ss_pred eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCC
Q 013238 284 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 363 (447)
Q Consensus 284 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 363 (447)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+........ ....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~-------~~~~ 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILACRW-------DLED 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCC-------CSCS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccC-------CCCh
Confidence 233458999999999999899999999999999999999999995321 1111222211110 0000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 364 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 364 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.........+.+++.+||+.||.+|||+.++++
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011123456889999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=331.40 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=204.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-----hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|++.+.||+|+||.||+|... +|+.||||.+....... ....+.+|+++++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467889999999999999999986 58999999997543221 345789999999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeec
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 270 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df 270 (447)
++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999997532 489999999999999999999999 999999999999999888 7999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+........
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITSV 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998754322 2234458999999999999999999999999999999999999995311 11111111111
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.. . .+.. ........+.+++.+||+.||.+|||+.++++.
T Consensus 234 ~~--~-~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SY--D-FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC--C-CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc--c-cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 0000 001123568899999999999999999999873
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=338.38 Aligned_cols=258 Identities=26% Similarity=0.325 Sum_probs=204.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE----CCCcEEEEEEeccccc---cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCC
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 192 (447)
.++|+..+.||+|+||.||+++. .+++.||||+++.... ......+.+|++++..+ .|+||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788999999999999999987 3689999999975431 12233567799999998 6999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997653 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCC--CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...............
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----EKNSQAEISRRILKS 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT----SCCCHHHHHHHHHHC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC----ccchHHHHHHHHhcc
Confidence 986543333333445699999999999863 47899999999999999999999996321 122222222222211
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhc
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRMLEG 400 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~ 400 (447)
. ...+......+.+++.+||+.||.+|| |+.++++...-
T Consensus 282 ~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 282 E-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp C-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred C-----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 1 011122345688999999999999999 89998875543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=336.81 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=193.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|...+.||+|+||+||+|... +++.||||++...........+.+|+++++.++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999986 68999999997544332222455799999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+. |+|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 96 589888876532 489999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc---ccc
Q 013238 281 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL---EQL 356 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 356 (447)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+......... ...
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHhchhh
Confidence 22233458999999999876 568999999999999999999999995321 11122222221111100 000
Q ss_pred cc---------cccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VD---------SDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d---------~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. +...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 0000000 0112356789999999999999999999886
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=345.69 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=203.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888899999999999999986 689999999975432 123456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999996532 489999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||+... . ...........
T Consensus 169 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~---~~~~~~i~~~~------ 232 (476)
T 2y94_A 169 G--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----V---PTLFKKICDGI------ 232 (476)
T ss_dssp T--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----S---HHHHHHHHTTC------
T ss_pred c--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----H---HHHHHHHhcCC------
Confidence 2 22334569999999999988776 789999999999999999999996321 1 11111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+|||+.++++
T Consensus 233 ---~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 ---F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 011112346889999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.29 Aligned_cols=247 Identities=25% Similarity=0.343 Sum_probs=196.5
Q ss_pred CeeeecCCeEEEEEEEC---CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
+.||+|+||+||+|.+. .++.||||+++.... ......+.+|++++.+++||||+++++++.. ...++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999976533 2335679999999999999999999999864 558899999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC--
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-- 281 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 281 (447)
|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997643 489999999999999999999999 999999999999999999999999999987643322
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......+|..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+........
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--------~~~~~~~i~~~---------- 588 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKG---------- 588 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTT----------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcC----------
Confidence 12223346788999999999999999999999999999998 999995321 11111111111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.....+..+...+.++|.+||+.||.+|||+.+|++.|+.
T Consensus 589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111222345679999999999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=329.08 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=197.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|+..+.||+|+||+||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888899999999999999986 5899999998654332 224567889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+++|..++.... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999998876543 389999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc--------
Q 013238 280 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------- 350 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 350 (447)
.. ......||..|+|||++.+ ..++.++||||||+++|+|++|+.||.... .......+......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-----DVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhcccccccccc
Confidence 22 2233458999999999876 568999999999999999999999995321 11111111111100
Q ss_pred ---c-ccccccccccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 351 ---K-KLEQLVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 351 ---~-~~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. .......+...... .......+.+++.+||+.||.+|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00000000000000 01234568899999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=337.62 Aligned_cols=269 Identities=25% Similarity=0.350 Sum_probs=195.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHH--HHhcCCCceeeEeeeeec-----CCc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM--ISMAVHRNLLRLRGFCMT-----PTE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~ 193 (447)
.++|+..+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46788899999999999999987 58999999996432 2233444444 456899999999985532 235
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceecCCCCCCEEECCCCcEEE
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------DPKIIHRDVKAANILLDEEFEAVV 267 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivH~dlk~~Nill~~~~~~kl 267 (447)
.++||||+++|+|.+++.... .++..++.++.||+.||+|||+.+ .++|+||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 689999999999999997653 588999999999999999999873 338999999999999999999999
Q ss_pred eecCCccccCCCC-------CceeeccccccCccccccccC-------CCCCchhhhHHHHHHHHHHHhCCCCccccccc
Q 013238 268 GDFGLAKLMDYKD-------THVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELITGQRAFDLARLA 333 (447)
Q Consensus 268 ~Dfgl~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~elltg~~p~~~~~~~ 333 (447)
+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998664321 112223468999999999977 35567899999999999999998877432211
Q ss_pred CCCcccH---------HHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 334 NDDDVML---------LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 334 ~~~~~~~---------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
....... ................+... ..........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 1110000 00111111111111000000 111234667799999999999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=339.31 Aligned_cols=252 Identities=22% Similarity=0.266 Sum_probs=189.4
Q ss_pred hCCCCC-CeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHH-HhcCCCceeeEeeeeec----CCcc
Q 013238 122 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 194 (447)
Q Consensus 122 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 194 (447)
++|... ++||+|+||+||++... +|+.||||++... ..+.+|++++ +..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 455555 68999999999999976 5889999998532 2466788876 45589999999998865 4567
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeecC
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 271 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 271 (447)
++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999976432 3489999999999999999999999 9999999999999998 7899999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+. . .
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~i~---~-~ 282 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRIR---M-G 282 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHHHHH---H-T
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHHHHH---c-C
Confidence 99865422 22334568999999999999999999999999999999999999996422111101 1111111 0 0
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.. .............+.+++.+||+.||.+|||+.++++.
T Consensus 283 ~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 00001112234568899999999999999999999983
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=328.39 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=197.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC-CcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-TERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 198 (447)
..++|+..+.||+|+||.||++... |+.||||.++... ....+.+|+++++.++||||+++++++... +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3467888999999999999999885 8899999997543 345688999999999999999999987654 4789999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999976432 1278899999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.. ....++..|+|||++.+..++.++||||||+++|||+| |+.||.... ..... ......
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~~~~---~~~~~~------- 230 (278)
T 1byg_A 170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVV---PRVEKG------- 230 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHH---HHHTTT-------
T ss_pred cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HHHHH---HHHhcC-------
Confidence 21 22347889999999999999999999999999999998 999995321 11111 111111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
............+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 231 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 231 ---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11111223346689999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=328.26 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=179.9
Q ss_pred CCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEEecccCC
Q 013238 127 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNG 204 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 204 (447)
.+.||+|+||+||+|... +++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999986 5899999999643 2346778999999997 999999999999999999999999999
Q ss_pred cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEEeecCCccccCCCCC
Q 013238 205 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 205 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~~~ 281 (447)
+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 163 (325)
T 3kn6_A 92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163 (325)
T ss_dssp BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence 9999997643 489999999999999999999999 999999999999997765 89999999998654332
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 361 (447)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+.......... ..
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~~~~-------~~ 235 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKKGDF-------SF 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCC-------CC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHcCCC-------CC
Confidence 22334458999999999999999999999999999999999999996422110 11112222222211100 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 362 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...........+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 01111223567899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=335.82 Aligned_cols=252 Identities=16% Similarity=0.184 Sum_probs=202.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEE------ECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC---CCceeeEeeeee
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCM 189 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 189 (447)
...++|...+.||+|+||+||+|. ..+++.||||++.... ...+..|.+++..++ |+||+.+++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 445788899999999999999994 3468899999996542 335777888887776 999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-------
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE------- 261 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~------- 261 (447)
..+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999976432 234599999999999999999999999 9999999999999998
Q ss_pred ----CCcEEEeecCCccccCC-CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCC
Q 013238 262 ----EFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 336 (447)
Q Consensus 262 ----~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~ 336 (447)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 89999999999976532 2333445567999999999999999999999999999999999999999532110
Q ss_pred cccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhc
Q 013238 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER-PKMSEVVRMLEG 400 (447)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~ 400 (447)
... +...+.... ..+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 292 -------------~~~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 292 -------------ECK----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -------------EEE----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -------------cee----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 001 111111111 23457778889999999999 678888877775
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=326.75 Aligned_cols=261 Identities=18% Similarity=0.225 Sum_probs=199.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeee-ecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv 197 (447)
..++|+..+.||+|+||.||+|... +++.||||++...... ..+.+|++++..++|++++..++.+ ......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3578999999999999999999974 6899999987544322 2477899999999998877777665 556678999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeecCCcc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 274 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~ 274 (447)
|||+ +++|.+++..... ++++..++.++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 9999999975432 489999999999999999999999 99999999999999 788999999999998
Q ss_pred ccCCCCCc------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh
Q 013238 275 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 275 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-hhhhhhhhcccc
Confidence 76543221 22345689999999999999999999999999999999999999964321111 111111111111
Q ss_pred hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 349 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.. .... .. ......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 236 ~~-~~~~-----~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 236 ST-PIEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HS-CHHH-----HT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred cc-hhhh-----hh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 10 0000 00 01135689999999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.37 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=198.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|+..+.||+|+||+||+|... +++.||||.+..... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999986 689999999975432 23345688899999888 899999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---------------
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--------------- 262 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~--------------- 262 (447)
|||+++++|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999987543334589999999999999999999999 99999999999999844
Q ss_pred ----CcEEEeecCCccccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCc
Q 013238 263 ----FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 337 (447)
Q Consensus 263 ----~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~ 337 (447)
..+||+|||++....... ...||..|+|||++.+. .++.++||||||+++|+|++|..++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 479999999998754322 23489999999999776 56789999999999999999988763210
Q ss_pred ccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 338 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. ... ..... +. .+......+.+++.+||+.||.+|||+.++++
T Consensus 236 -~~----~~~-~~~~~-----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -QW----HEI-RQGRL-----PR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HH----HHH-HTTCC-----CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HH----HHH-HcCCC-----CC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00 111 11111 11 11123456889999999999999999999876
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=325.47 Aligned_cols=260 Identities=18% Similarity=0.227 Sum_probs=202.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeee-ecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 198 (447)
.++|+..+.||+|+||.||+|.. .+|+.||||++...... ..+.+|++++..++|++++..++++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46788999999999999999997 47899999998654322 2578999999999998877766665 4566779999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeecCCccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 275 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~ 275 (447)
||+ +++|.+++..... ++++..++.++.|++.||+|||++ +++||||||+|||+ ++++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 9999999975432 489999999999999999999999 99999999999999 4888999999999987
Q ss_pred cCCCCCc------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 276 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 276 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
....... ......||..|+|||++.+..++.++||||||+++|||++|+.||....... ..............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-KRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-SSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh-hhhhhhhhcccccC
Confidence 6543321 1234568999999999999999999999999999999999999996432111 11111111111111
Q ss_pred ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
. .... +. ......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 237 ~-~~~~-----~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 237 T-PIEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp S-CHHH-----HT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred C-chHH-----HH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 1 0000 00 11235689999999999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=322.53 Aligned_cols=250 Identities=20% Similarity=0.230 Sum_probs=201.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||.||+|... ++..+|+|++..... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 467889999999999999999986 477899999976543 234578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeecCCcccc
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~ 276 (447)
|+++++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999887653 389999999999999999999999 99999999999999 88899999999999865
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
.... ......||+.|+|||++.+. ++.++||||||+++|||++|+.||.... ..+.......... .
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~-~-- 225 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVMLKIREGTF-T-- 225 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC-C--
T ss_pred cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCC-C--
Confidence 4332 23344589999999998654 8999999999999999999999995321 1111111111100 0
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............+.+++.+||+.||.+|||+.++++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 ----FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000012456889999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=333.85 Aligned_cols=252 Identities=20% Similarity=0.298 Sum_probs=199.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 197 (447)
..++|+..+.||+|+||.||+|... +|+.||||++...... ..+|++++.++ +||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999986 5889999999754322 34678888777 799999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC----CcEEEeecCCc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLA 273 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~ 273 (447)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 99999999999987543 489999999999999999999999 99999999999998543 35999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||... ......+......... .
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~~~~i~~~~-~ 240 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG-----PDDTPEEILARIGSGK-F 240 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS-----TTSCHHHHHHHHHHCC-C
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC-----CcCCHHHHHHHHccCC-c
Confidence 87643322 233456899999999998888899999999999999999999999631 1112222222221111 0
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.............+.+++.+||+.||.+|||+.++++
T Consensus 241 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 ------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111112233456889999999999999999999886
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=349.55 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=205.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|++++..++||||+++++++.+....++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888899999999999999986 689999999965432 22345678999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999976532 3489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ................
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~----~~~~~~~i~~~i~~~~------ 405 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK----KKIKREEVERLVKEVP------ 405 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS----SCCCHHHHHHHHHHCC------
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc----cchhHHHHHHHhhccc------
Confidence 322 2334579999999999999899999999999999999999999996421 1111111111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
...+......+.+++.+||+.||.+|| ++.|+++
T Consensus 406 -----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 -----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011122345688999999999999999 6777765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.05 Aligned_cols=278 Identities=24% Similarity=0.355 Sum_probs=204.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|+..+.||+|+||.||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888899999999999999986 4899999998654332 234457889999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.+++|..++.... .+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999888765432 389999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH-----------H
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG-----------L 347 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 347 (447)
. .......|+..|+|||++.+. .++.++||||||+++|+|++|+.||..... .......... .
T Consensus 178 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 178 G-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD----IDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHHHHHHH
T ss_pred c-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhhhHh
Confidence 2 222334589999999999775 789999999999999999999999953211 0111111100 0
Q ss_pred hhccccccccccccCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCchhhHHHH
Q 013238 348 LKEKKLEQLVDSDMEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGDGLAERWEEWQ 411 (447)
Q Consensus 348 ~~~~~~~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~~~~~ 411 (447)
...........+....... ......+.+++.+||+.||.+|||+.|+++ .++.....+.+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~ 323 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQEL 323 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHHHHHHH
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhhhhHHH
Confidence 0011111111111111111 123467899999999999999999999987 444444444444433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=328.49 Aligned_cols=256 Identities=20% Similarity=0.289 Sum_probs=188.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHH-HHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
..++|+..+.||+|+||+||+|... +|+.||||++........... +.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4568889999999999999999975 689999999976544333333 44444557888999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||++ |+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99996 5888887664333446999999999999999999999853 89999999999999999999999999998654
Q ss_pred CCCCceeeccccccCccccccc----cCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||... .. ....+........
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~-~~~~~~~~~~~~~- 231 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW------GT-PFQQLKQVVEEPS- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC------SC-HHHHHHHHHHSCC-
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc------Cc-hHHHHHHHhccCC-
Confidence 322 22233589999999996 5567899999999999999999999999531 11 1111111111111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...........+.+++.+||+.||.+|||+.++++
T Consensus 232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 --------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01111123456889999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=330.96 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=206.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-----CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC--c
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--E 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~ 193 (447)
.++|+..+.||+|+||.||++.+ .+++.||||++.... ......+.+|+++++.++||||+++++++.... .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 45788889999999999999984 358899999997543 334457899999999999999999999987643 6
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 7999999999999999987532 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCce--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccc------cCCC-cccHHHHH
Q 013238 274 KLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL------ANDD-DVMLLDWV 344 (447)
Q Consensus 274 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~------~~~~-~~~~~~~~ 344 (447)
.......... .....++..|+|||++.+..++.++||||||+++|||+||..|+..... .... .......+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8765433221 1223467789999999988899999999999999999999999863210 0000 00111111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..... .......+......+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 273 ~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 273 IELLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhh---------cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 1111111223446789999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.12 Aligned_cols=260 Identities=19% Similarity=0.218 Sum_probs=193.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 192 (447)
.++|+..+.||+|+||+||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468899999999999999999876 58999999997543 2233456889999999999999999999987553
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++||||+.+ +|...+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 45999999966 46655532 288999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc-
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK- 351 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 351 (447)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~-----~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-----YIDQWNKVIEQLGTPC 283 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCSCC
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCC
Confidence 9865432 22344569999999999999999999999999999999999999995321 111111110000000
Q ss_pred ---------ccccccc---------------cccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 ---------KLEQLVD---------------SDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ---------~~~~~~d---------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.....+. ..+.. .........+.+++.+||+.||.+|||+.|+++.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00000 0011225678999999999999999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.06 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=202.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec--------
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-------- 190 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 190 (447)
..++|+..+.||+|+||.||+|... +++.||+|.+.... ..+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567889999999999999999986 68999999996543 246789999999999999999998754
Q ss_pred --------CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 013238 191 --------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 262 (447)
Q Consensus 191 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~ 262 (447)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ +++||||||+||+++++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 3347899999999999999976432 3489999999999999999999999 99999999999999999
Q ss_pred CcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHH
Q 013238 263 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 263 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 342 (447)
+.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|||++|..|+... ..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~ 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SK 226 (284)
T ss_dssp TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HH
T ss_pred CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HH
Confidence 999999999998764332 223345899999999999999999999999999999999999988421 11
Q ss_pred HHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 343 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
..... .. ..... .....+.+++.+||+.||.+|||+.++++.|+...
T Consensus 227 ~~~~~-~~--------~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 227 FFTDL-RD--------GIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHH-HT--------TCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHh-hc--------ccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11111 11 11111 12345788999999999999999999999998654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.82 Aligned_cols=265 Identities=25% Similarity=0.287 Sum_probs=195.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc----hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
..++|+..+.||+|+||.||+|... +|+.||||++....... ....+.+|+++++.++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3568999999999999999999976 58999999997543221 123578899999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+.+ +|..++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999975 8888886543 2488889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.... .......+.........
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-----~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTE 234 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHHcCCCCh
Confidence 764332 223345689999999998764 58999999999999999999999985321 11111111111111000
Q ss_pred ccccc------cc---cCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 354 EQLVD------SD---MEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 354 ~~~~d------~~---~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
....+ .. ...... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 00 000001 1224678999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=336.37 Aligned_cols=200 Identities=25% Similarity=0.387 Sum_probs=175.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|+..+.||+|+||.||+|... +++.||+|++...........+.+|+++++.++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467888999999999999999986 6899999999766555555678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+++++|.+++.... .+++..+..++.+++.||+|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999997754 3899999999999999999999832 7999999999999999999999999998754321
Q ss_pred CCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12334689999999999999999999999999999999999999963
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=322.50 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=201.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-----chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+++++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467888999999999999999987 6899999998754322 1355789999999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeec
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 270 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df 270 (447)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997643 489999999999999999999999 999999999999999877 8999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+........
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~ 226 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETLTNISAV 226 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHHHHhHhc
Confidence 9998654322 2233458999999999999999999999999999999999999995321 11111111110
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ..............+.+++.+||+.||.+|||+.++++
T Consensus 227 ~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 N-------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C-------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 00000001112356889999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=329.40 Aligned_cols=260 Identities=22% Similarity=0.242 Sum_probs=194.5
Q ss_pred hCCCCC-CeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHh-cCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+.|.+. +.||+|+||.||+|... +++.||||++.... ......+.+|++++.+ .+||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 467764 78999999999999865 68999999997543 2334578899999988 47999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEeecCCccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 275 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~ 275 (447)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999997753 389999999999999999999999 9999999999999998776 99999999876
Q ss_pred cCCCCC------ceeeccccccCccccccccC-----CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCccc-----
Q 013238 276 MDYKDT------HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM----- 339 (447)
Q Consensus 276 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~----- 339 (447)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 11223458999999999875 45789999999999999999999999643211100000
Q ss_pred --HHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 340 --LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 340 --~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.......... .... ............+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~i~~-~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQE-GKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHH-CCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhc-cCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0011111111 0000 000000112356889999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.77 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=203.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|...+.||+|+||.||++... +++.||+|++..... ......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888899999999999999986 478999999875432 23345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987653 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.... ..+.........
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~------ 257 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNE------ 257 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTC------
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcCC------
Confidence 3222 2233468999999999999999999999999999999999999995321 111111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+ .......+.+++.+||+.||.+|||+.++++
T Consensus 258 -~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 -YSI----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001 1122345888999999999999999999886
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=323.45 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=196.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec----CCcceE
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLL 196 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 196 (447)
.|...+.||+|+||.||+|... ++..||+|.+..... ......+.+|+++++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667788999999999999875 578999999875432 3334568899999999999999999998764 345789
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEEC-CCCcEEEeecCCc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLA 273 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~ 273 (447)
||||+++++|.+++.... .+++..++.++.|++.||.|||++ + ++||||||+|||++ +++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999997653 389999999999999999999999 7 99999999999998 7899999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||... ................
T Consensus 180 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 180 TLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGVKP 248 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTCCC
T ss_pred cccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc-------CcHHHHHHHHhccCCc
Confidence 754332 223446899999999886 45899999999999999999999999531 1112222222111111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. .. .......+.+++.+||+.||.+|||+.++++
T Consensus 249 ~-~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 A-SF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G-GG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-cc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 01 1111245889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.36 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=203.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|...+.||+|+||.||++... +++.+|+|.+..... ......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888899999999999999986 578999999865432 23345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+.+++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999887653 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ..+.........
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~------ 231 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNE------ 231 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTC------
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhhcc------
Confidence 3222 2233458999999999999899999999999999999999999996321 111111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
... +......+.+++.+||+.||.+|||+.++++
T Consensus 232 -~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 -YSI----PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCC----ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 001 1122346889999999999999999999876
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=328.78 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=203.8
Q ss_pred HHHHHHHhhCCCCC-CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC-CCceeeEeeeee
Q 013238 114 LRELQVATDNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV-HRNLLRLRGFCM 189 (447)
Q Consensus 114 ~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 189 (447)
+...+...++|... +.||+|+||.||+|... +++.||+|++..... ......+.+|+.++..+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33345556777776 88999999999999976 589999999976443 233557889999999885 699999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEE
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAV 266 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~k 266 (447)
.....++||||+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999986532 23489999999999999999999999 9999999999999998 78999
Q ss_pred EeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 267 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 267 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+....
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~ 244 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------NQETYLN 244 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------chHHHHH
Confidence 99999998754322 2233468999999999999999999999999999999999999995321 1111111
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... ...............+.+++.+||+.||.+|||+.++++
T Consensus 245 i~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 245 ISQV-------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHT-------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhc-------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1110 001111112233456889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=339.28 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=192.1
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-------chHHHHHHHHHHHHhcCCCceeeEeeeeec
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLRLRGFCMT 190 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 190 (447)
...++|...+.||+|+||+||+|... +++.||||++...... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999876 5899999999754311 112247899999999999999999999754
Q ss_pred CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---cEEE
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 267 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~---~~kl 267 (447)
...++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 45799999999999999886543 489999999999999999999999 999999999999997544 5999
Q ss_pred eecCCccccCCCCCceeeccccccCccccccccC---CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 268 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 268 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+...+
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQI 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS----SSCCHHHHH
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc----chHHHHHHH
Confidence 999999875432 22334569999999999864 567889999999999999999999996321 111121111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.. .... .. ..........+.+++.+||+.||.+|||+.++++.
T Consensus 358 ~~----~~~~-~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TS----GKYN-FI-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HT----TCCC-CC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hc----CCCC-CC-----chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11 0000 00 00001124568899999999999999999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.59 Aligned_cols=261 Identities=18% Similarity=0.208 Sum_probs=201.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC---------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceee--------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTD---------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR-------- 183 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------- 183 (447)
.++|++.+.||+|+||.||+|.... ++.||||.+... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3578889999999999999999763 789999998654 24778999999999999987
Q ss_pred -------Eeeeeec-CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 013238 184 -------LRGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 255 (447)
Q Consensus 184 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~ 255 (447)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 5666665 67789999999 999999998642 23499999999999999999999999 9999999999
Q ss_pred CEEECCCC--cEEEeecCCccccCCCCCc------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCc
Q 013238 256 NILLDEEF--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327 (447)
Q Consensus 256 Nill~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~ 327 (447)
|||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 9999999999765432211 123346899999999999999999999999999999999999999
Q ss_pred ccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 328 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.... ............... ....+.+.... .......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 269 ~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 269 TNCL---PNTEDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GGGT---TCHHHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccCC---cCHHHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 6421 011112222221111 11111111100 011235689999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=319.17 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=202.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|...+.||+|+||.||+|... +++.||||.+..... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888899999999999999986 578999999965422 22345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|.+++.... .+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999997653 389999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ..+........
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~------- 227 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIVNV------- 227 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT-------
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHhcc-------
Confidence 321 233458999999999999999999999999999999999999996321 11111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+.. .+......+.+++.+||+.||.+|||+.++++
T Consensus 228 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 DLK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 001 11123356889999999999999999999876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=344.19 Aligned_cols=195 Identities=24% Similarity=0.364 Sum_probs=154.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Cc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 193 (447)
.++|++.+.||+|+||+||+|... +++.||||++..... ......+.+|+++++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999876 689999999965432 23345688999999999999999999998543 56
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+ +++|..++.... .+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 678999886542 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--------------------------ceeeccccccCccccccc-cCCCCCchhhhHHHHHHHHHHHhC
Q 013238 274 KLMDYKDT--------------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITG 323 (447)
Q Consensus 274 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltg 323 (447)
+....... ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87643211 122345689999999986 566799999999999999999994
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=335.99 Aligned_cols=200 Identities=23% Similarity=0.319 Sum_probs=167.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Cc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 193 (447)
.++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 588999999975432 23345788999999999999999999998765 56
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+. |+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999985 69999987542 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---------------------ceeeccccccCccccccc-cCCCCCchhhhHHHHHHHHHHHhCCCCcc
Q 013238 274 KLMDYKDT---------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFD 328 (447)
Q Consensus 274 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltg~~p~~ 328 (447)
+....... .......||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87643221 123455689999999986 56679999999999999999999766654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=331.82 Aligned_cols=256 Identities=24% Similarity=0.293 Sum_probs=185.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeee--------
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM-------- 189 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-------- 189 (447)
...+|+..+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 4457888999999999999999975 68999999985543 333456889999999996 999999999984
Q ss_pred cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCcEEE
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVV 267 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~dlk~~Nill~~~~~~kl 267 (447)
.....+++|||+. |+|.+++..... ..++++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 2334689999995 799998876322 22499999999999999999999999 8 999999999999999999999
Q ss_pred eecCCccccCCCCCce-----------eeccccccCccccccc---cCCCCCchhhhHHHHHHHHHHHhCCCCccccccc
Q 013238 268 GDFGLAKLMDYKDTHV-----------TTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 333 (447)
Q Consensus 268 ~Dfgl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~ 333 (447)
+|||+++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765332211 1133589999999998 5667899999999999999999999999532110
Q ss_pred CCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 334 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
. +................+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 260 --------~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 260 --------R-------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ---------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------H-------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 00000000011111234788999999999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=345.44 Aligned_cols=244 Identities=14% Similarity=0.124 Sum_probs=188.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHH---HHHHhcCCCceeeEe-------ee
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEV---EMISMAVHRNLLRLR-------GF 187 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 187 (447)
.++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+ +.++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 356888899999999999999964 68999999997532 223345788999 455666899999998 55
Q ss_pred eecCC-----------------cceEEEecccCCcchhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 013238 188 CMTPT-----------------ERLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247 (447)
Q Consensus 188 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 247 (447)
+.+.+ ..+++|||+ +|+|.+++...... ...+++..++.|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 68999999864321 11244688889999999999999999 99
Q ss_pred eecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCC-----------CCCchhhhHHHHHH
Q 013238 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGVM 316 (447)
Q Consensus 248 vH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG~i 316 (447)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999998532 23344557 999999999887 89999999999999
Q ss_pred HHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 317 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 317 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+|||++|+.||...... .....+... . . .....+.+++.+||+.||.+|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~-----------------~~~~~~~~~-~-~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAAL-----------------GGSEWIFRS-C-K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC-----------------------CCSGGGGSS-C-C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccc-----------------cchhhhhhh-c-c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999532110 011111110 0 1 12356889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=329.43 Aligned_cols=264 Identities=20% Similarity=0.282 Sum_probs=192.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
..++|+..+.||+|+||+||+|... +++.||||++....... ....+.+|+++++.++||||+++++++......++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3468999999999999999999875 68999999997543322 234577899999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE-----CCCCcEEEeecCC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGL 272 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfgl 272 (447)
|||+. |+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99997 59999987653 389999999999999999999999 99999999999999 4556699999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc-
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE- 350 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 350 (447)
++....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||.... ....+..........
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS----EIDQLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCC
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC----HHHHHHHHHHHhCCCc
Confidence 986643222 22334579999999999875 48999999999999999999999995321 111111111110000
Q ss_pred -cccccc------cc--cccCCCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 -KKLEQL------VD--SDMEGNYIE-----EEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 -~~~~~~------~d--~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...... .. +........ .....+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 00 000011111 12356889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=325.47 Aligned_cols=256 Identities=19% Similarity=0.246 Sum_probs=197.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeec--CCcceE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT--PTERLL 196 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~l 196 (447)
.++|++.+.||+|+||+||+|... +++.||||++.... ...+.+|+++++.++ ||||+++++++.+ ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 367888999999999999999874 68999999996432 346889999999997 9999999999987 566899
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeecCCccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKL 275 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~ 275 (447)
||||+.+++|.+++.. +++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 111 v~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 9999999999998853 78899999999999999999999 999999999999999776 899999999986
Q ss_pred cCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
...... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||... ....................
T Consensus 181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~----~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG----HDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC----SSHHHHHHHHHHHHCHHHHH
T ss_pred cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC----CchHHHHHHHHHhcCCchhh
Confidence 543322 233468999999999877 67899999999999999999999999421 11111111111111000000
Q ss_pred ccc-----------------------ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 355 QLV-----------------------DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 355 ~~~-----------------------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+ ...............+.+++.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000111112223567899999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.44 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=196.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
.|....+||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4555668999999999999975 68899999997543 233456889999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeecCCccccCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~ 280 (447)
++++|.+++..... ...+++..++.++.|++.||.|||++ +++|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999976532 23477999999999999999999999 9999999999999987 8999999999998654322
Q ss_pred CceeeccccccCccccccccCCC--CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||..... ...........
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~--------- 241 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMF--------- 241 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHH---------
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccc---------
Confidence 1 223345899999999987653 78999999999999999999999953210 00011010000
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
......+......+.+++.+||+.||.+|||+.++++
T Consensus 242 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 -KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0011112223456889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=336.38 Aligned_cols=263 Identities=19% Similarity=0.241 Sum_probs=195.1
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC-----
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP----- 191 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 191 (447)
+...++|+..+.||+|+||+||+|... +|+.||||++...... ..+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 455678999999999999999999875 6899999998654322 24799999999999999999998543
Q ss_pred ---------------------------------CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 013238 192 ---------------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238 (447)
Q Consensus 192 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~y 238 (447)
...++||||++ |+|.+.+.........+++..++.++.||+.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 23789999997 58888776543334469999999999999999999
Q ss_pred HHhCCCCCceecCCCCCCEEEC-CCCcEEEeecCCccccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHH
Q 013238 239 LHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVM 316 (447)
Q Consensus 239 LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~i 316 (447)
||++ +|+||||||+|||++ .++.+||+|||+++....... .....+|..|+|||++.+. .++.++|||||||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 999999999999997 688999999999986543322 2334589999999998775 48999999999999
Q ss_pred HHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc----------cccccccCCC-----CcHHHHHHHHHHHHHcc
Q 013238 317 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE----------QLVDSDMEGN-----YIEEEVEQLIQVALLCT 381 (447)
Q Consensus 317 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~d~~~~~~-----~~~~~~~~l~~li~~cl 381 (447)
+|||++|+.||.... ....+...+.. ....... ...-+..... ........+.+++.+||
T Consensus 232 l~ell~g~~pf~~~~----~~~~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 232 FGELILGKPLFSGET----SIDQLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHSSCSSCCSS----HHHHHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCCC----hHHHHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 999999999996321 11111111111 1100000 0000000011 11123456899999999
Q ss_pred CCCCCCCCCHHHHHH
Q 013238 382 QGSPMERPKMSEVVR 396 (447)
Q Consensus 382 ~~dP~~RPt~~evl~ 396 (447)
+.||.+|||+.|+++
T Consensus 307 ~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999886
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=330.56 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=192.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 192 (447)
.++|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 457888999999999999999975 689999999965432 233456889999999999999999999987653
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++||||+ +++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 88999998763 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKVTGTP 245 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCC
Confidence 9865432 233468999999999877 6789999999999999999999999963211 11111111100000
Q ss_pred c------------------cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 352 K------------------LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 352 ~------------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. +.......+ ..........+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 000000000 0011123456889999999999999999999988
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=327.69 Aligned_cols=258 Identities=29% Similarity=0.396 Sum_probs=196.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC--CCc--EEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT--DGS--LVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|+..+.||+|+||+||+|.+. +++ .||||+++... .......+.+|+++++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457888999999999999999853 233 68999987543 2233457889999999999999999999987654 8
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+.+++|.+++..... .+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999976532 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 275 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 275 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
......... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.... ..+.........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~ 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccC
Confidence 765433221 223347788999999988889999999999999999999 999995321 112222221111
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
. ...........+.+++.+||+.||.+|||+.++++.|+...
T Consensus 242 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 E---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 01111223466899999999999999999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=358.94 Aligned_cols=261 Identities=21% Similarity=0.326 Sum_probs=206.4
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 013238 116 ELQVATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 191 (447)
Q Consensus 116 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 191 (447)
+..+..++|+..+.||+|+||.||+|.+.. +..||||.+...........+.+|+.+++.++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 344456778888999999999999998742 45799999876554445567899999999999999999999984 4
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 66899999999999999997643 2489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
+++..............+++.|+|||++.+..++.++||||||+++|||++ |..||.... ..+........
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------~~~~~~~i~~~ 608 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENG 608 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHHT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHcC
Confidence 998765433333333456789999999998999999999999999999997 999995321 11111111111
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.. ...+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 609 ~~----------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 ER----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 111222345688999999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=320.57 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=203.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.++|...+.||+|+||.||++... +|+.||+|.+..... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 467888999999999999999976 689999999975432 223468899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeecCCcccc
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~ 276 (447)
|+++++|.+++.... .+++..++.++.|++.||.|||++ +++||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999987653 389999999999999999999999 99999999999999 78899999999998754
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ............ .
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~-~--- 224 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEKIKEGY-Y--- 224 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHCC-C---
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCC-C---
Confidence 321 1223458999999999999999999999999999999999999995311 111111111110 0
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGD 401 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 401 (447)
.............+.+++.+||+.||.+|||+.++++ .+.+.
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 225 ---EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0011111223456889999999999999999999997 45443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=327.63 Aligned_cols=267 Identities=25% Similarity=0.372 Sum_probs=186.0
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
.+..++|+..+.||+|+||.||+|... +++.||||.+...........+.+|++++..++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 455678999999999999999999865 6889999999765444445568899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 197 VYPFMVNGSVASCLRERG----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
||||+++++|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999987521 1223589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC----ceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHH
Q 013238 273 AKLMDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 347 (447)
Q Consensus 273 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 347 (447)
+........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ..... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~---~~ 239 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-----MKVLM---LT 239 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGHHH---HH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch-----hhHHH---HH
Confidence 876543211 11233458999999999876 5689999999999999999999999964211 11110 11
Q ss_pred hhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 348 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 348 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.... ....................+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 240 LQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1100 00000000000111122356889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.28 Aligned_cols=271 Identities=19% Similarity=0.254 Sum_probs=199.2
Q ss_pred cCHHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccc----------hHHHHHHHHHHHHhcCCCce
Q 013238 112 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG----------GELQFQTEVEMISMAVHRNL 181 (447)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~ni 181 (447)
..+.++....++|+..+.||+|+||.||+|...+|+.||||++....... ....+.+|+++++.++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34667788889999999999999999999998889999999996543221 12568899999999999999
Q ss_pred eeEeeeeecC-----CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 013238 182 LRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256 (447)
Q Consensus 182 v~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~N 256 (447)
+++++++... ...++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 9999998542 35699999997 68888886532 3489999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCC
Q 013238 257 ILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 335 (447)
Q Consensus 257 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~ 335 (447)
||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---- 238 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---- 238 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC----
Confidence 999999999999999997543222 2233458999999999877 678999999999999999999999996421
Q ss_pred CcccHHHHHHHHhhccccc-----------ccccccc---CCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 336 DDVMLLDWVKGLLKEKKLE-----------QLVDSDM---EGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~-----------~~~d~~~---~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.......+.......... ..+.... .... .......+.+++.+||+.||.+|||+.++++
T Consensus 239 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 239 -FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111111111100000 0000000 0000 1112356889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.45 Aligned_cols=254 Identities=11% Similarity=0.014 Sum_probs=179.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhc--CCCceeeEe-------eeee
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA--VHRNLLRLR-------GFCM 189 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~ 189 (447)
.+|...+.||+|+||+||+|.+. +|+.||||++..... ......+.+|++++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35778899999999999999976 689999999986543 22334567775444444 699988754 3443
Q ss_pred cC-----------------CcceEEEecccCCcchhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 013238 190 TP-----------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGAARGLAYLHDHCDPK 246 (447)
Q Consensus 190 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~~ 246 (447)
.. ...++||||+. |+|.+++..... .+.+..+ ..++.||+.||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 22 23699999998 899999987532 1444555 67889999999999999 9
Q ss_pred ceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccC--CCCCchhhhHHHHHHHHHHHhCC
Q 013238 247 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQ 324 (447)
Q Consensus 247 ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~ 324 (447)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 2223457799999999987 67899999999999999999999
Q ss_pred CCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 325 RAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 325 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.||......... .+........................+.+++.+||+.||.+|||+.++++
T Consensus 291 ~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKG----------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTT----------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCccccc----------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999643211000 00000000111111111111234567899999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=329.99 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=199.4
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec---
Q 013238 116 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--- 190 (447)
Q Consensus 116 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--- 190 (447)
++....++|+..+.||+|+||.||+|... +|+.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33445678999999999999999999985 68999999986543 2345688999999998 79999999999876
Q ss_pred ---CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEE
Q 013238 191 ---PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 267 (447)
Q Consensus 191 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl 267 (447)
....++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ +++|+||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 457899999999999999997643 22489999999999999999999999 9999999999999999999999
Q ss_pred eecCCccccCCCCCceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHH
Q 013238 268 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 268 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 342 (447)
+|||++........ ......|+..|+|||++. +..++.++||||||+++|+|++|+.||.... ...
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~ 241 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--------PMR 241 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHH
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHH
Confidence 99999986543221 123345899999999987 5678999999999999999999999995311 111
Q ss_pred HHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCC
Q 013238 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGDGL 403 (447)
Q Consensus 343 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 403 (447)
........ .... .. .......+.+++.+||+.||.+|||+.++++ .+.+...
T Consensus 242 ~~~~~~~~-~~~~-----~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 242 ALFLIPRN-PAPR-----LK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp HHHHHHHS-CCCC-----CS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred HHHHhhcC-cccc-----CC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 11111111 1111 10 1112356889999999999999999999998 5555443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=315.35 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=195.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|.+.+.||+|+||.||+|... +|+.||||.+..... ......+.+|+++++.++||||+++++++......++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999986 689999999965431 22345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+.+++|.+++.... .+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999997653 389999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... ......|++.|+|||++.+..+ +.++||||||+++|+|++|+.||.... ........... ..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~--- 228 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIRGG-VF--- 228 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC---
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhhcC-cc---
Confidence 322 2233458999999999988765 689999999999999999999995311 11111111111 00
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+......+.+++.+||+.||.+|||+.++++
T Consensus 229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011112356889999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.73 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=200.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 194 (447)
...++|++.+.||+|+||.||+|... +++.||||+++... .......+..|..++..+ +|+||+.+++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34567889999999999999999976 58899999997542 222344677888888877 699999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999998754 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~--- 558 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN--- 558 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHSSC---
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC---
Confidence 643222 23445679999999999999999999999999999999999999995321 122222222111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
...+......+.+++.+||+.||.+||++
T Consensus 559 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 --------VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred --------CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 01122334568899999999999999997
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.94 Aligned_cols=262 Identities=21% Similarity=0.313 Sum_probs=200.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Ccc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 194 (447)
.++|+..+.||+|+||.||+|... +++.||||++...........+.+|++++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999976 68899999997654444456788999999999999999999998654 357
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+. |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999996 5999988753 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 275 LMDYKDTHV--TTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 275 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-----YLDQLNHILGILGSP 251 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS-----GGGHHHHHHHHHCSC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHHHhCCC
Confidence 654322211 233468999999998654 458999999999999999999999995321 111222111111110
Q ss_pred ccccc---c--------cc-ccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 352 KLEQL---V--------DS-DMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 352 ~~~~~---~--------d~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....+ . .. ...... .......+.+++.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0 00 000000 0112356889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=340.22 Aligned_cols=260 Identities=18% Similarity=0.244 Sum_probs=202.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 198 (447)
.++|++.++||+|+||.||+|.+. +++.||||++...... ..+..|++++..+.| +++..+..++......++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 468999999999999999999974 6899999988654332 247789999999987 45555666667778889999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeecCCccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 275 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~ 275 (447)
||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 9999999975432 499999999999999999999999 99999999999999 6889999999999987
Q ss_pred cCCCCCc------eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 276 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 276 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~i~~ 230 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----GTKKQKYEKISE 230 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----SSHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc-----hhHHHHHHHHhh
Confidence 6543321 12245699999999999999999999999999999999999999964211 111111111111
Q ss_pred ccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 350 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 350 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
. .....+.. + .......+.+++..||+.+|.+||++.+|++.|+.+
T Consensus 231 ~-~~~~~~~~-l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 231 K-KVATSIEA-L----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp H-HHHSCHHH-H----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred c-cccccHHH-H----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 00000000 0 011235689999999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=323.48 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=200.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
..++|+..+.||+|+||.||+|... +|+.||||.+.... ....+.+|++++..++||||+++++++......++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4567889999999999999999986 58999999997543 2346889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+++|.+++.... ..+++..++.++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999997543 2489999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ........... ....
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~~--- 244 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAIFMIPTN-PPPT--- 244 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS-CCCC---
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcC-CCcc---
Confidence 222 2233458999999999999999999999999999999999999995311 11111111111 0000
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGD 401 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 401 (447)
..........+.+++.+||+.||.+|||+.++++ .+...
T Consensus 245 ----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 245 ----FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp ----CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0111223456889999999999999999999987 44443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=337.81 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=202.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
..++|++.+.||+|+||+||+|... +++.||||++..... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999986 689999999965432 23355788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCcEEEeecCCcc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAK 274 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~ 274 (447)
|||+.+|+|.+.+.... .+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999887653 389999999999999999999999 999999999999995 45679999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+............
T Consensus 173 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~ 241 (486)
T 3mwu_A 173 CFQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYAF 241 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCS
T ss_pred ECCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCC
Confidence 65432 22334569999999999876 58999999999999999999999995311 112222211111000
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
...........+.+++.+||+.||.+|||+.++++.
T Consensus 242 -------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 -------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001112234568899999999999999999999973
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=330.27 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=202.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccch----------------HHHHHHHHHHHHhcCCCceeeE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG----------------ELQFQTEVEMISMAVHRNLLRL 184 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~niv~l 184 (447)
.++|+..+.||+|+||.||+|.. +|+.||||.+........ ...+.+|+++++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999999999 899999999975432211 1678999999999999999999
Q ss_pred eeeeecCCcceEEEecccCCcchhh------hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCE
Q 013238 185 RGFCMTPTERLLVYPFMVNGSVASC------LRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANI 257 (447)
Q Consensus 185 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Ni 257 (447)
++++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||.|||+ + +++||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999999 4432 13459999999999999999999999 8 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCC-CCCc-hhhhHHHHHHHHHHHhCCCCcccccccCC
Q 013238 258 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSE-KTDVFGYGVMLLELITGQRAFDLARLAND 335 (447)
Q Consensus 258 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlG~il~elltg~~p~~~~~~~~~ 335 (447)
+++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|||++|+.||....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 256 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---- 256 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 9999999999999999865332 33445689999999999887 6666 9999999999999999999996321
Q ss_pred CcccHHHHHHHHhhccccccccc------cccC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 336 DDVMLLDWVKGLLKEKKLEQLVD------SDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~d------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. .+........ ......+ .... ..........+.+++.+||+.||.+|||+.++++
T Consensus 257 ~~---~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SL---VELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CS---HHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cH---HHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10 1111111111 1000000 0000 0001233467899999999999999999999988
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.47 Aligned_cols=252 Identities=25% Similarity=0.307 Sum_probs=199.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc------------chHHHHHHHHHHHHhcCCCceeeEee
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ------------GGELQFQTEVEMISMAVHRNLLRLRG 186 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~l~~ 186 (447)
..++|...+.||+|+||+||+|... +++.||||++...... .....+.+|+++++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3568999999999999999999986 5789999999754321 23456889999999999999999999
Q ss_pred eeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---
Q 013238 187 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF--- 263 (447)
Q Consensus 187 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~--- 263 (447)
++.+....++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999987653 389999999999999999999999 999999999999998876
Q ss_pred cEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHH
Q 013238 264 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 343 (447)
Q Consensus 264 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 343 (447)
.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.... ..+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~ 255 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDI 255 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHH
Confidence 69999999998764322 233456999999999986 468999999999999999999999995321 1122
Q ss_pred HHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 344 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 344 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............. .........+.+++.+||+.||.+|||+.++++
T Consensus 256 ~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKKVEKGKYYFDF-------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHCCCCCCH-------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCCCCc-------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2222111100000 000112356889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=327.02 Aligned_cols=255 Identities=20% Similarity=0.339 Sum_probs=202.6
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-------chHHHHHHHHHHHHhc-CCCceeeEeeee
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMA-VHRNLLRLRGFC 188 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 188 (447)
....++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.++..+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 444578999999999999999999986 6999999998654321 1134578899999998 799999999999
Q ss_pred ecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 013238 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 268 (447)
Q Consensus 189 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 268 (447)
......++||||+++++|.+++.... .+++..++.++.||+.||.|||+. +++|+||||+|||++.++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999997643 389999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCceeeccccccCccccccccC------CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHH
Q 013238 269 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 269 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 342 (447)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~~ 312 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------QIL 312 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------HHH
Confidence 999998765332 2334568999999999863 357889999999999999999999995311 111
Q ss_pred HHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 343 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
......... .. ...+. .......+.+++.+||+.||.+|||+.++++
T Consensus 313 ~~~~i~~~~-~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 MLRMIMEGQ-YQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHTC-CC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhCC-CC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111110 00 00000 0012355889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=340.53 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=197.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.++|+..+.||+|+||+||+|... ++..||||++..... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999986 688999999975432 223456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeecCCccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKL 275 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~ 275 (447)
||+.+|+|.+.+.... ++++..++.++.||+.||+|||++ +|+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999887653 389999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.... ..+...........
T Consensus 189 ~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~-- 255 (494)
T 3lij_A 189 FENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRKVEKGKYT-- 255 (494)
T ss_dssp CBTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCC--
T ss_pred CCCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC--
Confidence 5432 2233456999999999986 569999999999999999999999995321 11222222111100
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ...........+.+++.+||+.||.+|||+.++++
T Consensus 256 ~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 F-----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp C-----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0 00011123456889999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=315.33 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=197.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCceeeEeeeee--cCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 194 (447)
.++|.+.+.||+|+||.||++... +++.||+|++..... ......+.+|+++++.++|+||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999975 688999999975432 233457899999999999999999999985 34578
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+.++ |.+++..... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777765432 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CceeeccccccCccccccccCCC--CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 275 LMDYKD-THVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 275 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
...... ........|+..|+|||++.+.. ++.++||||||+++|||++|+.||.... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGKG- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhcC-
Confidence 764322 22233456899999999997654 3789999999999999999999996321 11222221111
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. .. .......+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 229 SY------AI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CC------CC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC------CC----CCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 01 1123456889999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=326.16 Aligned_cols=256 Identities=20% Similarity=0.241 Sum_probs=190.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 192 (447)
.++|+..+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357889999999999999999875 688999999975432 233456889999999999999999999987654
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++||||+. |+|.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 5799999996 578877752 288999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc--
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-- 350 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 350 (447)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+......
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~ 243 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--------IDQWNKVIEQLG 243 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHC-CC
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhC
Confidence 9865422 223345689999999999999999999999999999999999999953211 0111111000
Q ss_pred --------------------c-c-----cccccccccCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 --------------------K-K-----LEQLVDSDMEGN---YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 --------------------~-~-----~~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. . ............ ........+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0 000000000000 11233567899999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=339.79 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=204.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
..++|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3567999999999999999999986 689999999965432 2345678999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCcEEEeecCCc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 273 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~ 273 (447)
||||+.+|+|.+.+.... .+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999887543 489999999999999999999999 99999999999999 56789999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+...........
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~ 245 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILKKVEKGKYT 245 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 8764332 2234469999999999866 68999999999999999999999995321 11122222111100
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ...........+.+++.+||+.||.+|||+.++++
T Consensus 246 ~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 F-------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C-------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 00111223456889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=319.26 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=197.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3467889999999999999999986 58899999986543 233457889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++++|.+++..... .+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999876432 389999999999999999999999 999999999999999999999999998753211
Q ss_pred CCCceeeccccccCccccccc-----cCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYL-----STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
. ........|+..|+|||++ .+..++.++||||||+++|+|++|+.||.... ..............
T Consensus 170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSDPP 240 (302)
T ss_dssp H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCC
T ss_pred c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccCCc
Confidence 1 0112234589999999998 46678999999999999999999999995321 11111111111110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ..........+.+++.+||+.||.+|||+.++++
T Consensus 241 ~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 T--------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C--------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c--------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0111223456889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.94 Aligned_cols=265 Identities=25% Similarity=0.401 Sum_probs=201.3
Q ss_pred HHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 114 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
..++.+..++|+..+.||+|+||.||+|...+ .+|+|.++.... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445566789999999999999999999853 499999875432 222235778999999999999999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..+++|||+++++|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+||+++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999997643 2488999999999999999999999 999999999999998 67999999999
Q ss_pred ccccCCCC----CceeeccccccCccccccccC---------CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCccc
Q 013238 273 AKLMDYKD----THVTTAVRGTIGHIAPEYLST---------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339 (447)
Q Consensus 273 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~ 339 (447)
+....... ........|+..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------- 247 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------- 247 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Confidence 87543211 112223458899999999864 457889999999999999999999995321
Q ss_pred HHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCc
Q 013238 340 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLA 404 (447)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 404 (447)
........... ....... ......+.+++.+||+.||.+|||+.++++.|+.+.-.
T Consensus 248 ~~~~~~~~~~~-~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 248 AEAIIWQMGTG-MKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHHHHHHTT-CCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHHHHHhccC-CCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111111 1111110 01223488999999999999999999999999987554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=326.77 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=198.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecC--------
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 191 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 191 (447)
++|+..+.||+|+||.||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888999999999999999985 6899999998654332 2344678999999999999999999998763
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
+..++||||+.+ +|...+.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999965 7777775543 2489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC---CceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHH
Q 013238 272 LAKLMDYKD---THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 347 (447)
Q Consensus 272 l~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 347 (447)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHH
Confidence 998654222 122334568999999999876 45799999999999999999999999632 111111112111
Q ss_pred hhcccc---ccccc-----c----ccCCCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 348 LKEKKL---EQLVD-----S----DMEGNYIEEE------VEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 348 ~~~~~~---~~~~d-----~----~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...... ..... . .......... ...+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111000 00000 0 0000011111 245789999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=321.57 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=195.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-------cchHHHHHHHHHHHHhcCCCceeeEeeeeecC
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-------QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 191 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 191 (447)
..++|.+.+.||+|+||.||+|... +++.||||.+..... ......+.+|+++++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999976 588999999865421 11223478999999999999999999998765
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEe
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVG 268 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kl~ 268 (447)
. .++||||+++++|.+++.... .+++..++.++.||+.||.|||++ +++||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999999886532 489999999999999999999999 9999999999999987665 9999
Q ss_pred ecCCccccCCCCCceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 269 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 269 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
|||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|..||.... ....+...+.
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~ 233 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQIT 233 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT----CSSCHHHHHH
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hHHHHHHHHH
Confidence 99999865422 2223345899999999974 5678999999999999999999999996321 1112222211
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. .... .. + .........+.+++.+||+.||.+|||+.++++
T Consensus 234 ~----~~~~-~~-~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 S----GKYN-FI-P----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp H----TCCC-CC-H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred h----Cccc-cC-c----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 0000 00 0 000112456889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=330.32 Aligned_cols=265 Identities=21% Similarity=0.243 Sum_probs=199.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC--------CCceeeEeeeee--
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--------HRNLLRLRGFCM-- 189 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~-- 189 (447)
.++|++.+.||+|+||+||+|... +++.||||++... ......+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 468999999999999999999875 5889999999643 223456788999998885 788999999987
Q ss_pred --cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----
Q 013238 190 --TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---- 263 (447)
Q Consensus 190 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~---- 263 (447)
.....++||||+ +++|.+.+..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 456789999999 5666666654322 34899999999999999999999964 799999999999999775
Q ss_pred ---------------------------------------------cEEEeecCCccccCCCCCceeeccccccCcccccc
Q 013238 264 ---------------------------------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298 (447)
Q Consensus 264 ---------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~ 298 (447)
.+||+|||+++..... .....||..|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999865432 233468999999999
Q ss_pred ccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCC-cccHHHHHHHHhhcc---------ccccccccc--------
Q 013238 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-DVMLLDWVKGLLKEK---------KLEQLVDSD-------- 360 (447)
Q Consensus 299 ~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~d~~-------- 360 (447)
+.+..++.++|||||||++|||++|+.||......... .......+....... .........
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999642211100 011111111111100 000000000
Q ss_pred -----------cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 -----------MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............+.+++.+||+.||.+|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001234566778999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=326.12 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=198.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Ccc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 194 (447)
.++|...+.||+|+||.||+|... +|+.||||.+...........+.+|+++++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999976 68999999997554444455788999999999999999999987654 567
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+. ++|.+++... .+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 6899988763 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---------eeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 275 LMDYKDTH---------VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 275 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~ 235 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RHQLLLI 235 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHH
Confidence 76432211 1123458999999998754 6789999999999999999999999963211 1111111
Q ss_pred HHHhhccccc------------ccccc--ccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 345 KGLLKEKKLE------------QLVDS--DMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 345 ~~~~~~~~~~------------~~~d~--~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.......... +.+.. ...... .......+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111100000 00000 000000 0123456889999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=331.43 Aligned_cols=260 Identities=24% Similarity=0.332 Sum_probs=192.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC------Ccc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 194 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 194 (447)
.+|+..+.||+|+||+||+|.+. +|+.||||++..... ...+|+++++.++|+||+++++++... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 36788899999999999999986 589999999865432 234799999999999999999988542 125
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CcEEEeecCCc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 273 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~ 273 (447)
++||||+++ +|...+.........+++..++.++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999975 66666654323334599999999999999999999999 99999999999999955 67899999999
Q ss_pred cccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh---
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 349 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 349 (447)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+...+...-.
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~----~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS----GVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCSCCH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCH
Confidence 87543322 2334689999999998765 78999999999999999999999995321 11112222111100
Q ss_pred ------ccccccccccccCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 ------EKKLEQLVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 ------~~~~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.........+.+.... .......+.+++.+||+.||.+|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000011011111110 1122467899999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=333.78 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=191.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc------ce
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------RL 195 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 195 (447)
.+|+..+.||+|+||+||+|+...+..+|+|++...... ..+|+++++.++||||+++++++..... .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468889999999999999999987777999988654322 2369999999999999999999865432 67
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcEEEeecCCcc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAK 274 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~ 274 (447)
+||||+.++. ...+.........+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETV-YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEH-HHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccH-HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 9999997654 433332222234589999999999999999999999 999999999999999 79999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+...+... .....
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~l~~i~~~~-g~p~~ 263 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES----GIDQLVEIIKVL-GTPSR 263 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHH-CCCCH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHh-CCCCH
Confidence 7643322 2334689999999998765 58999999999999999999999995321 111111111110 00000
Q ss_pred cc-------ccc---cccCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQ-------LVD---SDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~-------~~d---~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. ... +..... ........+.+++.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 000 000000 01113457899999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=327.01 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=182.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCceeeEeeeeecC------C
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 192 (447)
.++|+..+.||+|+||.||+|... +|+.||||++.... .......+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999875 68999999996542 223345688999999999999999999998654 5
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++++|++ +++|.+++... .+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 579999999 78999988652 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCC
Confidence 9864322 233468999999999877 678999999999999999999999995321 111111111111100
Q ss_pred c---c--------cccccc--ccCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 K---L--------EQLVDS--DMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ~---~--------~~~~d~--~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. . ...+.. ....... ......+.+++.+||+.||.+|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0 000000 0000000 1123568899999999999999999999873
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=335.03 Aligned_cols=197 Identities=20% Similarity=0.263 Sum_probs=169.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhc------CCCceeeEeeeeecCCc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA------VHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~ 193 (447)
..+|++.+.||+|+||+||+|... +++.||||++.... .....+.+|++++..+ +|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457899999999999999999876 58999999997532 2234567788877766 57799999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--EEEeecC
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFG 271 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg 271 (447)
.++||||+. ++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999995 689998877543 2489999999999999999999999 9999999999999999987 9999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 99764322 2234689999999999999999999999999999999999999953
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=322.65 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=196.6
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcC--CCceeeEeeeeecCCc
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTE 193 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 193 (447)
+.+..++|++.+.||+|+||.||++...+++.||||++..... ......+.+|++++..++ |+||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3445678999999999999999999988899999999965432 233456889999999997 5999999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.+++|| +.+++|.+++.... .+++..++.++.|+++||.|||++ +++||||||+|||+++ +.+||+|||++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999 56889999998643 489999999999999999999999 9999999999999965 89999999999
Q ss_pred cccCCCCCc-eeeccccccCccccccccC-----------CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHH
Q 013238 274 KLMDYKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 274 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 341 (447)
......... ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||.... ...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~ 246 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQI 246 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-------HHH
Confidence 865433221 1233458999999999875 467889999999999999999999995311 111
Q ss_pred HHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 342 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 342 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........ ..............+.+++.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 SKLHAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11111111 11111111112356889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=313.88 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=202.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--------cchHHHHHHHHHHHHhcC-CCceeeEeeeeec
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--------QGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 190 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 190 (447)
.++|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468888999999999999999986 589999999965421 122345788999999996 9999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeec
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 270 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 270 (447)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999997653 389999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCceeeccccccCcccccccc------CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
|++....... ......|+..|+|||++. ...++.++||||||+++|||++|+.||.... .....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~ 238 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLML 238 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHH
Confidence 9998754332 223345899999999885 4568899999999999999999999995311 11111
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........ .............+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCc-------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111110 0011111234466899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=331.52 Aligned_cols=201 Identities=24% Similarity=0.380 Sum_probs=154.1
Q ss_pred hCCCC-CCeeeecCCeEEEEEEEC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec--CCcce
Q 013238 122 DNFSN-RNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERL 195 (447)
Q Consensus 122 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 195 (447)
+.|+. .++||+|+||+||+|... +++.||||++..... ...+.+|+++++.++||||+++++++.. ....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34555 458999999999999965 478999999975432 2357899999999999999999999854 56789
Q ss_pred EEEecccCCcchhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCcEE
Q 013238 196 LVYPFMVNGSVASCLRERG-----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAV 266 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill----~~~~~~k 266 (447)
+||||+. |+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999995 58887775422 1122489999999999999999999999 99999999999999 7789999
Q ss_pred EeecCCccccCCCCC--ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 267 VGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 267 l~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999987643211 223345689999999999874 589999999999999999999999963
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=323.45 Aligned_cols=270 Identities=21% Similarity=0.267 Sum_probs=188.4
Q ss_pred HHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc
Q 013238 115 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 193 (447)
Q Consensus 115 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 193 (447)
.......++|+..+.||+|+||.||+|... +|+.||||++...... .....++++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 344566789999999999999999999985 6899999998654322 2245677888889999999999999865433
Q ss_pred -------ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceecCCCCCCEEECC-CC
Q 013238 194 -------RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--DHCDPKIIHRDVKAANILLDE-EF 263 (447)
Q Consensus 194 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~ivH~dlk~~Nill~~-~~ 263 (447)
.++||||+.+ +|...+.........+++..++.++.|++.||.||| ++ +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 6899999976 555544433233445899999999999999999999 87 9999999999999997 89
Q ss_pred cEEEeecCCccccCCCCCceeeccccccCccccccccCCC-CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHH
Q 013238 264 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 342 (447)
Q Consensus 264 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 342 (447)
.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ....+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~ 243 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN----SAGQLHE 243 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC----hHHHHHH
Confidence 99999999998764332 223445899999999986654 8999999999999999999999996321 1111111
Q ss_pred HHHHHh-----------hccccccccccc------cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 343 WVKGLL-----------KEKKLEQLVDSD------MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 343 ~~~~~~-----------~~~~~~~~~d~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.+.... .........+.. ............+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111110 000000000000 000111124567999999999999999999999885
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.80 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=198.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC--CCcEEEEEEeccccccc-hHHHHHHHHHHHHhc---CCCceeeEeeeee----
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCM---- 189 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 189 (447)
..++|+..+.||+|+||.||+|... +|+.||+|++....... ....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3568999999999999999999983 58899999997543221 122456677776655 8999999999987
Q ss_pred -cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 013238 190 -TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 268 (447)
Q Consensus 190 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 268 (447)
.....++||||+. |+|.+++..... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4566899999997 699999976543 2489999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh
Q 013238 269 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 269 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
|||++...... .......|+..|+|||++.+..++.++||||||+++|||++|+.||.... .......+....
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~ 235 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVI 235 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHH
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHHHc
Confidence 99999765422 12233468999999999999999999999999999999999999996321 111111111111
Q ss_pred hccccccc----------cccc---cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 349 KEKKLEQL----------VDSD---MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 349 ~~~~~~~~----------~d~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........ .... ............+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10000000 0000 000011223456889999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.56 Aligned_cols=258 Identities=19% Similarity=0.263 Sum_probs=193.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc----
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER---- 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 194 (447)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999976 689999999975432 22345688999999999999999999999876654
Q ss_pred --eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 195 --LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 195 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
++||||+. ++|.+++.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 688877732 289999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+.......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVTGVP 261 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCC
Confidence 9854322 234468999999999887 678999999999999999999999996321 111111110000000
Q ss_pred c-----------ccccccc--ccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 K-----------LEQLVDS--DMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ~-----------~~~~~d~--~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
. ....... ...... .......+.+++.+||+.||.+|||+.++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 0000000 000000 01124668999999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=316.16 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=192.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec---------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------- 190 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 190 (447)
.++|+..+.||+|+||.||+|... +++.||||.+... ......+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467888999999999999999975 6899999999643 2334568899999999999999999998764
Q ss_pred ----CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEE
Q 013238 191 ----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 266 (447)
Q Consensus 191 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~k 266 (447)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 345689999999999999998643 2378899999999999999999999 999999999999999999999
Q ss_pred EeecCCccccCCCC-------------CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccc
Q 013238 267 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARL 332 (447)
Q Consensus 267 l~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~ 332 (447)
|+|||++....... ........|+..|+|||++.+. .++.++||||||+++|||++ ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-- 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-- 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--
Confidence 99999998654221 1122334589999999999764 68999999999999999998 54311
Q ss_pred cCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 333 ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
............. ...............+.+++.+||+.||.+|||+.++++.
T Consensus 232 -----~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 -----MERVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -----HHHHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----hhHHHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0111111111110 1111122233344568899999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=317.81 Aligned_cols=259 Identities=21% Similarity=0.271 Sum_probs=199.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-C-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc------eeeEeeeeecCC
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRL-T-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN------LLRLRGFCMTPT 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 192 (447)
.++|++.+.||+|+||.||+|.. . +++.||||+++... .....+.+|++++..++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 46889999999999999999987 3 58899999996432 23446788898888887654 999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-----------
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE----------- 261 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~----------- 261 (447)
..++||||+ +++|.+++..... .++++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 8899999976542 3489999999999999999999999 9999999999999987
Q ss_pred --------CCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccccccc
Q 013238 262 --------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 333 (447)
Q Consensus 262 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~ 333 (447)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-- 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-- 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC--
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--
Confidence 668999999999864332 233468999999999999999999999999999999999999995321
Q ss_pred CCCcccHHHHHHHHhhcccc--------cccc-ccc---------------------cCCCCcHHHHHHHHHHHHHccCC
Q 013238 334 NDDDVMLLDWVKGLLKEKKL--------EQLV-DSD---------------------MEGNYIEEEVEQLIQVALLCTQG 383 (447)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~--------~~~~-d~~---------------------~~~~~~~~~~~~l~~li~~cl~~ 383 (447)
.......+......... .... ... ............+.+++.+||+.
T Consensus 239 ---~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 239 ---SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp ---HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ---hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 11111111111100000 0000 000 00111234567799999999999
Q ss_pred CCCCCCCHHHHHH
Q 013238 384 SPMERPKMSEVVR 396 (447)
Q Consensus 384 dP~~RPt~~evl~ 396 (447)
||.+|||+.|+++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.81 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=179.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHH-HHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.++|+..+.||+|+||.||+|... +|+.||||++...........+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 468888999999999999999986 689999999976544444445666666 677789999999999999999999999
Q ss_pred ecccCCcchhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 199 PFMVNGSVASCLRERG-QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
||+.+ +|.+++.... .....+++..+..++.+++.||.|||+.. +++||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 8877775421 11335899999999999999999999953 79999999999999999999999999998654
Q ss_pred CCCCceeeccccccCccccccc----cCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
... ......||..|+|||++ .+..++.++||||||+++|||++|+.||...... . ...
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~---------~~~ 239 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------F---------DQL 239 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------------
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------H---------HHH
Confidence 322 12233589999999998 4567899999999999999999999999632100 0 001
Q ss_pred ccccc---cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVD---SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..+.. +.+...........+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111 11111111223456899999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=306.38 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=201.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
...++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++......++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 689999999965432 2345578899999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CcEEEeecCCc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLA 273 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~ 273 (447)
||||+.+++|.+++.... .+++..++.++.|++.||.|||++ +++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999887653 389999999999999999999999 99999999999999764 46999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
........ .....++..|+|||++.+ .++.++||||||+++|+|++|+.||.... ..+...........
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYA 240 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 86543221 223347899999999865 48999999999999999999999995321 11222222111100
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
... .........+.+++.+||+.||.+|||+.++++
T Consensus 241 ~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDL-------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCS-------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCc-------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 001122456889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=317.19 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=194.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc-----
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 193 (447)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888899999999999999976 689999999975432 2234568899999999999999999999887654
Q ss_pred -ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 194 -RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 194 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
.++||||+. ++|.+++.. .+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 688887742 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+.......
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGVP 243 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-----HHHHHHHHHHHCBC
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCC
Confidence 9864322 233458999999999877 6789999999999999999999999964211 11111111100000
Q ss_pred c---------------ccccc---ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 352 K---------------LEQLV---DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 352 ~---------------~~~~~---d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ...+. ...+ ..........+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000 0000 0111233567899999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=329.30 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=186.0
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEecc
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
.|...+.||+|+||+||.+...+|+.||||++.... ...+.+|++++..+ +||||+++++++.+....++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 344557899999999987766779999999986532 23567899999876 8999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-------------CcE
Q 013238 202 VNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-------------FEA 265 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~-------------~~~ 265 (447)
. |+|.+++......... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999865432221 13334678999999999999999 99999999999999754 489
Q ss_pred EEeecCCccccCCCCCc---eeeccccccCccccccccC-------CCCCchhhhHHHHHHHHHHHh-CCCCcccccccC
Q 013238 266 VVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 334 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~ 334 (447)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--- 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--- 244 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT---
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch---
Confidence 99999999876543221 1223469999999999976 568999999999999999999 999995311
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............. ..............+.+++.+||+.||.+|||+.++++
T Consensus 245 ---~~~~~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 ---SRESNIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---THHHHHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhHHHHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111111100 11111223456678999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.60 Aligned_cols=200 Identities=24% Similarity=0.317 Sum_probs=167.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CC-----ceeeEeeeeecCC
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HR-----NLLRLRGFCMTPT 192 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~ 192 (447)
..++|++.+.||+|+||+||+|... +++.||||+++... .....+..|+.++..++ |+ +++++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3578999999999999999999976 58899999997432 22345677888887775 44 4999999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCcEEEeec
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDF 270 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Df 270 (447)
..++||||+. |+|.+++..... ..+++..++.++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 599999977542 2489999999999999999999952 12899999999999994 5788999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999875432 2334689999999999999999999999999999999999999963
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.19 Aligned_cols=245 Identities=23% Similarity=0.382 Sum_probs=190.5
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-----hHHHHHHHHHHHHhc----CCCceeeEeee
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMA----VHRNLLRLRGF 187 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l----~h~niv~l~~~ 187 (447)
+...++|+..+.||+|+||.||+|... +++.||||++....... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344578999999999999999999875 68899999996543211 122356788888888 89999999999
Q ss_pred eecCCcceEEEec-ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcE
Q 013238 188 CMTPTERLLVYPF-MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEA 265 (447)
Q Consensus 188 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~-~~~~~ 265 (447)
+...+..++|||+ +.+++|.+++.... ++++..++.++.||+.||.|||++ +++||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9988899999999 78999999998753 389999999999999999999999 999999999999999 88999
Q ss_pred EEeecCCccccCCCCCceeeccccccCccccccccCCCCC-chhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH
Q 013238 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 344 (447)
||+|||++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------- 243 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------- 243 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------
Confidence 999999998764322 2344589999999999877664 58999999999999999999995311
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
..... . . .........+.+++.+||+.||.+|||+.++++.
T Consensus 244 -~~~~~-~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 -EILEA-E------L----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HHHHT-C------C----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHhhh-c------c----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0 0 0111233568899999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=317.81 Aligned_cols=253 Identities=23% Similarity=0.260 Sum_probs=173.0
Q ss_pred HhhCCCCCC-eeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec----CCc
Q 013238 120 ATDNFSNRN-ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTE 193 (447)
Q Consensus 120 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~ 193 (447)
..++|.+.+ +||+|+||+||+|... +|+.||||++.... ....+....+..+.|+||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 356788754 6999999999999987 68999999986432 112223334667899999999999875 344
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeec
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 270 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 270 (447)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 7899999999999999986532 3599999999999999999999999 9999999999999986 455999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|+++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ........ .
T Consensus 176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~-~- 246 (336)
T 3fhr_A 176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI----SPGMKRRI-R- 246 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh----hhhHHHhh-h-
Confidence 999865422 22334589999999999888899999999999999999999999954211100 00000000 0
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.................+.+++.+||+.||.+|||+.++++
T Consensus 247 -----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 247 -----LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000111111233456889999999999999999999997
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=315.24 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=189.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeee----------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM---------- 189 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~---------- 189 (447)
.++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 367888999999999999999987 48999999986542 333456889999999999999999999874
Q ss_pred ----cCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCc
Q 013238 190 ----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFE 264 (447)
Q Consensus 190 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~-~~~~ 264 (447)
.....++||||+. |+|.+++... ++++..++.++.|++.||+|||++ +++||||||+|||++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3356789999997 6999998642 389999999999999999999999 999999999999997 5679
Q ss_pred EEEeecCCccccCCCCC--ceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHH
Q 013238 265 AVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 341 (447)
Q Consensus 265 ~kl~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 341 (447)
+||+|||+++....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... .
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~ 231 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--------L 231 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--------H
Confidence 99999999986543211 11233457889999998865 6789999999999999999999999963211 1
Q ss_pred HHHHHHhhccc------cccc-------cccccC-CCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 342 DWVKGLLKEKK------LEQL-------VDSDME-GNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 342 ~~~~~~~~~~~------~~~~-------~d~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+.......... ..++ ...... ... .......+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11111111000 0000 000000 000 0123456899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=320.03 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=197.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-----------CCceeeEeeee
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----------HRNLLRLRGFC 188 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 188 (447)
.++|++.+.||+|+||+||+|... +++.||||++.... .....+.+|++++.++. |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 357889999999999999999975 68999999997432 23446778898888776 89999999998
Q ss_pred ecCC----cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC----
Q 013238 189 MTPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---- 260 (447)
Q Consensus 189 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~---- 260 (447)
.... ..+++|||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7543 678999999 8999999977433 24899999999999999999999954 899999999999994
Q ss_pred --CCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCC-c
Q 013238 261 --EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-D 337 (447)
Q Consensus 261 --~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~-~ 337 (447)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4558999999999865432 22345899999999999999999999999999999999999999643211000 0
Q ss_pred ccHHHHHHHHhhccc---------ccccccc-------------------ccCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 013238 338 VMLLDWVKGLLKEKK---------LEQLVDS-------------------DMEGNYIEEEVEQLIQVALLCTQGSPMERP 389 (447)
Q Consensus 338 ~~~~~~~~~~~~~~~---------~~~~~d~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 389 (447)
......+........ .....+. .............+.+++.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 000000001000000 0000000 001123456778899999999999999999
Q ss_pred CHHHHHH
Q 013238 390 KMSEVVR 396 (447)
Q Consensus 390 t~~evl~ 396 (447)
|+.++++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=320.98 Aligned_cols=244 Identities=22% Similarity=0.389 Sum_probs=197.9
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-----hHHHHHHHHHHHHhcC--CCceeeEeeeee
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAV--HRNLLRLRGFCM 189 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~niv~l~~~~~ 189 (447)
....++|+..+.||+|+||.||+|... +++.||||.+....... ....+.+|++++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 334568999999999999999999875 68899999997543221 1234667899999986 599999999999
Q ss_pred cCCcceEEEecccC-CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCcEEE
Q 013238 190 TPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVV 267 (447)
Q Consensus 190 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~-~~~~~kl 267 (447)
..+..+++||++.+ ++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 89999997653 389999999999999999999999 999999999999999 7899999
Q ss_pred eecCCccccCCCCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHH
Q 013238 268 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346 (447)
Q Consensus 268 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 346 (447)
+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .
T Consensus 192 ~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------------~ 254 (320)
T 3a99_A 192 IDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------E 254 (320)
T ss_dssp CCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------H
T ss_pred eeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------------h
Confidence 999999875432 2233458999999999987766 688999999999999999999995321 0
Q ss_pred HhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 347 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...... .... .....+.+++.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~-------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 IIRGQV-------FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHCCC-------CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhcccc-------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111000 0111 12356889999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=314.14 Aligned_cols=259 Identities=19% Similarity=0.244 Sum_probs=196.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CC-cEEEEEEeccccccchHHHHHHHHHHHHhcCCCc------eeeEeeeeecCC
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DG-SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN------LLRLRGFCMTPT 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 192 (447)
.++|++.+.||+|+||+||+|... ++ +.||||+++... .....+.+|+++++.++|++ ++.+.+++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 468999999999999999999975 34 689999996432 23446778999998887666 899999999999
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE-------------
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------------- 259 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill------------- 259 (447)
..++||||+ +++|.+++..... .++++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 6677777765432 3489999999999999999999999 99999999999999
Q ss_pred ------CCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccccccc
Q 013238 260 ------DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 333 (447)
Q Consensus 260 ------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~ 333 (447)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-- 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE-- 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC--
Confidence 56789999999999864322 233468999999999999999999999999999999999999996321
Q ss_pred CCCcccHHHHHHHHhhccc--------c-cccccccc---------------------CCCCcHHHHHHHHHHHHHccCC
Q 013238 334 NDDDVMLLDWVKGLLKEKK--------L-EQLVDSDM---------------------EGNYIEEEVEQLIQVALLCTQG 383 (447)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~--------~-~~~~d~~~---------------------~~~~~~~~~~~l~~li~~cl~~ 383 (447)
.......+........ . ........ ...........+.+++.+||+.
T Consensus 244 ---~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 244 ---NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp ---HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ---HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 1111111111110000 0 00000000 0011223456789999999999
Q ss_pred CCCCCCCHHHHHH
Q 013238 384 SPMERPKMSEVVR 396 (447)
Q Consensus 384 dP~~RPt~~evl~ 396 (447)
||.+|||+.++++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=308.36 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=179.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHH-HHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.++|+..+.||+|+||.||+|... +|+.||||++........... +..+..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999986 689999999976544333333 344445678889999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
||+ ++.+..+..... ..+++..++.++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 555555554332 248999999999999999999998 6 89999999999999999999999999997654
Q ss_pred CCCCceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
... ......|++.|+|||++. ...++.++||||||+++|||++|+.||.... ...+..........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-------TDFEVLTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHHHHHSCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-------ccHHHHHHHhccCC
Confidence 322 223345899999999984 4568899999999999999999999995311 11122222222111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. .... .......+.+++.+||+.||.+|||+.++++
T Consensus 248 ~------~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 P------LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C------CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C------CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 0000 0112356889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=325.86 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=185.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 199 (447)
..+|...++||+|+||+|+.....+++.||||++...... .+.+|+++++.+ +||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 4468888999999999976555567899999999654332 245799999998 79999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-----CCcEEEeecCCcc
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLAK 274 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~ 274 (447)
|+. |+|.+++...... +.+..++.++.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 995 6999999765432 34445678999999999999999 9999999999999953 3368899999998
Q ss_pred ccCCCCC--ceeeccccccCcccccccc---CCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHh
Q 013238 275 LMDYKDT--HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 348 (447)
Q Consensus 275 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 348 (447)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.... .... ....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~------~~~~---~~~~ 242 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------QRQA---NILL 242 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT------THHH---HHHT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh------HHHH---HHHh
Confidence 7643321 2233456999999999997 4567889999999999999999 999985311 0010 0111
Q ss_pred hccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 349 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...... . ..........+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 GACSLD-----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCCCCT-----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCcc-----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 110000 0 0111234455789999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=338.41 Aligned_cols=260 Identities=23% Similarity=0.298 Sum_probs=198.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec------CCc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 193 (447)
.++|++.+.||+|+||.||+|... +|+.||||++...........+.+|+++++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999875 6899999999765555556678999999999999999999998765 567
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---EEEeec
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDF 270 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df 270 (447)
.++||||+++|+|.+++..... ...+++..++.++.+++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7999999999999999986543 23488899999999999999999999 9999999999999997765 999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|++....... ......||..|+|||++.+..++.++||||||+++|||++|..||.... ....|.......
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-------~~~~~~~~i~~~ 239 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-------QPVQWHGKVREK 239 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-------HHHHSSTTCC--
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-------chhhhhhhhhcc
Confidence 9998764332 2234568999999999999999999999999999999999999995311 111111111000
Q ss_pred cccccccc----c------c--cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 013238 351 KKLEQLVD----S------D--MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 393 (447)
Q Consensus 351 ~~~~~~~d----~------~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 393 (447)
........ . . ............+.+++..||+.||.+|||+.+
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000000 0 0 011233446778999999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.31 Aligned_cols=239 Identities=21% Similarity=0.284 Sum_probs=193.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC--CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCc-----
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 193 (447)
.++|++.+.||+|+||+||+|.+. +|+.||||++...........+.+|++++..++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 5899999998765444445578899999999999999999999987655
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.++||||+++++|.+++.. ++++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999987753 489999999999999999999999 99999999999999986 9999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
+..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||......
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------- 282 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------- 282 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------------
Confidence 875432 3346899999999987654 88999999999999999999888531110
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhc
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVRMLEG 400 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~~ 400 (447)
.+. ...........+.+++.+||+.||.+||+ ++++.+.|.+
T Consensus 283 -~~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 283 -GLP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -SCC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -ccc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000 00111223456889999999999999995 5666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=296.94 Aligned_cols=231 Identities=12% Similarity=0.039 Sum_probs=182.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
.++|++.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+..+..++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 457888999999999999999986 4899999999765432 2335788999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++++|.+++... .....+..++.|++.||+|||++ +|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999998542 34556888999999999999999 99999999999999999999998443
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
|++ .++.++|||||||++|||+||+.||......... .......
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--------------~~~~~~~ 218 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--------------APAERDT 218 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--------------EECCBCT
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--------------HHHHHHh
Confidence 333 3688999999999999999999999642211000 0000000
Q ss_pred ccccCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 358 DSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 358 d~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
...... .........+.+++.+||+.||.+| |+.++++.|+....
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000000 0011234568999999999999999 99999999997544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.10 Aligned_cols=243 Identities=14% Similarity=0.094 Sum_probs=178.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCC-Ccee---------------
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVH-RNLL--------------- 182 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h-~niv--------------- 182 (447)
..|...+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.++..+.| .|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34666788999999999999965 6899999998743322 224568899999998887 2211
Q ss_pred eE------eeeeec-----CCcceEEEecccCCcchhhhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 013238 183 RL------RGFCMT-----PTERLLVYPFMVNGSVASCLRER---GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248 (447)
Q Consensus 183 ~l------~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 248 (447)
.+ ..++.. ....+++|+++ +++|.+++... .....++++..++.++.||++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 11 011111 12346677765 78999888522 22233578889999999999999999999 999
Q ss_pred ecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccc----------cCCCCCchhhhHHHHHHHH
Q 013238 249 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL----------STGKSSEKTDVFGYGVMLL 318 (447)
Q Consensus 249 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlG~il~ 318 (447)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998864322 344557 999999999 5556889999999999999
Q ss_pred HHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 319 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 319 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
||+||+.||...... .....++... . ..+..+.+++.+||+.||.+|||+.++++
T Consensus 309 elltg~~Pf~~~~~~-----------------~~~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAAL-----------------GGSEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGG-----------------SCSGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchh-----------------hhHHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999642211 1111111110 1 12356899999999999999999988865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=294.10 Aligned_cols=226 Identities=22% Similarity=0.297 Sum_probs=176.6
Q ss_pred hCCCCC-CeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHH-HhcCCCceeeEeeeeec----CCcc
Q 013238 122 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 194 (447)
Q Consensus 122 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 194 (447)
++|... +.||+|+||.||++... +++.||+|++... ..+.+|++++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 77999999999999975 6899999998542 2466788877 66789999999999876 5678
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeecC
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 271 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 271 (447)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999987532 3489999999999999999999999 9999999999999998 7899999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++.... +..++.++|||||||++|||++|+.||....... ....
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-------------~~~~ 209 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------------ISPG 209 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-------------hhHH
Confidence 986432 2346789999999999999999999995321100 0000
Q ss_pred ccccccccccCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 352 KLEQLVDSDMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....+..... ... ......+.+++.+||+.||.+|||+.++++
T Consensus 210 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000100000 111 123467899999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.82 Aligned_cols=243 Identities=16% Similarity=0.178 Sum_probs=184.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-------cchHHHHHHHHHHHHhcC---------CCceee
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-------QGGELQFQTEVEMISMAV---------HRNLLR 183 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~---------h~niv~ 183 (447)
..++|+..+.||+|+||+||+|+. +|+.||||++..... ......+.+|+++++.++ |+||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356788899999999999999998 689999999976532 222356888999888875 777777
Q ss_pred Eeeeee-----------------c-------------CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHH
Q 013238 184 LRGFCM-----------------T-------------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 233 (447)
Q Consensus 184 l~~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~ 233 (447)
+.+++. + ....++||||+++|++.+.+.. ..+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 766542 2 6788999999999987777643 2389999999999999
Q ss_pred HHHHHHH-hCCCCCceecCCCCCCEEECCCC--------------------cEEEeecCCccccCCCCCceeeccccccC
Q 013238 234 RGLAYLH-DHCDPKIIHRDVKAANILLDEEF--------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIG 292 (447)
Q Consensus 234 ~~l~yLH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~ 292 (447)
.||+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999865422 2358999
Q ss_pred ccccccccCCCCCchhhhHHHHHH-HHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc-ccccccCCCCcHHHH
Q 013238 293 HIAPEYLSTGKSSEKTDVFGYGVM-LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ-LVDSDMEGNYIEEEV 370 (447)
Q Consensus 293 y~aPE~~~~~~~~~~sDvwSlG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~~~~~~~~~~~ 370 (447)
|+|||++.+.. +.++||||||++ .+++++|..||.. ..|....... .... ...............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDK-MLKQMTFKTKCNTPAMKQIK 309 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHH-HHHTCCCSSCCCSHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHh-hhhhhccCcccchhhhhhcC
Confidence 99999998766 899999998777 7788999999842 1111111110 0000 001111111234567
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHH
Q 013238 371 EQLIQVALLCTQGSPMERPKMSEVV 395 (447)
Q Consensus 371 ~~l~~li~~cl~~dP~~RPt~~evl 395 (447)
..+.+++.+||+.| |+.|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 88999999999866 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-31 Score=270.80 Aligned_cols=186 Identities=15% Similarity=0.074 Sum_probs=129.7
Q ss_pred eeecCCeEEEEEE-ECCCcEEEEEEecccc---------ccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEEE
Q 013238 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEER---------TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 130 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 198 (447)
.+.|+.|.+..++ +-.|+.+++|.+.... .+....+|.+|+++|+++ .|+||+++++++.+.+..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455555555443 2247889999996542 122234689999999999 6999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||++|++|.++|...+ +++.. +|+.||+.||+|||++ |||||||||+||||+++|.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999997653 35554 5889999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~ 327 (447)
.. ......+||+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 392 ~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 32 22344569999999999865 4667899999999988887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-28 Score=244.88 Aligned_cols=185 Identities=14% Similarity=0.205 Sum_probs=145.1
Q ss_pred CCCCeeeecCCeEEEEEEECCCcEEEEEEecccccc-------chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 125 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 125 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
...+.||+|+||.||+|.. .++.+++|+....... .....+.+|++++++++||||+++..++......++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999955 4678899986542211 1123578999999999999999776666677888999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++++|.+++.. +..++.|+++||.|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 458999999999999999 9999999999999999 99999999998764
Q ss_pred CCCCce------eeccccccCccccccccC--CCCCchhhhHHHHHHHHHHHhCCCCc
Q 013238 278 YKDTHV------TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAF 327 (447)
Q Consensus 278 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltg~~p~ 327 (447)
...... .....||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 322111 234569999999999977 56788899999999988888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=202.72 Aligned_cols=151 Identities=15% Similarity=0.046 Sum_probs=119.8
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEecccccc-----------------chHHHHHHHHHHHHhcCCC
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----------------GGELQFQTEVEMISMAVHR 179 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~ 179 (447)
+......|...+.||+|+||.||+|...+|+.||||.++..... .....+.+|+++++.++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 33344556677999999999999999977999999999643211 12446889999999998
Q ss_pred ceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 013238 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 259 (447)
Q Consensus 180 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill 259 (447)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+|||+
T Consensus 163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 4 66666543 356799999999999998 421 12447999999999999999 99999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCCceeeccccccCcccccccc
Q 013238 260 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300 (447)
Q Consensus 260 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 300 (447)
+ ++.+||+|||+++. +..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9 99999999999863 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3e-20 Score=171.44 Aligned_cols=137 Identities=18% Similarity=0.192 Sum_probs=104.4
Q ss_pred CCCCCeeeecCCeEEEEEEE-CCCcE--EEEEEecccccc-----------------------chHHHHHHHHHHHHhcC
Q 013238 124 FSNRNILGRGGFGKVYKGRL-TDGSL--VAVKRLKEERTQ-----------------------GGELQFQTEVEMISMAV 177 (447)
Q Consensus 124 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~ 177 (447)
|...+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678899999999999998 67888 999987543111 01135788999999998
Q ss_pred CCce--eeEeeeeecCCcceEEEecccC-C----cchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcee
Q 013238 178 HRNL--LRLRGFCMTPTERLLVYPFMVN-G----SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDPKIIH 249 (447)
Q Consensus 178 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH 249 (447)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8764 333332 367899999942 4 44444322 223456789999999999999 88 9999
Q ss_pred cCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 250 RDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 250 ~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
|||||+|||+++ .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.6e-18 Score=162.66 Aligned_cols=139 Identities=15% Similarity=0.119 Sum_probs=99.9
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCcEEEEEEecccccc-------------chH--------HHHHHHHHHHHhcCCCce
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-------------GGE--------LQFQTEVEMISMAVHRNL 181 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------~~~--------~~~~~e~~~l~~l~h~ni 181 (447)
-|++.+.||+|++|.||+|...+|+.||||+++..... ... ....+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38888999999999999999989999999987532110 000 112345666666644433
Q ss_pred eeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 013238 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 261 (447)
Q Consensus 182 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~ 261 (447)
....-+.. ...++||||+.+++|..+... .....++.|++.+|.|||+. +||||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 21111111 234799999999888765421 12356789999999999999 9999999999999988
Q ss_pred CC----------cEEEeecCCcccc
Q 013238 262 EF----------EAVVGDFGLAKLM 276 (447)
Q Consensus 262 ~~----------~~kl~Dfgl~~~~ 276 (447)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 77 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=5e-12 Score=116.44 Aligned_cols=143 Identities=13% Similarity=0.036 Sum_probs=109.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 199 (447)
-+.|+....++.|+.+.||++... ++.+++|....... .....+.+|.++++.+. +..+.++++++...+..++|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 346777777888889999999764 67899999865321 11225788999998874 6778889998888888999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------------------------------------ 243 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------ 243 (447)
|++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999998776321 1123467888999999999810
Q ss_pred --------------------CCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 244 --------------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 244 --------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1368999999999999876566799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=3.2e-11 Score=110.64 Aligned_cols=128 Identities=14% Similarity=0.033 Sum_probs=94.8
Q ss_pred eecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc--eeeEeeeeecCCcceEEEecccCCcchh
Q 013238 131 GRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPFMVNGSVAS 208 (447)
Q Consensus 131 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~ 208 (447)
+.|..+.||++...+|..+++|...... ...+..|.++++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 3556699999987778889999975431 124678888888876544 455888887777789999999998884
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 013238 209 CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--------------------------------------------- 243 (447)
Q Consensus 209 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------------- 243 (447)
... .. ...++.++++.|+.||+..
T Consensus 104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2256677778888888642
Q ss_pred ----------CCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 244 ----------DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 244 ----------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.4e-10 Score=111.92 Aligned_cols=142 Identities=13% Similarity=0.159 Sum_probs=104.7
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEec--cccccchHHHHHHHHHHHHhcC--CCceeeEeeeeecC---CcceEEEe
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAV--HRNLLRLRGFCMTP---TERLLVYP 199 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 199 (447)
.+.|+.|.++.||+....+ ..+++|+.. ..........+.+|..+++.+. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 3568899999999998764 678888876 3322222345788999998887 45578888888765 44799999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------------------------------------ 243 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------ 243 (447)
|++|..+.+... ..++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999987754221 12678888899999999999999731
Q ss_pred -------------------CCCceecCCCCCCEEECCCCc--EEEeecCCccc
Q 013238 244 -------------------DPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL 275 (447)
Q Consensus 244 -------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~ 275 (447)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=2.8e-10 Score=107.11 Aligned_cols=184 Identities=20% Similarity=0.185 Sum_probs=119.9
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCc--eeeEeeeeecCC---cceEEEec
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRN--LLRLRGFCMTPT---ERLLVYPF 200 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~ 200 (447)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999863 45888886432 23446888999988773 322 344444433332 34899999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH-------------------------------------- 242 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-------------------------------------- 242 (447)
++|.+|...... .++...+..++.++++.|+.||+.
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999888754321 266677778888888888888861
Q ss_pred -----------------CCCCceecCCCCCCEEECC--CCcEEEeecCCccccCCCCCceeeccccccCc---ccccccc
Q 013238 243 -----------------CDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH---IAPEYLS 300 (447)
Q Consensus 243 -----------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y---~aPE~~~ 300 (447)
..+.++|+|+++.||++++ +..+.|+||+.+...+...... ....+ ..|+...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHH
Confidence 1235899999999999998 5567899999886543211000 00000 1222110
Q ss_pred ------CC--------CCCchhhhHHHHHHHHHHHhCCCCcc
Q 013238 301 ------TG--------KSSEKTDVFGYGVMLLELITGQRAFD 328 (447)
Q Consensus 301 ------~~--------~~~~~sDvwSlG~il~elltg~~p~~ 328 (447)
+. ......+.|++|.++|.+.+|..+|-
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00 01123689999999999999998873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.5e-06 Score=81.44 Aligned_cols=136 Identities=18% Similarity=0.165 Sum_probs=90.6
Q ss_pred CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCC---ceeeEeeeee-cCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR---NLLRLRGFCM-TPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 203 (447)
+.++.|....||+. |..+++|+-.. ......+.+|.+++..+.+. .+.+++.++. ..+..+++|++++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 45888999999988 46688887532 22344688999999988642 2555666664 34567899999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH----------------------------------------- 242 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------- 242 (447)
..+...... .++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 888653211 123334444444444444444432
Q ss_pred ----------------CCCCceecCCCCCCEEECC---CCc-EEEeecCCcccc
Q 013238 243 ----------------CDPKIIHRDVKAANILLDE---EFE-AVVGDFGLAKLM 276 (447)
Q Consensus 243 ----------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgl~~~~ 276 (447)
..+.++|+|+++.||+++. ++. +.|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2336799999999999997 455 489999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.1e-06 Score=80.78 Aligned_cols=135 Identities=19% Similarity=0.154 Sum_probs=93.2
Q ss_pred eeeecCCe-EEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcceEEEecccCCc
Q 013238 129 ILGRGGFG-KVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 129 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
.+..|..| .||+.... ++..+++|+-... ....+.+|...++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 35556555 68988765 4567889976432 2335778888887764 3336678888888888999999999988
Q ss_pred chhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 013238 206 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------------------------------------------ 243 (447)
Q Consensus 206 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------------ 243 (447)
+.+...... .....+..+++..|+-||...
T Consensus 107 ~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 776543211 122344555556666666321
Q ss_pred -------------CCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 244 -------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 244 -------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12479999999999999877777999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=2.2e-06 Score=82.16 Aligned_cols=81 Identities=7% Similarity=-0.008 Sum_probs=53.3
Q ss_pred Cee-eecCCeEEEEEEEC-------CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCC---CceeeEeeeeecC---
Q 013238 128 NIL-GRGGFGKVYKGRLT-------DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH---RNLLRLRGFCMTP--- 191 (447)
Q Consensus 128 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~--- 191 (447)
+.| +.|..+.+|+.... ++..+++|....... ......+.+|..+++.+.. ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998764 256788887654320 0011246677877776642 3466677776554
Q ss_pred CcceEEEecccCCcchh
Q 013238 192 TERLLVYPFMVNGSVAS 208 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~ 208 (447)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=4.1e-05 Score=72.58 Aligned_cols=140 Identities=17% Similarity=0.219 Sum_probs=77.1
Q ss_pred eeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-----CCceeeEe-e--eeecCCcceEEEec
Q 013238 129 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----HRNLLRLR-G--FCMTPTERLLVYPF 200 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 200 (447)
.|+.|..+.||+....+| .+++|+..... ..+..|.+++..+. .|.++... | +....+..+++|+|
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRPE-----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSCH-----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCCH-----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 466677899999987655 48899886521 22333444444332 34443311 1 11234567899999
Q ss_pred ccCCcch--------------hhhhhcCC-CC-C--------CCCHHHH-------------------------------
Q 013238 201 MVNGSVA--------------SCLRERGQ-SQ-P--------PLNWSVR------------------------------- 225 (447)
Q Consensus 201 ~~~gsL~--------------~~l~~~~~-~~-~--------~l~~~~~------------------------------- 225 (447)
++|..+. ..++.... .. + .-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986553 11221111 00 0 0123211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 226 KQIALGAARGLAYLHD----------HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 226 ~~i~~~i~~~l~yLH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
..+...+..++.+|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223345666653 123489999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=2.7e-05 Score=75.68 Aligned_cols=75 Identities=9% Similarity=-0.035 Sum_probs=47.6
Q ss_pred CeeeecCCeEEEEEEEC-CCcEEEEEEeccccc------cchHHHHHHHHHHHHhcCC--Cc-eeeEeeeeecCCcceEE
Q 013238 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT------QGGELQFQTEVEMISMAVH--RN-LLRLRGFCMTPTERLLV 197 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~lv 197 (447)
+.||.|..+.||++... +++.++||....... ......+..|.+++..+.. +. +.+++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999754 467899998653211 1112345678888776632 33 3445543 34567899
Q ss_pred EecccCC
Q 013238 198 YPFMVNG 204 (447)
Q Consensus 198 ~e~~~~g 204 (447)
||++.+.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.84 E-value=9.7e-05 Score=69.11 Aligned_cols=139 Identities=14% Similarity=0.112 Sum_probs=90.0
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC---CCceeeEeeeeecCCcceEEEecccC
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.++.+. ...+.+++.++...+..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 35688999999999886 4677889987532 2446788888887763 35677888888777889999999998
Q ss_pred Ccchh-----------hhhhcCC-C--C---------------CCCCHHHHH---HHH----------------HHHHHH
Q 013238 204 GSVAS-----------CLRERGQ-S--Q---------------PPLNWSVRK---QIA----------------LGAARG 235 (447)
Q Consensus 204 gsL~~-----------~l~~~~~-~--~---------------~~l~~~~~~---~i~----------------~~i~~~ 235 (447)
..+.. .|+.... . . ..-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76531 1232221 0 0 012454322 111 111111
Q ss_pred -HHHHHh-CCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 236 -LAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 236 -l~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123322 2356899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00018 Score=70.43 Aligned_cols=78 Identities=12% Similarity=0.018 Sum_probs=47.3
Q ss_pred CCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCC---CCCchhhhHHHHHHHHHHH
Q 013238 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELI 321 (447)
Q Consensus 245 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~ell 321 (447)
+.++|+|+++.|||++.++ ++++||+.+........-......-...|.+|+..... ......++......+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 99999998875321100000000011346666655321 1122355667788888877
Q ss_pred hC
Q 013238 322 TG 323 (447)
Q Consensus 322 tg 323 (447)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00013 Score=67.44 Aligned_cols=79 Identities=16% Similarity=0.220 Sum_probs=55.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC---CceeeEeeeeecCCcceEEEe
Q 013238 123 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH---RNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e 199 (447)
.....+.+|.|..+.||+....+|+.+++|+-..... .....|..|.+.|+.+.. -.+.+++++ +..+++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3444567999999999999999999999998754322 222357789888887742 224445544 23589999
Q ss_pred cccCCcc
Q 013238 200 FMVNGSV 206 (447)
Q Consensus 200 ~~~~gsL 206 (447)
|+.++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00048 Score=64.07 Aligned_cols=139 Identities=12% Similarity=0.068 Sum_probs=74.2
Q ss_pred CCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCce-eeEeeeeecCCcceEEEecc-cCC
Q 013238 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFM-VNG 204 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g 204 (447)
.+.|+.|....+|+. ..+++|+........ ....+|...++.+....+ .+++++ +....++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY--INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C--CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce--eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 567889999999998 458888875432111 123457766665542222 344443 344568999999 665
Q ss_pred cchhh------------------hhhcCCCC-CCCC-HHHHHHHHHH--------------HHHHHH----HHHh-CCCC
Q 013238 205 SVASC------------------LRERGQSQ-PPLN-WSVRKQIALG--------------AARGLA----YLHD-HCDP 245 (447)
Q Consensus 205 sL~~~------------------l~~~~~~~-~~l~-~~~~~~i~~~--------------i~~~l~----yLH~-~~~~ 245 (447)
++... +|...... .... +.....+... +...+. .+.. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 55321 11111000 0011 1111111110 111111 1111 1234
Q ss_pred CceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 246 ~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 6899999999999 5566789999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0021 Score=55.76 Aligned_cols=100 Identities=16% Similarity=0.115 Sum_probs=65.6
Q ss_pred CCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCc
Q 013238 203 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 282 (447)
Q Consensus 203 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 282 (447)
.-+|.+.|...+. |+++.++|.++.|.+.+|.-+-... .-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc--------
Confidence 3478899987653 6999999999999998887662210 111233457899999999998764 1111
Q ss_pred eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh
Q 013238 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 322 (447)
Q Consensus 283 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt 322 (447)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0123467888763 455788999999999999876
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00091 Score=63.07 Aligned_cols=33 Identities=42% Similarity=0.391 Sum_probs=28.1
Q ss_pred CCCceecCCCCCCEEECCC----CcEEEeecCCcccc
Q 013238 244 DPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLM 276 (447)
Q Consensus 244 ~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~~ 276 (447)
...++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999875 68999999988653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0011 Score=64.88 Aligned_cols=73 Identities=14% Similarity=0.188 Sum_probs=47.9
Q ss_pred CeeeecCCeEEEEEEECC--------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCce-eeEeeeeecCCcceEEE
Q 013238 128 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 198 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 198 (447)
+.|+.|....+|++...+ ++.+++|+..... ....+..|..++..+...++ .++++.+.+ .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 457888899999998753 4788899874321 11345578888777653333 456665432 4899
Q ss_pred ecccCCcch
Q 013238 199 PFMVNGSVA 207 (447)
Q Consensus 199 e~~~~gsL~ 207 (447)
+|++|.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0044 Score=57.92 Aligned_cols=159 Identities=11% Similarity=0.081 Sum_probs=84.4
Q ss_pred cCHHHHHHHhhCCCCC-----CeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc--eeeE
Q 013238 112 FSLRELQVATDNFSNR-----NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRL 184 (447)
Q Consensus 112 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l 184 (447)
++.+++......|... +.|+.|....+|+....+| .+++|........ ..+..|..++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence 3444554444556542 3466688899999987655 5789988652111 13455666665553212 2233
Q ss_pred eee------eecCCcceEEEecccCCcchh--------------hhhhcCCC-CCC----C---CHHHHHH---------
Q 013238 185 RGF------CMTPTERLLVYPFMVNGSVAS--------------CLRERGQS-QPP----L---NWSVRKQ--------- 227 (447)
Q Consensus 185 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~~----l---~~~~~~~--------- 227 (447)
+.. ....+..+++|+|++|..+.. .++..... ..+ . .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 112345689999998865431 12221110 000 1 1222110
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 228 ---IALGAARGLAYLHDH----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 228 ---i~~~i~~~l~yLH~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
+...+...+.+++.. ...+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001134455555532 23479999999999999987666899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0042 Score=58.24 Aligned_cols=142 Identities=18% Similarity=0.182 Sum_probs=79.0
Q ss_pred eeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc--eeeEeee-----eecCCcceEEEecc
Q 013238 129 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGF-----CMTPTERLLVYPFM 201 (447)
Q Consensus 129 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~ 201 (447)
.++ |....||+....+|+.+++|....... ....+..|..++..+.... +.+++.. ....+..+++|+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 788899998877777899999864321 2334566777766654212 3334332 11234457899999
Q ss_pred cCCcchh----h----------hhhcCC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 013238 202 VNGSVAS----C----------LRERGQ-----SQPPLNWSVR----KQI---------------ALGAARGLAYLHDH- 242 (447)
Q Consensus 202 ~~gsL~~----~----------l~~~~~-----~~~~l~~~~~----~~i---------------~~~i~~~l~yLH~~- 242 (447)
+|..+.. . ++.... ..+..++... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8765431 0 111100 0111222211 001 01111223333221
Q ss_pred ---CCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 243 ---CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 243 ---~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0054 Score=60.40 Aligned_cols=74 Identities=11% Similarity=0.115 Sum_probs=47.0
Q ss_pred CeeeecCCeEEEEEEECC-CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCce-eeEeeeeecCCcceEEEecccCCc
Q 013238 128 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFMVNGS 205 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 205 (447)
+.|+.|-...+|+....+ +..+++|+....... .....+|..++..+...++ .++++.+. ..+||||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence 458888899999998865 477888887432211 1123578888887765444 45666652 246999998765
Q ss_pred ch
Q 013238 206 VA 207 (447)
Q Consensus 206 L~ 207 (447)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0028 Score=60.81 Aligned_cols=141 Identities=14% Similarity=0.141 Sum_probs=80.8
Q ss_pred CeeeecCCeEEEEEEEC--------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc-eeeEeeeeecCCcceEEE
Q 013238 128 NILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 198 (447)
+.|..|....+|+.... +++.+++|+.... ......+.+|..+++.+.-.. ..++++.+.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45777888999998864 2478899986332 122345668888887664222 3456665533 3999
Q ss_pred ecccCCcchhh-----------------hhhcCC--CCCCC-CHHHHHHHHHHHHH-------------------HHHHH
Q 013238 199 PFMVNGSVASC-----------------LRERGQ--SQPPL-NWSVRKQIALGAAR-------------------GLAYL 239 (447)
Q Consensus 199 e~~~~gsL~~~-----------------l~~~~~--~~~~l-~~~~~~~i~~~i~~-------------------~l~yL 239 (447)
||++|.+|..- |+.... ...+. -+..+.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665421 111111 11111 24455555443321 23333
Q ss_pred H----hC-CCCCceecCCCCCCEEECCC----CcEEEeecCCcc
Q 013238 240 H----DH-CDPKIIHRDVKAANILLDEE----FEAVVGDFGLAK 274 (447)
Q Consensus 240 H----~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~ 274 (447)
. .. ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 21 23378999999999999876 789999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0028 Score=60.66 Aligned_cols=73 Identities=8% Similarity=0.048 Sum_probs=42.1
Q ss_pred CeeeecCCeEEEEEEECC---------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc-eeeEeeeeecCCcceEE
Q 013238 128 NILGRGGFGKVYKGRLTD---------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLV 197 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 197 (447)
+.|+.|....+|+....+ +..+++|+....... ......|.+++..+...+ ..++++.. ..+++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 357788889999998754 267888877543211 112356777776664323 33555443 24789
Q ss_pred EecccCCcc
Q 013238 198 YPFMVNGSV 206 (447)
Q Consensus 198 ~e~~~~gsL 206 (447)
|+|++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.018 Score=54.35 Aligned_cols=31 Identities=26% Similarity=0.354 Sum_probs=27.6
Q ss_pred CCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 245 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 245 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.00019 Score=71.75 Aligned_cols=30 Identities=20% Similarity=0.036 Sum_probs=25.6
Q ss_pred HHHHHHHHHHHHhcCCCceeeEeeeeecCC
Q 013238 163 ELQFQTEVEMISMAVHRNLLRLRGFCMTPT 192 (447)
Q Consensus 163 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 192 (447)
..+|..|++++.+++|+|+|+++|||....
T Consensus 323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 323 SETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 457999999999999999999999997653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.48 E-value=0.023 Score=55.23 Aligned_cols=141 Identities=9% Similarity=0.076 Sum_probs=82.5
Q ss_pred CeeeecCCeEEEEEEECC--------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCc-eeeEeeeeecCCcceEEE
Q 013238 128 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 198 (447)
+.+..|-...+|+....+ ++.+++|+...... ......+|..+++.+...+ ..++++.+ ..++||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 457778889999998763 57888988644221 1112356777776664222 34455433 248899
Q ss_pred ecccCCcchhh-----------------hhhc-------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 013238 199 PFMVNGSVASC-----------------LRER-------GQ--SQPPLNWSVRKQIALGA-------------------A 233 (447)
Q Consensus 199 e~~~~gsL~~~-----------------l~~~-------~~--~~~~l~~~~~~~i~~~i-------------------~ 233 (447)
+|++|.+|..- |+.. .. ...+.-+..+..+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 1110 00 11222344444443222 2
Q ss_pred HHHHHHHhC---------------------CCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 234 RGLAYLHDH---------------------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 234 ~~l~yLH~~---------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
..+.+|... ....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223333211 1236899999999999 7788999999998753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=95.35 E-value=0.0066 Score=64.13 Aligned_cols=39 Identities=44% Similarity=0.612 Sum_probs=34.9
Q ss_pred CCeeeCCCCcccccCCCCCCCCCCCccccccCCCCCCCC
Q 013238 1 MNCRDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 39 (447)
Q Consensus 1 l~~~~ls~N~lsG~iP~~~~~~~~~~~s~~~n~~~~~~~ 39 (447)
|..||||+|+|+|.||..+++..+...+|.||+..+++|
T Consensus 706 L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 706 LTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp CSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred CCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 678999999999999999999999999999998776554
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.72 E-value=0.08 Score=32.82 Aligned_cols=33 Identities=27% Similarity=0.327 Sum_probs=20.3
Q ss_pred ccchhhHHHHHHHHHHHHHHHHHHHHHhcCCCC
Q 013238 58 ATGAIAGGVAAGAALLFAAPAIALAYWRKRKPE 90 (447)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (447)
....++++++.++++++++....++++|+++.+
T Consensus 8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred CcceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 345566667766666666656666666666544
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.47 E-value=0.089 Score=32.68 Aligned_cols=32 Identities=22% Similarity=0.229 Sum_probs=18.2
Q ss_pred cchhhHHHHHHHHHHHHHHHHHHHHHhcCCCC
Q 013238 59 TGAIAGGVAAGAALLFAAPAIALAYWRKRKPE 90 (447)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (447)
+..++++++.++++++++.+..++++|+++.+
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 34455666666666555555555666665543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.06 E-value=0.18 Score=43.60 Aligned_cols=117 Identities=9% Similarity=0.087 Sum_probs=79.1
Q ss_pred cCCCceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 013238 176 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 255 (447)
Q Consensus 176 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~ 255 (447)
..||+++.. .+-.+.+...+.++.-..+.=...++. .+...+++++.+|+....+++.. +|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 358888866 455555655555554433322222332 77899999999998877666544 88899999
Q ss_pred CEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcc
Q 013238 256 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328 (447)
Q Consensus 256 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~ 328 (447)
|++++.++.+++.-.|+-..+ +|. ..+...=+-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764322 221 11222233357889999999999996
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.52 E-value=0.044 Score=52.94 Aligned_cols=30 Identities=30% Similarity=0.453 Sum_probs=25.2
Q ss_pred CceecCCCCCCEEE------CCCCcEEEeecCCccc
Q 013238 246 KIIHRDVKAANILL------DEEFEAVVGDFGLAKL 275 (447)
Q Consensus 246 ~ivH~dlk~~Nill------~~~~~~kl~Dfgl~~~ 275 (447)
.++|+|+.+.|||+ +++..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.01 E-value=0.69 Score=40.09 Aligned_cols=115 Identities=15% Similarity=0.169 Sum_probs=77.9
Q ss_pred cCCCceeeEeeeeecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCceecCCCC
Q 013238 176 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA-YLHDHCDPKIIHRDVKA 254 (447)
Q Consensus 176 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~ivH~dlk~ 254 (447)
..||++ -..+-.+.+...+.++.-+++.-...++. ++...+++++.+|+.... +++. -+|--|.|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 347877 33444566666666665544433334432 778899999988877655 4543 48889999
Q ss_pred CCEEECCCCcEEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhH-HHHHHHHHHHhCCCCcc
Q 013238 255 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF-GYGVMLLELITGQRAFD 328 (447)
Q Consensus 255 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw-SlG~il~elltg~~p~~ 328 (447)
+|+++|.++.+++.-.|+-.. ++|.-+ + ..|.| .+=+++..++.++..|+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKES------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETTT------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCccc------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999987776432 233211 1 23443 57789999999999885
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.14 E-value=0.7 Score=28.55 Aligned_cols=20 Identities=10% Similarity=0.110 Sum_probs=8.3
Q ss_pred HHHHHHHHHHHHHHHhcCCC
Q 013238 70 AALLFAAPAIALAYWRKRKP 89 (447)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~ 89 (447)
+++++++.....+++|||+.
T Consensus 21 vll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 21 ILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHhheehhhh
Confidence 44444433333444444443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=89.14 E-value=0.81 Score=27.40 Aligned_cols=9 Identities=22% Similarity=0.190 Sum_probs=4.0
Q ss_pred HHHHHHHhc
Q 013238 78 AIALAYWRK 86 (447)
Q Consensus 78 ~~~~~~~~~ 86 (447)
++.+++|||
T Consensus 29 ~l~~~~~rr 37 (38)
T 2k1k_A 29 GILVFRSRR 37 (38)
T ss_dssp HHHHHHHCC
T ss_pred HHHHHHeec
Confidence 334444544
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.80 E-value=0.73 Score=28.08 Aligned_cols=27 Identities=33% Similarity=0.557 Sum_probs=12.1
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHhc
Q 013238 60 GAIAGGVAAGAALLFAAPAIALAYWRK 86 (447)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (447)
..++++++.++++++++.+..++++||
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred EEEEeehhHHHHHHHHHHHHheeEeee
Confidence 444555555555433233333444443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=83.88 E-value=0.25 Score=51.94 Aligned_cols=39 Identities=23% Similarity=0.514 Sum_probs=22.7
Q ss_pred CCeeeCCCCcccccCCCC-CCCCCCCccccccCCCCCCCC
Q 013238 1 MNCRDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 39 (447)
Q Consensus 1 l~~~~ls~N~lsG~iP~~-~~~~~~~~~s~~~n~~~~~~~ 39 (447)
|..||||+|+|+|.||.. +.+..+..+++++|.+.+..|
T Consensus 658 L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip 697 (768)
T 3rgz_A 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP 697 (768)
T ss_dssp CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCC
T ss_pred CCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCC
Confidence 455666666666666643 455566666666666654433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.24 E-value=0.87 Score=48.38 Aligned_cols=34 Identities=21% Similarity=0.346 Sum_probs=25.4
Q ss_pred CCeeeCCCCcccccCCCCCCCCCCCccccccCCCCC
Q 013238 1 MNCRDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 36 (447)
Q Consensus 1 l~~~~ls~N~lsG~iP~~~~~~~~~~~s~~~n~~~~ 36 (447)
|..||||+|+|+|.+|.. +..+..+++.+|++.+
T Consensus 528 L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 528 LEILDISRNQLLAPNPDV--FVSLSVLDITHNKFIC 561 (844)
T ss_dssp CCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCC
T ss_pred ccEEECCCCcCCCCChhH--hCCcCEEEecCCCccc
Confidence 567888888888877754 5667777888888765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=81.12 E-value=0.94 Score=42.22 Aligned_cols=39 Identities=10% Similarity=0.039 Sum_probs=28.2
Q ss_pred CCeeeCCCCcccccCCCC-CCCCCCCccccccCCCCCCCC
Q 013238 1 MNCRDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 39 (447)
Q Consensus 1 l~~~~ls~N~lsG~iP~~-~~~~~~~~~s~~~n~~~~~~~ 39 (447)
|..||||+|+|+|-.|.. ..+..+..+.+.+|.+...|+
T Consensus 58 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 97 (347)
T 2ifg_A 58 LRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSW 97 (347)
T ss_dssp CSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCS
T ss_pred CCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCH
Confidence 567888888888876643 567777778888888765443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 447 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-67
Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 27/283 (9%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRN 180
+ +G G FG VYKG+ VAVK L +LQ F+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+L G+ T + +V + S+ L + IA A+G+ YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYL 299
IIHRD+K+ NI L E+ +GDFGLA + + +H + G+I +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 300 STGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356
S ++DV+ +G++L EL+TGQ + N+ D ++ +G L +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSK-- 233
Query: 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ + ++ C + ERP +++ +E
Sbjct: 234 --------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-66
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
+ LG G FG+V+ G + VAVK LK+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRL 70
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
+RL T ++ +M NGS+ L+ L + +A A G+A++ +
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
IHRD++AANIL+ + + DFGLA+L++ + + I APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 302 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361
G + K+DV+ +G++L E++T R + ++ Q ++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY-----------------PGMTNPEVIQNLERGY 227
Query: 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ E+L Q+ LC + P +RP + +LE
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-65
Identities = 69/290 (23%), Positives = 130/290 (44%), Gaps = 30/290 (10%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 172
++ + + ++G G FG+VYKG L S VA+K LK T+ + F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 173 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 232
+ H N++RL G +++ +M NG++ LRE+ + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGI 119
Query: 233 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGT 290
A G+ YL + +HRD+ A NIL++ V DFGL++++ D + T+ T+ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 291 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350
I APE +S K + +DV+ +G+++ E++T L
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------------LSN 219
Query: 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400
++ + ++ + + Q+ + C Q RPK +++V +L+
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (533), Expect = 3e-65
Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 42/306 (13%)
Query: 112 FSLRELQVATDNFSNR---------NILGRGGFGKVYKGRLT----DGSLVAVKRLKEER 158
F+ + A F+ ++G G FG+V G L VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 159 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP 218
T+ F +E ++ H N++ L G T +++ FM NGS+ S LR+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN---DG 123
Query: 219 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278
+ G A G+ YL D +HRD+ A NIL++ V DFGL++ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 279 KDTHVTT----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 333
+ T + I APE + K + +DV+ YG+++ E+++ G+R +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235
Query: 334 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 393
+ + + ++ D + L Q+ L C Q RPK +
Sbjct: 236 -------------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 394 VVRMLE 399
+V L+
Sbjct: 283 IVNTLD 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (532), Expect = 4e-65
Identities = 73/314 (23%), Positives = 128/314 (40%), Gaps = 47/314 (14%)
Query: 113 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQF 166
L L+ +N +G G FG+V++ R ++VAVK LKEE + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 167 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ--------- 217
Q E +++ + N+++L G C L++ +M G + LR
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 218 -----------PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 266
PPL+ + + IA A G+AYL + K +HRD+ N L+ E
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 267 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 325
+ DFGL++ + D I + PE + + + ++DV+ YGV+L E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 326 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 385
G+ E+ + + D ++ E +L + LC P
Sbjct: 241 ----------------QPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLP 283
Query: 386 MERPKMSEVVRMLE 399
+RP + R+L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 7e-64
Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 25/278 (8%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
+ +G G FG V+ G + VA+K ++E E F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKL 62
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
++L G C+ LV+ FM +G ++ LR + + L G+AYL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEE 119
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
C +IHRD+ A N L+ E V DFG+ + + +T + + +PE S
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 302 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361
+ S K+DV+ +GV++ E+ + + R ++ +V+ + + +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVV---------------EDISTGF 219
Query: 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ Q+ C + P +RP S ++R L
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-63
Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 33/285 (11%)
Query: 123 NFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVH 178
+F+ ++GRG FG VY G L D AVK L G QF TE ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 179 RNLLRLRGFCM-TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
N+L L G C+ + L+V P+M +G + + +R L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGM- 143
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHI 294
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354
A E L T K + K+DV+ +GV+L EL+T DV D LL+ ++L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTFDITVYLLQGRRLL 254
Query: 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
Q E + L +V L C RP SE+V +
Sbjct: 255 Q----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 5e-63
Identities = 62/307 (20%), Positives = 123/307 (40%), Gaps = 37/307 (12%)
Query: 117 LQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 175
+++ D+F + LG G G V+K G ++A K + E Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 176 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
++ G + E + M GS+ L++ G + + ++++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
L YL + KI+HRDVK +NIL++ E + DFG++ + + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMS 171
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355
PE L S ++D++ G+ L+E+ G+ A + ++M V+G E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPPRP 230
Query: 356 LVDSDMEGNYIEEEVEQLIQVALL--------------------------CTQGSPMERP 389
+Y + + LL C +P ER
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 390 KMSEVVR 396
+ +++
Sbjct: 291 DLKQLMV 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (515), Expect = 1e-62
Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 25/291 (8%)
Query: 110 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT 168
+ + ++ + + ++ LG G +G+VY+G VAVK LKE+ + E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 169 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 228
E ++ H NL++L G C ++ FM G++ LRE + ++ V +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYM 120
Query: 229 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 288
A + + YL IHRD+ A N L+ E V DFGL++LM +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 289 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 348
I APE L+ K S K+DV+ +GV+L E+ T + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------------PGI 220
Query: 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
++ +L++ D E E++ ++ C Q +P +RP +E+ + E
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-62
Identities = 66/292 (22%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 115 RELQVATDNFSNRNI-LGRGGFGKVYKGRL---TDGSLVAVKRLKEERTQGGELQFQTEV 170
++L + DN +I LG G FG V +G VA+K LK+ + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 171 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 230
+++ + ++RL G C +LV G + L + + + S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 231 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVR 288
+ G+ YL + +HRD+ A N+LL A + DFGL+K + D++ T +A +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 289 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 347
+ APE ++ K S ++DV+ YGV + E ++ GQ+ + ++ +++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-----KMKGPEVMAFIE-- 226
Query: 348 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ K++E E +L + C +RP V + +
Sbjct: 227 -QGKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-62
Identities = 55/279 (19%), Positives = 109/279 (39%), Gaps = 27/279 (9%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
+ + LG G FG V G+ VA+K +KE E +F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKL 61
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
++L G C ++ +M NG + + LRE + ++ + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
+HRD+ A N L++++ V DFGL++ + + + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 302 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
K S K+D++ +GV++ E+ + G+ ++ + + +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYE------------------RFTNSETAEHIAQG 217
Query: 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ E++ + C ERP ++ +
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-62
Identities = 69/278 (24%), Positives = 114/278 (41%), Gaps = 25/278 (8%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
++ LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 74
Query: 182 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
++L + +V +M GS+ +G++ L +A A G+AY+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLL--DFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 242 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 301
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 302 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361
G+ + K+DV+ +G++L EL T R +++ V+
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGM-----------------VNREVLDQVERGY 231
Query: 362 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
E E L + C + P ERP + LE
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-61
Identities = 63/294 (21%), Positives = 115/294 (39%), Gaps = 29/294 (9%)
Query: 127 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 186
+ +G+G FG+V++G+ G VAVK + + E+ M H N+L
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIA 64
Query: 187 FCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
T T+ LV + +GS+ L + ++AL A GLA+LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHME 119
Query: 243 C-----DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHI 294
P I HRD+K+ NIL+ + + D GLA D + GT ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 295 APEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND--DDVMLLDWVKG 346
APE L +S ++ D++ G++ E+ + D++ D
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 347 LLKEKKLEQLVDSDMEGNYIE-EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+++ EQ + ++ + E + + ++ C + R + + L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-61
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 41/302 (13%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMIS- 174
+ S LG G FGKV + VAVK LK +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS--------------QPPL 220
+ H N++ L G C L++ + G + + LR + S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 221 NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280
+ + A+G+A+L IHRD+ A NILL + DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 281 TH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
+ V R + +APE + + ++DV+ YG+ L EL + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 340 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
G+ + K +++ E ++ + C P++RP ++V+++E
Sbjct: 247 ---PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 400 GD 401
Sbjct: 304 KQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 3e-61
Identities = 65/306 (21%), Positives = 116/306 (37%), Gaps = 48/306 (15%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISM 175
+N +LG G FGKV S VAVK LKE+ +E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 176 AV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---------------- 218
H N++ L G C L++ + G + + LR + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 219 ---PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275
L + A A+G+ +L +HRD+ A N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 276 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 333
+ +V R + +APE L G + K+DV+ YG++L E+ + G +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----- 268
Query: 334 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 393
G+ + +L+ + + + E++ + C +RP
Sbjct: 269 ------------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 394 VVRMLE 399
+ L
Sbjct: 317 LTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-60
Identities = 70/317 (22%), Positives = 138/317 (43%), Gaps = 41/317 (12%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMIS-MAV 177
++ ++++G G FG+V K R+ L A+KR+KE ++ F E+E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER------------GQSQPPLNWSVR 225
H N++ L G C L + +G++ LR+ + L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285
A ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345
R + +A E L+ + +DV+ YGV+L E+++ + + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------YCGMTCAELYE 237
Query: 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 405
L + +LE+ ++ D +++ + C + P ERP ++++ L + E
Sbjct: 238 KLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN--RMLE 285
Query: 406 RWEEWQKEEMFRQDFNH 422
+ + ++ + F +
Sbjct: 286 ERKTYVNTTLY-EKFTY 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-59
Identities = 72/279 (25%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 181
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 62
Query: 182 LRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
++L G + L +V +M GS+ LR RG+S L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 120
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
+ +HRD+ A N+L+ E+ A V DFGL K + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
K S K+DV+ +G++L E+ + R + L D V + K K++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYKMDAPDGCP 226
Query: 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ +V C RP ++ LE
Sbjct: 227 ----------PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-59
Identities = 62/281 (22%), Positives = 117/281 (41%), Gaps = 25/281 (8%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHR 179
+++ +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 180 NLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
N++R + T L V + G +AS + + + + L+ ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 238 YLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
H ++HRD+K AN+ LD + +GDFGLA++++ DT A GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355
PE ++ +EK+D++ G +L EL F L + +E K +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKI----REGKFRR 233
Query: 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ +E+ ++I RP + E++
Sbjct: 234 IPYR------YSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-58
Identities = 57/278 (20%), Positives = 108/278 (38%), Gaps = 26/278 (9%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
+++ LG G +G+V VAVK + +R + E+ + M H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+++ G + L + G + + + ++ G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLH 120
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYL 299
I HRD+K N+LLDE + DFGLA + Y + + + GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 300 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
+ +E DV+ G++L ++ G+ +D +D DW + ++
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWKK--- 231
Query: 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
I+ L+ +P R + ++ +
Sbjct: 232 -------IDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-58
Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 33/279 (11%)
Query: 128 NILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLR 183
LG G FG V KG VAVK LK E + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 184 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 243
+ G C + +LV G + L++ + ++ + G+ YL +
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 244 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 301
+HRD+ A N+LL + A + DFGL+K + D T + + APE ++
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 302 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
K S K+DV+ +GV++ E + GQ+ + +K ++ +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYR------------------GMKGSEVTAMLEKG 226
Query: 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
++ + LC RP + V L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 8e-58
Identities = 66/276 (23%), Positives = 114/276 (41%), Gaps = 32/276 (11%)
Query: 128 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 185
+GRG F VYKG T+ VA L++ + E Q F+ E EM+ H N++R
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 186 GFCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 241
+ + +LV M +G++ + L+ + V + +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT 130
Query: 242 HCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
P IIHRD+K NI + +GD GLA L AV GT +APE
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360
K E DV+ +G+ +LE+ T + + + + V +K +++
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAI-- 239
Query: 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
++ ++ C + + ER + +++
Sbjct: 240 ----------PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 8e-57
Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 110 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQF 166
++++L ++F LG+G FG VY R ++A+K L + + G E Q
Sbjct: 1 RQWAL-------EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 167 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK 226
+ EVE+ S H N+LRL G+ T L+ + G+V L++ +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTA 109
Query: 227 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 286
A L+Y H ++IHRD+K N+LL E + DFG +
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 163
Query: 287 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 346
+ GT+ ++ PE + EK D++ GV+ E + G+ F+ AN +
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRV 219
Query: 347 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
++ E LI + +P +RP + EV+
Sbjct: 220 EFTFPD------------FVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 8e-56
Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 35/282 (12%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV 177
FS+ +G G FG VY R + + +VA+K++ Q E EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
H N ++ RG + LV + + + + PL + GA +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 129
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
YLH H +IHRDVKA NILL E +GDFG A +M ++ V GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 181
Query: 298 YLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354
+ G+ K DV+ G+ +EL + N + + L +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSAL---------YHIA 227
Query: 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
Q ++ + E + C Q P +RP +++
Sbjct: 228 QNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-55
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 32/285 (11%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMA 176
F +LG G FG VYKG VA+K L+E + + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 177 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 236
+ ++ RL G C+T T +L+ M G + +RE + + A+G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGM 124
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIA 295
YL D +++HRD+ A N+L+ + DFGLAKL+ ++ + + I +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354
E + + ++DV+ YGV + EL+T G + +D + ++
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------------GIPASEIS 223
Query: 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+++ + + + C RPK E++
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-54
Identities = 70/299 (23%), Positives = 130/299 (43%), Gaps = 33/299 (11%)
Query: 116 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTE 169
E +VA + + LG+G FG VY+G + VA+K + E + ++F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 170 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ------PPLNWS 223
++ +++RL G L++ M G + S LR + P + S
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 224 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-TH 282
Q+A A G+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 283 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 342
+ ++PE L G + +DV+ +GV+L E+ T ++ +L
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRF 247
Query: 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401
++G L +K + + L ++ +C Q +P RP E++ ++ +
Sbjct: 248 VMEGGLLDK--------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 6e-54
Identities = 76/299 (25%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 122 DNFSNRNILGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 175
D LGRG FG+V + VAVK LKE T +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 176 AVHR-NLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPP------------LN 221
H N++ L G C P L ++ F G++++ LR + P L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 222 WSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 282 HV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 340
+V R + +APE + + ++DV+ +GV+L E+ + + V +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKI 242
Query: 341 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ LKE + D ++ Q L C G P +RP SE+V L
Sbjct: 243 DEEFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-53
Identities = 76/287 (26%), Positives = 110/287 (38%), Gaps = 33/287 (11%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGEL--QFQTEVEMISM 175
+ LG G FG V +G VAVK LK + E F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 176 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
HRNL+RL G +TP ++ V GS+ LR+ Q + A+ A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 123
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGH 293
+ YL IHRD+ A N+LL +GDFGL + + D H + +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 352
APE L T S +D + +GV L E+ T GQ + GL +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----------------GLNGSQI 223
Query: 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
L ++ E+ + + V + C P +RP + L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 4e-53
Identities = 61/282 (21%), Positives = 116/282 (41%), Gaps = 30/282 (10%)
Query: 121 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
D + LG G FGKVYK + + L A K + + + E + E+++++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N+++L ++ F G+V + + E + PL S + + L YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYL 126
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
HD+ KIIHRD+KA NIL + + + DFG++ + + GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVV 182
Query: 300 STGKS-----SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354
S K DV+ G+ L+E+ + + + +L K +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-----ELNPMRVL--------LKIAK 229
Query: 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ + + + ++ C + + R S++++
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-52
Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 42/300 (14%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMI 173
D LG G FG+V + VAVK LK + T+ +E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 174 SMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG------------QSQPPL 220
M H+N++ L G C ++ + G++ L+ R + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 221 NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280
+ A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 281 THVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 339
+ T R + +APE L + ++DV+ +GV+L E+ T +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------- 240
Query: 340 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ ++L +L+ + +L + C P +RP ++V L+
Sbjct: 241 --------VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-52
Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 28/282 (9%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAV 177
+ +G G FG V++G VA+K K + +F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
H ++++L G T ++ G + S L+ R + L+ + A + LA
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALA 122
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
YL + +HRD+ A N+L+ +GDFGL++ M+ + + + I +APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
++ + + +DV+ +GV + E++ V D + + ++L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNNDVIGRIENGERLPMPP 232
Query: 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ L + C P RP+ +E+ L
Sbjct: 233 NCP----------PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-51
Identities = 50/277 (18%), Positives = 106/277 (38%), Gaps = 27/277 (9%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
++ +G+G G VY + G VA++++ ++ E E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N++ + E +V ++ GS+ + E + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFL 132
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
H + ++IHRD+K+ NILL + + DFG + + + +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359
+ K D++ G+M +E+I G+ + N++ + L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL-----NENPLRAL--------YLIATNGTPE 235
Query: 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ + C +R E+++
Sbjct: 236 LQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 7e-47
Identities = 54/282 (19%), Positives = 104/282 (36%), Gaps = 30/282 (10%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH 178
++F ILG G F V R L A+K L++ + E +++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
++L + + NG L + + + + + L Y
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPE 297
LH IIHRD+K NILL+E+ + DFG AK++ + + GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
L+ + + +D++ G ++ +L+ G F A ++ ++ +K +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKLEYDFPE----- 231
Query: 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
+ L++ +R E+
Sbjct: 232 -------KFFPKARDLVE---KLLVLDATKRLGCEEMEGYGP 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (412), Expect = 7e-47
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 27/276 (9%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
D++ LG G FG V++ G+ A K + E + E++ +S+ H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
L+ L E +++Y FM G + + + ++ + +GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141
Query: 241 DHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
++ +H D+K NI+ E + DFGL +D K + T GT APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
TD++ GV+ L++G F +DD L +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFG----GENDDETLRNVKSCDWNMD------- 245
Query: 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
D + I E+ + I+ P R + +
Sbjct: 246 -DSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-46
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 21/291 (7%)
Query: 120 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 176
A + +G G +GKV+K R G VA+KR++ + +G L EV ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 177 V---HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE--RGQSQPPLNWSVRKQIALG 231
H N++RL C +V V L +P + K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291
RGL +LH H +++HRD+K NIL+ + + DFGLA++ ++ + V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF----DLARLANDDDVMLL----DW 343
+ APE L + D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 344 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
+ + ++ + ++ + E + L C +P +R
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 4e-46
Identities = 62/289 (21%), Positives = 110/289 (38%), Gaps = 40/289 (13%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--------EERTQGGELQFQTEVE- 171
+N+ + ILGRG V + AVK + E Q EV+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 172 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 231
+ ++ H N+++L+ T T LV+ M G + L E+ L+ ++I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 118
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291
+ LH I+HRD+K NILLD++ + DFG + +D V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP 173
Query: 292 GHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345
++APE + ++ D++ GV++ L+ G F + +++L +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIM 228
Query: 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
+ + D + V+ L+ P +R E
Sbjct: 229 SGNYQFGSPEWDD-------YSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 5e-46
Identities = 61/310 (19%), Positives = 122/310 (39%), Gaps = 24/310 (7%)
Query: 115 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMI 173
++ + D + R++LG G F +V LVA+K + ++ +G E + E+ ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 174 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 233
H N++ L + L+ + G + + E+G ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 293
+ YLHD + LDE+ + ++ DFGL+K+ D V + GT G+
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGY 175
Query: 294 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353
+APE L+ S+ D + GV+ L+ G F +++D L + + E
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDS 230
Query: 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM--LEGDGLAERWEEWQ 411
D I + + I+ + P +R + ++ + GD ++
Sbjct: 231 PYWDD-------ISDSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280
Query: 412 KEEMFRQDFN 421
E +++F
Sbjct: 281 VSEQIKKNFA 290
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 7e-46
Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 27/278 (9%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
D + LG G FG V++ G + K + + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPK 87
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
L+ L E +L+ F+ G + + ++ + A GL ++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMH 144
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
+H I+H D+K NI+ + + + V DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
+ TD++ GV+ L++G F +DD+ L VK E +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAF-- 252
Query: 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ + E + I+ Q P +R + + +
Sbjct: 253 -----SSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 8e-45
Identities = 50/278 (17%), Positives = 100/278 (35%), Gaps = 28/278 (10%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
+ + LGRG FG V++ + K +K + T ++ + E+ ++++A HRN
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRN 62
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+L L + E ++++ F+ + + LN L +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH 119
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
H I H D++ NI+ + + +FG A+ + D + APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEV 174
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
S TD++ G ++ L++G F A + ++ + + +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFL----AETNQQIIENIMNA--------EYTF 222
Query: 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ I E + R SE ++
Sbjct: 223 DEEAFKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (398), Expect = 9e-45
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAV- 177
++FS I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 178 --HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
++ + TP + + M G + L + G + + + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
L ++H+ +++RD+K ANILLDE + D GLA K H + GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 296 PEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD 328
PE L G + D F G ML +L+ G F
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 7e-44
Identities = 56/286 (19%), Positives = 108/286 (37%), Gaps = 18/286 (6%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRN 180
+ + +G G +G VYK + G A+K+++ E+ +G E+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
+++L T +LV+ + G L K L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCH 117
Query: 241 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 300
D +++HRD+K N+L++ E E + DFGLA+ T + +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 301 TGKSSEKTDVFGYGVMLLELITGQRAFD----------LARLANDDDVMLLDWVKGLLKE 350
+ K S D++ G + E++ G F + R+ + V L K
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ + ++++ E I + + P +R + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 8e-44
Identities = 53/294 (18%), Positives = 98/294 (33%), Gaps = 31/294 (10%)
Query: 116 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 174
EL+V + + +G G FG +Y G + G VA+K + Q E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYK 57
Query: 175 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 234
M + +C + ++ ++ S+ + + +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMIS 114
Query: 235 GLAYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDTHV------TT 285
+ Y+H IHRDVK N L + + DFGLAK TH
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345
+ GT + + + S + D+ G +L+ G + + A
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-- 229
Query: 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
EKK+ ++ +G E + C ++P S + ++
Sbjct: 230 ----EKKMSTPIEVLCKG--YPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (384), Expect = 1e-43
Identities = 63/289 (21%), Positives = 117/289 (40%), Gaps = 32/289 (11%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEE--RTQGGELQFQTEVEMISMAV 177
+D + ILG GG +V+ R L VAVK L+ + R L+F+ E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 178 HRNLLRLRGFCMTPTERL----LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 233
H ++ + T +V ++ ++ + G P+ ++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121
Query: 234 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV--TTAVRGTI 291
+ L + H + IIHRDVK ANI++ V DFG+A+ + V T AV GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351
+++PE ++DV+ G +L E++TG+ F D + + +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPV------SVAYQH 226
Query: 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVRMLE 399
E + + +++ ++ +P R + +E+ L
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLV 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-42
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 31/279 (11%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV- 177
++F +LG+G FGKV+ A+K LK++ + E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 178 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
H L + T V ++ G + ++ + S A GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 297
+LH I++RD+K NILLD++ + DFG+ K D T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
L K + D + +GV+L E++ GQ F D+ L ++
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRM----------- 217
Query: 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
D+ ++E+E + L+ P +R + +R
Sbjct: 218 DNPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-42
Identities = 52/292 (17%), Positives = 117/292 (40%), Gaps = 20/292 (6%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 179
++N + +G G +G V + VA+K++ Q + E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N++ + PT + ++V + + L + ++Q L+ RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPE 297
H ++HRD+K +N+LL+ + + DFGLA++ D H T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 298 YLSTG-KSSEKTDVFGYGVMLLELITGQRAFD-------LARLANDDDVMLLDWVKGLLK 349
+ ++ D++ G +L E+++ + F L + + + ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 350 EKKLEQLVDSDMEGNYIEEEV-----EQLIQVALLCTQGSPMERPKMSEVVR 396
K L+ + + + + + +P +R ++ + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 24/288 (8%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 179
+NF +G G +G VYK R G +VA+K+++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N+++L T + LV+ F+ + + + K +GLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
H H ++HRD+K N+L++ E + DFGLA+ T V L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAFD-----------LARLANDDDVMLLDWVKGLL 348
S D++ G + E++T + F L D+V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 349 KEKKLEQLVDSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
+ + D ++E+ L+ P +R
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (369), Expect = 2e-41
Identities = 38/282 (13%), Positives = 84/282 (29%), Gaps = 32/282 (11%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
+G G FG +++G L + VA+K Q + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 248
++ ++ S+ L G + A + +H+ ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 249 HRDVKAANILLDEEFEAVVG-----DFGLAKLMDYKDTHV------TTAVRGTIGHIAPE 297
+RD+K N L+ DFG+ K T + GT +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 298 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357
+ S + D+ G + + + G + L + + + + L +L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQ--GLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399
EE + + + P + +
Sbjct: 242 AG------FPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-41
Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 33/277 (11%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRG 186
+LG G GKV + A+K L++ + + EVE+ A +++R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72
Query: 187 FCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
L+V + G + S +++RG +I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI 130
Query: 243 CDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
I HRDVK N+L + + DFG AK ++ T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 359
K + D++ GV++ L+ G F ++ + + +K ++ + E
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYEF---P 237
Query: 360 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ E + + EEV+ LI+ + P +R ++E +
Sbjct: 238 NPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-41
Identities = 64/290 (22%), Positives = 116/290 (40%), Gaps = 26/290 (8%)
Query: 122 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 180
++++ ++G G FG VY+ +L D G LVA+K++ +++ E++++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCN 74
Query: 181 LLRLRGFCMTPTE-RLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
++RLR F + E + VY +V +V R +++ L K R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 294
LAY+H I HRD+K N+LLD + + DFG AK + + +V+ +
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRA 190
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD----------LARLANDDDVMLLDWV 344
+ DV+ G +L EL+ GQ F + ++ + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 394
E K Q+ + + I + + +P R E
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (368), Expect = 7e-41
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVH 178
+F LG G FG+V+ R +G A+K LK+E + E M+S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
++R+ G + ++ ++ G + S LR+ + P+ ++ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------A 116
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
L II+RD+K NILLD+ + DFG AK + + GT +IAPE
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEV 172
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
+ST ++ D + +G+++ E++ G F
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-40
Identities = 75/320 (23%), Positives = 116/320 (36%), Gaps = 44/320 (13%)
Query: 128 NILGRGGFGKVYKGRLT-DGSLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLL 182
+ LG G F VYK R +VA+K++K E G E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 183 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 242
L + LV+ FM + L S K L +GL YLH H
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 243 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 302
I+HRD+K N+LLDE + DFGLAK + T V T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 303 KS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 361
+ D++ G +L EL+ D D+ L + L EQ D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLP-----GDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 362 EGNYIEEEV--------------EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 407
+Y+ + + L+ + +P R ++ ++M
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM---------- 280
Query: 408 EEWQKEEMFRQDFNHTPHPN 427
++ P PN
Sbjct: 281 -KYFSNRPGPTPGCQLPRPN 299
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 34/285 (11%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-----QFQTEVEMISM 175
D + LG G F V K R + G A K +K+ RT+ + EV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 176 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
H N++ L T+ +L+ + G L + + L + G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLMDYKDTHVTTAVRGTI 291
+ YLH I H D+K NI+L + + DFGLA +D+ + + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 180
Query: 292 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351
+APE ++ + D++ GV+ L++G F D L V + E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLANVSAVNYEF 235
Query: 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ E + + I+ P +R + + ++
Sbjct: 236 EDEYF-------SNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-38
Identities = 57/278 (20%), Positives = 112/278 (40%), Gaps = 44/278 (15%)
Query: 129 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE-----LQFQTEVEMISM--AVHRN 180
+LG GGFG VY G ++D VA+K ++++R + EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 181 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 240
++RL + P +L+ L + + L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 241 DHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
+ ++HRD+K NIL+D E + DFG L+ V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 300 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358
+ V+ G++L +++ G F+ +D++++ +G + ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII-----RGQVFFRQ------ 225
Query: 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
+ E + LI+ C P +RP E+
Sbjct: 226 ------RVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 7e-37
Identities = 50/288 (17%), Positives = 98/288 (34%), Gaps = 20/288 (6%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 179
+ +G G +G V+K + +VA+KR++ ++ +G E+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 180 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 239
N++RL + + LV+ F G P + S Q+ G L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG-------L 114
Query: 240 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 299
++HRD+K N+L++ E + +FGLA+ + V
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 300 STGKSSEKTDVFGYGVMLLELITGQRAF-----------DLARLANDDDVMLLDWVKGLL 348
S D++ G + EL R + RL + L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 349 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396
K + N + + + + +P++R E ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-36
Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 11/213 (5%)
Query: 119 VATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISM 175
V ++F +LG+G FGKV R G A+K L++E + TE ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 176 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 235
H L L+ T V + G + L +I
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA---- 117
Query: 236 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 295
L +++RD+K N++LD++ + DFGL K GT ++A
Sbjct: 118 ---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 296 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
PE L D +G GV++ E++ G+ F
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-36
Identities = 56/300 (18%), Positives = 112/300 (37%), Gaps = 34/300 (11%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHR 179
+ +G+G FG+V+K R G VA+K++ E +G + E++++ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 180 NLLRLRGFCMTPTER--------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 231
N++ L C T LV+ F + + V + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 232 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVR 288
L L+ KI+HRD+KAAN+L+ + + DFGLA+ + T
Sbjct: 127 ----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 289 GTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD-------LARLANDDDVML 340
T+ + PE L + D++G G ++ E+ T LA ++ +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 341 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALL------CTQGSPMERPKMSEV 394
+ + + E+L + +++ ++ ++ P +R +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (334), Expect = 9e-36
Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 19/226 (8%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVH 178
D F LG G FG+V + G+ A+K L +++ + E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
L++L + +V ++ G + S LR G + + A Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEY 156
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
LH +I+RD+K N+L+D++ V DFG AK + + + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEI 209
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 344
+ + ++ D + GV++ E+ G F D + + + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYEKI 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-35
Identities = 46/222 (20%), Positives = 88/222 (39%), Gaps = 12/222 (5%)
Query: 112 FSLRELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQ 165
F +E+ +G G +G V G+ VA+K+L + +++ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 166 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR 225
E+ ++ H N++ L F + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 226 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 285
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D+ +T
Sbjct: 124 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 286 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
V L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 9e-33
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 17/221 (7%)
Query: 118 QVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER---TQGGELQFQTEV 170
+V +NF +LG G +GKV+ R G L A+K LK+ +TE
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 171 EMISMAVHR-NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 229
+++ L+ L T T+ L+ ++ G + + L +R + +I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138
Query: 230 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 289
+ L II+RD+K NILLD V+ DFGL+K +T G
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 290 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFD 328
TI ++AP+ + G S + D + GV++ EL+TG F
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (298), Expect = 7e-31
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHR 179
D++ LGRG + +V++ +T+ V VK LK + + + + E++ + ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGP 90
Query: 180 NLLRLRGFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 237
N++ L P R LV+ + N + L + + L
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143
Query: 238 YLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 296
Y H I+HRDVK N+++D E + + D+GLA+ + + P
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 297 E-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 327
E + D++ G ML +I + F
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-29
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 8/210 (3%)
Query: 121 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVH 178
+ + N + +G G +G V G VAVK+L + E+ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
N++ L + + L + + RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
+H IIHRD+K +N+ ++E+ E + DFGLA+ D +T V
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
L+ ++ D++ G ++ EL+TG+ F
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-29
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 10/209 (4%)
Query: 122 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHR 179
+ N +G G G V VA+K+L + + Q + E+ ++ H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 180 NLLRLRGFCMTP-TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
N++ L T ++V + + L + Q + + G+ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCGIKH 134
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 298
LH IIHRD+K +NI++ + + DFGLA+ + + T T + APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEV 189
Query: 299 LSTGKSSEKTDVFGYGVMLLELITGQRAF 327
+ E D++ G ++ E++ + F
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (268), Expect = 2e-26
Identities = 39/214 (18%), Positives = 76/214 (35%), Gaps = 19/214 (8%)
Query: 130 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 188
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 189 MTPTERLLVYP------------FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 236
+LL + + + KQI+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 237 AYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHI 294
Y+H C IIH D+K N+L++ + +A L + T +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 295 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 328
+PE L D++ ++ ELITG F+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.2 bits (236), Expect = 1e-23
Identities = 24/162 (14%), Positives = 48/162 (29%), Gaps = 20/162 (12%)
Query: 128 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERT---------QGGELQFQTEVEMISMAVH 178
++G G V+ VK K T G+L F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 179 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 238
R L +L+G + + G+ + + ++ +A
Sbjct: 66 RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 239 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280
+ I+H D+ N+L+ E + DF + + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 46.3 bits (108), Expect = 3e-06
Identities = 13/38 (34%), Positives = 20/38 (52%)
Query: 5 DLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 42
++S N L G+IP G+ F ++ANN+ P P
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 447 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.74 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.7 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.55 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 88.3 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-55 Score=412.22 Aligned_cols=268 Identities=28% Similarity=0.377 Sum_probs=219.1
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
+++..++|+..+.||+|+||+||+|.+. +|+.||||+++.... ....+.+|++++++++|||||++++++.+.+..+
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 3455678888999999999999999986 588999999975432 3457899999999999999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+|||||++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.
T Consensus 90 iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999976433 3589999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
.............|++.|+|||++.+..++.++|||||||++|||++|..|+... ..........
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-------~~~~~~~~~i-------- 229 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-------IDLSQVYELL-------- 229 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHHHHHHHH--------
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-------chHHHHHHHH--------
Confidence 6655444445556899999999999999999999999999999999987776321 1111111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCchhhH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 408 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 408 (447)
........+...+..+.+++.+||+.||.+|||+.+|++.|+.+.-..+..
T Consensus 230 --~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~~ 280 (287)
T d1opja_ 230 --EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280 (287)
T ss_dssp --HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCHH
T ss_pred --hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCCC
Confidence 111112222334567899999999999999999999999998875544443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=405.21 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=199.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
++|+..+.||+|+||+||+|.+.+++.||||+++... .....|.+|++++++++||||++++|+|...+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 4678889999999999999999888899999997543 23457999999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++|+|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999987643 3489999999999999999999999 999999999999999999999999999987654444
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCC-cccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA-FDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......||..|+|||++.+..++.++|||||||++|||+|+..| |.. ....+.+........
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--------~~~~~~~~~i~~~~~-------- 220 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDISTGFR-------- 220 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--------CCHHHHHHHHHHTCC--------
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--------CCHHHHHHHHHhcCC--------
Confidence 444445689999999999999999999999999999999995444 431 112222222211111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+..+...+.+++.+||+.||.+|||+++|++.|+++
T Consensus 221 --~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 221 --LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111222345689999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=407.60 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=208.8
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+..++|++.+.||+|+||+||+|.+++++.||||+++... .....|.+|++++++++|||||+++|++.+ +..++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 3456788889999999999999999888899999997543 234579999999999999999999998754 5679999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++..... .++++..++.|+.||++||+|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 87 Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp ECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 99999999998765432 2489999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
..........||+.|+|||++.++.++.++|||||||++|||+||..|+... ....+.........
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-------~~~~~~~~~i~~~~------- 227 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGY------- 227 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC-------
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHhcC-------
Confidence 4444444566899999999999999999999999999999999976655311 11112222221111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
....+...+..+.+++.+||+.||.+||||++|++.|+.
T Consensus 228 ---~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 228 ---RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 111122334568999999999999999999999999984
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=402.38 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=201.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|++.+.||+|+||+||+|... +|+.||||++...........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57888999999999999999985 68999999997654444445688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
|++|+|.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999996533 499999999999999999999999 99999999999999999999999999998764332
Q ss_pred C-ceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 281 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 281 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. ......+||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... ....... .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~~----~~~~~------- 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSD----WKEKK------- 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST---TSHHHHH----HHTTC-------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh---HHHHHHH----HhcCC-------
Confidence 2 22344679999999999988776 5789999999999999999999964211 1111111 11100
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
............+.+++.+||+.||.+|||++|+++
T Consensus 224 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111223456788999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=395.11 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=212.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
++|+..++||+|+||+||+|++++++.||||+++.... ....+.+|++++++++||||++++|+|.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57899999999999999999998888999999976433 3457999999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++|+|..++..... .+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999998765432 488999999999999999999999 999999999999999999999999999987655444
Q ss_pred ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.......||..|+|||++.+..++.++|||||||++|||+| |+.||+... ..+.........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~~~~--------- 218 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGL--------- 218 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTC---------
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHHHhCC---------
Confidence 44444568999999999999999999999999999999998 899995321 112222221111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
....+......+.+++.+||+.||++|||++++++.|.++
T Consensus 219 -~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1112223346789999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=399.75 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=202.0
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
+..++|++.+.||+|+||+||+|+.. ..||||+++.... ......|.+|++++++++|||||++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 44578999999999999999999865 3599999975432 3345578999999999999999999998754 568999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
||||++|+|.+++..... ++++..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 82 ~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 999999999999976432 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-ceeeccccccCccccccccC---CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 278 YKDT-HVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 278 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
.... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.... ........+.........
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~----~~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CHHHHHHHHHHTSCCCCG
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC----hHHHHHHHHhcCCCCCcc
Confidence 3322 23345579999999999864 357999999999999999999999995311 111111111111101000
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
. .....++..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 232 ~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 232 S---------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp G---------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred h---------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 11222346789999999999999999999999999853
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-54 Score=405.16 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=199.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-C---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD-G---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
++|++.++||+|+||+||+|.+.. + ..||||.+...........|.+|++++++++|||||+++|++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456777899999999999998752 3 368999987665555566799999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
||||++|+|.+++..... .+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998876432 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCce----eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 278 YKDTHV----TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 278 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||... ...+.+.......
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--------~~~~~~~~i~~~~- 250 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------TNQDVINAIEQDY- 250 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTTC-
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCC-
Confidence 332211 122347899999999999999999999999999999998 89999531 1112222221111
Q ss_pred cccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 353 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 353 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
....+...+..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 251 ---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 ---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112233456789999999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=400.43 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=195.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec--CCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 197 (447)
++|++.+.||+|+||+||+|+.. +|+.||||.+..... +.....+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999975 689999999976543 3334568899999999999999999999865 3567899
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
||||++|+|.+++.........+++..++.++.||+.||+|||++. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765434456999999999999999999999872 11399999999999999999999999999987
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||... ...+....... .....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--------~~~~~~~~i~~-~~~~~ 233 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELAGKIRE-GKFRR 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHH-TCCCC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC--------CHHHHHHHHHc-CCCCC
Confidence 65332 2234456999999999999999999999999999999999999999531 11122222111 11111
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.+......+.+++.+||+.||.+|||+.|+++
T Consensus 234 ---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11223456889999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=397.35 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=205.9
Q ss_pred hCCCCCCe-eeecCCeEEEEEEEC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNI-LGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
++|...+. ||+|+||+||+|.+. ++..||||+++..........|.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45556664 999999999999864 3557999999876555556689999999999999999999999865 468999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
||||++|+|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999886543 2489999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCce--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 278 YKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 278 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||... ... +.........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-----~~~---~~~~~i~~~~--- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----KGP---EVMAFIEQGK--- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CTH---HHHHHHHTTC---
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-----CHH---HHHHHHHcCC---
Confidence 443322 223458899999999999999999999999999999998 99999531 111 1111111111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
....+...+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 230 -------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 230 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 112223345678999999999999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=395.04 Aligned_cols=249 Identities=19% Similarity=0.305 Sum_probs=206.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|+||+||+|... +|+.||||++..... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 47999999999999999999975 689999999975433 2345789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
|++|+|.+++... ++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999988653 389999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.+.........
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~~------- 234 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTP------- 234 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSC-------
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCC-------
Confidence 2 2344569999999999999999999999999999999999999995311 11111111111110
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....+......+.+++.+||+.||.+|||+.|+++
T Consensus 235 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112233466889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=388.42 Aligned_cols=246 Identities=27% Similarity=0.406 Sum_probs=205.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||+||+|+.. +|+.||+|++..... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57888999999999999999986 689999999865432 233557889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|||++|+|.+++.... ++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997654 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.........
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~------- 220 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------TYQETYKRISRVE------- 220 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTTC-------
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC-------
Confidence 2 233456999999999999999999999999999999999999999531 1112222211111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...+......+.+++.+||+.||.+|||++|+++
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0111223456889999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=397.86 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=201.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDG-----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
+.|+..++||+|+||+||+|.+.+. ..||||++...........|.+|++++++++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577788999999999999987532 47999999776655556679999999999999999999999999999999
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
||||+.+|++.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999988876432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 277 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 277 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..|+... ....+.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-------~~~~~~~~~i~~----- 228 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-------LSNHEVMKAIND----- 228 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHHHT-----
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc-------CCHHHHHHHHhc-----
Confidence 433221 223345899999999999999999999999999999999976665321 111122222111
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
......+...+..+.+++.+||+.||.+||||.+|++.|+.
T Consensus 229 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 229 -----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp -----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 11122223345678999999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=406.03 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=208.6
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEECC-C-----cEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLTD-G-----SLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
++..++|++.+.||+|+||+||+|++.. + ..||||.+...........+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3456789999999999999999998642 2 369999997665555556789999999988 89999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQS-------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 251 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~d 251 (447)
.+..++|||||++|+|.++++..... ...+++..++.++.||++||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 99999999999999999999765321 23589999999999999999999999 999999
Q ss_pred CCCCCEEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCccc
Q 013238 252 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 329 (447)
Q Consensus 252 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~ 329 (447)
|||+|||++.++.+||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 2334568999999999999999999999999999999998 8999953
Q ss_pred ccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 013238 330 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 399 (447)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 399 (447)
. .....+...+. .......+...+..+.++|.+||+.||++|||++||++.|.
T Consensus 270 ~----~~~~~~~~~~~-------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 I----PVDANFYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp C----CCSHHHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C----CHHHHHHHHHh-------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 11111222111 11111222334567899999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=390.50 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=197.6
Q ss_pred CeeeecCCeEEEEEEECC---CcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecccC
Q 013238 128 NILGRGGFGKVYKGRLTD---GSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 203 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 203 (447)
++||+|+||+||+|.+.+ ++.||||+++.... ......+.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 46899999975433 2334579999999999999999999999865 457899999999
Q ss_pred CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCCce
Q 013238 204 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 283 (447)
Q Consensus 204 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 283 (447)
|+|.+++.... ++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997643 489999999999999999999999 99999999999999999999999999998765443322
Q ss_pred --eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 284 --TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 284 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||... ...+.........
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--------~~~~~~~~i~~~~--------- 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTAMLEKGE--------- 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHTTC---------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--------CHHHHHHHHHcCC---------
Confidence 223458999999999999999999999999999999998 89999531 1111111111111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 361 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 361 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
....+...+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 228 -~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 228 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 112222345678899999999999999999999998874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=396.41 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=203.3
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+..++|++.+.||+|+||+||+|.+.+++.||||+++.... ....|.+|+.++++++|+|||+++|++. .+..++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 34578999999999999999999998888999999975433 3457999999999999999999999985 45689999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|..++..... ..++|..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 91 Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999999988876432 2389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
..........||+.|+|||++.+..++.++|||||||++|||+||..|+... ....+.+.......
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-------~~~~~~~~~i~~~~------- 231 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------MVNREVLDQVERGY------- 231 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC-------
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-------CCHHHHHHHHHhcC-------
Confidence 4444444456899999999999999999999999999999999977766321 11122222221111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
...........+.+++.+||+.||++|||+++|+++|+.
T Consensus 232 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 232 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 111222344678999999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=402.01 Aligned_cols=200 Identities=26% Similarity=0.397 Sum_probs=178.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
..++|++.+.||+|+||+||+|... +|+.||+|+++..........+.+|+.+++.++|||||++++++.+....++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678999999999999999999975 689999999976655555667899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
||+++|+|.+++...+ .+++..++.++.|++.||.|||+ + +|+||||||+|||+++++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999998654 38999999999999999999997 5 89999999999999999999999999998653
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 329 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~ 329 (447)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22 12345799999999999999999999999999999999999999954
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=391.79 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=202.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
+.|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|+++++.++|||||++++++.+.+..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 56888899999999999999976 68999999997543 23344688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
|++|+|.+++..... ++++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999999876432 499999999999999999999999 99999999999999999999999999997543211
Q ss_pred CceeeccccccCcccccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 281 THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
.......||+.|+|||++. +..++.++|||||||++|||+||+.||.... ..... ........ .
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-----~~~~~---~~i~~~~~-~- 233 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-----PMRVL---LKIAKSEP-P- 233 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----GGGHH---HHHHHSCC-C-
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-----HHHHH---HHHHcCCC-C-
Confidence 1223456999999999984 4567899999999999999999999996321 11111 11111110 0
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....+......+.+++.+||+.||.+|||+.|+++
T Consensus 234 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 ------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112234466889999999999999999999876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=384.21 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=194.6
Q ss_pred CCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec----CCcceEEE
Q 013238 125 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 198 (447)
Q Consensus 125 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 198 (447)
+..++||+|+||+||+|.+. +++.||+|.+..... ......+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45567999999999999976 588999999976542 3334568999999999999999999999864 34578999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEEC-CCCcEEEeecCCccc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKL 275 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~ 275 (447)
||+++|+|.+++.... .+++..++.++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+++.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997653 389999999999999999999998 7 99999999999996 578999999999986
Q ss_pred cCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||... .................
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-------~~~~~~~~~i~~~~~~~- 232 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGVKPA- 232 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTCCCG-
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-------ccHHHHHHHHHcCCCCc-
Confidence 4322 2344579999999999865 6999999999999999999999999521 11111222221111100
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. .......+.+++.+||+.||++|||+.|+++
T Consensus 233 ----~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ----SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01 1112345889999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-53 Score=391.15 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=199.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC----CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
+..++|++.+.||+|+||+||+|.+.. +..||||.++..........+.+|++++++++||||++++|++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345788899999999999999998753 35689999876655555667999999999999999999999985 4678
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+++|+|..++..... ++++..++.++.||++||.|||++ +++||||||+||++++++.+||+|||+++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999998765432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccc
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 353 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (447)
..............||+.|+|||++.+..++.++|||||||++|||+| |..||.... .......+ .....
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-----~~~~~~~i---~~~~~- 227 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRI---ENGER- 227 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHH---HTTCC-
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-----HHHHHHHH---HcCCC-
Confidence 765544444455568999999999999999999999999999999998 899986321 11222111 11111
Q ss_pred ccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 354 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 354 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...+...+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 228 ---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112223446789999999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-52 Score=394.33 Aligned_cols=267 Identities=26% Similarity=0.420 Sum_probs=215.6
Q ss_pred HHHHHHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeee
Q 013238 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 187 (447)
Q Consensus 114 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 187 (447)
+.++++..++|++.+.||+|+||+||+|+.. +++.||||+++..........+.+|+++++.++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456667789999999999999999999864 3578999999876555556679999999999999999999999
Q ss_pred eecCCcceEEEecccCCcchhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 013238 188 CMTPTERLLVYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 247 (447)
Q Consensus 188 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 247 (447)
|......+++|||+++|+|.+++..... ....+++..++.|+.|++.||+|||++ ++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999975321 123489999999999999999999999 99
Q ss_pred eecCCCCCCEEECCCCcEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCC-C
Q 013238 248 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-R 325 (447)
Q Consensus 248 vH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~-~ 325 (447)
+||||||+|||||.++.+||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986543322 2233456889999999999999999999999999999999986 5
Q ss_pred CcccccccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 326 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 326 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
||... ...+......... . ...+...+..+.+++.+||+.||.+||||.||+++|+++
T Consensus 242 p~~~~--------~~~e~~~~v~~~~-~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGM--------AHEEVIYYVRDGN-I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTS--------CHHHHHHHHHTTC-C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCC--------CHHHHHHHHHcCC-C---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 66421 1122222222111 1 111223345689999999999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=386.97 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=203.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||+||+|... +|+.||||++.... .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57899999999999999999985 68999999997543 2233456899999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|||++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999987754 389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ............
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~------ 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIKLE------ 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHcCC------
Confidence 332 23344569999999999999999999999999999999999999996321 111112211111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+|||++|+++
T Consensus 227 -~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 -Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -C----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0 111223456889999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-51 Score=389.39 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=192.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
.+.|++.+.||+|+||+||+|... +|+.||||++...........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467899999999999999999986 6899999999765544445568899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCcEEEeecCCcccc
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKLM 276 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~ 276 (447)
||++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997543 499999999999999999999999 999999999999994 5789999999999865
Q ss_pred CCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccc
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 356 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (447)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~---- 226 (307)
T d1a06a_ 161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKAEY---- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHTTCC----
T ss_pred cCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhccCC----
Confidence 432 22334569999999999999999999999999999999999999995311 1111112211110
Q ss_pred cccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 013238 357 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEG 400 (447)
Q Consensus 357 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 400 (447)
.............+.+++.+||+.||.+|||+.|+++ .+.+
T Consensus 227 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 227 ---EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ---CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 0111112223456889999999999999999999998 3554
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-52 Score=391.42 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=202.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
+.|+..+.||+|+||+||+|+.. +|+.||||++...... .....+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888999999999999999975 6889999999754432 23346889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|||.+|+|..++.... ++++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999977665432 499999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccCccccccccC---CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 355 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (447)
. ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+..........
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~--------~~~~~~~~i~~~~~--- 231 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNES--- 231 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCC---
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCCC---
Confidence 2 23469999999999864 46899999999999999999999999531 11111111111110
Q ss_pred ccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 013238 356 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGD 401 (447)
Q Consensus 356 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 401 (447)
+... .......+.+++.+||+.||.+|||+.|+++ .+.+.
T Consensus 232 ---~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 232 ---PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ---CCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ---CCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 1111 1122456889999999999999999999987 34443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=389.72 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=201.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCc----EEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 196 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 196 (447)
++|+..++||+|+||+||+|.+. +|+ .||||+++..........+.+|++++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999875 343 68999987665555667899999999999999999999999864 5678
Q ss_pred EEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcccc
Q 013238 197 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 276 (447)
Q Consensus 197 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 276 (447)
+++|+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998876532 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 277 DYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 277 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |..||+.. ....+...+.. .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-----~~~~~~~~i~~---~---- 229 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEISSILEK---G---- 229 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CGGGHHHHHHH---T----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHc---C----
Confidence 5433332 233458999999999999999999999999999999998 78888532 11122222211 1
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.....+..+...+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 230 ------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11112233456789999999999999999999999998753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=381.13 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=198.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec-CCcceEEE
Q 013238 120 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVY 198 (447)
Q Consensus 120 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 198 (447)
..++|+..+.||+|+||.||+|.++ |..||||+++... ....+.+|++++++++||||++++|+|.+ .+..++||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3457788899999999999999985 7889999996543 34578999999999999999999999865 45689999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+++|+|.+++..... .++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 99999999999976432 2389999999999999999999999 999999999999999999999999999986533
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
. .....++..|+|||++.+..++.++|||||||++|||+| |+.||... ........+..
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-----~~~~~~~~i~~----------- 215 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEK----------- 215 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHHHHTT-----------
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHc-----------
Confidence 2 223357889999999999999999999999999999998 68777531 11222222211
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
......+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 216 --~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 216 --GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111222233346788999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=378.27 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=204.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-----chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|++.+.||+|+||+||+|... +|+.||||++...... .....+.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999985 6899999999654322 2346789999999999999999999999999999
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----cEEEeec
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 270 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df 270 (447)
++|||||++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997754 499999999999999999999999 999999999999998876 4999999
Q ss_pred CCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 271 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 271 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~ 231 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV 231 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTT
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998764332 2334568999999999999999999999999999999999999995311 11111111111
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
.. .............+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NY-------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000001122356889999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=388.15 Aligned_cols=268 Identities=27% Similarity=0.379 Sum_probs=201.7
Q ss_pred HHHHHHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEee
Q 013238 114 LRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRG 186 (447)
Q Consensus 114 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 186 (447)
..++++..++|++.+.||+|+||.||+|.+. +++.||||+++..........+.+|.+.+.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 4455666788999999999999999999863 24689999998665555556778888877766 6899999999
Q ss_pred eeecC-CcceEEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 013238 187 FCMTP-TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVK 253 (447)
Q Consensus 187 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk 253 (447)
++... ...++|||||++|+|.++++.... ....+++..++.++.||++||+|||++ +|+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence 98765 467999999999999999976432 123589999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEeecCCccccCCCCCc-eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCC-CCccccc
Q 013238 254 AANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-RAFDLAR 331 (447)
Q Consensus 254 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~-~p~~~~~ 331 (447)
|+||||++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999865433322 233456999999999999999999999999999999999975 5674211
Q ss_pred ccCCCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 332 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
........ ..... ....+......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 242 ----~~~~~~~~----~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 242 ----IDEEFCRR----LKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ----CSHHHHHH----HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHH----HhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111111 11111 1111222345689999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=381.21 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=205.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 197 (447)
-++|++++.||+|+||+||+|+.. +|+.||||++++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357899999999999999999975 69999999997543 223345688999999999999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
||||++|+|..++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999998754 389999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~~~------ 221 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE------ 221 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC------
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhcCC------
Confidence 322 23344679999999999999999999999999999999999999995321 111222211111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+||+ +.++++
T Consensus 222 -~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 -I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -C----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0 111223455788999999999999995 677665
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-50 Score=385.62 Aligned_cols=252 Identities=20% Similarity=0.280 Sum_probs=205.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|++++++++|||||++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 58999999999999999999975 68999999997543 23345788999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CCcEEEeecCCccccCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~ 278 (447)
|++|+|.+++.... .++++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999986433 2499999999999999999999999 9999999999999964 67899999999987654
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.. ......||+.|||||++.+..++.++|||||||++|||++|+.||... ...+.+........
T Consensus 179 ~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~------ 242 (350)
T d1koaa2 179 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCDW------ 242 (350)
T ss_dssp TS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCC------
T ss_pred cc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCC------
Confidence 33 234456999999999999999999999999999999999999999532 11122222211110
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
.............+.+++.+||+.||.+|||+.|+++.
T Consensus 243 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111112234568899999999999999999999883
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-50 Score=384.01 Aligned_cols=251 Identities=19% Similarity=0.285 Sum_probs=205.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|++.+.||+|+||+||+|... +|+.||||+++.... .....+.+|++++++++|||||++++++.+.+..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999975 699999999975432 2345688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCcEEEeecCCccccCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~ 278 (447)
|++|+|.+++.... .++++..++.|+.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+++....
T Consensus 108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998876543 2499999999999999999999999 999999999999998 678999999999987654
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.........
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~------- 244 (352)
T d1koba_ 182 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCD------- 244 (352)
T ss_dssp TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCC-------
T ss_pred CC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-------
Confidence 32 2344568999999999999999999999999999999999999995311 111111211111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..............+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111112223456889999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=384.83 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=213.2
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeec
Q 013238 118 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 190 (447)
Q Consensus 118 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 190 (447)
++..++|++.+.||+|+||.||+|++. +++.||||+++..........+.+|+.+++.+ +|||||+++++|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 345678888999999999999999852 46789999998766666666799999999998 69999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 013238 191 PTERLLVYPFMVNGSVASCLRERGQ--------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 256 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~N 256 (447)
.+..+++||||++|+|.++++.... ....+++..+..++.||++||+|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999976432 123589999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhC-CCCcccccccC
Q 013238 257 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLAN 334 (447)
Q Consensus 257 ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg-~~p~~~~~~~~ 334 (447)
|+++.++.+|++|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|+ ..||...
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~---- 251 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM---- 251 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC----
Confidence 9999999999999999987654433 333445689999999999999999999999999999999995 4445321
Q ss_pred CCcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 335 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
.....+...+.. ......+......+.+++.+||+.||.+||||.+|+++|++.
T Consensus 252 ~~~~~~~~~i~~-------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 252 PVDSKFYKMIKE-------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp CSSHHHHHHHHH-------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHhc-------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111111122111 111122222346689999999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=385.01 Aligned_cols=266 Identities=24% Similarity=0.378 Sum_probs=214.8
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEEC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 190 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 190 (447)
+++..++|+..+.||+|+||+||+|.+. +++.||||+++..........+.+|++++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3445678888999999999999999863 2578999999866555555678999999999999999999999999
Q ss_pred CCcceEEEecccCCcchhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 013238 191 PTERLLVYPFMVNGSVASCLRERG------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 264 (447)
Q Consensus 191 ~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~ 264 (447)
....++||||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 999999999999999999886532 2223479999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCccccCCCCCce-eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCC-CCcccccccCCCcccHHH
Q 013238 265 AVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-RAFDLARLANDDDVMLLD 342 (447)
Q Consensus 265 ~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~ 342 (447)
+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||.. ....+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~~~~ 243 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQ 243 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--------CCHHH
Confidence 9999999998664333222 22335899999999999999999999999999999999985 56632 12223
Q ss_pred HHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 013238 343 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 403 (447)
Q Consensus 343 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 403 (447)
......+... ...+...+..+.+++.+||+.||.+|||+.+|++.|++...
T Consensus 244 ~~~~i~~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 VLRFVMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHhCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3332222211 11122334679999999999999999999999999988533
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=383.81 Aligned_cols=262 Identities=28% Similarity=0.410 Sum_probs=207.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC--------CcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeee
Q 013238 119 VATDNFSNRNILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 189 (447)
Q Consensus 119 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 189 (447)
+..++|++.+.||+|+||.||+|+... +..||||+++..........+.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 446788889999999999999998532 3479999998766655566788899888887 7999999999999
Q ss_pred cCCcceEEEecccCCcchhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 013238 190 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 257 (447)
Q Consensus 190 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Ni 257 (447)
+++..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999976532 124589999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecCCccccCCCCC-ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCC
Q 013238 258 LLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 335 (447)
Q Consensus 258 ll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~ 335 (447)
|++.++.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---- 242 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 242 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC----
Confidence 999999999999999987654332 22344568999999999999999999999999999999998 688885311
Q ss_pred CcccHHHHHHHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 336 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..... ..+... .....+......+.+++.+||+.||.+|||+.||++.|+++
T Consensus 243 ----~~~~~-~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 243 ----VEELF-KLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ----HHHHH-HHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHH-HHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11111 111111 11112223345689999999999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=378.82 Aligned_cols=252 Identities=33% Similarity=0.450 Sum_probs=201.5
Q ss_pred CCeeeecCCeEEEEEEECCC----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeec-CCcceEEEecc
Q 013238 127 RNILGRGGFGKVYKGRLTDG----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPFM 201 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 201 (447)
.++||+|+||+||+|.+.++ ..||||+++.........+|.+|++++++++||||++++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999997532 36899999765555556679999999999999999999999875 45789999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999876433 378899999999999999999999 999999999999999999999999999987653322
Q ss_pred c---eeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 282 H---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 282 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. ......||..|+|||.+.+..++.++||||||+++|||+||..||.... ...++........+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-------~~~~~~~~i~~g~~~----- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDITVYLLQGRRL----- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCC-----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHcCCCC-----
Confidence 1 2223458999999999999999999999999999999999888875311 111112222221111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
..+......+.+++.+||+.||++||||.||++.|+++
T Consensus 254 -----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122345688999999999999999999999999764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=377.02 Aligned_cols=256 Identities=29% Similarity=0.379 Sum_probs=196.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC--CC--cEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT--DG--SLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 194 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 194 (447)
.++|++.+.||+|+||.||+|++. ++ ..||||+++.... ......|.+|++++++++||||++++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 356888899999999999999864 22 3689999875432 2334578999999999999999999999975 467
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
++||||+++|+|.+++..... ++++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999998876533 389999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCce--eeccccccCccccccccCCCCCchhhhHHHHHHHHHHHh-CCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 275 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 275 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
......... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||... ...+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHHHHHhCC
Confidence 765443322 223457889999999999999999999999999999998 89999531 1222222222211
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.....+...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus 232 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111222334568999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-49 Score=374.69 Aligned_cols=245 Identities=26% Similarity=0.345 Sum_probs=203.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57888999999999999999975 689999999975432 233457889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
|||.+|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999887654 378899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||... ...+.........
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~------- 217 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNAE------- 217 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHCC-------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc--------CHHHHHHHHHcCC-------
Confidence 2 23457999999999999999999999999999999999999999532 1112222222111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+|+ |++++++
T Consensus 218 ~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 L----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0 11112235688999999999999996 8888876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=381.69 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=203.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-Cc--EEEEEEeccccccchHHHHHHHHHHHHhc-CCCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTD-GS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 197 (447)
++|++.++||+|+||+||+|.+.+ |. .||||+++..........+.+|+++++++ +||||++++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999998763 44 47888886554444555799999999998 799999999999999999999
Q ss_pred EecccCCcchhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcE
Q 013238 198 YPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 265 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~ 265 (447)
|||+++|+|.++++... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997542 2334699999999999999999999999 99999999999999999999
Q ss_pred EEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCC-CcccccccCCCcccHHHHH
Q 013238 266 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR-AFDLARLANDDDVMLLDWV 344 (447)
Q Consensus 266 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~ 344 (447)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||... ...+..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------~~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELY 236 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--------CHHHHH
Confidence 9999999975432221 223458999999999999999999999999999999999765 56421 122222
Q ss_pred HHHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 013238 345 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 401 (447)
Q Consensus 345 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 401 (447)
...... .....+......+.+++.+||+.||++||||.+|++.|+++
T Consensus 237 ~~i~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222111 11122233456799999999999999999999999998864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-49 Score=375.91 Aligned_cols=245 Identities=22% Similarity=0.290 Sum_probs=203.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 198 (447)
++|++.+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57899999999999999999985 699999999965432 233456889999999999999999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCC
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 278 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 278 (447)
||+.+|+|..++...+ .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997754 389999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||... .............
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~------- 254 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSGK------- 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-------
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--------CHHHHHHHHhcCC-------
Confidence 2 23356999999999999999999999999999999999999999531 1112222221111
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 396 (447)
. ..+......+.+++.+||+.||.+|+ |++++++
T Consensus 255 ~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 11122345688999999999999994 8888876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.4e-49 Score=365.54 Aligned_cols=258 Identities=25% Similarity=0.320 Sum_probs=200.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCceeeEeeeeecCCc----
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE---- 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 193 (447)
.++|++.+.||+|+||+||+|... +|+.||||+++..... .....+.+|+++++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 6899999999765432 234568999999999999999999999876543
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.|+||||+++|+|..++...+ ++++..++.++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 689999999999999887654 389999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC--ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 274 KLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 274 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||... ...+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--------SPVSVAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc--------CHHHHHHHHHhcC
Confidence 76543222 2334456999999999999999999999999999999999999999531 1112222222211
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEG 400 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~ 400 (447)
.... . ......+..+.+++.+||+.||.+|| |++++++.|.+
T Consensus 231 ~~~~---~----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIPP---S----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCG---G----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCC---c----hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1110 0 01112235688999999999999999 89999888865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=369.63 Aligned_cols=257 Identities=26% Similarity=0.264 Sum_probs=192.8
Q ss_pred CCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccch----HHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEecc
Q 013238 127 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG----ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 201 (447)
Q Consensus 127 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 201 (447)
+++||+|+||+||+|.+. +|+.||||+++....... ...+.+|+++++.++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 689999999965432211 235889999999999999999999999999999999999
Q ss_pred cCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCCC
Q 013238 202 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 281 (447)
Q Consensus 202 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 281 (447)
.++++..+.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 888777665432 2488899999999999999999999 999999999999999999999999999986654332
Q ss_pred ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccccc
Q 013238 282 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 360 (447)
Q Consensus 282 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 360 (447)
. .....||+.|+|||++.+. .++.++|||||||++|||+||..||... ........+.............+..
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~-----~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-----SDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC-----CHHHHHHHHHHhcCCCChhhccchh
Confidence 2 2334689999999998654 5799999999999999999999999532 1111111111111111111000000
Q ss_pred ---------cCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 361 ---------MEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 361 ---------~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...... ......+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000001 122356889999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-48 Score=362.77 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=203.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc--------chHHHHHHHHHHHHhcC-CCceeeEeeeeecC
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--------GGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 191 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 191 (447)
++|++.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999975 6899999999654321 12235788999999997 99999999999999
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
+..|+|||||++|+|.+++...+ ++++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997654 489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeccccccCccccccccC------CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 345 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 345 (447)
+++...... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.... ......
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~ 225 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLR 225 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------HHHHHH
Confidence 998765432 2344569999999998853 356889999999999999999999996321 111111
Q ss_pred HHhhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 346 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 346 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....... .............+.+++.+||+.||.+|||+.|+++
T Consensus 226 ~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCC-------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2221110 0111122234467899999999999999999999865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=371.85 Aligned_cols=268 Identities=22% Similarity=0.299 Sum_probs=198.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC----cceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 197 (447)
.+|...+.||+|+||.||+|++ +|+.||||+++.... .....+.|+..+..++||||++++++|.+.+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 3566778899999999999997 588999999964321 1222334555556789999999999998654 46899
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
||||++|+|.++++.. +++|..++.++.+++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999864 3899999999999999999999731 23899999999999999999999999999
Q ss_pred ccccCCCCCc---eeeccccccCccccccccCCC------CCchhhhHHHHHHHHHHHhCCCCcccccccCCC-------
Q 013238 273 AKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITGQRAFDLARLANDD------- 336 (447)
Q Consensus 273 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~------- 336 (447)
++........ ......||+.|+|||++.+.. ++.++|||||||+||||+||..||.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9876543322 223456999999999987653 577899999999999999999887532211110
Q ss_pred cccHHHHHHHHhhccccccccccccCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 013238 337 DVMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 402 (447)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 402 (447)
.... ........... .++.+... ........+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 235 ~~~~-~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 235 DPSV-EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SCCH-HHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchH-HHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111 11111111111 11111111 13345677999999999999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=371.03 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=200.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccc--ccchHHHHHHHHHHHH-hcCCCceeeEeeeeecCCcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 197 (447)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. .......+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999986 68999999997543 1223345566666654 68999999999999999999999
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccC
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 277 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 277 (447)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999998754 388999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc
Q 013238 278 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 357 (447)
Q Consensus 278 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (447)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ...........
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~------- 218 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMD------- 218 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-------
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-------
Confidence 333 23344569999999999999999999999999999999999999996321 11111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 013238 358 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS-EVVR 396 (447)
Q Consensus 358 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 396 (447)
... .+......+.+++.+||+.||.+|||+. ++++
T Consensus 219 ~~~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCC----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 011 1112345588999999999999999985 6653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=369.48 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=203.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|++.+.||+|+||+||+|... +|+.||||.++.... ....+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 67899999999999999999986 688999999976432 234688999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC--CcEEEeecCCccccCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMDY 278 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~~ 278 (447)
|++|+|.+++.... .++++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999997543 2489999999999999999999999 99999999999999854 5899999999987643
Q ss_pred CCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccccccc
Q 013238 279 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 358 (447)
Q Consensus 279 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 358 (447)
. .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+........... .+
T Consensus 157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~~---~~ 223 (321)
T d1tkia_ 157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYT---FD 223 (321)
T ss_dssp T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC---CC
T ss_pred C--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC---CC
Confidence 3 23344568999999999999999999999999999999999999995321 11222222111100 00
Q ss_pred cccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 359 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 359 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. .........+.+++.+||+.||.+|||+.|+++
T Consensus 224 ~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 E----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h----hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000112355889999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-48 Score=377.13 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=197.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc--cchHHHHHH---HHHHHHhcCCCceeeEeeeeecCCcce
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~ 195 (447)
++|++.++||+|+||.||+|+.. +|+.||||++..... ......+.+ ++.+++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999976 689999999864322 112223334 466677788999999999999999999
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+|||||++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999997754 388999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc
Q 013238 276 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 354 (447)
Q Consensus 276 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (447)
..... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.... ..............
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~~~~~~~~---- 224 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----TKDKHEIDRMTLTM---- 224 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC-----SSCHHHHHHHSSSC----
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcccC----
Confidence 64332 234569999999999975 568999999999999999999999996421 11111111111100
Q ss_pred cccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 355 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 355 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
. ...+......+.+++.+||+.||.+||| ++++++
T Consensus 225 ---~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ---A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---C----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---C----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 0111123456889999999999999999 577765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=371.64 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=196.3
Q ss_pred hCCCCCC-eeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHh-cCCCceeeEeeeeec----CCcc
Q 013238 122 DNFSNRN-ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMT----PTER 194 (447)
Q Consensus 122 ~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~ 194 (447)
++|.+.+ .||+|+||+||+|... +++.||||+++.. ..+.+|++++.+ .+||||+++++++.+ ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 5787764 6999999999999975 6899999998542 246789988655 589999999999865 3567
Q ss_pred eEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeecC
Q 013238 195 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 271 (447)
Q Consensus 195 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 271 (447)
|+|||||++|+|.+++...+. .++++..++.++.||+.||+|||++ +|+||||||+|||+++ .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 999999999999999976432 3599999999999999999999999 9999999999999985 5679999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .....+
T Consensus 160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-----~~~~~~------- 225 (335)
T d2ozaa1 160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGM------- 225 (335)
T ss_dssp TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH-----HHHHHH-------
Confidence 998765432 234456999999999999999999999999999999999999999642111 000000
Q ss_pred ccccccccc--cCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 352 KLEQLVDSD--MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 352 ~~~~~~d~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...+.... ............+.+++.+||+.||.+|||+.|+++
T Consensus 226 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 226 -KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00111111 111112344567899999999999999999999988
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=361.42 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=196.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|+..+.||+|+||+||+|++. +|+.||||+++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999975 6899999999654322 234578899999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
|+.++ +..++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~-~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99654 444443332 22499999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCceeeccccccCccccccccCCC-CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc--ccccc
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--KLEQL 356 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 356 (447)
. .......||+.|+|||++.... ++.++|||||||++|+|++|+.||..... ...+........... .....
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHhcCCCchhhcccc
Confidence 2 2233446999999999887665 58899999999999999999999963210 011111111110000 00000
Q ss_pred c---cc--c---cCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 357 V---DS--D---MEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 357 ~---d~--~---~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. +. . ..... .......+.+++.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 00 0 00000 0122356889999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=360.15 Aligned_cols=246 Identities=22% Similarity=0.378 Sum_probs=197.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccc-----hHHHHHHHHHHHHhcC--CCceeeEeeeeecCCc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAV--HRNLLRLRGFCMTPTE 193 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 193 (447)
++|++.++||+|+||+||+|... +|+.||||++....... ....+.+|++++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57889999999999999999975 68999999997543211 1123668999999886 8999999999999999
Q ss_pred ceEEEecccC-CcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCcEEEeecC
Q 013238 194 RLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFG 271 (447)
Q Consensus 194 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 271 (447)
.++||||+.+ +++.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 57777776643 389999999999999999999999 9999999999999985 5799999999
Q ss_pred CccccCCCCCceeeccccccCccccccccCCCC-CchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 272 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 272 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... .....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~ 219 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRG 219 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHC
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhc
Confidence 99865432 2344569999999999987765 577899999999999999999996321 11111
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCC
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGDG 402 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 402 (447)
. ...... ....+.+++.+||+.||.+|||++|+++ .++++.
T Consensus 220 ~-------~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 220 Q-------VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp C-------CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred c-------cCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 0 001111 2356889999999999999999999987 354443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.2e-47 Score=356.25 Aligned_cols=262 Identities=22% Similarity=0.317 Sum_probs=198.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEec
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 200 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 200 (447)
++|+..+.||+|+||+||+|++.+|+.||||+++.... ......+.+|+.++++++||||+++++++...+..+++|+|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57888999999999999999999999999999975432 23356789999999999999999999999999999999999
Q ss_pred ccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCCC
Q 013238 201 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 280 (447)
Q Consensus 201 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 280 (447)
+.++.+..+.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9877666665433 2499999999999999999999999 99999999999999999999999999998765332
Q ss_pred CceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcccccccc--
Q 013238 281 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV-- 357 (447)
Q Consensus 281 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 357 (447)
. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.... ......-+.............
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-----HHHHHHHHHHhhCCCChhhccch
Confidence 2 22334589999999998765 56899999999999999999999995321 111111111111100000000
Q ss_pred ------ccccC-------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 358 ------DSDME-------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 358 ------d~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
+.... ..........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0011122356889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=355.71 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=193.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-C-CcEEEEEEeccccccc-hHHHHHHHHHHHHhc---CCCceeeEeeeeec----
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-D-GSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT---- 190 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 190 (447)
.++|++.+.||+|+||+||+|.+. + ++.||||+++...... ....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 6679999996543221 222455677766554 79999999999853
Q ss_pred -CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEee
Q 013238 191 -PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 269 (447)
Q Consensus 191 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 269 (447)
....+++|||+.++.+....... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 24578999999887765544332 23489999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhh
Q 013238 270 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 349 (447)
Q Consensus 270 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 349 (447)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~ 232 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILDVIG 232 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHhhC
Confidence 9998864322 23344569999999999999999999999999999999999999996321 1111111111110
Q ss_pred ccccccc----------ccccc---CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 350 EKKLEQL----------VDSDM---EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 350 ~~~~~~~----------~d~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
....... ..... ...........+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 00000 00011123356788999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=353.04 Aligned_cols=263 Identities=20% Similarity=0.301 Sum_probs=194.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecCC----cce
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERL 195 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 195 (447)
+++|++++.||+|+||+||+|... +|+.||||++...........+.+|+++++.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357889999999999999999875 799999999976554445567889999999999999999999987543 235
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
++++++.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 566677799999999754 389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc--eeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 276 MDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 276 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
....... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||..... ...............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPS 233 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-----HHHHHHHhhhccCCC
Confidence 5433221 1234568999999999854 5678999999999999999999999953211 111111101000000
Q ss_pred ccc------------c-cccccCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 LEQ------------L-VDSDMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~~~------------~-~d~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
... . ..+....... ......+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0 0000000000 011245789999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=347.04 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=193.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeec--------C
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------P 191 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 191 (447)
++|++.+.||+|+||+||+|++. +|+.||||++..... ......+.+|++++++++|+|++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68899999999999999999975 799999999865433 2334568899999999999999999998865 3
Q ss_pred CcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecC
Q 013238 192 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 271 (447)
Q Consensus 192 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 271 (447)
+..+++|||+.++.+....... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 4578999999887766554332 2488999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC---ceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHH
Q 013238 272 LAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 347 (447)
Q Consensus 272 l~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 347 (447)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||... ............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-----~~~~~~~~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLALISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-----CHHHHHHHHHHh
Confidence 9976543221 122334689999999998765 6899999999999999999999999531 111111111111
Q ss_pred hhccc---ccccccc--------ccC-CCCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 348 LKEKK---LEQLVDS--------DME-GNYIEE------EVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 348 ~~~~~---~~~~~d~--------~~~-~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..... ....... ... .....+ ....+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11100 0000000 000 000111 1235678999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=351.99 Aligned_cols=259 Identities=24% Similarity=0.317 Sum_probs=190.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEeeeeecC------Ccce
Q 013238 123 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERL 195 (447)
Q Consensus 123 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 195 (447)
+|+..++||+|+||+||+|++. +|+.||||++...... ..+|++++++++|+||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5777889999999999999986 6899999999754322 34799999999999999999998543 2468
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeecCCcc
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 274 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~ 274 (447)
+|||||+++.+..+... ......+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 99999976644443322 22234599999999999999999999999 999999999999999775 89999999998
Q ss_pred ccCCCCCceeeccccccCccccccccC-CCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHH--------
Q 013238 275 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-------- 345 (447)
Q Consensus 275 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 345 (447)
...... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+.....
T Consensus 172 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~----~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 172 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp ECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHHHHHCCCCHH
T ss_pred hccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH----HHHHHHHHHHhCCChHH
Confidence 764332 2233568999999998765 4689999999999999999999999953211 011111111
Q ss_pred ---HHhhc---cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 346 ---GLLKE---KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 346 ---~~~~~---~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
..... ......................+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000000000111223456889999999999999999999886
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-45 Score=345.92 Aligned_cols=258 Identities=17% Similarity=0.188 Sum_probs=194.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCceeeEe-eeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR-GFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~-~~~~~~~~~~lv~e 199 (447)
++|++.+.||+|+||+||+|.+. +|+.||||++...... ..+..|+++++.++|+|++..+ ++....+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 57999999999999999999975 6899999988654322 2477899999999887765554 45566778889999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCcEEEeecCCcccc
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKLM 276 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~ 276 (447)
|+ +++|...+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+++..
T Consensus 84 ~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 556666665433 2489999999999999999999999 9999999999999864 457999999999876
Q ss_pred CCCCC------ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhc
Q 013238 277 DYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 350 (447)
Q Consensus 277 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 350 (447)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ......+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMS- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH-HHHHHHhhcccCC-
Confidence 53322 123345699999999999999999999999999999999999999964221110 0011111111000
Q ss_pred cccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 351 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 351 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
..... +.. ..+..+.+++..||+.+|.+||++.++.+.|+.
T Consensus 235 ~~~~~-----~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 TPIEV-----LCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp SCHHH-----HTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CChhH-----hcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00000 011 123568899999999999999999999888875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=341.33 Aligned_cols=263 Identities=22% Similarity=0.295 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCceeeEeeeeecCCcceEEEe
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 199 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 199 (447)
++|++++.||+|+||+||+|++. +|+.||||+++..... .....+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57889999999999999999975 6899999999654432 335678999999999999999999999999999999999
Q ss_pred cccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCccccCCC
Q 013238 200 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 279 (447)
Q Consensus 200 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 279 (447)
++.+++|..++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999888776543 388999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccCccccccccCCC-CCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccccc----
Q 013238 280 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---- 354 (447)
Q Consensus 280 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 354 (447)
.. ......++..|+|||++.+.. ++.++|||||||++|||++|+.||... .........+..........
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC----SSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC----CCHHHHHHHHHhhcCCCChhhhhh
Confidence 32 223344788999999987665 689999999999999999999997321 11111111111111110000
Q ss_pred --ccccc---------ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 355 --QLVDS---------DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 355 --~~~d~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
...+. .............+.+++.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0001112223456788999999999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=348.15 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=202.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC----CCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCC-CceeeEeeeeecCCc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTE 193 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 193 (447)
++|++.+.||+|+||+||+|... +|+.||||.++.... ......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999863 478999999975432 2223457789999999977 899999999999999
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.+++|||+.+|+|.+++..... +.+..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999987653 67889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCC--CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
+.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||.... ................
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~----~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSE 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT----SCCCHHHHHHHHHHCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcccCC
Confidence 87654444444456699999999999765 46889999999999999999999996432 1122222222222111
Q ss_pred ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 013238 352 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 396 (447)
Q Consensus 352 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 396 (447)
...+......+.+++.+||+.||.+||| ++|+++
T Consensus 253 -----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0111223466889999999999999995 777764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-44 Score=338.01 Aligned_cols=259 Identities=15% Similarity=0.198 Sum_probs=201.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CceeeEeeeeecCCcceEEE
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 198 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 198 (447)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ..+.+|++.++.+.| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 468999999999999999999976 6899999988654322 246788899988876 89999999999999999999
Q ss_pred ecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-----CCcEEEeecCCc
Q 013238 199 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLA 273 (447)
Q Consensus 199 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~ 273 (447)
||+ +++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 81 e~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 7899998876543 489999999999999999999999 9999999999999974 578999999999
Q ss_pred cccCCCCC------ceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHH
Q 013238 274 KLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 347 (447)
Q Consensus 274 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 347 (447)
+....... .......||+.|||||++.+..++.++|||||||++|||+||+.||...... ........+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--~~~~~~~~i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch--hHHHHHHHHHhc
Confidence 87643221 1233456999999999999999999999999999999999999999642111 111111111111
Q ss_pred hhccccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 013238 348 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 400 (447)
Q Consensus 348 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 400 (447)
.......++ ... .++.+.+++..|++.+|++||+++.+.+.|+.
T Consensus 232 ~~~~~~~~l-----~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 232 KQSTPLREL-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHSCHHHH-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cCCCChHHh-----cCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111111111 111 23568889999999999999999998887765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=349.37 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=190.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecCC------
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 192 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 192 (447)
.++|+..+.||+|+||+||+|.+. +|+.||||+++.... ......+.+|+++++.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468899999999999999999975 699999999975432 233456889999999999999999999987654
Q ss_pred cceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCC
Q 013238 193 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 272 (447)
Q Consensus 193 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 272 (447)
..++||||+ +.+|..+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 66777777543 399999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhcc
Q 013238 273 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 351 (447)
Q Consensus 273 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (447)
++..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ...............
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-----HLDQLKEIMKVTGTP 238 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC-----hHHHHHHHHhccCCC
Confidence 9865432 2345689999999998764 56899999999999999999999995321 101100000000000
Q ss_pred ------------------ccccccccccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013238 352 ------------------KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 397 (447)
Q Consensus 352 ------------------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 397 (447)
...+.....+ ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 00011223457889999999999999999999973
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-44 Score=342.78 Aligned_cols=255 Identities=19% Similarity=0.253 Sum_probs=194.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecC--CcceEE
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLV 197 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 197 (447)
++|+++++||+|+||+||+|+.. +|+.||||+++... ...+.+|+++++.+. ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 57999999999999999999975 68999999996432 346889999999985 99999999998753 468899
Q ss_pred EecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-cEEEeecCCcccc
Q 013238 198 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 276 (447)
Q Consensus 198 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~ 276 (447)
||||.+++|..+.+ .+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999877642 389999999999999999999999 999999999999998655 6999999999876
Q ss_pred CCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHh-------
Q 013238 277 DYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL------- 348 (447)
Q Consensus 277 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 348 (447)
.... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.... ........+....
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~----~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH----DNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS----SHHHHHHHHHHHHCHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc----hhHHHHHHHHHHHCCchhhh
Confidence 4332 23445689999999998765 47999999999999999999999995321 1111110010000
Q ss_pred --h---cc---cccccccc--------ccCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 349 --K---EK---KLEQLVDS--------DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 349 --~---~~---~~~~~~d~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. .. ........ .............+.+++.+||+.||.+|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 00000000 0011111223456889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=341.04 Aligned_cols=259 Identities=19% Similarity=0.216 Sum_probs=187.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC------Cc
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TE 193 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 193 (447)
++|++.++||+|+||+||+|.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57899999999999999999986 699999999975433 23344688999999999999999999998643 56
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.|+|||||.++.+. .+.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 79999999765544 4422 389999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHH---------
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--------- 344 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------- 344 (447)
+..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||..... ........
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~----~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHH
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH----HHHHHHHHHhccCCCHH
Confidence 865432 233445689999999999999999999999999999999999999953210 00000000
Q ss_pred ---------HHHhhccc------cccccccccCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 345 ---------KGLLKEKK------LEQLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 345 ---------~~~~~~~~------~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
........ ........... .........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 00000001111 112345667899999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=339.20 Aligned_cols=259 Identities=21% Similarity=0.275 Sum_probs=192.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCceeeEeeeeecC-----Cc
Q 013238 121 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 193 (447)
Q Consensus 121 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 193 (447)
.++|++.+.||+|+||+||+|... +|+.||||++..... ......+.+|+++++.++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999975 699999999975433 22344688999999999999999999998643 34
Q ss_pred ceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEeecCCc
Q 013238 194 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 273 (447)
Q Consensus 194 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 273 (447)
.+++|+|+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 46777888899999998643 399999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccCccccccccCC-CCCchhhhHHHHHHHHHHHhCCCCcccccccCCCcccHHHHHHHHhhccc
Q 013238 274 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 352 (447)
Q Consensus 274 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (447)
..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.... .......+........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-----~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLVGTPG 239 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCC
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCC
Confidence 75432 22334589999999987765 46889999999999999999999995311 1111111111100000
Q ss_pred c-----------cccccc--ccCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013238 353 L-----------EQLVDS--DMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 396 (447)
Q Consensus 353 ~-----------~~~~d~--~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 396 (447)
. ...... ...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 000000 000000 0112345789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-39 Score=309.75 Aligned_cols=265 Identities=21% Similarity=0.245 Sum_probs=187.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcC-----------CCceeeEeeeee
Q 013238 122 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----------HRNLLRLRGFCM 189 (447)
Q Consensus 122 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 189 (447)
++|+++++||+|+||+||+|+.. +|+.||||+++.... ....+.+|+++++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 46899999999999999999975 699999999975432 2345677888877764 578999998875
Q ss_pred c--CCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCc--
Q 013238 190 T--PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFE-- 264 (447)
Q Consensus 190 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill~~~~~-- 264 (447)
. ....++++.++..+.......... ....+++..++.++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 4 345566777665554433333222 23348899999999999999999998 6 8999999999999986653
Q ss_pred ----EEEeecCCccccCCCCCceeeccccccCccccccccCCCCCchhhhHHHHHHHHHHHhCCCCcccccccCCCc--c
Q 013238 265 ----AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD--V 338 (447)
Q Consensus 265 ----~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltg~~p~~~~~~~~~~~--~ 338 (447)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||.......... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999999865432 234568999999999999999999999999999999999999996432111110 0
Q ss_pred cHHHHHHHHhh--------cccccccccc-----c--------------cCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 013238 339 MLLDWVKGLLK--------EKKLEQLVDS-----D--------------MEGNYIEEEVEQLIQVALLCTQGSPMERPKM 391 (447)
Q Consensus 339 ~~~~~~~~~~~--------~~~~~~~~d~-----~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 391 (447)
.+...+..+.. ........+. . ............+.+++.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 01111110000 0000000000 0 0112345667789999999999999999999
Q ss_pred HHHHH
Q 013238 392 SEVVR 396 (447)
Q Consensus 392 ~evl~ 396 (447)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.6e-24 Score=187.41 Aligned_cols=163 Identities=12% Similarity=0.050 Sum_probs=118.6
Q ss_pred CCCeeeecCCeEEEEEEECCCcEEEEEEecccccc-----------------chHHHHHHHHHHHHhcCCCceeeEeeee
Q 013238 126 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----------------GGELQFQTEVEMISMAVHRNLLRLRGFC 188 (447)
Q Consensus 126 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~niv~l~~~~ 188 (447)
+.++||+|+||+||+|...+|+.||||+++..... ........|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 45789999999999999988999999987532110 0112345688889999999998887653
Q ss_pred ecCCcceEEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCcEEEe
Q 013238 189 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 268 (447)
Q Consensus 189 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 268 (447)
..+++|||+++..+.. ++......++.|++++|+|||++ +|+||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3489999998765543 22334567899999999999999 99999999999999975 58999
Q ss_pred ecCCccccCCCCCceeeccccccCccccc-----cccCCCCCchhhhHHHHHH
Q 013238 269 DFGLAKLMDYKDTHVTTAVRGTIGHIAPE-----YLSTGKSSEKTDVFGYGVM 316 (447)
Q Consensus 269 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~sDvwSlG~i 316 (447)
|||++......... .|.... .+....|+.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 99999765422211 111110 0123567888999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=3.2e-07 Score=81.69 Aligned_cols=148 Identities=13% Similarity=0.032 Sum_probs=93.5
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCceeeEeeeeecCCcce
Q 013238 117 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 195 (447)
Q Consensus 117 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 195 (447)
+...-..|+..+..+.++.+.||+... +++.+++|+....... ....+.+|...+..+. +--+.+++.+....+..+
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 333444555444433444578999865 4566788887543221 2224667887776653 333566777777788889
Q ss_pred EEEecccCCcchhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 013238 196 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-------------------------------- 243 (447)
Q Consensus 196 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------------------------------- 243 (447)
+||++++|.++....... . ....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999988776543211 1 11223444445555555321
Q ss_pred ------------------------CCCceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 244 ------------------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 244 ------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
.+.++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=5.1e-06 Score=73.24 Aligned_cols=75 Identities=12% Similarity=0.020 Sum_probs=51.8
Q ss_pred eeecC-CeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcC--CCceeeEeeeeecCCcceEEEecccCCcc
Q 013238 130 LGRGG-FGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYPFMVNGSV 206 (447)
Q Consensus 130 lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL 206 (447)
+..|. .+.||+....++..+++|........ .+..|...++.+. .-.+.+++.++.+.+..+++|++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 36789998887888899987544322 3556777666553 23356677877788888999999988765
Q ss_pred hh
Q 013238 207 AS 208 (447)
Q Consensus 207 ~~ 208 (447)
..
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.74 E-value=5.7e-05 Score=70.92 Aligned_cols=77 Identities=9% Similarity=-0.044 Sum_probs=47.3
Q ss_pred CeeeecCCeEEEEEEECC-CcEEEEEEecccc------ccchHHHHHHHHHHHHhcC---CCceeeEeeeeecCCcceEE
Q 013238 128 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEER------TQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLV 197 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 197 (447)
+.||.|....||+....+ ++.++||.-.... ......+...|.+.+..+. ...+.+++.+ +....+++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 458999999999998754 6789999754211 1112223456777776542 2335555544 45667899
Q ss_pred EecccCCcc
Q 013238 198 YPFMVNGSV 206 (447)
Q Consensus 198 ~e~~~~gsL 206 (447)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.00089 Score=60.72 Aligned_cols=137 Identities=15% Similarity=0.106 Sum_probs=75.8
Q ss_pred CeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCce--eeEee-----eeecCCcceEEEecccCCcch
Q 013238 135 FGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL--LRLRG-----FCMTPTERLLVYPFMVNGSVA 207 (447)
Q Consensus 135 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~ 207 (447)
-..||++...+|+.+++|+.+.... ...++..|+..+..+....+ +..+. ........+.+++++.|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 4689999999999999999876533 23456778877766542222 11111 112345567889998765432
Q ss_pred hh--------------hhhc----C-CCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCC
Q 013238 208 SC--------------LRER----G-QSQPPLNWS----------------------VRKQIALGAARGLAYL-HDHCDP 245 (447)
Q Consensus 208 ~~--------------l~~~----~-~~~~~l~~~----------------------~~~~i~~~i~~~l~yL-H~~~~~ 245 (447)
.. ++.. . ......++. .....+..+...+.-+ .+....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 10 1110 0 000111111 1112222222222211 122344
Q ss_pred CceecCCCCCCEEECCCCcEEEeecCCccc
Q 013238 246 KIIHRDVKAANILLDEEFEAVVGDFGLAKL 275 (447)
Q Consensus 246 ~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 275 (447)
+++|+|+.+.|||++++ ..+.||+.+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.70 E-value=0.0038 Score=58.00 Aligned_cols=73 Identities=14% Similarity=0.183 Sum_probs=48.0
Q ss_pred CeeeecCCeEEEEEEECC--------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCce-eeEeeeeecCCcceEEE
Q 013238 128 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 198 (447)
Q Consensus 128 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 198 (447)
+.|+.|-.-.+|++...+ .+.|.+++.... .......+|..+++.+.-.++ .++++++. -.+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence 468889999999998754 245666665421 122345678888877653343 46677653 37899
Q ss_pred ecccCCcch
Q 013238 199 PFMVNGSVA 207 (447)
Q Consensus 199 e~~~~gsL~ 207 (447)
+|++|..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.55 E-value=0.013 Score=52.26 Aligned_cols=159 Identities=10% Similarity=0.026 Sum_probs=78.9
Q ss_pred cCHHHHHHHhhCCCCCCee-----eecCCeEEEEEEECCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCce--eeE
Q 013238 112 FSLRELQVATDNFSNRNIL-----GRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL--LRL 184 (447)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l 184 (447)
++.++++....+|.+.+.. ..|---+.|+.+..+|+ +++|+....... ..+..|++++..+...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH---HHHHHHHHHHHhhhhcccccccc
Confidence 4556777777778776543 35666888999887655 889988653222 134445555555532221 111
Q ss_pred ee------eeecCCcceEEEecccCCcchhh--------------hhhcCCC---C--CCCCHHH---------------
Q 013238 185 RG------FCMTPTERLLVYPFMVNGSVASC--------------LRERGQS---Q--PPLNWSV--------------- 224 (447)
Q Consensus 185 ~~------~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~~---~--~~l~~~~--------------- 224 (447)
.. +.........++.+..+...... ++..... . .......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11 01112334556666655333211 1100000 0 0000000
Q ss_pred ---HHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCcEEEeecCCcc
Q 013238 225 ---RKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 274 (447)
Q Consensus 225 ---~~~i~~~i~~~l~yLH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 274 (447)
....+..+...+.-.+. ....+++|+|+.++||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01111112222222221 123489999999999999988777899999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=88.30 E-value=0.053 Score=47.94 Aligned_cols=14 Identities=43% Similarity=0.774 Sum_probs=5.7
Q ss_pred eeeCCCCcccccCC
Q 013238 3 CRDLSNNKLTGDIP 16 (447)
Q Consensus 3 ~~~ls~N~lsG~iP 16 (447)
.||||+|+|+|.||
T Consensus 248 ~L~Ls~N~l~g~iP 261 (313)
T d1ogqa_ 248 GLDLRNNRIYGTLP 261 (313)
T ss_dssp EEECCSSCCEECCC
T ss_pred cccCccCeecccCC
Confidence 33444444444443
|